,activity_id,assay_chembl_id,assay_description,assay_type,molecule_chembl_id,relation,standard_units,standard_value,target_chembl_id,target_organism,type,units,value
0,32260,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL68920,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
1,32267,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69960,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
2,32680,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137635,=,nM,9300.0,CHEMBL203,Homo sapiens,IC50,uM,9.3
3,32770,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL306988,=,nM,500000.0,CHEMBL203,Homo sapiens,IC50,uM,500.0
4,32772,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL66879,=,nM,3000000.0,CHEMBL203,Homo sapiens,IC50,uM,3000.0
5,32780,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77085,=,nM,96000.0,CHEMBL203,Homo sapiens,IC50,uM,96.0
6,33406,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL443268,=,nM,5310.0,CHEMBL203,Homo sapiens,IC50,uM,5.31
7,34039,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76979,=,nM,264000.0,CHEMBL203,Homo sapiens,IC50,uM,264.0
8,34041,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76589,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,uM,0.125
9,34049,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76904,=,nM,35000.0,CHEMBL203,Homo sapiens,IC50,uM,35.0
10,34051,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL1009,=,nM,900000.0,CHEMBL203,Homo sapiens,IC50,uM,900.0
11,34669,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL304271,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,uM,0.00045
12,35294,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL296407,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
13,35296,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL309625,=,nM,60000.0,CHEMBL203,Homo sapiens,IC50,uM,60.0
14,35297,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77825,=,nM,600000.0,CHEMBL203,Homo sapiens,IC50,uM,600.0
15,35301,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL421877,=,nM,850000.0,CHEMBL203,Homo sapiens,IC50,uM,850.0
16,36518,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL310798,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
17,37510,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL135592,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
18,40025,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL309866,=,nM,1300000.0,CHEMBL203,Homo sapiens,IC50,uM,1300.0
19,40026,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77381,=,nM,1360000.0,CHEMBL203,Homo sapiens,IC50,uM,1360.0
20,41220,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76602,=,nM,165000.0,CHEMBL203,Homo sapiens,IC50,uM,165.0
21,41222,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77737,=,nM,250000.0,CHEMBL203,Homo sapiens,IC50,uM,250.0
22,41226,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL308134,=,nM,125000.0,CHEMBL203,Homo sapiens,IC50,uM,125.0
23,42300,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL136491,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
24,43662,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76557,=,nM,625000.0,CHEMBL203,Homo sapiens,IC50,uM,625.0
25,44685,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL336113,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
26,44690,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL133024,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
27,44695,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL344652,=,nM,13350.0,CHEMBL203,Homo sapiens,IC50,uM,13.35
28,44885,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77814,=,nM,350000.0,CHEMBL203,Homo sapiens,IC50,uM,350.0
29,44886,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL47986,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
30,45867,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL138125,=,nM,238.0,CHEMBL203,Homo sapiens,IC50,uM,0.238
31,45872,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137364,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
32,45958,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL308339,=,nM,1400000.0,CHEMBL203,Homo sapiens,IC50,uM,1400.0
33,45961,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL78174,=,nM,430000.0,CHEMBL203,Homo sapiens,IC50,uM,430.0
34,46694,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL302552,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
35,47278,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL309598,=,nM,13500.0,CHEMBL203,Homo sapiens,IC50,uM,13.5
36,47933,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL67057,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,uM,0.0045
37,48459,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL332096,=,nM,508.0,CHEMBL203,Homo sapiens,IC50,uM,0.508
38,48552,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77387,=,nM,450000.0,CHEMBL203,Homo sapiens,IC50,uM,450.0
39,49320,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL432903,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
40,49323,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69964,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
41,49326,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL65848,=,nM,1410.0,CHEMBL203,Homo sapiens,IC50,uM,1.41
42,49986,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL78184,=,nM,833000.0,CHEMBL203,Homo sapiens,IC50,uM,833.0
43,49988,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76985,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
44,49992,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL145,=,nM,1200000.0,CHEMBL203,Homo sapiens,IC50,uM,1200.0
45,50668,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69629,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,uM,0.0065
46,51141,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL136492,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4
47,51244,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77197,=,nM,1100000.0,CHEMBL203,Homo sapiens,IC50,uM,1100.0
48,51249,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL305695,=,nM,560000.0,CHEMBL203,Homo sapiens,IC50,uM,560.0
49,52474,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76587,=,nM,6500000.0,CHEMBL203,Homo sapiens,IC50,uM,6500.0
50,53212,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL66570,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
51,53758,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL308048,=,nM,800000.0,CHEMBL203,Homo sapiens,IC50,uM,800.0
52,53761,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL311119,=,nM,60000.0,CHEMBL203,Homo sapiens,IC50,uM,60.0
53,53763,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76905,=,nM,37000.0,CHEMBL203,Homo sapiens,IC50,uM,37.0
54,53765,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77524,=,nM,833000.0,CHEMBL203,Homo sapiens,IC50,uM,833.0
55,54402,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL305194,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
56,54979,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL307250,=,nM,325000.0,CHEMBL203,Homo sapiens,IC50,uM,325.0
57,54990,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL80155,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
58,56107,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
59,57335,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL52765,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
60,57444,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL311564,=,nM,450000.0,CHEMBL203,Homo sapiens,IC50,uM,450.0
61,57445,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76642,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
62,58119,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL308645,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,uM,0.0047
63,58122,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL67003,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,uM,0.0018
64,58604,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL307248,=,nM,640000.0,CHEMBL203,Homo sapiens,IC50,uM,640.0
65,60010,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL310958,=,nM,225000.0,CHEMBL203,Homo sapiens,IC50,uM,225.0
66,60019,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL78005,=,nM,350000.0,CHEMBL203,Homo sapiens,IC50,uM,350.0
67,61241,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL134312,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
68,61373,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77243,=,nM,55000.0,CHEMBL203,Homo sapiens,IC50,uM,55.0
69,61374,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL80745,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
70,61378,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77778,=,nM,450000.0,CHEMBL203,Homo sapiens,IC50,uM,450.0
71,62047,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL305246,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,uM,0.0028
72,62054,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69966,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
73,62149,CHEMBL679674,Inhibition of Epidermal growth factor receptor,B,CHEMBL47940,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
74,62715,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL57712,=,nM,1300000.0,CHEMBL203,Homo sapiens,IC50,uM,1300.0
75,62720,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77869,=,nM,200000.0,CHEMBL203,Homo sapiens,IC50,uM,200.0
76,63367,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69358,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,uM,0.0012
77,63847,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137189,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
78,63852,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137617,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
79,63857,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137027,=,nM,482.0,CHEMBL203,Homo sapiens,IC50,uM,0.482
80,64040,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL78257,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
81,64049,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL76082,=,nM,560000.0,CHEMBL203,Homo sapiens,IC50,uM,560.0
82,64050,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77595,=,nM,850000.0,CHEMBL203,Homo sapiens,IC50,uM,850.0
83,65265,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL309334,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
84,65267,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL310514,=,nM,260000.0,CHEMBL203,Homo sapiens,IC50,uM,260.0
85,66030,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL304971,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,uM,0.41
86,66033,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL69071,=,nM,5.9,CHEMBL203,Homo sapiens,IC50,uM,0.0059
87,66490,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137534,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
88,66495,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL137788,=,nM,335.0,CHEMBL203,Homo sapiens,IC50,uM,0.335
89,67606,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL424093,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
90,67808,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77030,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
91,67822,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL78150,=,nM,460000.0,CHEMBL203,Homo sapiens,IC50,uM,460.0
92,68470,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL264382,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,uM,0.0011
93,69112,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL308133,=,nM,1500000.0,CHEMBL203,Homo sapiens,IC50,uM,1500.0
94,69116,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL307179,=,nM,160000.0,CHEMBL203,Homo sapiens,IC50,uM,160.0
95,69854,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL305782,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
96,69857,CHEMBL674637,Inhibitory activity towards tyrosine phosphorylation for the epidermal growth factor-receptor kinase,B,CHEMBL308672,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
97,70342,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL133023,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
98,70559,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL310400,=,nM,375000.0,CHEMBL203,Homo sapiens,IC50,uM,375.0
99,71575,CHEMBL677833,In vitro inhibition of Epidermal growth factor receptor tyrosine kinase isolated from A431 (human carcinoma).,B,CHEMBL136674,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
100,71725,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL73820,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
101,71727,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL79064,=,nM,230000.0,CHEMBL203,Homo sapiens,IC50,uM,230.0
102,71728,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77803,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
103,71729,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL75718,=,nM,2400000.0,CHEMBL203,Homo sapiens,IC50,uM,2400.0
104,71733,CHEMBL674643,Inhibitory concentration of EGF dependent autophosphorylation of epidermal growth factor receptor kinase,B,CHEMBL77298,=,nM,153000.0,CHEMBL203,Homo sapiens,IC50,uM,153.0
105,78012,CHEMBL679949,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,B,CHEMBL432941,=,nM,8880.0,CHEMBL203,Homo sapiens,IC50,uM,8.88
106,81208,CHEMBL674698,Inhibition of Epidermal growth factor receptor,B,CHEMBL322395,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,nM,3000.0
107,84549,CHEMBL679949,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,B,CHEMBL431996,=,nM,56500.0,CHEMBL203,Homo sapiens,IC50,uM,56.5
108,98667,CHEMBL679949,Evaluated for inhibitory activity towards tyrosine kinase Epidermal growth factor receptor,B,CHEMBL86531,=,nM,29100.0,CHEMBL203,Homo sapiens,IC50,uM,29.1
109,105739,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL138691,=,nM,2282.0,CHEMBL203,Homo sapiens,IC50,nM,2282.0
110,106878,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL139307,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,nM,194.0
111,107298,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL322298,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
112,107302,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL111434,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,uM,0.67
113,107306,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL111197,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
114,107991,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL136058,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
115,107993,CHEMBL677213,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL136058,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
116,108863,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL939,=,nM,515.0,CHEMBL203,Homo sapiens,IC50,uM,0.515
117,108868,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL95320,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
118,110218,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL292323,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5
119,110480,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL545315,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
120,110482,CHEMBL677213,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL545315,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
121,111014,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL111365,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
122,111936,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL422292,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
123,112452,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL113023,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
124,113112,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL304414,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
125,113789,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL106232,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
126,113793,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL327127,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
127,114538,CHEMBL677390,Inhibition of human epidermal growth factor receptor (EGFR),B,CHEMBL293261,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
128,115581,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL267019,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
129,115912,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL285063,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
130,115915,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL136404,=,nM,7.7,CHEMBL203,Homo sapiens,IC50,nM,7.7
131,116920,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL291979,=,nM,54100.0,CHEMBL203,Homo sapiens,IC50,uM,54.1
132,116922,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL62843,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
133,117229,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL434827,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
134,117231,CHEMBL679948,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL434827,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
135,118168,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL64430,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
136,118462,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL137082,=,nM,156.0,CHEMBL203,Homo sapiens,IC50,nM,156.0
137,118835,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL324926,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
138,119381,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL62176,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
139,120872,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL138363,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
140,120875,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL93464,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
141,121735,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL31965,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,uM,0.074
142,122057,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL344486,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,nM,64.0
143,122060,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL138940,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
144,122062,CHEMBL677213,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL138940,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
145,122509,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL321193,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
146,122513,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL419022,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
147,123350,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL344177,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
148,123353,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL136178,=,nM,1039.0,CHEMBL203,Homo sapiens,IC50,nM,1039.0
149,123356,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL136511,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
150,124325,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL44,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
151,124596,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL136102,=,nM,193.0,CHEMBL203,Homo sapiens,IC50,nM,193.0
152,125063,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL104153,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
153,125565,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL95774,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
154,125676,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL268868,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
155,125800,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL7775,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
156,127175,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL61119,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
157,127736,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL50647,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
158,127740,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL320705,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
159,128847,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL113863,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
160,129395,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL553,=,nM,1450.0,CHEMBL203,Homo sapiens,IC50,uM,1.45
161,129765,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL92086,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
162,130156,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL109631,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
163,130899,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL293913,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0
164,130930,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL7914,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
165,131069,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL334801,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
166,131071,CHEMBL679948,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL334801,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
167,131445,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL325589,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
168,132037,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL99024,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
169,132094,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL59812,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
170,132359,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL434828,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,nM,77.0
171,132779,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL49596,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
172,133314,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL293250,=,nM,40500.0,CHEMBL203,Homo sapiens,IC50,uM,40.5
173,133316,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL62701,=,nM,22300.0,CHEMBL203,Homo sapiens,IC50,uM,22.3
174,133542,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL51659,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
175,133545,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL135142,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
176,133548,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL343722,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
177,133984,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL448154,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
178,135131,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL50470,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
179,135135,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL104244,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
180,135765,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL293889,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
181,136080,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL140561,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
182,136082,CHEMBL679948,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL140561,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
183,136085,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL345077,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,nM,340.0
184,136425,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL107472,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
185,137103,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL139044,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
186,137106,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL139095,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
187,137444,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL113070,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
188,137455,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL104779,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
189,138953,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL301612,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
190,139390,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL293251,=,nM,11400.0,CHEMBL203,Homo sapiens,IC50,uM,11.4
191,139395,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL60472,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
192,139594,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL342828,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
193,139596,CHEMBL677213,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL342828,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
194,139961,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL299194,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
195,140478,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL291359,=,nM,9900.0,CHEMBL203,Homo sapiens,IC50,uM,9.9
196,141071,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL109296,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
197,141079,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL111339,=,nM,480.0,CHEMBL203,Homo sapiens,IC50,uM,0.48
198,142994,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL7939,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
199,143005,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL8095,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
200,143212,CHEMBL677216,Inhibition of autophosphorylation of EGFR in A431 cells,B,CHEMBL345109,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
201,143214,CHEMBL679948,Inhibition of EGF-stimulated autophosphorylation of EGFR in A431 cells,B,CHEMBL345109,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
202,144108,CHEMBL683041,Inhibition of Epidermal Growth Factor Receptor (EGFR) autophosphorylation,B,CHEMBL607707,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083
203,144215,CHEMBL677391,Inhibition of tyrosine phosphorylation activity of the epidermal growth factor receptor (EGFR) tyrosine kinase from human A-431 carcinoma cell-shed membrane vesicles,B,CHEMBL293986,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
204,144234,CHEMBL679549,Inhibitory activity against recombinant tyrosine kinase EGF-R (EGF-R ICD),B,CHEMBL8223,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
205,144667,CHEMBL680019,Inhibitory concentration was evaluated against epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL332269,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
206,182065,CHEMBL677888,Inhibition of Epidermal growth factor receptor (Her1/ErbB1),B,CHEMBL428690,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,nM,7600.0
207,183887,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL14932,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
208,185100,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL38199,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
209,185101,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL38199,=,nM,192.0,CHEMBL203,Homo sapiens,IC50,nM,192.0
210,186628,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
211,186630,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
212,187807,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
213,189000,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL287007,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
214,189001,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL287007,=,nM,9.7,CHEMBL203,Homo sapiens,IC50,nM,9.7
215,189002,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL37346,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,nM,5500.0
216,189082,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL15346,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,nM,74.0
217,189084,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL15202,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
218,190221,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
219,191433,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL36819,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
220,191434,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL36819,=,nM,1196.0,CHEMBL203,Homo sapiens,IC50,nM,1196.0
221,191435,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL40130,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
222,191436,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL40130,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
223,191437,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL35820,=,nM,0.006,CHEMBL203,Homo sapiens,IC50,nM,0.006
224,191495,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL14627,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,nM,74.0
225,192570,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL290096,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
226,198300,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL460731,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
227,199602,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL37543,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
228,199603,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL37543,=,nM,318.0,CHEMBL203,Homo sapiens,IC50,nM,318.0
229,199604,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL287289,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
230,199605,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL287289,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
231,199646,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL514436,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
232,200768,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL39320,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nM,0.37
233,200769,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL39320,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
234,200770,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL289162,=,nM,5.1,CHEMBL203,Homo sapiens,IC50,nM,5.1
235,200771,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL289162,=,nM,1780.0,CHEMBL203,Homo sapiens,IC50,nM,1780.0
236,200875,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL14952,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
237,202120,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL37373,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
238,202121,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL37373,=,nM,145.0,CHEMBL203,Homo sapiens,IC50,nM,145.0
239,202122,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL39715,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
240,202123,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL39715,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
241,202124,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL289213,=,nM,0.72,CHEMBL203,Homo sapiens,IC50,nM,0.72
242,202125,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL289213,=,nM,584.0,CHEMBL203,Homo sapiens,IC50,nM,584.0
243,203323,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL273789,=,nM,263.0,CHEMBL203,Homo sapiens,IC50,nM,263.0
244,203325,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL517907,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
245,203329,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL460732,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
246,204578,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL540701,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
247,205655,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL287832,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
248,205656,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL287832,=,nM,262.0,CHEMBL203,Homo sapiens,IC50,nM,262.0
249,208007,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL39337,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
250,208008,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL39337,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
251,208009,CHEMBL676158,Inhibition of Epidermal growth factor receptor from human A431 carcinoma cell membranes,B,CHEMBL39337,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
252,208010,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL40734,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
253,208011,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL40734,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
254,208012,CHEMBL676158,Inhibition of Epidermal growth factor receptor from human A431 carcinoma cell membranes,B,CHEMBL40734,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
255,209193,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL39811,=,nM,7.5,CHEMBL203,Homo sapiens,IC50,nM,7.5
256,209194,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL39811,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
257,210398,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL36727,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
258,210399,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL36727,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
259,210400,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL39355,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
260,210401,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL39355,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,nM,77.0
261,210448,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL493428,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
262,214991,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL289959,=,nM,346.0,CHEMBL203,Homo sapiens,IC50,nM,346.0
263,216291,CHEMBL674106,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL14874,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,nM,830.0
264,218693,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL416611,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
265,218694,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL416611,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,nM,49.0
266,219940,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL36967,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,nM,4.8
267,219941,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL36967,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
268,220991,CHEMBL677389,Inhibition of the phosphorylation of a random polyglutamic acid/tyrosine copolymer by human epidermal growth factor receptor(EGFR) prepared from human A431 carcinoma cells,B,CHEMBL36164,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
269,220992,CHEMBL676156,Inhibition of autophosphorylation of epidermal growth factor receptor prepared from human A431 carcinoma cells.,B,CHEMBL36164,=,nM,135.0,CHEMBL203,Homo sapiens,IC50,nM,135.0
270,224609,CHEMBL873605,Inhibition of Epidermal growth factor receptor,B,CHEMBL428690,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
271,244114,CHEMBL873605,Inhibition of Epidermal growth factor receptor,B,CHEMBL1242973,=,nM,590000.0,CHEMBL203,Homo sapiens,IC50,uM,590.0
272,257864,CHEMBL873605,Inhibition of Epidermal growth factor receptor,B,CHEMBL280074,=,nM,440000.0,CHEMBL203,Homo sapiens,IC50,uM,440.0
273,265169,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338448,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
274,266495,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL131715,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
275,266500,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL435809,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
276,271226,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL57323,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61
277,271231,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL57347,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
278,271238,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL75188,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
279,271592,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL131020,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
280,271596,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL131590,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
281,272862,CHEMBL680015,Inhibition of EGFR,B,CHEMBL160846,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
282,273532,CHEMBL675520,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cell membranes,B,CHEMBL26001,=,nM,250000.0,CHEMBL203,Homo sapiens,IC50,uM,250.0
283,274013,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL444337,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
284,274082,CHEMBL680015,Inhibition of EGFR,B,CHEMBL422347,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,uM,0.082
285,275168,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL131426,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
286,275243,CHEMBL680015,Inhibition of EGFR,B,CHEMBL160303,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
287,276578,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338935,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
288,276643,CHEMBL680015,Inhibition of EGFR,B,CHEMBL269620,=,nM,540.0,CHEMBL203,Homo sapiens,IC50,uM,0.54
289,277772,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL335012,=,nM,8180.0,CHEMBL203,Homo sapiens,IC50,uM,8.18
290,278588,CHEMBL675380,Inhibition of epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL76599,=,nM,5530.0,CHEMBL203,Homo sapiens,IC50,uM,5.53
291,278593,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL299026,=,nM,6200.0,CHEMBL203,Homo sapiens,IC50,uM,6.2
292,280104,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL132348,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
293,280108,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL132169,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
294,281325,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL335648,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
295,283629,CHEMBL680015,Inhibition of EGFR,B,CHEMBL155761,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
296,284487,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL45827,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
297,284859,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL335718,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
298,284863,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL130163,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
299,284868,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL335932,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
300,284872,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL336192,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
301,284919,CHEMBL680015,Inhibition of EGFR,B,CHEMBL157084,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
302,285883,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL388978,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
303,285888,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL129946,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
304,285893,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL337027,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
305,285899,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338449,=,nM,13500.0,CHEMBL203,Homo sapiens,IC50,uM,13.5
306,287115,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL130049,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
307,288014,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL56236,=,nM,6680.0,CHEMBL203,Homo sapiens,IC50,uM,6.68
308,288447,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL335931,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
309,288457,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL337026,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
310,289639,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL340611,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
311,294648,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338944,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
312,295509,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL57366,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
313,295884,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL337297,=,nM,8180.0,CHEMBL203,Homo sapiens,IC50,uM,8.18
314,295888,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338049,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
315,296902,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL432738,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36
316,297281,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL131193,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
317,299857,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL337035,=,nM,12500.0,CHEMBL203,Homo sapiens,IC50,uM,12.5
318,301082,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL338155,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
319,301871,CHEMBL675521,Inhibition of Epidermal growth factor receptor (EGFr) tyrosine kinase,B,CHEMBL301483,=,nM,1260.0,CHEMBL203,Homo sapiens,IC50,uM,1.26
320,302246,CHEMBL677890,Inhibitory activity against protein tyrosine kinase of Epidermal growth factor receptor was determined,B,CHEMBL130208,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
321,307859,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL2448064,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
322,309317,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL25579,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
323,309326,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL24026,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
324,313559,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL135861,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,uM,13.0
325,314572,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL428534,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
326,316940,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL281872,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
327,316968,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL281990,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
328,316975,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL422758,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
329,316982,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL25450,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
330,316989,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1907763,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
331,316996,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL24137,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
332,317294,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL263666,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
333,318309,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL24828,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
334,321871,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1744349,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
335,321879,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL24979,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
336,321888,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL2448065,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
337,322969,CHEMBL679946,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,B,CHEMBL63356,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
338,323343,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1907764,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
339,324429,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL283088,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
340,324436,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL2448067,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
341,325575,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1202477,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
342,326805,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL416191,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
343,327901,CHEMBL679946,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,B,CHEMBL67027,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
344,328342,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL533849,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
345,328373,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1907944,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
346,328640,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL336409,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
347,329898,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL342929,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
348,329906,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL135577,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
349,330836,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1744347,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,uM,0.075
350,331168,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL334915,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
351,332171,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL25610,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
352,332492,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL137422,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
353,333903,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL336174,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
354,334917,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL26641,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
355,335194,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL334439,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
356,335761,CHEMBL679946,Concentration required to inhibit phosphorylation of isolated human epidermal growth factor tyrosine kinase receptor by 50%,B,CHEMBL66101,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
357,337412,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL279459,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
358,338669,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1202473,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
359,338676,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL25425,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
360,340148,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL286160,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
361,340163,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL2448066,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
362,340430,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL336409,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
363,342469,CHEMBL677388,Inhibition of epidermal growth factor receptor kinase activity at a concentration of 2 uM of ATP,B,CHEMBL1202478,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
364,345343,CHEMBL677206,Inhibition of epidermal growth factor receptor (EGFr),B,CHEMBL336410,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
365,346388,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113996,=,nM,13570.0,CHEMBL203,Homo sapiens,IC50,uM,13.57
366,347654,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL607707,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
367,347659,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL325156,=,nM,4840.0,CHEMBL203,Homo sapiens,IC50,uM,4.84
368,348082,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126384,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
369,348083,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL129509,=,nM,9.3,CHEMBL203,Homo sapiens,IC50,nM,9.3
370,351746,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL114593,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
371,352154,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126137,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
372,352155,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL128987,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
373,352156,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL128987,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
374,352157,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL435993,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
375,352158,CHEMBL677386,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL340898,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
376,352160,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL338215,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
377,353187,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL116857,=,nM,2880.0,CHEMBL203,Homo sapiens,IC50,uM,2.88
378,353631,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL340484,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
379,353632,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL127058,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
380,353633,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL128467,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
381,354789,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL326280,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
382,354794,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL117326,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
383,355097,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL340700,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
384,355098,CHEMBL677386,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL338114,=,nM,0.91,CHEMBL203,Homo sapiens,IC50,nM,0.91
385,356555,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL341319,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
386,356556,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL340508,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
387,357623,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL115440,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
388,357628,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL29197,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
389,359002,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL285063,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
390,359320,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL127041,=,nM,0.24,CHEMBL203,Homo sapiens,IC50,nM,0.24
391,360394,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL116012,=,nM,10320.0,CHEMBL203,Homo sapiens,IC50,uM,10.32
392,360720,CHEMBL677386,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL126791,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
393,360722,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL54400,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
394,360723,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL54400,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
395,360724,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL128468,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
396,360725,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL341522,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
397,361550,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL111038,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
398,361830,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL339416,=,nM,0.74,CHEMBL203,Homo sapiens,IC50,nM,0.74
399,362975,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL30973,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
400,362980,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113985,=,nM,5390.0,CHEMBL203,Homo sapiens,IC50,uM,5.39
401,364684,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL327023,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
402,366137,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL115187,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
403,366476,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL92812,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
404,367543,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL283682,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
405,367856,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL129825,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
406,367865,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL420624,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
407,368896,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL332497,=,nM,3830.0,CHEMBL203,Homo sapiens,IC50,uM,3.83
408,368901,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL421047,=,nM,2640.0,CHEMBL203,Homo sapiens,IC50,uM,2.64
409,368906,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113901,=,nM,5220.0,CHEMBL203,Homo sapiens,IC50,uM,5.22
410,368911,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL281300,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
411,369171,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL129579,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,nM,4.8
412,369172,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126893,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
413,369173,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL127082,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
414,370697,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL128759,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
415,374988,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126372,=,nM,0.92,CHEMBL203,Homo sapiens,IC50,nM,0.92
416,374989,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL126372,=,nM,227.0,CHEMBL203,Homo sapiens,IC50,nM,227.0
417,375981,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL157128,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
418,375986,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL116853,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
419,375991,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL114728,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
420,375996,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL326811,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62
421,376356,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL53428,=,nM,0.09,CHEMBL203,Homo sapiens,IC50,nM,0.09
422,376357,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL53428,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
423,376358,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL125568,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
424,376359,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL129824,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
425,377315,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL114073,=,nM,10590.0,CHEMBL203,Homo sapiens,IC50,uM,10.59
426,379120,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL128432,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
427,380164,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL116525,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
428,380169,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL323630,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
429,381554,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL424252,=,nM,1910.0,CHEMBL203,Homo sapiens,IC50,uM,1.91
430,381559,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL324718,=,nM,810.0,CHEMBL203,Homo sapiens,IC50,uM,0.81
431,383110,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL114490,=,nM,2320.0,CHEMBL203,Homo sapiens,IC50,uM,2.32
432,383115,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113902,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
433,383120,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL114392,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
434,383125,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL94061,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
435,383411,CHEMBL677386,Inhibition of epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL340399,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
436,383413,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL52076,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
437,383414,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL52076,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
438,384687,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL127611,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
439,385794,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL113900,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
440,385799,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL118000,=,nM,2290.0,CHEMBL203,Homo sapiens,IC50,uM,2.29
441,386241,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126623,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
442,386242,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL126623,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
443,386249,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL126903,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
444,387974,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL127086,=,nM,0.61,CHEMBL203,Homo sapiens,IC50,nM,0.61
445,387975,CHEMBL673451,Inhibition of epidermal growth factor receptor (EGFR) autophosphorylation in A431 cells,B,CHEMBL127086,=,nM,11400.0,CHEMBL203,Homo sapiens,IC50,nM,11400.0
446,389022,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL263788,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
447,389440,CHEMBL677387,Inhibition of phosphorylation of polyglutamic acid/tyrosine random copolymer by epidermal growth factor receptor.,B,CHEMBL338175,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
448,390356,CHEMBL680028,Inhibition of autophosphorylation of cytoplasmic domain of epidermal growth factor receptor,B,CHEMBL414631,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
449,391087,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL355330,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
450,392440,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL170724,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
451,393597,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL168550,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
452,393852,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153525,=,nM,1.24,CHEMBL203,Homo sapiens,IC50,nM,1.24
453,393853,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL3085277,=,nM,538.0,CHEMBL203,Homo sapiens,IC50,nM,538.0
454,393859,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL152905,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
455,393860,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL152905,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,nM,86.0
456,394821,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL168555,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7
457,394825,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL168382,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,uM,0.46
458,394829,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL168285,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
459,394833,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL352801,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,uM,0.42
460,395224,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
461,396600,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL448730,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,nM,4100.0
462,396601,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL544867,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
463,396602,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL538814,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
464,397800,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL542755,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
465,400160,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL53753,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
466,400161,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153206,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
467,400162,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL153206,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
468,400167,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL346846,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
469,401413,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL169467,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
470,401417,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL168266,=,nM,2820.0,CHEMBL203,Homo sapiens,IC50,uM,2.82
471,401724,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153739,=,nM,19.8,CHEMBL203,Homo sapiens,IC50,nM,19.8
472,404127,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL354310,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
473,404725,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL152984,=,nM,742.0,CHEMBL203,Homo sapiens,IC50,nM,742.0
474,404726,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL152984,=,nM,769.0,CHEMBL203,Homo sapiens,IC50,nM,769.0
475,405888,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL544640,=,nM,2110.0,CHEMBL203,Homo sapiens,IC50,nM,2110.0
476,405889,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL150280,=,nM,264.0,CHEMBL203,Homo sapiens,IC50,nM,264.0
477,405890,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL553351,=,nM,12.3,CHEMBL203,Homo sapiens,IC50,nM,12.3
478,407148,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL423224,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
479,407149,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL423224,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,nM,630.0
480,407150,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL347282,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
481,409490,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL357097,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
482,409491,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL346863,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
483,410436,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL169570,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
484,410710,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL415738,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
485,410711,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153409,=,nM,732.0,CHEMBL203,Homo sapiens,IC50,nM,732.0
486,411591,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL171256,=,nM,14400.0,CHEMBL203,Homo sapiens,IC50,uM,14.4
487,411983,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL329672,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
488,412827,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL166765,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
489,414368,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL553137,=,nM,132.0,CHEMBL203,Homo sapiens,IC50,nM,132.0
490,415280,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL169390,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
491,415681,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL40734,=,nM,0.39,CHEMBL203,Homo sapiens,IC50,nM,0.39
492,416872,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153170,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
493,418071,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL355982,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
494,418072,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL345988,=,nM,147.0,CHEMBL203,Homo sapiens,IC50,nM,147.0
495,418073,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL345988,=,nM,493.0,CHEMBL203,Homo sapiens,IC50,nM,493.0
496,418074,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153518,=,nM,4270.0,CHEMBL203,Homo sapiens,IC50,nM,4270.0
497,418075,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL544868,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
498,418892,CHEMBL674026,Inhibition of EGFR kinase,B,CHEMBL97162,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
499,419114,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL345294,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
500,419115,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL2093928,=,nM,419.0,CHEMBL203,Homo sapiens,IC50,nM,419.0
501,419116,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL155278,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
502,419117,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL155278,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
503,419123,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL149512,=,nM,740.0,CHEMBL203,Homo sapiens,IC50,nM,740.0
504,420076,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL170438,=,nM,13200.0,CHEMBL203,Homo sapiens,IC50,uM,13.2
505,421928,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL539822,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
506,421929,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL540082,=,nM,158.0,CHEMBL203,Homo sapiens,IC50,nM,158.0
507,423336,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL356850,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
508,423337,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL356850,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
509,423343,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL357367,=,nM,9.4,CHEMBL203,Homo sapiens,IC50,nM,9.4
510,423344,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL151593,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
511,424483,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153419,=,nM,191.0,CHEMBL203,Homo sapiens,IC50,nM,191.0
512,424488,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL153573,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
513,424489,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL153573,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
514,424490,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL357570,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
515,424491,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL357570,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
516,425439,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL352954,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
517,425685,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL554983,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
518,425686,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL554983,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
519,425687,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL358934,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
520,425688,CHEMBL677214,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 cells,B,CHEMBL358934,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
521,426708,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL355191,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
522,427152,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL540590,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
523,427153,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL544865,=,nM,444.0,CHEMBL203,Homo sapiens,IC50,nM,444.0
524,428391,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL66031,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
525,428392,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL39337,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
526,428393,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL555921,=,nM,12.6,CHEMBL203,Homo sapiens,IC50,nM,12.6
527,430514,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL171311,=,nM,440.0,CHEMBL203,Homo sapiens,IC50,uM,0.44
528,430518,CHEMBL674693,Inhibition of Epidermal growth factor receptor (EGF-R) tyrosine kinase activity ,B,CHEMBL166766,=,nM,730.0,CHEMBL203,Homo sapiens,IC50,uM,0.73
529,430775,CHEMBL679944,Concentration needed to inhibit the phosphorylation of a 14-residue fragment of phospholipase C-gamma1 by Epidermal growth factor receptor (prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography),B,CHEMBL155100,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0
530,431817,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169780,=,nM,2540.0,CHEMBL203,Homo sapiens,IC50,uM,2.54
531,431823,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL355269,=,nM,750.0,CHEMBL203,Homo sapiens,IC50,uM,0.75
532,434419,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169200,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
533,435724,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL168829,=,nM,13400.0,CHEMBL203,Homo sapiens,IC50,uM,13.4
534,436946,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL262276,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
535,438300,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169920,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
536,440871,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL408683,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
537,442379,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL355891,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83
538,445004,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL168661,=,nM,295.0,CHEMBL203,Homo sapiens,IC50,uM,0.295
539,451559,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL355019,=,nM,740.0,CHEMBL203,Homo sapiens,IC50,uM,0.74
540,454181,CHEMBL677879,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL172514,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
541,454187,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL354033,=,nM,2670.0,CHEMBL203,Homo sapiens,IC50,uM,2.67
542,454191,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL355322,=,nM,440.0,CHEMBL203,Homo sapiens,IC50,uM,0.44
543,455583,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169519,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,uM,1.12
544,458336,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL263528,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
545,460720,CHEMBL677879,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL274732,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
546,460725,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL171545,=,nM,1530.0,CHEMBL203,Homo sapiens,IC50,uM,1.53
547,462007,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169064,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
548,463211,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL168921,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
549,465873,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL169065,=,nM,1470.0,CHEMBL203,Homo sapiens,IC50,uM,1.47
550,468916,CHEMBL672267,Inhibition of EGF receptor kinase,B,CHEMBL10,=,nM,96000.0,CHEMBL203,Homo sapiens,IC50,nM,96000.0
551,469967,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL353823,=,nM,8300.0,CHEMBL203,Homo sapiens,IC50,uM,8.3
552,469970,CHEMBL677878,Concentration required for inhibition of epidermal growth factor receptor (EGF-R) by tyrosine kinase enzyme activity,B,CHEMBL168656,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
553,476108,CHEMBL674700,Inhibition of Epidermal growth factor receptor (EGFr),B,CHEMBL113185,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,nM,5100.0
554,479781,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL543661,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
555,479831,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL545541,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
556,479833,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL541586,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
557,481121,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL540068,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
558,481537,CHEMBL677382,Inhibition of epidermal growth factor receptor,B,CHEMBL301483,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
559,485904,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL135853,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
560,485981,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL544833,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
561,487116,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL555201,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
562,488289,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL542484,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
563,490584,CHEMBL674700,Inhibition of Epidermal growth factor receptor (EGFr),B,CHEMBL322066,=,nM,1704.0,CHEMBL203,Homo sapiens,IC50,nM,1704.0
564,490968,CHEMBL677382,Inhibition of epidermal growth factor receptor,B,CHEMBL56983,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
565,491827,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL543669,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
566,495295,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL135902,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
567,497488,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL543904,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
568,497534,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL555797,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
569,500329,CHEMBL677382,Inhibition of epidermal growth factor receptor,B,CHEMBL57347,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
570,502540,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL542729,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
571,502776,CHEMBL677382,Inhibition of epidermal growth factor receptor,B,CHEMBL45827,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
572,509788,CHEMBL676161,"Inhibition of Epidermal growth factor receptor autophosphorylation, 0.05-0.10",B,CHEMBL555321,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
573,509882,CHEMBL676160,Inhibition of Epidermal growth factor receptor autophosphorylation.,B,CHEMBL542733,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
574,512206,CHEMBL674105,Inhibitory activity against HER1 kinase,B,CHEMBL131577,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
575,515465,CHEMBL674692,Inhibition of Epidermal growth factor receptor,B,CHEMBL48614,=,nM,1680.0,CHEMBL203,Homo sapiens,IC50,uM,1.68
576,516673,CHEMBL674692,Inhibition of Epidermal growth factor receptor,B,CHEMBL418203,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
577,548235,CHEMBL677830,Inhibitory activity against Epidermal growth factor receptor,B,CHEMBL150177,=,nM,84800.0,CHEMBL203,Homo sapiens,IC50,uM,84.8
578,553697,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56505,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
579,553703,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56802,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
580,554936,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL57990,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
581,556042,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL55794,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
582,558511,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL294395,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
583,561023,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7699,=,nM,58800.0,CHEMBL203,Homo sapiens,IC50,uM,58.8
584,563458,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL44,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
585,564328,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL301018,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
586,564386,CHEMBL674638,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,B,CHEMBL112925,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
587,564601,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7917,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
588,564605,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7917,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
589,565025,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL281467,=,nM,374.8,CHEMBL203,Homo sapiens,IC50,nM,374.8
590,565026,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL281467,=,nM,975.7,CHEMBL203,Homo sapiens,IC50,nM,975.7
591,565415,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL299672,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
592,565419,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL1788321,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
593,565745,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7827,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,uM,0.095
594,565749,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7827,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
595,566667,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56936,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
596,566671,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL60826,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
597,566924,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL440453,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
598,566928,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL440453,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
599,567342,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL31876,=,nM,330.2,CHEMBL203,Homo sapiens,IC50,nM,330.2
600,567343,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL31876,=,nM,1027.8,CHEMBL203,Homo sapiens,IC50,nM,1027.8
601,569181,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL14699,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
602,570012,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL281300,=,nM,9.7,CHEMBL203,Homo sapiens,IC50,nM,9.7
603,570013,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL281300,=,nM,86.9,CHEMBL203,Homo sapiens,IC50,nM,86.9
604,570519,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56912,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
605,570522,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL55425,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
606,570882,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7810,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
607,570883,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7810,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
608,571312,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL31276,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
609,571313,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL31276,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
610,571782,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56027,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,uM,0.069
611,571786,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL294034,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
612,571790,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL939,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
613,572076,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7981,=,nM,500000.0,CHEMBL203,Homo sapiens,IC50,uM,500.0
614,572080,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7866,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
615,572084,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7866,=,nM,12500.0,CHEMBL203,Homo sapiens,IC50,uM,12.5
616,572503,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL31745,=,nM,6266.2,CHEMBL203,Homo sapiens,IC50,nM,6266.2
617,572505,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL283682,=,nM,258.9,CHEMBL203,Homo sapiens,IC50,nM,258.9
618,572507,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL30973,=,nM,37.2,CHEMBL203,Homo sapiens,IC50,nM,37.2
619,572508,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL30973,=,nM,122.9,CHEMBL203,Homo sapiens,IC50,nM,122.9
620,573018,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL293090,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
621,573022,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56142,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
622,574894,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL287022,=,nM,3762.4,CHEMBL203,Homo sapiens,IC50,nM,3762.4
623,574895,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL287022,=,nM,6794.8,CHEMBL203,Homo sapiens,IC50,nM,6794.8
624,576663,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL293064,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,uM,0.093
625,577891,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56502,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
626,578009,CHEMBL674638,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,B,CHEMBL432416,=,nM,14100.0,CHEMBL203,Homo sapiens,IC50,uM,14.1
627,578203,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7819,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
628,578207,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL7819,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
629,581417,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL291514,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
630,582197,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL441518,=,nM,2043.6,CHEMBL203,Homo sapiens,IC50,nM,2043.6
631,582198,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL441518,=,nM,4128.6,CHEMBL203,Homo sapiens,IC50,nM,4128.6
632,582599,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL1744086,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,uM,0.095
633,583983,CHEMBL674638,Inhibition of in vitro activity of EGFr enzyme from A431 cells in presence of 5 uM ATP,B,CHEMBL325949,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
634,584258,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL7339,=,nM,1270.0,CHEMBL203,Homo sapiens,IC50,uM,1.27
635,585212,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL57759,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
636,586007,CHEMBL677385,Inhibition of peptide substrate phosphorylation by epidermal growth factor receptor,B,CHEMBL607707,=,nM,14.5,CHEMBL203,Homo sapiens,IC50,nM,14.5
637,586008,CHEMBL677384,Inhibition of epidermal growth factor receptor kinase autophosphorylation,B,CHEMBL607707,=,nM,97.6,CHEMBL203,Homo sapiens,IC50,nM,97.6
638,586420,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL300791,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
639,586424,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL57892,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
640,586428,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL57758,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,uM,0.087
641,586432,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL56266,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
642,587976,CHEMBL677887,Inhibition of Epidermal growth factor receptor,B,CHEMBL266995,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
643,587980,CHEMBL677889,Inhibition of Epidermal growth factor receptor-dependent phosphorylation,B,CHEMBL266995,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
644,588965,CHEMBL677210,In vitro inhibitory activity against Epidermal growth factor receptor (EGFR-TK) from A431 vulval squamous carcinoma cells using TKI assay,B,CHEMBL299893,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
645,592926,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL347668,=,nM,8500.0,CHEMBL203,Homo sapiens,IC50,uM,8.5
646,593023,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL541307,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
647,594123,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL348146,=,nM,28000.0,CHEMBL203,Homo sapiens,IC50,uM,28.0
648,594151,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL79704,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
649,595392,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL538757,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
650,596823,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL422531,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
651,596828,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL538507,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
652,598022,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL154969,=,nM,68000.0,CHEMBL203,Homo sapiens,IC50,uM,68.0
653,598045,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL552859,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
654,600251,CHEMBL843057,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL414013,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
655,601795,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL544074,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
656,602962,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL154260,=,nM,24000.0,CHEMBL203,Homo sapiens,IC50,uM,24.0
657,602964,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL346716,=,nM,51000.0,CHEMBL203,Homo sapiens,IC50,uM,51.0
658,604364,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL545006,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
659,605594,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL542891,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
660,606673,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL336174,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
661,606738,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL544538,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
662,607960,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL348116,=,nM,32000.0,CHEMBL203,Homo sapiens,IC50,uM,32.0
663,607986,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL80030,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
664,609155,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL157952,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
665,609156,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL156555,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
666,609241,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL44,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
667,612771,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL543361,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
668,613919,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL155607,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
669,615479,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL543600,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
670,618171,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL155389,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
671,618205,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL345203,=,nM,9400.0,CHEMBL203,Homo sapiens,IC50,uM,9.4
672,618238,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL78249,=,nM,70000.0,CHEMBL203,Homo sapiens,IC50,uM,70.0
673,620606,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL544770,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
674,621696,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL435831,=,nM,38000.0,CHEMBL203,Homo sapiens,IC50,uM,38.0
675,621730,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL542893,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
676,621736,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL540292,=,nM,7300.0,CHEMBL203,Homo sapiens,IC50,uM,7.3
677,622992,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL154080,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0
678,622994,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL155293,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
679,623061,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL544067,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
680,624259,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL293261,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
681,624335,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL468975,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
682,625510,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL158119,=,nM,89000.0,CHEMBL203,Homo sapiens,IC50,uM,89.0
683,625511,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL156797,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
684,625572,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL542887,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,uM,0.67
685,625578,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL552634,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
686,626714,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL154911,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
687,626777,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL157304,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
688,626778,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL157021,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0
689,628127,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL552860,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,uM,0.36
690,629452,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL79808,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
691,629480,CHEMBL677209,In vitro inhibition of the Epidermal growth factor receptor activity in A431 membranes,B,CHEMBL310580,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
692,630618,CHEMBL673450,Inhibition of the tyrosine kinase activity of the human epidermal growth factor receptor (EGFR),B,CHEMBL154822,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
693,631689,CHEMBL843057,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL6976,=,nM,160000.0,CHEMBL203,Homo sapiens,IC50,uM,160.0
694,634376,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144791,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
695,634377,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144791,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
696,634379,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL279138,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
697,634380,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL279138,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
698,634382,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL67535,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
699,634383,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL67535,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
700,635471,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL59150,=,nM,820000.0,CHEMBL203,Homo sapiens,IC50,uM,820.0
701,635570,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144770,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
702,635571,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144770,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
703,639238,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144159,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
704,639239,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144159,=,nM,10300.0,CHEMBL203,Homo sapiens,IC50,uM,10.3
705,640364,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144760,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
706,640365,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144760,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
707,641520,CHEMBL675238,Inhibition of EGF receptor,B,CHEMBL30432,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
708,641694,CHEMBL676154,Inhibition of Epidermal growth factor receptor tyrosine kinase,B,CHEMBL87084,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
709,645294,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144589,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
710,645295,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144589,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
711,645297,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL296407,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
712,645298,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL296407,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
713,646400,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL56393,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
714,646401,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL56393,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
715,648855,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL424302,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
716,649951,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL356324,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
717,649952,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL356324,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
718,651199,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL358494,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
719,651200,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL358494,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
720,652428,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL145266,=,nM,112000.0,CHEMBL203,Homo sapiens,IC50,uM,112.0
721,652429,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL145266,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
722,654747,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL357400,=,nM,102000.0,CHEMBL203,Homo sapiens,IC50,uM,102.0
723,654749,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL358746,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
724,654750,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL358746,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
725,658419,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144778,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
726,658420,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144778,=,nM,13500.0,CHEMBL203,Homo sapiens,IC50,uM,13.5
727,658422,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144908,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
728,658423,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144908,=,nM,113000.0,CHEMBL203,Homo sapiens,IC50,uM,113.0
729,660828,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL342792,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
730,660831,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL76904,=,nM,35000.0,CHEMBL203,Homo sapiens,IC50,uM,35.0
731,664702,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL144842,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
732,664703,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL144842,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
733,667171,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL343887,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
734,667172,CHEMBL679672,Inhibitory activity of compound against Epidermal growth factor receptor autophosphorylation,B,CHEMBL343887,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
735,667174,CHEMBL677831,"Inhibition of epidermal growth factor receptor (EGFR) phosphorylation of the exogenous substrate poly(Glu6, Ala3,Tyr) (polyGAT)",B,CHEMBL357161,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
736,672816,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL76432,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
737,674226,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL312818,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
738,674229,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL311111,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,uM,1.25
739,675130,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL53898,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
740,675593,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL80540,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
741,678269,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL312753,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
742,678271,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL80809,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
743,680623,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL312818,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
744,683569,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL310740,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
745,685057,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL308498,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
746,685060,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL78018,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
747,685998,CHEMBL674103,Inhibition of Epidermal growth factor receptor,B,CHEMBL327725,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0
748,689127,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL421326,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
749,689130,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL79060,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
750,690013,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL440298,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
751,691253,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL56731,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,uM,1.25
752,692413,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL56543,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
753,692855,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL79206,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
754,694027,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL76751,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
755,694029,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL311109,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
756,694287,CHEMBL674699,Inhibition of Epidermal growth factor receptor,B,CHEMBL47660,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
757,695402,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL312482,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
758,695860,CHEMBL674699,Inhibition of Epidermal growth factor receptor,B,CHEMBL296407,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
759,696922,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL79215,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
760,696924,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL431977,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
761,697275,CHEMBL674699,Inhibition of Epidermal growth factor receptor,B,CHEMBL47986,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
762,698441,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL81712,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
763,698443,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL310853,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
764,699509,CHEMBL674104,Inhibition of Epidermal growth factor receptor autophosphorylation,B,CHEMBL293749,<,nM,625.0,CHEMBL203,Homo sapiens,IC50,uM,0.625
765,699834,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL80302,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
766,701050,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL310827,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
767,701052,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL81375,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
768,701055,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL77342,=,nM,657.0,CHEMBL203,Homo sapiens,IC50,uM,0.657
769,702349,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL308498,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
770,703660,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL77782,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
771,703662,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL78700,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
772,704940,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL76432,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
773,704942,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL306732,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
774,704944,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL418909,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
775,706262,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL78685,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
776,706264,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL77452,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
777,707893,CHEMBL674699,Inhibition of Epidermal growth factor receptor,B,CHEMBL46946,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
778,708836,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL442749,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
779,708840,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL80164,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
780,710213,CHEMBL674107,Inhibitory activity against epidermal growth factor receptor,B,CHEMBL76751,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
781,715862,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL174634,=,nM,2650.0,CHEMBL203,Homo sapiens,IC50,uM,2.65
782,715867,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL429057,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
783,717180,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL176702,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
784,717675,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL161956,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
785,718312,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL367442,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
786,718933,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL351629,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
787,718935,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165731,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
788,720032,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL53711,=,nM,0.006,CHEMBL203,Homo sapiens,IC50,nM,0.006
789,720034,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165228,=,nM,117.0,CHEMBL203,Homo sapiens,IC50,nM,117.0
790,720612,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL176705,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
791,720617,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL176470,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
792,722125,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL166255,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
793,722128,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165630,=,nM,0.93,CHEMBL203,Homo sapiens,IC50,nM,0.93
794,722683,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL176309,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
795,723305,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165495,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
796,724536,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL163369,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
797,725109,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL369014,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
798,725650,CHEMBL676074,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL53753,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
799,726661,CHEMBL677212,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL13629,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
800,726940,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL166307,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
801,726943,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162223,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
802,727654,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL172973,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
803,727663,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL173453,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
804,728236,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162719,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
805,729369,CHEMBL676233,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL162821,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
806,729938,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL105436,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
807,729944,CHEMBL674012,Tested for inhibition of EGF-receptor tyrosine kinase in intact cells,B,CHEMBL105436,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
808,730448,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162053,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
809,730451,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165574,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
810,732757,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL53940,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
811,732758,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165788,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
812,734069,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL166093,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
813,735251,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL349070,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
814,735998,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL175409,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
815,736015,CHEMBL674025,Inhibition of EGFR kinase,B,CHEMBL22978,=,nM,797.0,CHEMBL203,Homo sapiens,IC50,uM,0.797
816,736586,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162142,=,nM,0.78,CHEMBL203,Homo sapiens,IC50,nM,0.78
817,738031,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165508,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
818,738048,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165547,=,nM,0.56,CHEMBL203,Homo sapiens,IC50,nM,0.56
819,739223,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL165864,=,nM,0.19,CHEMBL203,Homo sapiens,IC50,nM,0.19
820,740166,CHEMBL677212,Inhibition of epidermal growth factor receptor (EGF-R),B,CHEMBL13983,=,nM,,CHEMBL203,Homo sapiens,IC50,uM,
821,740499,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL161895,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
822,740501,CHEMBL676233,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL433520,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
823,740505,CHEMBL673924,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL433520,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,uM,0.0046
824,741235,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL176815,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
825,741240,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL424375,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
826,741246,CHEMBL674012,Tested for inhibition of EGF-receptor tyrosine kinase in intact cells,B,CHEMBL424375,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
827,742603,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL366831,=,nM,31000.0,CHEMBL203,Homo sapiens,IC50,uM,31.0
828,742608,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL173478,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
829,742614,CHEMBL674012,Tested for inhibition of EGF-receptor tyrosine kinase in intact cells,B,CHEMBL173478,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
830,743244,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL355816,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
831,743245,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL166154,=,nM,0.19,CHEMBL203,Homo sapiens,IC50,nM,0.19
832,743247,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL163188,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
833,744557,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL163168,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
834,746477,CHEMBL674015,Tested in vitro for inhibition of EGF-receptor tyrosine kinase,B,CHEMBL169757,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
835,746483,CHEMBL674012,Tested for inhibition of EGF-receptor tyrosine kinase in intact cells,B,CHEMBL169757,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
836,747072,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162508,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
837,747076,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL166358,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
838,748418,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162981,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
839,749597,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL51853,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
840,752015,CHEMBL676074,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL162034,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
841,752019,CHEMBL673924,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL162034,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,uM,0.0011
842,753172,CHEMBL674648,Inhibit of phosphorylation of a tyrosine/glutamic acid copolymer by epidermal growth factor receptor prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography.,B,CHEMBL162622,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
843,753176,CHEMBL673924,Inhibition of tyrosine/glutamic acid copolymer phosphorylation by epidermal growth factor receptor prepared of human A431,B,CHEMBL162622,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,uM,0.0007
844,755917,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL333454,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
845,755918,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL333454,=,nM,1750.0,CHEMBL203,Homo sapiens,IC50,uM,1.75
846,755921,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL119923,=,nM,14800.0,CHEMBL203,Homo sapiens,IC50,uM,14.8
847,755922,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL119923,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0
848,756378,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL76958,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
849,757020,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL419047,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
850,757021,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL419047,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
851,757024,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL333553,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5
852,757025,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL333553,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
853,757028,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL120564,=,nM,2600000.0,CHEMBL203,Homo sapiens,IC50,uM,2600.0
854,757029,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL120564,=,nM,87000.0,CHEMBL203,Homo sapiens,IC50,uM,87.0
855,757594,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL309075,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
856,758241,CHEMBL689289,Inhibition of polyGAT phosphorylation by EGF receptor,B,CHEMBL424625,=,nM,125000.0,CHEMBL203,Homo sapiens,IC50,uM,125.0
857,759231,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL116547,=,nM,750.0,CHEMBL203,Homo sapiens,IC50,uM,0.75
858,759232,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL116547,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
859,759235,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL118205,=,nM,12500.0,CHEMBL203,Homo sapiens,IC50,uM,12.5
860,759236,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL118205,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
861,759239,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL324030,=,nM,16300.0,CHEMBL203,Homo sapiens,IC50,uM,16.3
862,759240,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL324030,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
863,759243,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL119156,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
864,759244,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL119156,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
865,761453,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL432428,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
866,761454,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL432428,=,nM,640.0,CHEMBL203,Homo sapiens,IC50,uM,0.64
867,761457,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL326318,=,nM,1950.0,CHEMBL203,Homo sapiens,IC50,uM,1.95
868,761458,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL326318,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
869,761546,CHEMBL673783,Inhibition of erbB-1 receptor tyrosine kinase from A431 human epidermoid carcinoma cells,B,CHEMBL477,=,nM,195000.0,CHEMBL203,Homo sapiens,IC50,uM,195.0
870,761901,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL449093,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,uM,0.054
871,761905,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL78280,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
872,762431,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL122522,=,nM,370000.0,CHEMBL203,Homo sapiens,IC50,uM,370.0
873,762432,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL122522,=,nM,6700.0,CHEMBL203,Homo sapiens,IC50,uM,6.7
874,762840,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL78224,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
875,763581,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL119987,=,nM,37000.0,CHEMBL203,Homo sapiens,IC50,uM,37.0
876,763582,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL119987,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
877,765669,CHEMBL677530,Inhibition of Epidermal growth factor receptor,B,CHEMBL388978,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
878,769119,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL326044,=,nM,60000.0,CHEMBL203,Homo sapiens,IC50,uM,60.0
879,769120,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL326044,=,nM,48000.0,CHEMBL203,Homo sapiens,IC50,uM,48.0
880,770068,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL116595,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
881,770069,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL116595,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
882,771228,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL118321,=,nM,36000.0,CHEMBL203,Homo sapiens,IC50,uM,36.0
883,771229,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL118321,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
884,771708,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL309016,=,nM,7900.0,CHEMBL203,Homo sapiens,IC50,uM,7.9
885,771712,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL77397,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
886,772959,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL418906,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
887,774214,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL78049,=,nM,9400.0,CHEMBL203,Homo sapiens,IC50,uM,9.4
888,774218,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL309392,=,nM,17000.0,CHEMBL203,Homo sapiens,IC50,uM,17.0
889,774819,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL334032,=,nM,85000.0,CHEMBL203,Homo sapiens,IC50,uM,85.0
890,774820,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL334032,=,nM,23000.0,CHEMBL203,Homo sapiens,IC50,uM,23.0
891,775321,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL505705,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
892,776956,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL115519,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
893,776960,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL330879,=,nM,6600.0,CHEMBL203,Homo sapiens,IC50,uM,6.6
894,776961,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL330879,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
895,778538,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL76929,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
896,778541,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL311133,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
897,779149,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL118109,=,nM,18600.0,CHEMBL203,Homo sapiens,IC50,uM,18.6
898,779150,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL118109,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
899,779700,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL418907,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
900,782020,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL77401,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
901,782024,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL77100,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
902,783054,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL307481,=,nM,10100.0,CHEMBL203,Homo sapiens,IC50,uM,10.1
903,784236,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL78206,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
904,785277,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL453502,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
905,786019,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL115895,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
906,786020,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL115895,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
907,786023,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL331026,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
908,786024,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL331026,=,nM,14500.0,CHEMBL203,Homo sapiens,IC50,uM,14.5
909,786027,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL116423,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
910,786028,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL116423,=,nM,62000.0,CHEMBL203,Homo sapiens,IC50,uM,62.0
911,787149,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL326100,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
912,787150,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL326100,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
913,787153,CHEMBL677392,Inhibitory concentration against EGF receptor by polyGAT phosphorylation,B,CHEMBL120719,=,nM,96000.0,CHEMBL203,Homo sapiens,IC50,uM,96.0
914,787154,CHEMBL677393,Inhibitory concentration against EGF receptor by autophosphorylation,B,CHEMBL120719,=,nM,54000.0,CHEMBL203,Homo sapiens,IC50,uM,54.0
915,787623,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL74432,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
916,788630,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL77688,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
917,788634,CHEMBL674640,Inhibition of the epidermal growth factor receptor expressed in A431 cell line,B,CHEMBL312451,=,nM,40000.0,CHEMBL203,Homo sapiens,IC50,uM,40.0
918,789300,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL286343,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
919,789301,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL286343,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
920,790534,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31965,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
921,790535,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31965,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
922,792019,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL285063,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
923,792020,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL285063,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
924,796535,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL27685,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
925,796536,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL27685,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
926,796539,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31630,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
927,796540,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31630,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
928,798854,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL27688,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
929,798855,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL27688,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
930,800022,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31373,=,nM,0.75,CHEMBL203,Homo sapiens,IC50,nM,0.75
931,800023,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31373,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
932,801239,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31816,=,nM,0.95,CHEMBL203,Homo sapiens,IC50,nM,0.95
933,801240,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31816,=,nM,291.0,CHEMBL203,Homo sapiens,IC50,nM,291.0
934,802489,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL417478,=,nM,0.16,CHEMBL203,Homo sapiens,IC50,nM,0.16
935,802490,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL417478,=,nM,119.0,CHEMBL203,Homo sapiens,IC50,nM,119.0
936,803707,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL32844,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
937,803708,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL32844,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
938,803710,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31588,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
939,803711,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31588,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
940,803713,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31656,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
941,803714,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31656,=,nM,434.0,CHEMBL203,Homo sapiens,IC50,nM,434.0
942,806306,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31419,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
943,806307,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31419,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
944,807573,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31326,=,nM,0.78,CHEMBL203,Homo sapiens,IC50,nM,0.78
945,807574,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31326,=,nM,196.0,CHEMBL203,Homo sapiens,IC50,nM,196.0
946,807576,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31815,=,nM,0.42,CHEMBL203,Homo sapiens,IC50,nM,0.42
947,807577,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31815,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
948,811442,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL280757,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69
949,811443,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL280757,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
950,813921,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL28418,=,nM,0.75,CHEMBL203,Homo sapiens,IC50,nM,0.75
951,813922,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL28418,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
952,816305,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL281543,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
953,816306,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL281543,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,nM,5100.0
954,816309,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL284326,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
955,816310,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL284326,=,nM,264.0,CHEMBL203,Homo sapiens,IC50,nM,264.0
956,817636,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL32079,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
957,819945,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31622,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
958,819946,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31622,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
959,819948,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31570,=,nM,0.97,CHEMBL203,Homo sapiens,IC50,nM,0.97
960,819949,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31570,=,nM,377.0,CHEMBL203,Homo sapiens,IC50,nM,377.0
961,824519,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL283201,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
962,824520,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL283201,=,nM,416.0,CHEMBL203,Homo sapiens,IC50,nM,416.0
963,824522,CHEMBL674020,Inhibition of phosphorylation of a polyglutamic acid/tyrosine random copolymer by EGFR enzyme prepared from human A431 carcinoma cell vesicles by immunoaffinity chromatography,B,CHEMBL31369,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
964,824523,CHEMBL674019,Inhibition of EGF-stimulated autophosphorylation of EGFR enzyme in A431 cells detected by immunoblotting,B,CHEMBL31369,=,nM,7693.0,CHEMBL203,Homo sapiens,IC50,nM,7693.0
965,838576,CHEMBL677885,Inhibition of Epidermal growth factor receptor,B,CHEMBL57366,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
966,848306,CHEMBL674011,Inhibition of EGF-receptor,B,CHEMBL56236,=,nM,6680.0,CHEMBL203,Homo sapiens,IC50,uM,6.68
967,856140,CHEMBL677885,Inhibition of Epidermal growth factor receptor,B,CHEMBL299763,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
968,865808,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL293889,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
969,865810,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL160566,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
970,865829,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL420624,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
971,866294,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL85021,=,nM,15300.0,CHEMBL203,Homo sapiens,IC50,uM,15.3
972,867224,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL329161,=,nM,897.0,CHEMBL203,Homo sapiens,IC50,nM,897.0
973,867225,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL333082,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,nM,105.0
974,867376,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53690,=,nM,0.91,CHEMBL203,Homo sapiens,IC50,nM,0.91
975,867377,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL53690,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
976,868595,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL297968,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
977,868596,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL297968,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
978,868682,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL126192,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
979,869768,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL157807,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
980,869793,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL328216,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
981,869803,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL93032,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
982,870001,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL126483,=,nM,9300.0,CHEMBL203,Homo sapiens,IC50,uM,9.3
983,870936,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL336174,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
984,870938,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL345641,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
985,870945,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL117710,=,nM,756.0,CHEMBL203,Homo sapiens,IC50,nM,756.0
986,870946,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL119033,=,nM,139.0,CHEMBL203,Homo sapiens,IC50,nM,139.0
987,870961,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL116308,=,nM,355.0,CHEMBL203,Homo sapiens,IC50,nM,355.0
988,872175,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL345837,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
989,872177,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL346770,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
990,872202,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL116919,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
991,872518,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL340660,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
992,873416,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL347161,=,nM,16900.0,CHEMBL203,Homo sapiens,IC50,uM,16.9
993,873430,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL330882,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,nM,4900.0
994,873549,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL280757,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69
995,873550,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL280757,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
996,874495,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL326596,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
997,874496,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL333418,=,nM,439.0,CHEMBL203,Homo sapiens,IC50,nM,439.0
998,875638,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL347659,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,uM,13.0
999,875660,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL441083,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,nM,910.0
1000,875661,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL329672,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
1001,875861,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL430571,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
1002,875862,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL430571,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
1003,875865,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL52913,=,nM,0.25,CHEMBL203,Homo sapiens,IC50,nM,0.25
1004,875866,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL52913,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
1005,876977,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL158797,=,nM,43000.0,CHEMBL203,Homo sapiens,IC50,uM,43.0
1006,876981,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL346553,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
1007,876996,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL92825,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
1008,876997,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL52197,=,nM,348.0,CHEMBL203,Homo sapiens,IC50,nM,348.0
1009,876998,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL117697,=,nM,842.0,CHEMBL203,Homo sapiens,IC50,nM,842.0
1010,878224,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL94275,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
1011,878345,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL54091,=,nM,0.72,CHEMBL203,Homo sapiens,IC50,nM,0.72
1012,878346,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL54091,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
1013,878687,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL89723,=,nM,9500.0,CHEMBL203,Homo sapiens,IC50,uM,9.5
1014,879427,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL351920,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
1015,879450,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL333851,=,nM,588.0,CHEMBL203,Homo sapiens,IC50,nM,588.0
1016,879562,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53665,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
1017,879563,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL53665,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
1018,879690,CHEMBL678293,Inhibition of Epidermal growth factor receptor,B,CHEMBL126456,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
1019,879987,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL87746,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
1020,882053,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL93181,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1021,882799,CHEMBL676151,Inhibition of tyrosine kinase Epidermal growth factor receptor,B,CHEMBL278287,=,nM,49000.0,CHEMBL203,Homo sapiens,IC50,uM,49.0
1022,883183,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL161226,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
1023,883223,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL289787,=,nM,974.0,CHEMBL203,Homo sapiens,IC50,nM,974.0
1024,883298,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL296168,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
1025,883299,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL296168,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
1026,883301,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL51741,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
1027,883302,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL51741,=,nM,9.9,CHEMBL203,Homo sapiens,IC50,nM,9.9
1028,883858,CHEMBL676151,Inhibition of tyrosine kinase Epidermal growth factor receptor,B,CHEMBL277430,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
1029,884346,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL325245,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1030,885615,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL422540,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1031,885639,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL37346,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,nM,5500.0
1032,885851,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL51659,=,nM,0.91,CHEMBL203,Homo sapiens,IC50,nM,0.91
1033,885852,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL51659,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
1034,887028,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL435054,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
1035,888100,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL345211,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
1036,888111,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL332096,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,nM,1400.0
1037,888112,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL117804,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,nM,4100.0
1038,888113,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL324371,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,nM,100000.0
1039,888400,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL340862,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
1040,889314,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL158805,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
1041,889316,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL304414,=,nM,10900.0,CHEMBL203,Homo sapiens,IC50,uM,10.9
1042,889331,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL116748,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,nM,5900.0
1043,889332,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL115745,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
1044,889460,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL49986,=,nM,0.54,CHEMBL203,Homo sapiens,IC50,nM,0.54
1045,889461,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL49986,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
1046,889814,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL48760,=,nM,18500.0,CHEMBL203,Homo sapiens,IC50,uM,18.5
1047,890624,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL345862,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
1048,890631,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL119708,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,nM,8000.0
1049,891804,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL332938,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
1050,891879,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL443523,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
1051,891880,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL443523,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
1052,892035,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL125920,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
1053,892281,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL89505,=,nM,7900.0,CHEMBL203,Homo sapiens,IC50,uM,7.9
1054,893013,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL28418,=,nM,0.75,CHEMBL203,Homo sapiens,IC50,nM,0.75
1055,893014,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL28418,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
1056,893121,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL65250,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1057,894014,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL347854,=,nM,28700.0,CHEMBL203,Homo sapiens,IC50,uM,28.7
1058,894021,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL290096,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
1059,894023,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL52765,=,nM,0.79,CHEMBL203,Homo sapiens,IC50,nM,0.79
1060,894024,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,nM,0.029
1061,894025,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL117554,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,nM,7000.0
1062,894026,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL289959,=,nM,344.0,CHEMBL203,Homo sapiens,IC50,nM,344.0
1063,894034,CHEMBL677205,Inhibition of Epidermal growth factor receptor from A431 cells,B,CHEMBL102726,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,nM,320.0
1064,894143,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL285063,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
1065,894144,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL285063,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
1066,894163,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL31373,=,nM,0.75,CHEMBL203,Homo sapiens,IC50,nM,0.75
1067,894164,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL31373,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1068,895622,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL314146,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0
1069,896532,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL54088,=,nM,0.48,CHEMBL203,Homo sapiens,IC50,nM,0.48
1070,896533,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL54088,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3
1071,896556,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL31815,=,nM,0.42,CHEMBL203,Homo sapiens,IC50,nM,0.42
1072,896557,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL31815,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
1073,897991,CHEMBL676159,Concentration required to achieve 50% inhibition of tyrosine phosphorylation on human Epidermal growth factor receptor (EGF RTK).,B,CHEMBL86326,=,nM,19300.0,CHEMBL203,Homo sapiens,IC50,uM,19.3
1074,898778,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL160207,=,nM,21200.0,CHEMBL203,Homo sapiens,IC50,uM,21.2
1075,898965,CHEMBL674018,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53555,=,nM,0.77,CHEMBL203,Homo sapiens,IC50,nM,0.77
1076,898966,CHEMBL674017,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor (EGFR) in A431 cells,B,CHEMBL53555,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
1077,899026,CHEMBL856168,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53637,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
1078,899027,CHEMBL679551,Inhibition of EGF-stimulated autophosphorylation of epidermal growth factor receptor in A431 cells,B,CHEMBL53637,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
1079,899092,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL125086,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
1080,899094,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL127223,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
1081,900058,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL342929,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
1082,900061,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL348554,=,nM,17500.0,CHEMBL203,Homo sapiens,IC50,uM,17.5
1083,900240,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL127367,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
1084,900242,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL126974,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1085,901220,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL160935,=,nM,7700.0,CHEMBL203,Homo sapiens,IC50,uM,7.7
1086,901498,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL128027,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
1087,902565,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL347160,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
1088,902741,CHEMBL679676,Inhibition of phosphorylation of glutamic acid/tyrosine random copolymer by isolated epidermal growth factor receptor (EGFR),B,CHEMBL53203,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
1089,902742,CHEMBL679550,Inhibition of EGF-stimulated autophosphorylation of Epidermal growth factor receptor in A431 cells,B,CHEMBL53203,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,nM,4.8
1090,903740,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL79704,=,nM,4200.0,CHEMBL203,Homo sapiens,IC50,uM,4.2
1091,903742,CHEMBL677470,Inhibitory concentration compound against EFGR tyrosine kinase obtained from plasma membrane vesicles from cultured A431 cells,B,CHEMBL158275,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
1092,903749,CHEMBL677204,Evaluation of inhibitory activity against phospholipase C-gamma1 phosphorylation by Epidermal growth factor receptor enzyme isolated from A431 cells.,B,CHEMBL92824,=,nM,577.0,CHEMBL203,Homo sapiens,IC50,nM,577.0
1093,903968,CHEMBL678292,Inhibition of (EGFR) epidermal growth factor receptor tyrosine kinase,B,CHEMBL126996,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
1094,905960,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL266182,=,nM,180000.0,CHEMBL203,Homo sapiens,IC50,uM,180.0
1095,908509,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL277667,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1096,913864,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL19978,=,nM,95000.0,CHEMBL203,Homo sapiens,IC50,uM,95.0
1097,921287,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL59099,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
1098,922521,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL279035,=,nM,90000.0,CHEMBL203,Homo sapiens,IC50,uM,90.0
1099,925207,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL21096,=,nM,59000.0,CHEMBL203,Homo sapiens,IC50,uM,59.0
1100,926577,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL279481,=,nM,29000.0,CHEMBL203,Homo sapiens,IC50,uM,29.0
1101,926584,CHEMBL675381,In vitro activity against Epidermal growth factor receptor (using poly(Glu4Tyr1) as a substrate),B,CHEMBL21108,=,nM,90000.0,CHEMBL203,Homo sapiens,IC50,uM,90.0
1102,928092,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL58436,=,nM,7100.0,CHEMBL203,Homo sapiens,IC50,uM,7.1
1103,929355,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL299707,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1104,931991,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL55379,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
1105,933478,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL293991,=,nM,530.0,CHEMBL203,Homo sapiens,IC50,uM,0.53
1106,937850,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL20926,=,nM,65000.0,CHEMBL203,Homo sapiens,IC50,uM,65.0
1107,939143,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL57690,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1108,941716,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL57553,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
1109,942927,CHEMBL675386,Inhibition of the epidermal growth factor receptor.,B,CHEMBL56081,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1110,946785,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL49350,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
1111,949286,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL93173,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
1112,952014,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL90541,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
1113,953326,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL330323,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1114,956081,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL422066,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
1115,957261,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL301018,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
1116,958682,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL296407,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
1117,959794,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL48436,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
1118,962265,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL50415,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
1119,963430,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL94019,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
1120,963432,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL93423,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
1121,963525,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL296582,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
1122,963527,CHEMBL873595,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL48650,=,nM,7700.0,CHEMBL203,Homo sapiens,IC50,uM,7.7
1123,967483,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL91428,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
1124,967485,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL330668,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
1125,968670,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL92006,=,nM,730.0,CHEMBL203,Homo sapiens,IC50,uM,0.73
1126,968672,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL329867,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,uM,0.0064
1127,972501,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL420059,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
1128,974947,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL419137,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1129,976166,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL91484,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
1130,979936,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL328277,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
1131,984834,CHEMBL680029,Tested for inhibition of Epidermal growth factor receptor from A431 vulval squamous carcinoma cells,B,CHEMBL90540,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
1132,987820,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328106,=,nM,0.96,CHEMBL203,Homo sapiens,IC50,nM,0.96
1133,987821,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL316064,=,nM,0.24,CHEMBL203,Homo sapiens,IC50,nM,0.24
1134,989001,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL52765,=,nM,0.78,CHEMBL203,Homo sapiens,IC50,nM,0.78
1135,989128,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL329183,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,nM,6100.0
1136,989129,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93302,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
1137,990154,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL418967,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
1138,991403,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL96627,=,nM,1367.0,CHEMBL203,Homo sapiens,IC50,nM,1367.0
1139,992361,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL94275,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
1140,993446,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93032,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
1141,993447,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328216,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
1142,993448,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL94191,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
1143,994778,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328879,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
1144,996053,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL289959,=,nM,344.0,CHEMBL203,Homo sapiens,IC50,nM,344.0
1145,996179,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL318736,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,nM,105.0
1146,997297,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL96780,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
1147,997298,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL90013,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
1148,997299,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL433205,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
1149,998478,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL52197,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
1150,998479,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328244,=,nM,574.0,CHEMBL203,Homo sapiens,IC50,nM,574.0
1151,998480,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL91980,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
1152,998625,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93051,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1153,999805,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93966,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1154,999806,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328955,=,nM,0.25,CHEMBL203,Homo sapiens,IC50,nM,0.25
1155,999904,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93284,=,nM,540.0,CHEMBL203,Homo sapiens,IC50,nM,540.0
1156,1001015,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92174,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,nM,128.0
1157,1003161,CHEMBL675242,Inhibit of epidermal growth factor receptor (EGFR),B,CHEMBL367625,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
1158,1003166,CHEMBL675242,Inhibit of epidermal growth factor receptor (EGFR),B,CHEMBL368278,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
1159,1004778,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93461,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
1160,1006082,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL329672,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
1161,1006083,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL420254,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
1162,1007146,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL63469,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
1163,1007147,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL89940,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,nM,770.0
1164,1007148,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL52015,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,nM,84.0
1165,1007330,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL7917,=,nM,0.31,CHEMBL203,Homo sapiens,IC50,nM,0.31
1166,1008595,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93734,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
1167,1008596,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL35820,=,nM,0.006,CHEMBL203,Homo sapiens,IC50,nM,0.006
1168,1009649,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92985,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
1169,1009650,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL330224,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
1170,1010794,CHEMBL675242,Inhibit of epidermal growth factor receptor (EGFR),B,CHEMBL367625,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1171,1011134,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL66409,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
1172,1011135,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL447230,=,nM,152.0,CHEMBL203,Homo sapiens,IC50,nM,152.0
1173,1011136,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL94431,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
1174,1012251,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328295,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,nM,5000.0
1175,1012375,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92936,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
1176,1013384,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL329161,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,nM,900.0
1177,1013385,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92937,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69
1178,1014693,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92824,=,nM,577.0,CHEMBL203,Homo sapiens,IC50,nM,577.0
1179,1014694,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL50344,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1180,1016105,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL96489,=,nM,159.0,CHEMBL203,Homo sapiens,IC50,nM,159.0
1181,1016106,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL290096,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
1182,1016228,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93545,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
1183,1017580,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93544,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,nM,2000.0
1184,1018959,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93295,=,nM,463.0,CHEMBL203,Homo sapiens,IC50,nM,463.0
1185,1018963,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL96065,=,nM,0.89,CHEMBL203,Homo sapiens,IC50,nM,0.89
1186,1018964,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL328691,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
1187,1020224,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92709,=,nM,113.0,CHEMBL203,Homo sapiens,IC50,nM,113.0
1188,1020227,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL65038,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1189,1021310,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
1190,1022606,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL317925,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
1191,1023872,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92398,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
1192,1023873,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL91914,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,nM,12000.0
1193,1023994,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL327307,=,nM,0.072,CHEMBL203,Homo sapiens,IC50,nM,0.072
1194,1025006,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92825,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
1195,1026223,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93181,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1196,1026224,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL420624,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
1197,1026225,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL92812,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
1198,1026352,CHEMBL680017,Concentration required to inhibit the phosphorylation of a 14-residue fragment of phospholipase C gamma 1 by Epidermal growth factor receptor from A431 cell vesicles,B,CHEMBL93635,=,nM,810.0,CHEMBL203,Homo sapiens,IC50,nM,810.0
1199,1027809,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93783,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
1200,1030178,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL93032,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
1201,1030179,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL177053,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
1202,1031419,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL426580,=,nM,0.29,CHEMBL203,Homo sapiens,IC50,nM,0.29
1203,1031546,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92902,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,uM,0.115
1204,1032741,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL327838,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
1205,1033949,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL328704,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
1206,1036198,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL319620,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
1207,1036448,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL172652,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
1208,1036461,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94066,=,nM,107.0,CHEMBL203,Homo sapiens,IC50,uM,0.107
1209,1037671,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94061,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
1210,1038585,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL153525,=,nM,1.24,CHEMBL203,Homo sapiens,IC50,nM,1.24
1211,1038627,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL366580,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
1212,1038647,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL329642,=,nM,269.0,CHEMBL203,Homo sapiens,IC50,uM,0.269
1213,1039974,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92356,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
1214,1039979,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94062,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
1215,1040781,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL123046,=,nM,41900.0,CHEMBL203,Homo sapiens,IC50,uM,41.9
1216,1041043,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL153170,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
1217,1042298,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93784,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
1218,1043415,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL176582,=,nM,0.01,CHEMBL203,Homo sapiens,IC50,nM,0.01
1219,1043531,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93537,=,nM,203.0,CHEMBL203,Homo sapiens,IC50,uM,0.203
1220,1044669,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL122785,=,nM,10300.0,CHEMBL203,Homo sapiens,IC50,uM,10.3
1221,1044894,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL63786,=,nM,0.003,CHEMBL203,Homo sapiens,IC50,nM,0.003
1222,1044955,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94123,=,nM,215.0,CHEMBL203,Homo sapiens,IC50,uM,0.215
1223,1045079,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92882,=,nM,1132.0,CHEMBL203,Homo sapiens,IC50,uM,1.132
1224,1046188,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL39337,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
1225,1046286,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93386,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1226,1047042,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL122260,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7
1227,1047402,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92731,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
1228,1048576,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93049,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059
1229,1049594,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL40734,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
1230,1049630,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
1231,1049631,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL93051,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1232,1050875,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL155100,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0
1233,1050902,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93464,=,nM,236.0,CHEMBL203,Homo sapiens,IC50,uM,0.236
1234,1051048,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92961,=,nM,97.0,CHEMBL203,Homo sapiens,IC50,uM,0.097
1235,1052131,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL175101,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
1236,1052275,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL93754,=,nM,1124.0,CHEMBL203,Homo sapiens,IC50,uM,1.124
1237,1053097,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL123045,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
1238,1053375,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL328245,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
1239,1053380,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL91925,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,uM,0.073
1240,1053385,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL316127,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,uM,0.074
1241,1054530,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL66031,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
1242,1054540,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL174426,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
1243,1054576,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL91748,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
1244,1054703,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL91009,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
1245,1055840,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL173498,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
1246,1055868,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL92086,=,nM,339.0,CHEMBL203,Homo sapiens,IC50,uM,0.339
1247,1055970,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL2112369,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,uM,0.194
1248,1057345,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL90595,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
1249,1057350,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL419501,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
1250,1058147,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL122397,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
1251,1059548,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL290096,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
1252,1059667,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL91811,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
1253,1059672,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL328977,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,uM,0.095
1254,1059677,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94068,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,uM,0.106
1255,1060812,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL285063,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
1256,1062251,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL427298,=,nM,203.0,CHEMBL203,Homo sapiens,IC50,nM,203.0
1257,1062472,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL329856,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1258,1062477,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL442754,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
1259,1062482,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL94109,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
1260,1063559,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL96627,=,nM,1370.0,CHEMBL203,Homo sapiens,IC50,nM,1370.0
1261,1063646,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL91867,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1262,1063651,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL2112370,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,uM,0.131
1263,1064377,CHEMBL677211,Displacement of [gamma-32P]-ATP from Epidermal growth factor receptor in A431 cell-free extracts,B,CHEMBL122721,=,nM,27200.0,CHEMBL203,Homo sapiens,IC50,uM,27.2
1264,1064734,CHEMBL679548,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 cells,B,CHEMBL176891,=,nM,1.32,CHEMBL203,Homo sapiens,IC50,nM,1.32
1265,1064749,CHEMBL680018,Inhibition of epidermal growth factor receptor using enzyme assay,B,CHEMBL414220,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
1266,1065930,CHEMBL683040,Inhibition of tyrosine kinase activity of Epidermal growth factor receptor from human A431 carcinoma cells,B,CHEMBL328216,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
1267,1068012,CHEMBL674695,Inhibition of Epidermal growth factor receptor,B,CHEMBL101683,=,nM,7300.0,CHEMBL203,Homo sapiens,IC50,uM,7.3
1268,1068226,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL301359,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
1269,1069552,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53375,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
1270,1070683,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52472,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
1271,1074154,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL301549,=,nM,263.0,CHEMBL203,Homo sapiens,IC50,nM,263.0
1272,1075321,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53796,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
1273,1075322,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53796,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
1274,1076549,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53299,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
1275,1077738,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53940,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
1276,1077739,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL298637,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
1277,1077740,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL298637,=,nM,552.0,CHEMBL203,Homo sapiens,IC50,nM,552.0
1278,1077741,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL50519,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
1279,1078918,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53062,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
1280,1078919,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53062,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
1281,1078920,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54805,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
1282,1080041,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53300,=,nM,0.79,CHEMBL203,Homo sapiens,IC50,nM,0.79
1283,1082445,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54400,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
1284,1082446,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL54400,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
1285,1082447,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53711,=,nM,0.006,CHEMBL203,Homo sapiens,IC50,nM,0.006
1286,1082448,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53711,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
1287,1082449,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL291496,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
1288,1083481,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL300083,=,nM,578.0,CHEMBL203,Homo sapiens,IC50,nM,578.0
1289,1083482,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL300083,=,nM,2085.0,CHEMBL203,Homo sapiens,IC50,nM,2085.0
1290,1083483,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52418,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
1291,1083484,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53156,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1292,1083485,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53156,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
1293,1084595,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54784,=,nM,1460.0,CHEMBL203,Homo sapiens,IC50,nM,1460.0
1294,1084596,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL296377,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
1295,1084597,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53753,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
1296,1084598,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53753,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1297,1084599,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54474,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,nM,940.0
1298,1085648,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL51320,=,nM,2030.0,CHEMBL203,Homo sapiens,IC50,nM,2030.0
1299,1087766,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52882,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1300,1087767,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL51265,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
1301,1087768,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL50245,=,nM,324.0,CHEMBL203,Homo sapiens,IC50,nM,324.0
1302,1087769,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL50245,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,nM,2300.0
1303,1088915,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL51853,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
1304,1088916,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL51853,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
1305,1088917,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53552,=,nM,603.0,CHEMBL203,Homo sapiens,IC50,nM,603.0
1306,1092285,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL55150,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
1307,1093326,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52076,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1308,1093327,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL52076,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
1309,1093328,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL291701,=,nM,684.0,CHEMBL203,Homo sapiens,IC50,nM,684.0
1310,1093329,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53850,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
1311,1093330,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL55729,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
1312,1093331,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52784,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
1313,1095629,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL51707,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
1314,1096678,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54475,=,nM,688.0,CHEMBL203,Homo sapiens,IC50,nM,688.0
1315,1096679,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL295961,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1316,1097850,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL52665,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
1317,1099053,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL300217,=,nM,7.6,CHEMBL203,Homo sapiens,IC50,nM,7.6
1318,1099054,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL300217,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
1319,1099055,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL300491,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1320,1100187,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53428,=,nM,0.091,CHEMBL203,Homo sapiens,IC50,nM,0.091
1321,1100188,CHEMBL677215,Inhibition of Epidermal growth factor receptor autophosphorylation in A431 human epidermoid carcinoma cells,B,CHEMBL53428,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
1322,1100189,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53121,=,nM,124.0,CHEMBL203,Homo sapiens,IC50,nM,124.0
1323,1102400,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL53404,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
1324,1102401,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL54788,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
1325,1102402,CHEMBL680021,Inhibitory potency against isolated epidermal growth factor receptor (EGFR) from human A431 carcinoma cells,B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,nM,0.029
1326,1102403,CHEMBL676150,Inhibition of Epidermal growth factor receptor from human A431 cell membranes,B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,pM,29.0
1327,1111718,CHEMBL675388,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL132466,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
1328,1123674,CHEMBL675388,Inhibition of epidermal growth factor receptor (EGFR),B,CHEMBL109372,=,nM,5170.0,CHEMBL203,Homo sapiens,IC50,uM,5.17
1329,1133410,CHEMBL677207,In vitro inhibition of intrinsic tyrosine protein kinase activity of the Epidermal growth factor receptor using tripeptide RR-Src,B,CHEMBL358092,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
1330,1142979,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL49596,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
1331,1144128,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL54471,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
1332,1144129,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL54471,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
1333,1144133,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56543,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1334,1144134,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56543,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
1335,1144368,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332612,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
1336,1144376,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL118904,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
1337,1145368,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56879,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
1338,1145369,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56879,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
1339,1145373,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55979,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
1340,1145374,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL55979,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
1341,1145378,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56455,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
1342,1145604,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332333,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,uM,0.058
1343,1145611,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332882,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
1344,1146723,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56132,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
1345,1146724,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56132,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
1346,1146728,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56219,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1347,1146729,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56219,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
1348,1147073,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL62756,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
1349,1148095,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57251,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
1350,1148289,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL120979,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1351,1149249,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL292648,=,nM,1200000.0,CHEMBL203,Homo sapiens,IC50,uM,1200.0
1352,1149451,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL301612,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078
1353,1149518,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL122243,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
1354,1149523,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL122245,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
1355,1150480,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL296407,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
1356,1150481,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL296407,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
1357,1150683,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL49120,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
1358,1151705,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56731,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
1359,1151706,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56731,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,uM,1.25
1360,1151710,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56542,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
1361,1151711,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56542,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
1362,1151840,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL299763,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
1363,1152815,CHEMBL677883,"In vitro inhibition of Epidermal growth factor receptor (HER-1,ErbB) expressed in baculovirus",B,CHEMBL153843,=,nM,10400.0,CHEMBL203,Homo sapiens,IC50,nM,10400.0
1364,1152903,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL294213,=,nM,2200000.0,CHEMBL203,Homo sapiens,IC50,uM,2200.0
1365,1153154,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332765,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
1366,1153162,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL306081,=,nM,27000.0,CHEMBL203,Homo sapiens,IC50,uM,27.0
1367,1154213,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL291313,=,nM,40000.0,CHEMBL203,Homo sapiens,IC50,uM,40.0
1368,1154451,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL51028,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
1369,1154455,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL51485,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,uM,0.98
1370,1155542,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL294681,=,nM,1800000.0,CHEMBL203,Homo sapiens,IC50,uM,1800.0
1371,1155866,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL121796,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
1372,1158226,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55979,=,nM,860.0,CHEMBL203,Homo sapiens,IC50,uM,0.86
1373,1158327,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL121190,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
1374,1158334,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL331906,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
1375,1158342,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332906,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
1376,1159506,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57462,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
1377,1159508,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55994,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
1378,1159509,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL55994,=,nM,31000.0,CHEMBL203,Homo sapiens,IC50,uM,31.0
1379,1160795,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57712,=,nM,1300000.0,CHEMBL203,Homo sapiens,IC50,uM,1300.0
1380,1162210,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55993,=,nM,10700.0,CHEMBL203,Homo sapiens,IC50,uM,10.7
1381,1162211,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL55993,=,nM,24000.0,CHEMBL203,Homo sapiens,IC50,uM,24.0
1382,1162213,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55360,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
1383,1162214,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL55360,=,nM,10300.0,CHEMBL203,Homo sapiens,IC50,uM,10.3
1384,1162487,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL299194,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
1385,1162563,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL122068,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
1386,1162570,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL333231,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
1387,1162578,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL332971,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,uM,0.096
1388,1163641,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56281,=,nM,225000.0,CHEMBL203,Homo sapiens,IC50,uM,225.0
1389,1163642,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57170,=,nM,800000.0,CHEMBL203,Homo sapiens,IC50,uM,800.0
1390,1163643,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55748,=,nM,12500.0,CHEMBL203,Homo sapiens,IC50,uM,12.5
1391,1163645,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56393,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
1392,1163646,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56393,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
1393,1163650,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL293749,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
1394,1163651,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL293749,<,nM,625.0,CHEMBL203,Homo sapiens,IC50,uM,0.625
1395,1165016,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL59145,=,nM,1540.0,CHEMBL203,Homo sapiens,IC50,uM,1.54
1396,1165017,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL59145,=,nM,6600.0,CHEMBL203,Homo sapiens,IC50,uM,6.6
1397,1165160,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL55204,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
1398,1165161,CHEMBL676153,Inhibition of epidermal growth factor receptor autophosphorylation,B,CHEMBL55204,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
1399,1166648,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL65063,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
1400,1166657,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL120667,=,nM,450000.0,CHEMBL203,Homo sapiens,IC50,uM,450.0
1401,1167900,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL45827,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
1402,1167948,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL123189,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1403,1169051,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL293482,=,nM,532000.0,CHEMBL203,Homo sapiens,IC50,uM,532.0
1404,1169053,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL440298,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1405,1169054,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL440298,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
1406,1169278,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL420885,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
1407,1169286,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL334026,=,nM,24200.0,CHEMBL203,Homo sapiens,IC50,uM,24.2
1408,1170279,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL291986,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
1409,1170280,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL291986,=,nM,55000.0,CHEMBL203,Homo sapiens,IC50,uM,55.0
1410,1171429,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57663,=,nM,1400000.0,CHEMBL203,Homo sapiens,IC50,uM,1400.0
1411,1171615,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL333038,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
1412,1171626,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL119982,=,nM,870.0,CHEMBL203,Homo sapiens,IC50,uM,0.87
1413,1172792,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL59150,=,nM,820000.0,CHEMBL203,Homo sapiens,IC50,uM,820.0
1414,1172796,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL417941,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
1415,1172797,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL417941,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9
1416,1173026,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL120319,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
1417,1174090,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56964,=,nM,60000.0,CHEMBL203,Homo sapiens,IC50,uM,60.0
1418,1174092,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56319,=,nM,1530.0,CHEMBL203,Homo sapiens,IC50,uM,1.53
1419,1174093,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL56319,=,nM,49000.0,CHEMBL203,Homo sapiens,IC50,uM,49.0
1420,1174284,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL121260,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
1421,1174291,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL121954,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
1422,1175323,CHEMBL677883,"In vitro inhibition of Epidermal growth factor receptor (HER-1,ErbB) expressed in baculovirus",B,CHEMBL24828,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
1423,1175338,CHEMBL677882,In vitro inhibition of Epidermal growth factor receptor expressed in baculovirus,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
1424,1175565,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL298679,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
1425,1178188,CHEMBL683042,Inhibition of human epidermal growth factor receptor,B,CHEMBL50470,=,nM,1350.0,CHEMBL203,Homo sapiens,IC50,uM,1.35
1426,1179473,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL319540,=,nM,2710.0,CHEMBL203,Homo sapiens,IC50,uM,2.71
1427,1179474,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL122411,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1428,1179482,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL29197,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1429,1180614,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL298810,=,nM,1480000.0,CHEMBL203,Homo sapiens,IC50,uM,1480.0
1430,1180615,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL57300,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
1431,1181975,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL56201,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,uM,26.0
1432,1182242,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL122182,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1433,1183293,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL293584,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
1434,1183296,CHEMBL763200,Inhibition of polyGAT phosphorylation,B,CHEMBL53898,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
1435,1183297,CHEMBL676152,In vitro inhibition of HER1 autophosphorylation.,B,CHEMBL53898,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
1436,1183555,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL120069,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
1437,1183566,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL119977,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
1438,1183574,CHEMBL677832,Inhibitory activity against epidermal growth factor receptor tyrosine kinase.,B,CHEMBL118130,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1439,1191697,CHEMBL683037,"Inhibition of human Epidermal growth factor receptor, HER-1",B,CHEMBL2111784,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1440,1191699,CHEMBL683039,Inhibition of human epidermal growth factor receptor,B,CHEMBL2111784,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
1441,1196231,CHEMBL821544,Inhibition of c-erbB2 receptor,B,CHEMBL290389,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
1442,1197965,CHEMBL689294,Inhibition of human Epidermal growth factor receptor,B,CHEMBL419409,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
1443,1197972,CHEMBL683038,Inhibition of human Epidermal growth factor receptor,B,CHEMBL419409,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
1444,1199255,CHEMBL683039,Inhibition of human epidermal growth factor receptor,B,CHEMBL120185,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
1445,1200013,CHEMBL674642,Inhibition of EGF-R Tyrosine kinase (TK),B,CHEMBL103552,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
1446,1200655,CHEMBL683037,"Inhibition of human Epidermal growth factor receptor, HER-1",B,CHEMBL121405,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1447,1200657,CHEMBL683039,Inhibition of human epidermal growth factor receptor,B,CHEMBL121405,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1448,1204036,CHEMBL674642,Inhibition of EGF-R Tyrosine kinase (TK),B,CHEMBL319620,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
1449,1210610,CHEMBL674642,Inhibition of EGF-R Tyrosine kinase (TK),B,CHEMBL131653,=,nM,24400.0,CHEMBL203,Homo sapiens,IC50,uM,24.4
1450,1211938,CHEMBL674642,Inhibition of EGF-R Tyrosine kinase (TK),B,CHEMBL103860,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
1451,1227781,CHEMBL677529,Inhibition of Epidermal growth factor receptor,B,CHEMBL27085,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
1452,1257897,CHEMBL674697,Inhibition of Epidermal growth factor receptor,B,CHEMBL104466,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
1453,1266764,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL75208,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1454,1271111,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL76444,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
1455,1271113,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL306315,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1456,1272219,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL433305,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
1457,1274873,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL421686,=,nM,1080.0,CHEMBL203,Homo sapiens,IC50,uM,1.08
1458,1276122,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL307062,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
1459,1276129,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL74645,=,nM,25700.0,CHEMBL203,Homo sapiens,IC50,uM,25.7
1460,1277569,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL74778,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,uM,1.25
1461,1277570,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL307209,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,uM,0.096
1462,1278792,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL73406,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
1463,1280018,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL72393,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
1464,1281184,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL268868,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
1465,1282555,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL307599,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
1466,1283660,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL440873,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,uM,0.36
1467,1284931,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL308593,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
1468,1286124,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL4106341,=,nM,6920.0,CHEMBL203,Homo sapiens,IC50,uM,6.92
1469,1287415,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL74481,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1470,1288831,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL75177,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
1471,1288841,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL306029,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
1472,1291476,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL431191,=,nM,860.0,CHEMBL203,Homo sapiens,IC50,uM,0.86
1473,1292801,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL73301,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
1474,1292802,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL73710,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
1475,1292803,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL73625,=,nM,75100.0,CHEMBL203,Homo sapiens,IC50,uM,75.1
1476,1295550,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL72322,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,uM,0.42
1477,1295551,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL431001,=,nM,16300.0,CHEMBL203,Homo sapiens,IC50,uM,16.3
1478,1298448,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL75049,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
1479,1298455,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL306081,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
1480,1299791,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL309937,=,nM,77500.0,CHEMBL203,Homo sapiens,IC50,uM,77.5
1481,1301109,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL74722,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
1482,1302355,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL76116,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
1483,1302356,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL307026,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
1484,1305398,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL308582,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
1485,1306870,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL311129,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1486,1306877,CHEMBL677880,In vitro inhibitory activity against epidermal growth factor receptor,B,CHEMBL29197,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
1487,1400129,CHEMBL832814,Inhibition of epidermal growth factor receptor,B,CHEMBL177688,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36
1488,1418537,CHEMBL832627,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,B,CHEMBL181275,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1489,1418780,CHEMBL832627,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,B,CHEMBL182254,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
1490,1419025,CHEMBL832627,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,B,CHEMBL181742,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1491,1420571,CHEMBL832627,Inhibitory concentration against EGFR by using [gamma-33P]-ATP as radioligand in pH 7.5,B,CHEMBL361322,=,nM,5010.0,CHEMBL203,Homo sapiens,IC50,uM,5.01
1492,1423098,CHEMBL828723,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,B,CHEMBL52765,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
1493,1423099,CHEMBL828723,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1494,1423100,CHEMBL828723,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,B,CHEMBL181617,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1495,1423101,CHEMBL828723,Inhibition of poly(L-glutamic acid-L-tyrosine) phosphorylation by EGFR tyrosine kinase of A431 carcinoma cells,B,CHEMBL179451,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
1496,1429096,CHEMBL830975,Inhibition of Epidermal growth factor receptor,B,CHEMBL49120,=,nM,44000.0,CHEMBL203,Homo sapiens,IC50,uM,44.0
1497,1453093,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL186802,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
1498,1453199,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL186580,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
1499,1453202,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL185327,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
1500,1453211,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL186747,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
1501,1453214,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL182397,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
1502,1453217,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL360209,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
1503,1453223,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL187007,=,nM,29000.0,CHEMBL203,Homo sapiens,IC50,uM,29.0
1504,1453626,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL184682,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1505,1454928,CHEMBL832673,Inhibitory concentration against Epidermal growth factor receptor tyrosine kinase activity,B,CHEMBL7917,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
1506,1462325,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL185637,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1507,1462330,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL188304,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
1508,1462335,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL186080,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
1509,1462340,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL184311,=,nM,3250.0,CHEMBL203,Homo sapiens,IC50,uM,3.25
1510,1462345,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL185853,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
1511,1462471,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL188522,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
1512,1462476,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL184750,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
1513,1462481,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL187431,=,nM,29400.0,CHEMBL203,Homo sapiens,IC50,uM,29.4
1514,1462486,CHEMBL832893,In vitro inhibition of Epidermal growth factor receptor,B,CHEMBL186001,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1515,1482873,CHEMBL833554,Inhibition of epidermal growth factor receptor,B,CHEMBL177688,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36
1516,1483038,CHEMBL833554,Inhibition of epidermal growth factor receptor,B,CHEMBL188386,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
1517,1487653,CHEMBL829442,Inhibition of Epidermal growth factor receptor,B,CHEMBL363130,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4
1518,1489568,CHEMBL829442,Inhibition of Epidermal growth factor receptor,B,CHEMBL363607,=,nM,45800.0,CHEMBL203,Homo sapiens,IC50,uM,45.8
1519,1495537,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL190651,=,nM,252.0,CHEMBL203,Homo sapiens,IC50,nM,252.0
1520,1495538,CHEMBL832979,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1000-10000 nM,B,CHEMBL190651,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
1521,1495539,CHEMBL827826,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 10000-50000 nM,B,CHEMBL190651,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,nM,50000.0
1522,1495544,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL192737,=,nM,174.0,CHEMBL203,Homo sapiens,IC50,nM,174.0
1523,1495547,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL190567,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
1524,1495548,CHEMBL829928,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1000-5000 nM,B,CHEMBL190567,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,nM,5000.0
1525,1495549,CHEMBL833025,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL190567,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,nM,50000.0
1526,1495550,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL275762,=,nM,0.07,CHEMBL203,Homo sapiens,IC50,nM,0.07
1527,1495551,CHEMBL828302,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 5-25 nM,B,CHEMBL275762,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
1528,1495552,CHEMBL829089,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 25-50 nM,B,CHEMBL275762,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
1529,1495553,CHEMBL828032,Inhibition of HER1 kinase in intact DHER14 cells; Range = 5-15 nM,B,CHEMBL275762,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1530,1495556,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL193159,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
1531,1495652,CHEMBL831153,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL193159,<,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1532,1495653,CHEMBL833025,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL193159,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1533,1495654,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL193160,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
1534,1495655,CHEMBL828301,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 4-10 nM,B,CHEMBL193160,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1535,1495656,CHEMBL833025,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL193160,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
1536,1495657,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL190094,=,nM,0.11,CHEMBL203,Homo sapiens,IC50,nM,0.11
1537,1495658,CHEMBL828301,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 4-10 nM,B,CHEMBL190094,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1538,1495659,CHEMBL829088,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 10-50 nM,B,CHEMBL190094,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
1539,1495660,CHEMBL831695,Inhibition of HER1 kinase in intact DHER14 cells,B,CHEMBL190094,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1540,1495663,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL94061,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
1541,1495664,CHEMBL828300,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1-10 nM,B,CHEMBL94061,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1542,1495665,CHEMBL828089,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 1-10 nM,B,CHEMBL94061,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1543,1495666,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL189779,=,nM,0.94,CHEMBL203,Homo sapiens,IC50,nM,0.94
1544,1495667,CHEMBL831153,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL189779,<,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1545,1495668,CHEMBL833025,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL189779,<,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1546,1495669,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL372246,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,nM,6000.0
1547,1495670,CHEMBL831153,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL372246,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,nM,250.0
1548,1495672,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL365805,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,nM,13000.0
1549,1495673,CHEMBL832921,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 50-250 nM,B,CHEMBL365805,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,nM,250.0
1550,1495676,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL437879,=,nM,0.208,CHEMBL203,Homo sapiens,IC50,nM,0.208
1551,1495677,CHEMBL827827,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 3-5 nM,B,CHEMBL437879,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1552,1495678,CHEMBL832761,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate,B,CHEMBL363815,=,nM,0.037,CHEMBL203,Homo sapiens,IC50,nM,0.037
1553,1495679,CHEMBL832922,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 6.7-20 nM,B,CHEMBL363815,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
1554,1495680,CHEMBL829536,Inhibition of EGF Receptor autophosphorylation in A431 cell lysate; Range = 6.7-20 nM,B,CHEMBL363815,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
1555,1512374,CHEMBL830273,Inhibition of human epidermal growth factor receptor (HER-1),B,CHEMBL195218,=,nM,4200.0,CHEMBL203,Homo sapiens,IC50,uM,4.2
1556,1512386,CHEMBL830273,Inhibition of human epidermal growth factor receptor (HER-1),B,CHEMBL370266,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
1557,1601098,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196018,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
1558,1601100,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL370934,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
1559,1601102,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL372112,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1560,1601104,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL371863,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1561,1601106,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196925,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1562,1601108,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL194349,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61
1563,1601110,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL425738,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1564,1601112,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196738,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1565,1601114,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL365606,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1566,1601116,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL438805,=,nM,950.0,CHEMBL203,Homo sapiens,IC50,uM,0.95
1567,1601129,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196438,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1568,1601131,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL194958,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1569,1601133,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL197689,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
1570,1601135,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL372293,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1571,1601137,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL372523,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
1572,1601139,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL373025,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
1573,1601141,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL369967,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
1574,1601143,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL196548,=,nM,950.0,CHEMBL203,Homo sapiens,IC50,uM,0.95
1575,1601145,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL194160,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1576,1601152,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL372692,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
1577,1601154,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL193681,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
1578,1601158,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL193368,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
1579,1601162,CHEMBL881943,In vitro inhibitory concentration against EGFR cytoplasmic sequence expressed in Sf9 cells,B,CHEMBL412367,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
1580,1603448,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL371888,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059
1581,1603450,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL444619,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
1582,1603452,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL197640,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
1583,1603458,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL197525,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
1584,1603460,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL193578,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
1585,1603472,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL193544,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
1586,1603492,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL436511,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
1587,1603494,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL195204,=,nM,698.0,CHEMBL203,Homo sapiens,IC50,uM,0.698
1588,1603496,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL194337,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
1589,1603498,CHEMBL881949,Inhibitory concentration against EGFR kinase phosphorylation using synthetic peptide as a substrate,B,CHEMBL194389,=,nM,440.0,CHEMBL203,Homo sapiens,IC50,uM,0.44
1590,1605366,CHEMBL881766,In vitro inhibitory concentration EGF receptor with ATP concentration at 1/2Km,B,CHEMBL401930,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,nM,1600.0
1591,1607553,CHEMBL857670,Inhibitory concentration of EGFr,B,CHEMBL195029,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
1592,1664709,CHEMBL863537,Inhibitory activity against HER1,B,CHEMBL370808,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,uM,5.2
1593,1677858,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL201840,=,nM,12600.0,CHEMBL203,Homo sapiens,IC50,uM,12.6
1594,1677862,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL78257,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
1595,1677863,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL200976,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
1596,1677864,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL202244,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
1597,1677865,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL383030,=,nM,13600.0,CHEMBL203,Homo sapiens,IC50,uM,13.6
1598,1677866,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL202162,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
1599,1677867,CHEMBL862242,Inhibitory activity against EGFR kinase,B,CHEMBL201865,=,nM,31000.0,CHEMBL203,Homo sapiens,IC50,uM,31.0
1600,1678204,CHEMBL860874,Inhibitory activity against EGFR,B,CHEMBL201307,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
1601,1681964,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL545315,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
1602,1681969,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL437890,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
1603,1681970,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL203599,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
1604,1681971,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL205059,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
1605,1681972,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL204638,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
1606,1681973,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL203661,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
1607,1681974,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202556,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1608,1681975,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202421,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
1609,1681976,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL383499,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
1610,1681977,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202425,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1611,1681978,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202424,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1612,1681979,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL203645,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
1613,1681980,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL203644,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
1614,1681981,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL378144,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
1615,1681982,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL204085,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
1616,1681983,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL382073,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
1617,1681984,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202621,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,nM,86.0
1618,1681985,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202398,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
1619,1681986,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL380669,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
1620,1681987,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL373207,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1621,1681988,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202411,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
1622,1681989,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL91867,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
1623,1681990,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL202360,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
1624,1682080,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL553,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
1625,1682081,CHEMBL862512,Inhibition of erbB1 fusion protein expressed in baculovirus by ELISA,B,CHEMBL939,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
1626,1691387,CHEMBL867748,Inhibition of EGFR,B,CHEMBL382862,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
1627,1696689,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL203295,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
1628,1696691,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL205776,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,nM,66.0
1629,1696692,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL382041,=,nM,671.0,CHEMBL203,Homo sapiens,IC50,nM,671.0
1630,1696693,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL379017,=,nM,9601.0,CHEMBL203,Homo sapiens,IC50,nM,9601.0
1631,1696694,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL204330,=,nM,873.0,CHEMBL203,Homo sapiens,IC50,nM,873.0
1632,1696695,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL203779,<,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1633,1696696,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL204105,<,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1634,1696697,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL205149,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1635,1696698,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL203725,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
1636,1696699,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL203936,=,nM,225.0,CHEMBL203,Homo sapiens,IC50,nM,225.0
1637,1696700,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL377277,=,nM,8068.0,CHEMBL203,Homo sapiens,IC50,nM,8068.0
1638,1696701,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL204268,=,nM,187.0,CHEMBL203,Homo sapiens,IC50,nM,187.0
1639,1696702,CHEMBL868329,Inhibitory activity against EGFR,B,CHEMBL205783,=,nM,1384.0,CHEMBL203,Homo sapiens,IC50,nM,1384.0
1640,1697598,CHEMBL867748,Inhibition of EGFR,B,CHEMBL381306,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
1641,1697599,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL381306,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
1642,1697600,CHEMBL867748,Inhibition of EGFR,B,CHEMBL204223,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
1643,1697601,CHEMBL867748,Inhibition of EGFR,B,CHEMBL202970,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
1644,1697602,CHEMBL867748,Inhibition of EGFR,B,CHEMBL380972,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
1645,1697603,CHEMBL867748,Inhibition of EGFR,B,CHEMBL425402,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
1646,1697604,CHEMBL867748,Inhibition of EGFR,B,CHEMBL203219,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
1647,1697605,CHEMBL867748,Inhibition of EGFR,B,CHEMBL204164,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
1648,1697606,CHEMBL867748,Inhibition of EGFR,B,CHEMBL381541,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
1649,1697608,CHEMBL867748,Inhibition of EGFR,B,CHEMBL382186,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
1650,1697609,CHEMBL867748,Inhibition of EGFR,B,CHEMBL206197,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
1651,1697610,CHEMBL867748,Inhibition of EGFR,B,CHEMBL203132,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
1652,1697611,CHEMBL867748,Inhibition of EGFR,B,CHEMBL206848,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
1653,1697612,CHEMBL867748,Inhibition of EGFR,B,CHEMBL205148,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1654,1697616,CHEMBL867748,Inhibition of EGFR,B,CHEMBL206320,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1655,1697617,CHEMBL867748,Inhibition of EGFR,B,CHEMBL426124,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
1656,1697618,CHEMBL867748,Inhibition of EGFR,B,CHEMBL206347,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1657,1697619,CHEMBL867748,Inhibition of EGFR,B,CHEMBL424853,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1658,1697620,CHEMBL867748,Inhibition of EGFR,B,CHEMBL205676,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1659,1697621,CHEMBL867748,Inhibition of EGFR,B,CHEMBL206280,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1660,1697622,CHEMBL867748,Inhibition of EGFR,B,CHEMBL383444,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
1661,1697623,CHEMBL867748,Inhibition of EGFR,B,CHEMBL204715,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
1662,1697624,CHEMBL867748,Inhibition of EGFR,B,CHEMBL204965,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
1663,1697625,CHEMBL867748,Inhibition of EGFR,B,CHEMBL378145,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
1664,1697626,CHEMBL867748,Inhibition of EGFR,B,CHEMBL383614,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1665,1697627,CHEMBL867748,Inhibition of EGFR,B,CHEMBL205454,=,nM,5800.0,CHEMBL203,Homo sapiens,IC50,uM,5.8
1666,1697629,CHEMBL867748,Inhibition of EGFR,B,CHEMBL383121,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
1667,1697630,CHEMBL867748,Inhibition of EGFR,B,CHEMBL203529,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
1668,1697631,CHEMBL867748,Inhibition of EGFR,B,CHEMBL204335,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
1669,1697632,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL202970,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
1670,1697633,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL380972,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
1671,1697634,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL425402,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
1672,1697635,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL203219,=,nM,8100.0,CHEMBL203,Homo sapiens,IC50,uM,8.1
1673,1697636,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL204164,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
1674,1697637,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL381541,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
1675,1697639,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL382186,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
1676,1697640,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL206197,=,nM,9100.0,CHEMBL203,Homo sapiens,IC50,uM,9.1
1677,1697646,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL206370,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8
1678,1697647,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL206320,=,nM,9900.0,CHEMBL203,Homo sapiens,IC50,uM,9.9
1679,1697648,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL426124,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
1680,1697649,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL206347,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
1681,1697650,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL424853,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
1682,1697651,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL205676,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
1683,1697652,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL206280,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4
1684,1697653,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL383444,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1685,1697654,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL204715,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
1686,1697655,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL204965,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
1687,1697657,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL383614,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
1688,1697662,CHEMBL867749,Inhibition of EGFR autophosphorylation in DiFi cells,B,CHEMBL204335,=,nM,8500.0,CHEMBL203,Homo sapiens,IC50,uM,8.5
1689,1697664,CHEMBL867748,Inhibition of EGFR,B,CHEMBL379041,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
1690,1704010,CHEMBL861201,Inhibitory activity against recombinant human EGFR,B,CHEMBL606964,=,nM,545.0,CHEMBL203,Homo sapiens,IC50,nM,545.0
1691,1705156,CHEMBL863780,Inhibition of EGFR kinase activity,B,CHEMBL206483,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
1692,1709990,CHEMBL861550,Inhibition of EGFR,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1693,1710010,CHEMBL861550,Inhibition of EGFR,B,CHEMBL206029,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
1694,1710011,CHEMBL861550,Inhibition of EGFR,B,CHEMBL380078,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
1695,1710012,CHEMBL861550,Inhibition of EGFR,B,CHEMBL206003,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
1696,1710013,CHEMBL861550,Inhibition of EGFR,B,CHEMBL204570,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
1697,1710014,CHEMBL861550,Inhibition of EGFR,B,CHEMBL204467,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
1698,1710015,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205047,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
1699,1710016,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205765,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,uM,0.091
1700,1710017,CHEMBL861550,Inhibition of EGFR,B,CHEMBL381604,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
1701,1710018,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205284,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
1702,1710019,CHEMBL861550,Inhibition of EGFR,B,CHEMBL207869,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,uM,0.077
1703,1710020,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205045,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
1704,1710021,CHEMBL861550,Inhibition of EGFR,B,CHEMBL438440,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,uM,0.074
1705,1710022,CHEMBL861550,Inhibition of EGFR,B,CHEMBL206782,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
1706,1710023,CHEMBL861550,Inhibition of EGFR,B,CHEMBL381080,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1707,1710024,CHEMBL861550,Inhibition of EGFR,B,CHEMBL207247,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
1708,1710025,CHEMBL861550,Inhibition of EGFR,B,CHEMBL207410,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
1709,1710026,CHEMBL861550,Inhibition of EGFR,B,CHEMBL208358,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1710,1710027,CHEMBL861550,Inhibition of EGFR,B,CHEMBL438075,=,nM,25100.0,CHEMBL203,Homo sapiens,IC50,uM,25.1
1711,1710028,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205798,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
1712,1710029,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205966,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1713,1710030,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205235,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
1714,1710031,CHEMBL861550,Inhibition of EGFR,B,CHEMBL204625,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
1715,1710032,CHEMBL861550,Inhibition of EGFR,B,CHEMBL379093,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
1716,1710033,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205870,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
1717,1710034,CHEMBL861550,Inhibition of EGFR,B,CHEMBL205652,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32
1718,1715556,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
1719,1715557,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207815,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1720,1715558,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL425601,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
1721,1715559,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207718,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1722,1715560,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL383246,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
1723,1715561,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207130,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
1724,1715562,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL380889,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1725,1715563,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207445,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1726,1715564,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL379905,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1727,1715565,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL208286,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1728,1715566,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL376967,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1729,1715567,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL382823,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1730,1715568,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL208048,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
1731,1715569,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL378370,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1732,1715570,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL380006,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
1733,1715571,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL211003,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1734,1715572,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207687,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1735,1715573,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL208118,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
1736,1715574,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL379601,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1737,1715575,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL380386,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
1738,1715576,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207037,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1739,1715577,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207246,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
1740,1715578,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207674,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1741,1715579,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL206783,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
1742,1715580,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL204420,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1743,1715581,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL377772,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
1744,1715582,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL380454,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
1745,1715583,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL382822,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
1746,1715584,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL383760,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1747,1715585,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207235,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1748,1715586,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL208292,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
1749,1715587,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL207584,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1750,1715588,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL382638,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
1751,1715589,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL206955,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
1752,1715590,CHEMBL853149,Inhibition of EGFR in presence of 2 uM ATP,B,CHEMBL437885,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,uM,0.36
1753,1721395,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL336113,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
1754,1721396,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210893,=,nM,294.0,CHEMBL203,Homo sapiens,IC50,nM,294.0
1755,1721397,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210378,=,nM,204.0,CHEMBL203,Homo sapiens,IC50,nM,204.0
1756,1721398,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL209818,=,nM,1139.0,CHEMBL203,Homo sapiens,IC50,nM,1139.0
1757,1721399,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210660,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
1758,1721400,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210659,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,nM,67.0
1759,1721401,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210502,=,nM,1061.0,CHEMBL203,Homo sapiens,IC50,nM,1061.0
1760,1721402,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL379047,=,nM,156.0,CHEMBL203,Homo sapiens,IC50,nM,156.0
1761,1721403,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL208144,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
1762,1721404,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL208849,=,nM,1693.0,CHEMBL203,Homo sapiens,IC50,nM,1693.0
1763,1721405,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL207009,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
1764,1721406,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL210444,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
1765,1721407,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL208240,=,nM,676.0,CHEMBL203,Homo sapiens,IC50,nM,676.0
1766,1721408,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL50344,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1767,1721409,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL209343,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1768,1721410,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL208594,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
1769,1721411,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL52765,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
1770,1721412,CHEMBL870841,Inhibition of EGFR tyrosine kinase,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
1771,1758667,CHEMBL866710,Inhibition of EGFR-mediated polyGAT phosphorylation at 10 uM,B,CHEMBL213560,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
1772,1766862,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL554,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
1773,1766863,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL212965,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
1774,1766864,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL215716,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
1775,1766865,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL212954,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
1776,1766866,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL377250,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,uM,0.089
1777,1766867,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL445572,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
1778,1766868,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL384407,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
1779,1766869,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL212251,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
1780,1766870,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL212201,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1781,1766871,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL212250,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
1782,1766872,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL215171,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
1783,1766873,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL265367,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
1784,1766874,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL214023,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
1785,1766875,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL1794063,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
1786,1766876,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL214487,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
1787,1766877,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL383965,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
1788,1766878,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL215814,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
1789,1766879,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL387207,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
1790,1766880,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL215033,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
1791,1766881,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL214689,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
1792,1766882,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL380247,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
1793,1766883,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL214419,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,uM,0.091
1794,1766884,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL384711,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
1795,1766885,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL213818,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
1796,1766886,CHEMBL910357,Inhibition of ErbB1,B,CHEMBL213342,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
1797,1768008,CHEMBL856356,Inhibition of EGFR,B,CHEMBL939,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
1798,1768027,CHEMBL856356,Inhibition of EGFR,B,CHEMBL385479,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
1799,1768040,CHEMBL856356,Inhibition of EGFR,B,CHEMBL384699,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
1800,1768054,CHEMBL856356,Inhibition of EGFR,B,CHEMBL213874,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1801,1768058,CHEMBL856356,Inhibition of EGFR,B,CHEMBL214631,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
1802,1768059,CHEMBL856356,Inhibition of EGFR,B,CHEMBL385471,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
1803,1768060,CHEMBL856356,Inhibition of EGFR,B,CHEMBL276154,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1804,1768061,CHEMBL856356,Inhibition of EGFR,B,CHEMBL215786,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
1805,1768062,CHEMBL856356,Inhibition of EGFR,B,CHEMBL214798,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1806,1768207,CHEMBL856356,Inhibition of EGFR,B,CHEMBL213007,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
1807,1768208,CHEMBL856356,Inhibition of EGFR,B,CHEMBL214478,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
1808,1768209,CHEMBL856356,Inhibition of EGFR,B,CHEMBL215559,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
1809,1768210,CHEMBL856356,Inhibition of EGFR,B,CHEMBL387265,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1810,1768211,CHEMBL856356,Inhibition of EGFR,B,CHEMBL218677,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
1811,1768212,CHEMBL856356,Inhibition of EGFR,B,CHEMBL214857,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
1812,1777396,CHEMBL908277,Inhibition of EGFR tyrosine kinase activity,B,CHEMBL29197,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
1813,1777398,CHEMBL908277,Inhibition of EGFR tyrosine kinase activity,B,CHEMBL285063,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
1814,1777403,CHEMBL908277,Inhibition of EGFR tyrosine kinase activity,B,CHEMBL217536,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
1815,1778609,CHEMBL912344,Inhibition of Her1,B,CHEMBL364623,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,nM,5200.0
1816,1778613,CHEMBL912344,Inhibition of Her1,B,CHEMBL1421,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,nM,180.0
1817,1779364,CHEMBL854974,Inhibition of recombinant EGFR by ELISA,B,CHEMBL217090,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
1818,1779386,CHEMBL854974,Inhibition of recombinant EGFR by ELISA,B,CHEMBL217092,=,nM,2590.0,CHEMBL203,Homo sapiens,IC50,uM,2.59
1819,1790429,CHEMBL912717,Inhibition of human EGFR,B,CHEMBL201511,=,nM,32000.0,CHEMBL203,Homo sapiens,IC50,M,0.000032
1820,1790452,CHEMBL856400,Inhibition of EGFR,B,CHEMBL387187,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
1821,1800144,CHEMBL910453,Inhibitory activity against EGFR,B,CHEMBL219557,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
1822,1807171,CHEMBL908988,Inhibition of EGFR,B,CHEMBL436137,=,nM,965.0,CHEMBL203,Homo sapiens,IC50,uM,0.965
1823,1815207,CHEMBL908512,Inhibition of EGFR,B,CHEMBL373882,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
1824,1841816,CHEMBL914501,Inhibition of Her1 kinase,B,CHEMBL1421,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,nM,180.0
1825,1846664,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204261,=,nM,8.17,CHEMBL203,Homo sapiens,IC50,nM,8.17
1826,1846665,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203934,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
1827,1846666,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204360,=,nM,32.2,CHEMBL203,Homo sapiens,IC50,nM,32.2
1828,1846667,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203940,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
1829,1846668,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203939,=,nM,9.31,CHEMBL203,Homo sapiens,IC50,nM,9.31
1830,1846669,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203938,=,nM,47.7,CHEMBL203,Homo sapiens,IC50,nM,47.7
1831,1846670,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203937,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
1832,1846671,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203936,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
1833,1846672,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1203935,=,nM,8.95,CHEMBL203,Homo sapiens,IC50,nM,8.95
1834,1846673,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204305,=,nM,1.05,CHEMBL203,Homo sapiens,IC50,nM,1.05
1835,1846674,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204168,=,nM,0.66,CHEMBL203,Homo sapiens,IC50,nM,0.66
1836,1846675,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL540068,=,nM,1.26,CHEMBL203,Homo sapiens,IC50,nM,1.26
1837,1846676,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL541586,=,nM,31.9,CHEMBL203,Homo sapiens,IC50,nM,31.9
1838,1846677,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204262,=,nM,0.64,CHEMBL203,Homo sapiens,IC50,nM,0.64
1839,1846678,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL1204199,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
1840,1846679,CHEMBL916319,"Displacement of [125I]4-(3-iodoanilino)-6,7-dimethoxyquinazoline from EGFR tyrosine kinase in human A431 cell membranes",B,CHEMBL2447950,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
1841,1856212,CHEMBL919737,Inhibition of EGFR,B,CHEMBL534948,=,nM,2730.0,CHEMBL203,Homo sapiens,IC50,uM,2.73
1842,1881004,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1843,1881008,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL225721,=,nM,970.0,CHEMBL203,Homo sapiens,IC50,uM,0.97
1844,1881009,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL225720,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,uM,0.037
1845,1881010,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL225930,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
1846,1881011,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL388286,=,nM,3960.0,CHEMBL203,Homo sapiens,IC50,uM,3.96
1847,1881012,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL225929,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
1848,1881013,CHEMBL904734,Inhibition of EGFR tyrosine kinase expressed in A431 cells,B,CHEMBL225928,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,uM,0.0044
1849,1943156,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL607707,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
1850,1943157,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL607707,=,nM,34.9,CHEMBL203,Homo sapiens,IC50,nM,34.9
1851,1943179,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL242349,=,nM,7710.0,CHEMBL203,Homo sapiens,IC50,nM,7710.0
1852,1943180,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL24828,=,nM,112.4,CHEMBL203,Homo sapiens,IC50,nM,112.4
1853,1943181,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL101253,=,nM,457.7,CHEMBL203,Homo sapiens,IC50,nM,457.7
1854,1943182,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL939,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
1855,1943183,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL29197,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
1856,1943184,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL242131,<,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1857,1943185,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL241919,=,nM,24.9,CHEMBL203,Homo sapiens,IC50,nM,24.9
1858,1943186,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL241918,=,nM,107.3,CHEMBL203,Homo sapiens,IC50,nM,107.3
1859,1943187,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL243839,=,nM,47.5,CHEMBL203,Homo sapiens,IC50,nM,47.5
1860,1943188,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL243837,=,nM,12.2,CHEMBL203,Homo sapiens,IC50,nM,12.2
1861,1943189,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL398154,=,nM,90.8,CHEMBL203,Homo sapiens,IC50,nM,90.8
1862,1943190,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL243629,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7
1863,1943191,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL243628,=,nM,166.7,CHEMBL203,Homo sapiens,IC50,nM,166.7
1864,1943192,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL428741,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
1865,1943193,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL243410,=,nM,283.3,CHEMBL203,Homo sapiens,IC50,nM,283.3
1866,1943194,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL428039,=,nM,799.3,CHEMBL203,Homo sapiens,IC50,nM,799.3
1867,1943195,CHEMBL892951,Inhibition of human EGFR in presence of 1 uM ATP,B,CHEMBL180022,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
1868,1943201,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL939,=,nM,2753.0,CHEMBL203,Homo sapiens,IC50,nM,2753.0
1869,1943203,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL242131,=,nM,704.0,CHEMBL203,Homo sapiens,IC50,nM,704.0
1870,1943204,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL241919,=,nM,173.1,CHEMBL203,Homo sapiens,IC50,nM,173.1
1871,1943205,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL241918,=,nM,346.9,CHEMBL203,Homo sapiens,IC50,nM,346.9
1872,1943206,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL243839,=,nM,295.2,CHEMBL203,Homo sapiens,IC50,nM,295.2
1873,1943207,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL243837,=,nM,35.6,CHEMBL203,Homo sapiens,IC50,nM,35.6
1874,1943208,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL398154,=,nM,791.9,CHEMBL203,Homo sapiens,IC50,nM,791.9
1875,1943209,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL243629,=,nM,216.2,CHEMBL203,Homo sapiens,IC50,nM,216.2
1876,1943210,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL243628,=,nM,894.3,CHEMBL203,Homo sapiens,IC50,nM,894.3
1877,1943211,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL428741,=,nM,43.1,CHEMBL203,Homo sapiens,IC50,nM,43.1
1878,1943212,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL243410,=,nM,2089.0,CHEMBL203,Homo sapiens,IC50,nM,2089.0
1879,1943214,CHEMBL892954,Inhibition of human EGFR in presence of 1 mM ATP,B,CHEMBL180022,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
1880,1951262,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL427671,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
1881,1951288,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL398793,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
1882,1951289,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL392774,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
1883,1951290,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL234580,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
1884,1951291,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL393787,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1885,1951292,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL233325,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
1886,1951293,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL233324,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
1887,1951294,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL400413,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
1888,1951295,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL234577,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
1889,1951296,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL392273,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
1890,1951297,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL231885,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
1891,1951298,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL265629,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
1892,1951299,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL232082,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
1893,1951300,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL231875,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
1894,1951301,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL398388,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
1895,1951302,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL231663,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
1896,1951303,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL234772,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
1897,1951304,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL401443,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
1898,1951305,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL391675,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
1899,1951306,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL391521,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1900,1951307,CHEMBL893470,Inhibition of human EGFR,B,CHEMBL391321,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
1901,1980880,CHEMBL898017,Inhibition of EGFR kinase autophosphorylation in A431 cells,B,CHEMBL200381,<,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
1902,1980886,CHEMBL898017,Inhibition of EGFR kinase autophosphorylation in A431 cells,B,CHEMBL238322,<,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
1903,1980916,CHEMBL898017,Inhibition of EGFR kinase autophosphorylation in A431 cells,B,CHEMBL220037,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1904,2017697,CHEMBL885861,Inhibition of EGFR,B,CHEMBL391738,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,nM,720.0
1905,2021342,CHEMBL903494,Inhibition of EGFR,B,CHEMBL188304,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
1906,2021343,CHEMBL903494,Inhibition of EGFR,B,CHEMBL427671,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
1907,2021344,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394463,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
1908,2021345,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394462,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1909,2021346,CHEMBL903494,Inhibition of EGFR,B,CHEMBL429827,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
1910,2021347,CHEMBL903494,Inhibition of EGFR,B,CHEMBL247101,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
1911,2021348,CHEMBL903494,Inhibition of EGFR,B,CHEMBL247100,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
1912,2021366,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246276,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1913,2021367,CHEMBL903494,Inhibition of EGFR,B,CHEMBL395591,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
1914,2021368,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246492,=,nM,640.0,CHEMBL203,Homo sapiens,IC50,uM,0.64
1915,2021369,CHEMBL903494,Inhibition of EGFR,B,CHEMBL428046,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083
1916,2021370,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246284,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
1917,2021371,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246073,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
1918,2021372,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246072,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
1919,2021373,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245869,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,uM,0.073
1920,2021374,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245868,=,nM,620.0,CHEMBL203,Homo sapiens,IC50,uM,0.62
1921,2021375,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245867,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
1922,2021376,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245667,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
1923,2021377,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394333,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
1924,2021378,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246694,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
1925,2021379,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246491,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,uM,0.46
1926,2021380,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394057,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
1927,2021381,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246489,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
1928,2021382,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394056,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
1929,2021450,CHEMBL903494,Inhibition of EGFR,B,CHEMBL246493,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
1930,2021451,CHEMBL903494,Inhibition of EGFR,B,CHEMBL397122,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
1931,2021452,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245278,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
1932,2021453,CHEMBL903494,Inhibition of EGFR,B,CHEMBL245277,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
1933,2021454,CHEMBL903494,Inhibition of EGFR,B,CHEMBL394495,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
1934,2021455,CHEMBL903494,Inhibition of EGFR,B,CHEMBL247127,=,nM,810.0,CHEMBL203,Homo sapiens,IC50,uM,0.81
1935,2021456,CHEMBL903494,Inhibition of EGFR,B,CHEMBL396079,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
1936,2021465,CHEMBL903494,Inhibition of EGFR,B,CHEMBL395883,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
1937,2022204,CHEMBL902558,Inhibition of EGFR,B,CHEMBL247468,=,nM,397.0,CHEMBL203,Homo sapiens,IC50,uM,0.397
1938,2022212,CHEMBL902558,Inhibition of EGFR,B,CHEMBL247866,=,nM,1029.0,CHEMBL203,Homo sapiens,IC50,uM,1.029
1939,2025985,CHEMBL887090,Inhibition of EGFR by radioactive filtration assay,B,CHEMBL246356,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
1940,2038871,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL246284,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
1941,2038902,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248322,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
1942,2038903,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248321,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
1943,2038904,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248116,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
1944,2038905,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248115,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
1945,2038906,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL391387,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
1946,2038907,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248114,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
1947,2038908,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247916,=,nM,530.0,CHEMBL203,Homo sapiens,IC50,uM,0.53
1948,2038909,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247915,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
1949,2038910,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247914,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
1950,2038911,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL391181,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
1951,2038912,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247711,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
1952,2038913,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL395883,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
1953,2038914,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247710,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
1954,2038915,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247709,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
1955,2038916,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL246493,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
1956,2038917,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL393264,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1957,2038918,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247513,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1958,2038919,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247512,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
1959,2038920,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247309,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
1960,2038921,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL246898,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
1961,2038922,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL247104,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
1962,2038923,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL391779,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
1963,2038924,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL391778,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
1964,2038925,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL246687,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
1965,2038926,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL393848,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
1966,2038927,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL392664,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
1967,2038928,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL248108,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
1968,2038929,CHEMBL923201,Inhibition of human recombinant EGFR expressed in insect Sf9 cells,B,CHEMBL392273,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
1969,2045359,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248044,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
1970,2045383,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL399438,=,nM,234.0,CHEMBL203,Homo sapiens,IC50,nM,234.0
1971,2045384,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL247024,=,nM,2530.0,CHEMBL203,Homo sapiens,IC50,nM,2530.0
1972,2045385,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL245800,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,nM,2100.0
1973,2045386,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL245799,=,nM,5260.0,CHEMBL203,Homo sapiens,IC50,nM,5260.0
1974,2045387,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL245798,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
1975,2045388,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248393,=,nM,5.7,CHEMBL203,Homo sapiens,IC50,nM,5.7
1976,2045389,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248392,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1977,2045390,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL401251,=,nM,52.8,CHEMBL203,Homo sapiens,IC50,nM,52.8
1978,2045391,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248391,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0
1979,2045392,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248222,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
1980,2045394,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL401054,=,nM,405.0,CHEMBL203,Homo sapiens,IC50,nM,405.0
1981,2045395,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248220,=,nM,1610.0,CHEMBL203,Homo sapiens,IC50,nM,1610.0
1982,2045396,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL401644,=,nM,8270.0,CHEMBL203,Homo sapiens,IC50,nM,8270.0
1983,2045397,CHEMBL923922,Inhibition of human EGFR autophosphorylation in A431 cells,B,CHEMBL248045,=,nM,2580.0,CHEMBL203,Homo sapiens,IC50,nM,2580.0
1984,2047149,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250315,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,nM,5600.0
1985,2047150,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL251315,=,nM,662.0,CHEMBL203,Homo sapiens,IC50,nM,662.0
1986,2047151,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL399373,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
1987,2047152,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL251314,=,nM,11.7,CHEMBL203,Homo sapiens,IC50,nM,11.7
1988,2047153,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL251125,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
1989,2047154,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL399372,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
1990,2047155,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL251124,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
1991,2047156,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL251123,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0
1992,2047157,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL399371,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
1993,2047158,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250925,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
1994,2047159,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250924,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
1995,2047160,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250923,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
1996,2047161,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085381,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
1997,2047162,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085380,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0
1998,2047163,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085379,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
1999,2047164,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085378,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,nM,1200.0
2000,2047165,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085377,=,nM,7300.0,CHEMBL203,Homo sapiens,IC50,nM,7300.0
2001,2047166,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085376,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2002,2047167,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085375,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
2003,2047168,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL3085374,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2004,2047169,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250524,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
2005,2047170,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL399953,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
2006,2047171,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250523,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
2007,2047172,CHEMBL925198,Inhibition of partially purified EGFR tyrosine kinase from human A431 cells,B,CHEMBL250318,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
2008,2047569,CHEMBL924156,Inhibition of EGFR,B,CHEMBL249927,=,nM,97.0,CHEMBL203,Homo sapiens,IC50,nM,97.0
2009,2047570,CHEMBL924156,Inhibition of EGFR,B,CHEMBL413987,=,nM,191.0,CHEMBL203,Homo sapiens,IC50,nM,191.0
2010,2047571,CHEMBL924156,Inhibition of EGFR,B,CHEMBL250132,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
2011,2047572,CHEMBL924156,Inhibition of EGFR,B,CHEMBL403785,=,nM,2580.0,CHEMBL203,Homo sapiens,IC50,nM,2580.0
2012,2047573,CHEMBL924156,Inhibition of EGFR,B,CHEMBL250130,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2013,2047574,CHEMBL924156,Inhibition of EGFR,B,CHEMBL249928,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
2014,2047575,CHEMBL924156,Inhibition of EGFR,B,CHEMBL403569,=,nM,327.0,CHEMBL203,Homo sapiens,IC50,nM,327.0
2015,2048875,CHEMBL924351,Inhibition of EGFR,B,CHEMBL939,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
2016,2048876,CHEMBL924351,Inhibition of EGFR,B,CHEMBL553,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
2017,2048877,CHEMBL924351,Inhibition of EGFR,B,CHEMBL248864,=,nM,205.8,CHEMBL203,Homo sapiens,IC50,nM,205.8
2018,2048878,CHEMBL924351,Inhibition of EGFR,B,CHEMBL437197,=,nM,1362.6,CHEMBL203,Homo sapiens,IC50,nM,1362.6
2019,2048879,CHEMBL924351,Inhibition of EGFR,B,CHEMBL248674,=,nM,402.1,CHEMBL203,Homo sapiens,IC50,nM,402.1
2020,2048880,CHEMBL924351,Inhibition of EGFR,B,CHEMBL399736,=,nM,1643.6,CHEMBL203,Homo sapiens,IC50,nM,1643.6
2021,2048881,CHEMBL924351,Inhibition of EGFR,B,CHEMBL399735,=,nM,921.0,CHEMBL203,Homo sapiens,IC50,nM,921.0
2022,2048882,CHEMBL924351,Inhibition of EGFR,B,CHEMBL304929,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
2023,2048883,CHEMBL924351,Inhibition of EGFR,B,CHEMBL251700,=,nM,88.7,CHEMBL203,Homo sapiens,IC50,nM,88.7
2024,2048884,CHEMBL924351,Inhibition of EGFR,B,CHEMBL251498,=,nM,50.3,CHEMBL203,Homo sapiens,IC50,nM,50.3
2025,2048885,CHEMBL924351,Inhibition of EGFR,B,CHEMBL251497,=,nM,151.5,CHEMBL203,Homo sapiens,IC50,nM,151.5
2026,2048886,CHEMBL924351,Inhibition of EGFR,B,CHEMBL399928,=,nM,94.5,CHEMBL203,Homo sapiens,IC50,nM,94.5
2027,2048887,CHEMBL924351,Inhibition of EGFR,B,CHEMBL251291,=,nM,114.2,CHEMBL203,Homo sapiens,IC50,nM,114.2
2028,2048888,CHEMBL924351,Inhibition of EGFR,B,CHEMBL249921,=,nM,185.8,CHEMBL203,Homo sapiens,IC50,nM,185.8
2029,2048889,CHEMBL924351,Inhibition of EGFR,B,CHEMBL249919,=,nM,14.1,CHEMBL203,Homo sapiens,IC50,nM,14.1
2030,2048890,CHEMBL924351,Inhibition of EGFR,B,CHEMBL398963,=,nM,1640.6,CHEMBL203,Homo sapiens,IC50,nM,1640.6
2031,2048891,CHEMBL924351,Inhibition of EGFR,B,CHEMBL249511,=,nM,331.0,CHEMBL203,Homo sapiens,IC50,nM,331.0
2032,2048892,CHEMBL924351,Inhibition of EGFR,B,CHEMBL249509,=,nM,126.9,CHEMBL203,Homo sapiens,IC50,nM,126.9
2033,2080192,CHEMBL929547,Inhibition of EGFR,B,CHEMBL253292,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
2034,2082143,CHEMBL928913,Inhibition of EGFR,B,CHEMBL402011,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
2035,2082148,CHEMBL928914,Inhibition of EGF-stimulated human EGFR autophosphorylation in KB cells,B,CHEMBL257411,=,nM,366.0,CHEMBL203,Homo sapiens,IC50,uM,0.366
2036,2093098,CHEMBL930778,Inhibition of EGFR,B,CHEMBL428777,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
2037,2093140,CHEMBL930778,Inhibition of EGFR,B,CHEMBL256362,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
2038,2093141,CHEMBL930778,Inhibition of EGFR,B,CHEMBL257478,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2039,2098977,CHEMBL947896,Inhibition of EGFR,B,CHEMBL255376,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2040,2098978,CHEMBL947896,Inhibition of EGFR,B,CHEMBL272935,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
2041,2098979,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257860,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
2042,2098980,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257859,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2043,2098981,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257861,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2044,2098982,CHEMBL947896,Inhibition of EGFR,B,CHEMBL271705,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2045,2098983,CHEMBL947896,Inhibition of EGFR,B,CHEMBL411897,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
2046,2098984,CHEMBL947896,Inhibition of EGFR,B,CHEMBL270448,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2047,2098985,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257430,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
2048,2098986,CHEMBL947896,Inhibition of EGFR,B,CHEMBL402553,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
2049,2098987,CHEMBL947896,Inhibition of EGFR,B,CHEMBL258270,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
2050,2098988,CHEMBL947896,Inhibition of EGFR,B,CHEMBL258282,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
2051,2098989,CHEMBL947896,Inhibition of EGFR,B,CHEMBL255135,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
2052,2098990,CHEMBL947896,Inhibition of EGFR,B,CHEMBL401713,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,uM,0.104
2053,2098991,CHEMBL947896,Inhibition of EGFR,B,CHEMBL402339,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
2054,2098992,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257873,=,nM,1430.0,CHEMBL203,Homo sapiens,IC50,uM,1.43
2055,2098993,CHEMBL947896,Inhibition of EGFR,B,CHEMBL257872,=,nM,216.0,CHEMBL203,Homo sapiens,IC50,uM,0.216
2056,2098994,CHEMBL947896,Inhibition of EGFR,B,CHEMBL403435,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
2057,2098995,CHEMBL947896,Inhibition of EGFR,B,CHEMBL438536,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2058,2098996,CHEMBL947896,Inhibition of EGFR,B,CHEMBL255170,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
2059,2098997,CHEMBL947896,Inhibition of EGFR,B,CHEMBL404405,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
2060,2132653,CHEMBL921277,Inhibition of EGFR,B,CHEMBL410659,=,nM,9600.0,CHEMBL203,Homo sapiens,IC50,uM,9.6
2061,2133123,CHEMBL921778,Inhibition of EGFR,B,CHEMBL260861,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
2062,2136772,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL407534,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,nM,780.0
2063,2136802,CHEMBL940057,Inhibition of EGFR,B,CHEMBL406845,=,nM,480.0,CHEMBL203,Homo sapiens,IC50,nM,480.0
2064,2136831,CHEMBL937170,Inhibition of ErbB1,B,CHEMBL258940,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2065,2136832,CHEMBL937172,Inhibition of Her1,B,CHEMBL258940,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2066,2136920,CHEMBL940057,Inhibition of EGFR,B,CHEMBL244948,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,nM,7670.0
2067,2136927,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL328216,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,pM,120.0
2068,2136928,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL387187,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
2069,2136929,CHEMBL939338,Inhibition of EGFR L858R mutant,B,CHEMBL387187,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
2070,2136930,CHEMBL939339,Inhibition of EGFR L861Q mutant,B,CHEMBL387187,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
2071,2136934,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL35820,=,nM,0.006,CHEMBL203,Homo sapiens,IC50,pM,6.0
2072,2136956,CHEMBL939337,Inhibition of wild type EGFR,B,CHEMBL44,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,nM,2600.0
2073,2137059,CHEMBL937186,Inhibition of wild type EGFR,B,CHEMBL408565,=,nM,13300.0,CHEMBL203,Homo sapiens,IC50,nM,13300.0
2074,2137158,CHEMBL940057,Inhibition of EGFR,B,CHEMBL261238,=,nM,5000000.0,CHEMBL203,Homo sapiens,IC50,uM,5000.0
2075,2137189,CHEMBL940057,Inhibition of EGFR,B,CHEMBL258726,=,nM,320000.0,CHEMBL203,Homo sapiens,IC50,nM,320000.0
2076,2137195,CHEMBL940057,Inhibition of EGFR,B,CHEMBL437612,=,nM,440000.0,CHEMBL203,Homo sapiens,IC50,nM,440000.0
2077,2137199,CHEMBL921076,Inhibition of EGFR autophosphorylation,B,CHEMBL76904,=,nM,40000.0,CHEMBL203,Homo sapiens,IC50,nM,40000.0
2078,2137202,CHEMBL921076,Inhibition of EGFR autophosphorylation,B,CHEMBL56543,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
2079,2137367,CHEMBL940057,Inhibition of EGFR,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,pM,25.0
2080,2164862,CHEMBL929426,Inhibition of EGFR,B,CHEMBL258694,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
2081,2173105,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255871,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
2082,2173107,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255237,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
2083,2173108,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255236,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
2084,2173109,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255438,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
2085,2173110,CHEMBL934832,Inhibition of EGFR,B,CHEMBL402293,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
2086,2173111,CHEMBL934832,Inhibition of EGFR,B,CHEMBL430031,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
2087,2173112,CHEMBL934832,Inhibition of EGFR,B,CHEMBL402294,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
2088,2173113,CHEMBL934832,Inhibition of EGFR,B,CHEMBL256295,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
2089,2173115,CHEMBL934832,Inhibition of EGFR,B,CHEMBL256297,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
2090,2173116,CHEMBL934832,Inhibition of EGFR,B,CHEMBL257815,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2091,2173117,CHEMBL934832,Inhibition of EGFR,B,CHEMBL257814,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
2092,2173118,CHEMBL934832,Inhibition of EGFR,B,CHEMBL402316,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
2093,2173119,CHEMBL934832,Inhibition of EGFR,B,CHEMBL257816,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
2094,2173120,CHEMBL934832,Inhibition of EGFR,B,CHEMBL256527,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,uM,0.104
2095,2173121,CHEMBL934832,Inhibition of EGFR,B,CHEMBL256529,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
2096,2173122,CHEMBL934832,Inhibition of EGFR,B,CHEMBL403357,=,nM,267.0,CHEMBL203,Homo sapiens,IC50,uM,0.267
2097,2173123,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255865,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
2098,2173124,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255656,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
2099,2173125,CHEMBL934832,Inhibition of EGFR,B,CHEMBL402113,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
2100,2173126,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255866,=,nM,306.0,CHEMBL203,Homo sapiens,IC50,uM,0.306
2101,2173127,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255291,=,nM,1123.0,CHEMBL203,Homo sapiens,IC50,uM,1.123
2102,2173128,CHEMBL934832,Inhibition of EGFR,B,CHEMBL402149,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
2103,2173129,CHEMBL934832,Inhibition of EGFR,B,CHEMBL255490,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
2104,2181225,CHEMBL974188,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,B,CHEMBL498247,=,nM,10500.0,CHEMBL203,Homo sapiens,IC50,uM,10.5
2105,2181226,CHEMBL974188,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,B,CHEMBL498249,=,nM,41000.0,CHEMBL203,Homo sapiens,IC50,uM,41.0
2106,2181227,CHEMBL974188,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,B,CHEMBL498248,=,nM,27500.0,CHEMBL203,Homo sapiens,IC50,uM,27.5
2107,2181228,CHEMBL974188,Inhibition of human recombinant EGFR kinase expressed in Sf9 insect cells,B,CHEMBL524820,=,nM,37500.0,CHEMBL203,Homo sapiens,IC50,uM,37.5
2108,2182938,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL145,=,nM,1000000.0,CHEMBL203,Homo sapiens,IC50,10'3 uM,1.0
2109,2194200,CHEMBL978648,Inhibition of EGFR,B,CHEMBL285063,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
2110,2194204,CHEMBL978648,Inhibition of EGFR,B,CHEMBL553,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
2111,2194205,CHEMBL978648,Inhibition of EGFR,B,CHEMBL188762,=,nM,0.43,CHEMBL203,Homo sapiens,IC50,nM,0.43
2112,2194206,CHEMBL978648,Inhibition of EGFR,B,CHEMBL94061,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
2113,2199107,CHEMBL996040,Inhibition of EGFR,B,CHEMBL13485,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2114,2202593,CHEMBL941412,Inhibition of EGFR,B,CHEMBL521184,=,ug.mL-1,20.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,2.0
2115,2202594,CHEMBL941412,Inhibition of EGFR,B,CHEMBL485475,=,ug.mL-1,10.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,1.0
2116,2202595,CHEMBL941412,Inhibition of EGFR,B,CHEMBL483428,=,ug.mL-1,4.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,4.0
2117,2202596,CHEMBL941412,Inhibition of EGFR,B,CHEMBL518986,=,ug.mL-1,5.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,5.0
2118,2202597,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490960,=,ug.mL-1,5.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,5.0
2119,2202598,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490980,=,ug.mL-1,10.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,1.0
2120,2202599,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490773,=,ug.mL-1,10.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,1.0
2121,2202600,CHEMBL941412,Inhibition of EGFR,B,CHEMBL522082,=,ug.mL-1,2.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.0
2122,2202601,CHEMBL941412,Inhibition of EGFR,B,CHEMBL489139,=,ug.mL-1,2.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.0
2123,2202602,CHEMBL941412,Inhibition of EGFR,B,CHEMBL443171,=,ug.mL-1,2.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.0
2124,2202603,CHEMBL941412,Inhibition of EGFR,B,CHEMBL521472,=,ug.mL-1,2.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.0
2125,2202604,CHEMBL941412,Inhibition of EGFR,B,CHEMBL485070,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2126,2202605,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490780,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,9.0
2127,2202606,CHEMBL941412,Inhibition of EGFR,B,CHEMBL85021,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2128,2202607,CHEMBL941412,Inhibition of EGFR,B,CHEMBL522116,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2129,2202610,CHEMBL941412,Inhibition of EGFR,B,CHEMBL17329,=,ug.mL-1,20.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,2.0
2130,2202612,CHEMBL941412,Inhibition of EGFR,B,CHEMBL1202061,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2131,2202613,CHEMBL941412,Inhibition of EGFR,B,CHEMBL55748,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2132,2202614,CHEMBL941412,Inhibition of EGFR,B,CHEMBL56964,=,nM,60000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,6.0
2133,2202615,CHEMBL941412,Inhibition of EGFR,B,CHEMBL57462,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2134,2202616,CHEMBL941412,Inhibition of EGFR,B,CHEMBL57300,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
2135,2202617,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490768,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2136,2202618,CHEMBL941412,Inhibition of EGFR,B,CHEMBL293584,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,5.0
2137,2202619,CHEMBL941412,Inhibition of EGFR,B,CHEMBL504173,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2138,2202620,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490570,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,5.0
2139,2202621,CHEMBL941412,Inhibition of EGFR,B,CHEMBL538909,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,6.0
2140,2202622,CHEMBL941412,Inhibition of EGFR,B,CHEMBL490569,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,8.0
2141,2202623,CHEMBL941412,Inhibition of EGFR,B,CHEMBL483232,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
2142,2202624,CHEMBL941412,Inhibition of EGFR,B,CHEMBL483233,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2143,2202625,CHEMBL941412,Inhibition of EGFR,B,CHEMBL116595,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,5.0
2144,2202626,CHEMBL941412,Inhibition of EGFR,B,CHEMBL520839,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,2.0
2145,2202627,CHEMBL941412,Inhibition of EGFR,B,CHEMBL489146,=,ug.mL-1,3.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,3.0
2146,2202628,CHEMBL941412,Inhibition of EGFR,B,CHEMBL450484,=,ug.mL-1,8.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,8.0
2147,2202629,CHEMBL941412,Inhibition of EGFR,B,CHEMBL453504,=,ug.mL-1,0.9,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,9.0
2148,2202632,CHEMBL941412,Inhibition of EGFR,B,CHEMBL46946,=,ug.mL-1,1.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,1.0
2149,2202633,CHEMBL941412,Inhibition of EGFR,B,CHEMBL485485,=,ug.mL-1,0.3,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,3.0
2150,2202638,CHEMBL941412,Inhibition of EGFR,B,CHEMBL47986,=,ug.mL-1,0.55,CHEMBL203,Homo sapiens,IC50,ug ml-1,0.55
2151,2202639,CHEMBL941412,Inhibition of EGFR,B,CHEMBL44,=,ug.mL-1,0.7,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,7.0
2152,2202706,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL44,=,ug.mL-1,0.1,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,1.0
2153,2202707,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL241609,=,ug.mL-1,0.1,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,1.0
2154,2202708,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL418906,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2155,2202709,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL490987,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2156,2202710,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL76958,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2157,2202711,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL307481,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2158,2202712,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL56132,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2159,2202713,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL520493,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2160,2202714,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL490577,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,1.0
2161,2202715,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL296407,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2162,2202716,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL76589,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,1.0
2163,2202717,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL80745,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2164,2202718,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL309598,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2165,2202719,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL454002,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2166,2202720,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL474267,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,1.0
2167,2202721,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL483830,=,ug.mL-1,0.01,CHEMBL203,Homo sapiens,IC50,10'-2 ug/ml,1.0
2168,2202722,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL242741,=,ug.mL-1,0.1,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,1.0
2169,2202723,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL26001,=,nM,200000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,2.0
2170,2202724,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL488101,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,2.0
2171,2202725,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL76929,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2172,2202726,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77401,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2173,2202727,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL56879,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2174,2202728,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL59145,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2175,2202729,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL490774,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2176,2202730,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL56543,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2177,2202731,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL501368,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,2.0
2178,2202732,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL76602,=,nM,200000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,2.0
2179,2202733,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL483831,=,ug.mL-1,0.2,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,2.0
2180,2202734,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77397,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2181,2202735,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77688,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,3.0
2182,2202736,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL309334,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2183,2202737,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL418907,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2184,2202738,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL73820,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,3.0
2185,2202739,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77030,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2186,2202740,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL492199,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
2187,2202741,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL28,=,ug.mL-1,30.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,3.0
2188,2202742,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL150,=,ug.mL-1,3.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,3.0
2189,2202743,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL131921,=,ug.mL-1,30.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,3.0
2190,2202744,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL241609,=,ug.mL-1,3.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,3.0
2191,2202745,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL483234,=,nM,40000.0,CHEMBL203,Homo sapiens,IC50,10'1 uM,4.0
2192,2202746,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL78280,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
2193,2202747,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL74432,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2194,2202748,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL56393,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,4.0
2195,2202749,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL449114,=,nM,400000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,4.0
2196,2202750,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL103552,=,ug.mL-1,0.004,CHEMBL203,Homo sapiens,IC50,10'-3 ug/ml,4.0
2197,2202751,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL243664,=,ug.mL-1,40.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,4.0
2198,2202752,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL491174,=,ug.mL-1,4.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,4.0
2199,2202753,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL485065,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
2200,2202755,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77100,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
2201,2202756,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL453502,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,5.0
2202,2202757,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL449093,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,10'-2microM,5.0
2203,2202758,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL79064,=,nM,500000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,5.0
2204,2202759,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL77803,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,5.0
2205,2202760,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL485258,=,ug.mL-1,0.5,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,5.0
2206,2202761,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL275638,=,ug.mL-1,50.0,CHEMBL203,Homo sapiens,IC50,10'1 ug/ml,5.0
2207,2202762,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL505705,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,6.0
2208,2202763,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL55204,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,6.0
2209,2202764,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL489349,=,nM,600000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,6.0
2210,2202765,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL450319,=,nM,600000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,6.0
2211,2202766,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL489147,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
2212,2202767,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL490775,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
2213,2202768,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL53898,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,7.0
2214,2202769,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL56731,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,7.0
2215,2202770,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL44,=,ug.mL-1,0.7,CHEMBL203,Homo sapiens,IC50,10'-1 ug/ml,7.0
2216,2202771,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL309016,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
2217,2202772,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL308048,=,nM,800000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,8.0
2218,2202773,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL78257,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,8.0
2219,2202774,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL78049,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
2220,2202775,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL78224,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
2221,2202776,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL54471,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,9.0
2222,2202777,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL293749,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,10'-1microM,9.0
2223,2202778,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL489148,=,nM,900000.0,CHEMBL203,Homo sapiens,IC50,10'2 uM,9.0
2224,2202779,CHEMBL941404,Inhibition of EGFR in human A431 cells,B,CHEMBL441343,=,ug.mL-1,10.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,10.0
2225,2206757,CHEMBL976899,Inhibition of EGFR,B,CHEMBL553,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
2226,2206771,CHEMBL976899,Inhibition of EGFR,B,CHEMBL450786,=,nM,3800.0,CHEMBL203,Homo sapiens,IC50,uM,3.8
2227,2206793,CHEMBL976899,Inhibition of EGFR,B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
2228,2206881,CHEMBL976899,Inhibition of EGFR,B,CHEMBL217092,=,nM,2590.0,CHEMBL203,Homo sapiens,IC50,nM,2590.0
2229,2228670,CHEMBL1003093,Inhibition of EGFR,B,CHEMBL128000,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0
2230,2228674,CHEMBL1003097,Inhibition of human EGFR,B,CHEMBL607707,=,nM,38.5,CHEMBL203,Homo sapiens,IC50,nM,38.5
2231,2239225,CHEMBL971642,Inhibition of EGFR,B,CHEMBL461311,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
2232,2239961,CHEMBL971642,Inhibition of EGFR,B,CHEMBL472545,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2233,2239962,CHEMBL971642,Inhibition of EGFR,B,CHEMBL472544,=,nM,620.0,CHEMBL203,Homo sapiens,IC50,uM,0.62
2234,2239963,CHEMBL971642,Inhibition of EGFR,B,CHEMBL511478,=,nM,458.0,CHEMBL203,Homo sapiens,IC50,uM,0.458
2235,2239964,CHEMBL971642,Inhibition of EGFR,B,CHEMBL500591,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
2236,2239972,CHEMBL971642,Inhibition of EGFR,B,CHEMBL461114,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
2237,2239973,CHEMBL971642,Inhibition of EGFR,B,CHEMBL461113,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
2238,2239974,CHEMBL971642,Inhibition of EGFR,B,CHEMBL516487,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,uM,0.054
2239,2239975,CHEMBL971642,Inhibition of EGFR,B,CHEMBL512391,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
2240,2246100,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL461426,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
2241,2246101,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466586,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2242,2246102,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL512076,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
2243,2246103,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL517123,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
2244,2246104,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL517585,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2245,2246105,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL507329,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
2246,2246106,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL499534,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
2247,2246107,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL504034,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
2248,2246108,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL461869,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2249,2246109,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466412,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
2250,2246110,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL450109,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
2251,2246111,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466614,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
2252,2246112,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466615,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
2253,2246113,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL447365,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
2254,2246114,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466174,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
2255,2246115,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL466175,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
2256,2246116,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL450396,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2257,2246117,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
2258,2246118,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL553,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
2259,2246119,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL1201179,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
2260,2246120,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL31965,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
2261,2246121,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL180022,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2262,2246122,CHEMBL1009318,Inhibition of EGFR by HTRF assay,B,CHEMBL1173655,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
2263,2246219,CHEMBL1009326,Inhibition of EGFR by scintillation proximity assay,B,CHEMBL505626,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
2264,2246220,CHEMBL1009326,Inhibition of EGFR by scintillation proximity assay,B,CHEMBL451513,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,nM,99.0
2265,2251516,CHEMBL998566,Inhibition of EGFR,B,CHEMBL521887,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
2266,2256127,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL495979,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
2267,2256128,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL496174,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
2268,2256129,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL523573,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
2269,2256130,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL495733,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
2270,2256131,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL495734,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
2271,2256132,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL497803,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0
2272,2256133,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL497804,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
2273,2256134,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL497184,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,nM,115.0
2274,2256135,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL500115,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
2275,2256136,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL500381,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
2276,2256137,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL500640,=,nM,141.0,CHEMBL203,Homo sapiens,IC50,nM,141.0
2277,2256138,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL466586,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2278,2256139,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL512076,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
2279,2256140,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL517123,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
2280,2256141,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL507329,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
2281,2256142,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL525805,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0
2282,2256143,CHEMBL995846,Inhibition of EGFR kinase,B,CHEMBL501705,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2283,2256993,CHEMBL1001226,Inhibition of EGFR,B,CHEMBL485745,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
2284,2270107,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL507329,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
2285,2270111,CHEMBL964195,Inhibition of EGFR by SPA assay,B,CHEMBL504117,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2286,2270114,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL508760,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
2287,2270118,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL449949,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,nM,2600.0
2288,2270122,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL452716,=,nM,1050.0,CHEMBL203,Homo sapiens,IC50,nM,1050.0
2289,2270128,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL461811,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,nM,400.0
2290,2270132,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL505463,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,nM,280.0
2291,2270136,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL455433,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,nM,180.0
2292,2270140,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL455434,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0
2293,2270144,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL457250,=,nM,1650.0,CHEMBL203,Homo sapiens,IC50,nM,1650.0
2294,2270148,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL501050,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,nM,630.0
2295,2270152,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL507821,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
2296,2270156,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL510845,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
2297,2270160,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL500072,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
2298,2270164,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL503253,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
2299,2270168,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL451074,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
2300,2270174,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL500217,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
2301,2270179,CHEMBL964195,Inhibition of EGFR by SPA assay,B,CHEMBL447720,=,nM,3160.0,CHEMBL203,Homo sapiens,IC50,nM,3160.0
2302,2270182,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL451347,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,nM,680.0
2303,2270186,CHEMBL964194,Inhibition of EGFR by HTRF assay,B,CHEMBL452980,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0
2304,2270191,CHEMBL964195,Inhibition of EGFR by SPA assay,B,CHEMBL452768,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
2305,2270258,CHEMBL964195,Inhibition of EGFR by SPA assay,B,CHEMBL453398,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,nM,190.0
2306,2270441,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL515598,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
2307,2270443,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL462338,=,nM,7700.0,CHEMBL203,Homo sapiens,IC50,uM,7.7
2308,2270464,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL474543,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
2309,2270466,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL475351,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
2310,2270481,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL522785,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
2311,2270493,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL475352,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
2312,2270497,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL473351,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
2313,2270502,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL464210,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
2314,2270505,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL491686,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
2315,2270507,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL443906,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
2316,2270512,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL491677,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
2317,2270516,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL473556,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
2318,2270520,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL518803,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
2319,2270548,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL514016,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
2320,2270552,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL462162,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
2321,2270570,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL460746,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,uM,0.28
2322,2270571,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL514942,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
2323,2270577,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL473553,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
2324,2270579,CHEMBL964945,Inhibition of EGFR by virtual HTS assay,B,CHEMBL301018,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2325,2271252,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL249496,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0
2326,2271255,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL248877,=,nM,361.0,CHEMBL203,Homo sapiens,IC50,nM,361.0
2327,2271258,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL251732,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
2328,2271261,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL437584,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
2329,2271264,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL455208,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
2330,2271270,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL452717,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
2331,2271276,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL503638,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
2332,2271282,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL448628,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
2333,2271288,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL443098,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
2334,2271310,CHEMBL964130,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL446250,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2335,2301995,CHEMBL949877,Inhibition of EGFR,B,CHEMBL501256,=,nM,93000.0,CHEMBL203,Homo sapiens,IC50,uM,93.0
2336,2302019,CHEMBL949877,Inhibition of EGFR,B,CHEMBL504135,=,nM,89000.0,CHEMBL203,Homo sapiens,IC50,uM,89.0
2337,2302067,CHEMBL949877,Inhibition of EGFR,B,CHEMBL520515,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
2338,2302091,CHEMBL949877,Inhibition of EGFR,B,CHEMBL485246,=,nM,82000.0,CHEMBL203,Homo sapiens,IC50,uM,82.0
2339,2302115,CHEMBL949877,Inhibition of EGFR,B,CHEMBL521155,=,nM,35000.0,CHEMBL203,Homo sapiens,IC50,uM,35.0
2340,2316195,CHEMBL1005068,Displacement of [125I]-TGFalpha from human EGFR in human A431 cell membrane by SPA,B,CHEMBL464721,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
2341,2339008,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL485320,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
2342,2339015,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL482715,=,nM,122000.0,CHEMBL203,Homo sapiens,IC50,uM,122.0
2343,2339016,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL519147,=,nM,3180.0,CHEMBL203,Homo sapiens,IC50,uM,3.18
2344,2339017,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL483313,=,nM,1320.0,CHEMBL203,Homo sapiens,IC50,uM,1.32
2345,2339020,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL504416,=,nM,22800.0,CHEMBL203,Homo sapiens,IC50,uM,22.8
2346,2339022,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2347,2339023,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL484109,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
2348,2339024,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL484108,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
2349,2339025,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL482489,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
2350,2339026,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL485321,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
2351,2339093,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL502015,=,nM,1240.0,CHEMBL203,Homo sapiens,IC50,uM,1.24
2352,2339095,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL499345,=,nM,4310.0,CHEMBL203,Homo sapiens,IC50,uM,4.31
2353,2339096,CHEMBL957461,Inhibition of EGFR expressed in human tumor cells,B,CHEMBL499344,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67
2354,2340450,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL484119,=,/uM,2.3,CHEMBL203,Homo sapiens,IC50,/uM,2.3
2355,2340457,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL490267,=,/uM,18.4,CHEMBL203,Homo sapiens,IC50,/uM,18.4
2356,2340458,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL490266,=,/uM,1.8,CHEMBL203,Homo sapiens,IC50,/uM,1.8
2357,2340459,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL484321,=,/uM,213.0,CHEMBL203,Homo sapiens,IC50,/uM,213.0
2358,2340460,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL484121,=,/uM,21.3,CHEMBL203,Homo sapiens,IC50,/uM,21.3
2359,2340461,CHEMBL961515,Inhibition of human A431 cell EGFRK assessed as 32P phosphorylation by scintillation counter,B,CHEMBL484316,=,/uM,23.0,CHEMBL203,Homo sapiens,IC50,/uM,23.0
2360,2361179,CHEMBL970655,Inhibition of EGFR,B,CHEMBL505896,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0
2361,2361201,CHEMBL970655,Inhibition of EGFR,B,CHEMBL453737,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0
2362,2361602,CHEMBL980904,Inhibition of GST-tagged HER1,B,CHEMBL459729,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
2363,2376473,CHEMBL980757,Inhibition of EGFR,B,CHEMBL461571,=,nM,2240.0,CHEMBL203,Homo sapiens,IC50,uM,2.24
2364,2390290,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461792,=,nM,10.08,CHEMBL203,Homo sapiens,IC50,nM,10.08
2365,2390291,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL516979,=,nM,1.66,CHEMBL203,Homo sapiens,IC50,nM,1.66
2366,2390292,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL460736,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
2367,2390293,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461795,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
2368,2390294,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461967,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
2369,2390295,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL517130,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2370,2390296,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461968,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
2371,2390297,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL472945,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2372,2390298,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL91867,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
2373,2390299,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL329856,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
2374,2390300,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL285063,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
2375,2390303,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL473141,=,nM,10320.0,CHEMBL203,Homo sapiens,IC50,nM,10320.0
2376,2390304,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL472743,=,nM,5390.0,CHEMBL203,Homo sapiens,IC50,nM,5390.0
2377,2390305,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL472942,=,nM,13570.0,CHEMBL203,Homo sapiens,IC50,nM,13570.0
2378,2390306,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL472943,=,nM,5220.0,CHEMBL203,Homo sapiens,IC50,nM,5220.0
2379,2390307,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL514771,=,nM,10590.0,CHEMBL203,Homo sapiens,IC50,nM,10590.0
2380,2390308,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL490687,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,nM,7500.0
2381,2390319,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461781,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
2382,2390320,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL554,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
2383,2390321,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL939,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
2384,2390322,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL56802,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,uM,0.0046
2385,2390323,CHEMBL944276,Inhibition of human recombinant EGFR,B,CHEMBL461782,=,nM,11100.0,CHEMBL203,Homo sapiens,IC50,uM,11.1
2386,2409521,CHEMBL959256,Inhibition of EGFR,B,CHEMBL523586,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
2387,2411800,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470219,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
2388,2411802,CHEMBL987693,Inhibition of EGFR,B,CHEMBL471058,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
2389,2411803,CHEMBL987693,Inhibition of EGFR,B,CHEMBL513418,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
2390,2411804,CHEMBL987693,Inhibition of EGFR,B,CHEMBL469355,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2391,2411805,CHEMBL987693,Inhibition of EGFR,B,CHEMBL503418,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2392,2411807,CHEMBL987693,Inhibition of EGFR,B,CHEMBL469354,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
2393,2411808,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470011,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
2394,2411810,CHEMBL987693,Inhibition of EGFR,B,CHEMBL511990,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
2395,2411812,CHEMBL987693,Inhibition of EGFR,B,CHEMBL513208,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
2396,2411813,CHEMBL987693,Inhibition of EGFR,B,CHEMBL511637,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
2397,2411814,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470218,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
2398,2411817,CHEMBL987693,Inhibition of EGFR,B,CHEMBL513362,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
2399,2411818,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470012,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
2400,2411822,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470010,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
2401,2411823,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470003,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
2402,2411826,CHEMBL987693,Inhibition of EGFR,B,CHEMBL470391,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,nM,43.0
2403,2411828,CHEMBL987693,Inhibition of EGFR,B,CHEMBL469997,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
2404,2411829,CHEMBL987693,Inhibition of EGFR,B,CHEMBL511839,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,nM,82.0
2405,2411831,CHEMBL987693,Inhibition of EGFR,B,CHEMBL513716,=,nM,187.0,CHEMBL203,Homo sapiens,IC50,nM,187.0
2406,2411836,CHEMBL987693,Inhibition of EGFR,B,CHEMBL511623,=,nM,918.0,CHEMBL203,Homo sapiens,IC50,nM,918.0
2407,2411839,CHEMBL987693,Inhibition of EGFR,B,CHEMBL469996,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,nM,3300.0
2408,2411840,CHEMBL987693,Inhibition of EGFR,B,CHEMBL511449,=,nM,17900.0,CHEMBL203,Homo sapiens,IC50,nM,17900.0
2409,2419446,CHEMBL1022371,Inhibition of EGFR,B,CHEMBL523122,=,nM,7130.0,CHEMBL203,Homo sapiens,IC50,uM,7.13
2410,2419447,CHEMBL1022371,Inhibition of EGFR,B,CHEMBL217092,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
2411,2419448,CHEMBL1022371,Inhibition of EGFR,B,CHEMBL1421,=,nM,2870.0,CHEMBL203,Homo sapiens,IC50,uM,2.87
2412,2435784,CHEMBL1012122,Inhibition of EGFR,B,CHEMBL47986,=,ug.mL-1,0.2,CHEMBL203,Homo sapiens,IC50,ug ml-1,0.2
2413,2435785,CHEMBL1012122,Inhibition of EGFR,B,CHEMBL44,=,ug.mL-1,0.2,CHEMBL203,Homo sapiens,IC50,ug ml-1,0.2
2414,2461682,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL519982,=,ug.mL-1,5.5,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,5.5
2415,2461744,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL521470,=,ug.mL-1,3.5,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,3.5
2416,2461745,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL519395,=,ug.mL-1,6.5,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,6.5
2417,2461748,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL483532,=,ug.mL-1,4.2,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,4.2
2418,2461749,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL483531,=,ug.mL-1,9.8,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,9.8
2419,2461750,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL520144,=,ug.mL-1,1.1,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,1.1
2420,2461751,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL483526,=,ug.mL-1,1.7,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,1.7
2421,2461752,CHEMBL962866,Inhibition of recombinant EGFR,B,CHEMBL483525,=,ug.mL-1,4.2,CHEMBL203,Homo sapiens,IC50,10'-6g/ml,4.2
2422,2464995,CHEMBL957972,Inhibition of human recombinant EGFR,B,CHEMBL201511,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0
2423,2465039,CHEMBL957972,Inhibition of human recombinant EGFR,B,CHEMBL453336,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
2424,2465040,CHEMBL957972,Inhibition of human recombinant EGFR,B,CHEMBL488646,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
2425,2465041,CHEMBL957972,Inhibition of human recombinant EGFR,B,CHEMBL486437,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
2426,2465042,CHEMBL957972,Inhibition of human recombinant EGFR,B,CHEMBL529663,=,nM,23000.0,CHEMBL203,Homo sapiens,IC50,uM,23.0
2427,2467248,CHEMBL991653,Inhibition of EGFR in presence of 100 uM ATP,B,CHEMBL489058,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
2428,2488219,CHEMBL946770,Inhibition of EGFR,B,CHEMBL448929,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
2429,2488231,CHEMBL946770,Inhibition of EGFR,B,CHEMBL507714,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
2430,2488851,CHEMBL1028056,Inhibition of EGFR,B,CHEMBL480356,=,nM,3480.0,CHEMBL203,Homo sapiens,IC50,uM,3.48
2431,2489169,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL1201179,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
2432,2489170,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL479800,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
2433,2489171,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475594,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
2434,2489172,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475761,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
2435,2489173,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473428,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2436,2489174,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473429,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2437,2489175,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475768,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2438,2489176,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475769,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
2439,2489177,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473427,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
2440,2489178,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL474431,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
2441,2489179,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473436,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
2442,2489180,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473437,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
2443,2489181,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL473438,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
2444,2489182,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475446,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
2445,2489183,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL514938,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
2446,2489184,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL519757,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,nM,54.0
2447,2489185,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL480349,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
2448,2489186,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL506414,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2449,2489187,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL481324,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,nM,96.0
2450,2489188,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475599,=,nM,304.0,CHEMBL203,Homo sapiens,IC50,nM,304.0
2451,2489189,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475600,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,nM,115.0
2452,2489190,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL475767,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
2453,2489191,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL480348,=,nM,121.0,CHEMBL203,Homo sapiens,IC50,nM,121.0
2454,2489192,CHEMBL1028080,Inhibition of EGFR,B,CHEMBL481331,=,nM,138.0,CHEMBL203,Homo sapiens,IC50,nM,138.0
2455,2503040,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL77030,=,nM,1310.0,CHEMBL203,Homo sapiens,IC50,uM,1.31
2456,2503063,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL473320,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,nM,131.0
2457,2503064,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL474524,=,nM,333.0,CHEMBL203,Homo sapiens,IC50,nM,333.0
2458,2503065,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL474324,=,nM,472.0,CHEMBL203,Homo sapiens,IC50,nM,472.0
2459,2503066,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL474323,=,nM,533.0,CHEMBL203,Homo sapiens,IC50,nM,533.0
2460,2503067,CHEMBL945670,Inhibition of human EGFR tyrosine kinase activity,B,CHEMBL515401,=,nM,209.0,CHEMBL203,Homo sapiens,IC50,nM,209.0
2461,2503070,CHEMBL946651,Inhibition of human EGFR,B,CHEMBL939,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
2462,2503071,CHEMBL946651,Inhibition of human EGFR,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2463,2503652,CHEMBL960396,Inhibition of EGFR,B,CHEMBL77030,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
2464,2503655,CHEMBL960396,Inhibition of EGFR,B,CHEMBL78257,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
2465,2511574,CHEMBL972533,Inhibition of EGFR,B,CHEMBL388978,=,nM,132.0,CHEMBL203,Homo sapiens,IC50,uM,0.132
2466,2527196,CHEMBL984177,Inhibition of EGFR,B,CHEMBL451523,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
2467,2547490,CHEMBL970971,Inhibition of EGFR,B,CHEMBL128000,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
2468,2547492,CHEMBL970971,Inhibition of EGFR,B,CHEMBL490510,=,nM,19000000.0,CHEMBL203,Homo sapiens,IC50,mM,19.0
2469,2547493,CHEMBL970971,Inhibition of EGFR,B,CHEMBL45068,=,nM,25000000.0,CHEMBL203,Homo sapiens,IC50,mM,25.0
2470,2547504,CHEMBL970971,Inhibition of EGFR,B,CHEMBL44,=,ug.mL-1,0.2,CHEMBL203,Homo sapiens,IC50,ug ml-1,0.2
2471,2547512,CHEMBL970971,Inhibition of EGFR,B,CHEMBL242740,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
2472,2560138,CHEMBL986505,Inhibition of EGFR by ELISA,B,CHEMBL477197,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
2473,2567844,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL255871,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
2474,2567849,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL525725,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
2475,2567850,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL497863,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,uM,0.052
2476,2567851,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL497697,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
2477,2567862,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL515664,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
2478,2567863,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL456758,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
2479,2567864,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL514566,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
2480,2567865,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL498134,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2481,2567866,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL524457,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2482,2567867,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL498133,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2483,2567868,CHEMBL1007322,Inhibition of human EGFR expressed in SF9 cells,B,CHEMBL497459,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
2484,2573374,CHEMBL984786,Inhibition of EGF-tyrosine kinase,B,CHEMBL29197,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,uM,0.0053
2485,2582012,CHEMBL962243,Inhibition of human EGFR,B,CHEMBL487254,=,nM,9500.0,CHEMBL203,Homo sapiens,IC50,uM,9.5
2486,2582025,CHEMBL962243,Inhibition of human EGFR,B,CHEMBL489083,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
2487,2582039,CHEMBL962243,Inhibition of human EGFR,B,CHEMBL488271,=,nM,9900.0,CHEMBL203,Homo sapiens,IC50,uM,9.9
2488,2584904,CHEMBL955786,Inhibition of HER1,B,CHEMBL461140,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
2489,2612356,CHEMBL1016812,Inhibition of EGFR,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
2490,2615700,CHEMBL1026506,Inhibition of EGFR,B,CHEMBL31965,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,uM,0.0023
2491,2615718,CHEMBL1026506,Inhibition of EGFR,B,CHEMBL285063,<,nM,1.5,CHEMBL203,Homo sapiens,IC50,uM,0.0015
2492,2629151,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL496388,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2493,2629925,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL495617,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
2494,2629930,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL501709,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
2495,2629931,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL523059,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
2496,2629945,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL527026,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
2497,2629990,CHEMBL1008385,Inhibition of EGFR,B,CHEMBL230232,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
2498,2655735,CHEMBL1029460,Inhibition of EGFR,B,CHEMBL50,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
2499,2661406,CHEMBL1058612,Inhibition of EGFR,B,CHEMBL564829,=,nM,3069.0,CHEMBL203,Homo sapiens,IC50,uM,3.069
2500,2672254,CHEMBL1026226,Inhibition of recombinant EGFR,B,CHEMBL512054,=,ug.mL-1,6.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,6.0
2501,2672269,CHEMBL1026226,Inhibition of recombinant EGFR,B,CHEMBL556684,=,ug.mL-1,4.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,4.0
2502,2672284,CHEMBL1026226,Inhibition of recombinant EGFR,B,CHEMBL463054,=,ug.mL-1,2.7,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.7
2503,2672285,CHEMBL1026226,Inhibition of recombinant EGFR,B,CHEMBL554993,=,ug.mL-1,2.7,CHEMBL203,Homo sapiens,IC50,ug ml-1,2.7
2504,2716349,CHEMBL1059198,Inhibition of EGFR autophosphorylation in human A549 cells,B,CHEMBL213560,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
2505,2896192,CHEMBL1060165,Inhibition of EGFR,B,CHEMBL327127,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,M,8.2E-8
2506,2896193,CHEMBL1060165,Inhibition of EGFR,B,CHEMBL574059,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,M,3.8E-7
2507,2896194,CHEMBL1060165,Inhibition of EGFR,B,CHEMBL574058,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,M,3.9E-7
2508,2934399,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL565714,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
2509,2934403,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL565467,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
2510,2934405,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL583403,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
2511,2934408,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL583218,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
2512,2934410,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL1645462,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
2513,2934411,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL567873,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
2514,2934413,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL566350,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
2515,2934414,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL584714,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
2516,2934415,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL566337,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
2517,2934417,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL578044,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
2518,2934418,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL566559,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
2519,2934424,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL578255,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0
2520,2934431,CHEMBL1052827,Inhibition of human recombinant HER1 expressed in Sf9 cells by liquid scintillation counting,B,CHEMBL567197,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
2521,2943647,CHEMBL1044055,Inhibition of Her1 by fluorescence polarization assay,B,CHEMBL571040,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
2522,2943649,CHEMBL1044057,Inhibition of Her1 T790M mutant by fluorescence polarization assay,B,CHEMBL571040,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
2523,2943655,CHEMBL1044055,Inhibition of Her1 by fluorescence polarization assay,B,CHEMBL569880,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
2524,2943656,CHEMBL1044055,Inhibition of Her1 by fluorescence polarization assay,B,CHEMBL554,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
2525,2943661,CHEMBL1044057,Inhibition of Her1 T790M mutant by fluorescence polarization assay,B,CHEMBL569880,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
2526,3004524,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
2527,3004525,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL571809,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
2528,3004526,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL572030,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
2529,3004527,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL572031,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
2530,3004528,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL570918,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
2531,3004529,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL572028,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,uM,0.63
2532,3004530,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL583683,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
2533,3004531,CHEMBL1046364,Inhibition of EGFR-mediated poly(L-glutamic acid L-tyrosine) phosphorylation,B,CHEMBL570709,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
2534,3055906,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2535,3055912,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL605413,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
2536,3055931,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL595757,=,nM,18200.0,CHEMBL203,Homo sapiens,IC50,uM,18.2
2537,3055934,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL594790,=,nM,13400.0,CHEMBL203,Homo sapiens,IC50,uM,13.4
2538,3055940,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL603198,=,nM,56500.0,CHEMBL203,Homo sapiens,IC50,uM,56.5
2539,3055945,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL594810,=,nM,111400.0,CHEMBL203,Homo sapiens,IC50,uM,111.4
2540,3055946,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL595497,=,nM,160300.0,CHEMBL203,Homo sapiens,IC50,uM,160.3
2541,3055947,CHEMBL1038898,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA,B,CHEMBL604879,=,nM,529300.0,CHEMBL203,Homo sapiens,IC50,uM,529.3
2542,3072639,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL473556,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
2543,3072640,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL514942,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
2544,3072641,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593293,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
2545,3072642,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL596059,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
2546,3072643,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL595615,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
2547,3072644,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL595406,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
2548,3072645,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL595142,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
2549,3072648,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL594228,=,nM,805.0,CHEMBL203,Homo sapiens,IC50,uM,0.805
2550,3072649,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL596087,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
2551,3072650,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL606466,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
2552,3072651,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593860,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
2553,3072652,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593987,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
2554,3072653,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593274,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
2555,3072654,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593306,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2556,3072655,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL604992,=,nM,730.0,CHEMBL203,Homo sapiens,IC50,uM,0.73
2557,3072656,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593275,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
2558,3072659,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593909,=,nM,6200.0,CHEMBL203,Homo sapiens,IC50,uM,6.2
2559,3072660,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593770,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
2560,3072795,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593292,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,uM,0.67
2561,3072796,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL595374,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
2562,3072797,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593294,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
2563,3072799,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL594661,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
2564,3072800,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL604485,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
2565,3072801,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593911,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
2566,3072802,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL593760,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
2567,3072803,CHEMBL1073378,Inhibition of wild type EGF-R by microplate scintillation counting,B,CHEMBL604893,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
2568,3084397,CHEMBL1072676,Inhibition of EGFR,B,CHEMBL590109,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
2569,3103294,CHEMBL1070746,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,B,CHEMBL597492,=,nM,1688.0,CHEMBL203,Homo sapiens,IC50,nM,1688.0
2570,3103295,CHEMBL1070746,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,B,CHEMBL605957,=,nM,5797.0,CHEMBL203,Homo sapiens,IC50,nM,5797.0
2571,3103296,CHEMBL1070746,Inhibition of EGFR after 80 mins by radiometric protein kinase assay,B,CHEMBL201511,=,nM,10133.0,CHEMBL203,Homo sapiens,IC50,nM,10133.0
2572,3103919,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL591213,=,nM,9120.0,CHEMBL203,Homo sapiens,IC50,uM,9.12
2573,3103921,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL599524,=,nM,7230.0,CHEMBL203,Homo sapiens,IC50,uM,7.23
2574,3103923,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL603968,=,nM,5840.0,CHEMBL203,Homo sapiens,IC50,uM,5.84
2575,3103925,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL599145,=,nM,4960.0,CHEMBL203,Homo sapiens,IC50,uM,4.96
2576,3103927,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL599728,=,nM,3110.0,CHEMBL203,Homo sapiens,IC50,uM,3.11
2577,3103929,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL598305,=,nM,1720.0,CHEMBL203,Homo sapiens,IC50,uM,1.72
2578,3103931,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL598306,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,uM,1.01
2579,3103933,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL598307,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
2580,3103935,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL597096,=,nM,692.0,CHEMBL203,Homo sapiens,IC50,uM,0.692
2581,3103937,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL591495,=,nM,1589.0,CHEMBL203,Homo sapiens,IC50,uM,1.589
2582,3103939,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL611681,=,nM,8710.0,CHEMBL203,Homo sapiens,IC50,uM,8.71
2583,3103941,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL597303,=,nM,6280.0,CHEMBL203,Homo sapiens,IC50,uM,6.28
2584,3103943,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL597304,=,nM,5330.0,CHEMBL203,Homo sapiens,IC50,uM,5.33
2585,3103945,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL597708,=,nM,3580.0,CHEMBL203,Homo sapiens,IC50,uM,3.58
2586,3103947,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL605337,=,nM,2140.0,CHEMBL203,Homo sapiens,IC50,uM,2.14
2587,3103949,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL597914,=,nM,1270.0,CHEMBL203,Homo sapiens,IC50,uM,1.27
2588,3103951,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL598520,=,nM,316.0,CHEMBL203,Homo sapiens,IC50,uM,0.316
2589,3103953,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL601625,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
2590,3103955,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL600381,=,nM,464.0,CHEMBL203,Homo sapiens,IC50,uM,0.464
2591,3103957,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL592153,=,nM,1350.0,CHEMBL203,Homo sapiens,IC50,uM,1.35
2592,3103959,CHEMBL1071732,Inhibition of EGFR expressed in Sf9 cells assessed as inhibition of receptor autophosphorylation by DELFIA time resolved fluorimetry,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
2593,3105839,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589589,=,nM,750.0,CHEMBL203,Homo sapiens,IC50,uM,0.75
2594,3105840,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589588,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
2595,3105841,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL601040,=,nM,580.0,CHEMBL203,Homo sapiens,IC50,uM,0.58
2596,3105842,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589825,=,nM,11570.0,CHEMBL203,Homo sapiens,IC50,uM,11.57
2597,3105843,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL592710,=,nM,9460.0,CHEMBL203,Homo sapiens,IC50,uM,9.46
2598,3105844,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL604672,=,nM,7820.0,CHEMBL203,Homo sapiens,IC50,uM,7.82
2599,3105845,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL592711,=,nM,1720.0,CHEMBL203,Homo sapiens,IC50,uM,1.72
2600,3105846,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589830,=,nM,1490.0,CHEMBL203,Homo sapiens,IC50,uM,1.49
2601,3105847,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589831,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
2602,3105848,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589832,=,nM,19260.0,CHEMBL203,Homo sapiens,IC50,uM,19.26
2603,3105849,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL602645,=,nM,29830.0,CHEMBL203,Homo sapiens,IC50,uM,29.83
2604,3105850,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589119,=,nM,31180.0,CHEMBL203,Homo sapiens,IC50,uM,31.18
2605,3105851,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589120,=,nM,14720.0,CHEMBL203,Homo sapiens,IC50,uM,14.72
2606,3105852,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL590083,=,nM,22810.0,CHEMBL203,Homo sapiens,IC50,uM,22.81
2607,3105853,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589259,=,nM,31430.0,CHEMBL203,Homo sapiens,IC50,uM,31.43
2608,3105855,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589503,=,nM,35290.0,CHEMBL203,Homo sapiens,IC50,uM,35.29
2609,3105857,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL589847,=,nM,17510.0,CHEMBL203,Homo sapiens,IC50,uM,17.51
2610,3105858,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL602728,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
2611,3105859,CHEMBL1065784,Inhibition of recombinant EGFR expressed in Sf9-baculovirus system by ELISA,B,CHEMBL553,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
2612,3120246,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL597551,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
2613,3120249,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL597752,=,nM,7.8,CHEMBL203,Homo sapiens,IC50,nM,7.8
2614,3120252,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596736,=,nM,9.4,CHEMBL203,Homo sapiens,IC50,nM,9.4
2615,3120255,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL599398,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
2616,3120258,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598163,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
2617,3120261,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598164,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
2618,3120264,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598377,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
2619,3120267,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
2620,3120270,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598798,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
2621,3120273,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598799,=,nM,9.08,CHEMBL203,Homo sapiens,IC50,nM,9.08
2622,3120276,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL553,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
2623,3120278,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL554,=,nM,11.2,CHEMBL203,Homo sapiens,IC50,nM,11.2
2624,3120281,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL604094,=,nM,84.2,CHEMBL203,Homo sapiens,IC50,nM,84.2
2625,3120284,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL597569,=,nM,10.4,CHEMBL203,Homo sapiens,IC50,nM,10.4
2626,3120287,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL597773,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
2627,3120290,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596754,=,nM,1.99,CHEMBL203,Homo sapiens,IC50,nM,1.99
2628,3120293,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596755,=,nM,15.4,CHEMBL203,Homo sapiens,IC50,nM,15.4
2629,3120296,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596957,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
2630,3120299,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596761,=,nM,99.4,CHEMBL203,Homo sapiens,IC50,nM,99.4
2631,3120302,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL596964,=,nM,268.0,CHEMBL203,Homo sapiens,IC50,nM,268.0
2632,3120305,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL599218,=,nM,5077.0,CHEMBL203,Homo sapiens,IC50,nM,5077.0
2633,3120308,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL605976,=,nM,12.8,CHEMBL203,Homo sapiens,IC50,nM,12.8
2634,3120311,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598406,=,nM,125.6,CHEMBL203,Homo sapiens,IC50,nM,125.6
2635,3120314,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598407,=,nM,614.0,CHEMBL203,Homo sapiens,IC50,nM,614.0
2636,3120317,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598610,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
2637,3120320,CHEMBL1064921,Inhibition of EGFR,B,CHEMBL598611,=,nM,8.2,CHEMBL203,Homo sapiens,IC50,nM,8.2
2638,3124808,CHEMBL1069630,Inhibition of EGFR,B,CHEMBL602890,=,nM,56000.0,CHEMBL203,Homo sapiens,IC50,uM,56.0
2639,3124809,CHEMBL1069630,Inhibition of EGFR,B,CHEMBL599388,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
2640,3126238,CHEMBL1072146,Inhibition of EGFR,B,CHEMBL591897,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
2641,3126250,CHEMBL1072146,Inhibition of EGFR,B,CHEMBL606413,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
2642,3126272,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL606403,=,nM,129.0,CHEMBL203,Homo sapiens,IC50,nM,129.0
2643,3126298,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL597402,=,nM,23.6,CHEMBL203,Homo sapiens,IC50,nM,23.6
2644,3126299,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL604914,=,nM,9.25,CHEMBL203,Homo sapiens,IC50,nM,9.25
2645,3126300,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL597200,=,nM,8.43,CHEMBL203,Homo sapiens,IC50,nM,8.43
2646,3126301,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL285063,=,nM,1.69,CHEMBL203,Homo sapiens,IC50,nM,1.69
2647,3126302,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL598007,=,nM,1.24,CHEMBL203,Homo sapiens,IC50,nM,1.24
2648,3126303,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL599047,=,nM,0.85,CHEMBL203,Homo sapiens,IC50,nM,0.85
2649,3126304,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL2021575,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
2650,3126305,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL2021576,=,nM,0.49,CHEMBL203,Homo sapiens,IC50,nM,0.49
2651,3126306,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL599863,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nM,0.37
2652,3126307,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL603266,=,nM,0.36,CHEMBL203,Homo sapiens,IC50,nM,0.36
2653,3126308,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL604914,=,nM,292.0,CHEMBL203,Homo sapiens,IC50,uM,0.292
2654,3126309,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL597200,=,nM,291.0,CHEMBL203,Homo sapiens,IC50,uM,0.291
2655,3126310,CHEMBL1072157,Inhibition of human recombinant EGFR expressed in insect cells by time-resolved fluorimetry,B,CHEMBL592617,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
2656,3126311,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL285063,=,nM,152.0,CHEMBL203,Homo sapiens,IC50,uM,0.152
2657,3126312,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL2021575,=,nM,145.0,CHEMBL203,Homo sapiens,IC50,uM,0.145
2658,3126313,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL597402,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
2659,3126314,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL597402,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078
2660,3126315,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL604914,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
2661,3126316,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL2021576,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
2662,3126317,CHEMBL1072161,Inhibition of EGFR autophosphorylation in human A431 cells after 8 hrs by Western blot,B,CHEMBL598007,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
2663,3126318,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL2021576,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
2664,3126319,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL597200,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
2665,3126320,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL52765,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2666,3126321,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL285063,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
2667,3126322,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL2021575,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
2668,3126323,CHEMBL1072160,Inhibition of EGFR autophosphorylation in human A431 cells after 1 hr by Western blot,B,CHEMBL598007,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
2669,3130635,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL939,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
2670,3130636,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL188762,=,nM,2.62,CHEMBL203,Homo sapiens,IC50,nM,2.62
2671,3130637,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL553,=,nM,20.3,CHEMBL203,Homo sapiens,IC50,nM,20.3
2672,3130638,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL608860,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
2673,3130639,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL589826,=,nM,32.6,CHEMBL203,Homo sapiens,IC50,nM,32.6
2674,3130641,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL590559,=,nM,4.45,CHEMBL203,Homo sapiens,IC50,nM,4.45
2675,3130642,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL590558,=,nM,32.7,CHEMBL203,Homo sapiens,IC50,nM,32.7
2676,3130643,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL591040,=,nM,65.5,CHEMBL203,Homo sapiens,IC50,nM,65.5
2677,3130644,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL591039,=,nM,87.1,CHEMBL203,Homo sapiens,IC50,nM,87.1
2678,3130645,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL591038,=,nM,3.16,CHEMBL203,Homo sapiens,IC50,nM,3.16
2679,3130646,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL592216,=,nM,2.53,CHEMBL203,Homo sapiens,IC50,nM,2.53
2680,3130647,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL592215,=,nM,28.5,CHEMBL203,Homo sapiens,IC50,nM,28.5
2681,3130648,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL592713,=,nM,17.7,CHEMBL203,Homo sapiens,IC50,nM,17.7
2682,3130649,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL597950,=,nM,23.8,CHEMBL203,Homo sapiens,IC50,nM,23.8
2683,3130650,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL597949,=,nM,14.8,CHEMBL203,Homo sapiens,IC50,nM,14.8
2684,3130651,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL609321,=,nM,16.9,CHEMBL203,Homo sapiens,IC50,nM,16.9
2685,3130652,CHEMBL1071045,Inhibition of recombinant EGFR by ELISA,B,CHEMBL597948,=,nM,25.9,CHEMBL203,Homo sapiens,IC50,nM,25.9
2686,3133592,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2687,3133593,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592457,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
2688,3133596,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592480,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
2689,3133597,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL602328,=,nM,970.0,CHEMBL203,Homo sapiens,IC50,uM,0.97
2690,3133598,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590875,=,nM,1240.0,CHEMBL203,Homo sapiens,IC50,uM,1.24
2691,3133599,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592481,=,nM,1460.0,CHEMBL203,Homo sapiens,IC50,uM,1.46
2692,3133600,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591910,=,nM,1720.0,CHEMBL203,Homo sapiens,IC50,uM,1.72
2693,3133602,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589823,=,nM,1940.0,CHEMBL203,Homo sapiens,IC50,uM,1.94
2694,3133603,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589822,=,nM,2180.0,CHEMBL203,Homo sapiens,IC50,uM,2.18
2695,3133606,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592707,=,nM,3260.0,CHEMBL203,Homo sapiens,IC50,uM,3.26
2696,3133611,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590876,=,nM,4710.0,CHEMBL203,Homo sapiens,IC50,uM,4.71
2697,3133612,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592708,=,nM,5780.0,CHEMBL203,Homo sapiens,IC50,uM,5.78
2698,3133614,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL604671,=,nM,6820.0,CHEMBL203,Homo sapiens,IC50,uM,6.82
2699,3133616,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590524,=,nM,7460.0,CHEMBL203,Homo sapiens,IC50,uM,7.46
2700,3133620,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592139,=,nM,10780.0,CHEMBL203,Homo sapiens,IC50,uM,10.78
2701,3133621,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590877,=,nM,13530.0,CHEMBL203,Homo sapiens,IC50,uM,13.53
2702,3133623,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591051,=,nM,19320.0,CHEMBL203,Homo sapiens,IC50,uM,19.32
2703,3133625,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590568,=,nM,23490.0,CHEMBL203,Homo sapiens,IC50,uM,23.49
2704,3133626,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591050,=,nM,26610.0,CHEMBL203,Homo sapiens,IC50,uM,26.61
2705,3133627,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592240,=,nM,27000.0,CHEMBL203,Homo sapiens,IC50,uM,27.0
2706,3133630,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592141,=,nM,31250.0,CHEMBL203,Homo sapiens,IC50,uM,31.25
2707,3133632,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589165,=,nM,36000.0,CHEMBL203,Homo sapiens,IC50,uM,36.0
2708,3133634,CHEMBL1064820,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591053,=,nM,41000.0,CHEMBL203,Homo sapiens,IC50,uM,41.0
2709,3133686,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591706,=,nM,32120.0,CHEMBL203,Homo sapiens,IC50,uM,32.12
2710,3133689,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589068,=,nM,9260.0,CHEMBL203,Homo sapiens,IC50,uM,9.26
2711,3133692,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL601828,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,uM,1.12
2712,3133695,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590526,=,nM,1860.0,CHEMBL203,Homo sapiens,IC50,uM,1.86
2713,3133698,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590525,=,nM,7510.0,CHEMBL203,Homo sapiens,IC50,uM,7.51
2714,3133701,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590714,=,nM,1070.0,CHEMBL203,Homo sapiens,IC50,uM,1.07
2715,3133704,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592211,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
2716,3133707,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592210,=,nM,27350.0,CHEMBL203,Homo sapiens,IC50,uM,27.35
2717,3133710,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL603186,=,nM,4680.0,CHEMBL203,Homo sapiens,IC50,uM,4.68
2718,3133713,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589809,=,nM,4150.0,CHEMBL203,Homo sapiens,IC50,uM,4.15
2719,3133716,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL600048,=,nM,21710.0,CHEMBL203,Homo sapiens,IC50,uM,21.71
2720,3133719,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592427,=,nM,2240.0,CHEMBL203,Homo sapiens,IC50,uM,2.24
2721,3133722,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592426,=,nM,1980.0,CHEMBL203,Homo sapiens,IC50,uM,1.98
2722,3133723,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL590962,=,nM,36880.0,CHEMBL203,Homo sapiens,IC50,uM,36.88
2723,3133738,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589560,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,uM,0.67
2724,3133741,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589561,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,uM,0.98
2725,3133744,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589801,=,nM,8540.0,CHEMBL203,Homo sapiens,IC50,uM,8.54
2726,3133747,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592200,=,nM,1340.0,CHEMBL203,Homo sapiens,IC50,uM,1.34
2727,3133750,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592201,=,nM,1760.0,CHEMBL203,Homo sapiens,IC50,uM,1.76
2728,3133753,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592224,=,nM,19410.0,CHEMBL203,Homo sapiens,IC50,uM,19.41
2729,3133756,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592466,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
2730,3133759,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL604042,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
2731,3133762,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL604785,=,nM,3460.0,CHEMBL203,Homo sapiens,IC50,uM,3.46
2732,3133765,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591288,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
2733,3133768,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592004,=,nM,870.0,CHEMBL203,Homo sapiens,IC50,uM,0.87
2734,3133771,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL592247,=,nM,5830.0,CHEMBL203,Homo sapiens,IC50,uM,5.83
2735,3133774,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589413,=,nM,18120.0,CHEMBL203,Homo sapiens,IC50,uM,18.12
2736,3133777,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL606027,=,nM,22040.0,CHEMBL203,Homo sapiens,IC50,uM,22.04
2737,3133780,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591437,=,nM,43210.0,CHEMBL203,Homo sapiens,IC50,uM,43.21
2738,3133783,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL591440,=,nM,24650.0,CHEMBL203,Homo sapiens,IC50,uM,24.65
2739,3133786,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL589590,=,nM,31940.0,CHEMBL203,Homo sapiens,IC50,uM,31.94
2740,3133792,CHEMBL1064829,Inhibition of cloned EGFR autophosphorylation expressed in baculovirus-infected Sf9 cells by solid-phase ELISA,B,CHEMBL553,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
2741,3186207,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2742,3186210,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
2743,3186215,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
2744,3186228,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
2745,3186262,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL2374457,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
2746,3186263,CHEMBL1111474,Inhibition of EGFR,B,CHEMBL2374458,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
2747,3195637,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1087054,=,nM,93500.0,CHEMBL203,Homo sapiens,IC50,uM,93.5
2748,3195638,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1087055,=,nM,55600.0,CHEMBL203,Homo sapiens,IC50,uM,55.6
2749,3195639,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1088348,=,nM,23500.0,CHEMBL203,Homo sapiens,IC50,uM,23.5
2750,3195640,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1084117,=,nM,60900.0,CHEMBL203,Homo sapiens,IC50,uM,60.9
2751,3195643,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1077068,=,nM,88300.0,CHEMBL203,Homo sapiens,IC50,uM,88.3
2752,3195644,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1077069,=,nM,79800.0,CHEMBL203,Homo sapiens,IC50,uM,79.8
2753,3195648,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1077095,=,nM,47900.0,CHEMBL203,Homo sapiens,IC50,uM,47.9
2754,3195653,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1077107,=,nM,99300.0,CHEMBL203,Homo sapiens,IC50,uM,99.3
2755,3195654,CHEMBL1103281,Inhibition of EGFR,B,CHEMBL1077085,=,nM,80600.0,CHEMBL203,Homo sapiens,IC50,uM,80.6
2756,3210400,CHEMBL1109425,Inhibition of EGFR after 1 hr,B,CHEMBL1081198,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
2757,3222529,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1087368,=,nM,1160.0,CHEMBL203,Homo sapiens,IC50,uM,1.16
2758,3222530,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1081849,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,uM,0.98
2759,3222531,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1082012,=,nM,257.0,CHEMBL203,Homo sapiens,IC50,uM,0.257
2760,3222532,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1080506,=,nM,12650.0,CHEMBL203,Homo sapiens,IC50,uM,12.65
2761,3222533,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1080812,=,nM,867.0,CHEMBL203,Homo sapiens,IC50,uM,0.867
2762,3222534,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1080990,=,nM,1210.0,CHEMBL203,Homo sapiens,IC50,uM,1.21
2763,3222535,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1080271,=,nM,77220.0,CHEMBL203,Homo sapiens,IC50,uM,77.22
2764,3222536,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1080272,=,nM,15140.0,CHEMBL203,Homo sapiens,IC50,uM,15.14
2765,3222537,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1079742,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,uM,0.42
2766,3222538,CHEMBL1116652,Inhibition of EGFR in human A431 cells by HTRF assay,B,CHEMBL1201179,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
2767,3222539,CHEMBL1116653,Inhibition of EGFR by HTRF assay,B,CHEMBL1087368,=,nM,1280.0,CHEMBL203,Homo sapiens,IC50,uM,1.28
2768,3222542,CHEMBL1116653,Inhibition of EGFR by HTRF assay,B,CHEMBL1080506,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
2769,3222547,CHEMBL1116653,Inhibition of EGFR by HTRF assay,B,CHEMBL1079742,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
2770,3222548,CHEMBL1116653,Inhibition of EGFR by HTRF assay,B,CHEMBL1201179,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
2771,3222903,CHEMBL1113143,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1080815,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
2772,3240704,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1091613,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0
2773,3240707,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1093815,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
2774,3240710,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1093234,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
2775,3240713,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1093235,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
2776,3240716,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090350,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
2777,3240719,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090351,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
2778,3240722,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090352,=,nM,870.0,CHEMBL203,Homo sapiens,IC50,nM,870.0
2779,3240725,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090353,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,nM,660.0
2780,3240728,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090354,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
2781,3240731,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090355,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,nM,190.0
2782,3240734,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090356,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
2783,3240737,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1088931,=,nM,6.2,CHEMBL203,Homo sapiens,IC50,nM,6.2
2784,3240740,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090357,=,nM,0.78,CHEMBL203,Homo sapiens,IC50,nM,0.78
2785,3240743,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090358,=,nM,0.96,CHEMBL203,Homo sapiens,IC50,nM,0.96
2786,3240746,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090359,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
2787,3240749,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090360,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
2788,3240752,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090361,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
2789,3240755,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090362,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
2790,3240758,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090363,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
2791,3240761,CHEMBL1108837,Inhibition of EGFR L858R mutant by time resolved fluorescence assay,B,CHEMBL1090364,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
2792,3240764,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090357,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,nM,220.0
2793,3240767,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090358,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
2794,3240770,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090360,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,nM,610.0
2795,3240773,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090362,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,nM,350.0
2796,3240776,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL1090364,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
2797,3240779,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL553,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
2798,3240782,CHEMBL1108835,Inhibition of EGFR intracellular phosphorylation in human A431 cells by ELISA,B,CHEMBL554,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
2799,3242697,CHEMBL1115349,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,B,CHEMBL1093099,=,nM,15070.0,CHEMBL203,Homo sapiens,IC50,uM,15.07
2800,3242704,CHEMBL1115349,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,B,CHEMBL1093100,=,nM,10410.0,CHEMBL203,Homo sapiens,IC50,uM,10.41
2801,3242768,CHEMBL1115349,Inhibition of EGFR in human A431 cells by phosphotyrosine cell-based ELISA,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
2802,3260044,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1090840,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2803,3261328,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL304929,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2804,3261329,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1092250,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
2805,3261330,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL553,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
2806,3261331,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1089203,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
2807,3261332,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1088901,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2808,3261333,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1089524,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
2809,3261334,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL188762,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
2810,3261335,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL1092382,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
2811,3261336,CHEMBL1105216,Inhibition of wild type EGFR by HTRF assay,B,CHEMBL285063,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
2812,3277999,CHEMBL1117422,Inhibition of EGFR,B,CHEMBL1088240,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
2813,3288470,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1098119,=,nM,1630.0,CHEMBL203,Homo sapiens,IC50,uM,1.63
2814,3288471,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1098120,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,uM,1.01
2815,3288473,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1098121,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,umol/L,4.4
2816,3288474,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094194,=,nM,1920.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.92
2817,3288475,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094195,=,nM,1110.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.11
2818,3288476,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094196,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.25
2819,3288477,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1095154,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.3
2820,3288478,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1095957,=,nM,2070.0,CHEMBL203,Homo sapiens,IC50,umol/L,2.07
2821,3288480,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094835,=,nM,2450.0,CHEMBL203,Homo sapiens,IC50,umol/L,2.45
2822,3288481,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL3216254,=,nM,1910.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.91
2823,3288482,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094492,=,nM,1370.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.37
2824,3288483,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1094825,=,nM,2750.0,CHEMBL203,Homo sapiens,IC50,umol/L,2.75
2825,3288484,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL3216699,=,nM,2280.0,CHEMBL203,Homo sapiens,IC50,umol/L,2.28
2826,3288485,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1097189,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,umol/L,2.5
2827,3288486,CHEMBL1105615,Inhibition of EGFR after 30 mins by chemiluminescence ELISA,B,CHEMBL1097190,=,nM,15120.0,CHEMBL203,Homo sapiens,IC50,umol/L,15.12
2828,3288542,CHEMBL1105619,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 25 uM ATP,B,CHEMBL1098120,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.01
2829,3288543,CHEMBL1105619,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 25 uM ATP,B,CHEMBL1094195,=,nM,1110.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.11
2830,3288550,CHEMBL1105620,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 50 uM ATP,B,CHEMBL1098120,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,umol/L,0.98
2831,3288551,CHEMBL1105620,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 50 uM ATP,B,CHEMBL1094195,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.12
2832,3288558,CHEMBL1111024,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 250 uM ATP,B,CHEMBL1098120,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.0
2833,3288559,CHEMBL1111024,Noncompetitive inhibition of EGFR after 30 mins by chemiluminescence ELISA in presence of 250 uM ATP,B,CHEMBL1094195,=,nM,1060.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.06
2834,3295254,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL485320,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
2835,3295260,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL483108,=,nM,22800.0,CHEMBL203,Homo sapiens,IC50,uM,22.8
2836,3295262,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL482715,=,nM,122000.0,CHEMBL203,Homo sapiens,IC50,uM,122.0
2837,3295264,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL483313,=,nM,1320.0,CHEMBL203,Homo sapiens,IC50,uM,1.32
2838,3295265,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL1097368,=,nM,56100.0,CHEMBL203,Homo sapiens,IC50,uM,56.1
2839,3295267,CHEMBL1115598,Inhibition of EGFR,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2840,3299618,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095761,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2841,3299620,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095130,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
2842,3299621,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095131,=,nM,161600.0,CHEMBL203,Homo sapiens,IC50,uM,161.6
2843,3299622,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095445,=,nM,27200.0,CHEMBL203,Homo sapiens,IC50,uM,27.2
2844,3299623,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1094475,=,nM,55200.0,CHEMBL203,Homo sapiens,IC50,uM,55.2
2845,3299624,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1094808,=,nM,91700.0,CHEMBL203,Homo sapiens,IC50,uM,91.7
2846,3299625,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095463,=,nM,45600.0,CHEMBL203,Homo sapiens,IC50,uM,45.6
2847,3299626,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095776,=,nM,96400.0,CHEMBL203,Homo sapiens,IC50,uM,96.4
2848,3299627,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
2849,3299628,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
2850,3299629,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
2851,3299692,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095464,=,nM,9100.0,CHEMBL203,Homo sapiens,IC50,uM,9.1
2852,3299693,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1095465,=,nM,12600.0,CHEMBL203,Homo sapiens,IC50,uM,12.6
2853,3299697,CHEMBL1112818,Inhibition of EGFR phosphorylation in human A431 cells after 10 mins by FLISA,B,CHEMBL1094784,=,nM,33100.0,CHEMBL203,Homo sapiens,IC50,uM,33.1
2854,3357155,CHEMBL1174225,Inhibition of human EGFR autophosphorylation expressed in Sf9 cells DELFIA assay,B,CHEMBL1171792,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
2855,3357156,CHEMBL1174225,Inhibition of human EGFR autophosphorylation expressed in Sf9 cells DELFIA assay,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
2856,3359793,CHEMBL1177355,Inhibition EGFR,B,CHEMBL1172957,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
2857,3359855,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173324,=,nM,13370.0,CHEMBL203,Homo sapiens,IC50,uM,13.37
2858,3359856,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173191,=,nM,10640.0,CHEMBL203,Homo sapiens,IC50,uM,10.64
2859,3359857,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173192,=,nM,11270.0,CHEMBL203,Homo sapiens,IC50,uM,11.27
2860,3359858,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173193,=,nM,8090.0,CHEMBL203,Homo sapiens,IC50,uM,8.09
2861,3359859,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173262,=,nM,9830.0,CHEMBL203,Homo sapiens,IC50,uM,9.83
2862,3359860,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172855,=,nM,10060.0,CHEMBL203,Homo sapiens,IC50,uM,10.06
2863,3359861,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1169870,=,nM,8150.0,CHEMBL203,Homo sapiens,IC50,uM,8.15
2864,3359862,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172823,=,nM,8920.0,CHEMBL203,Homo sapiens,IC50,uM,8.92
2865,3359863,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173601,=,nM,6430.0,CHEMBL203,Homo sapiens,IC50,uM,6.43
2866,3359864,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173602,=,nM,7280.0,CHEMBL203,Homo sapiens,IC50,uM,7.28
2867,3359865,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173665,=,nM,6560.0,CHEMBL203,Homo sapiens,IC50,uM,6.56
2868,3359866,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173666,=,nM,7780.0,CHEMBL203,Homo sapiens,IC50,uM,7.78
2869,3359867,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173667,=,nM,5270.0,CHEMBL203,Homo sapiens,IC50,uM,5.27
2870,3359868,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172915,=,nM,5740.0,CHEMBL203,Homo sapiens,IC50,uM,5.74
2871,3359869,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172916,=,nM,7380.0,CHEMBL203,Homo sapiens,IC50,uM,7.38
2872,3359870,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172917,=,nM,6850.0,CHEMBL203,Homo sapiens,IC50,uM,6.85
2873,3359871,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172980,=,nM,7320.0,CHEMBL203,Homo sapiens,IC50,uM,7.32
2874,3359872,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172573,=,nM,6270.0,CHEMBL203,Homo sapiens,IC50,uM,6.27
2875,3359873,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173688,=,nM,4210.0,CHEMBL203,Homo sapiens,IC50,uM,4.21
2876,3359874,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173794,=,nM,3870.0,CHEMBL203,Homo sapiens,IC50,uM,3.87
2877,3359875,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1169856,=,nM,5190.0,CHEMBL203,Homo sapiens,IC50,uM,5.19
2878,3359876,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173454,=,nM,3060.0,CHEMBL203,Homo sapiens,IC50,uM,3.06
2879,3359877,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173815,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
2880,3359878,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173814,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
2881,3359879,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173813,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
2882,3359880,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173457,=,nM,2170.0,CHEMBL203,Homo sapiens,IC50,uM,2.17
2883,3359881,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173456,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36
2884,3359882,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173455,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83
2885,3359883,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173251,=,nM,12260.0,CHEMBL203,Homo sapiens,IC50,uM,12.26
2886,3359884,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173250,=,nM,10970.0,CHEMBL203,Homo sapiens,IC50,uM,10.97
2887,3359885,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173249,=,nM,18350.0,CHEMBL203,Homo sapiens,IC50,uM,18.35
2888,3359886,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173248,=,nM,16140.0,CHEMBL203,Homo sapiens,IC50,uM,16.14
2889,3359887,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173816,=,nM,18450.0,CHEMBL203,Homo sapiens,IC50,uM,18.45
2890,3359888,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1171822,=,nM,19320.0,CHEMBL203,Homo sapiens,IC50,uM,19.32
2891,3359889,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173680,=,nM,17190.0,CHEMBL203,Homo sapiens,IC50,uM,17.19
2892,3359890,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172418,=,nM,24150.0,CHEMBL203,Homo sapiens,IC50,uM,24.15
2893,3359891,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172419,=,nM,28690.0,CHEMBL203,Homo sapiens,IC50,uM,28.69
2894,3359892,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172602,=,nM,25470.0,CHEMBL203,Homo sapiens,IC50,uM,25.47
2895,3359893,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1172603,=,nM,15560.0,CHEMBL203,Homo sapiens,IC50,uM,15.56
2896,3359894,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173022,=,nM,19730.0,CHEMBL203,Homo sapiens,IC50,uM,19.73
2897,3359895,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173023,=,nM,20610.0,CHEMBL203,Homo sapiens,IC50,uM,20.61
2898,3359896,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173319,=,nM,17490.0,CHEMBL203,Homo sapiens,IC50,uM,17.49
2899,3359897,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173397,=,nM,15240.0,CHEMBL203,Homo sapiens,IC50,uM,15.24
2900,3359898,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1171638,=,nM,21480.0,CHEMBL203,Homo sapiens,IC50,uM,21.48
2901,3359899,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173398,=,nM,20040.0,CHEMBL203,Homo sapiens,IC50,uM,20.04
2902,3359900,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL1173105,=,nM,17310.0,CHEMBL203,Homo sapiens,IC50,uM,17.31
2903,3359901,CHEMBL1177399,Inhibition of histidine-tagged recombinant EGFR autophosphorylation expressed in Sf9 cells by solid-phase ELISA,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2904,3364619,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172802,=,nM,4120.0,CHEMBL203,Homo sapiens,IC50,uM,4.12
2905,3364620,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172803,=,nM,3620.0,CHEMBL203,Homo sapiens,IC50,uM,3.62
2906,3364621,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173651,=,nM,3240.0,CHEMBL203,Homo sapiens,IC50,uM,3.24
2907,3364622,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173652,=,nM,7830.0,CHEMBL203,Homo sapiens,IC50,uM,7.83
2908,3364623,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173653,=,nM,8110.0,CHEMBL203,Homo sapiens,IC50,uM,8.11
2909,3364624,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173713,=,nM,10850.0,CHEMBL203,Homo sapiens,IC50,uM,10.85
2910,3364625,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173714,=,nM,6820.0,CHEMBL203,Homo sapiens,IC50,uM,6.82
2911,3364626,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173718,=,nM,620.0,CHEMBL203,Homo sapiens,IC50,uM,0.62
2912,3364627,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173783,=,nM,1270.0,CHEMBL203,Homo sapiens,IC50,uM,1.27
2913,3364628,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172877,=,nM,26740.0,CHEMBL203,Homo sapiens,IC50,uM,26.74
2914,3364629,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172878,=,nM,20810.0,CHEMBL203,Homo sapiens,IC50,uM,20.81
2915,3364630,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172947,=,nM,24320.0,CHEMBL203,Homo sapiens,IC50,uM,24.32
2916,3364631,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173789,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
2917,3364632,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1171273,=,nM,32000.0,CHEMBL203,Homo sapiens,IC50,uM,32.0
2918,3364633,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172950,=,nM,14530.0,CHEMBL203,Homo sapiens,IC50,uM,14.53
2919,3364634,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1172951,=,nM,12420.0,CHEMBL203,Homo sapiens,IC50,uM,12.42
2920,3364635,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1173014,=,nM,13870.0,CHEMBL203,Homo sapiens,IC50,uM,13.87
2921,3364636,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1170278,=,nM,3880.0,CHEMBL203,Homo sapiens,IC50,uM,3.88
2922,3364637,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL1170459,=,nM,5760.0,CHEMBL203,Homo sapiens,IC50,uM,5.76
2923,3364638,CHEMBL1177207,Inhibition of human recombinant His6x-tagged EGFR autophosphorylation expressed in Sf9 cells after 1 hr by ELISA,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
2924,3365210,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL1172781,=,nM,223.0,CHEMBL203,Homo sapiens,IC50,nM,223.0
2925,3365211,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL1172773,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,nM,82.0
2926,3365212,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL1172843,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
2927,3365213,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL939,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
2928,3365214,CHEMBL1176122,Inhibition of GST-tagged EGFR expressed in Escherichia coli,B,CHEMBL1173655,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
2929,3365217,CHEMBL1176123,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1172843,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
2930,3365218,CHEMBL1176123,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL939,=,nM,2815.0,CHEMBL203,Homo sapiens,IC50,nM,2815.0
2931,3365219,CHEMBL1176123,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1173655,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
2932,3370975,CHEMBL1211280,Inhibition of EGFR,B,CHEMBL388978,=,nM,102.4,CHEMBL203,Homo sapiens,IC50,nM,102.4
2933,3419555,CHEMBL1226208,Inhibition of human recombinant EGFR expressed in baculovirus-infected Sf9 cells by radioactive phosphotransfer assay,B,CHEMBL285063,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2934,3419556,CHEMBL1226208,Inhibition of human recombinant EGFR expressed in baculovirus-infected Sf9 cells by radioactive phosphotransfer assay,B,CHEMBL1221700,=,nM,689.0,CHEMBL203,Homo sapiens,IC50,uM,0.689
2935,3419557,CHEMBL1226208,Inhibition of human recombinant EGFR expressed in baculovirus-infected Sf9 cells by radioactive phosphotransfer assay,B,CHEMBL1221699,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
2936,3436055,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243284,=,nM,8.12,CHEMBL203,Homo sapiens,IC50,nM,8.12
2937,3436057,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243255,=,nM,5.35,CHEMBL203,Homo sapiens,IC50,nM,5.35
2938,3436058,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL607707,=,nM,8.02,CHEMBL203,Homo sapiens,IC50,nM,8.02
2939,3436059,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243346,=,nM,4.05,CHEMBL203,Homo sapiens,IC50,nM,4.05
2940,3436063,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243283,=,nM,1.81,CHEMBL203,Homo sapiens,IC50,nM,1.81
2941,3436064,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243254,=,nM,0.57,CHEMBL203,Homo sapiens,IC50,nM,0.57
2942,3436071,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243255,=,nM,0.25,CHEMBL203,Homo sapiens,IC50,nM,0.25
2943,3436074,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243345,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
2944,3436076,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243284,=,nM,0.29,CHEMBL203,Homo sapiens,IC50,nM,0.29
2945,3436081,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL607707,=,nM,0.24,CHEMBL203,Homo sapiens,IC50,nM,0.24
2946,3436088,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL1243316,=,nM,0.03,CHEMBL203,Homo sapiens,IC50,nM,0.03
2947,3436089,CHEMBL1249168,Inhibition of EGFR,B,CHEMBL328216,=,nM,0.81,CHEMBL203,Homo sapiens,IC50,nM,0.81
2948,3436095,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243316,=,nM,60.2,CHEMBL203,Homo sapiens,IC50,nM,60.2
2949,3436098,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243345,=,nM,23.02,CHEMBL203,Homo sapiens,IC50,nM,23.02
2950,3436099,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243283,=,nM,21.97,CHEMBL203,Homo sapiens,IC50,nM,21.97
2951,3436100,CHEMBL1246645,Inhibition of EGFR autophosphorylation in human A431 cells,B,CHEMBL1243254,=,nM,16.52,CHEMBL203,Homo sapiens,IC50,nM,16.52
2952,3440726,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242285,=,nM,249.0,CHEMBL203,Homo sapiens,IC50,uM,0.249
2953,3440740,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242286,=,nM,4320.0,CHEMBL203,Homo sapiens,IC50,uM,4.32
2954,3440754,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241299,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
2955,3440768,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242287,=,nM,324.0,CHEMBL203,Homo sapiens,IC50,uM,0.324
2956,3440782,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242376,=,nM,236.0,CHEMBL203,Homo sapiens,IC50,uM,0.236
2957,3440796,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242377,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
2958,3440810,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242378,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
2959,3440824,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242468,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,uM,26.0
2960,3440838,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242469,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
2961,3440852,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242470,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
2962,3440866,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242566,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
2963,3440880,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242567,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
2964,3440894,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242568,=,nM,318.0,CHEMBL203,Homo sapiens,IC50,uM,0.318
2965,3440908,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242656,=,nM,366.0,CHEMBL203,Homo sapiens,IC50,uM,0.366
2966,3440922,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242657,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
2967,3440936,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242658,=,nM,15600.0,CHEMBL203,Homo sapiens,IC50,uM,15.6
2968,3440950,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242748,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
2969,3440964,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242749,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
2970,3440978,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242750,=,nM,775.0,CHEMBL203,Homo sapiens,IC50,uM,0.775
2971,3440992,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242844,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
2972,3441006,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242845,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
2973,3441020,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241482,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
2974,3441034,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241483,=,nM,3860.0,CHEMBL203,Homo sapiens,IC50,uM,3.86
2975,3441048,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241484,=,nM,158.0,CHEMBL203,Homo sapiens,IC50,uM,0.158
2976,3441062,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241579,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
2977,3441076,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240544,=,nM,9140.0,CHEMBL203,Homo sapiens,IC50,uM,9.14
2978,3441626,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241481,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
2979,3441640,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241578,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
2980,3441654,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1081312,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
2981,3441668,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1233882,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61
2982,3441682,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1233881,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
2983,3441696,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241674,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
2984,3441710,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241675,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
2985,3441867,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1230790,=,nM,954.0,CHEMBL203,Homo sapiens,IC50,uM,0.954
2986,3441881,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1234815,=,nM,388.0,CHEMBL203,Homo sapiens,IC50,uM,0.388
2987,3441979,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241241,=,nM,922.0,CHEMBL203,Homo sapiens,IC50,uM,0.922
2988,3442035,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242024,=,nM,954.0,CHEMBL203,Homo sapiens,IC50,uM,0.954
2989,3442063,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241270,=,nM,12400.0,CHEMBL203,Homo sapiens,IC50,uM,12.4
2990,3442077,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241271,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
2991,3442091,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242026,=,nM,663.0,CHEMBL203,Homo sapiens,IC50,uM,0.663
2992,3442105,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242109,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67
2993,3442119,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242110,=,nM,3720.0,CHEMBL203,Homo sapiens,IC50,uM,3.72
2994,3442133,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242111,=,nM,1770.0,CHEMBL203,Homo sapiens,IC50,uM,1.77
2995,3442147,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242198,=,nM,576.0,CHEMBL203,Homo sapiens,IC50,uM,0.576
2996,3442161,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242199,=,nM,751.0,CHEMBL203,Homo sapiens,IC50,uM,0.751
2997,3442175,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242200,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
2998,3442185,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242380,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
2999,3442199,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242381,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
3000,3442213,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240553,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
3001,3442227,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242471,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3002,3442241,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242472,=,nM,5950.0,CHEMBL203,Homo sapiens,IC50,uM,5.95
3003,3442255,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242569,=,nM,5080.0,CHEMBL203,Homo sapiens,IC50,uM,5.08
3004,3442269,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240554,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3005,3442283,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242659,=,nM,1160.0,CHEMBL203,Homo sapiens,IC50,uM,1.16
3006,3442297,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242660,=,nM,5140.0,CHEMBL203,Homo sapiens,IC50,uM,5.14
3007,3442311,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242751,=,nM,3660.0,CHEMBL203,Homo sapiens,IC50,uM,3.66
3008,3442325,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242752,=,nM,54200.0,CHEMBL203,Homo sapiens,IC50,uM,54.2
3009,3442339,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242753,=,nM,8010.0,CHEMBL203,Homo sapiens,IC50,uM,8.01
3010,3442353,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242846,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3011,3442367,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242847,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
3012,3442395,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242848,=,nM,2120.0,CHEMBL203,Homo sapiens,IC50,uM,2.12
3013,3442409,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241485,=,nM,3850.0,CHEMBL203,Homo sapiens,IC50,uM,3.85
3014,3442423,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241486,=,nM,5320.0,CHEMBL203,Homo sapiens,IC50,uM,5.32
3015,3442437,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241487,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
3016,3442451,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241581,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
3017,3442521,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241582,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3018,3442535,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241583,=,nM,17000.0,CHEMBL203,Homo sapiens,IC50,uM,17.0
3019,3442549,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240545,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,uM,13.0
3020,3442562,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241679,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3021,3442576,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241680,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3022,3442590,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241771,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
3023,3442604,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241772,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3024,3442618,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241390,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3025,3442632,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241391,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3026,3442646,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241773,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
3027,3442660,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241860,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
3028,3442674,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241861,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
3029,3442688,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241862,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3030,3442702,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241946,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
3031,3442716,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241439,=,nM,5960.0,CHEMBL203,Homo sapiens,IC50,uM,5.96
3032,3442730,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241947,=,nM,9900.0,CHEMBL203,Homo sapiens,IC50,uM,9.9
3033,3442743,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241948,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3034,3442756,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242030,=,nM,12800.0,CHEMBL203,Homo sapiens,IC50,uM,12.8
3035,3442770,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242031,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3036,3442784,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242032,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3037,3442798,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242115,=,nM,579.0,CHEMBL203,Homo sapiens,IC50,uM,0.579
3038,3442949,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241580,=,nM,1150.0,CHEMBL203,Homo sapiens,IC50,uM,1.15
3039,3442963,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241676,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
3040,3442977,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241677,=,nM,12400.0,CHEMBL203,Homo sapiens,IC50,uM,12.4
3041,3442991,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241678,=,nM,1580.0,CHEMBL203,Homo sapiens,IC50,uM,1.58
3042,3443005,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241768,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3043,3443019,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241769,=,nM,9380.0,CHEMBL203,Homo sapiens,IC50,uM,9.38
3044,3443033,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241770,=,nM,2010.0,CHEMBL203,Homo sapiens,IC50,uM,2.01
3045,3443047,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241858,=,nM,2720.0,CHEMBL203,Homo sapiens,IC50,uM,2.72
3046,3443061,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241859,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3047,3443075,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241943,=,nM,20500.0,CHEMBL203,Homo sapiens,IC50,uM,20.5
3048,3443089,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241944,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
3049,3443103,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241945,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
3050,3443117,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242027,=,nM,10200.0,CHEMBL203,Homo sapiens,IC50,uM,10.2
3051,3443131,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242028,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
3052,3443145,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242029,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3053,3443159,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242112,=,nM,908.0,CHEMBL203,Homo sapiens,IC50,uM,0.908
3054,3443173,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241300,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3055,3443187,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241301,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3056,3443201,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242113,=,nM,6450.0,CHEMBL203,Homo sapiens,IC50,uM,6.45
3057,3443215,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242114,=,nM,2190.0,CHEMBL203,Homo sapiens,IC50,uM,2.19
3058,3443229,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242201,=,nM,437.0,CHEMBL203,Homo sapiens,IC50,uM,0.437
3059,3443243,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242202,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
3060,3443257,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242203,=,nM,17000.0,CHEMBL203,Homo sapiens,IC50,uM,17.0
3061,3443271,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242288,=,nM,12600.0,CHEMBL203,Homo sapiens,IC50,uM,12.6
3062,3443285,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242289,=,nM,768.0,CHEMBL203,Homo sapiens,IC50,uM,0.768
3063,3443299,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242290,=,nM,3020.0,CHEMBL203,Homo sapiens,IC50,uM,3.02
3064,3443313,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242379,=,nM,6340.0,CHEMBL203,Homo sapiens,IC50,uM,6.34
3065,3443774,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242661,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
3066,3443788,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242662,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,uM,0.088
3067,3443802,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242663,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3068,3443816,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242754,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
3069,3443830,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242755,=,nM,540.0,CHEMBL203,Homo sapiens,IC50,uM,0.54
3070,3443844,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242756,=,nM,34000.0,CHEMBL203,Homo sapiens,IC50,uM,34.0
3071,3443998,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241681,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
3072,3444012,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241682,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3073,3444026,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241683,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3074,3444040,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241774,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
3075,3444054,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241775,=,nM,70000.0,CHEMBL203,Homo sapiens,IC50,uM,70.0
3076,3444068,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241776,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
3077,3444082,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241863,=,nM,6700.0,CHEMBL203,Homo sapiens,IC50,uM,6.7
3078,3444096,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241864,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3079,3444110,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241949,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
3080,3444124,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241950,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
3081,3444138,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242033,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3082,3444152,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242034,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3083,3444166,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242117,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
3084,3444180,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242118,=,nM,29000.0,CHEMBL203,Homo sapiens,IC50,uM,29.0
3085,3444194,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242119,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3086,3444208,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242207,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
3087,3444222,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242208,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3088,3444236,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242209,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
3089,3444250,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240565,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
3090,3444264,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242293,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3091,3444278,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242294,=,nM,176.0,CHEMBL203,Homo sapiens,IC50,uM,0.176
3092,3444292,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242295,=,nM,734.0,CHEMBL203,Homo sapiens,IC50,uM,0.734
3093,3444306,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242384,=,nM,955.0,CHEMBL203,Homo sapiens,IC50,uM,0.955
3094,3444320,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242385,=,nM,539.0,CHEMBL203,Homo sapiens,IC50,uM,0.539
3095,3444334,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242386,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
3096,3444348,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242475,=,nM,571.0,CHEMBL203,Homo sapiens,IC50,uM,0.571
3097,3444362,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242476,=,nM,207.0,CHEMBL203,Homo sapiens,IC50,uM,0.207
3098,3444376,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242477,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
3099,3444390,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242572,=,nM,760.0,CHEMBL203,Homo sapiens,IC50,uM,0.76
3100,3444404,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242573,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3101,3444418,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1240566,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
3102,3444432,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242574,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
3103,3444446,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242664,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,uM,0.085
3104,3444460,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242665,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
3105,3444474,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242666,=,nM,638.0,CHEMBL203,Homo sapiens,IC50,uM,0.638
3106,3444488,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242757,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
3107,3444502,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242758,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3108,3444516,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242852,=,nM,179.0,CHEMBL203,Homo sapiens,IC50,uM,0.179
3109,3444530,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1242853,=,nM,391.0,CHEMBL203,Homo sapiens,IC50,uM,0.391
3110,3444544,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241490,=,nM,964.0,CHEMBL203,Homo sapiens,IC50,uM,0.964
3111,3444558,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241491,=,nM,575.0,CHEMBL203,Homo sapiens,IC50,uM,0.575
3112,3444572,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241492,=,nM,8300.0,CHEMBL203,Homo sapiens,IC50,uM,8.3
3113,3444586,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241586,=,nM,937.0,CHEMBL203,Homo sapiens,IC50,uM,0.937
3114,3444600,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241587,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
3115,3444628,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241588,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
3116,3444656,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1241684,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
3117,3444669,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
3118,3444682,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL1421,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
3119,3444695,CHEMBL1243977,Inhibition of recombinant EGFR by radioactive phosphotransfer assay in presence of 10 uM ATP,B,CHEMBL535,=,nM,18000.0,CHEMBL203,Homo sapiens,IC50,uM,18.0
3120,3446243,CHEMBL1244583,Inhibition of EGFR T790M mutant,B,CHEMBL288441,=,nM,491.0,CHEMBL203,Homo sapiens,IC50,nM,491.0
3121,3446263,CHEMBL1244582,Inhibition of EGFR,B,CHEMBL1421,=,nM,322.0,CHEMBL203,Homo sapiens,IC50,nM,322.0
3122,3446274,CHEMBL1244582,Inhibition of EGFR,B,CHEMBL288441,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
3123,3447194,CHEMBL1249643,Inhibition of EGFR kinase,B,CHEMBL201307,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,nM,800.0
3124,3468957,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL499344,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67
3125,3468958,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1095464,=,nM,9190.0,CHEMBL203,Homo sapiens,IC50,uM,9.19
3126,3468959,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1095465,=,nM,12620.0,CHEMBL203,Homo sapiens,IC50,uM,12.62
3127,3468960,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254199,=,nM,53100.0,CHEMBL203,Homo sapiens,IC50,uM,53.1
3128,3468962,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254286,=,nM,253600.0,CHEMBL203,Homo sapiens,IC50,uM,253.6
3129,3468963,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254363,=,nM,31200.0,CHEMBL203,Homo sapiens,IC50,uM,31.2
3130,3468964,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254364,=,nM,12800.0,CHEMBL203,Homo sapiens,IC50,uM,12.8
3131,3468965,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254443,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3132,3468966,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254444,=,nM,143500.0,CHEMBL203,Homo sapiens,IC50,uM,143.5
3133,3468968,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL1254523,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
3134,3468969,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
3135,3468970,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3136,3468971,CHEMBL1252156,Inhibition of EGFR expressed in human A431 cells,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
3137,3503208,CHEMBL1261159,Inhibition of EGFR,B,CHEMBL1257795,=,nM,10900.0,CHEMBL203,Homo sapiens,IC50,uM,10.9
3138,3503209,CHEMBL1261159,Inhibition of EGFR,B,CHEMBL1257911,=,nM,989.0,CHEMBL203,Homo sapiens,IC50,uM,0.989
3139,3503210,CHEMBL1261159,Inhibition of EGFR,B,CHEMBL1257912,=,nM,726.0,CHEMBL203,Homo sapiens,IC50,uM,0.726
3140,3505042,CHEMBL1260610,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,B,CHEMBL553,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
3141,3505043,CHEMBL1260610,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,B,CHEMBL554,=,nM,433.0,CHEMBL203,Homo sapiens,IC50,nM,433.0
3142,3505085,CHEMBL1260610,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,B,CHEMBL1257998,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,nM,2300.0
3143,3505086,CHEMBL1260610,Inhibition of EGFR phosphorylation in human MIAPaCa cells by ELISA,B,CHEMBL1256432,=,nM,2880.0,CHEMBL203,Homo sapiens,IC50,nM,2880.0
3144,3521868,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271950,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
3145,3521872,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272006,=,nM,1090.0,CHEMBL203,Homo sapiens,IC50,uM,1.09
3146,3521874,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272061,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
3147,3521875,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272113,=,nM,1270.0,CHEMBL203,Homo sapiens,IC50,uM,1.27
3148,3521876,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272167,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,uM,0.091
3149,3521877,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272168,=,nM,3057.0,CHEMBL203,Homo sapiens,IC50,uM,3.057
3150,3521878,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272222,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
3151,3521879,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272223,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
3152,3521880,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272275,=,nM,3503.0,CHEMBL203,Homo sapiens,IC50,uM,3.503
3153,3521881,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272276,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
3154,3521882,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272324,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
3155,3521883,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1272325,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
3156,3521884,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271507,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,uM,0.089
3157,3521886,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271561,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
3158,3521887,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271562,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
3159,3521888,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271618,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,uM,0.149
3160,3521889,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1271619,=,nM,4884.0,CHEMBL203,Homo sapiens,IC50,uM,4.884
3161,3521890,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL939,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
3162,3521892,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272061,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
3163,3521895,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272167,=,nM,2480.0,CHEMBL203,Homo sapiens,IC50,uM,2.48
3164,3521897,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272222,=,nM,739.0,CHEMBL203,Homo sapiens,IC50,uM,0.739
3165,3521898,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272223,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
3166,3521900,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272276,=,nM,305.0,CHEMBL203,Homo sapiens,IC50,uM,0.305
3167,3521901,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272324,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
3168,3521902,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1272325,=,nM,1399.0,CHEMBL203,Homo sapiens,IC50,uM,1.399
3169,3521904,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1271561,=,nM,596.0,CHEMBL203,Homo sapiens,IC50,uM,0.596
3170,3521905,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1271562,=,nM,5750.0,CHEMBL203,Homo sapiens,IC50,uM,5.75
3171,3521906,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL1271618,=,nM,4107.0,CHEMBL203,Homo sapiens,IC50,uM,4.107
3172,3521908,CHEMBL1273339,Inhibition of EGFR L858R/T790M double mutant,B,CHEMBL939,=,nM,2815.0,CHEMBL203,Homo sapiens,IC50,uM,2.815
3173,3521915,CHEMBL1273341,Inhibition of EGFR,B,CHEMBL1172781,=,nM,223.0,CHEMBL203,Homo sapiens,IC50,nM,223.0
3174,3556136,CHEMBL1285874,Inhibition of EGFR,B,CHEMBL1276179,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0
3175,5112087,CHEMBL1640839,Inhibition of EGF-induced EGFR phosphorylation in human CAL27 cells overexpressing EGFR after 16 hrs by Western blot,B,CHEMBL1630107,<,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
3176,5112088,CHEMBL1640839,Inhibition of EGF-induced EGFR phosphorylation in human CAL27 cells overexpressing EGFR after 16 hrs by Western blot,B,CHEMBL554,<,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
3177,5112196,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630107,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,uM,0.0025
3178,5112197,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630108,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,uM,0.0048
3179,5112198,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630109,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
3180,5112199,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630110,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
3181,5112200,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630111,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,uM,0.0029
3182,5112201,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630112,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,uM,0.0028
3183,5112202,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630113,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
3184,5112203,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630114,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
3185,5112204,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630115,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
3186,5112205,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630116,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
3187,5112206,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630117,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,uM,0.0039
3188,5112207,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL1630118,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,uM,0.0022
3189,5112208,CHEMBL1640694,Inhibition of EGFR by flash plate based radioactive enzyme assay,B,CHEMBL554,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,uM,0.0029
3190,5112367,CHEMBL1640839,Inhibition of EGF-induced EGFR phosphorylation in human CAL27 cells overexpressing EGFR after 16 hrs by Western blot,B,CHEMBL1630109,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
3191,5133828,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641991,=,nM,20800.0,CHEMBL203,Homo sapiens,IC50,uM,20.8
3192,5133829,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641990,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
3193,5133830,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641989,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
3194,5133833,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641998,=,nM,28000.0,CHEMBL203,Homo sapiens,IC50,uM,28.0
3195,5133835,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641997,=,nM,45200.0,CHEMBL203,Homo sapiens,IC50,uM,45.2
3196,5133837,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641996,=,nM,55600.0,CHEMBL203,Homo sapiens,IC50,uM,55.6
3197,5133839,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641995,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
3198,5133841,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641994,=,nM,12800.0,CHEMBL203,Homo sapiens,IC50,uM,12.8
3199,5133843,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641993,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
3200,5133845,CHEMBL1646349,Inhibition of EGFR by HTRF assay,B,CHEMBL1641992,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
3201,5138055,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645462,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
3202,5138061,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL248108,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
3203,5138067,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL246284,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
3204,5138078,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645474,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
3205,5138082,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645473,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
3206,5138083,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645466,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
3207,5138084,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645476,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
3208,5138087,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645470,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
3209,5138088,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645472,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
3210,5138090,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645467,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
3211,5138091,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645471,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
3212,5138097,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645475,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
3213,5138100,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645477,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
3214,5138103,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645469,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
3215,5138104,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645465,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,uM,0.67
3216,5138107,CHEMBL1647391,Inhibition of EGFR,B,CHEMBL1645464,=,nM,950.0,CHEMBL203,Homo sapiens,IC50,uM,0.95
3217,5243225,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1201179,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
3218,5243227,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
3219,5243229,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
3220,5243231,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL205652,=,nM,920.0,CHEMBL203,Homo sapiens,IC50,uM,0.92
3221,5243233,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683949,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
3222,5243235,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683950,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3223,5243237,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683951,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
3224,5243239,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683952,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
3225,5243243,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683954,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
3226,5243245,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683955,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
3227,5243247,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683956,=,nM,640.0,CHEMBL203,Homo sapiens,IC50,uM,0.64
3228,5243249,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683957,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
3229,5243251,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683958,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
3230,5243253,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683959,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
3231,5243255,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683960,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
3232,5243257,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683961,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
3233,5243259,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683962,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
3234,5243261,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683963,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
3235,5243263,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683964,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
3236,5243265,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683965,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
3237,5243267,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683966,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,uM,0.114
3238,5243269,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683967,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
3239,5243271,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683968,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
3240,5243273,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683969,=,nM,156.0,CHEMBL203,Homo sapiens,IC50,uM,0.156
3241,5243275,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683970,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
3242,5243277,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683971,=,nM,4130.0,CHEMBL203,Homo sapiens,IC50,uM,4.13
3243,5243279,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683972,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
3244,5243281,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683973,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
3245,5243283,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683974,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
3246,5243285,CHEMBL1686143,Inhibition of EGFR by homogeneous time-resolved fluorescence assay,B,CHEMBL1683975,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
3247,5249865,CHEMBL1687360,Inhibition of EGFR,B,CHEMBL1684800,=,nM,101.4,CHEMBL203,Homo sapiens,IC50,nM,101.4
3248,5293856,CHEMBL1697113,Inhibition of EGFR after 60 mins by radiometric assay,B,CHEMBL1448,=,nM,10500.0,CHEMBL203,Homo sapiens,IC50,uM,10.5
3249,5310425,CHEMBL1693590,Inhibition of EGFR,B,CHEMBL1688860,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,nM,4900.0
3250,5310426,CHEMBL1693590,Inhibition of EGFR,B,CHEMBL1688861,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,nM,190.0
3251,6153994,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL24828,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
3252,6154008,CHEMBL1763553,Inhibition of EGFR,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
3253,6154009,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL29197,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
3254,6154011,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL98798,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
3255,6154012,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL301018,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3256,6154015,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL1277620,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
3257,6154017,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL1278149,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9
3258,6154020,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL1761929,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
3259,6154045,CHEMBL1763554,Inhibition of human EGFR-mediated poly(Glu4Tyr) phosphorylation after 1 hr,B,CHEMBL939,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
3260,6154882,CHEMBL1762895,Inhibition of EGFR,B,CHEMBL1762110,=,nM,3580.0,CHEMBL203,Homo sapiens,IC50,uM,3.58
3261,6157884,CHEMBL1764782,Inhibition of EGFR,B,CHEMBL1760035,=,nM,853.0,CHEMBL203,Homo sapiens,IC50,uM,0.853
3262,6157885,CHEMBL1764782,Inhibition of EGFR,B,CHEMBL1760057,=,nM,2290.0,CHEMBL203,Homo sapiens,IC50,uM,2.29
3263,6219885,CHEMBL1785573,Inhibition of human EGFR using poly[Glu:Tyr] by Hotspot assay,B,CHEMBL1784637,=,nM,736.0,CHEMBL203,Homo sapiens,IC50,nM,736.0
3264,6219886,CHEMBL1785574,Inhibition of human EGFR L858R mutant using poly[Glu:Tyr] by Hotspot assay,B,CHEMBL1784637,=,nM,231.0,CHEMBL203,Homo sapiens,IC50,nM,231.0
3265,6268161,CHEMBL1805338,Inhibition of EGFR,B,CHEMBL1270795,=,nM,5048.0,CHEMBL203,Homo sapiens,IC50,nM,5048.0
3266,6315899,CHEMBL1817212,Inhibition of EGFR after 1 hrs by luminescence assay,B,CHEMBL1812374,=,nM,1929.0,CHEMBL203,Homo sapiens,IC50,uM,1.929
3267,6315900,CHEMBL1817212,Inhibition of EGFR after 1 hrs by luminescence assay,B,CHEMBL1812491,=,nM,12070.0,CHEMBL203,Homo sapiens,IC50,uM,12.07
3268,6315901,CHEMBL1817212,Inhibition of EGFR after 1 hrs by luminescence assay,B,CHEMBL939,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
3269,6321174,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812431,=,nM,1210.0,CHEMBL203,Homo sapiens,IC50,uM,1.21
3270,6321175,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812434,=,nM,4280.0,CHEMBL203,Homo sapiens,IC50,uM,4.28
3271,6321176,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812435,=,nM,7220.0,CHEMBL203,Homo sapiens,IC50,uM,7.22
3272,6321177,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812555,=,nM,7710.0,CHEMBL203,Homo sapiens,IC50,uM,7.71
3273,6321178,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812556,=,nM,6020.0,CHEMBL203,Homo sapiens,IC50,uM,6.02
3274,6321179,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812559,=,nM,5160.0,CHEMBL203,Homo sapiens,IC50,uM,5.16
3275,6321180,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812560,=,nM,1020.0,CHEMBL203,Homo sapiens,IC50,uM,1.02
3276,6321181,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812561,=,nM,3610.0,CHEMBL203,Homo sapiens,IC50,uM,3.61
3277,6321182,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812564,=,nM,3490.0,CHEMBL203,Homo sapiens,IC50,uM,3.49
3278,6321183,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812566,=,nM,6630.0,CHEMBL203,Homo sapiens,IC50,uM,6.63
3279,6321184,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812569,=,nM,2810.0,CHEMBL203,Homo sapiens,IC50,uM,2.81
3280,6321185,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812571,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
3281,6321186,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3282,6321187,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL52765,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
3283,6321188,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL343352,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
3284,6321189,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812570,=,nM,3450.0,CHEMBL203,Homo sapiens,IC50,uM,3.45
3285,6321190,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812572,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
3286,6321191,CHEMBL1816084,Inhibition of recombinant EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1812573,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
3287,6327067,CHEMBL1820121,Inhibition of EGFR-induced AP1 activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817964,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
3288,6327068,CHEMBL1820121,Inhibition of EGFR-induced AP1 activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817965,<,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
3289,6327069,CHEMBL1820122,Inhibition of EGFR-induced HIF1alpha activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817964,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
3290,6327070,CHEMBL1820122,Inhibition of EGFR-induced HIF1alpha activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817965,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
3291,6327071,CHEMBL1820123,Inhibition of EGFR-induced Beta-casein activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817964,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
3292,6327072,CHEMBL1820123,Inhibition of EGFR-induced Beta-casein activation in human HeLa cells preincubated for 1 hr prior to EGF stimulation by luciferase reporter gene assay,B,CHEMBL1817965,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
3293,6340168,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821862,=,nM,1730.0,CHEMBL203,Homo sapiens,IC50,uM,1.73
3294,6340169,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821863,=,nM,2360.0,CHEMBL203,Homo sapiens,IC50,uM,2.36
3295,6340170,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821864,=,nM,1840.0,CHEMBL203,Homo sapiens,IC50,uM,1.84
3296,6340171,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821865,=,nM,2670.0,CHEMBL203,Homo sapiens,IC50,uM,2.67
3297,6340172,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821866,=,nM,3080.0,CHEMBL203,Homo sapiens,IC50,uM,3.08
3298,6340173,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821867,=,nM,1920.0,CHEMBL203,Homo sapiens,IC50,uM,1.92
3299,6340174,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821868,=,nM,3850.0,CHEMBL203,Homo sapiens,IC50,uM,3.85
3300,6340175,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821869,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
3301,6340176,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821870,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
3302,6340177,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821871,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
3303,6340178,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821872,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
3304,6340179,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821873,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
3305,6340180,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821874,=,nM,970.0,CHEMBL203,Homo sapiens,IC50,uM,0.97
3306,6340181,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821875,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,uM,0.63
3307,6340182,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821876,=,nM,11240.0,CHEMBL203,Homo sapiens,IC50,uM,11.24
3308,6340183,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821877,=,nM,9370.0,CHEMBL203,Homo sapiens,IC50,uM,9.37
3309,6340184,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821878,=,nM,8950.0,CHEMBL203,Homo sapiens,IC50,uM,8.95
3310,6340185,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821879,=,nM,19640.0,CHEMBL203,Homo sapiens,IC50,uM,19.64
3311,6340186,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821880,=,nM,10170.0,CHEMBL203,Homo sapiens,IC50,uM,10.17
3312,6340187,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821881,=,nM,22360.0,CHEMBL203,Homo sapiens,IC50,uM,22.36
3313,6340188,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821882,=,nM,15720.0,CHEMBL203,Homo sapiens,IC50,uM,15.72
3314,6340189,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3315,6340190,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821883,=,nM,24160.0,CHEMBL203,Homo sapiens,IC50,uM,24.16
3316,6340191,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821884,=,nM,17840.0,CHEMBL203,Homo sapiens,IC50,uM,17.84
3317,6340192,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821885,=,nM,25740.0,CHEMBL203,Homo sapiens,IC50,uM,25.74
3318,6340193,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821886,=,nM,28170.0,CHEMBL203,Homo sapiens,IC50,uM,28.17
3319,6340194,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821887,=,nM,19830.0,CHEMBL203,Homo sapiens,IC50,uM,19.83
3320,6340195,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821888,=,nM,21520.0,CHEMBL203,Homo sapiens,IC50,uM,21.52
3321,6340196,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821889,=,nM,24370.0,CHEMBL203,Homo sapiens,IC50,uM,24.37
3322,6340197,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821890,=,nM,5710.0,CHEMBL203,Homo sapiens,IC50,uM,5.71
3323,6340198,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821891,=,nM,4940.0,CHEMBL203,Homo sapiens,IC50,uM,4.94
3324,6340199,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821892,=,nM,5560.0,CHEMBL203,Homo sapiens,IC50,uM,5.56
3325,6340200,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821893,=,nM,7480.0,CHEMBL203,Homo sapiens,IC50,uM,7.48
3326,6340201,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821894,=,nM,6920.0,CHEMBL203,Homo sapiens,IC50,uM,6.92
3327,6340202,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821895,=,nM,5350.0,CHEMBL203,Homo sapiens,IC50,uM,5.35
3328,6340203,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821896,=,nM,8630.0,CHEMBL203,Homo sapiens,IC50,uM,8.63
3329,6340204,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1821897,=,nM,5070.0,CHEMBL203,Homo sapiens,IC50,uM,5.07
3330,6340205,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822061,=,nM,7780.0,CHEMBL203,Homo sapiens,IC50,uM,7.78
3331,6340206,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822062,=,nM,6310.0,CHEMBL203,Homo sapiens,IC50,uM,6.31
3332,6340207,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822063,=,nM,4680.0,CHEMBL203,Homo sapiens,IC50,uM,4.68
3333,6340208,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822064,=,nM,6270.0,CHEMBL203,Homo sapiens,IC50,uM,6.27
3334,6340209,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822065,=,nM,7660.0,CHEMBL203,Homo sapiens,IC50,uM,7.66
3335,6340210,CHEMBL1827038,Inhibition of recombinant (His)6-tagged EGFR cytoplasmic domain (645-1186) autophosphorylation pre-incubated for 10 mins measured after 1 hrs by DELFIA based time-resolved fluorimetry assay,B,CHEMBL1822066,=,nM,8430.0,CHEMBL203,Homo sapiens,IC50,uM,8.43
3336,6356806,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830257,=,nM,22360.0,CHEMBL203,Homo sapiens,IC50,uM,22.36
3337,6356807,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830258,=,nM,23270.0,CHEMBL203,Homo sapiens,IC50,uM,23.27
3338,6356808,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830259,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,uM,26.0
3339,6356809,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830260,=,nM,33000.0,CHEMBL203,Homo sapiens,IC50,uM,33.0
3340,6356810,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830261,=,nM,2080.0,CHEMBL203,Homo sapiens,IC50,uM,2.08
3341,6356811,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830262,=,nM,10950.0,CHEMBL203,Homo sapiens,IC50,uM,10.95
3342,6356812,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830263,=,nM,3740.0,CHEMBL203,Homo sapiens,IC50,uM,3.74
3343,6356813,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830264,=,nM,19120.0,CHEMBL203,Homo sapiens,IC50,uM,19.12
3344,6356814,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830265,=,nM,20480.0,CHEMBL203,Homo sapiens,IC50,uM,20.48
3345,6356815,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830266,=,nM,26560.0,CHEMBL203,Homo sapiens,IC50,uM,26.56
3346,6356816,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830267,=,nM,17390.0,CHEMBL203,Homo sapiens,IC50,uM,17.39
3347,6356817,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830268,=,nM,14830.0,CHEMBL203,Homo sapiens,IC50,uM,14.83
3348,6356818,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830269,=,nM,1570.0,CHEMBL203,Homo sapiens,IC50,uM,1.57
3349,6356819,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830270,=,nM,5110.0,CHEMBL203,Homo sapiens,IC50,uM,5.11
3350,6356820,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830271,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
3351,6356821,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830272,=,nM,2380.0,CHEMBL203,Homo sapiens,IC50,uM,2.38
3352,6356822,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830273,=,nM,12240.0,CHEMBL203,Homo sapiens,IC50,uM,12.24
3353,6356823,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830274,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
3354,6356824,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830275,=,nM,8660.0,CHEMBL203,Homo sapiens,IC50,uM,8.66
3355,6356825,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830276,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
3356,6356826,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830277,=,nM,9780.0,CHEMBL203,Homo sapiens,IC50,uM,9.78
3357,6356827,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830278,=,nM,2170.0,CHEMBL203,Homo sapiens,IC50,uM,2.17
3358,6356828,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830279,=,nM,7830.0,CHEMBL203,Homo sapiens,IC50,uM,7.83
3359,6356829,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL1830280,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,uM,0.41
3360,6356830,CHEMBL1831627,Inhibition of His-tagged EGFR expressed in insect Sf9 cells after 1 hr by time-resolved fluorimetric analysis,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3361,6358465,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828860,=,nM,2940.0,CHEMBL203,Homo sapiens,IC50,uM,2.94
3362,6358466,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828861,=,nM,3430.0,CHEMBL203,Homo sapiens,IC50,uM,3.43
3363,6358467,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828862,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
3364,6358468,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828863,=,nM,1510.0,CHEMBL203,Homo sapiens,IC50,uM,1.51
3365,6358469,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828864,=,nM,2170.0,CHEMBL203,Homo sapiens,IC50,uM,2.17
3366,6358470,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828865,=,nM,6740.0,CHEMBL203,Homo sapiens,IC50,uM,6.74
3367,6358471,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828866,=,nM,8280.0,CHEMBL203,Homo sapiens,IC50,uM,8.28
3368,6358472,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828867,=,nM,5170.0,CHEMBL203,Homo sapiens,IC50,uM,5.17
3369,6358473,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828868,=,nM,5930.0,CHEMBL203,Homo sapiens,IC50,uM,5.93
3370,6358474,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828869,=,nM,6410.0,CHEMBL203,Homo sapiens,IC50,uM,6.41
3371,6358475,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828870,=,nM,11910.0,CHEMBL203,Homo sapiens,IC50,uM,11.91
3372,6358476,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828871,=,nM,13730.0,CHEMBL203,Homo sapiens,IC50,uM,13.73
3373,6358477,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828872,=,nM,9590.0,CHEMBL203,Homo sapiens,IC50,uM,9.59
3374,6358478,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828873,=,nM,10340.0,CHEMBL203,Homo sapiens,IC50,uM,10.34
3375,6358479,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828874,=,nM,11290.0,CHEMBL203,Homo sapiens,IC50,uM,11.29
3376,6358480,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL553,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
3377,6358481,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828875,=,nM,17810.0,CHEMBL203,Homo sapiens,IC50,uM,17.81
3378,6358482,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828876,=,nM,18350.0,CHEMBL203,Homo sapiens,IC50,uM,18.35
3379,6358483,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828877,=,nM,14530.0,CHEMBL203,Homo sapiens,IC50,uM,14.53
3380,6358484,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828878,=,nM,15920.0,CHEMBL203,Homo sapiens,IC50,uM,15.92
3381,6358485,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828879,=,nM,17260.0,CHEMBL203,Homo sapiens,IC50,uM,17.26
3382,6358486,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828880,=,nM,26200.0,CHEMBL203,Homo sapiens,IC50,uM,26.2
3383,6358487,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828881,=,nM,38520.0,CHEMBL203,Homo sapiens,IC50,uM,38.52
3384,6358488,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828882,=,nM,21840.0,CHEMBL203,Homo sapiens,IC50,uM,21.84
3385,6358489,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828883,=,nM,32850.0,CHEMBL203,Homo sapiens,IC50,uM,32.85
3386,6358490,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1828884,=,nM,24150.0,CHEMBL203,Homo sapiens,IC50,uM,24.15
3387,6358491,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1829271,=,nM,24680.0,CHEMBL203,Homo sapiens,IC50,uM,24.68
3388,6358492,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1829272,=,nM,26170.0,CHEMBL203,Homo sapiens,IC50,uM,26.17
3389,6358493,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1829273,=,nM,18720.0,CHEMBL203,Homo sapiens,IC50,uM,18.72
3390,6358494,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1829274,=,nM,21280.0,CHEMBL203,Homo sapiens,IC50,uM,21.28
3391,6358495,CHEMBL1831700,Inhibition of human recombinant (His)6-tagged EGFR autophosphorylation pre-incubated for 10 mins by DELFIA/Time-resolved fluorimetry,B,CHEMBL1829275,=,nM,24330.0,CHEMBL203,Homo sapiens,IC50,uM,24.33
3392,6358549,CHEMBL1831702,Inhibition of EGFR,B,CHEMBL1173718,=,nM,620.0,CHEMBL203,Homo sapiens,IC50,uM,0.62
3393,7599140,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1200558,=,nM,5377.0,CHEMBL203,Homo sapiens,IC50,uM,5.377
3394,7601338,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1458880,=,nM,486.0,CHEMBL203,Homo sapiens,IC50,uM,0.486
3395,7602938,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL319244,=,nM,1005.0,CHEMBL203,Homo sapiens,IC50,uM,1.005
3396,7611407,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1016,=,nM,3276.9,CHEMBL203,Homo sapiens,IC50,uM,3.2769
3397,7615261,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL290106,=,nM,614.0,CHEMBL203,Homo sapiens,IC50,uM,0.614
3398,7620394,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL296419,=,nM,6057.0,CHEMBL203,Homo sapiens,IC50,uM,6.057
3399,7621398,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1476898,=,nM,244.0,CHEMBL203,Homo sapiens,IC50,uM,0.244
3400,7632999,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL195437,=,nM,16219.0,CHEMBL203,Homo sapiens,IC50,uM,16.219
3401,7649828,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL305660,=,nM,559.1,CHEMBL203,Homo sapiens,IC50,uM,0.5591
3402,7652096,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL808,=,nM,32404.0,CHEMBL203,Homo sapiens,IC50,uM,32.404
3403,7653318,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL64894,=,nM,473.0,CHEMBL203,Homo sapiens,IC50,uM,0.473
3404,7655914,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL496,=,nM,748.6,CHEMBL203,Homo sapiens,IC50,uM,0.7486
3405,7666254,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL306043,=,nM,2379.0,CHEMBL203,Homo sapiens,IC50,uM,2.379
3406,7670058,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL726,=,nM,40107.0,CHEMBL203,Homo sapiens,IC50,uM,40.107
3407,7670673,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL434063,=,nM,10896.0,CHEMBL203,Homo sapiens,IC50,uM,10.896
3408,7679694,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL334255,=,nM,3472.0,CHEMBL203,Homo sapiens,IC50,uM,3.472
3409,7679918,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1200528,=,nM,2955.0,CHEMBL203,Homo sapiens,IC50,uM,2.955
3410,7683898,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL280998,=,nM,26043.0,CHEMBL203,Homo sapiens,IC50,uM,26.043
3411,7688490,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL7002,=,nM,4655.0,CHEMBL203,Homo sapiens,IC50,uM,4.655
3412,7690831,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL11359,=,nM,2621.0,CHEMBL203,Homo sapiens,IC50,uM,2.621
3413,7693413,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL2221249,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
3414,7695404,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL12131,=,nM,564.0,CHEMBL203,Homo sapiens,IC50,uM,0.564
3415,7699678,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL104,=,nM,69421.0,CHEMBL203,Homo sapiens,IC50,uM,69.421
3416,7702946,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL926,=,nM,5551.0,CHEMBL203,Homo sapiens,IC50,uM,5.551
3417,7708206,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL954,=,nM,1050.0,CHEMBL203,Homo sapiens,IC50,uM,1.05
3418,7709886,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL71,=,nM,28868.0,CHEMBL203,Homo sapiens,IC50,uM,28.868
3419,7734214,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL75880,=,nM,1485.2,CHEMBL203,Homo sapiens,IC50,uM,1.4852
3420,7739512,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL307145,=,nM,1230.0,CHEMBL203,Homo sapiens,IC50,uM,1.23
3421,7741872,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL584,=,nM,55629.0,CHEMBL203,Homo sapiens,IC50,uM,55.629
3422,7747751,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL58,=,nM,5385.9,CHEMBL203,Homo sapiens,IC50,uM,5.3859
3423,7753173,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1909064,=,nM,188.0,CHEMBL203,Homo sapiens,IC50,uM,0.188
3424,7756293,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL91,=,nM,29256.0,CHEMBL203,Homo sapiens,IC50,uM,29.256
3425,7757154,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1221512,=,nM,3216.0,CHEMBL203,Homo sapiens,IC50,uM,3.216
3426,7764927,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL787,=,nM,3197.0,CHEMBL203,Homo sapiens,IC50,uM,3.197
3427,7765934,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1009,=,nM,2880.0,CHEMBL203,Homo sapiens,IC50,uM,2.88
3428,7766694,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL459,=,nM,5228.0,CHEMBL203,Homo sapiens,IC50,uM,5.228
3429,7780138,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL86754,=,nM,1889.0,CHEMBL203,Homo sapiens,IC50,uM,1.889
3430,7782551,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL603,=,nM,5751.0,CHEMBL203,Homo sapiens,IC50,uM,5.751
3431,7788730,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL24944,=,nM,2987.0,CHEMBL203,Homo sapiens,IC50,uM,2.987
3432,7790477,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1386,=,nM,1063.3,CHEMBL203,Homo sapiens,IC50,uM,1.0633
3433,7791308,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1200679,=,nM,2188.4,CHEMBL203,Homo sapiens,IC50,uM,2.1884
3434,7797919,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL1630578,=,nM,20397.0,CHEMBL203,Homo sapiens,IC50,uM,20.397
3435,7802109,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL479,=,nM,2947.0,CHEMBL203,Homo sapiens,IC50,uM,2.947
3436,7803872,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL83,=,nM,3553.0,CHEMBL203,Homo sapiens,IC50,uM,3.553
3437,7805856,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL18797,=,nM,23981.0,CHEMBL203,Homo sapiens,IC50,uM,23.981
3438,7814390,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL588119,=,nM,794.4,CHEMBL203,Homo sapiens,IC50,uM,0.7944
3439,7819078,CHEMBL1909203,"DRUGMATRIX: Protein Tyrosine Kinase, EGF Receptor enzyme inhibition (substrate: Poly(Glu:Tyr))",B,CHEMBL17157,=,nM,3566.0,CHEMBL203,Homo sapiens,IC50,uM,3.566
3440,7853989,CHEMBL1912180,Inhibition of human EGFR,B,CHEMBL1910268,=,nM,93300.0,CHEMBL203,Homo sapiens,IC50,uM,93.3
3441,7853994,CHEMBL1912180,Inhibition of human EGFR,B,CHEMBL1910273,=,nM,29500.0,CHEMBL203,Homo sapiens,IC50,uM,29.5
3442,7853996,CHEMBL1912180,Inhibition of human EGFR,B,CHEMBL1910275,=,nM,47900.0,CHEMBL203,Homo sapiens,IC50,uM,47.9
3443,7853999,CHEMBL1912180,Inhibition of human EGFR,B,CHEMBL1910278,=,nM,66100.0,CHEMBL203,Homo sapiens,IC50,uM,66.1
3444,7930439,CHEMBL1919050,Inhibition of EGFR preincubated for 60 mins measured after 60 mins by TR-FRET Assay,B,CHEMBL1916891,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
3445,7930440,CHEMBL1919050,Inhibition of EGFR preincubated for 60 mins measured after 60 mins by TR-FRET Assay,B,CHEMBL1916897,=,nM,3.35,CHEMBL203,Homo sapiens,IC50,nM,3.35
3446,7930441,CHEMBL1919051,Inhibition of EGFR after 60 mins by TR-FRET Assay,B,CHEMBL1916891,=,nM,17.2,CHEMBL203,Homo sapiens,IC50,nM,17.2
3447,7930442,CHEMBL1919051,Inhibition of EGFR after 60 mins by TR-FRET Assay,B,CHEMBL1916897,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
3448,7931077,CHEMBL1919256,Inhibition of ErbB1 relative to control,B,CHEMBL1873475,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
3449,7931140,CHEMBL1919477,Inhibition of EGFR relative to control,B,CHEMBL1916891,=,nM,75.6,CHEMBL203,Homo sapiens,IC50,nM,75.6
3450,7943730,CHEMBL1921573,Inhibition EGFR,B,CHEMBL388978,=,nM,188.3,CHEMBL203,Homo sapiens,IC50,nM,188.3
3451,7943904,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914653,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
3452,7943905,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914654,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
3453,7943906,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914655,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,nM,62.0
3454,7943907,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914656,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,nM,450.0
3455,7943908,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914657,=,nM,4608.0,CHEMBL203,Homo sapiens,IC50,nM,4608.0
3456,7943909,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914658,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
3457,7943910,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914659,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
3458,7943911,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914660,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
3459,7943912,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914661,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,nM,95.0
3460,7943913,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914461,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
3461,7943914,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914662,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
3462,7943915,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914663,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
3463,7943916,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914664,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
3464,7943917,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914665,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
3465,7943918,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914666,=,nM,1008.0,CHEMBL203,Homo sapiens,IC50,nM,1008.0
3466,7943919,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914667,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
3467,7943920,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL105053,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
3468,7943921,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914668,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
3469,7943922,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914669,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
3470,7943923,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914670,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
3471,7943924,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914671,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
3472,7943925,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914672,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
3473,7943926,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914673,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
3474,7943927,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL1914674,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
3475,7943928,CHEMBL1920033,Inhibition of EGFR by Z-LYTE assay,B,CHEMBL587723,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
3476,7957745,CHEMBL1932379,Inhibition of EGFR autophosphorylation in EGF-stimulated human A431 cells after 1 hr by immunoblotting,B,CHEMBL1928309,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
3477,7957746,CHEMBL1932379,Inhibition of EGFR autophosphorylation in EGF-stimulated human A431 cells after 1 hr by immunoblotting,B,CHEMBL1928311,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
3478,7959054,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929312,=,nM,34250.0,CHEMBL203,Homo sapiens,IC50,uM,34.25
3479,7959058,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929308,=,nM,7440.0,CHEMBL203,Homo sapiens,IC50,uM,7.44
3480,7959059,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929307,=,nM,12320.0,CHEMBL203,Homo sapiens,IC50,uM,12.32
3481,7959060,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929306,=,nM,38430.0,CHEMBL203,Homo sapiens,IC50,uM,38.43
3482,7959061,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929305,=,nM,1510.0,CHEMBL203,Homo sapiens,IC50,uM,1.51
3483,7959062,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929304,=,nM,38320.0,CHEMBL203,Homo sapiens,IC50,uM,38.32
3484,7959063,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1440725,=,nM,5720.0,CHEMBL203,Homo sapiens,IC50,uM,5.72
3485,7959064,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929303,=,nM,5110.0,CHEMBL203,Homo sapiens,IC50,uM,5.11
3486,7959065,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929302,=,nM,16630.0,CHEMBL203,Homo sapiens,IC50,uM,16.63
3487,7959066,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL939,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
3488,7959129,CHEMBL1931161,Inhibition of recombinant His6-tagged EGFR expressed in baculovirus infected insect Sf9 cells using ATP as substrate and cofactor MgCl2 after 2 hrs by DELFIA/Time-resolved fluorometric analysis,B,CHEMBL1929314,=,nM,26060.0,CHEMBL203,Homo sapiens,IC50,uM,26.06
3489,7959216,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928311,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
3490,7959734,CHEMBL1932841,Inhibition of EGFR,B,CHEMBL103667,=,nM,3800.0,CHEMBL203,Homo sapiens,IC50,uM,3.8
3491,7963942,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928944,=,nM,1204.0,CHEMBL203,Homo sapiens,IC50,nM,1204.0
3492,7963943,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928945,=,nM,473.0,CHEMBL203,Homo sapiens,IC50,nM,473.0
3493,7963944,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928946,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
3494,7963945,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928947,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
3495,7963946,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928948,=,nM,129.0,CHEMBL203,Homo sapiens,IC50,nM,129.0
3496,7963947,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928949,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,nM,370.0
3497,7963948,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928950,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
3498,7963950,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928952,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,nM,61.0
3499,7963952,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928954,=,nM,1671.0,CHEMBL203,Homo sapiens,IC50,nM,1671.0
3500,7963953,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928955,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
3501,7963954,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928956,=,nM,627.0,CHEMBL203,Homo sapiens,IC50,nM,627.0
3502,7963955,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928957,=,nM,821.0,CHEMBL203,Homo sapiens,IC50,nM,821.0
3503,7963956,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928958,=,nM,523.0,CHEMBL203,Homo sapiens,IC50,nM,523.0
3504,7963957,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL1928959,=,nM,721.0,CHEMBL203,Homo sapiens,IC50,nM,721.0
3505,7963959,CHEMBL1932747,Inhibition of human EGFR preincubated 2 hrs prior addition of ATP by HTRF assay,B,CHEMBL554,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
3506,7968505,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1095464,=,nM,9190.0,CHEMBL203,Homo sapiens,IC50,uM,9.19
3507,7968507,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1095465,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
3508,7968510,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1929554,=,nM,112100.0,CHEMBL203,Homo sapiens,IC50,uM,112.1
3509,7968511,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1929555,=,nM,12620.0,CHEMBL203,Homo sapiens,IC50,uM,12.62
3510,7968512,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL1929556,=,nM,112700.0,CHEMBL203,Homo sapiens,IC50,uM,112.7
3511,7968514,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
3512,7968515,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3513,7968516,CHEMBL1932339,Inhibition of EGFR tyrosine kinase activity in EGF-stimulated human A431 cells after 60 mins by ELISA,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
3514,7978864,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928707,=,nM,3220.0,CHEMBL203,Homo sapiens,IC50,uM,3.22
3515,7978865,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928708,=,nM,870.0,CHEMBL203,Homo sapiens,IC50,uM,0.87
3516,7978866,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928709,=,nM,11220.0,CHEMBL203,Homo sapiens,IC50,uM,11.22
3517,7978867,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928711,=,nM,1640.0,CHEMBL203,Homo sapiens,IC50,uM,1.64
3518,7978868,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928712,=,nM,3130.0,CHEMBL203,Homo sapiens,IC50,uM,3.13
3519,7978869,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928716,=,nM,3540.0,CHEMBL203,Homo sapiens,IC50,uM,3.54
3520,7978870,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928886,=,nM,1870.0,CHEMBL203,Homo sapiens,IC50,uM,1.87
3521,7978871,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928887,=,nM,13880.0,CHEMBL203,Homo sapiens,IC50,uM,13.88
3522,7978872,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928889,=,nM,4410.0,CHEMBL203,Homo sapiens,IC50,uM,4.41
3523,7978873,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL1928890,=,nM,5670.0,CHEMBL203,Homo sapiens,IC50,uM,5.67
3524,7978874,CHEMBL1930231,Inhibition of EGFR expressed in baculovirus infected Sf9 cells assessed as inhibition of autophosphorylation preincubated for 10 mins measured after 1 hr by DELFIA/Time-Resolved Fluorometry,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3525,7980767,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928291,=,nM,5.54,CHEMBL203,Homo sapiens,IC50,nM,5.54
3526,7980768,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928293,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7
3527,7980769,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928301,=,nM,18.5,CHEMBL203,Homo sapiens,IC50,nM,18.5
3528,7980770,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928309,=,nM,16.6,CHEMBL203,Homo sapiens,IC50,nM,16.6
3529,7980771,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928310,=,nM,43.7,CHEMBL203,Homo sapiens,IC50,nM,43.7
3530,7980772,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928312,=,nM,5.93,CHEMBL203,Homo sapiens,IC50,nM,5.93
3531,7980773,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL1928315,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
3532,7980774,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL553,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
3533,7980775,CHEMBL1930721,"Inhibition of EGFR using poly(Glu,Tyr)4:1 as substrate and [gamma33P]ATP after 60 mins by scintillation counting",B,CHEMBL554,=,nM,8.9,CHEMBL203,Homo sapiens,IC50,nM,8.9
3534,7995654,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934621,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
3535,7995655,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934622,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
3536,7995656,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934623,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
3537,7995657,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934624,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
3538,7995658,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934625,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
3539,7995659,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934626,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
3540,7995660,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934627,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
3541,7995661,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934628,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3542,7995662,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934629,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,uM,0.074
3543,7995663,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1933083,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,uM,0.055
3544,7995664,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934630,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
3545,7995665,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934631,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
3546,7995666,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934632,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
3547,7995667,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL1934633,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
3548,7995668,CHEMBL1935838,Inhibition of EGFR by time-resolved fluorescence assay,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
3549,7995731,CHEMBL1935855,Inhibition of EGFR phosphorylation in EGF-stimulated human A431 after 2 hrs by Western blot analysis,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
3550,7995732,CHEMBL1935855,Inhibition of EGFR phosphorylation in EGF-stimulated human A431 after 2 hrs by Western blot analysis,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
3551,7995733,CHEMBL1935855,Inhibition of EGFR phosphorylation in EGF-stimulated human A431 after 2 hrs by Western blot analysis,B,CHEMBL1201179,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
3552,8017320,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL343352,=,nM,189.0,CHEMBL203,Homo sapiens,IC50,nM,189.0
3553,8017321,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL52765,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
3554,8017322,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL242541,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
3555,8017323,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947122,=,nM,9021.0,CHEMBL203,Homo sapiens,IC50,nM,9021.0
3556,8017324,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL541988,=,nM,8719.0,CHEMBL203,Homo sapiens,IC50,nM,8719.0
3557,8017325,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947123,=,nM,9284.0,CHEMBL203,Homo sapiens,IC50,nM,9284.0
3558,8017326,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947125,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
3559,8017327,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1946926,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
3560,8017328,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947124,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
3561,8017329,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947126,=,nM,623.0,CHEMBL203,Homo sapiens,IC50,nM,623.0
3562,8017330,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947127,=,nM,342.0,CHEMBL203,Homo sapiens,IC50,nM,342.0
3563,8017331,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1947121,=,nM,422.0,CHEMBL203,Homo sapiens,IC50,nM,422.0
3564,8017332,CHEMBL1949352,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL939,=,nM,7.3,CHEMBL203,Homo sapiens,IC50,nM,7.3
3565,8019345,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1916951,=,nM,24830.0,CHEMBL203,Homo sapiens,IC50,uM,24.83
3566,8019348,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1916949,=,nM,25360.0,CHEMBL203,Homo sapiens,IC50,uM,25.36
3567,8019349,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945444,=,nM,20190.0,CHEMBL203,Homo sapiens,IC50,uM,20.19
3568,8019350,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945445,=,nM,12110.0,CHEMBL203,Homo sapiens,IC50,uM,12.11
3569,8019351,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945446,=,nM,3270.0,CHEMBL203,Homo sapiens,IC50,uM,3.27
3570,8019352,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945447,=,nM,2080.0,CHEMBL203,Homo sapiens,IC50,uM,2.08
3571,8019353,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945448,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
3572,8019355,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945450,=,nM,27050.0,CHEMBL203,Homo sapiens,IC50,uM,27.05
3573,8019356,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945451,=,nM,28660.0,CHEMBL203,Homo sapiens,IC50,uM,28.66
3574,8019357,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945452,=,nM,15680.0,CHEMBL203,Homo sapiens,IC50,uM,15.68
3575,8019358,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945453,=,nM,19830.0,CHEMBL203,Homo sapiens,IC50,uM,19.83
3576,8019362,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945644,=,nM,29070.0,CHEMBL203,Homo sapiens,IC50,uM,29.07
3577,8019363,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945645,=,nM,18150.0,CHEMBL203,Homo sapiens,IC50,uM,18.15
3578,8019364,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945646,=,nM,21560.0,CHEMBL203,Homo sapiens,IC50,uM,21.56
3579,8019365,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945647,=,nM,15020.0,CHEMBL203,Homo sapiens,IC50,uM,15.02
3580,8019366,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945648,=,nM,2640.0,CHEMBL203,Homo sapiens,IC50,uM,2.64
3581,8019367,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL1945649,=,nM,1190.0,CHEMBL203,Homo sapiens,IC50,uM,1.19
3582,8019368,CHEMBL1949030,Inhibition of autophosphorylation of recombinant His-tagged EGFR expressed in baculovirus infected Sf9 cells after 1 hr by DELFIA/time-resolved fluorimetry assay,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3583,8025209,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1946843,=,nM,25900.0,CHEMBL203,Homo sapiens,IC50,uM,25.9
3584,8025215,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1947045,=,nM,7700.0,CHEMBL203,Homo sapiens,IC50,uM,7.7
3585,8025216,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1947046,=,nM,90400.0,CHEMBL203,Homo sapiens,IC50,uM,90.4
3586,8025217,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL554,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
3587,8025221,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944921,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
3588,8025223,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944923,=,nM,35800.0,CHEMBL203,Homo sapiens,IC50,uM,35.8
3589,8025228,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944928,=,nM,76400.0,CHEMBL203,Homo sapiens,IC50,uM,76.4
3590,8025230,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944641,=,nM,81600.0,CHEMBL203,Homo sapiens,IC50,uM,81.6
3591,8025231,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944930,=,nM,85600.0,CHEMBL203,Homo sapiens,IC50,uM,85.6
3592,8025232,CHEMBL1947770,Inhibition of wild-type EGFR expressed using baculovirus expression system by ELISA,B,CHEMBL1944931,=,nM,92400.0,CHEMBL203,Homo sapiens,IC50,uM,92.4
3593,8025233,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1946843,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5
3594,8025234,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1946844,=,nM,13000.0,CHEMBL203,Homo sapiens,IC50,uM,13.0
3595,8025235,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1946845,=,nM,31000.0,CHEMBL203,Homo sapiens,IC50,uM,31.0
3596,8025236,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1946846,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
3597,8025237,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1348499,=,nM,20900.0,CHEMBL203,Homo sapiens,IC50,uM,20.9
3598,8025238,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1946847,=,nM,30700.0,CHEMBL203,Homo sapiens,IC50,uM,30.7
3599,8025239,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1947045,=,nM,36100.0,CHEMBL203,Homo sapiens,IC50,uM,36.1
3600,8025242,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL180022,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
3601,8025244,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944920,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
3602,8025245,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944921,=,nM,17600.0,CHEMBL203,Homo sapiens,IC50,uM,17.6
3603,8025246,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944922,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
3604,8025247,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944923,=,nM,23500.0,CHEMBL203,Homo sapiens,IC50,uM,23.5
3605,8025248,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944924,=,nM,24700.0,CHEMBL203,Homo sapiens,IC50,uM,24.7
3606,8025249,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944925,=,nM,40900.0,CHEMBL203,Homo sapiens,IC50,uM,40.9
3607,8025250,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944926,=,nM,56800.0,CHEMBL203,Homo sapiens,IC50,uM,56.8
3608,8025251,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944927,=,nM,65600.0,CHEMBL203,Homo sapiens,IC50,uM,65.6
3609,8025252,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944928,=,nM,65100.0,CHEMBL203,Homo sapiens,IC50,uM,65.1
3610,8025253,CHEMBL1947771,Inhibition of EGFR T790M/L858R mutant expressed using baculovirus expression system by ELISA,B,CHEMBL1944929,=,nM,66000.0,CHEMBL203,Homo sapiens,IC50,uM,66.0
3611,8030298,CHEMBL1955670,Inhibition of EGFR,B,CHEMBL1950289,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3612,8037535,CHEMBL1954388,Inhibition of EGFR,B,CHEMBL1951415,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
3613,8039804,CHEMBL1952840,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,B,CHEMBL1952210,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,nM,310.0
3614,8039888,CHEMBL1952840,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,B,CHEMBL1952210,=,nM,239.0,CHEMBL203,Homo sapiens,IC50,nM,239.0
3615,8039892,CHEMBL1952840,Inhibition of human recombinant His-tagged intracellular domain of EGFR using biotin-EEEEYFELV as substrate by HTRF assay,B,CHEMBL1952211,=,nM,365.0,CHEMBL203,Homo sapiens,IC50,nM,365.0
3616,8048992,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958019,=,nM,3380.0,CHEMBL203,Homo sapiens,IC50,uM,3.38
3617,8048993,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958020,=,nM,4860.0,CHEMBL203,Homo sapiens,IC50,uM,4.86
3618,8048994,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958021,=,nM,3490.0,CHEMBL203,Homo sapiens,IC50,uM,3.49
3619,8048995,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958022,=,nM,1350.0,CHEMBL203,Homo sapiens,IC50,uM,1.35
3620,8048996,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958023,=,nM,3030.0,CHEMBL203,Homo sapiens,IC50,uM,3.03
3621,8048997,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958024,=,nM,4270.0,CHEMBL203,Homo sapiens,IC50,uM,4.27
3622,8048998,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958025,=,nM,8140.0,CHEMBL203,Homo sapiens,IC50,uM,8.14
3623,8048999,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958026,=,nM,16920.0,CHEMBL203,Homo sapiens,IC50,uM,16.92
3624,8049000,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958027,=,nM,10920.0,CHEMBL203,Homo sapiens,IC50,uM,10.92
3625,8049001,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958028,=,nM,4790.0,CHEMBL203,Homo sapiens,IC50,uM,4.79
3626,8049002,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958029,=,nM,8360.0,CHEMBL203,Homo sapiens,IC50,uM,8.36
3627,8049003,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958030,=,nM,10690.0,CHEMBL203,Homo sapiens,IC50,uM,10.69
3628,8049004,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958031,=,nM,5340.0,CHEMBL203,Homo sapiens,IC50,uM,5.34
3629,8049005,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958032,=,nM,14210.0,CHEMBL203,Homo sapiens,IC50,uM,14.21
3630,8049006,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958033,=,nM,8160.0,CHEMBL203,Homo sapiens,IC50,uM,8.16
3631,8049007,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958034,=,nM,2280.0,CHEMBL203,Homo sapiens,IC50,uM,2.28
3632,8049008,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958035,=,nM,6670.0,CHEMBL203,Homo sapiens,IC50,uM,6.67
3633,8049009,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958036,=,nM,8580.0,CHEMBL203,Homo sapiens,IC50,uM,8.58
3634,8049010,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958037,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
3635,8049011,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958038,=,nM,6480.0,CHEMBL203,Homo sapiens,IC50,uM,6.48
3636,8049012,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958039,=,nM,4120.0,CHEMBL203,Homo sapiens,IC50,uM,4.12
3637,8049013,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958209,=,nM,2030.0,CHEMBL203,Homo sapiens,IC50,uM,2.03
3638,8049014,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958210,=,nM,5580.0,CHEMBL203,Homo sapiens,IC50,uM,5.58
3639,8049015,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958211,=,nM,7960.0,CHEMBL203,Homo sapiens,IC50,uM,7.96
3640,8049016,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958212,=,nM,1080.0,CHEMBL203,Homo sapiens,IC50,uM,1.08
3641,8049017,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958213,=,nM,2010.0,CHEMBL203,Homo sapiens,IC50,uM,2.01
3642,8049018,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958214,=,nM,1660.0,CHEMBL203,Homo sapiens,IC50,uM,1.66
3643,8049019,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958215,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
3644,8049020,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958216,=,nM,1160.0,CHEMBL203,Homo sapiens,IC50,uM,1.16
3645,8049021,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958217,=,nM,4240.0,CHEMBL203,Homo sapiens,IC50,uM,4.24
3646,8049022,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958218,=,nM,2370.0,CHEMBL203,Homo sapiens,IC50,uM,2.37
3647,8049023,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958219,=,nM,5950.0,CHEMBL203,Homo sapiens,IC50,uM,5.95
3648,8049024,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958220,=,nM,5350.0,CHEMBL203,Homo sapiens,IC50,uM,5.35
3649,8049025,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958221,=,nM,1260.0,CHEMBL203,Homo sapiens,IC50,uM,1.26
3650,8049026,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958222,=,nM,5460.0,CHEMBL203,Homo sapiens,IC50,uM,5.46
3651,8049027,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1958223,=,nM,8890.0,CHEMBL203,Homo sapiens,IC50,uM,8.89
3652,8049028,CHEMBL1958796,Inhibition of histidine-tagged human recombinant cytoplasmic domain of EGFR expressed in baculovirus infected insect Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
3653,8058278,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1956886,=,nM,19770.0,CHEMBL203,Homo sapiens,IC50,uM,19.77
3654,8058279,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1956885,=,nM,17420.0,CHEMBL203,Homo sapiens,IC50,uM,17.42
3655,8058280,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1095465,=,nM,12620.0,CHEMBL203,Homo sapiens,IC50,uM,12.62
3656,8058281,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1095464,=,nM,9190.0,CHEMBL203,Homo sapiens,IC50,uM,9.19
3657,8058282,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1956887,=,nM,6160.0,CHEMBL203,Homo sapiens,IC50,uM,6.16
3658,8058283,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL499345,=,nM,4310.0,CHEMBL203,Homo sapiens,IC50,uM,4.31
3659,8058284,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL499344,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67
3660,8058285,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL502015,=,nM,1240.0,CHEMBL203,Homo sapiens,IC50,uM,1.24
3661,8058286,CHEMBL1959298,Inhibition of EGFR,B,CHEMBL1095761,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
3662,8058341,CHEMBL1959286,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
3663,8058349,CHEMBL1959286,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,B,CHEMBL1956888,=,nM,166400.0,CHEMBL203,Homo sapiens,IC50,uM,166.4
3664,8058350,CHEMBL1959286,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,B,CHEMBL1956889,=,nM,113300.0,CHEMBL203,Homo sapiens,IC50,uM,113.3
3665,8058351,CHEMBL1959286,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,B,CHEMBL1956891,=,nM,99900.0,CHEMBL203,Homo sapiens,IC50,uM,99.9
3666,8058352,CHEMBL1959286,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells incubated for 60 mins prior to EGF-induction measured after 10 mins by phosphotyrosine ELISA,B,CHEMBL1956892,=,nM,69200.0,CHEMBL203,Homo sapiens,IC50,uM,69.2
3667,8060112,CHEMBL1961280,"Inhibition of human recombinant EGF-R expressed in Sf9 cells using poly(E,Y)4:1 as substrate after 80 mins by scintillation counting",B,CHEMBL6246,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
3668,10844877,CHEMBL2015060,"Inhibition of wild type EGFR using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting",B,CHEMBL2011291,=,nM,113.0,CHEMBL203,Homo sapiens,IC50,uM,0.113
3669,10844878,CHEMBL2015061,"Inhibition of EGFR L858R mutant using poly(Glu,Tyr) as substrate assessed as [33P-gamma]-ATP incorporation after 60 mins by microplate scintillation counting",B,CHEMBL2011291,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
3670,10855796,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL94191,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
3671,10855797,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL328106,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
3672,10855798,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL301018,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3673,10855799,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL1277620,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
3674,10855803,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL1761929,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
3675,10855805,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018748,=,nM,7050.0,CHEMBL203,Homo sapiens,IC50,uM,7.05
3676,10855806,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018749,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
3677,10855807,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018750,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
3678,10855808,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018751,=,nM,6150.0,CHEMBL203,Homo sapiens,IC50,uM,6.15
3679,10855809,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018752,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
3680,10855810,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018753,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
3681,10855811,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018754,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
3682,10855812,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018755,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
3683,10855813,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018756,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
3684,10855814,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018757,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
3685,10855815,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018758,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
3686,10855816,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018759,=,nM,5800.0,CHEMBL203,Homo sapiens,IC50,uM,5.8
3687,10855817,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018760,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
3688,10855818,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018761,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
3689,10855819,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018762,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
3690,10855825,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018765,=,nM,9900.0,CHEMBL203,Homo sapiens,IC50,uM,9.9
3691,10855827,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018767,=,nM,9450.0,CHEMBL203,Homo sapiens,IC50,uM,9.45
3692,10855833,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018773,=,nM,9100.0,CHEMBL203,Homo sapiens,IC50,uM,9.1
3693,10855837,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL2018777,=,nM,9150.0,CHEMBL203,Homo sapiens,IC50,uM,9.15
3694,10855841,CHEMBL2020642,Inhibition of human EGFR expressed in human A431 cells using poly(Glu4/Tyr) and [gamma32P]ATP as substrate after 1 hr by scintillation counting,B,CHEMBL1278149,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9
3695,10883601,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,6.18,CHEMBL203,Homo sapiens,IC50,nM,6.18
3696,10883602,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2032376,=,nM,1.16,CHEMBL203,Homo sapiens,IC50,nM,1.16
3697,10883603,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2032377,=,nM,4.99,CHEMBL203,Homo sapiens,IC50,nM,4.99
3698,10883604,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2032378,=,nM,29.5,CHEMBL203,Homo sapiens,IC50,nM,29.5
3699,10883605,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2032379,=,nM,16.4,CHEMBL203,Homo sapiens,IC50,nM,16.4
3700,10883606,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2032380,=,nM,1.47,CHEMBL203,Homo sapiens,IC50,nM,1.47
3701,10883607,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029425,=,nM,3.52,CHEMBL203,Homo sapiens,IC50,nM,3.52
3702,10883608,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029426,=,nM,6.95,CHEMBL203,Homo sapiens,IC50,nM,6.95
3703,10883609,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029427,=,nM,929.0,CHEMBL203,Homo sapiens,IC50,nM,929.0
3704,10883610,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029428,=,nM,0.43,CHEMBL203,Homo sapiens,IC50,nM,0.43
3705,10883611,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029429,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
3706,10883612,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029430,=,nM,4.41,CHEMBL203,Homo sapiens,IC50,nM,4.41
3707,10883613,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029431,=,nM,8.81,CHEMBL203,Homo sapiens,IC50,nM,8.81
3708,10883614,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029432,=,nM,1.95,CHEMBL203,Homo sapiens,IC50,nM,1.95
3709,10883616,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029434,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
3710,10883617,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029435,=,nM,0.58,CHEMBL203,Homo sapiens,IC50,nM,0.58
3711,10883618,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029436,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
3712,10883619,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029437,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
3713,10883620,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029438,=,nM,0.29,CHEMBL203,Homo sapiens,IC50,nM,0.29
3714,10883621,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029439,=,nM,1.41,CHEMBL203,Homo sapiens,IC50,nM,1.41
3715,10883622,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029440,=,nM,1.52,CHEMBL203,Homo sapiens,IC50,nM,1.52
3716,10883623,CHEMBL2033651,Inhibition of EGFR after 1.5 hr by FRET assay,B,CHEMBL2029441,=,nM,1.67,CHEMBL203,Homo sapiens,IC50,nM,1.67
3717,10883626,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,3.77,CHEMBL203,Homo sapiens,IC50,nM,3.77
3718,10883627,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032376,=,nM,6.56,CHEMBL203,Homo sapiens,IC50,nM,6.56
3719,10883628,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032377,=,nM,24.9,CHEMBL203,Homo sapiens,IC50,nM,24.9
3720,10883629,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032378,=,nM,95.71,CHEMBL203,Homo sapiens,IC50,nM,95.71
3721,10883630,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032379,=,nM,60.31,CHEMBL203,Homo sapiens,IC50,nM,60.31
3722,10883631,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032380,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
3723,10883632,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029425,=,nM,9.52,CHEMBL203,Homo sapiens,IC50,nM,9.52
3724,10883633,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029426,=,nM,45.7,CHEMBL203,Homo sapiens,IC50,nM,45.7
3725,10883635,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029428,=,nM,1.66,CHEMBL203,Homo sapiens,IC50,nM,1.66
3726,10883636,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029429,=,nM,1.67,CHEMBL203,Homo sapiens,IC50,nM,1.67
3727,10883637,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029430,=,nM,12.7,CHEMBL203,Homo sapiens,IC50,nM,12.7
3728,10883638,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029431,=,nM,39.9,CHEMBL203,Homo sapiens,IC50,nM,39.9
3729,10883639,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029432,=,nM,9.37,CHEMBL203,Homo sapiens,IC50,nM,9.37
3730,10883641,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029434,=,nM,6.02,CHEMBL203,Homo sapiens,IC50,nM,6.02
3731,10883642,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029435,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5
3732,10883643,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029436,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
3733,10883644,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029437,=,nM,1.34,CHEMBL203,Homo sapiens,IC50,nM,1.34
3734,10883645,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029438,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
3735,10883646,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029439,=,nM,5.24,CHEMBL203,Homo sapiens,IC50,nM,5.24
3736,10883647,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029440,=,nM,2.03,CHEMBL203,Homo sapiens,IC50,nM,2.03
3737,10883648,CHEMBL2033652,Inhibition of EGFR T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029441,=,nM,2.43,CHEMBL203,Homo sapiens,IC50,nM,2.43
3738,10883651,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,5.37,CHEMBL203,Homo sapiens,IC50,nM,5.37
3739,10883652,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2032376,=,nM,1.08,CHEMBL203,Homo sapiens,IC50,nM,1.08
3740,10883653,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2032377,=,nM,4.95,CHEMBL203,Homo sapiens,IC50,nM,4.95
3741,10883654,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2032378,=,nM,10.42,CHEMBL203,Homo sapiens,IC50,nM,10.42
3742,10883655,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2032379,=,nM,10.33,CHEMBL203,Homo sapiens,IC50,nM,10.33
3743,10883656,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2032380,=,nM,2.11,CHEMBL203,Homo sapiens,IC50,nM,2.11
3744,10883657,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029425,=,nM,2.41,CHEMBL203,Homo sapiens,IC50,nM,2.41
3745,10883658,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029426,=,nM,10.9,CHEMBL203,Homo sapiens,IC50,nM,10.9
3746,10883660,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029428,=,nM,0.53,CHEMBL203,Homo sapiens,IC50,nM,0.53
3747,10883661,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029429,=,nM,0.63,CHEMBL203,Homo sapiens,IC50,nM,0.63
3748,10883662,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029430,=,nM,2.68,CHEMBL203,Homo sapiens,IC50,nM,2.68
3749,10883663,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029431,=,nM,13.7,CHEMBL203,Homo sapiens,IC50,nM,13.7
3750,10883664,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029432,=,nM,1.21,CHEMBL203,Homo sapiens,IC50,nM,1.21
3751,10883666,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029434,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
3752,10883667,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029435,=,nM,0.66,CHEMBL203,Homo sapiens,IC50,nM,0.66
3753,10883668,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029436,=,nM,0.46,CHEMBL203,Homo sapiens,IC50,nM,0.46
3754,10883669,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029437,=,nM,1.16,CHEMBL203,Homo sapiens,IC50,nM,1.16
3755,10883984,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029438,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
3756,10883985,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029439,=,nM,1.67,CHEMBL203,Homo sapiens,IC50,nM,1.67
3757,10883986,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029440,=,nM,1.66,CHEMBL203,Homo sapiens,IC50,nM,1.66
3758,10883987,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029441,=,nM,2.42,CHEMBL203,Homo sapiens,IC50,nM,2.42
3759,10883988,CHEMBL2033653,Inhibition of EGFR L858R mutant after 1.5 hr by FRET assay,B,CHEMBL2029442,=,nM,478.0,CHEMBL203,Homo sapiens,IC50,nM,478.0
3760,10883990,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,6.13,CHEMBL203,Homo sapiens,IC50,nM,6.13
3761,10883991,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2032376,=,nM,1.21,CHEMBL203,Homo sapiens,IC50,nM,1.21
3762,10883992,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2032377,=,nM,6.22,CHEMBL203,Homo sapiens,IC50,nM,6.22
3763,10883993,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2032378,=,nM,15.4,CHEMBL203,Homo sapiens,IC50,nM,15.4
3764,10883994,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2032379,=,nM,12.74,CHEMBL203,Homo sapiens,IC50,nM,12.74
3765,10883995,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2032380,=,nM,2.75,CHEMBL203,Homo sapiens,IC50,nM,2.75
3766,10883996,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029425,=,nM,2.83,CHEMBL203,Homo sapiens,IC50,nM,2.83
3767,10883997,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029426,=,nM,12.1,CHEMBL203,Homo sapiens,IC50,nM,12.1
3768,10883998,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029427,=,nM,837.1,CHEMBL203,Homo sapiens,IC50,nM,837.1
3769,10883999,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029428,=,nM,0.56,CHEMBL203,Homo sapiens,IC50,nM,0.56
3770,10884000,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029429,=,nM,2.31,CHEMBL203,Homo sapiens,IC50,nM,2.31
3771,10884001,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029430,=,nM,3.02,CHEMBL203,Homo sapiens,IC50,nM,3.02
3772,10884002,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029431,=,nM,13.5,CHEMBL203,Homo sapiens,IC50,nM,13.5
3773,10884003,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029432,=,nM,1.31,CHEMBL203,Homo sapiens,IC50,nM,1.31
3774,10884005,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029434,=,nM,0.46,CHEMBL203,Homo sapiens,IC50,nM,0.46
3775,10884006,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029435,=,nM,0.73,CHEMBL203,Homo sapiens,IC50,nM,0.73
3776,10884007,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029436,=,nM,0.93,CHEMBL203,Homo sapiens,IC50,nM,0.93
3777,10884008,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029437,=,nM,1.59,CHEMBL203,Homo sapiens,IC50,nM,1.59
3778,10884009,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029438,=,nM,0.72,CHEMBL203,Homo sapiens,IC50,nM,0.72
3779,10884010,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029439,=,nM,3.43,CHEMBL203,Homo sapiens,IC50,nM,3.43
3780,10884011,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029440,=,nM,2.31,CHEMBL203,Homo sapiens,IC50,nM,2.31
3781,10884012,CHEMBL2033654,Inhibition of EGFR L861Q mutant after 1.5 hr by FRET assay,B,CHEMBL2029441,=,nM,2.56,CHEMBL203,Homo sapiens,IC50,nM,2.56
3782,10884015,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL1229592,=,nM,1.88,CHEMBL203,Homo sapiens,IC50,nM,1.88
3783,10884016,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032376,=,nM,3.14,CHEMBL203,Homo sapiens,IC50,nM,3.14
3784,10884017,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032377,=,nM,11.5,CHEMBL203,Homo sapiens,IC50,nM,11.5
3785,10884018,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032378,=,nM,36.43,CHEMBL203,Homo sapiens,IC50,nM,36.43
3786,10884019,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032379,=,nM,28.85,CHEMBL203,Homo sapiens,IC50,nM,28.85
3787,10884020,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2032380,=,nM,5.17,CHEMBL203,Homo sapiens,IC50,nM,5.17
3788,10884021,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029425,=,nM,5.2,CHEMBL203,Homo sapiens,IC50,nM,5.2
3789,10884022,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029426,=,nM,28.3,CHEMBL203,Homo sapiens,IC50,nM,28.3
3790,10884024,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029428,=,nM,1.19,CHEMBL203,Homo sapiens,IC50,nM,1.19
3791,10884025,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029429,=,nM,2.04,CHEMBL203,Homo sapiens,IC50,nM,2.04
3792,10884026,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029430,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
3793,10884027,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029431,=,nM,36.3,CHEMBL203,Homo sapiens,IC50,nM,36.3
3794,10884028,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029432,=,nM,4.18,CHEMBL203,Homo sapiens,IC50,nM,4.18
3795,10884030,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029434,=,nM,4.42,CHEMBL203,Homo sapiens,IC50,nM,4.42
3796,10884031,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029435,=,nM,6.02,CHEMBL203,Homo sapiens,IC50,nM,6.02
3797,10884032,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029436,=,nM,0.98,CHEMBL203,Homo sapiens,IC50,nM,0.98
3798,10884033,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029437,=,nM,2.44,CHEMBL203,Homo sapiens,IC50,nM,2.44
3799,10884034,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029438,=,nM,0.93,CHEMBL203,Homo sapiens,IC50,nM,0.93
3800,10884035,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029439,=,nM,4.64,CHEMBL203,Homo sapiens,IC50,nM,4.64
3801,10884036,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029440,=,nM,3.57,CHEMBL203,Homo sapiens,IC50,nM,3.57
3802,10884037,CHEMBL2033655,Inhibition of EGFR L858R/T790M mutant after 1.5 hr by FRET assay,B,CHEMBL2029441,=,nM,6.31,CHEMBL203,Homo sapiens,IC50,nM,6.31
3803,10888036,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031297,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
3804,10888037,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031298,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
3805,10888038,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031299,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
3806,10888039,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031300,=,nM,0.23,CHEMBL203,Homo sapiens,IC50,nM,0.23
3807,10888040,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031301,=,nM,17.4,CHEMBL203,Homo sapiens,IC50,nM,17.4
3808,10888041,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031302,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
3809,10888042,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031303,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
3810,10888043,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031304,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
3811,10888044,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031305,=,nM,0.29,CHEMBL203,Homo sapiens,IC50,nM,0.29
3812,10888045,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031306,=,nM,1.46,CHEMBL203,Homo sapiens,IC50,nM,1.46
3813,10888046,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031307,=,nM,0.68,CHEMBL203,Homo sapiens,IC50,nM,0.68
3814,10888047,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031308,=,nM,2.21,CHEMBL203,Homo sapiens,IC50,nM,2.21
3815,10888048,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031309,=,nM,2.02,CHEMBL203,Homo sapiens,IC50,nM,2.02
3816,10888049,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031310,=,nM,50.7,CHEMBL203,Homo sapiens,IC50,nM,50.7
3817,10888050,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031311,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
3818,10888051,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031312,=,nM,24.8,CHEMBL203,Homo sapiens,IC50,nM,24.8
3819,10888052,CHEMBL2033041,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate after 15 mins by time-resolved fluorimetric analysis,B,CHEMBL2031313,=,nM,37.5,CHEMBL203,Homo sapiens,IC50,nM,37.5
3820,10888117,CHEMBL2033042,Inhibition of EGFR T790M mutant autophosphorylation in human NCI-H1975 cells after 1 hr by Western blot analysis,B,CHEMBL2031297,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
3821,10888118,CHEMBL2033042,Inhibition of EGFR T790M mutant autophosphorylation in human NCI-H1975 cells after 1 hr by Western blot analysis,B,CHEMBL2031312,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
3822,10890024,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029689,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7
3823,10890025,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029690,=,nM,74300.0,CHEMBL203,Homo sapiens,IC50,uM,74.3
3824,10890026,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029691,=,nM,48600.0,CHEMBL203,Homo sapiens,IC50,uM,48.6
3825,10890027,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029692,=,nM,6800.0,CHEMBL203,Homo sapiens,IC50,uM,6.8
3826,10890028,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029693,=,nM,23100.0,CHEMBL203,Homo sapiens,IC50,uM,23.1
3827,10890029,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029694,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4
3828,10890030,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029695,=,nM,83900.0,CHEMBL203,Homo sapiens,IC50,uM,83.9
3829,10890031,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029696,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
3830,10890032,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029697,=,nM,72400.0,CHEMBL203,Homo sapiens,IC50,uM,72.4
3831,10890033,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL1504817,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
3832,10890034,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029698,=,nM,26600.0,CHEMBL203,Homo sapiens,IC50,uM,26.6
3833,10890035,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029699,=,nM,8600.0,CHEMBL203,Homo sapiens,IC50,uM,8.6
3834,10890036,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL2029700,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
3835,10890037,CHEMBL2034705,Inhibition of EGFR after 50 mins by HTRF assay,B,CHEMBL554,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
3836,10896848,CHEMBL2038916,Inhibition of wild-type EGFR preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,B,CHEMBL554,=,nM,52.2,CHEMBL203,Homo sapiens,IC50,nM,52.2
3837,10896849,CHEMBL2038916,Inhibition of wild-type EGFR preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,B,CHEMBL2035810,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
3838,10896851,CHEMBL2038917,Inhibition of EGFR T790M mutant preincubated for 10 mins followed by incubation for 30 mins by fluorescence polarization assay,B,CHEMBL2035810,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
3839,10940862,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047015,=,nM,2340.0,CHEMBL203,Homo sapiens,IC50,uM,2.34
3840,10940863,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047016,=,nM,1410.0,CHEMBL203,Homo sapiens,IC50,uM,1.41
3841,10940864,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047017,=,nM,2220.0,CHEMBL203,Homo sapiens,IC50,uM,2.22
3842,10940865,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047018,=,nM,3530.0,CHEMBL203,Homo sapiens,IC50,uM,3.53
3843,10940866,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047019,=,nM,4200.0,CHEMBL203,Homo sapiens,IC50,uM,4.2
3844,10940867,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047020,=,nM,3310.0,CHEMBL203,Homo sapiens,IC50,uM,3.31
3845,10940868,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047021,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
3846,10940869,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047022,=,nM,1410.0,CHEMBL203,Homo sapiens,IC50,uM,1.41
3847,10940870,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047023,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
3848,10940871,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047024,=,nM,2250.0,CHEMBL203,Homo sapiens,IC50,uM,2.25
3849,10940872,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047025,=,nM,1560.0,CHEMBL203,Homo sapiens,IC50,uM,1.56
3850,10940873,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047026,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,uM,1.12
3851,10940874,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047027,=,nM,6170.0,CHEMBL203,Homo sapiens,IC50,uM,6.17
3852,10940875,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047028,=,nM,5160.0,CHEMBL203,Homo sapiens,IC50,uM,5.16
3853,10940876,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL2047029,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
3854,10940878,CHEMBL2050675,Inhibition of EGFR derived from human A431 cell membrane assessed as inhibition of poly-Glu-Tyr phosphorylation after 30 mins by ELISA assay,B,CHEMBL939,=,nM,1080.0,CHEMBL203,Homo sapiens,IC50,uM,1.08
3855,10944953,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
3856,10944954,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
3857,10944955,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
3858,10944956,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047253,=,nM,11700.0,CHEMBL203,Homo sapiens,IC50,uM,11.7
3859,10944961,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047248,=,nM,24100.0,CHEMBL203,Homo sapiens,IC50,uM,24.1
3860,10944962,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047247,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,uM,26.0
3861,10944963,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047242,=,nM,19600.0,CHEMBL203,Homo sapiens,IC50,uM,19.6
3862,10944964,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047241,=,nM,276100.0,CHEMBL203,Homo sapiens,IC50,uM,276.1
3863,10944966,CHEMBL2050143,Inhibition of EGFR in human A431 cells pretreated for 60 mins measured after 1 hr by ELISA,B,CHEMBL2047245,=,nM,42600.0,CHEMBL203,Homo sapiens,IC50,uM,42.6
3864,10949867,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048912,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
3865,10949868,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048911,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
3866,10949869,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048910,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
3867,10949870,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048909,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
3868,10949871,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048908,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
3869,10949872,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048907,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
3870,10949873,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048906,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,nM,2.9
3871,10949874,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048905,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
3872,10949875,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048904,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
3873,10949876,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048903,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
3874,10949877,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048798,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
3875,10949878,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048797,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
3876,10949879,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048796,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
3877,10949880,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048795,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
3878,10949881,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048794,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
3879,10949882,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048793,=,nM,890.0,CHEMBL203,Homo sapiens,IC50,nM,890.0
3880,10949883,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048792,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,nM,2300.0
3881,10949884,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048791,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,nM,960.0
3882,10949885,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048790,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,nM,510.0
3883,10949886,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048789,=,nM,7.8,CHEMBL203,Homo sapiens,IC50,nM,7.8
3884,10949887,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL2048788,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
3885,10949888,CHEMBL2050649,Inhibition of N-terminus peptide-tagged human recombinant EGFR expressed using baculovirus infection system using [gamma-33P]-ATP preincubated with compound for 5 mins measured after 10 mins by scintillation counting,B,CHEMBL1923007,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
3886,10967414,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064372,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078
3887,10967415,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064373,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3888,10967416,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064374,=,nM,5800.0,CHEMBL203,Homo sapiens,IC50,uM,5.8
3889,10967417,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064376,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,uM,0.38
3890,10967418,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064379,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
3891,10967419,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064380,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
3892,10967420,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064382,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
3893,10967421,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064383,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
3894,10967422,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064384,=,nM,990.0,CHEMBL203,Homo sapiens,IC50,uM,0.99
3895,10967423,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064386,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
3896,10967424,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064388,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
3897,10967425,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064389,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
3898,10967426,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064390,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
3899,10967427,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064391,=,nM,6800.0,CHEMBL203,Homo sapiens,IC50,uM,6.8
3900,10967428,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064392,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
3901,10967429,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064393,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,uM,0.099
3902,10967430,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064394,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
3903,10967431,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064395,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
3904,10967432,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064396,=,nM,79000.0,CHEMBL203,Homo sapiens,IC50,uM,79.0
3905,10967433,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL939,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,uM,0.072
3906,10967434,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064397,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
3907,10967435,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064398,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
3908,10967436,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064399,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
3909,10967437,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064400,=,nM,65000.0,CHEMBL203,Homo sapiens,IC50,uM,65.0
3910,10967438,CHEMBL2066000,Inhibition of EGFR,B,CHEMBL2064403,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
3911,10975682,CHEMBL2064929,Inhibition of EGFR in presence of 10 uM ATP,B,CHEMBL1990583,=,nM,2090.0,CHEMBL203,Homo sapiens,IC50,nM,2090.0
3912,10980301,CHEMBL2065145,Inhibition of EGFR by FRET assay,B,CHEMBL2063926,<,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
3913,10988317,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070190,=,nM,1630.0,CHEMBL203,Homo sapiens,IC50,uM,1.63
3914,10988318,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070194,=,nM,1290.0,CHEMBL203,Homo sapiens,IC50,uM,1.29
3915,10988319,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070195,=,nM,3680.0,CHEMBL203,Homo sapiens,IC50,uM,3.68
3916,10988320,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070196,=,nM,2750.0,CHEMBL203,Homo sapiens,IC50,uM,2.75
3917,10988321,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070197,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,uM,0.63
3918,10988322,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070191,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
3919,10988323,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070192,=,nM,1020.0,CHEMBL203,Homo sapiens,IC50,uM,1.02
3920,10988324,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070193,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
3921,10988325,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070198,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
3922,10988326,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070199,=,nM,216.0,CHEMBL203,Homo sapiens,IC50,uM,0.216
3923,10988327,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070200,=,nM,1140.0,CHEMBL203,Homo sapiens,IC50,uM,1.14
3924,10988328,CHEMBL2071758,Inhibition of EGFR in human A431 cell lysate using tyrosine/glutamic acid polymer as substrate by ELISA,B,CHEMBL2070201,=,nM,920.0,CHEMBL203,Homo sapiens,IC50,uM,0.92
3925,10991148,CHEMBL2072949,Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins,B,CHEMBL2070045,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
3926,10991150,CHEMBL2072949,Inhibition of human EGFR using poly glu-Tyr as substrate after 30 mins,B,CHEMBL2070048,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
3927,11020078,CHEMBL2089890,Inhibition of EGFR,B,CHEMBL2086760,=,nM,137.0,CHEMBL203,Homo sapiens,IC50,nM,137.0
3928,11022065,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL1198361,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
3929,11022066,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087352,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
3930,11022067,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087353,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
3931,11022068,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087354,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
3932,11022069,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087355,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
3933,11022070,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087356,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
3934,11022071,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087357,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
3935,11022072,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087358,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
3936,11022073,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087359,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
3937,11022074,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087360,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
3938,11022075,CHEMBL2090277,Inhibition of EGFR using GST-Crk as substrate assessed as phosphorylated Crk level after 20 mins by SDS-PAGE analysis,B,CHEMBL2087361,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
3939,11022080,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087355,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
3940,11022081,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087356,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
3941,11022083,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087358,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
3942,11022085,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087360,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
3943,11022086,CHEMBL2090278,Inhibition of EGFR-mediated intracellular tyrosine phosphorylation in EGF-stimulated human A431 cells after 2.5 hrs by SDS-PAGE analysis,B,CHEMBL2087361,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
3944,12035992,CHEMBL2150828,Inhibition of EGFR phosphorylation in human PC9 cells after 24 hrs by by Western blot analysis,B,CHEMBL553,=,nM,1360.0,CHEMBL203,Homo sapiens,IC50,uM,1.36
3945,12036052,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148044,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
3946,12036053,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148045,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
3947,12036054,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148046,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
3948,12036055,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148047,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
3949,12036077,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148048,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
3950,12036078,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148049,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
3951,12036079,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148050,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
3952,12036080,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148051,=,nM,9.8,CHEMBL203,Homo sapiens,IC50,nM,9.8
3953,12036081,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148052,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
3954,12036094,CHEMBL2150609,Inhibition of human N-terminal DYKDDDD tagged EGFR cytoplasmic domain amino acid 669 to 1210 expressed in baculovirus after 5 mins by scintillation counter,B,CHEMBL2148053,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
3955,12057080,CHEMBL2154039,Inhibition of recombinant EGFR catalytic domain in presence of 1 uM radiolabeled ATP,B,CHEMBL2152704,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62
3956,12060770,CHEMBL2156898,Inhibition of EGFR,B,CHEMBL2152252,=,nM,739.0,CHEMBL203,Homo sapiens,IC50,nM,739.0
3957,12060771,CHEMBL2156898,Inhibition of EGFR,B,CHEMBL2152253,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,nM,410.0
3958,12077635,CHEMBL2162537,Inhibition of EGFR,B,CHEMBL2159053,=,nM,10490.0,CHEMBL203,Homo sapiens,IC50,uM,10.49
3959,12150547,CHEMBL2188083,Inhibition of EGFR in human NCI-H1975 cells assessed as reduction in ERK phosphorylation incubated for 8 hrs by Western blotting method,B,CHEMBL2178352,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
3960,12150548,CHEMBL2188084,Inhibition of EGFR in human NCI-H1975 cells assessed as reduction in AKT phosphorylation incubated for 8 hrs by Western blotting method,B,CHEMBL2178352,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
3961,12150549,CHEMBL2188085,Inhibition of EGFR phosphorylation in human NCI-H1975 cells incubated for 8 hrs by Western blotting method,B,CHEMBL2178352,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
3962,12150606,CHEMBL2188539,Inhibition of human recombinant EGFR by radiometric kinase assay,B,CHEMBL2178352,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
3963,12150690,CHEMBL2183197,Inhibition of EGFR L858R/T790M mutant,B,CHEMBL2178368,=,nM,978.0,CHEMBL203,Homo sapiens,IC50,uM,0.978
3964,12150691,CHEMBL2183198,Inhibition of EGFR L858R mutant,B,CHEMBL2178368,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
3965,12165631,CHEMBL2208630,Inhibition of human EGFR kinase activity,B,CHEMBL111038,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,nM,190.0
3966,12165632,CHEMBL2208630,Inhibition of human EGFR kinase activity,B,CHEMBL29197,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
3967,12165668,CHEMBL2208688,Inhibition of HER1,B,CHEMBL2205030,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
3968,12165670,CHEMBL2208688,Inhibition of HER1,B,CHEMBL605161,=,nM,22000.0,CHEMBL203,Homo sapiens,IC50,uM,22.0
3969,12165682,CHEMBL2208688,Inhibition of HER1,B,CHEMBL1917092,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
3970,12205227,CHEMBL2217241,Inhibition of GST-tagged EGFR expressed in sf9 cells by ELISA,B,CHEMBL2105719,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
3971,12205231,CHEMBL2217238,Inhibition of EGF-induced autophosphorylation of EGFR in human A431 cells,B,CHEMBL91867,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
3972,12205232,CHEMBL2217237,Inhibition of EGFR,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
3973,12205233,CHEMBL2217237,Inhibition of EGFR,B,CHEMBL31965,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
3974,12205234,CHEMBL2217237,Inhibition of EGFR,B,CHEMBL91867,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nM,0.37
3975,12205235,CHEMBL2217236,Irreversible inhibition of EGFR,B,CHEMBL285063,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
3976,12531904,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL553,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
3977,12531905,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283259,=,nM,29850.0,CHEMBL203,Homo sapiens,IC50,uM,29.85
3978,12531906,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283258,=,nM,38460.0,CHEMBL203,Homo sapiens,IC50,uM,38.46
3979,12531907,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283257,=,nM,15740.0,CHEMBL203,Homo sapiens,IC50,uM,15.74
3980,12531908,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283256,=,nM,13930.0,CHEMBL203,Homo sapiens,IC50,uM,13.93
3981,12531909,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283255,=,nM,16170.0,CHEMBL203,Homo sapiens,IC50,uM,16.17
3982,12531910,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336335,=,nM,13710.0,CHEMBL203,Homo sapiens,IC50,uM,13.71
3983,12531911,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL1830131,=,nM,14590.0,CHEMBL203,Homo sapiens,IC50,uM,14.59
3984,12531912,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL1981977,=,nM,9860.0,CHEMBL203,Homo sapiens,IC50,uM,9.86
3985,12531913,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283253,=,nM,12880.0,CHEMBL203,Homo sapiens,IC50,uM,12.88
3986,12531914,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283252,=,nM,13230.0,CHEMBL203,Homo sapiens,IC50,uM,13.23
3987,12531915,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283251,=,nM,11690.0,CHEMBL203,Homo sapiens,IC50,uM,11.69
3988,12531916,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336361,=,nM,10020.0,CHEMBL203,Homo sapiens,IC50,uM,10.02
3989,12531917,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL1998736,=,nM,7370.0,CHEMBL203,Homo sapiens,IC50,uM,7.37
3990,12531918,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283249,=,nM,10230.0,CHEMBL203,Homo sapiens,IC50,uM,10.23
3991,12531919,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283248,=,nM,9350.0,CHEMBL203,Homo sapiens,IC50,uM,9.35
3992,12531920,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336357,=,nM,9050.0,CHEMBL203,Homo sapiens,IC50,uM,9.05
3993,12531921,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336355,=,nM,5160.0,CHEMBL203,Homo sapiens,IC50,uM,5.16
3994,12531922,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2283245,=,nM,14580.0,CHEMBL203,Homo sapiens,IC50,uM,14.58
3995,12531923,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336359,=,nM,12690.0,CHEMBL203,Homo sapiens,IC50,uM,12.69
3996,12531924,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL1830130,=,nM,19690.0,CHEMBL203,Homo sapiens,IC50,uM,19.69
3997,12531925,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL2336358,=,nM,12290.0,CHEMBL203,Homo sapiens,IC50,uM,12.29
3998,12531926,CHEMBL3077166,Inhibition of autophosphorylation of His6-tagged EGFR cytoplasmic domain (unknown origin) expressed in Sf9 cells by DELFIA time resolved fluorometry,B,CHEMBL1830129,=,nM,23160.0,CHEMBL203,Homo sapiens,IC50,uM,23.16
3999,12615142,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
4000,12615143,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL116438,=,nM,8600.0,CHEMBL203,Homo sapiens,IC50,uM,8.6
4001,12615144,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316159,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
4002,12615145,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316158,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
4003,12615146,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316157,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4004,12615147,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316156,=,nM,18600.0,CHEMBL203,Homo sapiens,IC50,uM,18.6
4005,12615148,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316155,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
4006,12615149,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316154,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
4007,12615150,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316153,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
4008,12615151,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316152,=,nM,20800.0,CHEMBL203,Homo sapiens,IC50,uM,20.8
4009,12615152,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316151,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
4010,12615153,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316150,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
4011,12615154,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316149,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
4012,12615155,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316148,=,nM,15300.0,CHEMBL203,Homo sapiens,IC50,uM,15.3
4013,12615156,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316147,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
4014,12615157,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316146,=,nM,7100.0,CHEMBL203,Homo sapiens,IC50,uM,7.1
4015,12615158,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316145,=,nM,6800.0,CHEMBL203,Homo sapiens,IC50,uM,6.8
4016,12615159,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316144,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
4017,12615160,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316143,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
4018,12615161,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316142,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4019,12615162,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316141,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
4020,12615163,CHEMBL2318907,Inhibition of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA time resolved fluorometry,B,CHEMBL2316140,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
4021,12629537,CHEMBL2319132,Inhibition of EGFR (unknown origin),B,CHEMBL2312304,=,nM,4090.0,CHEMBL203,Homo sapiens,IC50,uM,4.09
4022,12629538,CHEMBL2319132,Inhibition of EGFR (unknown origin),B,CHEMBL2312303,=,nM,4290.0,CHEMBL203,Homo sapiens,IC50,uM,4.29
4023,12631697,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312654,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
4024,12631698,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312652,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
4025,12631699,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312649,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
4026,12631700,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312646,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
4027,12631701,CHEMBL2317775,Inhibition of EGFR (unknown origin) in presence of ATP,B,CHEMBL2312645,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
4028,12637786,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315700,=,ug.mL-1,125.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,125.0
4029,12637789,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315699,=,ug.mL-1,148.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,148.0
4030,12637790,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315698,=,ug.mL-1,130.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,130.0
4031,12637791,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315697,=,ug.mL-1,130.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,130.0
4032,12637792,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315696,=,ug.mL-1,193.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,193.0
4033,12637795,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315410,=,ug.mL-1,120.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,120.0
4034,12637796,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315409,=,ug.mL-1,94.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,94.0
4035,12639316,CHEMBL2318217,Inhibition of EGFR (unknown origin) by Z-LYTE assay,B,CHEMBL2315701,=,ug.mL-1,197.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,197.0
4036,12655314,CHEMBL2328801,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL2322330,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
4037,12655315,CHEMBL2328801,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL180022,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
4038,12655316,CHEMBL2328801,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL2322329,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
4039,12655317,CHEMBL2328801,Inhibition of human wild type EGFR expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL1614725,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
4040,12655318,CHEMBL2328802,Inhibition of human EGFR T790M/L858R mutant expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL2322330,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
4041,12655319,CHEMBL2328802,Inhibition of human EGFR T790M/L858R mutant expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL180022,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,nM,66.0
4042,12655320,CHEMBL2328802,Inhibition of human EGFR T790M/L858R mutant expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL2322329,=,nM,8100.0,CHEMBL203,Homo sapiens,IC50,nM,8100.0
4043,12655321,CHEMBL2328802,Inhibition of human EGFR T790M/L858R mutant expressed in Sf9 cells using [gamma32P]-ATP after 10 mins by scintillation counting,B,CHEMBL1614725,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,nM,8400.0
4044,12657554,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
4045,12657555,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325101,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
4046,12657556,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325100,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
4047,12657557,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325099,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
4048,12657558,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325098,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
4049,12657559,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325097,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
4050,12657560,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325096,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
4051,12657561,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325095,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
4052,12657562,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325094,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
4053,12657563,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325093,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
4054,12657564,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325092,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
4055,12657565,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325091,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
4056,12657566,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325090,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,uM,0.68
4057,12657567,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325089,=,nM,1070.0,CHEMBL203,Homo sapiens,IC50,uM,1.07
4058,12657568,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325088,=,nM,2520.0,CHEMBL203,Homo sapiens,IC50,uM,2.52
4059,12657569,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325087,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
4060,12657570,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2324873,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52
4061,12657571,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2324872,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
4062,12657572,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2324871,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
4063,12657573,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2324870,=,nM,530.0,CHEMBL203,Homo sapiens,IC50,uM,0.53
4064,12657574,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325110,=,nM,3280.0,CHEMBL203,Homo sapiens,IC50,uM,3.28
4065,12657575,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325109,=,nM,3010.0,CHEMBL203,Homo sapiens,IC50,uM,3.01
4066,12657576,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325108,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
4067,12657577,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325107,=,nM,2060.0,CHEMBL203,Homo sapiens,IC50,uM,2.06
4068,12657578,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325106,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
4069,12657579,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325105,=,nM,5680.0,CHEMBL203,Homo sapiens,IC50,uM,5.68
4070,12657580,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325104,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
4071,12657581,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325103,=,nM,8250.0,CHEMBL203,Homo sapiens,IC50,uM,8.25
4072,12657582,CHEMBL2327216,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation after 1 hr,B,CHEMBL2325102,=,nM,2230.0,CHEMBL203,Homo sapiens,IC50,uM,2.23
4073,12674062,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL2333163,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
4074,12674063,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL505637,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
4075,12674064,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL510730,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4076,12674065,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL360190,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4077,12674066,CHEMBL2344161,Inhibition of EGFR (unknown origin),B,CHEMBL2333164,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
4078,12684824,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
4079,12684825,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
4080,12684826,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL29197,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
4081,12684827,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337372,=,nM,130500.0,CHEMBL203,Homo sapiens,IC50,uM,130.5
4082,12684828,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337371,=,nM,30800.0,CHEMBL203,Homo sapiens,IC50,uM,30.8
4083,12684830,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337369,=,nM,58700.0,CHEMBL203,Homo sapiens,IC50,uM,58.7
4084,12684831,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337368,=,nM,39200.0,CHEMBL203,Homo sapiens,IC50,uM,39.2
4085,12684832,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337367,=,nM,114700.0,CHEMBL203,Homo sapiens,IC50,uM,114.7
4086,12684833,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337366,=,nM,82900.0,CHEMBL203,Homo sapiens,IC50,uM,82.9
4087,12684835,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337364,=,nM,38900.0,CHEMBL203,Homo sapiens,IC50,uM,38.9
4088,12684836,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337363,=,nM,63600.0,CHEMBL203,Homo sapiens,IC50,uM,63.6
4089,12684837,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337362,=,nM,42000.0,CHEMBL203,Homo sapiens,IC50,uM,42.0
4090,12684839,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL2337373,=,nM,147.0,CHEMBL203,Homo sapiens,IC50,nM,147.0
4091,12684840,CHEMBL2344596,Inhibition of EGFR in human A431 cells assessed as inhibition of EGF-induced tyrosine phosphorylation incubated for 60 mins prior to EGF-activation measured 10 mins by ELISA,B,CHEMBL306315,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
4092,12692760,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL535,=,nM,172100.0,CHEMBL203,Homo sapiens,IC50,uM,172.1
4093,12692767,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335378,=,nM,110600.0,CHEMBL203,Homo sapiens,IC50,uM,110.6
4094,12692772,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335377,=,nM,85900.0,CHEMBL203,Homo sapiens,IC50,uM,85.9
4095,12692778,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335019,=,nM,26900.0,CHEMBL203,Homo sapiens,IC50,uM,26.9
4096,12692780,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335379,=,nM,19900.0,CHEMBL203,Homo sapiens,IC50,uM,19.9
4097,12692782,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335013,=,nM,19300.0,CHEMBL203,Homo sapiens,IC50,uM,19.3
4098,12692786,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335016,=,nM,16300.0,CHEMBL203,Homo sapiens,IC50,uM,16.3
4099,12692787,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335014,=,nM,15600.0,CHEMBL203,Homo sapiens,IC50,uM,15.6
4100,12692792,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335018,=,nM,12800.0,CHEMBL203,Homo sapiens,IC50,uM,12.8
4101,12692805,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335015,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
4102,12692819,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL553,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
4103,12692825,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL2335376,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
4104,12692826,CHEMBL2343569,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells overexpressing EGFR pretreated for 60 mins prior to EGF addition measured after 10 mins by phosphotyrosine ELISA cytoblot analysis,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
4105,12697484,CHEMBL2343159,Inhibition of EGFR (unknown origin) after 20 mins by scintillation counting,B,CHEMBL2332119,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
4106,12712337,CHEMBL2341278,Inhibition of EGFR (unknown origin),B,CHEMBL2333986,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
4107,12712338,CHEMBL2341278,Inhibition of EGFR (unknown origin),B,CHEMBL2333985,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
4108,12712339,CHEMBL2341278,Inhibition of EGFR (unknown origin),B,CHEMBL316064,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
4109,12712340,CHEMBL2341279,Inhibition of EGFR in human A431 cells,B,CHEMBL301018,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
4110,12712341,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL294034,=,nM,60.2,CHEMBL203,Homo sapiens,IC50,nM,60.2
4111,12712342,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2334003,=,nM,13.6,CHEMBL203,Homo sapiens,IC50,nM,13.6
4112,12712343,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2334002,=,nM,12.1,CHEMBL203,Homo sapiens,IC50,nM,12.1
4113,12712344,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2334001,=,nM,63.4,CHEMBL203,Homo sapiens,IC50,nM,63.4
4114,12712346,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2333999,=,nM,18.1,CHEMBL203,Homo sapiens,IC50,nM,18.1
4115,12712347,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2333998,=,nM,412.8,CHEMBL203,Homo sapiens,IC50,nM,412.8
4116,12712354,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL2333991,=,nM,126.7,CHEMBL203,Homo sapiens,IC50,nM,126.7
4117,12712356,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL29641,=,nM,126.7,CHEMBL203,Homo sapiens,IC50,nM,126.7
4118,12712360,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL94191,=,nM,201.0,CHEMBL203,Homo sapiens,IC50,nM,201.0
4119,12712361,CHEMBL2341281,Inhibition of EGFR (unknown origin) using biotinylated-PTP1B (Tyr66) as substrate incubated for 5 mins prior to substrate addition measured after 1 hr by ELISA,B,CHEMBL301018,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
4120,12713623,CHEMBL2351374,"Inhibition of EGFR tyrosine kinase (unknown origin) using poly (Glu,Tyr) as substrate after 30 mins by ADP-GloTM assay",B,CHEMBL2347231,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
4121,12722999,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
4122,12723000,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL484270,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
4123,12723002,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347962,=,nM,4327.0,CHEMBL203,Homo sapiens,IC50,nM,4327.0
4124,12723003,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347961,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
4125,12723004,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347960,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
4126,12723005,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347963,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
4127,12723006,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347966,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
4128,12723007,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347965,=,nM,218.0,CHEMBL203,Homo sapiens,IC50,nM,218.0
4129,12723008,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347964,=,nM,179.0,CHEMBL203,Homo sapiens,IC50,nM,179.0
4130,12723009,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2346678,=,nM,203.0,CHEMBL203,Homo sapiens,IC50,nM,203.0
4131,12723010,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347967,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,nM,820.0
4132,12723011,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347972,=,nM,258.0,CHEMBL203,Homo sapiens,IC50,nM,258.0
4133,12723012,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347971,=,nM,352.0,CHEMBL203,Homo sapiens,IC50,nM,352.0
4134,12723013,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347970,=,nM,434.0,CHEMBL203,Homo sapiens,IC50,nM,434.0
4135,12723014,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347969,=,nM,452.0,CHEMBL203,Homo sapiens,IC50,nM,452.0
4136,12723015,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347968,=,nM,589.0,CHEMBL203,Homo sapiens,IC50,nM,589.0
4137,12723016,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2347973,=,nM,7893.0,CHEMBL203,Homo sapiens,IC50,nM,7893.0
4138,12723018,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL2348194,=,nM,2991.0,CHEMBL203,Homo sapiens,IC50,nM,2991.0
4139,12723019,CHEMBL2351567,Inhibition of human wild type GST-tagged EGFR kinase domain expressed in Sf9 cells by luminescence assay,B,CHEMBL1172781,=,nM,393.0,CHEMBL203,Homo sapiens,IC50,nM,393.0
4140,12728106,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL1614725,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
4141,12728107,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348418,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
4142,12728108,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348417,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
4143,12728109,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348416,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
4144,12728110,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348415,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,nM,75.0
4145,12728111,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348414,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
4146,12728112,CHEMBL2351562,Inhibition of human N-terminal DYKDDDD-tagged EGFR cytoplasmic domain (669 to 1210) expressed in baculovirus expression system incubated for 5 mins prior to [gamma-32P]ATP addition measured after 10 mins by scintillation counting analysis,B,CHEMBL2348419,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
4147,12732262,CHEMBL2351374,"Inhibition of EGFR tyrosine kinase (unknown origin) using poly (Glu,Tyr) as substrate after 30 mins by ADP-GloTM assay",B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
4148,13297469,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381511,=,nM,292.0,CHEMBL203,Homo sapiens,IC50,uM,0.292
4149,13297470,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381510,=,nM,101.0,CHEMBL203,Homo sapiens,IC50,uM,0.101
4150,13297471,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381509,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,uM,0.052
4151,13297472,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381508,=,nM,174.0,CHEMBL203,Homo sapiens,IC50,uM,0.174
4152,13297473,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381507,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,uM,0.099
4153,13297474,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381506,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059
4154,13297475,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381505,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,uM,0.073
4155,13297476,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381504,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
4156,13297477,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381516,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
4157,13297478,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381515,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059
4158,13297479,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381514,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,uM,0.051
4159,13297480,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL1229592,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,uM,0.0032
4160,13297481,CHEMBL2383984,Inhibition of wild type EGFR (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL939,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,uM,0.0001
4161,13297482,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381511,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
4162,13297483,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381510,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
4163,13297484,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381509,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
4164,13297485,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381508,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
4165,13297486,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381507,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
4166,13297487,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381506,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
4167,13297488,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381505,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
4168,13297489,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381504,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
4169,13297490,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381516,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
4170,13297491,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381515,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,uM,0.013
4171,13297492,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381514,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
4172,13297493,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL1229592,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,uM,0.0008
4173,13297494,CHEMBL2383986,Inhibition of EGFR L858R/T90M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL939,=,nM,941.0,CHEMBL203,Homo sapiens,IC50,uM,0.941
4174,13297495,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381511,=,nM,305.0,CHEMBL203,Homo sapiens,IC50,uM,0.305
4175,13297496,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381510,=,nM,113.0,CHEMBL203,Homo sapiens,IC50,uM,0.113
4176,13297497,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381509,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
4177,13297498,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381508,=,nM,189.0,CHEMBL203,Homo sapiens,IC50,uM,0.189
4178,13297499,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381507,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
4179,13297500,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381506,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083
4180,13297501,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381505,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,uM,0.099
4181,13297502,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381504,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
4182,13297503,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381516,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
4183,13297504,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381515,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
4184,13297505,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL2381514,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
4185,13297506,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL1229592,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,uM,0.0054
4186,13297507,CHEMBL2383987,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'Lyte assay,B,CHEMBL939,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,uM,0.0002
4187,13322639,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385993,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
4188,13322640,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385992,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
4189,13322641,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385991,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
4190,13322642,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385990,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
4191,13322643,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385988,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
4192,13322644,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385987,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
4193,13322645,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385986,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
4194,13322646,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385985,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
4195,13322647,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385984,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
4196,13322648,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385983,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
4197,13322649,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385982,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
4198,13322650,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385981,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
4199,13322651,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385980,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
4200,13322652,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385979,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4201,13322653,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385978,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4202,13322654,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385977,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
4203,13322655,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385976,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4204,13322656,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385975,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
4205,13322657,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385974,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
4206,13322660,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385971,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
4207,13322661,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385970,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
4208,13322662,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385969,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
4209,13322663,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385968,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
4210,13322664,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385967,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
4211,13322668,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385959,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,uM,0.46
4212,13322669,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385960,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
4213,13322673,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2385964,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4214,13322674,CHEMBL2390159,Inhibition of recombinant EGFR (unknown origin) after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL180022,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
4215,13367213,CHEMBL2406344,Inhibition of EGFR (unknown origin) after 60 mins,B,CHEMBL2403108,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4216,13380866,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL1229592,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,uM,0.0008
4217,13380867,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL939,=,nM,941.0,CHEMBL203,Homo sapiens,IC50,uM,0.941
4218,13380868,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408830,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
4219,13380869,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408829,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
4220,13380870,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408828,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
4221,13380871,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408827,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,uM,0.41
4222,13380872,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408826,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
4223,13380873,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408825,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
4224,13380874,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408824,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
4225,13380875,CHEMBL2412778,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408823,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
4226,13380876,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL1229592,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,uM,0.0054
4227,13380877,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL939,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,uM,0.0002
4228,13380878,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408830,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
4229,13380879,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408829,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
4230,13380880,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408828,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
4231,13380882,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408826,=,nM,3220.0,CHEMBL203,Homo sapiens,IC50,uM,3.22
4232,13380883,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408825,=,nM,1530.0,CHEMBL203,Homo sapiens,IC50,uM,1.53
4233,13380884,CHEMBL2412779,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408824,=,nM,5360.0,CHEMBL203,Homo sapiens,IC50,uM,5.36
4234,13380886,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL1229592,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,uM,0.0032
4235,13380887,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL939,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,uM,0.0001
4236,13380888,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408830,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
4237,13380889,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408829,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
4238,13380890,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408828,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
4239,13380892,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408826,=,nM,3150.0,CHEMBL203,Homo sapiens,IC50,uM,3.15
4240,13381787,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408825,=,nM,1090.0,CHEMBL203,Homo sapiens,IC50,uM,1.09
4241,13381788,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408824,=,nM,2940.0,CHEMBL203,Homo sapiens,IC50,uM,2.94
4242,13381789,CHEMBL2412780,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET based Z'-lyte assay,B,CHEMBL2408823,=,nM,2280.0,CHEMBL203,Homo sapiens,IC50,uM,2.28
4243,13391023,CHEMBL2412606,Inhibition of human EGFR kinase domain expressed in baculovirus/Sf21 system by ELISA,B,CHEMBL2408045,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
4244,13391046,CHEMBL2412605,Inhibition of EGF-stimulated EGFR phosphorylation in human KB cells,B,CHEMBL2408045,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
4245,13414494,CHEMBL2422326,Inhibition of EGFR (unknown origin),B,CHEMBL2419762,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
4246,13414495,CHEMBL2422326,Inhibition of EGFR (unknown origin),B,CHEMBL2419760,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4247,13443186,CHEMBL2427710,Inhibition of wild type human EGFR after 50 mins by HTRF assay,B,CHEMBL2426280,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
4248,13443221,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426279,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
4249,13443222,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426278,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
4250,13443223,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2424676,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
4251,13443224,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426277,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
4252,13443226,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426377,=,nM,24000.0,CHEMBL203,Homo sapiens,IC50,uM,24.0
4253,13443227,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426290,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
4254,13443228,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426289,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
4255,13445997,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426288,=,nM,23000.0,CHEMBL203,Homo sapiens,IC50,uM,23.0
4256,13445998,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426287,=,nM,1550.0,CHEMBL203,Homo sapiens,IC50,uM,1.55
4257,13445999,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426286,=,nM,12800.0,CHEMBL203,Homo sapiens,IC50,uM,12.8
4258,13446003,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426282,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
4259,13446004,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426281,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
4260,13446005,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL1229592,=,nM,1180.0,CHEMBL203,Homo sapiens,IC50,uM,1.18
4261,13446006,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2110732,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
4262,13446007,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL1173655,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
4263,13446008,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL553,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,uM,0.077
4264,13446009,CHEMBL2427713,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL939,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
4265,13446031,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426248,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
4266,13446032,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426279,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
4267,13446033,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426278,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,uM,0.0056
4268,13446034,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2424676,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,uM,0.071
4269,13446035,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426277,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
4270,13446036,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426378,=,nM,15200.0,CHEMBL203,Homo sapiens,IC50,uM,15.2
4271,13446037,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426377,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,uM,0.29
4272,13446038,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426290,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
4273,13446039,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426289,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
4274,13446040,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426288,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,uM,0.096
4275,13446041,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426287,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,uM,0.053
4276,13446042,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426286,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
4277,13446043,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426285,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
4278,13446044,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426284,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
4279,13446045,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426283,=,nM,12900.0,CHEMBL203,Homo sapiens,IC50,uM,12.9
4280,13446046,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426282,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
4281,13446047,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426281,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
4282,13446048,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426280,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
4283,13446049,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL1229592,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
4284,13446050,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2110732,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
4285,13446051,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL1173655,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
4286,13446052,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL553,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
4287,13446053,CHEMBL2427158,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL939,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
4288,13452584,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
4289,13452585,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424794,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
4290,13452586,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424804,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
4291,13452587,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL1812567,=,nM,8800.0,CHEMBL203,Homo sapiens,IC50,uM,8.8
4292,13452588,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424801,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
4293,13452589,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424799,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
4294,13452590,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424796,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4295,13452591,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424795,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
4296,13452592,CHEMBL2427414,Inhibition of recombinant EGFR kinase cytoplasmic domain (unknown origin) expressed in baculovirus expression vector-infected insect sf9 cells assessed as level of autophosphorylation after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL2424807,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
4297,13452932,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425088,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
4298,13452933,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2424664,=,nM,158.0,CHEMBL203,Homo sapiens,IC50,uM,0.158
4299,13452936,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425091,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
4300,13452939,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425092,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,uM,0.056
4301,13452940,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425089,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,uM,0.052
4302,13452943,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425094,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
4303,13452946,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425093,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
4304,13452947,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425085,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
4305,13452949,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425090,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
4306,13452950,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425084,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
4307,13452951,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425083,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
4308,13452953,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL939,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
4309,13452955,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425086,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
4310,13452956,CHEMBL2429426,Inhibition of wild type EGFR (unknown origin) after 24 hrs by fluorescence assay,B,CHEMBL2425087,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
4311,13453572,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL597402,=,nM,118.0,CHEMBL203,Homo sapiens,IC50,nM,118.0
4312,13453573,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL2425737,=,nM,38.4,CHEMBL203,Homo sapiens,IC50,nM,38.4
4313,13453574,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL2425736,=,nM,14.1,CHEMBL203,Homo sapiens,IC50,nM,14.1
4314,13453575,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL2425735,=,nM,13.5,CHEMBL203,Homo sapiens,IC50,nM,13.5
4315,13453576,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL2031297,=,nM,38.2,CHEMBL203,Homo sapiens,IC50,nM,38.2
4316,13453578,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL285063,=,nM,17.9,CHEMBL203,Homo sapiens,IC50,nM,17.9
4317,13453579,CHEMBL2428431,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured after 8 hrs by Western blot analysis,B,CHEMBL939,=,nM,498.0,CHEMBL203,Homo sapiens,IC50,nM,498.0
4318,13453580,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL597402,=,nM,49.8,CHEMBL203,Homo sapiens,IC50,nM,49.8
4319,13453581,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL2425737,=,nM,21.7,CHEMBL203,Homo sapiens,IC50,nM,21.7
4320,13453582,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL2425736,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
4321,13453583,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL2425735,=,nM,5.7,CHEMBL203,Homo sapiens,IC50,nM,5.7
4322,13453584,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL2031297,=,nM,8.59,CHEMBL203,Homo sapiens,IC50,nM,8.59
4323,13453585,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL52765,=,nM,21.45,CHEMBL203,Homo sapiens,IC50,nM,21.45
4324,13453586,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL285063,=,nM,3.94,CHEMBL203,Homo sapiens,IC50,nM,3.94
4325,13453587,CHEMBL2428432,Inhibition of wild type EGFR autophosphorylation in human A549 cells incubated for 1 hr followed by compound washout measured at 1 hr by Western blot analysis,B,CHEMBL939,=,nM,39.9,CHEMBL203,Homo sapiens,IC50,nM,39.9
4326,13453598,CHEMBL2428558,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,B,CHEMBL597402,=,nM,23.6,CHEMBL203,Homo sapiens,IC50,nM,23.6
4327,13453599,CHEMBL2428558,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,B,CHEMBL2425737,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
4328,13453600,CHEMBL2428558,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,B,CHEMBL2425736,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
4329,13453601,CHEMBL2428558,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,B,CHEMBL2425735,=,nM,0.63,CHEMBL203,Homo sapiens,IC50,nM,0.63
4330,13453602,CHEMBL2428558,Inhibition of wild type human EGFR tyrosine kinase assessed as Ulight-CAGAGAIETDKEYYTVKD phosphorylation after 15 mins by time-resolved fluorometry,B,CHEMBL939,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
4331,13480566,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL1201179,=,nM,16.3,CHEMBL203,Homo sapiens,IC50,nM,16.3
4332,13480567,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL2437227,=,nM,21.1,CHEMBL203,Homo sapiens,IC50,nM,21.1
4333,13480568,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL2437226,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
4334,13480569,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL2437225,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7
4335,13480570,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL2437224,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
4336,13480571,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL2437223,=,nM,25.1,CHEMBL203,Homo sapiens,IC50,nM,25.1
4337,13480684,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436354,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
4338,13480685,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436355,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
4339,13480686,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436356,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
4340,13480687,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436357,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
4341,13480688,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436358,=,nM,59.9,CHEMBL203,Homo sapiens,IC50,nM,59.9
4342,13480689,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436359,=,nM,11.4,CHEMBL203,Homo sapiens,IC50,nM,11.4
4343,13480690,CHEMBL2439214,Inhibition of EGFR (unknown origin) using poly-(Glu4-Tyr) as substrate after 1 hr by ELISA-based spectrophotometry,B,CHEMBL3436360,=,nM,232.4,CHEMBL203,Homo sapiens,IC50,nM,232.4
4344,13483410,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL1229592,=,nM,0.66,CHEMBL203,Homo sapiens,IC50,nM,0.66
4345,13483411,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437471,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
4346,13483412,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437470,=,nM,35020.0,CHEMBL203,Homo sapiens,IC50,nM,35020.0
4347,13483413,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437469,=,nM,1.07,CHEMBL203,Homo sapiens,IC50,nM,1.07
4348,13483414,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437468,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0
4349,13483415,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437467,=,nM,3.97,CHEMBL203,Homo sapiens,IC50,nM,3.97
4350,13483416,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437466,=,nM,4.53,CHEMBL203,Homo sapiens,IC50,nM,4.53
4351,13483417,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437465,=,nM,4.72,CHEMBL203,Homo sapiens,IC50,nM,4.72
4352,13483418,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437464,=,nM,4.96,CHEMBL203,Homo sapiens,IC50,nM,4.96
4353,13483419,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437463,=,nM,5.12,CHEMBL203,Homo sapiens,IC50,nM,5.12
4354,13483420,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437462,=,nM,0.677,CHEMBL203,Homo sapiens,IC50,nM,0.677
4355,13483421,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437461,=,nM,691.0,CHEMBL203,Homo sapiens,IC50,nM,691.0
4356,13483422,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437460,=,nM,2.86,CHEMBL203,Homo sapiens,IC50,nM,2.86
4357,13483423,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437459,=,nM,3456.0,CHEMBL203,Homo sapiens,IC50,nM,3456.0
4358,13483424,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437458,=,nM,17.6,CHEMBL203,Homo sapiens,IC50,nM,17.6
4359,13483425,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437457,=,nM,144.1,CHEMBL203,Homo sapiens,IC50,nM,144.1
4360,13483426,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437488,=,nM,4.94,CHEMBL203,Homo sapiens,IC50,nM,4.94
4361,13483428,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437486,=,nM,39.7,CHEMBL203,Homo sapiens,IC50,nM,39.7
4362,13483430,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437484,=,nM,56157.0,CHEMBL203,Homo sapiens,IC50,nM,56157.0
4363,13483431,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437483,=,nM,31.3,CHEMBL203,Homo sapiens,IC50,nM,31.3
4364,13483432,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437482,=,nM,59.1,CHEMBL203,Homo sapiens,IC50,nM,59.1
4365,13483435,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437479,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
4366,13483436,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437478,=,nM,4802.0,CHEMBL203,Homo sapiens,IC50,nM,4802.0
4367,13483437,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437477,=,nM,70240.0,CHEMBL203,Homo sapiens,IC50,nM,70240.0
4368,13483439,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437475,=,nM,6754.0,CHEMBL203,Homo sapiens,IC50,nM,6754.0
4369,13483440,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437474,=,nM,3836.0,CHEMBL203,Homo sapiens,IC50,nM,3836.0
4370,13483441,CHEMBL2439334,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437473,=,nM,21280.0,CHEMBL203,Homo sapiens,IC50,nM,21280.0
4371,13483443,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL1229592,=,nM,3.82,CHEMBL203,Homo sapiens,IC50,nM,3.82
4372,13483444,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437471,=,nM,5.73,CHEMBL203,Homo sapiens,IC50,nM,5.73
4373,13483445,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437470,=,nM,7167.0,CHEMBL203,Homo sapiens,IC50,nM,7167.0
4374,13483446,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437469,=,nM,2.56,CHEMBL203,Homo sapiens,IC50,nM,2.56
4375,13483447,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437468,=,nM,496.0,CHEMBL203,Homo sapiens,IC50,nM,496.0
4376,13483448,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437467,=,nM,11.8,CHEMBL203,Homo sapiens,IC50,nM,11.8
4377,13483449,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437466,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
4378,13483450,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437465,=,nM,14.1,CHEMBL203,Homo sapiens,IC50,nM,14.1
4379,13483451,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437464,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
4380,13483452,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437463,=,nM,14.8,CHEMBL203,Homo sapiens,IC50,nM,14.8
4381,13483453,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437462,=,nM,1.32,CHEMBL203,Homo sapiens,IC50,nM,1.32
4382,13483454,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437461,=,nM,1510.0,CHEMBL203,Homo sapiens,IC50,nM,1510.0
4383,13483455,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437460,=,nM,7.26,CHEMBL203,Homo sapiens,IC50,nM,7.26
4384,13483456,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437459,=,nM,8671.0,CHEMBL203,Homo sapiens,IC50,nM,8671.0
4385,13483457,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437458,=,nM,49.1,CHEMBL203,Homo sapiens,IC50,nM,49.1
4386,13483458,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437457,=,nM,496.0,CHEMBL203,Homo sapiens,IC50,nM,496.0
4387,13483459,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437488,=,nM,11.1,CHEMBL203,Homo sapiens,IC50,nM,11.1
4388,13483461,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437486,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
4389,13483463,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437484,=,nM,32847.0,CHEMBL203,Homo sapiens,IC50,nM,32847.0
4390,13483464,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437483,=,nM,76.5,CHEMBL203,Homo sapiens,IC50,nM,76.5
4391,13483465,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437482,=,nM,122.6,CHEMBL203,Homo sapiens,IC50,nM,122.6
4392,13483468,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437479,=,nM,14.8,CHEMBL203,Homo sapiens,IC50,nM,14.8
4393,13483469,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437478,=,nM,23747.0,CHEMBL203,Homo sapiens,IC50,nM,23747.0
4394,13483470,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437477,=,nM,70620.0,CHEMBL203,Homo sapiens,IC50,nM,70620.0
4395,13483472,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437475,=,nM,8452.0,CHEMBL203,Homo sapiens,IC50,nM,8452.0
4396,13483473,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437474,=,nM,8039.0,CHEMBL203,Homo sapiens,IC50,nM,8039.0
4397,13483474,CHEMBL2439335,Inhibition of EGFR L858R mutant (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437473,=,nM,55920.0,CHEMBL203,Homo sapiens,IC50,nM,55920.0
4398,13483476,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL1229592,=,nM,2.16,CHEMBL203,Homo sapiens,IC50,nM,2.16
4399,13483477,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437471,=,nM,5.29,CHEMBL203,Homo sapiens,IC50,nM,5.29
4400,13483478,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437470,=,nM,16338.0,CHEMBL203,Homo sapiens,IC50,nM,16338.0
4401,13483479,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437469,=,nM,3.82,CHEMBL203,Homo sapiens,IC50,nM,3.82
4402,13483480,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437468,=,nM,395.0,CHEMBL203,Homo sapiens,IC50,nM,395.0
4403,13483481,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437467,=,nM,12.1,CHEMBL203,Homo sapiens,IC50,nM,12.1
4404,13483482,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437466,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
4405,13483483,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437465,=,nM,14.5,CHEMBL203,Homo sapiens,IC50,nM,14.5
4406,13483484,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437464,=,nM,15.3,CHEMBL203,Homo sapiens,IC50,nM,15.3
4407,13483485,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437463,=,nM,15.7,CHEMBL203,Homo sapiens,IC50,nM,15.7
4408,13483486,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437462,=,nM,1.21,CHEMBL203,Homo sapiens,IC50,nM,1.21
4409,13483487,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437461,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0
4410,13483488,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437460,=,nM,6.95,CHEMBL203,Homo sapiens,IC50,nM,6.95
4411,13483489,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437459,=,nM,5585.0,CHEMBL203,Homo sapiens,IC50,nM,5585.0
4412,13483490,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437458,=,nM,47.1,CHEMBL203,Homo sapiens,IC50,nM,47.1
4413,13483491,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437457,=,nM,373.5,CHEMBL203,Homo sapiens,IC50,nM,373.5
4414,13483492,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437488,=,nM,12.8,CHEMBL203,Homo sapiens,IC50,nM,12.8
4415,13483494,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437486,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,nM,115.0
4416,13483496,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437484,=,nM,26283.0,CHEMBL203,Homo sapiens,IC50,nM,26283.0
4417,13483497,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437483,=,nM,59.1,CHEMBL203,Homo sapiens,IC50,nM,59.1
4418,13483498,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437482,=,nM,60.4,CHEMBL203,Homo sapiens,IC50,nM,60.4
4419,13483501,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437479,=,nM,13.8,CHEMBL203,Homo sapiens,IC50,nM,13.8
4420,13483502,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437478,=,nM,5129.0,CHEMBL203,Homo sapiens,IC50,nM,5129.0
4421,13483503,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437477,=,nM,33885.0,CHEMBL203,Homo sapiens,IC50,nM,33885.0
4422,13483505,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437475,=,nM,25825.0,CHEMBL203,Homo sapiens,IC50,nM,25825.0
4423,13483506,CHEMBL2439336,Inhibition of wild type EGFR (unknown origin) using Tyr 4 peptide as substrate after 1.5 hrs by FRET-based Z'-LYTE assay,B,CHEMBL2437474,=,nM,18280.0,CHEMBL203,Homo sapiens,IC50,nM,18280.0
4424,13484280,CHEMBL2437777,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) (4:1) as substrate after 30 mins by spectrophotometric analysis",B,CHEMBL2435999,=,nM,90.05,CHEMBL203,Homo sapiens,IC50,nM,90.05
4425,13492102,CHEMBL2444715,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL939,=,nM,10480.0,CHEMBL203,Homo sapiens,IC50,uM,10.48
4426,13492141,CHEMBL2444715,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL2441567,=,nM,3610.0,CHEMBL203,Homo sapiens,IC50,uM,3.61
4427,13492144,CHEMBL2444715,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL2441565,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
4428,13492149,CHEMBL2444968,Inhibition of wild type EGFR in human A431 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL2441567,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4429,13492151,CHEMBL2444968,Inhibition of wild type EGFR in human A431 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL2441565,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
4430,13492161,CHEMBL2444968,Inhibition of wild type EGFR in human A431 cells assessed as growth inhibition after 48 hrs by MTT assay,B,CHEMBL939,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
4431,13492173,CHEMBL2444969,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins prior to ATP addition measured after 30 mins by HTRF method,B,CHEMBL2441568,=,nM,1.29,CHEMBL203,Homo sapiens,IC50,nM,1.29
4432,13515682,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL939,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
4433,13515683,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442333,=,nM,1180.0,CHEMBL203,Homo sapiens,IC50,uM,1.18
4434,13515684,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442332,=,nM,1230.0,CHEMBL203,Homo sapiens,IC50,uM,1.23
4435,13515685,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442329,=,nM,1380.0,CHEMBL203,Homo sapiens,IC50,uM,1.38
4436,13515686,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442327,=,nM,3060.0,CHEMBL203,Homo sapiens,IC50,uM,3.06
4437,13515687,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442324,=,nM,2120.0,CHEMBL203,Homo sapiens,IC50,uM,2.12
4438,13515688,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442320,=,nM,5490.0,CHEMBL203,Homo sapiens,IC50,uM,5.49
4439,13515689,CHEMBL2446217,Inhibition of EGFR in shed membrane vesicles of human A431 cells using poly-Glu-Tyr as substrate after 30 mins by ELISA,B,CHEMBL2442319,=,nM,3510.0,CHEMBL203,Homo sapiens,IC50,uM,3.51
4440,13826432,CHEMBL3088500,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3086102,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
4441,13826433,CHEMBL3088501,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL3086102,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
4442,13826557,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3086102,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
4443,13826558,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3086104,=,nM,35.6,CHEMBL203,Homo sapiens,IC50,nM,35.6
4444,13826559,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3086103,=,nM,55.5,CHEMBL203,Homo sapiens,IC50,nM,55.5
4445,13826560,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3086105,=,nM,17.1,CHEMBL203,Homo sapiens,IC50,nM,17.1
4446,13826561,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3086106,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
4447,13826562,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087194,=,nM,41.3,CHEMBL203,Homo sapiens,IC50,nM,41.3
4448,13826563,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087193,=,nM,16.2,CHEMBL203,Homo sapiens,IC50,nM,16.2
4449,13826564,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087195,=,nM,97.9,CHEMBL203,Homo sapiens,IC50,nM,97.9
4450,13826565,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087196,=,nM,29.1,CHEMBL203,Homo sapiens,IC50,nM,29.1
4451,13826566,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087197,=,nM,235.4,CHEMBL203,Homo sapiens,IC50,nM,235.4
4452,13826567,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087198,=,nM,15.2,CHEMBL203,Homo sapiens,IC50,nM,15.2
4453,13826568,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087200,=,nM,42.9,CHEMBL203,Homo sapiens,IC50,nM,42.9
4454,13826569,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087199,=,nM,58.7,CHEMBL203,Homo sapiens,IC50,nM,58.7
4455,13826570,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087201,=,nM,864.0,CHEMBL203,Homo sapiens,IC50,nM,864.0
4456,13826571,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087202,=,nM,525.0,CHEMBL203,Homo sapiens,IC50,nM,525.0
4457,13826573,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087205,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
4458,13826574,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087204,=,nM,107.1,CHEMBL203,Homo sapiens,IC50,nM,107.1
4459,13826575,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087207,=,nM,204.1,CHEMBL203,Homo sapiens,IC50,nM,204.1
4460,13826576,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087206,=,nM,40.3,CHEMBL203,Homo sapiens,IC50,nM,40.3
4461,13826577,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087208,=,nM,143.6,CHEMBL203,Homo sapiens,IC50,nM,143.6
4462,13826578,CHEMBL3088813,Inhibition of EGFR L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3087209,=,nM,708.5,CHEMBL203,Homo sapiens,IC50,nM,708.5
4463,13833370,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL553,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
4464,13833371,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088218,=,nM,8190.0,CHEMBL203,Homo sapiens,IC50,uM,8.19
4465,13833372,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088219,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
4466,13833373,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088220,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
4467,13833374,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088221,=,nM,1890.0,CHEMBL203,Homo sapiens,IC50,uM,1.89
4468,13833375,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088222,=,nM,2580.0,CHEMBL203,Homo sapiens,IC50,uM,2.58
4469,13833376,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088223,=,nM,12450.0,CHEMBL203,Homo sapiens,IC50,uM,12.45
4470,13833377,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088224,=,nM,6130.0,CHEMBL203,Homo sapiens,IC50,uM,6.13
4471,13833378,CHEMBL3091175,Inhibition of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) autophosphorylation expressed in baculovirus infected insect Sf9 cells preincubated for 10 mins followed by ATP-MgCl2 addition measured after 1 hr by fluorometric analysis,B,CHEMBL3088225,=,nM,10020.0,CHEMBL203,Homo sapiens,IC50,uM,10.02
4472,13852012,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL1173655,=,nM,0.19,CHEMBL203,Homo sapiens,IC50,nM,0.19
4473,13852013,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL553,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
4474,13852014,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092305,=,nM,404.0,CHEMBL203,Homo sapiens,IC50,uM,0.404
4475,13852015,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092304,=,nM,232.0,CHEMBL203,Homo sapiens,IC50,uM,0.232
4476,13852016,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092303,=,nM,331.0,CHEMBL203,Homo sapiens,IC50,uM,0.331
4477,13852017,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092302,=,nM,304.0,CHEMBL203,Homo sapiens,IC50,uM,0.304
4478,13852018,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092301,=,nM,265.0,CHEMBL203,Homo sapiens,IC50,uM,0.265
4479,13852019,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092300,=,nM,1715.0,CHEMBL203,Homo sapiens,IC50,uM,1.715
4480,13852020,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092299,=,nM,884.0,CHEMBL203,Homo sapiens,IC50,uM,0.884
4481,13852021,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092298,=,nM,859.0,CHEMBL203,Homo sapiens,IC50,uM,0.859
4482,13852022,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092297,=,nM,699.0,CHEMBL203,Homo sapiens,IC50,uM,0.699
4483,13852023,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092321,=,nM,464.0,CHEMBL203,Homo sapiens,IC50,uM,0.464
4484,13852024,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092320,=,nM,1581.0,CHEMBL203,Homo sapiens,IC50,uM,1.581
4485,13852025,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092319,=,nM,967.0,CHEMBL203,Homo sapiens,IC50,uM,0.967
4486,13852026,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092318,=,nM,543.0,CHEMBL203,Homo sapiens,IC50,uM,0.543
4487,13852027,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092317,=,nM,464.0,CHEMBL203,Homo sapiens,IC50,uM,0.464
4488,13852028,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092316,=,nM,505.0,CHEMBL203,Homo sapiens,IC50,uM,0.505
4489,13852029,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092315,=,nM,281.0,CHEMBL203,Homo sapiens,IC50,uM,0.281
4490,13852030,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092314,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
4491,13852031,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092313,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
4492,13852032,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092312,=,nM,544.0,CHEMBL203,Homo sapiens,IC50,uM,0.544
4493,13852033,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092311,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,uM,0.197
4494,13852034,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092310,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,uM,0.082
4495,13852035,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092309,=,nM,165.0,CHEMBL203,Homo sapiens,IC50,uM,0.165
4496,13852036,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092308,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
4497,13852037,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092307,=,nM,365.0,CHEMBL203,Homo sapiens,IC50,uM,0.365
4498,13852038,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092306,=,nM,635.0,CHEMBL203,Homo sapiens,IC50,uM,0.635
4499,13852039,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092324,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
4500,13852040,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092323,=,nM,479.0,CHEMBL203,Homo sapiens,IC50,uM,0.479
4501,13852041,CHEMBL3095060,"Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3092322,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
4502,13868165,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098312,=,nM,67200.0,CHEMBL203,Homo sapiens,IC50,uM,67.2
4503,13868166,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098315,=,nM,61500.0,CHEMBL203,Homo sapiens,IC50,uM,61.5
4504,13868169,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098326,=,nM,37600.0,CHEMBL203,Homo sapiens,IC50,uM,37.6
4505,13868170,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098319,=,nM,36000.0,CHEMBL203,Homo sapiens,IC50,uM,36.0
4506,13868171,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098318,=,nM,34600.0,CHEMBL203,Homo sapiens,IC50,uM,34.6
4507,13868174,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098313,=,nM,18300.0,CHEMBL203,Homo sapiens,IC50,uM,18.3
4508,13868175,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL525527,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7
4509,13868177,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098322,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
4510,13868178,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098317,=,nM,2370.0,CHEMBL203,Homo sapiens,IC50,uM,2.37
4511,13868181,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098321,=,nM,1630.0,CHEMBL203,Homo sapiens,IC50,uM,1.63
4512,13868184,CHEMBL3101602,Inhibition of wild type EGFR (unknown origin) assessed as inhibition of 33[Pi] incorporation after 60 mins by scintillation counting,B,CHEMBL3098325,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4513,13924656,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
4514,13924657,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
4515,13924658,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114690,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4516,13924659,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114689,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
4517,13924660,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114688,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
4518,13924661,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114687,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4519,13924662,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114686,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4520,13924663,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114701,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4521,13924664,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114700,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4522,13924665,CHEMBL3118714,Inhibition of EGFR (unknown origin) after 10 mins,B,CHEMBL3114699,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
4523,13924666,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL939,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
4524,13924667,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL553,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
4525,13924676,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114690,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
4526,13924677,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114689,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
4527,13924678,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114688,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
4528,13924679,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114687,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
4529,13924680,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114686,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
4530,13924681,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114701,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,uM,0.082
4531,13924682,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114700,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
4532,13924683,CHEMBL3118715,Inhibition of EGF-stimulated autophosphorylation of EGFR in human KB cells incubated for 1 hr prior to EGF challenge measured after 6 mins by ELISA,B,CHEMBL3114699,=,nM,640.0,CHEMBL203,Homo sapiens,IC50,uM,0.64
4533,13973092,CHEMBL3136749,Inhibition of EGFR (unknown origin),B,CHEMBL3134612,=,nM,2145.0,CHEMBL203,Homo sapiens,IC50,uM,2.145
4534,13973380,CHEMBL3134653,"Inhibition of EGFR (unknown origin) using poly(Glu,Tyr) as substrate after 60 mins by scintillation counting",B,CHEMBL3133821,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0
4535,13973662,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133758,=,nM,165.0,CHEMBL203,Homo sapiens,IC50,nM,165.0
4536,13973663,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133757,=,nM,188.0,CHEMBL203,Homo sapiens,IC50,nM,188.0
4537,13973664,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133756,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,nM,99.0
4538,13973665,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133755,=,nM,3315.0,CHEMBL203,Homo sapiens,IC50,nM,3315.0
4539,13973666,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133754,=,nM,2350.0,CHEMBL203,Homo sapiens,IC50,nM,2350.0
4540,13973668,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133752,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,nM,82.0
4541,13973669,CHEMBL3136336,Inhibition of EGFR (unknown origin) after 1 hr by Caliper mobility shift assay,B,CHEMBL3133751,=,nM,285.0,CHEMBL203,Homo sapiens,IC50,nM,285.0
4542,13974919,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL285063,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
4543,13974920,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL939,=,nM,13980.0,CHEMBL203,Homo sapiens,IC50,uM,13.98
4544,13974922,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133899,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
4545,13974926,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133895,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,uM,0.28
4546,13974927,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133894,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
4547,13974928,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133893,=,nM,4390.0,CHEMBL203,Homo sapiens,IC50,uM,4.39
4548,13974933,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133908,=,nM,275.0,CHEMBL203,Homo sapiens,IC50,uM,0.275
4549,13974934,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133907,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4550,13974935,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133906,=,nM,931.0,CHEMBL203,Homo sapiens,IC50,uM,0.931
4551,13974937,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3133904,=,nM,111000.0,CHEMBL203,Homo sapiens,IC50,uM,111.0
4552,13974940,CHEMBL3137113,Inhibition of EGFR L858R/T790M mutant in human NCI-H1975 cells assessed as inhibition of EGF-mediated autophosphorylation incubated for 30 mins prior to EGF challenge by cytoblot assay,B,CHEMBL3132872,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
4553,13975581,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL285063,=,nM,3500.0,CHEMBL203,Homo sapiens,IC50,uM,3.5
4554,13975582,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL939,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
4555,13975584,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133899,=,nM,7380.0,CHEMBL203,Homo sapiens,IC50,uM,7.38
4556,13975585,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133898,=,nM,8730.0,CHEMBL203,Homo sapiens,IC50,uM,8.73
4557,13975586,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133897,=,nM,4400.0,CHEMBL203,Homo sapiens,IC50,uM,4.4
4558,13975587,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133896,=,nM,3710.0,CHEMBL203,Homo sapiens,IC50,uM,3.71
4559,13975588,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133895,=,nM,3950.0,CHEMBL203,Homo sapiens,IC50,uM,3.95
4560,13975589,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133894,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
4561,13975590,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133893,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8
4562,13975591,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133912,=,nM,43700.0,CHEMBL203,Homo sapiens,IC50,uM,43.7
4563,13975592,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133911,=,nM,53300.0,CHEMBL203,Homo sapiens,IC50,uM,53.3
4564,13975593,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133910,=,nM,76500.0,CHEMBL203,Homo sapiens,IC50,uM,76.5
4565,13975594,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133909,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
4566,13975595,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133908,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
4567,13975596,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133907,=,nM,18900.0,CHEMBL203,Homo sapiens,IC50,uM,18.9
4568,13975597,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133906,=,nM,53600.0,CHEMBL203,Homo sapiens,IC50,uM,53.6
4569,13975598,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133905,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
4570,13975599,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133904,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
4571,13975600,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133903,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
4572,13975601,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133902,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
4573,13975602,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3132872,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
4574,13975603,CHEMBL3134707,Inhibition of recombinant wild type EGFR kinase(unknown origin) after 30 mins in presence of [gamma32P]ATP,B,CHEMBL3133901,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
4575,14533834,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL1229592,=,nM,6.47,CHEMBL203,Homo sapiens,IC50,nM,6.47
4576,14533835,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219125,=,nM,9.14,CHEMBL203,Homo sapiens,IC50,nM,9.14
4577,14533837,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219127,=,nM,2.45,CHEMBL203,Homo sapiens,IC50,nM,2.45
4578,14533838,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219128,=,nM,22.12,CHEMBL203,Homo sapiens,IC50,nM,22.12
4579,14533839,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219129,=,nM,24.83,CHEMBL203,Homo sapiens,IC50,nM,24.83
4580,14533840,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219130,=,nM,10.18,CHEMBL203,Homo sapiens,IC50,nM,10.18
4581,14533841,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219131,=,nM,77.19,CHEMBL203,Homo sapiens,IC50,nM,77.19
4582,14533842,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219132,=,nM,6.99,CHEMBL203,Homo sapiens,IC50,nM,6.99
4583,14533843,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219133,=,nM,4.68,CHEMBL203,Homo sapiens,IC50,nM,4.68
4584,14533844,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219134,=,nM,33.95,CHEMBL203,Homo sapiens,IC50,nM,33.95
4585,14533845,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219135,=,nM,37.37,CHEMBL203,Homo sapiens,IC50,nM,37.37
4586,14533846,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219347,=,nM,5.78,CHEMBL203,Homo sapiens,IC50,nM,5.78
4587,14533847,CHEMBL3223691,Inhibition of wild type EGFR kinase (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219348,=,nM,6.26,CHEMBL203,Homo sapiens,IC50,nM,6.26
4588,14533848,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL1229592,=,nM,2.47,CHEMBL203,Homo sapiens,IC50,nM,2.47
4589,14533849,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219125,=,nM,110.1,CHEMBL203,Homo sapiens,IC50,nM,110.1
4590,14533851,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219127,=,nM,114.99,CHEMBL203,Homo sapiens,IC50,nM,114.99
4591,14533852,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219128,=,nM,122.45,CHEMBL203,Homo sapiens,IC50,nM,122.45
4592,14533853,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219129,=,nM,44.05,CHEMBL203,Homo sapiens,IC50,nM,44.05
4593,14533854,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219130,=,nM,86.76,CHEMBL203,Homo sapiens,IC50,nM,86.76
4594,14533855,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219131,=,nM,778.15,CHEMBL203,Homo sapiens,IC50,nM,778.15
4595,14533856,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219132,=,nM,221.2,CHEMBL203,Homo sapiens,IC50,nM,221.2
4596,14533857,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219133,=,nM,16.46,CHEMBL203,Homo sapiens,IC50,nM,16.46
4597,14533858,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219134,=,nM,88.34,CHEMBL203,Homo sapiens,IC50,nM,88.34
4598,14533859,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219135,=,nM,87.23,CHEMBL203,Homo sapiens,IC50,nM,87.23
4599,14533860,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219347,=,nM,17.91,CHEMBL203,Homo sapiens,IC50,nM,17.91
4600,14533861,CHEMBL3223692,Inhibition of EGFR kinase T790M mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219348,=,nM,84.25,CHEMBL203,Homo sapiens,IC50,nM,84.25
4601,14533862,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL1229592,=,nM,8.13,CHEMBL203,Homo sapiens,IC50,nM,8.13
4602,14533863,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219125,=,nM,15.11,CHEMBL203,Homo sapiens,IC50,nM,15.11
4603,14533865,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219127,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
4604,14533866,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219128,=,nM,41.59,CHEMBL203,Homo sapiens,IC50,nM,41.59
4605,14533867,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219129,=,nM,56.49,CHEMBL203,Homo sapiens,IC50,nM,56.49
4606,14533868,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219130,=,nM,13.25,CHEMBL203,Homo sapiens,IC50,nM,13.25
4607,14533869,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219131,=,nM,173.73,CHEMBL203,Homo sapiens,IC50,nM,173.73
4608,14533870,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219132,=,nM,30.74,CHEMBL203,Homo sapiens,IC50,nM,30.74
4609,14533871,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219133,=,nM,8.33,CHEMBL203,Homo sapiens,IC50,nM,8.33
4610,14533872,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219134,=,nM,50.02,CHEMBL203,Homo sapiens,IC50,nM,50.02
4611,14533873,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219135,=,nM,62.19,CHEMBL203,Homo sapiens,IC50,nM,62.19
4612,14533874,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219347,=,nM,24.53,CHEMBL203,Homo sapiens,IC50,nM,24.53
4613,14533875,CHEMBL3223693,Inhibition of EGFR kinase L858R mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219348,=,nM,9.12,CHEMBL203,Homo sapiens,IC50,nM,9.12
4614,14533876,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL1229592,=,nM,4.25,CHEMBL203,Homo sapiens,IC50,nM,4.25
4615,14533877,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219125,=,nM,22.34,CHEMBL203,Homo sapiens,IC50,nM,22.34
4616,14533879,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219127,=,nM,2.74,CHEMBL203,Homo sapiens,IC50,nM,2.74
4617,14533880,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219128,=,nM,6.02,CHEMBL203,Homo sapiens,IC50,nM,6.02
4618,14533881,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219129,=,nM,24.11,CHEMBL203,Homo sapiens,IC50,nM,24.11
4619,14533882,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219130,=,nM,7.25,CHEMBL203,Homo sapiens,IC50,nM,7.25
4620,14533883,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219131,=,nM,77.09,CHEMBL203,Homo sapiens,IC50,nM,77.09
4621,14533884,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219132,=,nM,6.86,CHEMBL203,Homo sapiens,IC50,nM,6.86
4622,14533885,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219133,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
4623,14533886,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219134,=,nM,97.12,CHEMBL203,Homo sapiens,IC50,nM,97.12
4624,14533887,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219135,=,nM,34.67,CHEMBL203,Homo sapiens,IC50,nM,34.67
4625,14533888,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219347,=,nM,7.57,CHEMBL203,Homo sapiens,IC50,nM,7.57
4626,14533889,CHEMBL3223694,Inhibition of EGFR kinase L861Q mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219348,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
4627,14533890,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL1229592,=,nM,1.82,CHEMBL203,Homo sapiens,IC50,nM,1.82
4628,14533891,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219125,=,nM,52.63,CHEMBL203,Homo sapiens,IC50,nM,52.63
4629,14533893,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219127,=,nM,40.73,CHEMBL203,Homo sapiens,IC50,nM,40.73
4630,14533894,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219128,=,nM,50.85,CHEMBL203,Homo sapiens,IC50,nM,50.85
4631,14533895,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219129,=,nM,24.83,CHEMBL203,Homo sapiens,IC50,nM,24.83
4632,14533896,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219130,=,nM,87.45,CHEMBL203,Homo sapiens,IC50,nM,87.45
4633,14533898,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219132,=,nM,193.97,CHEMBL203,Homo sapiens,IC50,nM,193.97
4634,14533899,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219133,=,nM,8.95,CHEMBL203,Homo sapiens,IC50,nM,8.95
4635,14533900,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219134,=,nM,53.94,CHEMBL203,Homo sapiens,IC50,nM,53.94
4636,14533901,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219135,=,nM,59.36,CHEMBL203,Homo sapiens,IC50,nM,59.36
4637,14533902,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219347,=,nM,14.08,CHEMBL203,Homo sapiens,IC50,nM,14.08
4638,14533903,CHEMBL3223695,Inhibition of EGFR kinase L858R/T790M double mutant (unknown origin) after 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3219348,=,nM,32.83,CHEMBL203,Homo sapiens,IC50,nM,32.83
4639,14537513,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219502,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
4640,14537514,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219505,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
4641,14537515,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3218424,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
4642,14537516,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219504,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
4643,14537517,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219503,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52
4644,14537518,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219506,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
4645,14537519,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219507,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,uM,0.46
4646,14537520,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL3219508,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
4647,14537527,CHEMBL3223148,Inhibition of EGFR catalytic domain (unknown origin) assessed as reduction of poly(Glu:Tyr) substrate phosphorylation after 20 mins by ELISA,B,CHEMBL553,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
4648,14543393,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL3217993,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
4649,14543394,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL3218000,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078
4650,14543395,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL3218001,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
4651,14543396,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL3218002,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
4652,14543397,CHEMBL3226013,Inhibition of recombinant EGFR (unknown origin) using poly-Glu-Tyr peptide as substrate,B,CHEMBL553,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4653,14547458,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
4654,14547466,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL24828,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
4655,14547467,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221551,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
4656,14547471,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221554,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4657,14547472,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221556,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4658,14547473,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221561,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4659,14547478,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221560,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
4660,14547479,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221258,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
4661,14547490,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221542,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
4662,14547493,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221552,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
4663,14547501,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221555,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
4664,14547510,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221547,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
4665,14547513,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL1277620,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
4666,14547520,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221558,=,nM,6150.0,CHEMBL203,Homo sapiens,IC50,uM,6.15
4667,14547522,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221259,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
4668,14548148,CHEMBL3223203,Inhibition of wild type EGFR (unknown origin) using Y12-Sox peptide as substrate preincubated for 30 mins by fluorescence assay,B,CHEMBL3218346,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
4669,14548149,CHEMBL3223203,Inhibition of wild type EGFR (unknown origin) using Y12-Sox peptide as substrate preincubated for 30 mins by fluorescence assay,B,CHEMBL3218347,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
4670,14548150,CHEMBL3223204,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Y12-Sox peptide as substrate preincubated for 30 mins by fluorescence assay,B,CHEMBL3218346,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
4671,14548158,CHEMBL3223208,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218346,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,nM,49.0
4672,14548159,CHEMBL3223208,Inhibition of EGF-induced EGFR autophosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218347,=,nM,166.0,CHEMBL203,Homo sapiens,IC50,nM,166.0
4673,14548160,CHEMBL3223209,Inhibition of EGF-induced EGFR-mediated Akt phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218346,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
4674,14548161,CHEMBL3223209,Inhibition of EGF-induced EGFR-mediated Akt phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218347,=,nM,136.0,CHEMBL203,Homo sapiens,IC50,nM,136.0
4675,14548162,CHEMBL3223210,Inhibition of EGF-induced EGFR-mediated ERK phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218346,=,nM,509.0,CHEMBL203,Homo sapiens,IC50,nM,509.0
4676,14548163,CHEMBL3223210,Inhibition of EGF-induced EGFR-mediated ERK phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218347,=,nM,1158.0,CHEMBL203,Homo sapiens,IC50,nM,1158.0
4677,14548164,CHEMBL3223211,Inhibition of EGF-induced EGFR-mediated pS6 phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218346,=,nM,511.0,CHEMBL203,Homo sapiens,IC50,nM,511.0
4678,14548165,CHEMBL3223211,Inhibition of EGF-induced EGFR-mediated pS6 phosphorylation in human A431 cells after 1 hr by immunoblotting method,B,CHEMBL3218347,=,nM,243.0,CHEMBL203,Homo sapiens,IC50,nM,243.0
4679,14549670,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL1761929,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,uM,6.9
4680,14549671,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221550,=,nM,7050.0,CHEMBL203,Homo sapiens,IC50,uM,7.05
4681,14549673,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221553,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
4682,14549676,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221557,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
4683,14549678,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221541,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
4684,14549680,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221546,=,nM,8500.0,CHEMBL203,Homo sapiens,IC50,uM,8.5
4685,14549686,CHEMBL3226103,Inhibition of EGFR (unknown origin),B,CHEMBL3221548,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8
4686,14549720,CHEMBL3226105,Inhibition of recombinant EGFR (unknown origin) by ELISA,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
4687,14553219,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1081312,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
4688,14553228,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1234815,=,nM,388.0,CHEMBL203,Homo sapiens,IC50,uM,0.388
4689,14553235,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1233882,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61
4690,14553242,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1230790,=,nM,954.0,CHEMBL203,Homo sapiens,IC50,uM,0.954
4691,14553259,CHEMBL3223623,Inhibition of EGFR (unknown origin),B,CHEMBL1233881,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
4692,14566291,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234864,=,nM,10350.0,CHEMBL203,Homo sapiens,IC50,uM,10.35
4693,14566292,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234865,=,nM,23130.0,CHEMBL203,Homo sapiens,IC50,uM,23.13
4694,14568922,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234866,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
4695,14568923,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234867,=,nM,21020.0,CHEMBL203,Homo sapiens,IC50,uM,21.02
4696,14568924,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235199,=,nM,5120.0,CHEMBL203,Homo sapiens,IC50,uM,5.12
4697,14568925,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235200,=,nM,3170.0,CHEMBL203,Homo sapiens,IC50,uM,3.17
4698,14568926,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235201,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
4699,14568927,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235202,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
4700,14568928,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235203,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,uM,0.42
4701,14568929,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235204,=,nM,8660.0,CHEMBL203,Homo sapiens,IC50,uM,8.66
4702,14568930,CHEMBL3240620,Inhibition of autophosphorylation of EGFR cytoplasmic domain (amino acids 645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL553,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
4703,14568931,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234864,=,nM,15300.0,CHEMBL203,Homo sapiens,IC50,uM,15.3
4704,14568932,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234865,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,uM,7.67
4705,14568933,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234866,=,nM,12020.0,CHEMBL203,Homo sapiens,IC50,uM,12.02
4706,14568934,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3234867,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
4707,14568935,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235199,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
4708,14568936,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235200,=,nM,1580.0,CHEMBL203,Homo sapiens,IC50,uM,1.58
4709,14568937,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235201,=,nM,17000.0,CHEMBL203,Homo sapiens,IC50,uM,17.0
4710,14568938,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235202,=,nM,2180.0,CHEMBL203,Homo sapiens,IC50,uM,2.18
4711,14568939,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235203,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
4712,14568940,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL3235204,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
4713,14568941,CHEMBL3240621,Inhibition of autophosphorylation of human HER2 cytoplasmic domain (amino acids 676 to 1245) (unknown origin) expressed in Sf9 cells after 1 hr by time-resolved fluorometry,B,CHEMBL553,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
4714,14571447,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
4715,14571448,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234736,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
4716,14571449,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234737,=,nM,575.0,CHEMBL203,Homo sapiens,IC50,uM,0.575
4717,14571452,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234740,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
4718,14571453,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234741,=,nM,1920.0,CHEMBL203,Homo sapiens,IC50,uM,1.92
4719,14571454,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234742,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
4720,14571455,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234743,=,nM,1330.0,CHEMBL203,Homo sapiens,IC50,uM,1.33
4721,14571456,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234744,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
4722,14571457,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234745,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
4723,14571458,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234746,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
4724,14571459,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234747,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,uM,0.044
4725,14571460,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234748,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
4726,14571461,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234749,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
4727,14571462,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234750,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
4728,14571463,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234751,=,nM,5540.0,CHEMBL203,Homo sapiens,IC50,uM,5.54
4729,14571464,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234752,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
4730,14571465,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234753,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
4731,14571467,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234755,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,uM,0.68
4732,14571468,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234756,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,uM,0.099
4733,14571469,CHEMBL3240253,Inhibition of EGFR (unknown origin) after 1 to 1.5 hrs by FRET-based Z'-Lyte assay,B,CHEMBL3234757,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
4734,14574799,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237931,=,nM,525.0,CHEMBL203,Homo sapiens,IC50,uM,0.525
4735,14574800,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237930,=,nM,877.0,CHEMBL203,Homo sapiens,IC50,uM,0.877
4736,14574801,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237929,=,nM,638.0,CHEMBL203,Homo sapiens,IC50,uM,0.638
4737,14574802,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL1229592,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,uM,0.0044
4738,14574803,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL939,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,uM,0.0001
4739,14574804,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237932,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
4740,14574806,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237934,=,nM,7442.0,CHEMBL203,Homo sapiens,IC50,uM,7.442
4741,14574807,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237935,=,nM,698.0,CHEMBL203,Homo sapiens,IC50,uM,0.698
4742,14574808,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237936,=,nM,2388.0,CHEMBL203,Homo sapiens,IC50,uM,2.388
4743,14574809,CHEMBL3241595,Inhibition of EGFR (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237937,=,nM,201.0,CHEMBL203,Homo sapiens,IC50,uM,0.201
4744,14574810,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL939,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,uM,0.0002
4745,14574811,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL1229592,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,uM,0.0048
4746,14574812,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237929,=,nM,804.0,CHEMBL203,Homo sapiens,IC50,uM,0.804
4747,14574813,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237930,=,nM,818.0,CHEMBL203,Homo sapiens,IC50,uM,0.818
4748,14574814,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237931,=,nM,427.0,CHEMBL203,Homo sapiens,IC50,uM,0.427
4749,14574815,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237932,=,nM,4527.0,CHEMBL203,Homo sapiens,IC50,uM,4.527
4750,14574817,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237934,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
4751,14574818,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237935,=,nM,2385.0,CHEMBL203,Homo sapiens,IC50,uM,2.385
4752,14574819,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237936,=,nM,5866.0,CHEMBL203,Homo sapiens,IC50,uM,5.866
4753,14574820,CHEMBL3241596,Inhibition of EGFR L858R mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237937,=,nM,262.0,CHEMBL203,Homo sapiens,IC50,uM,0.262
4754,14574821,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL939,=,nM,941.0,CHEMBL203,Homo sapiens,IC50,uM,0.941
4755,14574822,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL1229592,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,uM,0.0007
4756,14574823,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237929,=,nM,184.0,CHEMBL203,Homo sapiens,IC50,uM,0.184
4757,14574824,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237930,=,nM,181.0,CHEMBL203,Homo sapiens,IC50,uM,0.181
4758,14574825,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237931,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,uM,0.088
4759,14574826,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237932,=,nM,2177.0,CHEMBL203,Homo sapiens,IC50,uM,2.177
4760,14574828,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237934,=,nM,4706.0,CHEMBL203,Homo sapiens,IC50,uM,4.706
4761,14574829,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237935,=,nM,537.0,CHEMBL203,Homo sapiens,IC50,uM,0.537
4762,14574830,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237936,=,nM,2419.0,CHEMBL203,Homo sapiens,IC50,uM,2.419
4763,14574831,CHEMBL3241597,Inhibition of EGFR L858R/T790M mutant (unknown origin) after 1.5 hr by FRET-based Z-lyte assay,B,CHEMBL3237937,=,nM,263.0,CHEMBL203,Homo sapiens,IC50,uM,0.263
4764,14574927,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237938,=,nM,18020.0,CHEMBL203,Homo sapiens,IC50,uM,18.02
4765,14574928,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237939,=,nM,10120.0,CHEMBL203,Homo sapiens,IC50,uM,10.12
4766,14574929,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237940,=,nM,4150.0,CHEMBL203,Homo sapiens,IC50,uM,4.15
4767,14574930,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237941,=,nM,32130.0,CHEMBL203,Homo sapiens,IC50,uM,32.13
4768,14574931,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237942,=,nM,14700.0,CHEMBL203,Homo sapiens,IC50,uM,14.7
4769,14574932,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237943,=,nM,24050.0,CHEMBL203,Homo sapiens,IC50,uM,24.05
4770,14574933,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237944,=,nM,2090.0,CHEMBL203,Homo sapiens,IC50,uM,2.09
4771,14574934,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237945,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
4772,14574935,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237946,=,nM,6150.0,CHEMBL203,Homo sapiens,IC50,uM,6.15
4773,14574936,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237947,=,nM,11180.0,CHEMBL203,Homo sapiens,IC50,uM,11.18
4774,14574937,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237948,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
4775,14574938,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3237949,=,nM,1030.0,CHEMBL203,Homo sapiens,IC50,uM,1.03
4776,14574939,CHEMBL3240469,Inhibition of autophosphorylation of recombinant EGFR cytoplasmic domain (645 to 1186) (unknown origin) expressed in Sf9 cells after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL553,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
4777,14586315,CHEMBL3239790,Inhibition of EGFR (unknown origin),B,CHEMBL3133758,=,nM,165.0,CHEMBL203,Homo sapiens,IC50,nM,165.0
4778,14586655,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233759,=,nM,4997.0,CHEMBL203,Homo sapiens,IC50,uM,4.997
4779,14586657,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233761,=,nM,799.0,CHEMBL203,Homo sapiens,IC50,uM,0.799
4780,14586658,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233762,=,nM,4286.0,CHEMBL203,Homo sapiens,IC50,uM,4.286
4781,14586659,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233763,=,nM,5222.0,CHEMBL203,Homo sapiens,IC50,uM,5.222
4782,14586660,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233764,=,nM,542.0,CHEMBL203,Homo sapiens,IC50,uM,0.542
4783,14586661,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233765,=,nM,3399.0,CHEMBL203,Homo sapiens,IC50,uM,3.399
4784,14586662,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233766,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
4785,14586663,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233767,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
4786,14586664,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233768,=,nM,6414.0,CHEMBL203,Homo sapiens,IC50,uM,6.414
4787,14586665,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233769,=,nM,1792.0,CHEMBL203,Homo sapiens,IC50,uM,1.792
4788,14586666,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233770,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
4789,14586667,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL1173655,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
4790,14586668,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL553,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4791,14586669,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233771,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
4792,14586670,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233772,=,nM,1196.0,CHEMBL203,Homo sapiens,IC50,uM,1.196
4793,14586671,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233773,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4794,14586672,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233774,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
4795,14586673,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233775,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
4796,14586674,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233776,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
4797,14586675,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233777,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
4798,14586676,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233778,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
4799,14586677,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233779,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4800,14586678,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233780,=,nM,139.0,CHEMBL203,Homo sapiens,IC50,uM,0.139
4801,14586679,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233781,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,uM,0.093
4802,14586680,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233782,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
4803,14586681,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233783,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
4804,14586682,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233784,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
4805,14586683,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233785,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,uM,0.0009
4806,14586684,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233786,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
4807,14586685,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233787,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
4808,14586686,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233788,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
4809,14586687,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233789,=,nM,124.0,CHEMBL203,Homo sapiens,IC50,uM,0.124
4810,14586688,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233790,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
4811,14586689,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233791,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
4812,14586690,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233792,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4813,14586691,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233793,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
4814,14586692,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233020,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
4815,14586693,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233794,=,nM,2159.0,CHEMBL203,Homo sapiens,IC50,uM,2.159
4816,14586694,CHEMBL3238947,Inhibition of wild type EGFR domain (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233795,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4817,14586700,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233761,=,nM,1803.0,CHEMBL203,Homo sapiens,IC50,uM,1.803
4818,14586702,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233763,=,nM,1699.0,CHEMBL203,Homo sapiens,IC50,uM,1.699
4819,14586706,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233767,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
4820,14586708,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233769,=,nM,9859.0,CHEMBL203,Homo sapiens,IC50,uM,9.859
4821,14586709,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233770,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
4822,14586710,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL1173655,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
4823,14586711,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL553,=,nM,1024.0,CHEMBL203,Homo sapiens,IC50,uM,1.024
4824,14586712,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233771,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4825,14586713,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233772,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,uM,0.0007
4826,14586714,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233773,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
4827,14586715,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233774,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
4828,14586716,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233775,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
4829,14586717,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233776,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,uM,0.055
4830,14586718,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233777,=,nM,324.0,CHEMBL203,Homo sapiens,IC50,uM,0.324
4831,14586719,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233778,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
4832,14586720,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233779,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
4833,14586721,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233780,=,nM,354.0,CHEMBL203,Homo sapiens,IC50,uM,0.354
4834,14586722,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233781,=,nM,1042.0,CHEMBL203,Homo sapiens,IC50,uM,1.042
4835,14586723,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233782,=,nM,305.0,CHEMBL203,Homo sapiens,IC50,uM,0.305
4836,14586724,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233783,=,nM,1755.0,CHEMBL203,Homo sapiens,IC50,uM,1.755
4837,14586725,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233784,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4838,14586726,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233785,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
4839,14586727,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233786,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
4840,14586728,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233787,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
4841,14586729,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233788,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
4842,14586730,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233789,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4843,14586731,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233790,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
4844,14586732,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233791,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4845,14586733,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233792,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
4846,14586734,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233793,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
4847,14586735,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233020,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
4848,14586736,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233794,=,nM,2252.0,CHEMBL203,Homo sapiens,IC50,uM,2.252
4849,14586737,CHEMBL3238948,Inhibition of EGFR T790M/L858R double mutant (unknown origin) expressed in baculovirus expression system using Poly(Glu:Tyr)4:1 substrate after 60 mins by ELISA,B,CHEMBL3233795,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
4850,14652512,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263959,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,uM,7.67
4851,14652513,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263960,=,nM,3860.0,CHEMBL203,Homo sapiens,IC50,uM,3.86
4852,14652514,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263961,=,nM,1370.0,CHEMBL203,Homo sapiens,IC50,uM,1.37
4853,14652515,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263962,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
4854,14652516,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263963,=,nM,168.0,CHEMBL203,Homo sapiens,IC50,uM,0.168
4855,14652517,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263964,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
4856,14652518,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263965,=,nM,572.0,CHEMBL203,Homo sapiens,IC50,uM,0.572
4857,14652519,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263966,=,nM,4354.0,CHEMBL203,Homo sapiens,IC50,uM,4.354
4858,14652520,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263967,=,nM,1201.0,CHEMBL203,Homo sapiens,IC50,uM,1.201
4859,14652521,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263968,=,nM,1052.0,CHEMBL203,Homo sapiens,IC50,uM,1.052
4860,14652522,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL3263969,=,nM,1907.0,CHEMBL203,Homo sapiens,IC50,uM,1.907
4861,14652523,CHEMBL3266279,Inhibition of recombinant EGFR (unknown origin) using poly-GT peptide as substrate by Transcreener assay,B,CHEMBL553,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
4862,14652530,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263960,=,nM,2895.0,CHEMBL203,Homo sapiens,IC50,uM,2.895
4863,14652531,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263961,=,nM,1969.0,CHEMBL203,Homo sapiens,IC50,uM,1.969
4864,14652532,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263962,=,nM,369.0,CHEMBL203,Homo sapiens,IC50,uM,0.369
4865,14652533,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263963,=,nM,283.0,CHEMBL203,Homo sapiens,IC50,uM,0.283
4866,14652534,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263964,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
4867,14652535,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263965,=,nM,578.0,CHEMBL203,Homo sapiens,IC50,uM,0.578
4868,14652536,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263966,=,nM,7538.0,CHEMBL203,Homo sapiens,IC50,uM,7.538
4869,14652537,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263967,=,nM,1849.0,CHEMBL203,Homo sapiens,IC50,uM,1.849
4870,14652538,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263968,=,nM,1157.0,CHEMBL203,Homo sapiens,IC50,uM,1.157
4871,14652539,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL3263969,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
4872,14652540,CHEMBL3266280,Inhibition of recombinant EGFR L858R mutant (unknown origin) using poly-GT peptide as substrate after 1 hr by Transcreener assay,B,CHEMBL553,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
4873,14655699,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263359,=,nM,3960.0,CHEMBL203,Homo sapiens,IC50,uM,3.96
4874,14655700,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263364,=,nM,5530.0,CHEMBL203,Homo sapiens,IC50,uM,5.53
4875,14655701,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263366,=,nM,1320.0,CHEMBL203,Homo sapiens,IC50,uM,1.32
4876,14655702,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263372,=,nM,5260.0,CHEMBL203,Homo sapiens,IC50,uM,5.26
4877,14655703,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263373,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
4878,14655704,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263374,=,nM,6310.0,CHEMBL203,Homo sapiens,IC50,uM,6.31
4879,14655705,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263378,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
4880,14655706,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263379,=,nM,3250.0,CHEMBL203,Homo sapiens,IC50,uM,3.25
4881,14655707,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL3263380,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
4882,14655708,CHEMBL3267504,Inhibition of autophosphorylation of recombinant his-tagged EGFR (amino acid 645-1186) (unknown origin) expressed in Sf-9 cells after 10 mins by time-resolved fluorometry,B,CHEMBL939,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
4883,14730368,CHEMBL3292439,Inhibition of EGFR (unknown origin) after 1 hr by HTRF assay,B,CHEMBL3290142,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
4884,14730369,CHEMBL3292439,Inhibition of EGFR (unknown origin) after 1 hr by HTRF assay,B,CHEMBL3290148,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
4885,14742029,CHEMBL3294216,Inhibition of EGF receptor (unknown origin),B,CHEMBL3287898,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
4886,14752082,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL553,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
4887,14752123,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297893,=,nM,122.1,CHEMBL203,Homo sapiens,IC50,nM,122.1
4888,14752130,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297894,=,nM,30.2,CHEMBL203,Homo sapiens,IC50,nM,30.2
4889,14752135,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297892,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
4890,14752140,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297898,=,nM,68.2,CHEMBL203,Homo sapiens,IC50,nM,68.2
4891,14752144,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297897,=,nM,42.2,CHEMBL203,Homo sapiens,IC50,nM,42.2
4892,14752153,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297900,=,nM,73.3,CHEMBL203,Homo sapiens,IC50,nM,73.3
4893,14752160,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3298000,=,nM,82.3,CHEMBL203,Homo sapiens,IC50,nM,82.3
4894,14752161,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297896,=,nM,90.2,CHEMBL203,Homo sapiens,IC50,nM,90.2
4895,14752162,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297999,=,nM,84.4,CHEMBL203,Homo sapiens,IC50,nM,84.4
4896,14752165,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297899,=,nM,70.7,CHEMBL203,Homo sapiens,IC50,nM,70.7
4897,14752171,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297895,=,nM,102.3,CHEMBL203,Homo sapiens,IC50,nM,102.3
4898,14752172,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL535,=,nM,172.1,CHEMBL203,Homo sapiens,IC50,nM,172.1
4899,14752174,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297891,=,nM,145.2,CHEMBL203,Homo sapiens,IC50,nM,145.2
4900,14752177,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297998,=,nM,340.1,CHEMBL203,Homo sapiens,IC50,nM,340.1
4901,14752178,CHEMBL3299340,Inhibition of EGFR in human A431 cells by phosphotyrosine ELISA assay,B,CHEMBL3297816,=,nM,113.2,CHEMBL203,Homo sapiens,IC50,nM,113.2
4902,14753620,CHEMBL3300694,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,B,CHEMBL3040861,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
4903,14753621,CHEMBL3300694,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,B,CHEMBL3040806,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,uM,0.042
4904,14753622,CHEMBL3300694,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,B,CHEMBL3040910,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
4905,14753630,CHEMBL3300694,Inhibition of EGFR (unknown origin) assessed as incorporation of [32P] gamma-ATP in to myelin basic protein after 30 mins by autoradiographic analysis,B,CHEMBL24828,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
4906,14926877,CHEMBL3391161,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,B,CHEMBL3347498,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
4907,14926878,CHEMBL3391161,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,B,CHEMBL3347488,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
4908,14926879,CHEMBL3391161,Inhibition of EGFR kinase (unknown origin) using poly(Glu:Tyr) as substrate,B,CHEMBL3347487,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
4909,14974582,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360602,=,nM,0.77,CHEMBL203,Homo sapiens,IC50,nM,0.77
4910,14974583,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360603,=,nM,0.31,CHEMBL203,Homo sapiens,IC50,nM,0.31
4911,14974584,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360604,=,nM,0.52,CHEMBL203,Homo sapiens,IC50,nM,0.52
4912,14974585,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360605,=,nM,1.44,CHEMBL203,Homo sapiens,IC50,nM,1.44
4913,14974586,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360606,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
4914,14974587,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360607,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
4915,14974588,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360608,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
4916,14974589,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360609,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
4917,14974590,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360610,=,nM,0.57,CHEMBL203,Homo sapiens,IC50,nM,0.57
4918,14974591,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360611,=,nM,0.54,CHEMBL203,Homo sapiens,IC50,nM,0.54
4919,14974592,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360612,=,nM,30.5,CHEMBL203,Homo sapiens,IC50,nM,30.5
4920,14974593,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360613,=,nM,11.9,CHEMBL203,Homo sapiens,IC50,nM,11.9
4921,14974594,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360614,=,nM,16.6,CHEMBL203,Homo sapiens,IC50,nM,16.6
4922,14974595,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360615,=,nM,35.5,CHEMBL203,Homo sapiens,IC50,nM,35.5
4923,14974596,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360616,=,nM,20.1,CHEMBL203,Homo sapiens,IC50,nM,20.1
4924,14974597,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360617,=,nM,0.49,CHEMBL203,Homo sapiens,IC50,nM,0.49
4925,14974598,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360618,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nM,0.37
4926,14974599,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360619,=,nM,0.33,CHEMBL203,Homo sapiens,IC50,nM,0.33
4927,14974600,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3352899,=,nM,0.78,CHEMBL203,Homo sapiens,IC50,nM,0.78
4928,14974601,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3360620,=,nM,0.82,CHEMBL203,Homo sapiens,IC50,nM,0.82
4929,14974602,CHEMBL3375345,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL939,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
4930,14983517,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355873,=,nM,3.05,CHEMBL203,Homo sapiens,IC50,nM,3.05
4931,14983518,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355874,=,nM,0.89,CHEMBL203,Homo sapiens,IC50,nM,0.89
4932,14983519,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355875,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
4933,14983520,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355876,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
4934,14983521,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355877,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
4935,14983522,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355878,=,nM,0.66,CHEMBL203,Homo sapiens,IC50,nM,0.66
4936,14983523,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355879,=,nM,1.08,CHEMBL203,Homo sapiens,IC50,nM,1.08
4937,14983524,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355880,=,nM,0.56,CHEMBL203,Homo sapiens,IC50,nM,0.56
4938,14983525,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355881,=,nM,0.49,CHEMBL203,Homo sapiens,IC50,nM,0.49
4939,14983526,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355882,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
4940,14983527,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355883,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
4941,14983528,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355884,=,nM,28.5,CHEMBL203,Homo sapiens,IC50,nM,28.5
4942,14983529,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355885,=,nM,51.2,CHEMBL203,Homo sapiens,IC50,nM,51.2
4943,14983530,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355886,=,nM,15.1,CHEMBL203,Homo sapiens,IC50,nM,15.1
4944,14983531,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355887,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
4945,14983532,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355888,=,nM,3.43,CHEMBL203,Homo sapiens,IC50,nM,3.43
4946,14983533,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355889,=,nM,0.53,CHEMBL203,Homo sapiens,IC50,nM,0.53
4947,14983534,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL3355890,=,nM,1.18,CHEMBL203,Homo sapiens,IC50,nM,1.18
4948,14983535,CHEMBL3372999,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte kinase assay,B,CHEMBL939,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
4949,14992852,CHEMBL3372237,Inhibition of recombinant EGFR (unknown origin) after 60 mins by z'-lyte kinase assay,B,CHEMBL3361128,=,nM,100000.0,CHEMBL203,Homo sapiens,IC50,uM,100.0
4950,15034995,CHEMBL3370854,Inhibition of EGFR (unknown origin),B,CHEMBL607707,=,nM,38.5,CHEMBL203,Homo sapiens,IC50,nM,38.5
4951,15034997,CHEMBL3370854,Inhibition of EGFR (unknown origin),B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
4952,15073002,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426288,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,uM,0.091
4953,15073016,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353410,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
4954,15073018,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353410,=,nM,480000.0,CHEMBL203,Homo sapiens,IC50,uM,480.0
4955,15073047,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426279,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,uM,0.063
4956,15073049,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426279,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
4957,15073057,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL2426277,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
4958,15073059,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL2426277,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
4959,15073068,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353395,=,nM,16000.0,CHEMBL203,Homo sapiens,IC50,uM,16.0
4960,15073070,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353395,=,nM,10000000.0,CHEMBL203,Homo sapiens,IC50,uM,10000.0
4961,15073072,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353396,=,nM,19000.0,CHEMBL203,Homo sapiens,IC50,uM,19.0
4962,15073074,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353396,=,nM,1600000.0,CHEMBL203,Homo sapiens,IC50,uM,1600.0
4963,15073075,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353397,=,nM,31000.0,CHEMBL203,Homo sapiens,IC50,uM,31.0
4964,15073077,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353397,=,nM,6060000.0,CHEMBL203,Homo sapiens,IC50,uM,6060.0
4965,15073079,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353398,=,nM,57000.0,CHEMBL203,Homo sapiens,IC50,uM,57.0
4966,15073081,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353398,=,nM,5600000.0,CHEMBL203,Homo sapiens,IC50,uM,5600.0
4967,15073083,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353399,=,nM,66000.0,CHEMBL203,Homo sapiens,IC50,uM,66.0
4968,15073085,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353399,=,nM,7500000.0,CHEMBL203,Homo sapiens,IC50,uM,7500.0
4969,15073087,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353400,=,nM,75000.0,CHEMBL203,Homo sapiens,IC50,uM,75.0
4970,15073089,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353400,=,nM,11000000.0,CHEMBL203,Homo sapiens,IC50,uM,11000.0
4971,15073090,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353401,=,nM,135000.0,CHEMBL203,Homo sapiens,IC50,uM,135.0
4972,15073092,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353401,=,nM,10300000.0,CHEMBL203,Homo sapiens,IC50,uM,10300.0
4973,15073094,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353402,=,nM,177000.0,CHEMBL203,Homo sapiens,IC50,uM,177.0
4974,15073096,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353402,=,nM,9000000.0,CHEMBL203,Homo sapiens,IC50,uM,9000.0
4975,15073098,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353403,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4976,15073100,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353403,=,nM,357000.0,CHEMBL203,Homo sapiens,IC50,uM,357.0
4977,15073144,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353404,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
4978,15073146,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353404,=,nM,145000.0,CHEMBL203,Homo sapiens,IC50,uM,145.0
4979,15073196,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353405,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
4980,15073198,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353405,=,nM,938000.0,CHEMBL203,Homo sapiens,IC50,uM,938.0
4981,15073247,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353406,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
4982,15073249,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353406,=,nM,46000.0,CHEMBL203,Homo sapiens,IC50,uM,46.0
4983,15073264,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353407,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4984,15073266,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353407,=,nM,58000.0,CHEMBL203,Homo sapiens,IC50,uM,58.0
4985,15073278,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353408,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
4986,15073280,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353408,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
4987,15077745,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353409,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
4988,15077747,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353409,=,nM,71000.0,CHEMBL203,Homo sapiens,IC50,uM,71.0
4989,15077759,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353411,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
4990,15077761,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353411,=,nM,33000.0,CHEMBL203,Homo sapiens,IC50,uM,33.0
4991,15077782,CHEMBL3389020,Inhibition of EGFR L858R/T970M double mutant phosphorylation in human NCI-H1975 cells after 2 hrs by fluorescence assay,B,CHEMBL3353412,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
4992,15077784,CHEMBL3389022,Inhibition of wild type EGFR phosphorylation in human LoVo cells after 2 hrs by fluorescence assay,B,CHEMBL3353412,=,nM,786000.0,CHEMBL203,Homo sapiens,IC50,uM,786.0
4993,15078039,CHEMBL3384643,Inhibition of EGFR (unknown origin),B,CHEMBL3358006,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
4994,15105145,CHEMBL3382433,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,B,CHEMBL3335244,=,nM,88670.0,CHEMBL203,Homo sapiens,IC50,uM,88.67
4995,15105146,CHEMBL3382433,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,B,CHEMBL3335245,=,nM,76700.0,CHEMBL203,Homo sapiens,IC50,uM,76.7
4996,15105147,CHEMBL3382433,Inhibition of EGFR (unknown origin) expressed in HEK293 cells assessed as decrease in phosphorylation by chemiluminescence assay,B,CHEMBL44,=,nM,25120.0,CHEMBL203,Homo sapiens,IC50,uM,25.12
4997,15112212,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL939,=,nM,1730.0,CHEMBL203,Homo sapiens,IC50,nM,1730.0
4998,15112213,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.97,CHEMBL203,Homo sapiens,IC50,nM,0.97
4999,15112214,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357654,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3
5000,15112215,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357652,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
5001,15112216,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357650,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
5002,15112217,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357649,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
5003,15112218,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357647,=,nM,37.9,CHEMBL203,Homo sapiens,IC50,nM,37.9
5004,15112219,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357645,=,nM,16.4,CHEMBL203,Homo sapiens,IC50,nM,16.4
5005,15112220,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357643,=,nM,59.8,CHEMBL203,Homo sapiens,IC50,nM,59.8
5006,15112221,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357642,=,nM,25.8,CHEMBL203,Homo sapiens,IC50,nM,25.8
5007,15112222,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357641,=,nM,5.52,CHEMBL203,Homo sapiens,IC50,nM,5.52
5008,15112223,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357640,=,nM,42.9,CHEMBL203,Homo sapiens,IC50,nM,42.9
5009,15112224,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357639,=,nM,21.3,CHEMBL203,Homo sapiens,IC50,nM,21.3
5010,15112225,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357637,=,nM,3.77,CHEMBL203,Homo sapiens,IC50,nM,3.77
5011,15112226,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357635,=,nM,14.5,CHEMBL203,Homo sapiens,IC50,nM,14.5
5012,15112227,CHEMBL3385195,Inhibition of wild type EGFR T790M mutant (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357634,=,nM,6.67,CHEMBL203,Homo sapiens,IC50,nM,6.67
5013,15112228,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL939,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
5014,15112229,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
5015,15112230,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357655,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5016,15112231,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357654,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
5017,15112232,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357653,=,nM,11.2,CHEMBL203,Homo sapiens,IC50,nM,11.2
5018,15112233,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357652,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
5019,15112234,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357651,=,nM,9.5,CHEMBL203,Homo sapiens,IC50,nM,9.5
5020,15112235,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357650,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
5021,15112236,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3352869,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
5022,15112237,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357649,=,nM,1.56,CHEMBL203,Homo sapiens,IC50,nM,1.56
5023,15112238,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357648,=,nM,39.2,CHEMBL203,Homo sapiens,IC50,nM,39.2
5024,15112239,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357647,=,nM,12.9,CHEMBL203,Homo sapiens,IC50,nM,12.9
5025,15112240,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357646,=,nM,2.55,CHEMBL203,Homo sapiens,IC50,nM,2.55
5026,15112241,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357645,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
5027,15112242,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357644,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
5028,15112243,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357643,=,nM,0.53,CHEMBL203,Homo sapiens,IC50,nM,0.53
5029,15112244,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357642,=,nM,0.31,CHEMBL203,Homo sapiens,IC50,nM,0.31
5030,15112245,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357641,=,nM,0.16,CHEMBL203,Homo sapiens,IC50,nM,0.16
5031,15112246,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357640,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5032,15112247,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357639,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
5033,15112248,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357638,=,nM,0.89,CHEMBL203,Homo sapiens,IC50,nM,0.89
5034,15112249,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357637,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
5035,15112250,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357636,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
5036,15112251,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357635,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
5037,15112252,CHEMBL3385194,Inhibition of wild type EGFR (unknown origin) incubated for 5 mins by HTRF assay,B,CHEMBL3357634,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
5038,15118440,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
5039,15118441,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325480,=,nM,16700.0,CHEMBL203,Homo sapiens,IC50,uM,16.7
5040,15118442,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325479,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
5041,15118443,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325478,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
5042,15118444,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325477,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
5043,15118445,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325476,=,nM,8100.0,CHEMBL203,Homo sapiens,IC50,uM,8.1
5044,15118446,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325475,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
5045,15118447,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325474,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
5046,15118448,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325473,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
5047,15118449,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325472,=,nM,18300.0,CHEMBL203,Homo sapiens,IC50,uM,18.3
5048,15118450,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325471,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
5049,15118451,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3325470,=,nM,10400.0,CHEMBL203,Homo sapiens,IC50,uM,10.4
5050,15118452,CHEMBL3375023,Inhibition of histidine-tagged recombinant EGFR cytoplasmic domain (amino acids 645-1186) (unknown origin) expressed in Sf9 cells assessed as reduction in enzyme autophosphorylation by DELFIA/time-resolved fluorometry,B,CHEMBL3327179,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
5051,15130258,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL554,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
5052,15130259,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344221,=,nM,30.4,CHEMBL203,Homo sapiens,IC50,nM,30.4
5053,15130260,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344220,=,nM,13.5,CHEMBL203,Homo sapiens,IC50,nM,13.5
5054,15130261,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344219,=,nM,110.2,CHEMBL203,Homo sapiens,IC50,nM,110.2
5055,15130262,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344218,=,nM,92.8,CHEMBL203,Homo sapiens,IC50,nM,92.8
5056,15130263,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344217,=,nM,89.6,CHEMBL203,Homo sapiens,IC50,nM,89.6
5057,15130264,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344216,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
5058,15130265,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344215,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
5059,15130266,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344214,=,nM,28.7,CHEMBL203,Homo sapiens,IC50,nM,28.7
5060,15130267,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344213,=,nM,39.2,CHEMBL203,Homo sapiens,IC50,nM,39.2
5061,15130268,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344212,=,nM,77.2,CHEMBL203,Homo sapiens,IC50,nM,77.2
5062,15130269,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344211,=,nM,14.7,CHEMBL203,Homo sapiens,IC50,nM,14.7
5063,15130270,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344208,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
5064,15130271,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344210,=,nM,34.8,CHEMBL203,Homo sapiens,IC50,nM,34.8
5065,15130272,CHEMBL3385740,Inhibition of HER1 (unknown origin) assessed as reduction in autophosphorylation by ELISA method,B,CHEMBL3344209,=,nM,17.6,CHEMBL203,Homo sapiens,IC50,nM,17.6
5066,15139266,CHEMBL3385132,Inhibition of EGFR (unknown origin),B,CHEMBL1230609,=,nM,2990.0,CHEMBL203,Homo sapiens,IC50,nM,2990.0
5067,15146897,CHEMBL3395991,Inhibition of human full length HER1 assessed as phosphorylation state by ELISA assay,B,CHEMBL3393072,=,nM,8490.0,CHEMBL203,Homo sapiens,IC50,uM,8.49
5068,15146899,CHEMBL3395991,Inhibition of human full length HER1 assessed as phosphorylation state by ELISA assay,B,CHEMBL1365395,=,nM,3920.0,CHEMBL203,Homo sapiens,IC50,uM,3.92
5069,15156222,CHEMBL3399407,Inhibition of EGFR (unknown origin),B,CHEMBL3397275,=,nM,1210.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.21
5070,15156223,CHEMBL3399407,Inhibition of EGFR (unknown origin),B,CHEMBL3397276,=,nM,950.0,CHEMBL203,Homo sapiens,IC50,umol/L,0.95
5071,15156264,CHEMBL3399407,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,umol/L,0.03
5072,15175179,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3297898,=,nM,68.2,CHEMBL203,Homo sapiens,IC50,nM,68.2
5073,15175203,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403513,=,nM,226.4,CHEMBL203,Homo sapiens,IC50,nM,226.4
5074,15175217,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403512,=,nM,298.2,CHEMBL203,Homo sapiens,IC50,nM,298.2
5075,15175245,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403510,=,nM,90.3,CHEMBL203,Homo sapiens,IC50,nM,90.3
5076,15175259,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403509,=,nM,162.3,CHEMBL203,Homo sapiens,IC50,nM,162.3
5077,15176258,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403514,=,nM,306.6,CHEMBL203,Homo sapiens,IC50,nM,306.6
5078,15176332,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403515,=,nM,103.2,CHEMBL203,Homo sapiens,IC50,nM,103.2
5079,15176360,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403517,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
5080,15176435,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL3403518,=,nM,102.2,CHEMBL203,Homo sapiens,IC50,nM,102.2
5081,15176475,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL553,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
5082,15176494,CHEMBL3404061,Inhibition of EGFR in human A431 cells compound pretreated for 60 min before EGF stimulation for 10 mins by phosphotyrosine ELISA cytoblot method,B,CHEMBL535,=,nM,172.1,CHEMBL203,Homo sapiens,IC50,nM,172.1
5083,15197519,CHEMBL3412565,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,B,CHEMBL3409484,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
5084,15197520,CHEMBL3412565,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,B,CHEMBL3409483,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
5085,15197521,CHEMBL3412565,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,B,CHEMBL3409482,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
5086,15197522,CHEMBL3412565,Inhibition of EGFR intracellular domain (unknown origin) purified from a baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKK-CONH2 as substrate after 10 mins by scintillation counting in presence of [gamma-33P]ATP,B,CHEMBL30432,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
5087,15229658,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL3416636,=,nM,372.0,CHEMBL203,Homo sapiens,IC50,nM,372.0
5088,15229659,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL3416635,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
5089,15229660,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL3416634,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,nM,71.0
5090,15229661,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL3416633,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,nM,69.0
5091,15229662,CHEMBL3418214,Inhibition of EGFR (unknown origin) after 40 mins by scintillation proximity assay,B,CHEMBL554,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
5092,15229663,CHEMBL3418213,Inhibition of EGFR (unknown origin) using Poly(Glu:Tyr) 4:1 as substrate after 12 to 16 hrs,B,CHEMBL939,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,nM,380.0
5093,15229665,CHEMBL3418213,Inhibition of EGFR (unknown origin) using Poly(Glu:Tyr) 4:1 as substrate after 12 to 16 hrs,B,CHEMBL3416631,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,nM,600.0
5094,15229666,CHEMBL3418213,Inhibition of EGFR (unknown origin) using Poly(Glu:Tyr) 4:1 as substrate after 12 to 16 hrs,B,CHEMBL3416630,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,nM,600.0
5095,15229667,CHEMBL3418212,Inhibition of human GST-tagged EGFR expressed in baculovirus-infected insect Sf9 cells using biotinylating polyGluTyr as substrate after 1 hr by scintillation counting analysis in presence of [gamma-33P]-ATP,B,CHEMBL3416629,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
5096,15229668,CHEMBL3418212,Inhibition of human GST-tagged EGFR expressed in baculovirus-infected insect Sf9 cells using biotinylating polyGluTyr as substrate after 1 hr by scintillation counting analysis in presence of [gamma-33P]-ATP,B,CHEMBL3416628,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5097,15229669,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL554,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5098,15229670,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416627,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,nM,220.0
5099,15229671,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416626,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
5100,15229672,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416625,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5101,15229673,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416624,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0
5102,15229674,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416623,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
5103,15229675,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416622,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
5104,15229676,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416437,=,nM,153.0,CHEMBL203,Homo sapiens,IC50,nM,153.0
5105,15229677,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3414594,=,nM,183.0,CHEMBL203,Homo sapiens,IC50,nM,183.0
5106,15229678,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416598,=,nM,275.0,CHEMBL203,Homo sapiens,IC50,nM,275.0
5107,15229679,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416597,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
5108,15229680,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416596,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
5109,15229681,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416595,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
5110,15229682,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416594,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5111,15229683,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416593,=,nM,629.0,CHEMBL203,Homo sapiens,IC50,nM,629.0
5112,15229684,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416592,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5113,15229685,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416591,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
5114,15229686,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416590,=,nM,1860.0,CHEMBL203,Homo sapiens,IC50,nM,1860.0
5115,15229687,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416447,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5116,15229688,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416446,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
5117,15229693,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416441,=,nM,257.0,CHEMBL203,Homo sapiens,IC50,nM,257.0
5118,15229695,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416439,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
5119,15229696,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416438,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
5120,15229697,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416621,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
5121,15229698,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416620,=,nM,415.0,CHEMBL203,Homo sapiens,IC50,nM,415.0
5122,15229699,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416619,=,nM,1374.0,CHEMBL203,Homo sapiens,IC50,nM,1374.0
5123,15229701,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416617,=,nM,2079.0,CHEMBL203,Homo sapiens,IC50,nM,2079.0
5124,15229702,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416616,=,nM,7904.0,CHEMBL203,Homo sapiens,IC50,nM,7904.0
5125,15229704,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416614,=,nM,3883.0,CHEMBL203,Homo sapiens,IC50,nM,3883.0
5126,15229706,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416612,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
5127,15229710,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416608,=,nM,183.0,CHEMBL203,Homo sapiens,IC50,nM,183.0
5128,15229712,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416606,=,nM,262.0,CHEMBL203,Homo sapiens,IC50,nM,262.0
5129,15229713,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416605,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
5130,15229715,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416603,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
5131,15229716,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416602,=,nM,156.0,CHEMBL203,Homo sapiens,IC50,nM,156.0
5132,15229718,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416600,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
5133,15229719,CHEMBL3418211,Inhibition of EGFR (unknown origin) by Z'-LYTE assay,B,CHEMBL3416599,=,nM,241.0,CHEMBL203,Homo sapiens,IC50,nM,241.0
5134,15253807,CHEMBL3429887,Inhibition of human EGFR,B,CHEMBL3426225,=,nM,3518.0,CHEMBL203,Homo sapiens,IC50,uM,3.518
5135,15257009,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425655,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
5136,15257010,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425656,=,nM,4800.0,CHEMBL203,Homo sapiens,IC50,uM,4.8
5137,15257015,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425661,=,nM,8700.0,CHEMBL203,Homo sapiens,IC50,uM,8.7
5138,15257018,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425664,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
5139,15257618,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425672,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
5140,15257620,CHEMBL3430219,Inhibition of wild type N-terminal His6-tagged human EGFR kinase domain (702 to 1016 residues) expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
5141,15257621,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425655,=,nM,540.0,CHEMBL203,Homo sapiens,IC50,uM,0.54
5142,15257622,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425656,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83
5143,15257623,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425657,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
5144,15257624,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425658,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5145,15257626,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425660,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5146,15257627,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425661,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
5147,15257628,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425662,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
5148,15257629,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425663,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
5149,15257630,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425664,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
5150,15257631,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425665,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
5151,15257632,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425666,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
5152,15257633,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425667,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
5153,15257635,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425669,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
5154,15257637,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425671,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,uM,0.49
5155,15257638,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425672,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
5156,15257639,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425673,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
5157,15257640,CHEMBL3430220,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,=,nM,0.42,CHEMBL203,Homo sapiens,IC50,uM,0.00042
5158,15257641,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425655,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
5159,15257642,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425656,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
5160,15257643,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425657,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
5161,15257644,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425658,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
5162,15257646,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425660,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
5163,15257647,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425661,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,uM,0.037
5164,15257648,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425662,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
5165,15257649,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425663,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
5166,15257650,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425664,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083
5167,15257651,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425665,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
5168,15257652,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425666,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
5169,15257653,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425667,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
5170,15257654,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425668,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
5171,15257655,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425669,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
5172,15257656,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425670,=,nM,8900.0,CHEMBL203,Homo sapiens,IC50,uM,8.9
5173,15257657,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425671,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
5174,15257658,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425672,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83
5175,15257659,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL3425673,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
5176,15257660,CHEMBL3430221,Inhibition of GST-tagged human recombinant EGFR catalytic domain (668 to 1210 amino acids) T790M/L858R mutant expressed in Sf9 cells pre-incubated for 30 mins before ATP and substrate addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,=,nM,0.19,CHEMBL203,Homo sapiens,IC50,uM,0.00019
5177,15628370,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586189,=,nM,13200.0,CHEMBL203,Homo sapiens,IC50,uM,13.2
5178,15628371,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586185,=,nM,7600.0,CHEMBL203,Homo sapiens,IC50,uM,7.6
5179,15628372,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586179,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8
5180,15628373,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586178,=,nM,7400.0,CHEMBL203,Homo sapiens,IC50,uM,7.4
5181,15628374,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586177,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
5182,15628375,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586176,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5
5183,15628376,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586175,=,nM,31400.0,CHEMBL203,Homo sapiens,IC50,uM,31.4
5184,15628377,CHEMBL3588418,Inhibition of recombinant EGFR (unknown origin) assessed as inhibition of autophosphorylation after 1 hr by DELFIA/Time-resolved fluorometry,B,CHEMBL3586174,=,nM,8100.0,CHEMBL203,Homo sapiens,IC50,uM,8.1
5185,15648708,CHEMBL3594721,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL1230609,=,nM,2990.0,CHEMBL203,Homo sapiens,IC50,nM,2990.0
5186,15666991,CHEMBL3603321,Inhibition of wild type EGFR (unknown origin) by Z'-Lyte assay,B,CHEMBL3601223,=,nM,409.0,CHEMBL203,Homo sapiens,IC50,nM,409.0
5187,15684498,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604927,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
5188,15684506,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604935,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
5189,15685106,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604936,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
5190,15685107,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604937,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
5191,15685109,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604939,=,nM,6700.0,CHEMBL203,Homo sapiens,IC50,uM,6.7
5192,15685110,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604940,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
5193,15685111,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604941,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
5194,15685112,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604943,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
5195,15685113,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3545308,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
5196,15685114,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5197,15685115,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
5198,15685117,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604917,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
5199,15685119,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604920,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
5200,15685121,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604922,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
5201,15685124,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604915,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
5202,15685127,CHEMBL3606403,Inhibition of wild type EGFR (unknown origin) expressed in Sf9 cells pre-incubated for 30 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604912,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
5203,15685133,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604919,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
5204,15685134,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604942,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
5205,15685135,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL1232944,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5206,15685136,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604910,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
5207,15685137,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604911,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
5208,15685138,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604912,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
5209,15685141,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604915,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5210,15685143,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604917,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
5211,15685144,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604918,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
5212,15685145,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604920,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
5213,15685146,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604921,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
5214,15685147,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604922,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5215,15685149,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604924,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5216,15685150,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604925,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5217,15685151,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604926,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5218,15685152,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604927,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
5219,15685153,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604928,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5220,15685155,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604930,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
5221,15685156,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604931,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5222,15685158,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604933,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
5223,15685160,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604935,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
5224,15685161,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604936,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
5225,15685162,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604937,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
5226,15685164,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604939,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
5227,15685165,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604940,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
5228,15685166,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604941,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
5229,15685167,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604943,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5230,15685168,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3545308,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
5231,15685169,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5232,15685170,CHEMBL3606404,Inhibition of EGFR L858R mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5233,15685171,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604919,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
5234,15685172,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604942,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
5235,15685173,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL1232944,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
5236,15685174,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604910,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
5237,15685175,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604911,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
5238,15685176,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604912,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
5239,15685179,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604915,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
5240,15685181,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604917,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
5241,15685183,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604920,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
5242,15685184,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604921,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
5243,15685185,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604922,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
5244,15685188,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604925,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
5245,15685189,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604926,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
5246,15685190,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604927,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
5247,15685191,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604928,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
5248,15685192,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604929,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
5249,15685193,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604930,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
5250,15685194,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604931,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
5251,15685196,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604933,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
5252,15685199,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604936,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
5253,15685200,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604937,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
5254,15685201,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604938,=,nM,8600.0,CHEMBL203,Homo sapiens,IC50,uM,8.6
5255,15685202,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604939,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
5256,15685203,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604940,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
5257,15685204,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604941,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
5258,15685205,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3604943,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5259,15685206,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL3545308,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
5260,15685207,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL939,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
5261,15685208,CHEMBL3606405,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in Sf9 cells pre-incubated for 60 mins before substrate and ATP addition by homogeneous time-resolved FRET assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5262,15689330,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608434,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5263,15689331,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608433,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5264,15689332,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608432,=,nM,6138.0,CHEMBL203,Homo sapiens,IC50,nM,6138.0
5265,15689333,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608431,=,nM,387.0,CHEMBL203,Homo sapiens,IC50,nM,387.0
5266,15689334,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608430,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
5267,15689335,CHEMBL3609987,Inhibition of EGFR L858R/T790M double mutant in human H1975 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608429,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5268,15689338,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608429,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5269,15689339,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608430,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5270,15689340,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608431,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5271,15689342,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608433,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5272,15689343,CHEMBL3609989,Inhibition of EGFR L858R mutant in human H3255 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608434,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5273,15689344,CHEMBL3609990,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608429,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5274,15689345,CHEMBL3609990,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608430,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
5275,15689347,CHEMBL3609990,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608432,=,nM,2127.0,CHEMBL203,Homo sapiens,IC50,nM,2127.0
5276,15689348,CHEMBL3609990,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608433,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5277,15689349,CHEMBL3609990,Inhibition of EGFR deletion/T790M mutant in human PC9-DRH cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608434,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5278,15689350,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608429,=,nM,178.0,CHEMBL203,Homo sapiens,IC50,nM,178.0
5279,15689351,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608430,=,nM,181.0,CHEMBL203,Homo sapiens,IC50,nM,181.0
5280,15689352,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608431,=,nM,4192.0,CHEMBL203,Homo sapiens,IC50,nM,4192.0
5281,15689353,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608432,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
5282,15689354,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608433,=,nM,142.0,CHEMBL203,Homo sapiens,IC50,nM,142.0
5283,15689355,CHEMBL3609991,Inhibition of wild type EGFR in human A549 cells assessed as inhibition of phosphorylation at Y1068 after 2 hrs by sandwich ELISA method,B,CHEMBL3608434,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,nM,194.0
5284,15698265,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612585,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
5285,15698267,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612587,=,nM,7.3,CHEMBL203,Homo sapiens,IC50,uM,0.0073
5286,15698270,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612590,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
5287,15698271,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612591,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
5288,15698272,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612592,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
5289,15698273,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612593,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,uM,0.053
5290,15698274,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612594,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
5291,15698275,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612595,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,uM,0.0087
5292,15698276,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612596,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
5293,15698279,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612598,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,uM,0.66
5294,15698280,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612599,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
5295,15698281,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL553,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
5296,15698597,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
5297,15698598,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL3613691,=,nM,5283.0,CHEMBL203,Homo sapiens,IC50,uM,5.283
5298,15698599,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL3613695,=,nM,4824.0,CHEMBL203,Homo sapiens,IC50,uM,4.824
5299,15698600,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL91867,=,nM,0.25,CHEMBL203,Homo sapiens,IC50,pM,250.0
5300,15698601,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,pM,29.0
5301,15698602,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL607707,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
5302,15698603,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
5303,15698604,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL939,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
5304,15698605,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5305,15698606,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL31965,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
5306,15698607,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL3613702,=,nM,0.037,CHEMBL203,Homo sapiens,IC50,nM,0.037
5307,15698608,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL115187,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
5308,15698609,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL157128,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
5309,15698610,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL220037,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
5310,15698611,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL30973,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,uM,0.31
5311,15698612,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL281300,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,uM,0.59
5312,15698613,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL327023,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
5313,15698614,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL113900,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
5314,15698615,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL441279,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
5315,15698616,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL115440,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
5316,15698617,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL283682,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
5317,15698618,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL114593,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
5318,15698619,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL326811,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62
5319,15698620,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL118000,=,nM,2290.0,CHEMBL203,Homo sapiens,IC50,uM,2.29
5320,15698621,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL114392,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
5321,15698670,CHEMBL3616083,Inhibition of epidermal growth factor receptor kinase (unknown origin) using [33P]-ATP after 20 to 30 mins by radiometric assay,B,CHEMBL323630,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
5322,15711353,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612561,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
5323,15711354,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612562,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
5324,15711355,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612563,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
5325,15711356,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612564,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
5326,15711359,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612567,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,uM,0.34
5327,15711396,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612570,=,nM,560.0,CHEMBL203,Homo sapiens,IC50,uM,0.56
5328,15711397,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612571,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
5329,15711398,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612572,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
5330,15711399,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612573,=,nM,440.0,CHEMBL203,Homo sapiens,IC50,uM,0.44
5331,15711400,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612574,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
5332,15711401,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612575,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
5333,15711404,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612578,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
5334,15711406,CHEMBL3614855,Inhibition of EGFR (unknown origin) assessed as incorporation of 33Pi after 1 hr by ELISA,B,CHEMBL3612580,=,nM,7500.0,CHEMBL203,Homo sapiens,IC50,uM,7.5
5335,15723432,CHEMBL3620024,Inhibition of EGFR (unknown origin) after 40 mins by scintillation counting analysis,B,CHEMBL388978,=,nM,283.0,CHEMBL203,Homo sapiens,IC50,nM,283.0
5336,15743407,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3621220,=,nM,102.2,CHEMBL203,Homo sapiens,IC50,nM,102.2
5337,15743408,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622617,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
5338,15743410,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622619,=,nM,115.1,CHEMBL203,Homo sapiens,IC50,nM,115.1
5339,15743411,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622620,=,nM,195.8,CHEMBL203,Homo sapiens,IC50,nM,195.8
5340,15743412,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622621,=,nM,560.4,CHEMBL203,Homo sapiens,IC50,nM,560.4
5341,15743413,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622622,=,nM,72.2,CHEMBL203,Homo sapiens,IC50,nM,72.2
5342,15743432,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622679,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
5343,15743433,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622678,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
5344,15743434,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622677,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
5345,15743435,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622676,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
5346,15743436,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622675,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
5347,15743437,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622674,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
5348,15743438,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622673,=,nM,6.1,CHEMBL203,Homo sapiens,IC50,nM,6.1
5349,15743439,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622672,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
5350,15743440,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622671,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
5351,15743441,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622670,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5352,15743442,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622669,=,nM,141.0,CHEMBL203,Homo sapiens,IC50,nM,141.0
5353,15743443,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622668,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
5354,15743444,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622667,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
5355,15743445,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622666,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
5356,15743446,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622665,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
5357,15743447,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622664,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
5358,15743452,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622659,=,nM,356.6,CHEMBL203,Homo sapiens,IC50,nM,356.6
5359,15743453,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622658,=,nM,109.4,CHEMBL203,Homo sapiens,IC50,nM,109.4
5360,15743456,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622655,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5361,15743457,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622654,=,nM,8.9,CHEMBL203,Homo sapiens,IC50,nM,8.9
5362,15743458,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622653,=,nM,26.9,CHEMBL203,Homo sapiens,IC50,nM,26.9
5363,15743459,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622652,=,nM,520.2,CHEMBL203,Homo sapiens,IC50,nM,520.2
5364,15743460,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622651,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
5365,15743461,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622650,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
5366,15743462,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL2110732,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
5367,15743463,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL1173655,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5368,15743464,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622649,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
5369,15743465,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622648,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5370,15743466,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622647,=,nM,147.4,CHEMBL203,Homo sapiens,IC50,nM,147.4
5371,15743468,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622645,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
5372,15743469,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622644,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5373,15743470,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622643,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
5374,15743471,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622642,=,nM,133.9,CHEMBL203,Homo sapiens,IC50,nM,133.9
5375,15743472,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622641,=,nM,510.2,CHEMBL203,Homo sapiens,IC50,nM,510.2
5376,15743473,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622640,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5377,15743474,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622639,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
5378,15743475,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622638,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
5379,15743476,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622637,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
5380,15743477,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622636,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,nM,91.0
5381,15743479,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622634,=,nM,102.3,CHEMBL203,Homo sapiens,IC50,nM,102.3
5382,15743480,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622633,=,nM,573.6,CHEMBL203,Homo sapiens,IC50,nM,573.6
5383,15743481,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622632,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
5384,15743483,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622630,=,nM,121.1,CHEMBL203,Homo sapiens,IC50,nM,121.1
5385,15743484,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622629,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
5386,15743485,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622628,=,nM,167.3,CHEMBL203,Homo sapiens,IC50,nM,167.3
5387,15743487,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622626,=,nM,104.7,CHEMBL203,Homo sapiens,IC50,nM,104.7
5388,15743488,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622625,=,nM,32.2,CHEMBL203,Homo sapiens,IC50,nM,32.2
5389,15743489,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622624,=,nM,100.1,CHEMBL203,Homo sapiens,IC50,nM,100.1
5390,15743490,CHEMBL3625155,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL3622623,=,nM,134.9,CHEMBL203,Homo sapiens,IC50,nM,134.9
5391,15745745,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL939,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
5392,15745746,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623278,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
5393,15745747,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623279,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
5394,15745748,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623280,=,nM,166.0,CHEMBL203,Homo sapiens,IC50,nM,166.0
5395,15745749,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623281,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
5396,15745750,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623282,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5397,15745751,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623283,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
5398,15745752,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623284,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
5399,15745753,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623285,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
5400,15745754,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623286,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
5401,15745755,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623287,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
5402,15745756,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623287,=,nM,12.8,CHEMBL203,Homo sapiens,IC50,nM,12.8
5403,15745757,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623288,=,nM,16.9,CHEMBL203,Homo sapiens,IC50,nM,16.9
5404,15745758,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623289,=,nM,21.5,CHEMBL203,Homo sapiens,IC50,nM,21.5
5405,15745759,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623290,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
5406,15745760,CHEMBL3624312,Inhibition of EGFR L858R mutant phosphorylation in human H3255 cells,B,CHEMBL3623291,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
5407,15745892,CHEMBL3624467,Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of Km of ATP,B,CHEMBL3623290,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
5408,15745893,CHEMBL3624468,Inhibition of EGFR L858R mutant (unknown origin) by HTRF assay in presence of 2 mM of ATP,B,CHEMBL3623290,=,nM,7.6,CHEMBL203,Homo sapiens,IC50,nM,7.6
5409,15745894,CHEMBL3624469,Inhibition of EGFR (unknown origin) by HTRF assay in presence of Km of ATP,B,CHEMBL3623290,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
5410,15745895,CHEMBL3624465,Inhibition of EGFR (unknown origin) by HTRF assay in presence of 2 mM of ATP,B,CHEMBL3623290,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,nM,102.0
5411,15745896,CHEMBL3624470,Inhibition of EGFR phosphorylation in human H838 cells,B,CHEMBL3623290,=,nM,64.5,CHEMBL203,Homo sapiens,IC50,nM,64.5
5412,15753804,CHEMBL3630441,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,B,CHEMBL939,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
5413,15753827,CHEMBL3630441,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,B,CHEMBL3628817,=,nM,21560.0,CHEMBL203,Homo sapiens,IC50,uM,21.56
5414,15753887,CHEMBL3630441,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,B,CHEMBL481789,=,nM,4720.0,CHEMBL203,Homo sapiens,IC50,uM,4.72
5415,15753962,CHEMBL3630441,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,B,CHEMBL3628818,=,nM,45700.0,CHEMBL203,Homo sapiens,IC50,uM,45.7
5416,15753985,CHEMBL3630441,Inhibition of EGFR (unknown origin) using omnia tyr peptide 7 substrate by fluorescence assay,B,CHEMBL3628816,=,nM,21180.0,CHEMBL203,Homo sapiens,IC50,uM,21.18
5417,15759234,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL301018,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,nM,400.0
5418,15759235,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL1688539,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
5419,15759236,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628791,=,nM,2980.0,CHEMBL203,Homo sapiens,IC50,nM,2980.0
5420,15759237,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628792,=,nM,1330.0,CHEMBL203,Homo sapiens,IC50,nM,1330.0
5421,15759238,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL2018756,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,nM,900.0
5422,15759242,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628796,=,nM,7710.0,CHEMBL203,Homo sapiens,IC50,nM,7710.0
5423,15759245,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628799,=,nM,3950.0,CHEMBL203,Homo sapiens,IC50,nM,3950.0
5424,15759247,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628800,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,nM,590.0
5425,15760010,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628907,=,nM,1260.0,CHEMBL203,Homo sapiens,IC50,nM,1260.0
5426,15760011,CHEMBL3631055,Inhibition of human EGFR after 1 hr using [gamma-32P]ATP,B,CHEMBL3628906,=,nM,3290.0,CHEMBL203,Homo sapiens,IC50,nM,3290.0
5427,15771533,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633141,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
5428,15771534,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633142,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5429,15771535,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633143,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5430,15771536,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633151,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5431,15771537,CHEMBL3635658,Inhibition of EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells after 60 mins by mesoscale multiplex assay,B,CHEMBL3633152,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5432,15774378,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
5433,15774379,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633942,=,nM,1460.0,CHEMBL203,Homo sapiens,IC50,uM,1.46
5434,15774380,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633941,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
5435,15774381,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633940,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
5436,15774382,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633939,=,nM,3050.0,CHEMBL203,Homo sapiens,IC50,uM,3.05
5437,15774383,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633938,=,nM,445.0,CHEMBL203,Homo sapiens,IC50,uM,0.445
5438,15774385,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3632637,=,nM,1020.0,CHEMBL203,Homo sapiens,IC50,uM,1.02
5439,15774386,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633936,=,nM,812.0,CHEMBL203,Homo sapiens,IC50,uM,0.812
5440,15774388,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633934,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
5441,15774389,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633933,=,nM,227.0,CHEMBL203,Homo sapiens,IC50,uM,0.227
5442,15774390,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633932,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
5443,15774392,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633930,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
5444,15774393,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633929,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
5445,15774394,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633928,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,uM,0.099
5446,15774395,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633775,=,nM,543.0,CHEMBL203,Homo sapiens,IC50,uM,0.543
5447,15774396,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL3633774,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
5448,15774434,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL1614725,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5449,15774436,CHEMBL3636784,Inhibition of EGFR (unknown origin) after 120 mins by HotSpot assay,B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,uM,0.092
5450,16259840,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178352,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5451,16259841,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4113919,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5452,16260061,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699581,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5453,16261131,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699581,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5454,16261214,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699588,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5455,16262068,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699595,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5456,16265086,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699611,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5457,16265515,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699615,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5458,16266034,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699604,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5459,16267165,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699605,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5460,16268251,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699619,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5461,16268426,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674151,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5462,16268827,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699609,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5463,16269238,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699590,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5464,16269750,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680375,=,nM,11.35,CHEMBL203,Homo sapiens,IC50,nM,11.35
5465,16270157,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699598,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5466,16270554,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699616,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
5467,16270851,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678949,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5468,16273830,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678960,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5469,16274043,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699601,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5470,16274402,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699605,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5471,16275284,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL1643971,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5472,16276056,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680374,=,nM,9.87,CHEMBL203,Homo sapiens,IC50,nM,9.87
5473,16278372,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680377,=,nM,18.08,CHEMBL203,Homo sapiens,IC50,nM,18.08
5474,16278740,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678953,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
5475,16280732,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699619,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
5476,16281441,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699593,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5477,16282219,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699583,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5478,16282827,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699582,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5479,16282840,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699599,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
5480,16285332,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699608,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5481,16285836,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699600,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5482,16289091,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699618,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5483,16290260,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699614,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5484,16290285,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699589,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5485,16290567,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678957,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
5486,16290646,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699587,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5487,16292051,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699612,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5488,16292665,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699584,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5489,16293567,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699609,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5490,16293868,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699607,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5491,16293924,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680376,=,nM,45.34,CHEMBL203,Homo sapiens,IC50,nM,45.34
5492,16295360,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699617,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5493,16295833,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699601,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5494,16296917,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699593,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5495,16299253,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699582,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5496,16299320,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL1643971,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5497,16299782,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699596,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5498,16301121,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699584,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5499,16301315,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674152,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5500,16302782,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699614,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5501,16303161,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699607,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5502,16303696,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680373,=,nM,6.44,CHEMBL203,Homo sapiens,IC50,nM,6.44
5503,16303701,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699586,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5504,16304502,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678950,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5505,16304646,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699599,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5506,16305733,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5507,16305808,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699587,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5508,16306473,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699606,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5509,16307681,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699602,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5510,16307831,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3639984,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5511,16307896,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699603,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5512,16308147,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL1643971,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5513,16309679,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699595,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
5514,16310230,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699591,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5515,16312189,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699610,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5516,16312323,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699586,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5517,16314053,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699598,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5518,16315112,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699590,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5519,16315164,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699585,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5520,16316390,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699621,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5521,16318147,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699613,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5522,16318467,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699615,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5523,16319333,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678959,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
5524,16319370,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699606,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5525,16319689,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699597,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5526,16324098,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699585,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5527,16324369,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699594,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5528,16326261,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699621,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5529,16327151,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699589,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5530,16328233,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5531,16328317,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178351,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5532,16328431,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699596,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5533,16329229,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678958,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
5534,16329358,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL1643971,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5535,16329434,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699613,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
5536,16332141,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3545308,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5537,16332455,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699620,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5538,16335936,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3545308,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5539,16336716,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL3680378,=,nM,12.13,CHEMBL203,Homo sapiens,IC50,nM,12.13
5540,16337378,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678954,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5541,16337651,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4111809,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
5542,16338110,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699618,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5543,16338280,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699611,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
5544,16338369,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699612,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5545,16338662,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678955,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
5546,16338892,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3639984,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5547,16338927,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678952,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5548,16340105,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699622,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5549,16340276,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699588,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5550,16340491,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699617,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
5551,16340797,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699592,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5552,16341971,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
5553,16342116,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699600,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5554,16342131,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699591,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5555,16342235,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678951,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5556,16342749,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699597,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5557,16343110,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699610,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5558,16343890,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178350,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5559,16344165,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699603,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5560,16344652,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678956,=,nM,117.0,CHEMBL203,Homo sapiens,IC50,nM,117.0
5561,16346120,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678948,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5562,16346143,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699602,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5563,16346190,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178349,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
5564,16346371,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699608,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5565,16346645,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674148,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5566,16346938,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678946,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5567,16347940,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699604,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5568,16348584,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699583,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
5569,16348924,CHEMBL3707998,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699616,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
5570,16350973,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178368,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
5571,16352077,CHEMBL3705968,"ELISA-Based Kinase Assay: Inhibition of erbB tyrosine kinase activity was assessed using an ELISA-based receptor tyrosine kinase assay. Kinase reactions (50 mM HEPES, pH 7.4, 125 mM NaCl, 10 mM MgCl2, 100 M sodium orthovanadate, 2 mM dithiothreitol, 20 uM ATP, test compound or vehicle control and 1-5 nM GST-erbB per 50 uL reaction) were run in 96-well plates coated with 0.25 mg/ml poly-Glu-Tyr (Sigma). The reactions were incubated for 6 minutes at room temperature while shaking. Kinase reactions were stopped by removal of reaction mixture, then wells were washed with wash buffer comprising 3% Bovine Serum Albumin and 0.1% Tween 20 in Phosphate Buffered Saline (PBS). Phosphorylated tyrosine residues were detected by adding 0.2 g/ml anti-phosphotyrosine antibody (Oncogene Ab-4; 50 L/well) coupled to Horse Radish Peroxidase (HRP) for 25 minutes while shaking at room temperature.",B,CHEMBL2110732,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
5572,16353439,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699622,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
5573,16354332,CHEMBL3706157,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678947,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5574,16355210,CHEMBL3706050,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13xATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM beta-glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at lamda ex360/lamda em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics (R2, 95% confidence interval, absolute sum of squares). Initial velocity (0 minutes to 30 minutes) from each reaction was determined from the slope of a plot of relative fluorescence units vs time (minutes) and then plotted against inhibitor concentration to estimate IC50 from log [Inhibitor] vs Response, Variable Slope model in GraphPad Prism from GraphPad Software (San Diego, Calif.).",B,CHEMBL3699613,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5575,16390277,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3735952,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
5576,16390278,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3736508,=,nM,882.0,CHEMBL203,Homo sapiens,IC50,uM,0.882
5577,16390279,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734877,=,nM,2360.0,CHEMBL203,Homo sapiens,IC50,uM,2.36
5578,16390280,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3736183,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
5579,16390281,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734933,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,uM,0.29
5580,16390282,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3735958,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
5581,16390283,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734934,=,nM,2530.0,CHEMBL203,Homo sapiens,IC50,uM,2.53
5582,16390284,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3735474,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
5583,16390285,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734786,=,nM,1040.0,CHEMBL203,Homo sapiens,IC50,uM,1.04
5584,16390292,CHEMBL3737957,Inhibition of EGFR phosphorylation in human NCI-H292 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL553,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
5585,16390300,CHEMBL3737962,Inhibition of EGFR T790M/del (746 to 750) deletion mutant phosphorylation in erlotinib-resistant human PC9 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3736121,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
5586,16390301,CHEMBL3737962,Inhibition of EGFR T790M/del (746 to 750) deletion mutant phosphorylation in erlotinib-resistant human PC9 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734988,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
5587,16390322,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3736121,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
5588,16390323,CHEMBL3737956,Inhibition of EGFR phosphorylation in human NCI-H1975 cells preincubated for 1 hr followed by stimulation with EGF for 8 mins by electrochemiluminescent immunoassay,B,CHEMBL3734988,=,nM,261000.0,CHEMBL203,Homo sapiens,IC50,uM,261.0
5589,16395721,CHEMBL3745460,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL3740144,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
5590,16395722,CHEMBL3745460,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL3741473,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5591,16395723,CHEMBL3745460,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL3740910,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
5592,16395724,CHEMBL3745460,Inhibition of wild-type EGFR tyrosine kinase (unknown origin) assessed as ATP level by luminescence analysis,B,CHEMBL939,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
5593,16398677,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3739750,=,nM,4670.0,CHEMBL203,Homo sapiens,IC50,uM,4.67
5594,16398678,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740247,=,nM,9190.0,CHEMBL203,Homo sapiens,IC50,uM,9.19
5595,16398679,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3739587,=,nM,4480.0,CHEMBL203,Homo sapiens,IC50,uM,4.48
5596,16398680,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740131,=,nM,3220.0,CHEMBL203,Homo sapiens,IC50,uM,3.22
5597,16398681,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3742349,=,nM,7880.0,CHEMBL203,Homo sapiens,IC50,uM,7.88
5598,16398682,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3741526,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
5599,16398683,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740930,=,nM,3560.0,CHEMBL203,Homo sapiens,IC50,uM,3.56
5600,16398684,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740713,=,nM,4490.0,CHEMBL203,Homo sapiens,IC50,uM,4.49
5601,16398685,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740385,=,nM,3780.0,CHEMBL203,Homo sapiens,IC50,uM,3.78
5602,16398686,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3741069,=,nM,2560.0,CHEMBL203,Homo sapiens,IC50,uM,2.56
5603,16398687,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740582,=,nM,3890.0,CHEMBL203,Homo sapiens,IC50,uM,3.89
5604,16398688,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3742060,=,nM,5430.0,CHEMBL203,Homo sapiens,IC50,uM,5.43
5605,16398689,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3741655,=,nM,2550.0,CHEMBL203,Homo sapiens,IC50,uM,2.55
5606,16398690,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740923,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
5607,16398691,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3739586,=,nM,3450.0,CHEMBL203,Homo sapiens,IC50,uM,3.45
5608,16398692,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3742200,=,nM,4390.0,CHEMBL203,Homo sapiens,IC50,uM,4.39
5609,16398693,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740003,=,nM,2890.0,CHEMBL203,Homo sapiens,IC50,uM,2.89
5610,16398694,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3741960,=,nM,3670.0,CHEMBL203,Homo sapiens,IC50,uM,3.67
5611,16398695,CHEMBL3744325,Inhibition of EGFR (unknown origin) by microfluidic assay relative to control,B,CHEMBL3740492,=,nM,5100.0,CHEMBL203,Homo sapiens,IC50,uM,5.1
5612,16404680,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740577,=,nM,860.0,CHEMBL203,Homo sapiens,IC50,uM,0.86
5613,16404681,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3739812,=,nM,1510.0,CHEMBL203,Homo sapiens,IC50,uM,1.51
5614,16404682,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740614,=,nM,11570.0,CHEMBL203,Homo sapiens,IC50,uM,11.57
5615,16404683,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741245,=,nM,1680.0,CHEMBL203,Homo sapiens,IC50,uM,1.68
5616,16404684,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740257,=,nM,2270.0,CHEMBL203,Homo sapiens,IC50,uM,2.27
5617,16404685,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741796,=,nM,5670.0,CHEMBL203,Homo sapiens,IC50,uM,5.67
5618,16404686,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741436,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
5619,16404687,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741762,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,uM,0.68
5620,16404688,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3742128,=,nM,2520.0,CHEMBL203,Homo sapiens,IC50,uM,2.52
5621,16404690,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741219,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
5622,16404691,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740102,=,nM,2350.0,CHEMBL203,Homo sapiens,IC50,uM,2.35
5623,16404692,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740907,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
5624,16404693,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741324,=,nM,2380.0,CHEMBL203,Homo sapiens,IC50,uM,2.38
5625,16404694,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3742146,=,nM,4320.0,CHEMBL203,Homo sapiens,IC50,uM,4.32
5626,16404695,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL939,=,nM,12720.0,CHEMBL203,Homo sapiens,IC50,uM,12.72
5627,16404696,CHEMBL3743364,Inhibition of human recombinant EGFR T790M/L858R double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL1229592,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
5628,16404697,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740577,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,uM,0.57
5629,16404698,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3739812,=,nM,1910.0,CHEMBL203,Homo sapiens,IC50,uM,1.91
5630,16404700,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741245,=,nM,1290.0,CHEMBL203,Homo sapiens,IC50,uM,1.29
5631,16404703,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741436,=,nM,3270.0,CHEMBL203,Homo sapiens,IC50,uM,3.27
5632,16404704,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741762,=,nM,2230.0,CHEMBL203,Homo sapiens,IC50,uM,2.23
5633,16404705,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3742128,=,nM,5110.0,CHEMBL203,Homo sapiens,IC50,uM,5.11
5634,16404707,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741219,=,nM,760.0,CHEMBL203,Homo sapiens,IC50,uM,0.76
5635,16404709,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740907,=,nM,1250.0,CHEMBL203,Homo sapiens,IC50,uM,1.25
5636,16404712,CHEMBL3743365,Inhibition of human recombinant EGFR T790M/delE746_A750 double mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL939,=,nM,10620.0,CHEMBL203,Homo sapiens,IC50,uM,10.62
5637,16404714,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740577,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,uM,1.12
5638,16404715,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3739812,=,nM,4740.0,CHEMBL203,Homo sapiens,IC50,uM,4.74
5639,16404717,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741245,=,nM,2530.0,CHEMBL203,Homo sapiens,IC50,uM,2.53
5640,16404720,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741436,=,nM,1560.0,CHEMBL203,Homo sapiens,IC50,uM,1.56
5641,16404721,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741762,=,nM,1490.0,CHEMBL203,Homo sapiens,IC50,uM,1.49
5642,16404722,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3742128,=,nM,2510.0,CHEMBL203,Homo sapiens,IC50,uM,2.51
5643,16404724,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741219,=,nM,790.0,CHEMBL203,Homo sapiens,IC50,uM,0.79
5644,16404726,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740907,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
5645,16404729,CHEMBL3743366,Inhibition of human recombinant EGFR T790M mutant preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL939,=,nM,4270.0,CHEMBL203,Homo sapiens,IC50,uM,4.27
5646,16404735,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740257,=,nM,11750.0,CHEMBL203,Homo sapiens,IC50,uM,11.75
5647,16404738,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3741762,=,nM,10650.0,CHEMBL203,Homo sapiens,IC50,uM,10.65
5648,16404742,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL3740102,=,nM,15320.0,CHEMBL203,Homo sapiens,IC50,uM,15.32
5649,16404746,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL939,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
5650,16404747,CHEMBL3743367,Inhibition of wild type recombinant human EGFR preincubated for 10 mins followed by FAM-labeled peptide/ATP addition measured after 1 hr by mobility shift assay,B,CHEMBL1229592,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
5651,16410641,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741490,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5652,16410642,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3740105,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
5653,16410643,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3739771,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
5654,16410644,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741768,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
5655,16410645,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3739527,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
5656,16410647,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741399,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
5657,16410648,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741304,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
5658,16410649,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3740595,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
5659,16410650,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3740850,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,uM,0.072
5660,16410651,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3742059,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
5661,16410652,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741026,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
5662,16410653,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL3741424,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
5663,16410660,CHEMBL3745491,Inhibition of EGFR (unknown origin) using tyrosine 4 as substrate by fluorescence analysis,B,CHEMBL553,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,uM,0.0005
5664,16416924,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746473,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
5665,16416925,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL553,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
5666,16416926,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746557,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
5667,16416927,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL554,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,uM,0.28
5668,16416928,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746642,=,nM,1450.0,CHEMBL203,Homo sapiens,IC50,uM,1.45
5669,16416929,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746421,=,nM,6670.0,CHEMBL203,Homo sapiens,IC50,uM,6.67
5670,16416930,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746711,=,nM,1260.0,CHEMBL203,Homo sapiens,IC50,uM,1.26
5671,16416931,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746212,=,nM,4130.0,CHEMBL203,Homo sapiens,IC50,uM,4.13
5672,16416932,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747079,=,nM,9580.0,CHEMBL203,Homo sapiens,IC50,uM,9.58
5673,16416933,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747281,=,nM,5020.0,CHEMBL203,Homo sapiens,IC50,uM,5.02
5674,16416934,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746387,=,nM,21310.0,CHEMBL203,Homo sapiens,IC50,uM,21.31
5675,16416935,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747055,=,nM,8540.0,CHEMBL203,Homo sapiens,IC50,uM,8.54
5676,16416936,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747277,=,nM,7370.0,CHEMBL203,Homo sapiens,IC50,uM,7.37
5677,16416937,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746168,=,nM,9260.0,CHEMBL203,Homo sapiens,IC50,uM,9.26
5678,16416938,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747152,=,nM,6580.0,CHEMBL203,Homo sapiens,IC50,uM,6.58
5679,16416939,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747776,=,nM,5960.0,CHEMBL203,Homo sapiens,IC50,uM,5.96
5680,16416940,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746564,=,nM,10690.0,CHEMBL203,Homo sapiens,IC50,uM,10.69
5681,16416941,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746980,=,nM,25580.0,CHEMBL203,Homo sapiens,IC50,uM,25.58
5682,16416942,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3746268,=,nM,10920.0,CHEMBL203,Homo sapiens,IC50,uM,10.92
5683,16416943,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747570,=,nM,12240.0,CHEMBL203,Homo sapiens,IC50,uM,12.24
5684,16416944,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3745929,=,nM,26920.0,CHEMBL203,Homo sapiens,IC50,uM,26.92
5685,16416945,CHEMBL3750872,Inhibition of His-tagged EGFR cytoplasmic domain (645-1186 aa) (unknown origin) assessed as inhibition of autophosphorylation by TR-fluorometry,B,CHEMBL3747407,=,nM,15160.0,CHEMBL203,Homo sapiens,IC50,uM,15.16
5686,16435150,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754722,=,nM,290.46,CHEMBL203,Homo sapiens,IC50,nM,290.46
5687,16435151,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752404,=,nM,189.49,CHEMBL203,Homo sapiens,IC50,nM,189.49
5688,16435153,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752008,=,nM,14.83,CHEMBL203,Homo sapiens,IC50,nM,14.83
5689,16435154,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753886,=,nM,97.22,CHEMBL203,Homo sapiens,IC50,nM,97.22
5690,16435155,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753623,=,nM,102.93,CHEMBL203,Homo sapiens,IC50,nM,102.93
5691,16435156,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752370,=,nM,18.04,CHEMBL203,Homo sapiens,IC50,nM,18.04
5692,16435157,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754709,=,nM,317.12,CHEMBL203,Homo sapiens,IC50,nM,317.12
5693,16435158,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753142,=,nM,78.17,CHEMBL203,Homo sapiens,IC50,nM,78.17
5694,16435159,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3751967,=,nM,476.66,CHEMBL203,Homo sapiens,IC50,nM,476.66
5695,16435160,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754556,=,nM,71.82,CHEMBL203,Homo sapiens,IC50,nM,71.82
5696,16435161,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753811,=,nM,121.09,CHEMBL203,Homo sapiens,IC50,nM,121.09
5697,16435162,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753157,=,nM,495.3,CHEMBL203,Homo sapiens,IC50,nM,495.3
5698,16435163,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752248,=,nM,71.71,CHEMBL203,Homo sapiens,IC50,nM,71.71
5699,16435164,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753532,=,nM,24.81,CHEMBL203,Homo sapiens,IC50,nM,24.81
5700,16435165,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754301,=,nM,165.6,CHEMBL203,Homo sapiens,IC50,nM,165.6
5701,16435166,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752825,=,nM,94.82,CHEMBL203,Homo sapiens,IC50,nM,94.82
5702,16435167,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752129,=,nM,362.0,CHEMBL203,Homo sapiens,IC50,nM,362.0
5703,16435168,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752916,=,nM,310.76,CHEMBL203,Homo sapiens,IC50,nM,310.76
5704,16435169,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL1336,=,nM,2.96,CHEMBL203,Homo sapiens,IC50,nM,2.96
5705,16435174,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753444,=,nM,455.17,CHEMBL203,Homo sapiens,IC50,nM,455.17
5706,16435175,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753836,=,nM,131.09,CHEMBL203,Homo sapiens,IC50,nM,131.09
5707,16435176,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754057,=,nM,26.56,CHEMBL203,Homo sapiens,IC50,nM,26.56
5708,16436353,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3753208,=,nM,90.57,CHEMBL203,Homo sapiens,IC50,nM,90.57
5709,16436354,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3754785,=,nM,66.59,CHEMBL203,Homo sapiens,IC50,nM,66.59
5710,16436355,CHEMBL3756968,Inhibition of EGFR (unknown origin) incubated for 1 hr assessed as luminescence changes using ATP by ADP-Glo Kinase assay,B,CHEMBL3752074,=,nM,48.81,CHEMBL203,Homo sapiens,IC50,nM,48.81
5711,16443117,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752365,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
5712,16443118,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL939,=,nM,845.0,CHEMBL203,Homo sapiens,IC50,nM,845.0
5713,16443119,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752204,=,nM,9.5,CHEMBL203,Homo sapiens,IC50,nM,9.5
5714,16444024,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL1229592,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
5715,16444025,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3545308,=,nM,14.3,CHEMBL203,Homo sapiens,IC50,nM,14.3
5716,16444026,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3353410,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5717,16444036,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3754213,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
5718,16444037,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3754564,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
5719,16444038,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3754803,=,nM,23.5,CHEMBL203,Homo sapiens,IC50,nM,23.5
5720,16444039,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3633146,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,nM,2.9
5721,16444040,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753461,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,nM,280.0
5722,16444042,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753305,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
5723,16444043,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752139,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,nM,95.0
5724,16444044,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753228,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
5725,16444045,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3754040,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,nM,94.0
5726,16444046,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752448,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
5727,16444047,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753874,=,nM,17.8,CHEMBL203,Homo sapiens,IC50,nM,17.8
5728,16444048,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3751976,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
5729,16444049,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3633143,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
5730,16444050,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753011,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
5731,16444051,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3633145,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
5732,16444052,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3753235,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
5733,16444053,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3752363,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
5734,16444054,CHEMBL3755797,"Inhibition of EGFR L858R/T790M mutant (unknown origin) using Poly(Glu,Tyr)4:1 as substrate incubated for 1 hr by ELISA",B,CHEMBL3633142,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
5735,16451653,CHEMBL3761494,Inhibition of EGFR T790M/L858R mutant autophosphorylation in human H1975 cells,B,CHEMBL3758502,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
5736,16451792,CHEMBL3761494,Inhibition of EGFR T790M/L858R mutant autophosphorylation in human H1975 cells,B,CHEMBL3759096,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
5737,16452420,CHEMBL3761494,Inhibition of EGFR T790M/L858R mutant autophosphorylation in human H1975 cells,B,CHEMBL3758739,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
5738,16457535,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759815,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
5739,16457536,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759649,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
5740,16457537,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759356,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5741,16457538,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758939,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5742,16457539,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3760023,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
5743,16457540,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758471,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5744,16457541,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758951,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5745,16457542,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759085,=,nM,276.0,CHEMBL203,Homo sapiens,IC50,nM,276.0
5746,16457543,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759963,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
5747,16457544,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759780,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5748,16457545,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758868,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5749,16457546,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759961,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5750,16457547,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759199,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
5751,16457548,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758800,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5752,16457549,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758376,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5753,16457550,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759369,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
5754,16457551,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758278,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5755,16457552,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759480,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
5756,16457553,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759478,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5757,16457554,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758761,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
5758,16457555,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759359,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
5759,16457556,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758990,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5760,16457557,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759725,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5761,16457558,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758946,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
5762,16457559,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759257,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
5763,16457560,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759459,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5764,16457561,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758770,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
5765,16457562,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3760082,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5766,16457563,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759929,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5767,16457564,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758758,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5768,16457565,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758582,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
5769,16457566,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3760071,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5770,16457567,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759317,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
5771,16457568,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759022,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5772,16457569,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758768,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
5773,16457570,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758802,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5774,16457571,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758351,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5775,16457572,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759900,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
5776,16457573,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759733,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
5777,16457574,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759280,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
5778,16457575,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759986,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5779,16457576,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3759980,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
5780,16457577,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758762,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5781,16457578,CHEMBL3761557,Inhibition of EGFR (unknown origin) by Z -LYTE assay,B,CHEMBL3758889,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
5782,16461806,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL1336,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
5783,16461807,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759848,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
5784,16461808,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759015,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
5785,16461810,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3758875,=,nM,760.0,CHEMBL203,Homo sapiens,IC50,uM,0.76
5786,16461812,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759754,=,nM,1350.0,CHEMBL203,Homo sapiens,IC50,uM,1.35
5787,16461813,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759155,=,nM,4610.0,CHEMBL203,Homo sapiens,IC50,uM,4.61
5788,16461814,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759830,=,nM,1110.0,CHEMBL203,Homo sapiens,IC50,uM,1.11
5789,16461815,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3758585,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
5790,16461816,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3760090,=,nM,1330.0,CHEMBL203,Homo sapiens,IC50,uM,1.33
5791,16461817,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759190,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
5792,16461818,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3758749,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
5793,16461819,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759127,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
5794,16461823,CHEMBL3760417,Inhibition of human EGFR preincubated for 10 mins followed by addition of FAM-labeled peptide and incubated for 10 mins by Caliper motility shift assay,B,CHEMBL3759203,=,nM,730.0,CHEMBL203,Homo sapiens,IC50,uM,0.73
5795,16478354,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL939,=,nM,832.3,CHEMBL203,Homo sapiens,IC50,nM,832.3
5796,16478355,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763796,=,nM,10.4,CHEMBL203,Homo sapiens,IC50,nM,10.4
5797,16478356,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763757,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
5798,16478357,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764589,=,nM,66.3,CHEMBL203,Homo sapiens,IC50,nM,66.3
5799,16478358,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764312,=,nM,16.5,CHEMBL203,Homo sapiens,IC50,nM,16.5
5800,16478359,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765789,=,nM,159.0,CHEMBL203,Homo sapiens,IC50,nM,159.0
5801,16478360,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764603,=,nM,14.5,CHEMBL203,Homo sapiens,IC50,nM,14.5
5802,16478361,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765815,=,nM,6.02,CHEMBL203,Homo sapiens,IC50,nM,6.02
5803,16478362,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765425,=,nM,5.71,CHEMBL203,Homo sapiens,IC50,nM,5.71
5804,16478363,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763405,=,nM,4.62,CHEMBL203,Homo sapiens,IC50,nM,4.62
5805,16478364,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763627,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
5806,16478365,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763701,=,nM,32.7,CHEMBL203,Homo sapiens,IC50,nM,32.7
5807,16478366,CHEMBL3767532,Inhibition of recombinant human EGFR L858R/T790M double mutant assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765263,=,nM,11.5,CHEMBL203,Homo sapiens,IC50,nM,11.5
5808,16478367,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL939,=,nM,15.5,CHEMBL203,Homo sapiens,IC50,nM,15.5
5809,16478368,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763796,=,nM,5.01,CHEMBL203,Homo sapiens,IC50,nM,5.01
5810,16478369,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763757,=,nM,5.94,CHEMBL203,Homo sapiens,IC50,nM,5.94
5811,16478370,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764589,=,nM,2.92,CHEMBL203,Homo sapiens,IC50,nM,2.92
5812,16478371,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764312,=,nM,4.52,CHEMBL203,Homo sapiens,IC50,nM,4.52
5813,16478372,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765789,=,nM,3.11,CHEMBL203,Homo sapiens,IC50,nM,3.11
5814,16478373,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3764603,=,nM,1.63,CHEMBL203,Homo sapiens,IC50,nM,1.63
5815,16478374,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765815,=,nM,9.61,CHEMBL203,Homo sapiens,IC50,nM,9.61
5816,16478375,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765425,=,nM,4.71,CHEMBL203,Homo sapiens,IC50,nM,4.71
5817,16478376,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763405,=,nM,6.42,CHEMBL203,Homo sapiens,IC50,nM,6.42
5818,16478377,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763627,=,nM,2.01,CHEMBL203,Homo sapiens,IC50,nM,2.01
5819,16478378,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3763701,=,nM,15.4,CHEMBL203,Homo sapiens,IC50,nM,15.4
5820,16478379,CHEMBL3767531,Inhibition of wild type recombinant human EGFR assessed as reduction in autophosphorylation of cytoplasmic domain by Z'-Lyte assay,B,CHEMBL3765263,=,nM,1.12,CHEMBL203,Homo sapiens,IC50,nM,1.12
5821,16479888,CHEMBL3766407,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,CHEMBL3763360,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1
5822,16479889,CHEMBL3766407,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,CHEMBL3763790,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
5823,16479890,CHEMBL3766407,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,CHEMBL1173655,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
5824,16479891,CHEMBL3766407,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by addition of substrate by mobility shift assay,B,CHEMBL388978,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
5825,16496308,CHEMBL3779159,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL3774451,=,nM,582.17,CHEMBL203,Homo sapiens,IC50,nM,582.17
5826,16499778,CHEMBL3776285,Inhibition of EGFR-T790M/L858 mutant (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL553,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,uM,0.068
5827,16499779,CHEMBL3776285,Inhibition of EGFR-T790M/L858 mutant (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL939,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
5828,16499780,CHEMBL3776285,Inhibition of EGFR-T790M/L858 mutant (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775664,=,nM,336.0,CHEMBL203,Homo sapiens,IC50,uM,0.336
5829,16499781,CHEMBL3776285,Inhibition of EGFR-T790M/L858 mutant (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774926,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
5830,16499782,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL939,=,nM,11.8,CHEMBL203,Homo sapiens,IC50,nM,11.8
5831,16499783,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775046,=,nM,137.9,CHEMBL203,Homo sapiens,IC50,nM,137.9
5832,16499784,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774396,=,nM,211.4,CHEMBL203,Homo sapiens,IC50,nM,211.4
5833,16499785,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775897,=,nM,456.2,CHEMBL203,Homo sapiens,IC50,nM,456.2
5834,16499786,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775112,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,nM,99.0
5835,16499787,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775536,=,nM,115.9,CHEMBL203,Homo sapiens,IC50,nM,115.9
5836,16499788,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774808,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
5837,16499789,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774578,=,nM,162.7,CHEMBL203,Homo sapiens,IC50,nM,162.7
5838,16499791,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775148,=,nM,518.6,CHEMBL203,Homo sapiens,IC50,nM,518.6
5839,16499792,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774712,=,nM,594.5,CHEMBL203,Homo sapiens,IC50,nM,594.5
5840,16499793,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774609,=,nM,823.9,CHEMBL203,Homo sapiens,IC50,nM,823.9
5841,16499794,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775911,=,nM,353.7,CHEMBL203,Homo sapiens,IC50,nM,353.7
5842,16499795,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774471,=,nM,434.1,CHEMBL203,Homo sapiens,IC50,nM,434.1
5843,16499796,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775664,=,nM,53.1,CHEMBL203,Homo sapiens,IC50,nM,53.1
5844,16499797,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774926,=,nM,139.0,CHEMBL203,Homo sapiens,IC50,nM,139.0
5845,16499798,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774982,=,nM,829.2,CHEMBL203,Homo sapiens,IC50,nM,829.2
5846,16499800,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775459,=,nM,186.9,CHEMBL203,Homo sapiens,IC50,nM,186.9
5847,16499801,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774906,=,nM,89.6,CHEMBL203,Homo sapiens,IC50,nM,89.6
5848,16499802,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3774947,=,nM,63.1,CHEMBL203,Homo sapiens,IC50,nM,63.1
5849,16499803,CHEMBL3776094,Inhibition of wildtype EGFR (unknown origin) preincubated for 30 mins followed by addition of 2x ATP-substrate mixture measured after 1 hr by Kinase Glo luminescent kinase assay,B,CHEMBL3775285,=,nM,245.1,CHEMBL203,Homo sapiens,IC50,nM,245.1
5850,16532758,CHEMBL3789494,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs by ELISA,B,CHEMBL3353410,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
5851,16532759,CHEMBL3789482,Inhibition of EGFR L858R / T790M double mutant phosphorylation in human NCI-H1975 cells after 1 hr by Western blot analysis,B,CHEMBL3545308,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,nM,62.0
5852,16532762,CHEMBL3789495,Inhibition of wild type EGFR phosphorylation in human LoVo cells preincubated for 2 hrs followed by EGF stimulation measured after 30 mins by ELISA,B,CHEMBL3353410,=,nM,480.0,CHEMBL203,Homo sapiens,IC50,nM,480.0
5853,16532768,CHEMBL3789506,Inhibition of EGFR L858R/T790M double mutant in human NCI-H1975 cells assessed as suppression of cell proliferation,B,CHEMBL3787344,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
5854,16532771,CHEMBL3789506,Inhibition of EGFR L858R/T790M double mutant in human NCI-H1975 cells assessed as suppression of cell proliferation,B,CHEMBL3663929,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5855,16532774,CHEMBL3789748,Inhibition of EGFR Del ex19/T790M double mutant in human PC9 cells assessed as suppression of cell proliferation,B,CHEMBL3663929,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5856,16532775,CHEMBL3789751,Inhibition of wild type EGFR in human NCI-H1666 cells assessed as suppression of cell proliferation,B,CHEMBL3663929,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
5857,16532776,CHEMBL3789506,Inhibition of EGFR L858R/T790M double mutant in human NCI-H1975 cells assessed as suppression of cell proliferation,B,CHEMBL3786343,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
5858,16532778,CHEMBL3789494,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs by ELISA,B,CHEMBL3353411,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5859,16532779,CHEMBL3789495,Inhibition of wild type EGFR phosphorylation in human LoVo cells preincubated for 2 hrs followed by EGF stimulation measured after 30 mins by ELISA,B,CHEMBL3353411,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
5860,16532782,CHEMBL3789494,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs by ELISA,B,CHEMBL3353412,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
5861,16532783,CHEMBL3789495,Inhibition of wild type EGFR phosphorylation in human LoVo cells preincubated for 2 hrs followed by EGF stimulation measured after 30 mins by ELISA,B,CHEMBL3353412,=,nM,786.0,CHEMBL203,Homo sapiens,IC50,nM,786.0
5862,16539480,CHEMBL3789407,Inhibition of Her1 (unknown origin),B,CHEMBL3787112,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
5863,16540069,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3787662,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
5864,16540070,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786453,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
5865,16540071,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786962,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
5866,16540073,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3785393,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
5867,16540074,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786858,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
5868,16540075,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786802,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5869,16540076,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3787220,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5870,16540077,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786220,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,nM,210.0
5871,16540078,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786647,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,nM,710.0
5872,16540079,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786523,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
5873,16540080,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3787132,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
5874,16540081,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3787386,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5875,16540082,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786812,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
5876,16540083,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3786098,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
5877,16540084,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL553,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,nM,9000.0
5878,16540085,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL31965,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
5879,16540086,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3545308,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
5880,16540087,CHEMBL3790961,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells after 2 hrs by sandwich ELISA,B,CHEMBL3353410,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
5881,16540164,CHEMBL3790969,Inhibition of EGFR deletion/T790M mutant autophosphorylation in human PC9-DRH cells after 2 hrs by sandwich ELISA,B,CHEMBL3786098,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
5882,16540165,CHEMBL3790969,Inhibition of EGFR deletion/T790M mutant autophosphorylation in human PC9-DRH cells after 2 hrs by sandwich ELISA,B,CHEMBL553,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,nM,9700.0
5883,16540166,CHEMBL3790969,Inhibition of EGFR deletion/T790M mutant autophosphorylation in human PC9-DRH cells after 2 hrs by sandwich ELISA,B,CHEMBL3545308,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
5884,16540167,CHEMBL3790969,Inhibition of EGFR deletion/T790M mutant autophosphorylation in human PC9-DRH cells after 2 hrs by sandwich ELISA,B,CHEMBL3353410,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
5885,16540763,CHEMBL3789980,Inhibition of EGFR (unknown origin) in presence of [gamma33P]ATP,B,CHEMBL1614712,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,uM,5.2
5886,16540806,CHEMBL3789991,Inhibition of HER1 (unknown origin) in presence of [gamma33P]ATP,B,CHEMBL3787112,=,nM,2300.0,CHEMBL203,Homo sapiens,IC50,uM,2.3
5887,16577164,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3800262,=,nM,57000.0,CHEMBL203,Homo sapiens,IC50,uM,57.0
5888,16577165,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3797839,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
5889,16577166,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3799956,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
5890,16577167,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3799345,=,nM,49000.0,CHEMBL203,Homo sapiens,IC50,uM,49.0
5891,16577168,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3800448,=,nM,34000.0,CHEMBL203,Homo sapiens,IC50,uM,34.0
5892,16577169,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3798556,=,nM,35000.0,CHEMBL203,Homo sapiens,IC50,uM,35.0
5893,16577170,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3798658,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
5894,16577171,CHEMBL3804124,Inhibition of EGFR in human MDA231 cells assessed as growth inhibition after 24 hrs by MTT assay,B,CHEMBL3799332,=,nM,38000.0,CHEMBL203,Homo sapiens,IC50,uM,38.0
5895,16581378,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3797606,=,nM,271.6,CHEMBL203,Homo sapiens,IC50,nM,271.6
5896,16581379,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798501,=,nM,87.5,CHEMBL203,Homo sapiens,IC50,nM,87.5
5897,16581380,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3797963,=,nM,730.5,CHEMBL203,Homo sapiens,IC50,nM,730.5
5898,16581381,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799864,=,nM,389.4,CHEMBL203,Homo sapiens,IC50,nM,389.4
5899,16581382,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798887,=,nM,173.6,CHEMBL203,Homo sapiens,IC50,nM,173.6
5900,16581383,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3800597,=,nM,153.7,CHEMBL203,Homo sapiens,IC50,nM,153.7
5901,16581384,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799138,=,nM,409.7,CHEMBL203,Homo sapiens,IC50,nM,409.7
5902,16581385,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799255,=,nM,247.8,CHEMBL203,Homo sapiens,IC50,nM,247.8
5903,16581386,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798128,=,nM,38.8,CHEMBL203,Homo sapiens,IC50,nM,38.8
5904,16581387,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799428,=,nM,46.4,CHEMBL203,Homo sapiens,IC50,nM,46.4
5905,16581388,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL1229592,=,nM,31.1,CHEMBL203,Homo sapiens,IC50,nM,31.1
5906,16581389,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3699588,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
5907,16581390,CHEMBL3804024,Inhibition of wild-type EGFR (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3353410,=,nM,408.5,CHEMBL203,Homo sapiens,IC50,nM,408.5
5908,16581391,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3797606,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
5909,16581392,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798501,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
5910,16581393,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3797963,=,nM,7.3,CHEMBL203,Homo sapiens,IC50,nM,7.3
5911,16581394,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799864,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
5912,16581395,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798887,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
5913,16581396,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3800597,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
5914,16581397,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799138,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
5915,16581398,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799255,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
5916,16581399,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3798128,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
5917,16581400,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3799428,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
5918,16581401,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL1229592,=,nM,9.7,CHEMBL203,Homo sapiens,IC50,nM,9.7
5919,16581402,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3699588,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
5920,16581403,CHEMBL3804025,Inhibition of EGFR T790M/L858R mutant (unknown origin) expressed in baculovirus expression system after 1 hr by ELISA,B,CHEMBL3353410,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
5921,16588546,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805218,=,nM,25.86,CHEMBL203,Homo sapiens,IC50,nM,25.86
5922,16588547,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL939,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
5923,16588548,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806145,=,nM,57.8,CHEMBL203,Homo sapiens,IC50,nM,57.8
5924,16588549,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806222,=,nM,58.8,CHEMBL203,Homo sapiens,IC50,nM,58.8
5925,16588550,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806170,=,nM,16.7,CHEMBL203,Homo sapiens,IC50,nM,16.7
5926,16588551,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805782,=,nM,20.5,CHEMBL203,Homo sapiens,IC50,nM,20.5
5927,16588552,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805584,=,nM,473.6,CHEMBL203,Homo sapiens,IC50,nM,473.6
5928,16588553,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805775,=,nM,247.2,CHEMBL203,Homo sapiens,IC50,nM,247.2
5929,16588555,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805654,=,nM,351.8,CHEMBL203,Homo sapiens,IC50,nM,351.8
5930,16588556,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805260,=,nM,363.3,CHEMBL203,Homo sapiens,IC50,nM,363.3
5931,16588557,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806172,=,nM,232.3,CHEMBL203,Homo sapiens,IC50,nM,232.3
5932,16588559,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805509,=,nM,23.7,CHEMBL203,Homo sapiens,IC50,nM,23.7
5933,16588560,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805283,=,nM,29.1,CHEMBL203,Homo sapiens,IC50,nM,29.1
5934,16588561,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806321,=,nM,416.1,CHEMBL203,Homo sapiens,IC50,nM,416.1
5935,16588562,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805949,=,nM,313.6,CHEMBL203,Homo sapiens,IC50,nM,313.6
5936,16588563,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805177,=,nM,102.6,CHEMBL203,Homo sapiens,IC50,nM,102.6
5937,16588564,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805089,=,nM,184.5,CHEMBL203,Homo sapiens,IC50,nM,184.5
5938,16588565,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805383,=,nM,82.5,CHEMBL203,Homo sapiens,IC50,nM,82.5
5939,16588567,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805325,=,nM,27.3,CHEMBL203,Homo sapiens,IC50,nM,27.3
5940,16588568,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806213,=,nM,24.1,CHEMBL203,Homo sapiens,IC50,nM,24.1
5941,16588569,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805280,=,nM,387.8,CHEMBL203,Homo sapiens,IC50,nM,387.8
5942,16588570,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806200,=,nM,36.2,CHEMBL203,Homo sapiens,IC50,nM,36.2
5943,16588571,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805299,=,nM,74.6,CHEMBL203,Homo sapiens,IC50,nM,74.6
5944,16588572,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805333,=,nM,43.8,CHEMBL203,Homo sapiens,IC50,nM,43.8
5945,16588574,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806066,=,nM,159.9,CHEMBL203,Homo sapiens,IC50,nM,159.9
5946,16588575,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806005,=,nM,200.3,CHEMBL203,Homo sapiens,IC50,nM,200.3
5947,16588576,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805461,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
5948,16588577,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806110,=,nM,13.1,CHEMBL203,Homo sapiens,IC50,nM,13.1
5949,16588578,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805859,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
5950,16588579,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805238,=,nM,9.7,CHEMBL203,Homo sapiens,IC50,nM,9.7
5951,16588580,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3804868,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
5952,16588581,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805774,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
5953,16588582,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805039,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
5954,16588583,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806248,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
5955,16588584,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805236,=,nM,10.9,CHEMBL203,Homo sapiens,IC50,nM,10.9
5956,16588585,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806292,=,nM,22.5,CHEMBL203,Homo sapiens,IC50,nM,22.5
5957,16588586,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806143,=,nM,18.48,CHEMBL203,Homo sapiens,IC50,nM,18.48
5958,16588587,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805681,=,nM,21.95,CHEMBL203,Homo sapiens,IC50,nM,21.95
5959,16588588,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3804886,=,nM,83.88,CHEMBL203,Homo sapiens,IC50,nM,83.88
5960,16588589,CHEMBL3807186,Inhibition of wild type EGFR (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805588,=,nM,97.18,CHEMBL203,Homo sapiens,IC50,nM,97.18
5961,16588590,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806292,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
5962,16588592,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806248,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
5963,16588593,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805039,=,nM,21.5,CHEMBL203,Homo sapiens,IC50,nM,21.5
5964,16588594,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805774,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
5965,16588595,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3804868,=,nM,33.8,CHEMBL203,Homo sapiens,IC50,nM,33.8
5966,16588596,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805238,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,nM,71.0
5967,16588597,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805859,=,nM,123.5,CHEMBL203,Homo sapiens,IC50,nM,123.5
5968,16588598,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806110,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5
5969,16588599,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805461,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
5970,16588601,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806066,=,nM,109.1,CHEMBL203,Homo sapiens,IC50,nM,109.1
5971,16589185,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805325,=,nM,121.0,CHEMBL203,Homo sapiens,IC50,nM,121.0
5972,16589189,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805177,=,nM,1303.2,CHEMBL203,Homo sapiens,IC50,nM,1303.2
5973,16589192,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805283,=,nM,46.28,CHEMBL203,Homo sapiens,IC50,nM,46.28
5974,16589193,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805509,=,nM,31.4,CHEMBL203,Homo sapiens,IC50,nM,31.4
5975,16589195,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806172,=,nM,270.6,CHEMBL203,Homo sapiens,IC50,nM,270.6
5976,16589199,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805775,=,nM,89.2,CHEMBL203,Homo sapiens,IC50,nM,89.2
5977,16589200,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805584,=,nM,76.1,CHEMBL203,Homo sapiens,IC50,nM,76.1
5978,16589201,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3805782,=,nM,150.9,CHEMBL203,Homo sapiens,IC50,nM,150.9
5979,16589202,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL3806170,=,nM,323.6,CHEMBL203,Homo sapiens,IC50,nM,323.6
5980,16589205,CHEMBL3807187,Inhibition of EGFR T790M/L858R double mutant (unknown origin) autophosphorylation preincubated for 30 mins followed by ATP addition measured after 1 hr by kinase-glo luminescence assay,B,CHEMBL939,=,nM,22.5,CHEMBL203,Homo sapiens,IC50,nM,22.5
5981,16589236,CHEMBL3807185,Competitive binding affinity to EGFR (unknown origin) ATP binding site,B,CHEMBL29197,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
5982,16589317,CHEMBL3807568,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3805508,=,nM,7920.0,CHEMBL203,Homo sapiens,IC50,uM,7.92
5983,16589318,CHEMBL3807568,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3805409,=,nM,81200.0,CHEMBL203,Homo sapiens,IC50,uM,81.2
5984,16589319,CHEMBL3807568,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3805893,=,nM,9040.0,CHEMBL203,Homo sapiens,IC50,uM,9.04
5985,16589321,CHEMBL3807568,Inhibition of recombinant His6-tagged EGFR (unknown origin) cytoplasmic domain (645 to 1186 residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL3805849,=,nM,192000.0,CHEMBL203,Homo sapiens,IC50,uM,192.0
5986,16593614,CHEMBL3811753,Inhibition of GST-tagged human recombinant EGFR (668 to1210 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate,B,CHEMBL3808884,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
5987,16593625,CHEMBL3810820,Inhibition of GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus using Fluorescein-Poly GT as substrate,B,CHEMBL3808884,=,nM,112.0,CHEMBL203,Homo sapiens,IC50,nM,112.0
5988,16605961,CHEMBL3813356,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,B,CHEMBL285063,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
5989,16605962,CHEMBL3813356,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,B,CHEMBL48802,=,nM,9000.0,CHEMBL203,Homo sapiens,IC50,uM,9.0
5990,16605963,CHEMBL3813356,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,B,CHEMBL3809045,=,nM,880.0,CHEMBL203,Homo sapiens,IC50,uM,0.88
5991,16605964,CHEMBL3813356,Inhibition of EGFR-TK in human A431 cell lysate assessed as reduction in EGF stimulated kinase activity after 60 mins using biotinylated peptide substrate by ELISA,B,CHEMBL52765,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
5992,16609940,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3815045,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
5993,16609941,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3813979,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,uM,0.29
5994,16609942,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3814825,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
5995,16609943,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3814878,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
5996,16609944,CHEMBL3817134,Inhibition of recombinant N-terminal GST-tagged human EGFR T790M/L858R double mutant using biotinylated TK substrate incubated for 50 mins by HTRF assay,B,CHEMBL3813746,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,uM,2.2
5997,16612183,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814959,=,nM,0.803,CHEMBL203,Homo sapiens,IC50,nM,0.803
5998,16612184,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL2031296,=,nM,1.01,CHEMBL203,Homo sapiens,IC50,nM,1.01
5999,16612185,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814447,=,nM,2.22,CHEMBL203,Homo sapiens,IC50,nM,2.22
6000,16612186,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3815074,=,nM,2.04,CHEMBL203,Homo sapiens,IC50,nM,2.04
6001,16612187,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814211,=,nM,0.854,CHEMBL203,Homo sapiens,IC50,nM,0.854
6002,16612188,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814257,=,nM,0.662,CHEMBL203,Homo sapiens,IC50,nM,0.662
6003,16612189,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3633928,=,nM,2.03,CHEMBL203,Homo sapiens,IC50,nM,2.03
6004,16612190,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814846,=,nM,3.96,CHEMBL203,Homo sapiens,IC50,nM,3.96
6005,16612191,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814320,=,nM,1.43,CHEMBL203,Homo sapiens,IC50,nM,1.43
6006,16612192,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814882,=,nM,0.772,CHEMBL203,Homo sapiens,IC50,nM,0.772
6007,16612193,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3815161,=,nM,2.92,CHEMBL203,Homo sapiens,IC50,nM,2.92
6008,16612194,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814956,=,nM,1.06,CHEMBL203,Homo sapiens,IC50,nM,1.06
6009,16612196,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL939,=,nM,0.509,CHEMBL203,Homo sapiens,IC50,nM,0.509
6010,16612197,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814445,=,nM,2.25,CHEMBL203,Homo sapiens,IC50,nM,2.25
6011,16612198,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814694,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
6012,16612199,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3815163,=,nM,1.81,CHEMBL203,Homo sapiens,IC50,nM,1.81
6013,16612200,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3813728,=,nM,2.26,CHEMBL203,Homo sapiens,IC50,nM,2.26
6014,16612201,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814182,=,nM,9.05,CHEMBL203,Homo sapiens,IC50,nM,9.05
6015,16612202,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814816,=,nM,5.06,CHEMBL203,Homo sapiens,IC50,nM,5.06
6016,16612204,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3813876,<,nM,0.495,CHEMBL203,Homo sapiens,IC50,nM,0.495
6017,16612205,CHEMBL3815405,Inhibition of recombinant human EGFR expressed in baculovirus by fluorescence based assay,B,CHEMBL3814812,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
6018,16612213,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814959,=,nM,273.0,CHEMBL203,Homo sapiens,IC50,uM,0.273
6019,16612214,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL2031296,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
6020,16612215,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814447,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,uM,0.194
6021,16612216,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3815074,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
6022,16612217,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814211,=,nM,315.0,CHEMBL203,Homo sapiens,IC50,uM,0.315
6023,16612218,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814257,=,nM,264.0,CHEMBL203,Homo sapiens,IC50,uM,0.264
6024,16612219,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3633928,=,nM,186.0,CHEMBL203,Homo sapiens,IC50,uM,0.186
6025,16612220,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814846,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,uM,0.41
6026,16612221,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814320,=,nM,269.0,CHEMBL203,Homo sapiens,IC50,uM,0.269
6027,16612222,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814882,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
6028,16612223,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3815161,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,uM,0.087
6029,16612224,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814956,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
6030,16612225,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814460,=,nM,259.0,CHEMBL203,Homo sapiens,IC50,uM,0.259
6031,16612227,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL939,=,nM,127.0,CHEMBL203,Homo sapiens,IC50,uM,0.127
6032,16612228,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814445,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
6033,16612229,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814694,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
6034,16612230,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3815163,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
6035,16612231,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3813728,=,nM,332.0,CHEMBL203,Homo sapiens,IC50,uM,0.332
6036,16612232,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814940,=,nM,296.0,CHEMBL203,Homo sapiens,IC50,uM,0.296
6037,16612233,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814182,=,nM,772.0,CHEMBL203,Homo sapiens,IC50,uM,0.772
6038,16612234,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814816,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
6039,16612235,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3815115,=,nM,247.0,CHEMBL203,Homo sapiens,IC50,uM,0.247
6040,16612236,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3813876,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
6041,16612237,CHEMBL3815441,Inhibition of wild type EGFR (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814812,=,nM,271.0,CHEMBL203,Homo sapiens,IC50,uM,0.271
6042,16612269,CHEMBL3815445,Inhibition of EGFR L858R/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814846,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
6043,16612270,CHEMBL3815445,Inhibition of EGFR L858R/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814021,=,nM,2030.0,CHEMBL203,Homo sapiens,IC50,uM,2.03
6044,16612272,CHEMBL3815445,Inhibition of EGFR L858R/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814940,=,nM,1760.0,CHEMBL203,Homo sapiens,IC50,uM,1.76
6045,16612273,CHEMBL3815446,Inhibition of EGFR Del19/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814846,=,nM,2280.0,CHEMBL203,Homo sapiens,IC50,uM,2.28
6046,16612274,CHEMBL3815446,Inhibition of EGFR Del19/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814021,=,nM,2380.0,CHEMBL203,Homo sapiens,IC50,uM,2.38
6047,16612276,CHEMBL3815446,Inhibition of EGFR Del19/T790M double mutant (unknown origin) expressed in mouse BaF/3 cells assessed as cell growth inhibition after 72 hrs by MTS assay,B,CHEMBL3814940,=,nM,2310.0,CHEMBL203,Homo sapiens,IC50,uM,2.31
6048,16619740,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818364,=,nM,110.6,CHEMBL203,Homo sapiens,IC50,nM,110.6
6049,16619741,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818062,=,nM,40.16,CHEMBL203,Homo sapiens,IC50,nM,40.16
6050,16619742,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3819553,=,nM,294.6,CHEMBL203,Homo sapiens,IC50,nM,294.6
6051,16619743,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL939,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,nM,173.0
6052,16622200,CHEMBL3820478,Inhibition of EGFR (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,CHEMBL388978,=,nM,74.2,CHEMBL203,Homo sapiens,IC50,nM,74.2
6053,16622202,CHEMBL3820480,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,CHEMBL388978,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
6054,16622203,CHEMBL3820481,Inhibition of EGFR T790M/L858R mutant (unknown origin) incubated for 1 hr by spectrophotometric analysis,B,CHEMBL388978,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
6055,16631000,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818547,=,nM,1.06,CHEMBL203,Homo sapiens,IC50,nM,1.06
6056,16631001,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818115,=,nM,1.34,CHEMBL203,Homo sapiens,IC50,nM,1.34
6057,16631002,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818015,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
6058,16631003,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818563,=,nM,5.52,CHEMBL203,Homo sapiens,IC50,nM,5.52
6059,16631004,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818970,=,nM,37.81,CHEMBL203,Homo sapiens,IC50,nM,37.81
6060,16631005,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3819120,=,nM,25.53,CHEMBL203,Homo sapiens,IC50,nM,25.53
6061,16631006,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818289,=,nM,4.54,CHEMBL203,Homo sapiens,IC50,nM,4.54
6062,16631007,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818364,=,nM,1.19,CHEMBL203,Homo sapiens,IC50,nM,1.19
6063,16631008,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818062,=,nM,1.98,CHEMBL203,Homo sapiens,IC50,nM,1.98
6064,16631009,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3819553,=,nM,2.57,CHEMBL203,Homo sapiens,IC50,nM,2.57
6065,16631010,CHEMBL3820192,Inhibition of wild type human EGFR preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL939,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
6066,16631021,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818547,=,nM,26.33,CHEMBL203,Homo sapiens,IC50,nM,26.33
6067,16631022,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818115,=,nM,53.16,CHEMBL203,Homo sapiens,IC50,nM,53.16
6068,16631023,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818015,=,nM,126.3,CHEMBL203,Homo sapiens,IC50,nM,126.3
6069,16631025,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818970,=,nM,80.84,CHEMBL203,Homo sapiens,IC50,nM,80.84
6070,16631026,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3819120,=,nM,332.6,CHEMBL203,Homo sapiens,IC50,nM,332.6
6071,16631027,CHEMBL3820194,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 5 mins followed by ATP addition for 30 mins by HTRF assay,B,CHEMBL3818289,=,nM,58.73,CHEMBL203,Homo sapiens,IC50,nM,58.73
6072,16639380,CHEMBL3826532,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate incubated for 30 mins by HTRF assay",B,CHEMBL3823520,=,nM,529.4,CHEMBL203,Homo sapiens,IC50,nM,529.4
6073,16655123,CHEMBL3830418,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M/L858R double mutant (696 residues) expressed in insect Sf21 cells using poly(Glu,Tyr)4:1 as substrate incubated for 60 mins by ELISA",B,CHEMBL3735648,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,nM,350.0
6074,16655513,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3828269,=,nM,2.97,CHEMBL203,Homo sapiens,IC50,nM,2.97
6075,16655514,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3828079,=,nM,44.1,CHEMBL203,Homo sapiens,IC50,nM,44.1
6076,16655515,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3828021,=,nM,3.58,CHEMBL203,Homo sapiens,IC50,nM,3.58
6077,16655516,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3828092,=,nM,31.9,CHEMBL203,Homo sapiens,IC50,nM,31.9
6078,16655517,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL3827349,=,nM,28.2,CHEMBL203,Homo sapiens,IC50,nM,28.2
6079,16655518,CHEMBL3829377,Inhibition of cytoplasmic GST-tagged human recombinant EGFR expressed in baculovirus system by z-lyte assay,B,CHEMBL939,=,nM,0.585,CHEMBL203,Homo sapiens,IC50,nM,0.585
6080,16655540,CHEMBL3829370,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL939,=,nM,1013.0,CHEMBL203,Homo sapiens,IC50,nM,1013.0
6081,16666119,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL554,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
6082,16666120,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3912361,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
6083,16666121,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3982289,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
6084,16666122,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3921302,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
6085,16666124,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3930270,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
6086,16666125,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3902295,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
6087,16666126,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3908711,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,uM,0.46
6088,16666127,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3936642,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,uM,0.077
6089,16666128,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3917657,=,nM,870.0,CHEMBL203,Homo sapiens,IC50,uM,0.87
6090,16666129,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3945555,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
6091,16666132,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3960786,=,nM,9300.0,CHEMBL203,Homo sapiens,IC50,uM,9.3
6092,16666133,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3891774,=,nM,8500.0,CHEMBL203,Homo sapiens,IC50,uM,8.5
6093,16666134,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3906330,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
6094,16666136,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3915306,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,uM,6.4
6095,16666139,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3910361,=,nM,5200.0,CHEMBL203,Homo sapiens,IC50,uM,5.2
6096,16666140,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3897363,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
6097,16666141,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3965948,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6098,16666142,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3969628,=,nM,184.0,CHEMBL203,Homo sapiens,IC50,uM,0.184
6099,16666143,CHEMBL3854309,Inhibition of GST-tagged wild type recombinant human EGFR (668 to 1210 residues) expressed in baculovirus after 1 hr by Z-lyte assay,B,CHEMBL3940060,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
6100,16668203,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3948084,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
6101,16668204,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3977326,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
6102,16668205,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3921347,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
6103,16668206,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3963723,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
6104,16668207,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3930316,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6105,16668208,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3957801,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
6106,16668209,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3946232,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
6107,16668210,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3918330,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
6108,16668211,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3974571,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
6109,16668212,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL545315,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6110,16668213,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3968839,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
6111,16668214,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3939300,=,nM,714.0,CHEMBL203,Homo sapiens,IC50,uM,0.714
6112,16668215,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3919183,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
6113,16668216,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3981041,=,nM,127.0,CHEMBL203,Homo sapiens,IC50,uM,0.127
6114,16668217,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3964380,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
6115,16668218,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3904205,=,nM,175.0,CHEMBL203,Homo sapiens,IC50,uM,0.175
6116,16668219,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3960911,=,nM,519.0,CHEMBL203,Homo sapiens,IC50,uM,0.519
6117,16668220,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3962032,=,nM,421.0,CHEMBL203,Homo sapiens,IC50,uM,0.421
6118,16668221,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3934539,=,nM,136.0,CHEMBL203,Homo sapiens,IC50,uM,0.136
6119,16668222,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3973028,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
6120,16668223,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3943512,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
6121,16668224,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3944572,=,nM,881.0,CHEMBL203,Homo sapiens,IC50,uM,0.881
6122,16668225,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3916644,=,nM,509.0,CHEMBL203,Homo sapiens,IC50,uM,0.509
6123,16668226,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3951754,=,nM,531.0,CHEMBL203,Homo sapiens,IC50,uM,0.531
6124,16668227,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3980622,=,nM,205.0,CHEMBL203,Homo sapiens,IC50,uM,0.205
6125,16668228,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3942999,=,nM,388.0,CHEMBL203,Homo sapiens,IC50,uM,0.388
6126,16668229,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3972605,=,nM,343.0,CHEMBL203,Homo sapiens,IC50,uM,0.343
6127,16668230,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3934034,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
6128,16668231,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3961532,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
6129,16668232,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3925158,=,nM,116.0,CHEMBL203,Homo sapiens,IC50,uM,0.116
6130,16668233,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3916141,=,nM,747.0,CHEMBL203,Homo sapiens,IC50,uM,0.747
6131,16668234,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3944095,=,nM,383.0,CHEMBL203,Homo sapiens,IC50,uM,0.383
6132,16668235,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3970738,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
6133,16668236,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3941175,=,nM,593.0,CHEMBL203,Homo sapiens,IC50,uM,0.593
6134,16668237,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3923650,=,nM,522.0,CHEMBL203,Homo sapiens,IC50,uM,0.522
6135,16668238,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3932176,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
6136,16668239,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3950966,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
6137,16668240,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3923228,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
6138,16668241,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3942228,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
6139,16668242,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3914227,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
6140,16668243,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3907533,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
6141,16668244,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3921129,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
6142,16668245,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3941823,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
6143,16668246,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3971413,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,uM,0.072
6144,16668247,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3950549,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6145,16668248,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
6146,16668249,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3959248,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
6147,16668250,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3890186,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6148,16668251,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3970330,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
6149,16668252,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3899132,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
6150,16668253,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3890751,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
6151,16668254,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3933895,=,nM,122.0,CHEMBL203,Homo sapiens,IC50,uM,0.122
6152,16668255,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3958482,=,nM,132.0,CHEMBL203,Homo sapiens,IC50,uM,0.132
6153,16668256,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3930965,=,nM,148.0,CHEMBL203,Homo sapiens,IC50,uM,0.148
6154,16668257,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3962365,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
6155,16668258,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3939985,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
6156,16668259,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3977926,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
6157,16668260,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3922922,=,nM,164.0,CHEMBL203,Homo sapiens,IC50,uM,0.164
6158,16668261,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3986103,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
6159,16668262,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3957416,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,uM,0.069
6160,16668263,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3936505,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,uM,0.082
6161,16668264,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3968417,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6162,16668265,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3930506,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
6163,16668266,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3958006,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
6164,16668267,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3921555,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
6165,16668268,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3949347,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
6166,16668269,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3948267,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
6167,16668270,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3977504,=,nM,201.0,CHEMBL203,Homo sapiens,IC50,uM,0.201
6168,16668271,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3896779,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
6169,16668272,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3969056,=,nM,304.0,CHEMBL203,Homo sapiens,IC50,uM,0.304
6170,16668273,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3967962,=,nM,405.0,CHEMBL203,Homo sapiens,IC50,uM,0.405
6171,16668274,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3921446,=,nM,857.0,CHEMBL203,Homo sapiens,IC50,uM,0.857
6172,16668275,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3981551,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
6173,16668276,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL3904257,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,uM,0.037
6174,16668277,CHEMBL3854863,Irreversible inhibition of GST-tagged ERBB1 (unknown origin) (Met-668 to Ala-1211 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in Glu/Tyr copolymer phosphorylation after 6 mins by ELISA,B,CHEMBL939,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
6175,16668403,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL545315,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6176,16668404,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3974571,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
6177,16668405,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3918330,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,uM,0.075
6178,16668406,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3946232,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
6179,16668407,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3957801,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
6180,16668408,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3932176,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6181,16668409,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3950966,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
6182,16668410,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3923228,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
6183,16668411,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3942228,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6184,16668412,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3914227,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
6185,16668413,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3907533,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
6186,16668414,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3921129,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
6187,16668415,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3941823,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
6188,16668416,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3950549,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
6189,16668417,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
6190,16668418,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3959248,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
6191,16668419,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3890186,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
6192,16668420,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3970330,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,uM,0.026
6193,16668421,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3899132,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
6194,16668422,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3890751,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,uM,0.053
6195,16668423,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3933895,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
6196,16668424,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3958482,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
6197,16668425,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3930965,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
6198,16668426,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3962365,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
6199,16668427,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3939985,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6200,16668428,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3977926,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
6201,16668429,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3922922,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
6202,16668430,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3986103,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,uM,0.061
6203,16668431,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3957416,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
6204,16668432,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3936505,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
6205,16668433,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3968417,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
6206,16668434,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3930506,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6207,16668435,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3958006,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6208,16668436,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3921555,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
6209,16668437,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3949347,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
6210,16668438,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3948267,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
6211,16668439,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3977504,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
6212,16668440,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3896779,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
6213,16668441,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3969056,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6214,16668442,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3967962,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6215,16668443,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3921446,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6216,16668444,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3981551,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
6217,16668445,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL3904257,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
6218,16668446,CHEMBL3854867,Irreversible inhibition of full length human ERBB1 autophosphorylation transfected in EGF-stimulated mouse NIH/3T3 cells incubated for 2 hrs followed by stimulation with EGF for 10 mins,B,CHEMBL939,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
6219,16739489,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL553,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
6220,16739490,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3952877,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
6221,16739491,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3981621,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
6222,16739492,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3961553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6223,16739493,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3892567,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
6224,16739497,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3973601,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
6225,16739498,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3953210,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
6226,16739499,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3925584,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
6227,16739500,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3961961,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6228,16739501,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3934461,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
6229,16739502,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3972981,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
6230,16739503,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3943438,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
6231,16739504,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3939429,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,nM,74.0
6232,16739505,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3952157,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
6233,16739506,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3891846,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
6234,16739507,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3960853,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
6235,16739508,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3901622,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
6236,16739509,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3929584,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
6237,16739510,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3928512,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6238,16739511,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3956112,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
6239,16739512,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3919609,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
6240,16739513,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3947406,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6241,16739514,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3946396,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
6242,16739515,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3975699,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
6243,16739516,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3937527,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
6244,16739517,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3967219,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
6245,16739518,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3908303,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
6246,16739519,CHEMBL3857034,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL3933539,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
6247,16739552,CHEMBL3857083,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by XTT assay,B,CHEMBL3901622,=,nM,217.0,CHEMBL203,Homo sapiens,IC50,nM,217.0
6248,16739553,CHEMBL3857083,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by XTT assay,B,CHEMBL3891846,=,nM,196.0,CHEMBL203,Homo sapiens,IC50,nM,196.0
6249,16739554,CHEMBL3857083,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse BA/F3 cells assessed as reduction in cell viability after 48 hrs by XTT assay,B,CHEMBL553,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,nM,87.0
6250,16752236,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3965075,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
6251,16752237,CHEMBL3860364,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3965075,=,nM,2080.0,CHEMBL203,Homo sapiens,IC50,uM,2.08
6252,16752239,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3954370,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
6253,16752240,CHEMBL3860364,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3954370,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
6254,16752242,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3918367,=,nM,1370.0,CHEMBL203,Homo sapiens,IC50,uM,1.37
6255,16752243,CHEMBL3860364,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3918367,=,nM,11750.0,CHEMBL203,Homo sapiens,IC50,uM,11.75
6256,16752245,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3946259,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
6257,16752248,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3909438,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,uM,0.28
6258,16752251,CHEMBL3860363,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3937373,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
6259,16752252,CHEMBL3860364,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 10 uM ATP addition by HTRF assay,B,CHEMBL3937373,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,uM,0.68
6260,16752254,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3972316,=,nM,1.39,CHEMBL203,Homo sapiens,IC50,nM,1.39
6261,16752255,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3972316,=,nM,14.84,CHEMBL203,Homo sapiens,IC50,nM,14.84
6262,16752277,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3951434,=,nM,2.18,CHEMBL203,Homo sapiens,IC50,nM,2.18
6263,16752278,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3951434,=,nM,45.9,CHEMBL203,Homo sapiens,IC50,nM,45.9
6264,16752292,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3939913,=,nM,1.51,CHEMBL203,Homo sapiens,IC50,nM,1.51
6265,16752293,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3939913,=,nM,2.65,CHEMBL203,Homo sapiens,IC50,nM,2.65
6266,16752312,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3960167,=,nM,2.11,CHEMBL203,Homo sapiens,IC50,nM,2.11
6267,16752313,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3960167,=,nM,3.05,CHEMBL203,Homo sapiens,IC50,nM,3.05
6268,16752335,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3966111,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
6269,16752336,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3966111,=,nM,525.0,CHEMBL203,Homo sapiens,IC50,nM,525.0
6270,16752345,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3953921,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
6271,16752346,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3953921,=,nM,24.7,CHEMBL203,Homo sapiens,IC50,nM,24.7
6272,16752347,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3953921,=,nM,421.0,CHEMBL203,Homo sapiens,IC50,nM,421.0
6273,16752351,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3982602,=,nM,16460.0,CHEMBL203,Homo sapiens,IC50,uM,16.46
6274,16752352,CHEMBL3860366,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 0 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3901943,=,nM,830.0,CHEMBL203,Homo sapiens,IC50,uM,0.83
6275,16752353,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3901943,<,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
6276,16752354,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3901943,=,nM,6.1,CHEMBL203,Homo sapiens,IC50,nM,6.1
6277,16752355,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3901943,=,nM,74.9,CHEMBL203,Homo sapiens,IC50,nM,74.9
6278,16752361,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3892960,=,nM,6810.0,CHEMBL203,Homo sapiens,IC50,uM,6.81
6279,16752367,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3953221,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
6280,16752368,CHEMBL3860372,Inhibition of EGFR L858R/T790M mutant (unknown origin) phosphorylation expressed in mouse NIH/3T3 cells incubated for 3 hrs by ELISA method,B,CHEMBL3953221,=,nM,41.4,CHEMBL203,Homo sapiens,IC50,nM,41.4
6281,16752369,CHEMBL3860373,Inhibition of EGFR L858R mutant (unknown origin) phosphorylation expressed in mouse NIH/3T3 cells incubated for 3 hrs by ELISA method,B,CHEMBL3953221,=,nM,543.0,CHEMBL203,Homo sapiens,IC50,nM,543.0
6282,16752372,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3973973,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
6283,16752373,CHEMBL3860372,Inhibition of EGFR L858R/T790M mutant (unknown origin) phosphorylation expressed in mouse NIH/3T3 cells incubated for 3 hrs by ELISA method,B,CHEMBL3973973,=,nM,409.0,CHEMBL203,Homo sapiens,IC50,nM,409.0
6284,16752383,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3959632,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
6285,16752384,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3959632,=,nM,134.8,CHEMBL203,Homo sapiens,IC50,nM,134.8
6286,16752385,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3959632,=,nM,1041.0,CHEMBL203,Homo sapiens,IC50,nM,1041.0
6287,16752388,CHEMBL3860366,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 0 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3961202,=,nM,22310.0,CHEMBL203,Homo sapiens,IC50,uM,22.31
6288,16752389,CHEMBL3860367,Inhibition of N-terminal 6x-HIS-tagged human recombinant EGFR (696 to 1022 residues) L858R/T790M mutant expressed in Sf9 cells pre-incubated for 90 mins followed by 1 mM ATP addition by HTRF assay,B,CHEMBL3961202,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
6289,16752390,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3961202,=,nM,181.0,CHEMBL203,Homo sapiens,IC50,nM,181.0
6290,16752391,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3961202,=,nM,660.0,CHEMBL203,Homo sapiens,IC50,nM,660.0
6291,16752404,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3787344,=,nM,4.18,CHEMBL203,Homo sapiens,IC50,nM,4.18
6292,16752405,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3787344,=,nM,6.11,CHEMBL203,Homo sapiens,IC50,nM,6.11
6293,16752448,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3353410,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
6294,16752449,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3353410,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
6295,16752452,CHEMBL3860368,Inhibition of EGFR L858R/T790M mutant phosphorylation in human patient derived H1975 cells incubated for 3 hrs by ELISA method,B,CHEMBL3545308,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
6296,16752453,CHEMBL3860369,Inhibition of EGFR L858R mutant phosphorylation in human patient derived H3255 cells incubated for 3 hrs by ELISA method,B,CHEMBL3545308,=,nM,13.8,CHEMBL203,Homo sapiens,IC50,nM,13.8
6297,16756448,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3947759,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
6298,16756449,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3977022,=,nM,103.4,CHEMBL203,Homo sapiens,IC50,nM,103.4
6299,16756450,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3956430,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1
6300,16756451,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3985086,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
6301,16756452,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3967512,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
6302,16756453,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3930539,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
6303,16756454,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3903063,=,nM,118.7,CHEMBL203,Homo sapiens,IC50,nM,118.7
6304,16756455,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3931038,=,nM,98.2,CHEMBL203,Homo sapiens,IC50,nM,98.2
6305,16756456,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3953593,=,nM,40.6,CHEMBL203,Homo sapiens,IC50,nM,40.6
6306,16756457,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3925959,=,nM,100.6,CHEMBL203,Homo sapiens,IC50,nM,100.6
6307,16756458,CHEMBL3861200,Inhibition of human recombinant N-terminal GST-tagged EGFR T790M/L858R double mutant cytoplasmic domain (695 end residues) autophosphorylation expressed in baculovirus infected Sf9 insect cells by ADP-Glo luminescence assay,B,CHEMBL3545308,=,nM,21.5,CHEMBL203,Homo sapiens,IC50,nM,21.5
6308,16808361,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3921664,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,nmol/L,570.0
6309,16808362,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3893810,=,nM,593.0,CHEMBL203,Homo sapiens,IC50,nmol/L,593.0
6310,16808363,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3894726,=,nM,587.0,CHEMBL203,Homo sapiens,IC50,nmol/L,587.0
6311,16808364,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3913728,=,nM,898.0,CHEMBL203,Homo sapiens,IC50,nmol/L,898.0
6312,16808365,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3905284,=,nM,601.0,CHEMBL203,Homo sapiens,IC50,nmol/L,601.0
6313,16808366,CHEMBL3870418,Inhibition of EGFR (unknown origin) using peptide as substrate after 60 mins by HTRF assay,B,CHEMBL3934594,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nmol/L,460.0
6314,16808781,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3924500,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
6315,16808782,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3905411,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
6316,16808783,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL1380839,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
6317,16808784,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3977192,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,nM,77.0
6318,16808785,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3906533,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
6319,16808786,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3937949,=,nM,6.2,CHEMBL203,Homo sapiens,IC50,nM,6.2
6320,16808787,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3915508,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
6321,16808788,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3979610,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6322,16808789,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3950630,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
6323,16808790,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3908272,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,nM,86.0
6324,16808791,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3978686,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,nM,84.0
6325,16808792,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3899216,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
6326,16808793,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3970399,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
6327,16809229,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3926223,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0
6328,16809230,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3896476,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,nM,64.0
6329,16809231,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3927914,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
6330,16809232,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3938794,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
6331,16809233,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3893698,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
6332,16809234,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3921710,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
6333,16809235,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3982619,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
6334,16809236,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3912723,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
6335,16809237,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3974626,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6336,16809238,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3903713,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
6337,16809239,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3966129,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
6338,16809240,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3963403,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
6339,16809241,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3900264,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
6340,16809242,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3983586,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
6341,16809243,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3897723,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
6342,16809244,CHEMBL3870506,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL590878,=,nM,6.27,CHEMBL203,Homo sapiens,IC50,nM,6.27
6343,16811346,CHEMBL3870703,Inhibition of recombinant human amino-terminal GST-His6-fused EGFR expressed in baculovirus expression system assessed as phosphorylation using Biotin-PTP1B as substrate by HTScan assay,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
6344,16811349,CHEMBL3870719,"Inhibition of recombinant human GST-fused EGFR (668 to 1211 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins",B,CHEMBL3890526,=,nM,670.0,CHEMBL203,Homo sapiens,IC50,nM,670.0
6345,16811350,CHEMBL3870719,"Inhibition of recombinant human GST-fused EGFR (668 to 1211 residues) assessed as phosphotyrosine formation using poly(Glu:Tyr, 4:1) as substrate and ATP measured after 6 mins",B,CHEMBL483321,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,nM,6400.0
6346,16811352,CHEMBL3870717,Inhibition of EGFR (unknown origin),B,CHEMBL2103842,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
6347,16811354,CHEMBL3870715,Inhibition of EGFR (unknown origin) expressed in baculovirus expression system using Biotin-(amino hexonoic acid)-EEEEYFELVAKKKCONH2 as substrate and [gamma32]-ATP measured after 10 mins by Topcount scintillation counting method,B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
6348,16811356,CHEMBL3870713,Inhibition of human EGFR expressed in baculovirus/Sf21 system in presence of ATP by ELISA,B,CHEMBL2408045,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
6349,16811358,CHEMBL3870711,Inhibition of EGFR in human A431 cell membranes preincubated for 30 mins prior to addition of peptide substrate and [gamma32]-ATP measured after 10 mins by scintillation counting method,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
6350,16811409,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL939,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
6351,16811410,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3982710,=,nM,11.6,CHEMBL203,Homo sapiens,IC50,nM,11.6
6352,16811411,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3921816,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
6353,16811412,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3893822,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
6354,16811413,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3930762,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
6355,16811414,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3902778,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
6356,16811415,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3939771,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
6357,16811416,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3911796,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
6358,16811417,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3964033,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
6359,16811418,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3930620,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
6360,16811419,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3929484,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
6361,16811420,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3957055,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69
6362,16811421,CHEMBL3870704,Inhibition of wild-type EGFR (unknown origin) assessed as remaining ATP level measured after 15 mins by luminescence analysis,B,CHEMBL3920583,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
6363,16829736,CHEMBL3874958,Inhibition of EGFR (unknown origin),B,CHEMBL3931223,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,nM,690.0
6364,16835838,CHEMBL3875840,Inhibition of human EGFR using poly (Glu:Tyr) as substrate measured for 1.5 hrs by oregon green 488 dye-based fluorescence assay,B,CHEMBL3883652,=,nM,11000.0,CHEMBL203,Homo sapiens,IC50,uM,11.0
6365,16837433,CHEMBL3876067,Inhibition of human recombinant GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system,B,CHEMBL3884319,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
6366,16847198,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL24828,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
6367,16847199,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3917723,=,nM,9941.0,CHEMBL203,Homo sapiens,IC50,nM,9941.0
6368,16847200,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3904787,=,nM,763.0,CHEMBL203,Homo sapiens,IC50,nM,763.0
6369,16847201,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3975598,=,nM,611.0,CHEMBL203,Homo sapiens,IC50,nM,611.0
6370,16847202,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3939588,=,nM,817.0,CHEMBL203,Homo sapiens,IC50,nM,817.0
6371,16847204,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3948354,=,nM,212.0,CHEMBL203,Homo sapiens,IC50,nM,212.0
6372,16847205,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3920551,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
6373,16847206,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3957025,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
6374,16847207,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3929448,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
6375,16847208,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3968039,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6376,16847209,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3938494,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
6377,16847210,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3962233,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6378,16847211,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3979264,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
6379,16847212,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3905552,=,nM,668.0,CHEMBL203,Homo sapiens,IC50,nM,668.0
6380,16847213,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3933568,=,nM,502.0,CHEMBL203,Homo sapiens,IC50,nM,502.0
6381,16847214,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3896615,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
6382,16847215,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3905242,=,nM,235.0,CHEMBL203,Homo sapiens,IC50,nM,235.0
6383,16847216,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3923551,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,nM,194.0
6384,16847220,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3894623,=,nM,4649.0,CHEMBL203,Homo sapiens,IC50,nM,4649.0
6385,16847222,CHEMBL3877875,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system preincubated for 10 mins followed by FAM-labelled peptide substrate addition by caliper mobility shift assay,B,CHEMBL3983460,=,nM,2933.0,CHEMBL203,Homo sapiens,IC50,nM,2933.0
6386,16894417,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3949197,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6387,16894418,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL597551,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6388,16894419,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL597752,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6389,16894420,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL596736,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6390,16894421,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598163,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6391,16894422,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598377,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
6392,16894423,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3896110,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6393,16894424,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3976436,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6394,16894425,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3941197,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6395,16894426,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL599398,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6396,16894427,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598164,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6397,16894428,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
6398,16894429,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3922584,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6399,16894430,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3930226,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6400,16894431,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3909214,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6401,16894432,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3905086,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6402,16894433,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3928963,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6403,16894434,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL604094,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6404,16894435,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3959855,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6405,16894436,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3979482,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6406,16894437,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3915273,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6407,16894438,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3912598,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6408,16894439,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3975990,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6409,16894440,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL597569,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6410,16894441,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3893111,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6411,16894442,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3890344,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6412,16894443,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL597773,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6413,16894444,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3939206,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6414,16894445,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3898372,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6415,16894446,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3901144,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6416,16894447,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3922068,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6417,16894448,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3924787,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6418,16894449,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3975710,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
6419,16894450,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3943805,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6420,16894451,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3944171,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6421,16894452,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3946801,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6422,16894453,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3970892,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6423,16894454,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3959043,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6424,16894455,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3909900,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6425,16894456,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3907094,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6426,16894457,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3984008,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6427,16894458,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL605976,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6428,16894459,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL599218,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
6429,16894460,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL2309506,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6430,16894461,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL2309507,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6431,16894463,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3917951,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6432,16894464,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL596761,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6433,16894465,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL596964,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6434,16894466,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3914607,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6435,16894467,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3967530,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6436,16894468,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3906200,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6437,16894469,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3916142,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6438,16894470,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3951191,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6439,16894471,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3953871,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6440,16894472,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3892811,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6441,16894473,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3959884,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6442,16894474,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3985245,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6443,16894475,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL596754,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6444,16894476,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598611,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6445,16894477,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3901210,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6446,16894478,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3898444,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6447,16894479,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3936512,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6448,16894480,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3935462,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6449,16894481,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL598799,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6450,16894482,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3930003,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6451,16894483,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3980430,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6452,16894484,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3976961,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6453,16894485,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3976389,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6454,16894717,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3910297,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
6455,16894718,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3907491,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6456,16894719,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3948072,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6457,16894720,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3945421,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6458,16894721,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3903506,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6459,16894722,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3972249,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6460,16894723,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3938265,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6461,16894724,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3916600,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6462,16894725,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3900967,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6463,16894726,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3977186,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6464,16894727,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3899385,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6465,16894728,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3902161,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6466,16894729,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3951620,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6467,16894730,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3961102,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6468,16894731,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3921652,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6469,16894732,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3924346,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6470,16894733,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3952709,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6471,16894734,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3950023,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6472,16894735,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3984573,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6473,16894736,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3905131,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6474,16894737,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3939306,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6475,16894738,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3936547,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6476,16894739,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3901236,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6477,16894740,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3898480,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6478,16894741,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3917105,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6479,16894742,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3914322,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6480,16894743,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3985004,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6481,16894744,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3917670,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6482,16894745,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3981584,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6483,16894746,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3984055,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6484,16894747,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3929290,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6485,16894748,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3932057,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6486,16894749,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3968968,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6487,16894751,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3956995,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6488,16894752,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3928197,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6489,16894753,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3986286,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6490,16895015,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL3937516,<=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
6491,16895080,CHEMBL3881964,Inhibition of N-terminal GST-fused human EGFR (His672 to Ala1210 residues) expressed in baculovirus expression system using biotinylated PTP1B at Tyr66 as substrate preincubated for 5 mins followed by substrate addition measured after 30 mins by DELFIA,B,CHEMBL553,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
6492,16895087,CHEMBL3881990,Inhibition of EGFR phosphorylation at Tyr1068 in human MDA-MB-468 cells,B,CHEMBL598797,=,nM,17.6,CHEMBL203,Homo sapiens,IC50,nM,17.6
6493,16895088,CHEMBL3881990,Inhibition of EGFR phosphorylation at Tyr1068 in human MDA-MB-468 cells,B,CHEMBL553,=,nM,31.8,CHEMBL203,Homo sapiens,IC50,nM,31.8
6494,16895175,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3965391,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6495,16895176,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3904966,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
6496,16895177,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3968784,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
6497,16895178,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3922182,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
6498,16895179,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3919447,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
6499,16895180,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3940909,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
6500,16895181,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3965087,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
6501,16895182,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3909201,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
6502,16895183,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3970231,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
6503,16895184,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3926558,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6504,16895185,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3954587,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6505,16895186,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3914159,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6506,16895187,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3898690,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
6507,16895188,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3898447,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6508,16895189,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3545154,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
6509,16895190,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3932286,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
6510,16895191,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3940089,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
6511,16895192,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3929060,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
6512,16895193,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3972168,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
6513,16895194,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3958624,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
6514,16895195,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL939,=,nM,639.0,CHEMBL203,Homo sapiens,IC50,nM,639.0
6515,16895196,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL554,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
6516,16895197,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL1173655,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
6517,16895198,CHEMBL3882125,"Inhibition of N-terminal GST-tagged human EGFR (696 to end residues) expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3900054,=,nM,204.0,CHEMBL203,Homo sapiens,IC50,nM,204.0
6518,16895199,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3965391,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
6519,16895200,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3904966,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
6520,16895201,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3968784,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
6521,16895202,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3922182,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
6522,16895203,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3919447,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
6523,16895204,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3940909,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,nM,54.0
6524,16895205,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3965087,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
6525,16895206,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3909201,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
6526,16895207,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3970231,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
6527,16895208,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3926558,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
6528,16895209,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3954587,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6529,16895210,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3914159,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
6530,16895211,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3916927,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
6531,16895212,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3898690,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
6532,16895213,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3898447,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
6533,16895214,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3545154,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,nM,4.4
6534,16895215,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3910915,=,nM,7.6,CHEMBL203,Homo sapiens,IC50,nM,7.6
6535,16895216,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3971939,=,nM,9.3,CHEMBL203,Homo sapiens,IC50,nM,9.3
6536,16895217,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3935007,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
6537,16895218,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3932286,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
6538,16895219,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3978740,=,nM,16.2,CHEMBL203,Homo sapiens,IC50,nM,16.2
6539,16895220,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3961848,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6540,16895221,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3898077,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6541,16895222,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3895411,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6542,16895223,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3940089,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6543,16895224,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3929060,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
6544,16895225,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3985465,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
6545,16895226,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3980793,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
6546,16895227,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3932784,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
6547,16895228,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3935492,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6548,16895229,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3979366,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
6549,16895230,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3972168,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
6550,16895231,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3958624,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
6551,16895232,CHEMBL3882126,"Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 cells using poly (Glu,Tyr)4:1 as substrate preincubated for 10 mins followed by substrate addition measured after 1 hr by fluorescence polarization assay",B,CHEMBL3946096,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
6552,16905376,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3951527,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6553,16905946,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3544983,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6554,16905947,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968192,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6555,16905948,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977450,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6556,16905949,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959516,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6557,16905950,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3956820,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6558,16905951,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893890,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6559,16905952,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928396,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6560,16905953,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3946242,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6561,16905954,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3943570,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6562,16905955,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3908311,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6563,16905956,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3905501,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6564,16905957,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3924147,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6565,16905958,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3971781,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6566,16905959,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914441,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6567,16905960,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3917220,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6568,16905961,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968522,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6569,16905962,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977759,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6570,16905963,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928883,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6571,16905964,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3931623,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6572,16905965,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959774,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6573,16905966,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3962487,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6574,16905967,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3922278,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6575,16905968,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3924998,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6576,16905969,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3896122,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6577,16905970,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893416,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6578,16905971,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3934134,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6579,16905972,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3931427,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6580,16905973,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3940489,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6581,16905974,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3900059,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6582,16905975,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3947712,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6583,16905976,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945072,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6584,16905977,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986135,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6585,16905978,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983466,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6586,16905979,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3917294,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6587,16905980,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3920036,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6588,16905981,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3946590,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6589,16905982,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986404,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6590,16905983,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3961005,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6591,16905984,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958481,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6592,16905985,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3919145,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6593,16905986,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895424,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6594,16905987,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3964605,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6595,16905988,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955486,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6596,16905989,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3924380,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6597,16905990,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3921689,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6598,16905991,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955359,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6599,16905992,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3964556,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6600,16905993,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3910031,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6601,16905994,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3907230,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6602,16905995,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895458,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6603,16905996,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959160,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6604,16905997,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3932115,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6605,16905998,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3929354,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6606,16905999,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968322,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6607,16906000,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928696,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6608,16906001,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3926038,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6609,16906002,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952048,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6610,16906003,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3949434,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6611,16906004,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914264,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6612,16906005,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3904510,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6613,16906006,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958507,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6614,16906007,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955873,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6615,16906008,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3922630,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6616,16906009,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3943632,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6617,16906010,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3979687,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6618,16906011,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3954731,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6619,16906012,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3919501,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6620,16906013,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3929188,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6621,16906014,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3949535,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6622,16906015,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968843,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6623,16906016,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3905012,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6624,16906017,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3907764,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6625,16906018,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3909626,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6626,16906019,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3896044,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6627,16906020,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3976826,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6628,16906021,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916485,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6629,16906022,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923250,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6630,16906023,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3936025,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6631,16906024,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3960730,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6632,16906025,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3913860,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6633,16906026,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945353,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6634,16906027,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3942671,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6635,16906028,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952188,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6636,16906029,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3984213,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6637,16906030,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3936151,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6638,16906031,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945860,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6639,16906032,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3898088,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6640,16906033,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3900858,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6641,16906034,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3957171,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6642,16906035,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959857,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6643,16906036,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952693,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6644,16906037,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977320,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6645,16906038,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3985840,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6646,16906039,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983201,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6647,16906040,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3963620,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6648,16906041,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3937857,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6649,16906042,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3929002,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6650,16906043,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3951099,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6651,16906044,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933848,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6652,16906045,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3944502,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6653,16906046,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895848,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6654,16906047,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893128,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6655,16906048,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952493,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6656,16906049,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3961982,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6657,16906050,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3900296,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6658,16906051,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3903022,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6659,16906052,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3946018,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6660,16906053,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3948661,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6661,16906054,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914671,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6662,16906055,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959254,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6663,16906056,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3960016,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6664,16906057,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3971864,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6665,16906058,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983938,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6666,16906059,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3904481,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6667,16906060,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952023,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6668,16906061,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3949400,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6669,16906062,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3900567,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6670,16906063,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3939717,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6671,16906064,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3938621,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6672,16906065,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3927549,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6673,16906066,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977030,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6674,16906067,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3967776,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6675,16906068,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893575,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6676,16906069,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3930406,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6677,16906070,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952805,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6678,16906071,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3897215,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6679,16906072,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3898627,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6680,16906073,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3910064,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6681,16906074,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959195,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6682,16906075,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914599,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6683,16906076,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3966752,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6684,16906077,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986301,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6685,16906078,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3947408,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6686,16906079,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3944780,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6687,16906080,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3909596,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6688,16906081,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3906789,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6689,16906082,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933123,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6690,16906083,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3930429,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6691,16906084,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895123,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6692,16906085,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983179,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6693,16906086,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3965096,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6694,16906087,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952315,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6695,16906088,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3899485,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6696,16906089,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923013,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6697,16906090,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3937598,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6698,16906091,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955495,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6699,16906092,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3918670,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6700,16906093,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3978177,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6701,16906094,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923153,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6702,16906095,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3925935,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6703,16906096,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3898808,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6704,16906097,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3910102,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6705,16906098,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3979195,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6706,16906099,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3981613,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6707,16906100,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3942082,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6708,16906101,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3949560,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6709,16906102,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3985254,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6710,16906103,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3897256,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6711,16906104,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3932578,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6712,16906105,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3935265,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6713,16906106,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916759,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6714,16906107,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3919493,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6715,16906108,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958678,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6716,16906109,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3956056,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6717,16906110,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893032,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6718,16906111,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3890263,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6719,16906112,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3944702,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6720,16906113,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3912287,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6721,16906114,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3906715,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6722,16906115,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3896927,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6723,16906116,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968519,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6724,16906117,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3966040,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6725,16906118,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3949155,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6726,16906119,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3951755,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6727,16906120,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3904192,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6728,16906121,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3913993,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6729,16906122,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3944791,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6730,16906123,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968030,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6731,16906124,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3897525,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6732,16906125,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3900295,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6733,16906126,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928180,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6734,16906127,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3921228,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6735,16906128,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895890,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6736,16906129,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893176,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6737,16906130,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933897,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6738,16906131,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3931193,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6739,16906132,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3979728,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6740,16906133,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3951403,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6741,16906134,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3944857,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6742,16906135,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3985896,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6743,16906136,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983245,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6744,16906137,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895645,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6745,16906138,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3965938,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6746,16906139,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3929942,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6747,16906140,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3932698,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6748,16906141,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3976896,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6749,16906142,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3979317,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6750,16906143,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916297,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6751,16906144,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3919051,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6752,16906145,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3946469,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6753,16906146,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3965160,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6754,16906147,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955447,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6755,16906148,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3932218,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6756,16906149,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3898138,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6757,16906150,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916567,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6758,16906151,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3963821,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6759,16906152,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3947769,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6760,16906153,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3912646,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6761,16906154,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914394,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6762,16906155,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928439,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6763,16906156,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3925803,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6764,16906157,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3951258,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6765,16906158,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3953937,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6766,16906159,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3913496,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6767,16906160,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916225,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6768,16906161,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3937092,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6769,16906162,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3939874,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6770,16906163,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3892030,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6771,16906164,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3901787,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6772,16906165,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958778,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6773,16906166,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3961472,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6774,16906167,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933398,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6775,16906168,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923692,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6776,16906169,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893845,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6777,16906170,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3970332,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6778,16906171,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3947700,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6779,16906172,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945062,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6780,16906173,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986123,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6781,16906174,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3983450,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6782,16906175,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3941200,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6783,16906176,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959038,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6784,16906177,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3942387,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6785,16906178,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3982666,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6786,16906179,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3920114,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6787,16906180,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3894418,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6788,16906181,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3929966,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6789,16906182,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3969472,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6790,16906183,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3976226,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6791,16906184,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3931724,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6792,16906185,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3953606,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6793,16906186,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3918306,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6794,16906187,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3907879,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6795,16906188,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3905114,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6796,16906189,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968956,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6797,16906190,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3966429,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6798,16906191,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3962355,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6799,16906192,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959638,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6800,16906193,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3964536,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6801,16906194,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3917442,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6802,16906195,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3941402,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6803,16906196,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3892117,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6804,16906197,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3907215,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6805,16906198,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3904460,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6806,16906199,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945177,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6807,16906200,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3937297,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6808,16906201,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3913719,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6809,16906202,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3911207,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6810,16906203,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958466,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6811,16906204,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955824,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6812,16906205,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3899410,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6813,16906206,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3896699,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6814,16906207,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3899440,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6815,16906208,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977221,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6816,16906209,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986102,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6817,16906210,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3942161,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6818,16906211,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3940839,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6819,16906212,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3971050,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6820,16906213,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3973632,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6821,16906214,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3931393,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6822,16906215,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3934095,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6823,16906216,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914189,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6824,16906217,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3928601,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6825,16906218,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3962203,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6826,16906219,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3959495,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6827,16906220,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916953,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6828,16906221,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3914180,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6829,16906222,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3977503,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6830,16906223,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3968233,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6831,16906224,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3939133,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6832,16906225,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3941947,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6833,16906226,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3952465,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6834,16906227,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3955083,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6835,16906228,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3921390,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6836,16906229,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3924098,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6837,16906230,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958898,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6838,16906231,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923449,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6839,16906232,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3906936,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6840,16906233,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3909744,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6841,16906234,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3891059,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6842,16906235,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893846,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6843,16906236,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3981432,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6844,16906237,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3972712,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6845,16906238,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3921482,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6846,16906239,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3918761,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6847,16906240,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3939671,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6848,16906241,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3895129,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6849,16906242,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3935851,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6850,16906243,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933130,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6851,16906244,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3891130,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6852,16906245,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3909603,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6853,16906246,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3965625,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6854,16906247,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3986082,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6855,16906248,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3945028,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6856,16906249,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3947643,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6857,16906250,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3921861,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6858,16906251,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3972940,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6859,16906252,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3923645,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6860,16906253,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3933359,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6861,16906254,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893363,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6862,16906255,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3896067,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6863,16906256,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3976788,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6864,16906257,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3974328,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6865,16906258,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3909572,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6866,16906259,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3927849,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6867,16906260,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3961417,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6868,16906261,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3958721,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6869,16906262,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3943734,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6870,16906263,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3971560,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6871,16906264,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3939828,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6872,16906265,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3937048,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6873,16906266,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3916828,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6874,16906267,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3924442,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6875,16906268,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3890300,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6876,16906269,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3893058,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6877,16906270,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3985116,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6878,16906271,CHEMBL3883067,Inhibition of recombinant human N-terminal GST His6-tagged thrombin cleavage site-fused EGFR (H672 to A1210 residues) expressed in baculovirus using poly-EY as substrate after 210 mins by luciferase coupled chemiluminescence assay,B,CHEMBL3938869,<,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
6879,17601741,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676392,=,nM,956.0,CHEMBL203,Homo sapiens,IC50,nM,956.0
6880,17601742,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676391,=,nM,246.0,CHEMBL203,Homo sapiens,IC50,nM,246.0
6881,17601745,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676393,=,nM,172.0,CHEMBL203,Homo sapiens,IC50,nM,172.0
6882,17601747,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676394,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,nM,149.0
6883,17607121,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655336,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6884,17607122,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655337,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
6885,17607123,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655338,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6886,17607124,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655339,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6887,17607125,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655340,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6888,17607126,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL1271561,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
6889,17607127,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655341,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6890,17607128,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655342,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6891,17607129,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655343,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
6892,17607130,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655344,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
6893,17607131,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655345,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
6894,17607132,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655346,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
6895,17607133,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655347,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6896,17607134,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655348,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
6897,17607135,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655349,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6898,17607136,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655350,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6899,17607137,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655351,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6900,17607138,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3639542,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
6901,17607139,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655352,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
6902,17607140,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655353,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
6903,17607141,CHEMBL3705330,Inhibition Assay: EGFR inhibitory activity of compounds of the present invention is quantified employing the EGFR HTRF assay.,B,CHEMBL3655354,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
6904,17649031,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671475,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6905,17649032,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671476,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
6906,17649033,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671477,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
6907,17649034,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671478,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
6908,17649035,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671479,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6909,17649036,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671480,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
6910,17649037,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671481,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
6911,17649038,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671482,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
6912,17649039,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671483,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6913,17649040,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671484,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
6914,17649041,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671485,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
6915,17649042,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671486,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6916,17649043,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671487,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6917,17649044,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671488,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
6918,17649045,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3639703,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
6919,17649046,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671489,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
6920,17649047,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671490,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6921,17649048,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671491,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6922,17649049,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671492,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
6923,17649050,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671493,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
6924,17649051,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671494,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
6925,17649052,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671495,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
6926,17649053,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671496,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6927,17649054,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671497,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6928,17649055,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671498,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
6929,17649056,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671499,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
6930,17649057,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671500,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
6931,17649058,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671501,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
6932,17649059,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671502,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
6933,17649060,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671503,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,nM,96.0
6934,17649061,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671504,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
6935,17649062,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671505,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
6936,17649063,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671506,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
6937,17649064,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671507,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
6938,17649065,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671508,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
6939,17649066,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671509,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,nM,91.0
6940,17649067,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671510,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6941,17649068,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671511,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
6942,17649069,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671512,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
6943,17649070,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671513,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
6944,17649071,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671514,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
6945,17649072,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671515,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
6946,17649073,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671516,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
6947,17649074,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671517,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
6948,17649075,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671518,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
6949,17649076,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671519,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
6950,17649077,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671520,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
6951,17649078,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671521,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,nM,128.0
6952,17649079,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671522,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,nM,69.0
6953,17649080,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671523,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
6954,17649081,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671524,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
6955,17649082,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671525,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6956,17649083,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671526,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
6957,17649084,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671527,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
6958,17649085,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676390,=,nM,589.0,CHEMBL203,Homo sapiens,IC50,nM,589.0
6959,17649086,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671528,=,nM,198.0,CHEMBL203,Homo sapiens,IC50,nM,198.0
6960,17649087,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671529,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,nM,89.0
6961,17649088,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671530,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
6962,17649089,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671531,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
6963,17649090,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671532,=,nM,136.0,CHEMBL203,Homo sapiens,IC50,nM,136.0
6964,17649091,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671533,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
6965,17649092,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671534,=,nM,258.0,CHEMBL203,Homo sapiens,IC50,nM,258.0
6966,17649093,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671535,=,nM,158.0,CHEMBL203,Homo sapiens,IC50,nM,158.0
6967,17649094,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671536,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
6968,17649095,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671537,=,nM,652.0,CHEMBL203,Homo sapiens,IC50,nM,652.0
6969,17649096,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671538,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
6970,17649097,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671539,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,nM,89.0
6971,17649098,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671540,=,nM,156.0,CHEMBL203,Homo sapiens,IC50,nM,156.0
6972,17649099,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671541,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
6973,17649100,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671542,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,nM,102.0
6974,17649101,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671543,=,nM,256.0,CHEMBL203,Homo sapiens,IC50,nM,256.0
6975,17649102,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671544,=,nM,251.0,CHEMBL203,Homo sapiens,IC50,nM,251.0
6976,17649103,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671545,=,nM,325.0,CHEMBL203,Homo sapiens,IC50,nM,325.0
6977,17649104,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671546,=,nM,1020.0,CHEMBL203,Homo sapiens,IC50,nM,1020.0
6978,17649105,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671547,=,nM,866.0,CHEMBL203,Homo sapiens,IC50,nM,866.0
6979,17649106,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671548,=,nM,389.0,CHEMBL203,Homo sapiens,IC50,nM,389.0
6980,17649107,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671549,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
6981,17649108,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671550,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6982,17649109,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671551,=,nM,154.0,CHEMBL203,Homo sapiens,IC50,nM,154.0
6983,17649110,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671552,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
6984,17649111,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671553,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
6985,17649112,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671554,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
6986,17649113,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671555,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
6987,17649114,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671556,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,nM,69.0
6988,17649115,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671557,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
6989,17649116,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671558,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,nM,94.0
6990,17649117,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671559,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,nM,128.0
6991,17649118,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671560,=,nM,295.0,CHEMBL203,Homo sapiens,IC50,nM,295.0
6992,17649119,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671561,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
6993,17649120,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671562,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
6994,17649121,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671563,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
6995,17649122,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671564,=,nM,698.0,CHEMBL203,Homo sapiens,IC50,nM,698.0
6996,17649123,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671565,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
6997,17649124,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671566,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
6998,17649125,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671567,=,nM,1954.0,CHEMBL203,Homo sapiens,IC50,nM,1954.0
6999,17649126,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671568,=,nM,69.0,CHEMBL203,Homo sapiens,IC50,nM,69.0
7000,17649127,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671569,=,nM,368.0,CHEMBL203,Homo sapiens,IC50,nM,368.0
7001,17649128,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671568,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
7002,17649129,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671570,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
7003,17649130,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671571,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7004,17649131,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671572,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
7005,17649132,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671573,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7006,17649133,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671574,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
7007,17649134,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671575,=,nM,196.0,CHEMBL203,Homo sapiens,IC50,nM,196.0
7008,17649135,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671576,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
7009,17649136,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671577,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
7010,17649137,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671578,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
7011,17649138,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671579,=,nM,987.0,CHEMBL203,Homo sapiens,IC50,nM,987.0
7012,17649139,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671580,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7013,17649140,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671581,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7014,17649141,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671582,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,nM,49.0
7015,17649142,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671583,=,nM,456.0,CHEMBL203,Homo sapiens,IC50,nM,456.0
7016,17649143,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671584,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
7017,17649144,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3671585,=,nM,419.0,CHEMBL203,Homo sapiens,IC50,nM,419.0
7018,17649145,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676338,=,nM,924.0,CHEMBL203,Homo sapiens,IC50,nM,924.0
7019,17649146,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676339,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7020,17649147,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3639752,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7021,17649148,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676340,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7022,17649149,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676341,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7023,17649150,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676342,=,nM,876.0,CHEMBL203,Homo sapiens,IC50,nM,876.0
7024,17649151,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676343,=,nM,175.0,CHEMBL203,Homo sapiens,IC50,nM,175.0
7025,17649152,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676344,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7026,17649153,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676345,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
7027,17649154,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676346,=,nM,894.0,CHEMBL203,Homo sapiens,IC50,nM,894.0
7028,17649155,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676347,=,nM,568.0,CHEMBL203,Homo sapiens,IC50,nM,568.0
7029,17649156,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676348,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7030,17649157,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676349,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
7031,17649158,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676350,=,nM,796.0,CHEMBL203,Homo sapiens,IC50,nM,796.0
7032,17649159,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676351,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
7033,17649160,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676352,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
7034,17649161,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676353,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
7035,17649162,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676354,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7036,17649163,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676355,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
7037,17649164,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676356,=,nM,321.0,CHEMBL203,Homo sapiens,IC50,nM,321.0
7038,17649165,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676357,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7039,17649166,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676358,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7040,17649167,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676359,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
7041,17649168,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676360,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
7042,17649169,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676361,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7043,17649170,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676362,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7044,17649171,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676363,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
7045,17649172,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676364,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
7046,17649173,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676365,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
7047,17649174,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676366,=,nM,213.0,CHEMBL203,Homo sapiens,IC50,nM,213.0
7048,17649175,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676367,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7049,17649176,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676368,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
7050,17649177,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676369,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
7051,17649178,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676370,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
7052,17649179,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676371,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
7053,17649180,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676372,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,nM,75.0
7054,17649181,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676373,=,nM,222.0,CHEMBL203,Homo sapiens,IC50,nM,222.0
7055,17649182,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676374,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
7056,17649183,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676375,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
7057,17649184,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676376,=,nM,23.1,CHEMBL203,Homo sapiens,IC50,nM,23.1
7058,17649185,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676377,=,nM,286.0,CHEMBL203,Homo sapiens,IC50,nM,286.0
7059,17649186,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676378,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
7060,17649187,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676379,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
7061,17649188,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676380,=,nM,126.0,CHEMBL203,Homo sapiens,IC50,nM,126.0
7062,17649189,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676376,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7063,17649190,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676377,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7064,17649191,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676381,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
7065,17649192,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676382,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7066,17649193,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676383,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
7067,17649194,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676384,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
7068,17649195,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676385,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
7069,17649196,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676386,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
7070,17649197,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676387,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7071,17649198,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676388,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,nM,87.0
7072,17649199,CHEMBL3705421,"Tyrosine Kinase Assay: EGFR1 (HER-1) enzyme assay was carried out by using Tyrosine Kinase Assay Kit Green. The entire assay was conducted in accordance with EGFR PTK inhibitor cellular activity test S.O.P.A typical kinase inhibition reaction requires a protein tyrosine kinase, a suitable buffer solution system, a peptide substrate and ATP. In the present EGFR tyrosine kinase assay, a buffer solution system containing 20 mM HEPES (pH 7.4), 5 mM MgCl2 and 2 mM MnCl2; 50 uM Na3VO4; 50 ng/10 ul EGFR (Proquinase); 100 uM ATP; and 10 ng/ml poly(Glu, Tyr) (4:1, Sigma) as a substrate were used.First, 10 ul of EGFR was added to each well of a 96-well plate, 10 ul of the test compounds diluted as described in Test Example 2 (Examples 1 to 173) was added to each well, and the plate was incubated at room temperature for 10 min. The compounds of Test Example 1 were used as control compounds at a concentration of 0.0001 to 10 uM.",B,CHEMBL3676389,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7073,17657269,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3647417,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
7074,17657270,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3647418,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7075,17657271,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3941626,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
7076,17657272,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3647417,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7077,17657273,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3647421,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7078,17657274,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3952953,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7079,17657275,CHEMBL3705672,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes.",B,CHEMBL3647421,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7080,17658531,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3040566,=,nM,2.71,CHEMBL203,Homo sapiens,IC50,nM,2.71
7081,17658532,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3040548,=,nM,52.67,CHEMBL203,Homo sapiens,IC50,nM,52.67
7082,17658533,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3040455,=,nM,56.24,CHEMBL203,Homo sapiens,IC50,nM,56.24
7083,17658534,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3040597,=,nM,15.54,CHEMBL203,Homo sapiens,IC50,nM,15.54
7084,17658535,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3040543,=,nM,14.61,CHEMBL203,Homo sapiens,IC50,nM,14.61
7085,17658536,CHEMBL3705522,"In Vitro Kinase Assay: In vitro kinase analysis was performed by using HTScan EGF Receptor Kinase Assay Kit (#7909) and HTScan HER2/ErbB2 Kinase Assay Kit (#7058) from Cell Signaling Technology Company. Operation steps refer to the specification of the used kits, and the method was used to measure the inhibition effects of the compound to be tested on substrate peptide phosphorylation of EGFR or Her2 receptor tyrosine kinase. At room temperature, ATP and substrate peptide as well as the compound to be tested were incubated in kinase reaction buffer, after a period of incubation, a stop buffer was added to terminate the reaction and the sample was transferred to a streptavidin-coated 96-well plate, the plate was washed and the phosphorylation level of substrate peptide was detected by using HRP-marked antibody against substrate phosphorylation, colorated with TMB, terminated the reaction with 2M sulfuric acid. Absorption at 450 nm wavelength was detected, and IC50 value (M) was calculated.",B,CHEMBL3666714,=,nM,32.4,CHEMBL203,Homo sapiens,IC50,nM,32.4
7086,17692703,CHEMBL3887169,"Enzyme Assay: BT474 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3960332,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
7087,17692704,CHEMBL3887169,"Enzyme Assay: BT474 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3622645,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
7088,17694618,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663921,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7089,17694619,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663922,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7090,17694620,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663923,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7091,17694621,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663924,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
7092,17694622,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663925,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7093,17694623,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663926,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7094,17694624,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663927,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7095,17694625,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663928,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7096,17694626,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663929,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
7097,17694627,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663930,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7098,17694628,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663931,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
7099,17694629,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663932,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
7100,17694630,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663933,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7101,17694631,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663934,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7102,17694632,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663935,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7103,17694633,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663936,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7104,17694634,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663937,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
7105,17694635,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663921,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7106,17694636,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663922,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
7107,17694637,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663923,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7108,17694638,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663924,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7109,17694639,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663925,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
7110,17694640,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663926,=,nM,0.92,CHEMBL203,Homo sapiens,IC50,nM,0.92
7111,17694641,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663927,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7112,17694642,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663928,=,nM,0.66,CHEMBL203,Homo sapiens,IC50,nM,0.66
7113,17694643,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663929,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
7114,17694644,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663930,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7115,17694645,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663931,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7116,17694646,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663932,=,nM,0.56,CHEMBL203,Homo sapiens,IC50,nM,0.56
7117,17694647,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663933,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7118,17694648,CHEMBL3705896,"Inhibition Assay: The phosphorylation activity on the peptide substrate of EGFR was investigated using LabChip (trademark) Systems (Caliper Life Sciences, Inc.). For the enzyme, EGFR [T790M/L858R] (Carna Biosciences, Inc.) was used. The test compound was added to a reaction liquid containing the enzyme protein to give 8 stages of final concentrations ranging from 300 nM to 0.1 nM, followed by incubation for 2 hours. Then, the substrate and the ATP solution were added thereto, followed by reaction for 1 hour. An ATP concentration of 1000 uM was used. A reaction liquid containing the enzyme protein but no test compound (in which the DMSO alone was added as a solvent at 0.4% in place of the test compound) was prepared, followed by reaction in the same manner with or without ATP addition.",B,CHEMBL3663934,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
7119,17698843,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4113919,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
7120,17698844,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674148,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7121,17698845,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4111809,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0
7122,17698846,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7123,17698847,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674151,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7124,17698848,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7125,17698849,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674152,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7126,17698850,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678946,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7127,17698851,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178351,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7128,17698852,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678947,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7129,17698853,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678948,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7130,17698854,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678949,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7131,17698855,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678950,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7132,17698856,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678951,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7133,17698857,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678952,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7134,17698858,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678953,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7135,17698859,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678954,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7136,17698860,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678955,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7137,17698861,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678956,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
7138,17698862,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178350,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7139,17698863,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178349,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7140,17698864,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178368,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7141,17698865,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178352,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7142,17698866,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678957,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7143,17698867,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678958,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7144,17698868,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678959,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7145,17698869,CHEMBL3887185,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678960,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
7146,17698870,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4113919,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
7147,17698871,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674148,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7148,17698872,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL4111809,=,nM,245.0,CHEMBL203,Homo sapiens,IC50,nM,245.0
7149,17698873,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
7150,17698874,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674151,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7151,17698875,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674150,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7152,17698876,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3674152,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,nM,128.0
7153,17698877,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678946,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7154,17698878,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178351,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
7155,17698879,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678947,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7156,17698880,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678948,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7157,17698881,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678949,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
7158,17698882,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678950,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
7159,17698883,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678951,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7160,17698884,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678952,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7161,17698885,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678953,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
7162,17698886,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678954,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7163,17698887,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678955,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7164,17698888,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678956,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,nM,87.0
7165,17698889,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178350,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
7166,17698890,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178349,=,nM,522.0,CHEMBL203,Homo sapiens,IC50,nM,522.0
7167,17698891,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178368,=,nM,458.0,CHEMBL203,Homo sapiens,IC50,nM,458.0
7168,17698892,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL2178352,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7169,17698893,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678957,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,nM,54.0
7170,17698894,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678958,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,nM,64.0
7171,17698895,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678959,=,nM,228.0,CHEMBL203,Homo sapiens,IC50,nM,228.0
7172,17698896,CHEMBL3887186,"Inhibition Assay: The object of this assay was to test the inventive compounds for the kinase inhibitory activity in vitro. In this assay, an isotopic labeling method was used to label the gamma phosphate group on ATP. EGFR (including wild type, L858R mutant type and L858R/T790M double mutant type), VEGFR2, ALK, BTK, c-KIT, c-SRC, MET, PDGFRalpha and FLT3 kinases were tested in vitro for the activity inhibition. Staurosporine was used as a reference molecule (or referred to as a positive control). The kinase inhibitory activities of the tested compounds were expressed in the IC50 value (half inhibition concentration) or the kinase activity inhibitory rate by the tested compounds at 10 uM. The IC50 value can be obtained by the calculation of the inhibitory rates at a series of different concentrations of the tested compounds. 1. Materials:  20mM 3-(N-morpholinyl)propylsulfonic acid (MOPS);  1mM Ethylenediaminetetraacetic acid (EDTA);  0.01% Polyethylene glycol lauryl ether (Brij-35).",B,CHEMBL3678960,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
7173,17719996,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL1873475,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7174,17720017,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647967,=,nM,20.6,CHEMBL203,Homo sapiens,IC50,nM,20.6
7175,17720078,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL1873475,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7176,17720079,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647970,=,nM,48.8,CHEMBL203,Homo sapiens,IC50,nM,48.8
7177,17720080,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3931858,=,nM,74.5,CHEMBL203,Homo sapiens,IC50,nM,74.5
7178,17720081,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3926657,=,nM,487.6,CHEMBL203,Homo sapiens,IC50,nM,487.6
7179,17720082,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3902180,=,nM,326.0,CHEMBL203,Homo sapiens,IC50,nM,326.0
7180,17720083,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647973,=,nM,60.9,CHEMBL203,Homo sapiens,IC50,nM,60.9
7181,17720084,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3917698,=,nM,268.7,CHEMBL203,Homo sapiens,IC50,nM,268.7
7182,17720085,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3889694,=,nM,83.4,CHEMBL203,Homo sapiens,IC50,nM,83.4
7183,17720086,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647967,=,nM,20.6,CHEMBL203,Homo sapiens,IC50,nM,20.6
7184,17720087,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3912266,=,nM,44.5,CHEMBL203,Homo sapiens,IC50,nM,44.5
7185,17720088,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3903870,=,nM,18.85,CHEMBL203,Homo sapiens,IC50,nM,18.85
7186,17720089,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3903249,=,nM,698.3,CHEMBL203,Homo sapiens,IC50,nM,698.3
7187,17720090,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL4109796,=,nM,18.75,CHEMBL203,Homo sapiens,IC50,nM,18.75
7188,17720091,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3910496,=,nM,2.298,CHEMBL203,Homo sapiens,IC50,nM,2.298
7189,17720092,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL4107879,=,nM,289.4,CHEMBL203,Homo sapiens,IC50,nM,289.4
7190,17720093,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3905432,=,nM,2807.0,CHEMBL203,Homo sapiens,IC50,nM,2807.0
7191,17720094,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL4106607,=,nM,435.3,CHEMBL203,Homo sapiens,IC50,nM,435.3
7192,17720095,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3893004,=,nM,22.53,CHEMBL203,Homo sapiens,IC50,nM,22.53
7193,17720096,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3921017,=,nM,28.22,CHEMBL203,Homo sapiens,IC50,nM,28.22
7194,17720097,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3982014,=,nM,303.6,CHEMBL203,Homo sapiens,IC50,nM,303.6
7195,17720098,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3915538,=,nM,6238.0,CHEMBL203,Homo sapiens,IC50,nM,6238.0
7196,17720099,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3921655,=,nM,156.3,CHEMBL203,Homo sapiens,IC50,nM,156.3
7197,17720100,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3894938,=,nM,70.49,CHEMBL203,Homo sapiens,IC50,nM,70.49
7198,17720101,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL4110614,=,nM,383.7,CHEMBL203,Homo sapiens,IC50,nM,383.7
7199,17720102,CHEMBL3887533,"HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3894102,=,nM,272.9,CHEMBL203,Homo sapiens,IC50,nM,272.9
7200,17721221,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL4112924,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7201,17721222,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL3892310,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
7202,17721223,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL4110258,=,nM,0.54,CHEMBL203,Homo sapiens,IC50,nM,0.54
7203,17721224,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL3901296,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
7204,17721225,CHEMBL3887593,"Time-Resolved Fret (TR-FRET) Assay: 1) The compound is dissolved in DMSO to prepare a 10 mM solution, and was diluted to 100 micoM with water. When used for IC50 measurement, series dilutions of 10 fold from 100 micoM are used. Kinase activity was determined with time-resolved Fret (TR-FRET) assay (LanthaScreen kinase activity assay, from InVitrogen).2) The assay is performed in a Black 384-well plate (from Corning). The kinase and the compound was incubated for 30 mM at room temperature. ATP (1 mM) and fluorescein-poly GT were added, and the reaction was incubated for 15 mM. Detection agent SA-XL665 (from Cisbio Assay) and TK Ab-Cryptate detection antibody (from InVitrogen) were added to stop the reaction.3) The 384-well plate was sealed and incubated for 1 hour. The fluorescence was then measured at 620 nM (Cryptate) and 665 nM (XL655) wavelength.4) Each concentration of compound was done in triplicate, and vehicle (without compound) and a positive control were used.",B,CHEMBL3895468,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nM,0.37
7205,17734085,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3903641,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7206,17734086,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3978161,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7207,17734087,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954684,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7208,17734088,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3986363,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7209,17734089,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954273,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7210,17734090,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3894076,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
7211,17734091,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3944027,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7212,17734092,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3973862,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7213,17734093,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3947802,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7214,17734094,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3985134,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7215,17734095,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3956465,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7216,17734096,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3975588,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
7217,17734097,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3904778,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7218,17734098,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3894076,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
7219,17734099,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3913778,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7220,17734100,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3891187,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7221,17734101,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3919271,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
7222,17734102,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3903707,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
7223,17734103,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3928176,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7224,17734104,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3910422,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
7225,17734105,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3938358,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7226,17734106,CHEMBL3887857,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954906,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,nM,200.0
7227,17734108,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3903641,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7228,17734109,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3978161,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7229,17734110,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954684,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7230,17734111,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3986363,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7231,17734112,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954273,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7232,17734113,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3894076,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7233,17734114,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3944027,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7234,17734115,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3973862,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7235,17734116,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3947802,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7236,17734117,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3985134,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7237,17734118,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3956465,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7238,17734119,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3975588,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7239,17734120,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3904778,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7240,17734121,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3894076,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7241,17734122,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3913778,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7242,17734123,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3891187,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7243,17734124,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3919271,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
7244,17734125,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3903707,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7245,17734126,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3928176,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7246,17734127,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3910422,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7247,17734128,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3938358,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7248,17734129,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3954906,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
7249,17734130,CHEMBL3887858,"Omnia Assay: Briefly, 10x stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13x ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1x kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10x stock, KB002A) and 0.2 mM DTT (DS001A). 5 uL of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25 C. with a 0.5 uL volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 uL of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.). At the conclusion of each assay, progress curves from each well were examined for linear reaction kinetics and fit statistics.",B,CHEMBL3930810,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7250,17758419,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL1873475,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7251,17758440,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647967,=,nM,20.6,CHEMBL203,Homo sapiens,IC50,nM,20.6
7252,17758501,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL1873475,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7253,17758502,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647970,=,nM,48.8,CHEMBL203,Homo sapiens,IC50,nM,48.8
7254,17758503,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3931858,=,nM,74.5,CHEMBL203,Homo sapiens,IC50,nM,74.5
7255,17758504,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3926657,=,nM,487.6,CHEMBL203,Homo sapiens,IC50,nM,487.6
7256,17758505,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3902180,=,nM,326.0,CHEMBL203,Homo sapiens,IC50,nM,326.0
7257,17758506,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647973,=,nM,60.9,CHEMBL203,Homo sapiens,IC50,nM,60.9
7258,17758507,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3917698,=,nM,268.7,CHEMBL203,Homo sapiens,IC50,nM,268.7
7259,17758508,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3889694,=,nM,83.4,CHEMBL203,Homo sapiens,IC50,nM,83.4
7260,17758509,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3647967,=,nM,20.6,CHEMBL203,Homo sapiens,IC50,nM,20.6
7261,17758510,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3912266,=,nM,44.5,CHEMBL203,Homo sapiens,IC50,nM,44.5
7262,17758511,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL4107818,=,nM,18.85,CHEMBL203,Homo sapiens,IC50,nM,18.85
7263,17758512,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3903249,=,nM,698.3,CHEMBL203,Homo sapiens,IC50,nM,698.3
7264,17758513,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3910496,=,nM,18.75,CHEMBL203,Homo sapiens,IC50,nM,18.75
7265,17758514,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3910496,=,nM,2.298,CHEMBL203,Homo sapiens,IC50,nM,2.298
7266,17758515,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3905432,=,nM,289.4,CHEMBL203,Homo sapiens,IC50,nM,289.4
7267,17758516,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3905432,=,nM,2807.0,CHEMBL203,Homo sapiens,IC50,nM,2807.0
7268,17758517,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3929922,=,nM,435.3,CHEMBL203,Homo sapiens,IC50,nM,435.3
7269,17758518,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3980550,=,nM,22.53,CHEMBL203,Homo sapiens,IC50,nM,22.53
7270,17758519,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3921017,=,nM,28.22,CHEMBL203,Homo sapiens,IC50,nM,28.22
7271,17758520,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3982014,=,nM,303.6,CHEMBL203,Homo sapiens,IC50,nM,303.6
7272,17758521,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3915538,=,nM,6238.0,CHEMBL203,Homo sapiens,IC50,nM,6238.0
7273,17758522,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3921655,=,nM,156.3,CHEMBL203,Homo sapiens,IC50,nM,156.3
7274,17758523,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3894938,=,nM,70.49,CHEMBL203,Homo sapiens,IC50,nM,70.49
7275,17758524,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3968716,=,nM,383.7,CHEMBL203,Homo sapiens,IC50,nM,383.7
7276,17758525,CHEMBL3888240,"In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.",B,CHEMBL3894102,=,nM,272.9,CHEMBL203,Homo sapiens,IC50,nM,272.9
7277,17772641,CHEMBL3888516,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",B,CHEMBL3647417,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7278,17772642,CHEMBL3888516,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",B,CHEMBL3647418,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7279,17772643,CHEMBL3888516,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",B,CHEMBL3647419,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
7280,17772644,CHEMBL3888516,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",B,CHEMBL3647420,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
7281,17772645,CHEMBL3888516,"Cell Proliferation Inhibition Assay: The following in vitro assay is to determine the activity of the tested compounds for inhibiting the proliferation of cancer cells, which has high expression of EGFR. The activity is represented by the IC50 value. The general procedures of the assay are given as follows: The cancer cells A431 that highly expressing EGFR (Institute of biochemistry and cell biology) were chosen and seeded to 96-well cell culture plate at a suitable concentration (e.g., 5000 cells/mL medium). The cells then were incubated in carbon dioxide (CO2) incubator until they reached 85% confluency. Then, the cell culture medium was replaced by fresh one with tested compounds added in it at serial concentrations (general 6 to 7 concentrations). Then the cells were put back to the incubator and cultured continuously. 72 hours later, the activity of the tested compounds for inhibiting the cell proliferation was determined by using Sulforhodamine B (SRB) method.",B,CHEMBL3647423,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
7282,17772646,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647417,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
7283,17772647,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647418,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7284,17772648,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647419,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
7285,17772649,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647420,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7286,17772650,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647421,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7287,17772651,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647422,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7288,17772652,CHEMBL3888517,"Time-Resolved Fluorescence Assay: The following assay may be used to determine the activity of the compounds of the invention for inhibiting EGFR kinase activity. The half maximal inhibitory concentration IC50 (the concentration of the tested compound showing 50% inhibition of the enzyme activity) of each compound was determined by incubating several different concentrations of the tested compounds with a specific enzyme and substrate. EGFR kinase used in this assay is a human-derived recombinant protein (Cell signaling technology, #7908), which was reacted with peptide substrate and different concentrations of tested compounds in a buffer solution containing 60 mM HEPES (pH7.5), 5 mM MgCl2, 5 mM MnCl2, 3 M Na3VO4, 1.25 M DTT (1000) and 20 M ATP at 25 C., for 45 minutes. The EGFR kinase activity was determined by using a Time-Resolved fluorescence method.",B,CHEMBL3647423,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7289,17775376,CHEMBL3888588,"Enzyme Assay: BT474 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL1173655,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
7290,17775377,CHEMBL3888589,"Enzyme Assay: A431 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3622645,=,nM,3099.0,CHEMBL203,Homo sapiens,IC50,nM,3099.0
7291,17775378,CHEMBL3888588,"Enzyme Assay: BT474 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3622645,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
7292,17775379,CHEMBL3888589,"Enzyme Assay: A431 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3960332,=,nM,1791.0,CHEMBL203,Homo sapiens,IC50,nM,1791.0
7293,17775380,CHEMBL3888588,"Enzyme Assay: BT474 Cell Line: 1. 5103 cells per well in 100 l of medium were seeded in 96-well plate, here the medium contained 5% FBS2. 24 hours later, 100 l fresh medium was added with various concentrations of compounds into each well, while the medium here was free of FBS.3. After the cells were treated with compounds for 72 hours, 20 l MTT (5 mg/ml) was added into each well, and then the assay plate was incubated at 37 C. for 4 more hours.4. The assay plate was centrifuged at 800 g for 10 min. The medium was aspirated, 150 l DMSO was added into each well. The plate was gently shaken for 10 min.5. The absorbance at 570 nm was measured on the plate reader.6. IR %=(WCWT)/WC100%.",B,CHEMBL3960332,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
7294,17775382,CHEMBL3888591,"Luminescence Kinase Assay: The assay was performed using Kinase-Glo Plus luminescence kinase assay kit (Promega). The compounds were diluted in 10% DMSO and 5 l of the dilution was added to a 50 l reaction so that the final concentration of DMSO is 1% in all of reactions. All of the enzymatic reactions were conducted at 30 C. for 25 minutes. The 50 l reaction mixture contains 40 mM Tris, pH 7.4, 10 mM MgCl2, 0.1 mg/ml BSA, 1 mM DTT, 0.2 mg/ml Poly (Glu, Tyr) substrate, 10 M ATP and EGFR (Table 2.3.1). After the enzymatic reaction, 50 l of Kinase-Glo Plus Luminescence kinase assay solution (Promega) was added to each reaction and incubate the plate for 5 minutes at room temperature. Luminescence signal was measured using a BioTek Synergy 2 microplate reader. EGFR activity assays were performed in duplicate at each concentration.",B,CHEMBL3622672,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7295,17775384,CHEMBL3888591,"Luminescence Kinase Assay: The assay was performed using Kinase-Glo Plus luminescence kinase assay kit (Promega). The compounds were diluted in 10% DMSO and 5 l of the dilution was added to a 50 l reaction so that the final concentration of DMSO is 1% in all of reactions. All of the enzymatic reactions were conducted at 30 C. for 25 minutes. The 50 l reaction mixture contains 40 mM Tris, pH 7.4, 10 mM MgCl2, 0.1 mg/ml BSA, 1 mM DTT, 0.2 mg/ml Poly (Glu, Tyr) substrate, 10 M ATP and EGFR (Table 2.3.1). After the enzymatic reaction, 50 l of Kinase-Glo Plus Luminescence kinase assay solution (Promega) was added to each reaction and incubate the plate for 5 minutes at room temperature. Luminescence signal was measured using a BioTek Synergy 2 microplate reader. EGFR activity assays were performed in duplicate at each concentration.",B,CHEMBL3622672,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
7296,17779174,CHEMBL3888772,"Omnia Assay: Briefly, 10 stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1 kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10 stock, KB002A) and 0.2 mM DTT (DS001A). 5 L of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25ree; C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 L of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3985592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7297,17779175,CHEMBL3888772,"Omnia Assay: Briefly, 10 stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1 kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10 stock, KB002A) and 0.2 mM DTT (DS001A). 5 L of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25ree; C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 L of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3956925,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7298,17779176,CHEMBL3888772,"Omnia Assay: Briefly, 10 stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1 kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10 stock, KB002A) and 0.2 mM DTT (DS001A). 5 L of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25ree; C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 L of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3967836,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7299,17779177,CHEMBL3888772,"Omnia Assay: Briefly, 10 stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1 kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10 stock, KB002A) and 0.2 mM DTT (DS001A). 5 L of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25ree; C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 L of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3962343,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7300,17779178,CHEMBL3888772,"Omnia Assay: Briefly, 10 stocks of EGFR-WT (PV3872) from Invitrogen and EGFR-T790M/L858R (40350) from BPS Bioscience, San Diego, Calif., 1.13ATP (AS001A) and appropriate Tyr-Sox conjugated peptide substrates (KCZ1001) were prepared in 1 kinase reaction buffer consisting of 20 mM Tris, pH 7.5, 5 mM MgCl2, 1 mM EGTA, 5 mM -glycerophosphate, 5% glycerol (10 stock, KB002A) and 0.2 mM DTT (DS001A). 5 L of each enzyme were pre-incubated in a Corning (#3574) 384-well, white, non-binding surface microtiter plate (Corning, N.Y.) for 30 min. at 25ree; C. with a 0.5 L volume of 50% DMSO and serially diluted compounds prepared in 50% DMSO. Kinase reactions were started with the addition of 45 L of the ATP/Tyr-Sox peptide substrate mix and monitored every 71 seconds for 60 minutes at ex360/em485 in a Synergy4 plate reader from BioTek (Winooski, Vt.).",B,CHEMBL3973190,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7301,17780693,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316140,=,nM,1680.0,CHEMBL203,Homo sapiens,IC50,nM,1680.0
7302,17780694,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316141,=,nM,2270.0,CHEMBL203,Homo sapiens,IC50,nM,2270.0
7303,17780695,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316142,=,nM,1540.0,CHEMBL203,Homo sapiens,IC50,nM,1540.0
7304,17780696,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316143,=,nM,2170.0,CHEMBL203,Homo sapiens,IC50,nM,2170.0
7305,17780697,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316144,=,nM,8080.0,CHEMBL203,Homo sapiens,IC50,nM,8080.0
7306,17780698,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316145,=,nM,6850.0,CHEMBL203,Homo sapiens,IC50,nM,6850.0
7307,17780699,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316146,=,nM,7120.0,CHEMBL203,Homo sapiens,IC50,nM,7120.0
7308,17780700,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316147,=,nM,5690.0,CHEMBL203,Homo sapiens,IC50,nM,5690.0
7309,17780701,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316148,=,nM,15320.0,CHEMBL203,Homo sapiens,IC50,nM,15320.0
7310,17780702,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316149,=,nM,7520.0,CHEMBL203,Homo sapiens,IC50,nM,7520.0
7311,17780703,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316150,=,nM,6130.0,CHEMBL203,Homo sapiens,IC50,nM,6130.0
7312,17780704,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316151,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,nM,430.0
7313,17780705,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316152,=,nM,20890.0,CHEMBL203,Homo sapiens,IC50,nM,20890.0
7314,17780706,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316153,=,nM,4660.0,CHEMBL203,Homo sapiens,IC50,nM,4660.0
7315,17780707,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316154,=,nM,3980.0,CHEMBL203,Homo sapiens,IC50,nM,3980.0
7316,17780708,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316155,=,nM,5370.0,CHEMBL203,Homo sapiens,IC50,nM,5370.0
7317,17780709,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL3982407,=,nM,18670.0,CHEMBL203,Homo sapiens,IC50,nM,18670.0
7318,17780710,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316157,=,nM,2080.0,CHEMBL203,Homo sapiens,IC50,nM,2080.0
7319,17780711,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316158,=,nM,1960.0,CHEMBL203,Homo sapiens,IC50,nM,1960.0
7320,17780712,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL2316159,=,nM,4810.0,CHEMBL203,Homo sapiens,IC50,nM,4810.0
7321,17780713,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL140,=,nM,8650.0,CHEMBL203,Homo sapiens,IC50,nM,8650.0
7322,17780714,CHEMBL3888815,"Time-Resolved Fluorescence Assay: The kinase activity of EGFR was detected according to time-resolved fluorescence detection technology to evaluate automatic phosphorylation levels. The test compound was dissolved in 100% DMSO, diluted with 25 mM HEPES (pH=7.4) to the desired concentration, added into each well with 10 L of the test compounds and 10 L solution containing 5 ng EGFR, then cultured for 10 min at room temperature using the recombinase diluted by 100 mM HEPES with a dilution ratio of 1:80, subsequently added with 10 L solution containing 20 mM HEPES, 2 mM MnCl2, 100 M Na3VO4, 1 mM DTT buffer, and 20 L of 0.1 mM ATP and 50 mM MgCl2 and cultured for 1 h. The positive group in each plate was added with ATP-MgCl2 enzyme, the negative control group without adding with ATP-MgCl2 enzyme, the liquid was sucked out completely after cultured for 1 h, and each well was washed with buffer for three times. The wells were added with 75 L anti-phosphorylated tyrosine antibody containing 400 ng europium labeling and cultured 1 h, washed, then added with enhancing solution. At the excitation wavelength 340 nm and the emission wavelength 615 nm, the fluorescence intensities were detected by using Victor type 2 time-resolved luminoscope, wherein the inhibitory rate of the compound on automatic phosphorylation: the inhibitory rate of autophosphorylation=100%[(negative control)/(positive controlnegative control)].",B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
7323,17784807,CHEMBL3888879,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
7324,17784808,CHEMBL3888880,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,nM,2000.0
7325,17784809,CHEMBL3888881,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
7326,17784810,CHEMBL3888882,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,1780.0,CHEMBL203,Homo sapiens,IC50,nM,1780.0
7327,17784814,CHEMBL3888879,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
7328,17784815,CHEMBL3888885,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
7329,17784816,CHEMBL3888886,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
7330,17784817,CHEMBL3888887,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,nM,91.0
7331,17784818,CHEMBL3888888,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,nM,1400.0
7332,17784819,CHEMBL3888889,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,nM,2600.0
7333,17784820,CHEMBL3888881,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,nM,67.0
7334,17784821,CHEMBL3888890,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
7335,17784822,CHEMBL3888880,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,nM,3300.0
7336,17784823,CHEMBL3888882,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,nM,2800.0
7337,17784824,CHEMBL3888879,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL2011291,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,nM,210.0
7338,17784830,CHEMBL3888879,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7339,17784831,CHEMBL3888885,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
7340,17784832,CHEMBL3888886,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7341,17784833,CHEMBL3888887,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
7342,17784834,CHEMBL3888888,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7343,17784835,CHEMBL3888889,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
7344,17784836,CHEMBL3888881,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7345,17784837,CHEMBL3888890,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7346,17784838,CHEMBL3888880,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,nM,280.0
7347,17784839,CHEMBL3888882,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,nM,3100.0
7348,17784840,CHEMBL3888879,"Kinase Assay: FlashPlates from Perkin Elmer (Boston, Mass., USA) with a 50 l reaction volume are used. The reaction cocktail was pipetted in 4 steps in the following order: 15 l of ATP solution (in H2O), 20 l of assay buffer (see below), 5 l of test sample in 10% DMSO, 10 l of enzyme/substrate mixture (in H2O). The assay for all enzymes contained 60 mM HEPES-NaOH, pH 7.5, 3 mM MgCl2, 3 mM MnCl2, 3 M Na-orthovanadate, 1.2 mM DTT, 50 g/ml PEG20000, 1 M [-33P]-ATP (approx. 810^5 cpm per well), protein kinase (variable amounts; see Table 1), and substrate (variable amounts). Certain assays also contained 1 mM CaCl2, 4 mM EDTA, 5 g/ml Phosphatidylserine and 1 g/ml 1.2-Dioleyl-glycerol. The MYLK2, CAMK1D, CAMK2A, CAMK2B, CAMK2D, CAMK4, CAMKK2, DAPK2 and EEF2K assays additionally contained 1 g/ml Calmodulin and 0.5 mM CaCl2. The PRKG1 and PRKG2 assays additionally contained 1 M cGMP. Recombinant Protein Kinases: All protein kinases were expressed in Sf9 insect cells or in E. coli as recombinant GST-fusion proteins or His-tagged proteins. All kinases were produced from human cDNAs, except JAK2, for which the mouse cDNA was used. Kinases were purified by affinity chromatography using either GSH-agarose (Sigma) or Ni-NTH-agarose (Qiagen). The purity of the protein kinases was examined by SDS-PAGE/coomassie staining. The identity of the protein kinases was checked by mass spectroscopy. Assays were made under license from Chemicon International Inc. for JAK2. The reaction cocktails were incubated at 30 C. for 80 minutes. The reaction was stopped with 50 l of 2% (v/v) H3PO4, plates were aspirated and washed two times with 200 l 0.9% (w/v) NaCl. All assays were performed with a BeckmanCoulter Biomek 2000/SL robotic system. Incorporation of 33Pi (counting of ""cpm"") was determined with a microplate scintillation counter (Microbeta, Wallac).",B,CHEMBL939,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7349,17786102,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL1093099,=,nM,15070.0,CHEMBL203,Homo sapiens,IC50,nM,15070.0
7350,17786116,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL2047245,=,nM,42600.0,CHEMBL203,Homo sapiens,IC50,nM,42600.0
7351,17786117,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL2047248,=,nM,24100.0,CHEMBL203,Homo sapiens,IC50,nM,24100.0
7352,17786118,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL2047253,=,nM,11700.0,CHEMBL203,Homo sapiens,IC50,nM,11700.0
7353,17786119,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL2047247,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,nM,26000.0
7354,17786120,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL2047242,=,nM,19600.0,CHEMBL203,Homo sapiens,IC50,nM,19600.0
7355,17786121,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL29197,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,nM,230.0
7356,17786122,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL285063,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
7357,17786149,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL3970063,=,nM,45100.0,CHEMBL203,Homo sapiens,IC50,nM,45100.0
7358,17786150,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL3902576,=,nM,98800.0,CHEMBL203,Homo sapiens,IC50,nM,98800.0
7359,17786153,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL3948546,=,nM,23000.0,CHEMBL203,Homo sapiens,IC50,nM,23000.0
7360,17786154,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL3985894,=,nM,232700.0,CHEMBL203,Homo sapiens,IC50,nM,232700.0
7361,17786157,CHEMBL3888922,Inhibition Assay: Inhibition of various kinase enzyme.,B,CHEMBL285063,=,nM,521.0,CHEMBL203,Homo sapiens,IC50,nM,521.0
7362,17791532,CHEMBL3889034,Inhibition Assay: Inhibition of recombinant EGFR tyrosine kinase using exogenous substrate.,B,CHEMBL253969,=,nM,5853.4,CHEMBL203,Homo sapiens,IC50,nM,5853.4
7363,17956893,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4077956,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
7364,17956894,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4084847,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
7365,17956895,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4069003,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
7366,17956896,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4090083,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
7367,17956897,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4060320,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
7368,17956898,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4091626,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
7369,17956899,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4087646,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7370,17956900,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4105530,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
7371,17956901,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4079768,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
7372,17956902,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4097795,=,nM,5.7,CHEMBL203,Homo sapiens,IC50,nM,5.7
7373,17956903,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4097216,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,nM,75.0
7374,17956904,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4078431,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
7375,17956905,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4080720,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7376,17956906,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4104950,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7377,17956907,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4070053,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
7378,17956908,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4097245,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
7379,17956909,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL4061382,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
7380,17956910,CHEMBL3993803,"Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly (Glu, Tyr) as substrate after 40 mins in presence of ATP by luminescence assay",B,CHEMBL388978,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
7381,17967041,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4103370,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
7382,17967042,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4079125,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
7383,17967043,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4095623,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,uM,25.0
7384,17967044,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4068254,=,nM,31800.0,CHEMBL203,Homo sapiens,IC50,uM,31.8
7385,17967045,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4087921,=,nM,46300.0,CHEMBL203,Homo sapiens,IC50,uM,46.3
7386,17967047,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4094471,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
7387,17967048,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4074782,=,nM,39700.0,CHEMBL203,Homo sapiens,IC50,uM,39.7
7388,17967050,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4065301,=,nM,61000.0,CHEMBL203,Homo sapiens,IC50,uM,61.0
7389,17967053,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4102214,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
7390,17967054,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4084249,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,uM,0.098
7391,17967058,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4068814,=,nM,65400.0,CHEMBL203,Homo sapiens,IC50,uM,65.4
7392,17967059,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4094647,=,nM,70000.0,CHEMBL203,Homo sapiens,IC50,uM,70.0
7393,17967061,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4066118,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
7394,17967062,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4087489,=,nM,86200.0,CHEMBL203,Homo sapiens,IC50,uM,86.2
7395,17967063,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4074726,=,nM,73500.0,CHEMBL203,Homo sapiens,IC50,uM,73.5
7396,17967064,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4095195,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,uM,50.0
7397,17967065,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4084996,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,uM,0.98
7398,17967066,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4102942,=,nM,45100.0,CHEMBL203,Homo sapiens,IC50,uM,45.1
7399,17967069,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL4083493,=,nM,33200.0,CHEMBL203,Homo sapiens,IC50,uM,33.2
7400,17967070,CHEMBL3995335,Inhibition of EGF induced EGFR phosphorylation in human KB cells preincubated for 90 mins followed by EGF addition for 5 mins by sandwich ELISA method,B,CHEMBL939,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
7401,17979737,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4098409,=,nM,167.1,CHEMBL203,Homo sapiens,IC50,nM,167.1
7402,17979738,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4069672,=,nM,33.6,CHEMBL203,Homo sapiens,IC50,nM,33.6
7403,17979739,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4099682,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
7404,17979740,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4060996,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
7405,17979741,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4104515,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
7406,17979742,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4099329,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7407,17979743,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL4072383,=,nM,47.1,CHEMBL203,Homo sapiens,IC50,nM,47.1
7408,17979747,CHEMBL3998244,Inhibition of EGFR in human A431 cells assessed as reduction in EGF induced phosphorylation preincubated for 60 mins followed by EGF addition measured after 10 mins by ELISA method,B,CHEMBL553,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7409,17979966,CHEMBL3998355,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4092990,=,nM,16.8,CHEMBL203,Homo sapiens,IC50,nM,16.8
7410,17989460,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4100647,=,nM,11.42,CHEMBL203,Homo sapiens,IC50,nM,11.42
7411,17989461,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4094174,=,nM,83.82,CHEMBL203,Homo sapiens,IC50,nM,83.82
7412,17989462,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4067373,=,nM,379.7,CHEMBL203,Homo sapiens,IC50,nM,379.7
7413,17989463,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4094823,=,nM,32.35,CHEMBL203,Homo sapiens,IC50,nM,32.35
7414,17989464,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4082840,=,nM,94.72,CHEMBL203,Homo sapiens,IC50,nM,94.72
7415,17989465,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4088200,=,nM,177.8,CHEMBL203,Homo sapiens,IC50,nM,177.8
7416,17989466,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4091166,=,nM,169.4,CHEMBL203,Homo sapiens,IC50,nM,169.4
7417,17989467,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4063301,=,nM,6.13,CHEMBL203,Homo sapiens,IC50,nM,6.13
7418,17989469,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL343352,=,nM,3.38,CHEMBL203,Homo sapiens,IC50,nM,3.38
7419,17989470,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL939,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
7420,17989471,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4100647,=,nM,17.15,CHEMBL203,Homo sapiens,IC50,nM,17.15
7421,17989472,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4094174,=,nM,112.2,CHEMBL203,Homo sapiens,IC50,nM,112.2
7422,17989473,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4067373,=,nM,373.7,CHEMBL203,Homo sapiens,IC50,nM,373.7
7423,17989474,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4094823,=,nM,48.9,CHEMBL203,Homo sapiens,IC50,nM,48.9
7424,17989475,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4082840,=,nM,112.4,CHEMBL203,Homo sapiens,IC50,nM,112.4
7425,17989476,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4088200,=,nM,235.6,CHEMBL203,Homo sapiens,IC50,nM,235.6
7426,17989477,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4091166,=,nM,132.1,CHEMBL203,Homo sapiens,IC50,nM,132.1
7427,17989478,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4063301,=,nM,6.963,CHEMBL203,Homo sapiens,IC50,nM,6.963
7428,17989480,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL343352,=,nM,4.053,CHEMBL203,Homo sapiens,IC50,nM,4.053
7429,17989481,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL939,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
7430,17989522,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4082840,=,nM,117.5,CHEMBL203,Homo sapiens,IC50,nM,117.5
7431,17989523,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4082840,=,nM,174.9,CHEMBL203,Homo sapiens,IC50,nM,174.9
7432,17989529,CHEMBL3999845,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-Lyte assay,B,CHEMBL4088200,=,nM,127.8,CHEMBL203,Homo sapiens,IC50,nM,127.8
7433,17989530,CHEMBL3999846,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain (695-end residues) expressed in insect cells by Z'-Lyte assay,B,CHEMBL4088200,=,nM,146.2,CHEMBL203,Homo sapiens,IC50,nM,146.2
7434,17998426,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3545308,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
7435,17998427,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
7436,17998428,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3633143,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
7437,17998429,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4082515,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
7438,17998430,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4064475,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
7439,17998431,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4086000,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7440,17998432,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4063421,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
7441,17998433,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4091276,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7442,17998434,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4072048,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
7443,17998435,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4099008,=,nM,63.8,CHEMBL203,Homo sapiens,IC50,nM,63.8
7444,17998436,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4093766,=,nM,91.8,CHEMBL203,Homo sapiens,IC50,nM,91.8
7445,17998437,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4073062,=,nM,436.3,CHEMBL203,Homo sapiens,IC50,nM,436.3
7446,17998439,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4083486,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
7447,17998440,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4078120,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
7448,17998441,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4102389,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
7449,17998442,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4079861,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
7450,17998443,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4097883,=,nM,17.7,CHEMBL203,Homo sapiens,IC50,nM,17.7
7451,17998444,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4087740,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
7452,17998445,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4105621,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
7453,17998446,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4095439,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
7454,17998447,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4068047,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7455,17998448,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4103194,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7456,17998449,CHEMBL4001768,"Inhibition of N-terminal 6His/TEV protease cleavage site-tagged human EGFR L858R/T790M double mutant (696 to 1022 residues) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4078914,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
7457,18003765,CHEMBL4002953,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu4, Tyr) as substrate after 60 mins by ADP-glo kinase assay",B,CHEMBL4105434,=,nM,23700.0,CHEMBL203,Homo sapiens,IC50,uM,23.7
7458,18028152,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL554,=,nM,27.06,CHEMBL203,Homo sapiens,IC50,nM,27.06
7459,18028153,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4066845,=,nM,23.99,CHEMBL203,Homo sapiens,IC50,nM,23.99
7460,18028154,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4088135,=,nM,34.16,CHEMBL203,Homo sapiens,IC50,nM,34.16
7461,18028156,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3542268,=,nM,5.06,CHEMBL203,Homo sapiens,IC50,nM,5.06
7462,18028158,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4089347,=,nM,15.69,CHEMBL203,Homo sapiens,IC50,nM,15.69
7463,18028164,CHEMBL4007059,"Inhibition of wild type recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL939,=,nM,3.22,CHEMBL203,Homo sapiens,IC50,nM,3.22
7464,18029896,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4060383,=,nM,20000.0,CHEMBL203,Homo sapiens,IC50,uM,20.0
7465,18029897,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4088617,=,nM,167300.0,CHEMBL203,Homo sapiens,IC50,uM,167.3
7466,18029898,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4069070,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
7467,18029899,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4096329,=,nM,20800.0,CHEMBL203,Homo sapiens,IC50,uM,20.8
7468,18029900,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4079829,=,nM,8300.0,CHEMBL203,Homo sapiens,IC50,uM,8.3
7469,18029901,CHEMBL4007193,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 60 mins followed by EGF induction measured after 10 mins by ELISA,B,CHEMBL4087709,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
7470,18039936,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4097594,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7471,18039937,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4079566,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
7472,18039938,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4089863,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7473,18039939,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4068763,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7474,18039940,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4082000,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
7475,18039941,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4060103,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
7476,18039942,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4071463,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7477,18039943,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4098500,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
7478,18039944,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4103757,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7479,18039945,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4079501,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7480,18039946,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4080424,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
7481,18039947,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4098444,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,nM,4.8
7482,18039948,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4088277,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7483,18039949,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4060039,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
7484,18039950,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4061043,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
7485,18039951,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7486,18039952,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL3545308,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
7487,18039953,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL939,=,nM,188.0,CHEMBL203,Homo sapiens,IC50,nM,188.0
7488,18039955,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4074766,=,nM,462.0,CHEMBL203,Homo sapiens,IC50,nM,462.0
7489,18039956,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4069284,=,nM,9726.0,CHEMBL203,Homo sapiens,IC50,nM,9726.0
7490,18039957,CHEMBL4009508,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4090330,=,nM,2626.0,CHEMBL203,Homo sapiens,IC50,nM,2626.0
7491,18039958,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4097594,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
7492,18039959,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4079566,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7493,18039960,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4089863,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7494,18039961,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4068763,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7495,18039962,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4082000,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
7496,18039963,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4060103,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
7497,18039964,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4071463,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7498,18039965,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4098500,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
7499,18039966,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4103757,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
7500,18039967,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4079501,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7501,18039968,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4080424,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
7502,18039969,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4098444,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
7503,18039970,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4088277,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7504,18039971,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4060039,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7505,18039972,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4061043,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
7506,18039973,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL3353410,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7507,18039974,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL3545308,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7508,18039975,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7509,18039977,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4074766,=,nM,3352.0,CHEMBL203,Homo sapiens,IC50,nM,3352.0
7510,18039978,CHEMBL4009507,Inhibition of human N-terminal GST-tagged EGFR L858R mutant cytoplasmic domain (669 to 1210 end amino acid residues) expressed in baculovirus expression system using TK peptide substrate preincubated with enzyme for 30 mins followed by substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4069284,=,nM,8470.0,CHEMBL203,Homo sapiens,IC50,nM,8470.0
7511,18048449,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4088718,=,nM,17.2,CHEMBL203,Homo sapiens,IC50,nM,17.2
7512,18048450,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL3132872,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
7513,18048451,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL3133904,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
7514,18048452,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4097369,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
7515,18048454,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL939,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7516,18048457,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4091921,=,nM,11.4,CHEMBL203,Homo sapiens,IC50,nM,11.4
7517,18048458,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4072769,=,nM,36.8,CHEMBL203,Homo sapiens,IC50,nM,36.8
7518,18048465,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4080711,=,nM,63.6,CHEMBL203,Homo sapiens,IC50,nM,63.6
7519,18048471,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4076434,=,nM,15.8,CHEMBL203,Homo sapiens,IC50,nM,15.8
7520,18048472,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4102455,=,nM,15.8,CHEMBL203,Homo sapiens,IC50,nM,15.8
7521,18048473,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4078182,=,nM,20.6,CHEMBL203,Homo sapiens,IC50,nM,20.6
7522,18048474,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4097862,=,nM,19.5,CHEMBL203,Homo sapiens,IC50,nM,19.5
7523,18048475,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4075530,=,nM,8.9,CHEMBL203,Homo sapiens,IC50,nM,8.9
7524,18048476,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4075103,=,nM,9.5,CHEMBL203,Homo sapiens,IC50,nM,9.5
7525,18048477,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4101774,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7526,18048478,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4066504,=,nM,25.3,CHEMBL203,Homo sapiens,IC50,nM,25.3
7527,18048480,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4093114,=,nM,112.4,CHEMBL203,Homo sapiens,IC50,nM,112.4
7528,18048482,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4085352,=,nM,60.7,CHEMBL203,Homo sapiens,IC50,nM,60.7
7529,18048484,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4088760,=,nM,35.4,CHEMBL203,Homo sapiens,IC50,nM,35.4
7530,18048485,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4067514,=,nM,48.9,CHEMBL203,Homo sapiens,IC50,nM,48.9
7531,18048486,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4072928,=,nM,133.1,CHEMBL203,Homo sapiens,IC50,nM,133.1
7532,18048487,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4077419,=,nM,146.3,CHEMBL203,Homo sapiens,IC50,nM,146.3
7533,18048488,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4092951,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1
7534,18048489,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4065288,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
7535,18048490,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4071170,=,nM,28.3,CHEMBL203,Homo sapiens,IC50,nM,28.3
7536,18048491,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL3815163,=,nM,10.7,CHEMBL203,Homo sapiens,IC50,nM,10.7
7537,18048492,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4062528,=,nM,26.9,CHEMBL203,Homo sapiens,IC50,nM,26.9
7538,18048493,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4103464,=,nM,8.9,CHEMBL203,Homo sapiens,IC50,nM,8.9
7539,18048494,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4089588,=,nM,19.3,CHEMBL203,Homo sapiens,IC50,nM,19.3
7540,18048496,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4065300,=,nM,60.1,CHEMBL203,Homo sapiens,IC50,nM,60.1
7541,18048497,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4092966,=,nM,55.5,CHEMBL203,Homo sapiens,IC50,nM,55.5
7542,18048498,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4073912,=,nM,137.0,CHEMBL203,Homo sapiens,IC50,nM,137.0
7543,18048499,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4072986,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
7544,18048500,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4065503,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
7545,18048501,CHEMBL4011053,Inhibition of human recombinant N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using KHKKLAEGSAYEEV as substrate after 30 mins in presence of gamma-[32P]ATP by densitometry,B,CHEMBL4077608,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
7546,18048729,CHEMBL4011075,Inhibition of human recombinant GST-tagged EGFR (668 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system,B,CHEMBL4078182,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
7547,18052742,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4071058,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,uM,0.0032
7548,18052745,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4091010,=,nM,145.0,CHEMBL203,Homo sapiens,IC50,uM,0.145
7549,18052746,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4061283,=,nM,55.5,CHEMBL203,Homo sapiens,IC50,uM,0.0555
7550,18052749,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL202721,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
7551,18052804,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4098587,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
7552,18052807,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4087241,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
7553,18052812,CHEMBL4011794,Inhibition of EGFR (unknown origin) measured after 40 mins by Kinase Glo luminescence assay,B,CHEMBL4092491,=,nM,1021.0,CHEMBL203,Homo sapiens,IC50,uM,1.021
7554,18060513,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4087268,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7555,18060514,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4102577,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
7556,18060515,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4079393,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7557,18060516,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4098072,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7558,18060517,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4094927,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7559,18060518,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4100777,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7560,18060519,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4089279,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
7561,18060520,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4068092,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
7562,18060521,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4096980,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7563,18060522,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4078963,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7564,18060523,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4076854,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
7565,18060524,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4101193,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
7566,18060525,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4086878,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
7567,18060526,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4105526,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7568,18060527,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4100377,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7569,18060528,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4082362,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7570,18060529,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4082884,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
7571,18060530,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4100860,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7572,18060531,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4090686,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7573,18060532,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4062722,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
7574,18060533,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4098412,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7575,18060534,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4071368,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7576,18060535,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4060003,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7577,18060536,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL321494,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
7578,18060537,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4064942,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
7579,18060538,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4091569,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
7580,18060539,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4067255,=,nM,1246.0,CHEMBL203,Homo sapiens,IC50,nM,1246.0
7581,18060540,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4081860,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
7582,18060541,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4071012,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
7583,18060542,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4102224,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
7584,18060543,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4062543,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
7585,18060544,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4084248,=,nM,646.0,CHEMBL203,Homo sapiens,IC50,nM,646.0
7586,18060545,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4071180,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
7587,18060546,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4092003,=,nM,1328.0,CHEMBL203,Homo sapiens,IC50,nM,1328.0
7588,18060564,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4100860,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7589,18060565,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4068092,=,nM,597.0,CHEMBL203,Homo sapiens,IC50,nM,597.0
7590,18060566,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4102577,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
7591,18060567,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4086078,=,nM,417.0,CHEMBL203,Homo sapiens,IC50,nM,417.0
7592,18060568,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7593,18060583,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4071368,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7594,18060584,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4082884,=,nM,485.0,CHEMBL203,Homo sapiens,IC50,nM,485.0
7595,18060585,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4100777,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
7596,18060586,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7597,18060587,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4061473,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
7598,18060588,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7599,18060589,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4076363,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7600,18060590,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4102224,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
7601,18060591,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL321494,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
7602,18060595,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4092003,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
7603,18060596,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4081860,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
7604,18060614,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4062722,=,nM,586.0,CHEMBL203,Homo sapiens,IC50,nM,586.0
7605,18060615,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4076854,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
7606,18060616,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4098072,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7607,18060617,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL1173655,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7608,18060618,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4076363,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0
7609,18060625,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4105526,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
7610,18060626,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4096980,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7611,18060627,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL939,=,nM,185.0,CHEMBL203,Homo sapiens,IC50,nM,185.0
7612,18060628,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL3353410,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7613,18060629,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4061473,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
7614,18060630,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4084248,=,nM,144.0,CHEMBL203,Homo sapiens,IC50,nM,144.0
7615,18060631,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4091569,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7616,18060654,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4060003,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7617,18060655,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4086878,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
7618,18060656,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4089279,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,nM,89.0
7619,18060657,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4087268,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
7620,18060658,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4070707,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,nM,66.0
7621,18060659,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL1173655,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7622,18060660,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4089601,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7623,18060661,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4062543,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
7624,18060662,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4064942,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7625,18060687,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4098412,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7626,18060688,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4082362,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
7627,18060689,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4101193,=,nM,3511.0,CHEMBL203,Homo sapiens,IC50,nM,3511.0
7628,18060690,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4094927,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
7629,18060691,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7630,18060692,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4089601,=,nM,321.0,CHEMBL203,Homo sapiens,IC50,nM,321.0
7631,18060693,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4086078,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
7632,18060694,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4081732,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
7633,18060695,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4071012,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7634,18060720,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4090686,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7635,18060721,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4100377,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
7636,18060722,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4078963,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7637,18060723,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4079393,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
7638,18060724,CHEMBL4013157,Inhibition of human N-terminal GST-fused EGFR T790M/L858R double mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 20 mins by HTFR assay,B,CHEMBL4081732,=,nM,746.0,CHEMBL203,Homo sapiens,IC50,nM,746.0
7639,18060725,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4070707,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7640,18060726,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4071180,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7641,18060727,CHEMBL4013155,Inhibition of human N-terminal GST-fused EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 30 mins followed by substrate addition measured after 15 mins by HTFR assay,B,CHEMBL4067255,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,nM,75.0
7642,18084681,CHEMBL4018334,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method,B,CHEMBL388978,=,nM,178000.0,CHEMBL203,Homo sapiens,IC50,uM,178.0
7643,18085948,CHEMBL4018631,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4105329,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
7644,18085949,CHEMBL4018631,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4067871,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
7645,18085950,CHEMBL4018631,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4062877,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
7646,18085951,CHEMBL4018631,"Inhibition of recombinant EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4075917,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
7647,18085952,CHEMBL4018632,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4105329,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
7648,18085953,CHEMBL4018632,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4067871,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7649,18085954,CHEMBL4018632,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4062877,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7650,18085955,CHEMBL4018632,"Inhibition of recombinant EGFR T790M/L858R mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4075917,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
7651,18086083,CHEMBL4018689,Inhibition of EGFR exon 19 deletion mutant in human HCC827 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay,B,CHEMBL4062877,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7652,18086084,CHEMBL4018690,Inhibition of EGFR L858R mutant in human PC9 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay,B,CHEMBL4062877,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
7653,18086085,CHEMBL4018691,Inhibition of EGFR T790M/L858R mutant in human NCI-H1975 cells assessed as inhibition of cell proliferation after 72 hrs by cell counting kit-8 assay,B,CHEMBL4062877,=,nM,447.6,CHEMBL203,Homo sapiens,IC50,nM,447.6
7654,18096424,CHEMBL4021255,Inhibition of EGFR (unknown origin) by HTRF method,B,CHEMBL388978,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
7655,18096425,CHEMBL4021255,Inhibition of EGFR (unknown origin) by HTRF method,B,CHEMBL2105717,=,nM,225.0,CHEMBL203,Homo sapiens,IC50,nM,225.0
7656,18113644,CHEMBL4024819,Inhibition of N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (696-end residues) expressed in baculovirus infected Sf21 insect cells,B,CHEMBL3353410,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
7657,18113645,CHEMBL4024820,Inhibition of EGF-stimulated wild type EGFR phosphorylation in human LoVo cells incubated for 2 hrs followed by EGF stimulation for 10 mins by ELISA,B,CHEMBL3353410,=,nM,480.0,CHEMBL203,Homo sapiens,IC50,nM,480.0
7658,18114690,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL3290142,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
7659,18114691,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL2216827,=,nM,737.0,CHEMBL203,Homo sapiens,IC50,nM,737.0
7660,18114692,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL3301625,=,nM,442.0,CHEMBL203,Homo sapiens,IC50,nM,442.0
7661,18114693,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL4077064,=,nM,874.0,CHEMBL203,Homo sapiens,IC50,nM,874.0
7662,18114694,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL1873475,=,nM,123.0,CHEMBL203,Homo sapiens,IC50,nM,123.0
7663,18114695,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL4096207,=,nM,6863.0,CHEMBL203,Homo sapiens,IC50,nM,6863.0
7664,18114696,CHEMBL4024934,"Inhibition of recombinant human N-terminal GST-tagged wild-type EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using poly (Glu,Tyr)4:1 as substrate pretreated for 60 mins followed by substrate addition after 1 hr by ADP-Glo luminescence assay",B,CHEMBL4085868,=,nM,5882.0,CHEMBL203,Homo sapiens,IC50,nM,5882.0
7665,18117552,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4083815,=,nM,7230.0,CHEMBL203,Homo sapiens,IC50,uM,7.23
7666,18117553,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4077349,=,nM,780.0,CHEMBL203,Homo sapiens,IC50,uM,0.78
7667,18117554,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4072392,=,nM,720.0,CHEMBL203,Homo sapiens,IC50,uM,0.72
7668,18117555,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4083467,=,nM,12120.0,CHEMBL203,Homo sapiens,IC50,uM,12.12
7669,18117556,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4060821,=,nM,1120.0,CHEMBL203,Homo sapiens,IC50,uM,1.12
7670,18117557,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4079183,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102
7671,18117558,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4103440,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
7672,18117559,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL4074248,=,nM,287.0,CHEMBL203,Homo sapiens,IC50,uM,0.287
7673,18117615,CHEMBL4025907,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system preincubated for 5 mins with substrate followed by ATP addition measued after 30 mins by HTRF method,B,CHEMBL939,=,nM,173.0,CHEMBL203,Homo sapiens,IC50,uM,0.173
7674,18117869,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4081703,=,nM,22.4,CHEMBL203,Homo sapiens,IC50,nM,22.4
7675,18117870,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4059772,=,nM,14.2,CHEMBL203,Homo sapiens,IC50,nM,14.2
7676,18117871,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4093954,=,nM,15.7,CHEMBL203,Homo sapiens,IC50,nM,15.7
7677,18117872,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4073278,=,nM,26.5,CHEMBL203,Homo sapiens,IC50,nM,26.5
7678,18117873,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4087570,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
7679,18117874,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4105442,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
7680,18117875,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4095271,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
7681,18117876,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL4067855,=,nM,11.3,CHEMBL203,Homo sapiens,IC50,nM,11.3
7682,18117877,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL939,=,nM,1202.0,CHEMBL203,Homo sapiens,IC50,nM,1202.0
7683,18117878,CHEMBL4025984,"Inhibition of recombinant human EGFR T790M/L858R double mutant (695 to end residues) using Poly (4:1 Glu, Tyr) as substrate after 1 hr by ADP-Glo assay",B,CHEMBL3545308,=,nM,21.5,CHEMBL203,Homo sapiens,IC50,nM,21.5
7684,18152584,CHEMBL4034169,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4066684,=,nM,725.3,CHEMBL203,Homo sapiens,IC50,nM,725.3
7685,18154935,CHEMBL4034720,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4064776,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
7686,18154936,CHEMBL4034720,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL1173655,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7687,18154937,CHEMBL4034720,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL388978,=,nM,238.0,CHEMBL203,Homo sapiens,IC50,nM,238.0
7688,18155514,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4100075,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
7689,18155515,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4083642,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
7690,18155516,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4104427,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
7691,18155517,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4081727,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
7692,18155518,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4063890,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
7693,18155519,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4075241,=,nM,3100.0,CHEMBL203,Homo sapiens,IC50,uM,3.1
7694,18155520,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4094546,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
7695,18155521,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4078023,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7696,18155522,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4102284,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
7697,18155523,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4085902,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
7698,18155524,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4064361,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7699,18155525,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL4093642,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
7700,18155526,CHEMBL4034792,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (unknown origin) (645 to 1186 residues) expressed in baculovirus infected Sf-9 cells preincubated for 10 mins followed by ATP addition measured after 1 hr by DELFIA/Time-Resolved fluorometry,B,CHEMBL553,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
7701,18172231,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4071474,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7702,18172232,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4098507,=,nM,15.7,CHEMBL203,Homo sapiens,IC50,nM,15.7
7703,18172233,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4074601,=,nM,12.1,CHEMBL203,Homo sapiens,IC50,nM,12.1
7704,18172234,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4095063,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
7705,18172235,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4065970,=,nM,28.9,CHEMBL203,Homo sapiens,IC50,nM,28.9
7706,18172236,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4087375,=,nM,22.2,CHEMBL203,Homo sapiens,IC50,nM,22.2
7707,18172237,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4092632,=,nM,29.4,CHEMBL203,Homo sapiens,IC50,nM,29.4
7708,18172238,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4064937,=,nM,28.7,CHEMBL203,Homo sapiens,IC50,nM,28.7
7709,18172239,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4084868,=,nM,25.5,CHEMBL203,Homo sapiens,IC50,nM,25.5
7710,18172240,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4102822,=,nM,24.9,CHEMBL203,Homo sapiens,IC50,nM,24.9
7711,18172241,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4062178,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
7712,18172242,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4083904,=,nM,26.6,CHEMBL203,Homo sapiens,IC50,nM,26.6
7713,18172243,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4062830,=,nM,52.8,CHEMBL203,Homo sapiens,IC50,nM,52.8
7714,18172244,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4098591,=,nM,23.4,CHEMBL203,Homo sapiens,IC50,nM,23.4
7715,18172246,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4060198,=,nM,17.6,CHEMBL203,Homo sapiens,IC50,nM,17.6
7716,18172247,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4089951,=,nM,7.6,CHEMBL203,Homo sapiens,IC50,nM,7.6
7717,18172248,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4070404,=,nM,35.8,CHEMBL203,Homo sapiens,IC50,nM,35.8
7718,18172249,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4097682,=,nM,71.6,CHEMBL203,Homo sapiens,IC50,nM,71.6
7719,18172250,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4079649,=,nM,144.0,CHEMBL203,Homo sapiens,IC50,nM,144.0
7720,18172251,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4105392,=,nM,383.0,CHEMBL203,Homo sapiens,IC50,nM,383.0
7721,18172252,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4087525,=,nM,365.0,CHEMBL203,Homo sapiens,IC50,nM,365.0
7722,18172253,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4097770,=,nM,377.0,CHEMBL203,Homo sapiens,IC50,nM,377.0
7723,18172254,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4070640,=,nM,27.4,CHEMBL203,Homo sapiens,IC50,nM,27.4
7724,18172255,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4105503,=,nM,417.0,CHEMBL203,Homo sapiens,IC50,nM,417.0
7725,18172256,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4081252,=,nM,153.0,CHEMBL203,Homo sapiens,IC50,nM,153.0
7726,18172257,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4067916,=,nM,257.0,CHEMBL203,Homo sapiens,IC50,nM,257.0
7727,18172258,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4089120,=,nM,889.0,CHEMBL203,Homo sapiens,IC50,nM,889.0
7728,18172259,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4078801,=,nM,421.0,CHEMBL203,Homo sapiens,IC50,nM,421.0
7729,18172260,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4096822,=,nM,362.0,CHEMBL203,Homo sapiens,IC50,nM,362.0
7730,18172261,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4063067,=,nM,413.0,CHEMBL203,Homo sapiens,IC50,nM,413.0
7731,18172262,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4084726,=,nM,373.0,CHEMBL203,Homo sapiens,IC50,nM,373.0
7732,18172263,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4095071,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0
7733,18172264,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4074615,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,nM,2500.0
7734,18172265,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4087383,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,nM,1600.0
7735,18172266,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4065984,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,nM,600.0
7736,18172267,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4079506,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,nM,1300.0
7737,18172268,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4103761,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,nM,1200.0
7738,18172269,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4068695,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,nM,3400.0
7739,18172270,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4096014,=,nM,518.0,CHEMBL203,Homo sapiens,IC50,nM,518.0
7740,18172271,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4083916,=,nM,365.0,CHEMBL203,Homo sapiens,IC50,nM,365.0
7741,18172272,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4062192,=,nM,467.0,CHEMBL203,Homo sapiens,IC50,nM,467.0
7742,18172273,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4102288,=,nM,626.0,CHEMBL203,Homo sapiens,IC50,nM,626.0
7743,18172274,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4078026,=,nM,148.0,CHEMBL203,Homo sapiens,IC50,nM,148.0
7744,18172275,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4083224,=,nM,209.0,CHEMBL203,Homo sapiens,IC50,nM,209.0
7745,18172276,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4076405,=,nM,286.0,CHEMBL203,Homo sapiens,IC50,nM,286.0
7746,18172277,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4086821,=,nM,295.7,CHEMBL203,Homo sapiens,IC50,nM,295.7
7747,18172278,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4104717,=,nM,224.5,CHEMBL203,Homo sapiens,IC50,nM,224.5
7748,18172279,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4078973,=,nM,218.0,CHEMBL203,Homo sapiens,IC50,nM,218.0
7749,18172280,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4096988,=,nM,216.0,CHEMBL203,Homo sapiens,IC50,nM,216.0
7750,18172281,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4076515,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,nM,1300.0
7751,18172282,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4093535,=,nM,715.0,CHEMBL203,Homo sapiens,IC50,nM,715.0
7752,18172283,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4103893,=,nM,888.2,CHEMBL203,Homo sapiens,IC50,nM,888.2
7753,18172284,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4072688,=,nM,302.0,CHEMBL203,Homo sapiens,IC50,nM,302.0
7754,18172285,CHEMBL4038017,Inhibition of recombinant human wild type GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus using tyr4 peptide as substrate after 1 hr by FRET-based Z'-Lyte assay,B,CHEMBL4066141,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
7755,18189804,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4094527,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,uM,2.5
7756,18189805,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4091966,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7757,18189806,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4071151,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
7758,18189807,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4099713,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
7759,18189808,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4081698,=,nM,4700.0,CHEMBL203,Homo sapiens,IC50,uM,4.7
7760,18189809,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4073874,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
7761,18189810,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4100655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
7762,18189811,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4084214,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
7763,18189812,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4062509,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
7764,18189813,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4103121,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
7765,18189814,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL2180204,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
7766,18189816,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4101735,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
7767,18189817,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL2180203,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
7768,18189818,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4063701,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9
7769,18189819,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4099254,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
7770,18189820,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4072299,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
7771,18189821,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4060919,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
7772,18189822,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4082783,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
7773,18189823,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4069586,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
7774,18189824,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4090601,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7775,18189825,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4095447,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7776,18189826,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4103201,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
7777,18189827,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4094959,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
7778,18189828,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4075015,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
7779,18189835,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL4073960,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7780,18189836,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL1873475,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
7781,18189837,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7782,18189838,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7783,18189839,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL3353410,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7784,18189840,CHEMBL4041413,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 15 mins by HTRF assay,B,CHEMBL3545308,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
7785,18189841,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4094527,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
7786,18189842,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4091966,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7787,18189843,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4071151,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
7788,18189844,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4099713,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
7789,18189846,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4073874,=,nM,6600.0,CHEMBL203,Homo sapiens,IC50,uM,6.6
7790,18189847,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4100655,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
7791,18189849,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4062509,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,uM,0.28
7792,18189851,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL2180204,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
7793,18189853,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4101735,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
7794,18189854,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL2180203,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
7795,18189856,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4099254,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
7796,18189857,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4072299,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
7797,18189858,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4060919,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
7798,18189859,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4082783,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
7799,18189860,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4069586,=,nM,920.0,CHEMBL203,Homo sapiens,IC50,uM,0.92
7800,18189861,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4090601,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7801,18189862,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4103201,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
7802,18189863,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4094959,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
7803,18189864,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4095447,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
7804,18189865,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4075015,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
7805,18189866,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL4073960,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
7806,18189867,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL1873475,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
7807,18189868,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL939,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
7808,18189869,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL1229592,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7809,18189870,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
7810,18189871,CHEMBL4041414,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system preincubated for 30 mins followed by ATP and TK-substrate addition measured after 20 mins by HTRF assay,B,CHEMBL3545308,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
7811,18205201,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL3353410,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
7812,18205202,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4079658,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
7813,18205203,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4103912,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
7814,18205204,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4087538,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
7815,18205205,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4066170,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
7816,18205206,CHEMBL4044503,Inhibition of EGFR L858R/T790M mutant (unknown origin) using Tyr 4 peptide as substrate in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4072620,=,nM,17.8,CHEMBL203,Homo sapiens,IC50,nM,17.8
7817,18214734,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL939,=,nM,3.22,CHEMBL203,Homo sapiens,IC50,nM,3.22
7818,18214735,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL554,=,nM,27.06,CHEMBL203,Homo sapiens,IC50,nM,27.06
7819,18214739,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL4073595,=,nM,4.53,CHEMBL203,Homo sapiens,IC50,nM,4.53
7820,18214743,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL4102886,=,nM,4.87,CHEMBL203,Homo sapiens,IC50,nM,4.87
7821,18214745,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL4079553,=,nM,10.71,CHEMBL203,Homo sapiens,IC50,nM,10.71
7822,18214747,CHEMBL4046770,Inhibition of wild type recombinant EGFR (unknown origin) by ELISA,B,CHEMBL4086056,=,nM,1.79,CHEMBL203,Homo sapiens,IC50,nM,1.79
7823,18232358,CHEMBL4050456,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus by Z'-LYTE assay,B,CHEMBL4068839,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
7824,18243178,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4071494,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,nM,1300.0
7825,18243179,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4070454,=,nM,11.2,CHEMBL203,Homo sapiens,IC50,nM,11.2
7826,18243180,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4097627,=,nM,23.6,CHEMBL203,Homo sapiens,IC50,nM,23.6
7827,18243181,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4061829,<,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
7828,18243182,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4089892,<,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
7829,18243183,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4088971,=,nM,24.4,CHEMBL203,Homo sapiens,IC50,nM,24.4
7830,18243184,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179119,=,nM,24.1,CHEMBL203,Homo sapiens,IC50,nM,24.1
7831,18243185,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179128,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,nM,102.0
7832,18243186,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179124,=,nM,631.0,CHEMBL203,Homo sapiens,IC50,nM,631.0
7833,18243187,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL388978,=,nM,11.4,CHEMBL203,Homo sapiens,IC50,nM,11.4
7834,18243188,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4100759,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7835,18243189,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4090582,=,nM,7.41,CHEMBL203,Homo sapiens,IC50,nM,7.41
7836,18243190,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4062617,=,nM,3920.0,CHEMBL203,Homo sapiens,IC50,nM,3920.0
7837,18243191,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4066951,=,nM,15.4,CHEMBL203,Homo sapiens,IC50,nM,15.4
7838,18243192,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4094438,=,nM,32.1,CHEMBL203,Homo sapiens,IC50,nM,32.1
7839,18243193,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4077917,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7
7840,18243194,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4102179,=,nM,34.2,CHEMBL203,Homo sapiens,IC50,nM,34.2
7841,18243196,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4064224,=,nM,459.0,CHEMBL203,Homo sapiens,IC50,nM,459.0
7842,18243197,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4071827,<,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
7843,18243198,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4077228,=,nM,279.0,CHEMBL203,Homo sapiens,IC50,nM,279.0
7844,18243199,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4078920,=,nM,258.0,CHEMBL203,Homo sapiens,IC50,nM,258.0
7845,18243201,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4069229,=,nM,297.0,CHEMBL203,Homo sapiens,IC50,nM,297.0
7846,18243202,CHEMBL4052479,Inhibition of recombinant human GST-tagged EGFR L858R mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4072874,=,nM,7.8,CHEMBL203,Homo sapiens,IC50,nM,7.8
7847,18243204,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4071494,=,nM,3310.0,CHEMBL203,Homo sapiens,IC50,nM,3310.0
7848,18243205,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4070454,=,nM,658.0,CHEMBL203,Homo sapiens,IC50,nM,658.0
7849,18243206,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4097627,=,nM,706.0,CHEMBL203,Homo sapiens,IC50,nM,706.0
7850,18243207,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4061829,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
7851,18243208,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4089892,=,nM,8.39,CHEMBL203,Homo sapiens,IC50,nM,8.39
7852,18243209,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4088971,=,nM,893.0,CHEMBL203,Homo sapiens,IC50,nM,893.0
7853,18243210,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179119,=,nM,916.0,CHEMBL203,Homo sapiens,IC50,nM,916.0
7854,18243211,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179128,=,nM,1450.0,CHEMBL203,Homo sapiens,IC50,nM,1450.0
7855,18243213,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL388978,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
7856,18243214,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4100759,=,nM,263.0,CHEMBL203,Homo sapiens,IC50,nM,263.0
7857,18243215,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4090582,=,nM,368.0,CHEMBL203,Homo sapiens,IC50,nM,368.0
7858,18243216,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4062617,=,nM,11300.0,CHEMBL203,Homo sapiens,IC50,nM,11300.0
7859,18243217,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4066951,=,nM,651.0,CHEMBL203,Homo sapiens,IC50,nM,651.0
7860,18243218,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4094438,=,nM,908.0,CHEMBL203,Homo sapiens,IC50,nM,908.0
7861,18243219,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4077917,=,nM,987.0,CHEMBL203,Homo sapiens,IC50,nM,987.0
7862,18243220,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4102179,=,nM,683.0,CHEMBL203,Homo sapiens,IC50,nM,683.0
7863,18243222,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4064224,=,nM,67.9,CHEMBL203,Homo sapiens,IC50,nM,67.9
7864,18243223,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4071827,=,nM,1.52,CHEMBL203,Homo sapiens,IC50,nM,1.52
7865,18243224,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4077228,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,nM,5900.0
7866,18243227,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4069229,=,nM,1880.0,CHEMBL203,Homo sapiens,IC50,nM,1880.0
7867,18243228,CHEMBL4052480,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain expressed in baculovirus expression system preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4072874,=,nM,112.0,CHEMBL203,Homo sapiens,IC50,nM,112.0
7868,18243230,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4097627,=,nM,782.0,CHEMBL203,Homo sapiens,IC50,nM,782.0
7869,18243231,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4061829,=,nM,7.64,CHEMBL203,Homo sapiens,IC50,nM,7.64
7870,18243232,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4089892,=,nM,8.83,CHEMBL203,Homo sapiens,IC50,nM,8.83
7871,18243233,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4088971,=,nM,943.0,CHEMBL203,Homo sapiens,IC50,nM,943.0
7872,18243234,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL2179128,=,nM,1430.0,CHEMBL203,Homo sapiens,IC50,nM,1430.0
7873,18243236,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL1229592,=,nM,2050.0,CHEMBL203,Homo sapiens,IC50,nM,2050.0
7874,18243237,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL3353410,=,nM,278.0,CHEMBL203,Homo sapiens,IC50,nM,278.0
7875,18243238,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL388978,=,nM,0.29,CHEMBL203,Homo sapiens,IC50,nM,0.29
7876,18243239,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4082764,=,nM,336.0,CHEMBL203,Homo sapiens,IC50,nM,336.0
7877,18243240,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4090582,=,nM,364.0,CHEMBL203,Homo sapiens,IC50,nM,364.0
7878,18243252,CHEMBL4052483,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4101719,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7879,18243253,CHEMBL4052483,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL1229592,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
7880,18243254,CHEMBL4052483,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3353410,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7881,18243255,CHEMBL4052483,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4082764,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7882,18243256,CHEMBL4052484,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4101719,=,nM,6.47,CHEMBL203,Homo sapiens,IC50,nM,6.47
7883,18243257,CHEMBL4052484,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL1229592,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7884,18243258,CHEMBL4052484,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL3353410,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
7885,18243259,CHEMBL4052484,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4082764,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,nM,160.0
7886,18243312,CHEMBL4052481,Inhibition of recombinant human N-terminally GST-tagged EGFR L858R/T790M/C797S triple mutant expressed in baculovirus in Sf9 insect cells preincubated for 20 mins followed by addition of [33P]-ATP measured after 2 hrs by filter-binding method,B,CHEMBL4101719,=,nM,21.1,CHEMBL203,Homo sapiens,IC50,nM,21.1
7887,18248384,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4069277,=,nM,188.2,CHEMBL203,Homo sapiens,IC50,nM,188.2
7888,18248385,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4092788,=,nM,278.2,CHEMBL203,Homo sapiens,IC50,nM,278.2
7889,18248386,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4087243,=,nM,34.8,CHEMBL203,Homo sapiens,IC50,nM,34.8
7890,18248387,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL3353410,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7891,18248388,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4082763,=,nM,10.9,CHEMBL203,Homo sapiens,IC50,nM,10.9
7892,18248389,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4066569,=,nM,60.6,CHEMBL203,Homo sapiens,IC50,nM,60.6
7893,18248390,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4086559,=,nM,212.5,CHEMBL203,Homo sapiens,IC50,nM,212.5
7894,18248391,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4099377,=,nM,94.8,CHEMBL203,Homo sapiens,IC50,nM,94.8
7895,18248392,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4077973,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
7896,18248393,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4096021,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
7897,18248394,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4085842,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
7898,18248395,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4094086,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
7899,18248396,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4104658,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
7900,18248398,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4067014,=,nM,287.4,CHEMBL203,Homo sapiens,IC50,nM,287.4
7901,18248399,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4081429,=,nM,427.7,CHEMBL203,Homo sapiens,IC50,nM,427.7
7902,18248400,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4099445,=,nM,64.3,CHEMBL203,Homo sapiens,IC50,nM,64.3
7903,18248401,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4098967,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
7904,18248402,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4080934,=,nM,14.5,CHEMBL203,Homo sapiens,IC50,nM,14.5
7905,18248403,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4080008,=,nM,11.6,CHEMBL203,Homo sapiens,IC50,nM,11.6
7906,18248404,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4097141,=,nM,13.6,CHEMBL203,Homo sapiens,IC50,nM,13.6
7907,18248405,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4069277,=,nM,385.5,CHEMBL203,Homo sapiens,IC50,nM,385.5
7908,18248406,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4092788,=,nM,498.0,CHEMBL203,Homo sapiens,IC50,nM,498.0
7909,18248407,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4087243,=,nM,192.3,CHEMBL203,Homo sapiens,IC50,nM,192.3
7910,18248408,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL3353410,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
7911,18248409,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4082763,=,nM,123.4,CHEMBL203,Homo sapiens,IC50,nM,123.4
7912,18248410,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4066569,=,nM,46.5,CHEMBL203,Homo sapiens,IC50,nM,46.5
7913,18248411,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4086559,=,nM,55.5,CHEMBL203,Homo sapiens,IC50,nM,55.5
7914,18248412,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4099377,=,nM,9.9,CHEMBL203,Homo sapiens,IC50,nM,9.9
7915,18248413,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4077973,=,nM,181.1,CHEMBL203,Homo sapiens,IC50,nM,181.1
7916,18248414,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4096021,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7917,18248415,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4085842,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
7918,18248416,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4094086,=,nM,154.6,CHEMBL203,Homo sapiens,IC50,nM,154.6
7919,18248417,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4104658,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
7920,18248419,CHEMBL4053811,Inhibition of human recombinant cytoplasmic GST-tagged EGFR L858R mutant expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4067014,=,nM,185.6,CHEMBL203,Homo sapiens,IC50,nM,185.6
7921,18248441,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4097141,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
7922,18248442,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4080008,=,nM,6.7,CHEMBL203,Homo sapiens,IC50,nM,6.7
7923,18248443,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4080934,=,nM,11.8,CHEMBL203,Homo sapiens,IC50,nM,11.8
7924,18248444,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4098967,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7925,18248445,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4099445,=,nM,55.5,CHEMBL203,Homo sapiens,IC50,nM,55.5
7926,18248446,CHEMBL4053812,Inhibition of human recombinant cytoplasmic GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus using TK-substrate-biotin preincubated for 15 mins followed by substrate addition measured after 60 mins by FRET-based Z'-Lyte assay,B,CHEMBL4081429,=,nM,1230.0,CHEMBL203,Homo sapiens,IC50,nM,1230.0
7927,18267650,CHEMBL4057894,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4082724,=,nM,980.83,CHEMBL203,Homo sapiens,IC50,nM,980.83
7928,18267694,CHEMBL4057894,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL1230609,=,nM,2990.0,CHEMBL203,Homo sapiens,IC50,nM,2990.0
7929,18268983,CHEMBL4058115,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
7930,18268993,CHEMBL4058124,Inhibition of recombinant human N-terminal GST-tagged EGFR (696 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay,B,CHEMBL4095253,=,nM,642.7,CHEMBL203,Homo sapiens,IC50,nM,642.7
7931,18299296,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4125764,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
7932,18299297,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127809,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
7933,18299298,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129209,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
7934,18299299,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129287,=,nM,14.2,CHEMBL203,Homo sapiens,IC50,nM,14.2
7935,18299300,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127897,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
7936,18299301,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4125840,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
7937,18299302,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129138,=,nM,4.5,CHEMBL203,Homo sapiens,IC50,nM,4.5
7938,18299303,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4126810,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
7939,18299304,CHEMBL4124414,"Inhibition of EGFR L858R mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
7940,18299305,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4125764,=,nM,36.6,CHEMBL203,Homo sapiens,IC50,nM,36.6
7941,18299306,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127809,=,nM,26.5,CHEMBL203,Homo sapiens,IC50,nM,26.5
7942,18299307,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129209,=,nM,163.7,CHEMBL203,Homo sapiens,IC50,nM,163.7
7943,18299308,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129287,=,nM,361.1,CHEMBL203,Homo sapiens,IC50,nM,361.1
7944,18299309,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127897,=,nM,106.4,CHEMBL203,Homo sapiens,IC50,nM,106.4
7945,18299310,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4125840,=,nM,238.1,CHEMBL203,Homo sapiens,IC50,nM,238.1
7946,18299311,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4129138,=,nM,130.2,CHEMBL203,Homo sapiens,IC50,nM,130.2
7947,18299312,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4126810,=,nM,23.3,CHEMBL203,Homo sapiens,IC50,nM,23.3
7948,18299313,CHEMBL4124415,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
7949,18299315,CHEMBL4124416,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4127809,=,nM,285.0,CHEMBL203,Homo sapiens,IC50,nM,285.0
7950,18299321,CHEMBL4124416,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL4126810,=,nM,582.2,CHEMBL203,Homo sapiens,IC50,nM,582.2
7951,18299322,CHEMBL4124416,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using Poly(Glu,Tyr) as substrate after 40 mins by Kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
7952,18299335,CHEMBL4124427,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3353410,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7953,18299336,CHEMBL4124428,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7954,18299337,CHEMBL4124429,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL3353410,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,nM,77.0
7955,18304093,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126797,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
7956,18304094,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126654,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
7957,18304095,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4125772,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,nM,91.0
7958,18304096,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4129387,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
7959,18304097,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4128726,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
7960,18304098,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL3545308,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
7961,18304099,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126358,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
7962,18304100,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4129646,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
7963,18304101,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4129781,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
7964,18304102,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4128415,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
7965,18304103,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4128567,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7966,18304104,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4130016,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
7967,18304105,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4127317,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
7968,18304106,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4125940,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
7969,18304107,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126630,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
7970,18304108,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4129902,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
7971,18304109,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4126986,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,nM,115.0
7972,18304110,CHEMBL4125335,"Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant expressed in baculovirus expression system using Poly(Glu,Tyr)4:1 as substrate after 1 hr by ELISA",B,CHEMBL4129607,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
7973,18308314,CHEMBL4131304,Inhibition of recombinant human His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells using Tyr66-biotinylated PTP1B peptide as substrate preincubated for 5 mins followed by substrate addition measured after 1 hr by ELISA,B,CHEMBL4168235,=,nM,3.62,CHEMBL203,Homo sapiens,IC50,nM,3.62
7974,18308315,CHEMBL4131304,Inhibition of recombinant human His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells using Tyr66-biotinylated PTP1B peptide as substrate preincubated for 5 mins followed by substrate addition measured after 1 hr by ELISA,B,CHEMBL939,=,nM,2.21,CHEMBL203,Homo sapiens,IC50,nM,2.21
7975,18311468,CHEMBL4132129,Inhibition of EGFR1 (unknown origin) after 1 hr in presence of adenosine 5'[gamma-33P]triphosphate by microbeta microplate counting method,B,CHEMBL4171764,=,nM,2.61,CHEMBL203,Homo sapiens,IC50,nM,2.61
7976,18324904,CHEMBL4135134,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,B,CHEMBL4166412,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
7977,18324905,CHEMBL4135134,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,B,CHEMBL553,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
7978,18324909,CHEMBL4135134,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,B,CHEMBL4176629,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
7979,18324910,CHEMBL4135134,Inhibition of recombinant human GST-tagged EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus virus expression system after 1 hr by ELISA,B,CHEMBL4164936,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
7980,18328500,CHEMBL4135864,Inhibition of EGFR (unknown origin),B,CHEMBL4171543,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
7981,18332217,CHEMBL4136451,Inhibition of recombinant human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay,B,CHEMBL4166436,=,nM,865.0,CHEMBL203,Homo sapiens,IC50,nM,865.0
7982,18332218,CHEMBL4136451,Inhibition of recombinant human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using peptide substrate after 1 hr by mobility shift assay,B,CHEMBL4166038,=,nM,890.0,CHEMBL203,Homo sapiens,IC50,nM,890.0
7983,18343070,CHEMBL4139114,Inhibition of human A431 cells derived EGFR by ELISA,B,CHEMBL4163321,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32
7984,18356034,CHEMBL4140585,Inhibition of EGFR (unknown origin),B,CHEMBL4160854,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,uM,5.4
7985,18379696,CHEMBL4145703,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant expressed in Baculovirus expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE assay,B,CHEMBL4159909,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
7986,18379697,CHEMBL4145702,Inhibition of recombinant human GST-tagged EGFR T790M mutant expressed in Baculovirus expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE assay,B,CHEMBL4159909,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
7987,18379698,CHEMBL4145701,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in Baculovirus expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE assay,B,CHEMBL4159909,=,nM,82.5,CHEMBL203,Homo sapiens,IC50,nM,82.5
7988,18379699,CHEMBL4145700,Inhibition of recombinant human wild-type His-tagged EGFR expressed in mammalian expression system using Tyr 4 peptide as substrate after 1 hr in presence of ATP by Z-LYTE kinase assay,B,CHEMBL4159909,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,nM,108.0
7989,18390495,CHEMBL4147642,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL2105717,=,nM,3110.0,CHEMBL203,Homo sapiens,IC50,umol/L,3.11
7990,18390496,CHEMBL4147642,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4171115,=,nM,812.0,CHEMBL203,Homo sapiens,IC50,umol/L,0.812
7991,18392938,CHEMBL4148356,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL939,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
7992,18392939,CHEMBL4148356,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL554,=,nM,27.1,CHEMBL203,Homo sapiens,IC50,nM,27.1
7993,18392940,CHEMBL4148356,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL4173696,=,nM,20.7,CHEMBL203,Homo sapiens,IC50,nM,20.7
7994,18392941,CHEMBL4148356,Inhibition of recombinant human N-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL4161938,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
7995,18392942,CHEMBL4148357,Inhibition of EGFR L858R mutant (unknown origin) using ULight-poly GT as substrate preincubated for 120 mins followed by substrate addition measured after 2 hrs by spectrophotometric method,B,CHEMBL939,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
7996,18392944,CHEMBL4148357,Inhibition of EGFR L858R mutant (unknown origin) using ULight-poly GT as substrate preincubated for 120 mins followed by substrate addition measured after 2 hrs by spectrophotometric method,B,CHEMBL4173696,=,nM,235.5,CHEMBL203,Homo sapiens,IC50,nM,235.5
7997,18392945,CHEMBL4148357,Inhibition of EGFR L858R mutant (unknown origin) using ULight-poly GT as substrate preincubated for 120 mins followed by substrate addition measured after 2 hrs by spectrophotometric method,B,CHEMBL4161938,=,nM,322.5,CHEMBL203,Homo sapiens,IC50,nM,322.5
7998,18392950,CHEMBL4148359,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 10 mins followed by TK substrate-botion addition measured after 1 hr by spectrophotometric method,B,CHEMBL939,=,nM,127.9,CHEMBL203,Homo sapiens,IC50,nM,127.9
7999,18392953,CHEMBL4148359,Inhibition of EGFR T790M mutant (unknown origin) preincubated for 10 mins followed by TK substrate-botion addition measured after 1 hr by spectrophotometric method,B,CHEMBL4161938,=,nM,9.3,CHEMBL203,Homo sapiens,IC50,nM,9.3
8000,18415118,CHEMBL4152882,Inhibition of EGFR exon 19 deletion and L858R mutant phosphorylation in human NCI-H1975 cells,B,CHEMBL3786343,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
8001,18415143,CHEMBL4152873,Inhibition of wild type EGFR phosphorylation in human H358 cells,B,CHEMBL3786343,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,nM,2000.0
8002,18423618,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4162767,=,nM,33.1,CHEMBL203,Homo sapiens,IC50,nM,33.1
8003,18423619,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4173470,=,nM,202.3,CHEMBL203,Homo sapiens,IC50,nM,202.3
8004,18423620,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4173032,=,nM,174.5,CHEMBL203,Homo sapiens,IC50,nM,174.5
8005,18423621,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4165126,=,nM,838.5,CHEMBL203,Homo sapiens,IC50,nM,838.5
8006,18423622,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4175782,=,nM,7.7,CHEMBL203,Homo sapiens,IC50,nM,7.7
8007,18423623,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,12.4,CHEMBL203,Homo sapiens,IC50,nM,12.4
8008,18423643,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4166210,=,nM,142.7,CHEMBL203,Homo sapiens,IC50,nM,142.7
8009,18423644,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4166609,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
8010,18423647,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4159404,=,nM,38.5,CHEMBL203,Homo sapiens,IC50,nM,38.5
8011,18423648,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4164396,=,nM,16.4,CHEMBL203,Homo sapiens,IC50,nM,16.4
8012,18423649,CHEMBL4154496,"Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system using poly (Glu, Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4175045,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
8013,18427397,CHEMBL4155044,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8014,18427398,CHEMBL4155044,Inhibition of EGFR (unknown origin),B,CHEMBL31965,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
8015,18427399,CHEMBL4155044,Inhibition of EGFR (unknown origin),B,CHEMBL2347958,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8016,18427553,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4162882,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
8017,18427554,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4165267,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
8018,18427555,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4162530,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
8019,18427556,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4165894,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8020,18427557,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4161396,=,nM,45.4,CHEMBL203,Homo sapiens,IC50,nM,45.4
8021,18427558,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4172718,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8022,18427559,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4168254,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8023,18427560,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4176787,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
8024,18427561,CHEMBL4155049,Inhibition of wild type EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL2347958,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8025,18427562,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4162882,=,nM,186.0,CHEMBL203,Homo sapiens,IC50,nM,186.0
8026,18427563,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4165267,=,nM,192.0,CHEMBL203,Homo sapiens,IC50,nM,192.0
8027,18427564,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4162530,=,nM,162.0,CHEMBL203,Homo sapiens,IC50,nM,162.0
8028,18427565,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4165894,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
8029,18427566,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4161396,=,nM,115.0,CHEMBL203,Homo sapiens,IC50,nM,115.0
8030,18427567,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4172718,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
8031,18427568,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4168254,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8032,18427569,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4176787,=,nM,107.0,CHEMBL203,Homo sapiens,IC50,nM,107.0
8033,18427570,CHEMBL4155050,Inhibition of wild type EGFR T790M mutant (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL2347958,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8034,18439532,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4167162,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
8035,18439533,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4166069,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
8036,18439534,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4177348,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
8037,18439535,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4169489,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
8038,18439536,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL4170916,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,nM,71.0
8039,18439537,CHEMBL4156805,Inhibition of EGFR in human MCF7 cell lysates after 24 to 48 hrs by ELISA,B,CHEMBL553,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,nM,73.0
8040,18450557,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4213400,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
8041,18450558,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4206312,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
8042,18450559,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4213741,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,nM,280.0
8043,18450560,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4208811,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
8044,18450562,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4212326,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
8045,18450564,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4207951,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,nM,49.0
8046,18450565,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608429,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8047,18450566,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4204566,=,nM,713.0,CHEMBL203,Homo sapiens,IC50,nM,713.0
8048,18450567,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608432,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8049,18450568,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4216679,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8050,18450569,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4218154,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8051,18450570,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4208829,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
8052,18450571,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4205392,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
8053,18450572,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3989970,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8054,18450573,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4213609,=,nM,675.0,CHEMBL203,Homo sapiens,IC50,nM,675.0
8055,18450574,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4206501,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8056,18450575,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3545308,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
8057,18450576,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL553,=,nM,9003.0,CHEMBL203,Homo sapiens,IC50,nM,9003.0
8058,18450577,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3883534,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8059,18450578,CHEMBL4178351,Inhibition of EGFR T790M/L858R double mutant phosphorylation in human H1975 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3786098,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
8060,18450672,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608429,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8061,18450673,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608432,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8062,18450674,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4216679,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8063,18450675,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4218154,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8064,18450676,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3989970,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8065,18450677,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4206501,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
8066,18450678,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3545308,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8067,18450679,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL553,=,nM,9736.0,CHEMBL203,Homo sapiens,IC50,nM,9736.0
8068,18450681,CHEMBL4178360,Inhibition of EGFR T790M/exon 19 deletion mutant phosphorylation in human PC9-DRH cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3786098,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8069,18450682,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608429,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8070,18450683,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3608432,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
8071,18450684,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4216679,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8072,18450686,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3989970,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8073,18450687,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL4206501,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
8074,18450688,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3545308,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
8075,18450689,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL553,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
8076,18450690,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3883534,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8077,18450691,CHEMBL4178361,Inhibition of EGFR exon 19 deletion mutant phosphorylation in human PC9 cells preincubated for 2 hrs followed by EGF stimulation for 10 mins by sandwich ELISA,B,CHEMBL3786098,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0
8078,18456056,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL1229592,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
8079,18456057,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210237,=,nM,8420.0,CHEMBL203,Homo sapiens,IC50,uM,8.42
8080,18456058,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211322,=,nM,7590.0,CHEMBL203,Homo sapiens,IC50,uM,7.59
8081,18456059,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216784,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
8082,18456060,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216265,=,nM,4210.0,CHEMBL203,Homo sapiens,IC50,uM,4.21
8083,18456061,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204596,=,nM,1820.0,CHEMBL203,Homo sapiens,IC50,uM,1.82
8084,18456062,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203110,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
8085,18456063,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202780,=,nM,6070.0,CHEMBL203,Homo sapiens,IC50,uM,6.07
8086,18456064,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215496,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
8087,18456065,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4212450,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
8088,18456066,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218320,=,nM,1980.0,CHEMBL203,Homo sapiens,IC50,uM,1.98
8089,18456067,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208712,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
8090,18456068,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205869,=,nM,8870.0,CHEMBL203,Homo sapiens,IC50,uM,8.87
8091,18456069,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210744,=,nM,6490.0,CHEMBL203,Homo sapiens,IC50,uM,6.49
8092,18456070,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL3425671,=,nM,3270.0,CHEMBL203,Homo sapiens,IC50,uM,3.27
8093,18456071,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218052,=,nM,5610.0,CHEMBL203,Homo sapiens,IC50,uM,5.61
8094,18456072,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214620,=,nM,7430.0,CHEMBL203,Homo sapiens,IC50,uM,7.43
8095,18456073,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202955,=,nM,5010.0,CHEMBL203,Homo sapiens,IC50,uM,5.01
8096,18456074,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202413,=,nM,2550.0,CHEMBL203,Homo sapiens,IC50,uM,2.55
8097,18456075,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4207305,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
8098,18456076,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204937,=,nM,1410.0,CHEMBL203,Homo sapiens,IC50,uM,1.41
8099,18456077,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215164,=,nM,1590.0,CHEMBL203,Homo sapiens,IC50,uM,1.59
8100,18456078,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4213082,=,nM,2820.0,CHEMBL203,Homo sapiens,IC50,uM,2.82
8101,18456079,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208167,=,nM,9360.0,CHEMBL203,Homo sapiens,IC50,uM,9.36
8102,18456080,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205469,=,nM,7370.0,CHEMBL203,Homo sapiens,IC50,uM,7.37
8103,18456081,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203804,=,nM,3080.0,CHEMBL203,Homo sapiens,IC50,uM,3.08
8104,18456082,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204354,=,nM,9040.0,CHEMBL203,Homo sapiens,IC50,uM,9.04
8105,18456083,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216025,=,nM,9760.0,CHEMBL203,Homo sapiens,IC50,uM,9.76
8106,18456084,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216551,=,nM,8070.0,CHEMBL203,Homo sapiens,IC50,uM,8.07
8107,18456085,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211573,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
8108,18456086,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214040,=,nM,1060.0,CHEMBL203,Homo sapiens,IC50,uM,1.06
8109,18456087,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4209119,=,nM,1090.0,CHEMBL203,Homo sapiens,IC50,uM,1.09
8110,18456088,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4217686,=,nM,6120.0,CHEMBL203,Homo sapiens,IC50,uM,6.12
8111,18456089,CHEMBL4179474,Inhibition of EGFR E746_A750 deletion mutant in human PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL939,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
8112,18456090,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL1229592,=,nM,8600.0,CHEMBL203,Homo sapiens,IC50,uM,8.6
8113,18456091,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210237,=,nM,9040.0,CHEMBL203,Homo sapiens,IC50,uM,9.04
8114,18456092,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211322,=,nM,9350.0,CHEMBL203,Homo sapiens,IC50,uM,9.35
8115,18456093,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216784,=,nM,1160.0,CHEMBL203,Homo sapiens,IC50,uM,1.16
8116,18456094,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216265,=,nM,5640.0,CHEMBL203,Homo sapiens,IC50,uM,5.64
8117,18456095,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204596,=,nM,3070.0,CHEMBL203,Homo sapiens,IC50,uM,3.07
8118,18456096,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203110,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52
8119,18456097,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202780,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
8120,18456098,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215496,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,uM,0.26
8121,18456099,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4212450,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
8122,18456100,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218320,=,nM,2140.0,CHEMBL203,Homo sapiens,IC50,uM,2.14
8123,18456101,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208712,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,uM,1.01
8124,18456102,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205869,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
8125,18456103,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210744,=,nM,3150.0,CHEMBL203,Homo sapiens,IC50,uM,3.15
8126,18456104,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL3425671,=,nM,6100.0,CHEMBL203,Homo sapiens,IC50,uM,6.1
8127,18456105,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218052,=,nM,4780.0,CHEMBL203,Homo sapiens,IC50,uM,4.78
8128,18456106,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214620,=,nM,6220.0,CHEMBL203,Homo sapiens,IC50,uM,6.22
8129,18456107,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202955,=,nM,3800.0,CHEMBL203,Homo sapiens,IC50,uM,3.8
8130,18456108,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202413,=,nM,1070.0,CHEMBL203,Homo sapiens,IC50,uM,1.07
8131,18456109,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4207305,=,nM,1230.0,CHEMBL203,Homo sapiens,IC50,uM,1.23
8132,18456110,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204937,=,nM,2080.0,CHEMBL203,Homo sapiens,IC50,uM,2.08
8133,18456111,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215164,=,nM,1180.0,CHEMBL203,Homo sapiens,IC50,uM,1.18
8134,18456112,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4213082,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,uM,6.5
8135,18456113,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208167,=,nM,9970.0,CHEMBL203,Homo sapiens,IC50,uM,9.97
8136,18456114,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205469,=,nM,7390.0,CHEMBL203,Homo sapiens,IC50,uM,7.39
8137,18456115,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203804,=,nM,3610.0,CHEMBL203,Homo sapiens,IC50,uM,3.61
8138,18456116,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204354,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
8139,18456117,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216025,=,nM,15130.0,CHEMBL203,Homo sapiens,IC50,uM,15.13
8140,18456118,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216551,=,nM,5800.0,CHEMBL203,Homo sapiens,IC50,uM,5.8
8141,18456119,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211573,=,nM,940.0,CHEMBL203,Homo sapiens,IC50,uM,0.94
8142,18456120,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214040,=,nM,860.0,CHEMBL203,Homo sapiens,IC50,uM,0.86
8143,18456121,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4209119,=,nM,1670.0,CHEMBL203,Homo sapiens,IC50,uM,1.67
8144,18456122,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4217686,=,nM,3250.0,CHEMBL203,Homo sapiens,IC50,uM,3.25
8145,18456123,CHEMBL4179475,Inhibition of EGFR E746_A750 deletion/T790M mutant in human growth-resistant PC9 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL939,=,nM,7680.0,CHEMBL203,Homo sapiens,IC50,uM,7.68
8146,18456124,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL1229592,=,nM,18210.0,CHEMBL203,Homo sapiens,IC50,uM,18.21
8147,18456125,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210237,=,nM,6980.0,CHEMBL203,Homo sapiens,IC50,uM,6.98
8148,18456126,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211322,=,nM,19630.0,CHEMBL203,Homo sapiens,IC50,uM,19.63
8149,18456127,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216784,=,nM,9780.0,CHEMBL203,Homo sapiens,IC50,uM,9.78
8150,18456128,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216265,=,nM,33210.0,CHEMBL203,Homo sapiens,IC50,uM,33.21
8151,18456129,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204596,=,nM,20120.0,CHEMBL203,Homo sapiens,IC50,uM,20.12
8152,18456130,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203110,=,nM,6340.0,CHEMBL203,Homo sapiens,IC50,uM,6.34
8153,18456131,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202780,=,nM,12020.0,CHEMBL203,Homo sapiens,IC50,uM,12.02
8154,18456132,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215496,=,nM,3530.0,CHEMBL203,Homo sapiens,IC50,uM,3.53
8155,18456133,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4212450,=,nM,2010.0,CHEMBL203,Homo sapiens,IC50,uM,2.01
8156,18456134,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218320,=,nM,3060.0,CHEMBL203,Homo sapiens,IC50,uM,3.06
8157,18456135,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208712,=,nM,2150.0,CHEMBL203,Homo sapiens,IC50,uM,2.15
8158,18456136,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205869,=,nM,23570.0,CHEMBL203,Homo sapiens,IC50,uM,23.57
8159,18456137,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4210744,=,nM,6680.0,CHEMBL203,Homo sapiens,IC50,uM,6.68
8160,18456138,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL3425671,=,nM,17410.0,CHEMBL203,Homo sapiens,IC50,uM,17.41
8161,18456139,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4218052,=,nM,22330.0,CHEMBL203,Homo sapiens,IC50,uM,22.33
8162,18456140,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214620,=,nM,6020.0,CHEMBL203,Homo sapiens,IC50,uM,6.02
8163,18456141,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202955,=,nM,10020.0,CHEMBL203,Homo sapiens,IC50,uM,10.02
8164,18456142,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4202413,=,nM,9500.0,CHEMBL203,Homo sapiens,IC50,uM,9.5
8165,18456143,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4207305,=,nM,15830.0,CHEMBL203,Homo sapiens,IC50,uM,15.83
8166,18456144,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204937,=,nM,17930.0,CHEMBL203,Homo sapiens,IC50,uM,17.93
8167,18456145,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4215164,=,nM,18300.0,CHEMBL203,Homo sapiens,IC50,uM,18.3
8168,18456146,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4213082,=,nM,2480.0,CHEMBL203,Homo sapiens,IC50,uM,2.48
8169,18456147,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4208167,=,nM,12030.0,CHEMBL203,Homo sapiens,IC50,uM,12.03
8170,18456148,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4205469,=,nM,14010.0,CHEMBL203,Homo sapiens,IC50,uM,14.01
8171,18456149,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4203804,=,nM,8550.0,CHEMBL203,Homo sapiens,IC50,uM,8.55
8172,18456150,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4204354,=,nM,15270.0,CHEMBL203,Homo sapiens,IC50,uM,15.27
8173,18456151,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216025,=,nM,26870.0,CHEMBL203,Homo sapiens,IC50,uM,26.87
8174,18456152,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4216551,=,nM,5020.0,CHEMBL203,Homo sapiens,IC50,uM,5.02
8175,18456153,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4211573,=,nM,4790.0,CHEMBL203,Homo sapiens,IC50,uM,4.79
8176,18456154,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4214040,=,nM,3870.0,CHEMBL203,Homo sapiens,IC50,uM,3.87
8177,18456155,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4209119,=,nM,16970.0,CHEMBL203,Homo sapiens,IC50,uM,16.97
8178,18456156,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL4217686,=,nM,23310.0,CHEMBL203,Homo sapiens,IC50,uM,23.31
8179,18456157,CHEMBL4179476,Inhibition of EGFR in human NCI-H460 cells assessed as reduction in cell viability after 72 hrs by MTT assay,B,CHEMBL939,=,nM,22800.0,CHEMBL203,Homo sapiens,IC50,uM,22.8
8180,18456234,CHEMBL4179481,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
8181,18456235,CHEMBL4179481,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8182,18456236,CHEMBL4179482,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8183,18456237,CHEMBL4179482,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL3353410,=,nM,493.88,CHEMBL203,Homo sapiens,IC50,nM,493.88
8184,18456238,CHEMBL4179483,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL1173655,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
8185,18456239,CHEMBL4179484,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
8186,18456240,CHEMBL4179484,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL3353410,=,nM,11.44,CHEMBL203,Homo sapiens,IC50,nM,11.44
8187,18456241,CHEMBL4179485,Inhibition of EGFR exon 19 deletion mutant (unknown origin),B,CHEMBL3353410,=,nM,12.92,CHEMBL203,Homo sapiens,IC50,nM,12.92
8188,18466938,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL1173655,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
8189,18466940,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4215397,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
8190,18466943,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4211835,=,nM,8.9,CHEMBL203,Homo sapiens,IC50,nM,8.9
8191,18466944,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4205688,=,nM,232.9,CHEMBL203,Homo sapiens,IC50,nM,232.9
8192,18466945,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4210550,=,nM,82.6,CHEMBL203,Homo sapiens,IC50,nM,82.6
8193,18466947,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4206193,=,nM,188.3,CHEMBL203,Homo sapiens,IC50,nM,188.3
8194,18466948,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4213519,=,nM,559.8,CHEMBL203,Homo sapiens,IC50,nM,559.8
8195,18466949,CHEMBL4181934,Inhibition of recombinant EGFR (unknown origin) T790M/L858R double mutant preincubated for 30 mins followed by poly (Glu-Tyr) biotinylated peptide substrate addition measured after 30 mins in presence of ATP by ELISA,B,CHEMBL4218447,=,nM,396.7,CHEMBL203,Homo sapiens,IC50,nM,396.7
8196,18485984,CHEMBL4186277,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8197,18485992,CHEMBL4186280,Inhibition of wild type N-terminal GST-fused human EGFR cytoplasmic domain expressed in baculovirus expression system using TK-substrate after 25 mins by HTRF KinEASE-TK assay,B,CHEMBL4094959,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
8198,18485993,CHEMBL4186280,Inhibition of wild type N-terminal GST-fused human EGFR cytoplasmic domain expressed in baculovirus expression system using TK-substrate after 25 mins by HTRF KinEASE-TK assay,B,CHEMBL4095447,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
8199,18485994,CHEMBL4186280,Inhibition of wild type N-terminal GST-fused human EGFR cytoplasmic domain expressed in baculovirus expression system using TK-substrate after 25 mins by HTRF KinEASE-TK assay,B,CHEMBL4090601,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
8200,18485995,CHEMBL4186281,Inhibition of N-terminal GST-fused human EGFR cytoplasmic domain T790M/C797S mutant expressed in baculovirus expression system using TK-substrate after 20 mins by HTRF KinEASE-TK assay,B,CHEMBL4094959,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
8201,18485996,CHEMBL4186281,Inhibition of N-terminal GST-fused human EGFR cytoplasmic domain T790M/C797S mutant expressed in baculovirus expression system using TK-substrate after 20 mins by HTRF KinEASE-TK assay,B,CHEMBL4095447,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
8202,18485997,CHEMBL4186281,Inhibition of N-terminal GST-fused human EGFR cytoplasmic domain T790M/C797S mutant expressed in baculovirus expression system using TK-substrate after 20 mins by HTRF KinEASE-TK assay,B,CHEMBL4090601,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8203,18485998,CHEMBL4186282,Inhibition of recombinant human EGFR L858R/T790M/C797S mutant using TK-substrate after 10 mins by HTRF KinEASE-TK assay,B,CHEMBL4094959,=,nM,838.0,CHEMBL203,Homo sapiens,IC50,nM,838.0
8204,18485999,CHEMBL4186282,Inhibition of recombinant human EGFR L858R/T790M/C797S mutant using TK-substrate after 10 mins by HTRF KinEASE-TK assay,B,CHEMBL4095447,=,nM,7900.0,CHEMBL203,Homo sapiens,IC50,nM,7900.0
8205,18486000,CHEMBL4186282,Inhibition of recombinant human EGFR L858R/T790M/C797S mutant using TK-substrate after 10 mins by HTRF KinEASE-TK assay,B,CHEMBL4090601,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
8206,18486008,CHEMBL4186284,Inhibition of wild type recombinant N-terminal GST-tagged human EGFR catalytic domain expressed in Sf9 insect cells using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL1328065,=,nM,24300.0,CHEMBL203,Homo sapiens,IC50,uM,24.3
8207,18486012,CHEMBL4186285,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL1328065,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,uM,0.149
8208,18486013,CHEMBL4186285,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL4207984,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
8209,18486014,CHEMBL4186285,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL4214588,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
8210,18486015,CHEMBL4186285,Inhibition of recombinant human EGFR d746-750/T790M/C797S mutant using poly-Glu-Tyr (4:1) as substrate after 2 hrs in presence of [gamma-33P]-ATP by filter-binding method,B,CHEMBL4218431,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
8211,18487170,CHEMBL4186567,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate after 10 mins by mobility shift assay,B,CHEMBL4215703,=,nM,6900.0,CHEMBL203,Homo sapiens,IC50,nM,6900.0
8212,18499364,CHEMBL4188985,"Inhibition of wild-type human partial length EGFR (R669 to V1011 residues) expressed in bacterial expression system using poly [Glu, Try] 4:1 as substrate in presence of [gamma-33P]ATP",B,CHEMBL3809489,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
8213,18514732,CHEMBL4192705,Inhibition of recombinant human C-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL4173696,=,nM,20.72,CHEMBL203,Homo sapiens,IC50,nM,20.72
8214,18514740,CHEMBL4192705,Inhibition of recombinant human C-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL554,=,nM,27.06,CHEMBL203,Homo sapiens,IC50,nM,27.06
8215,18514741,CHEMBL4192705,Inhibition of recombinant human C-terminal His-tagged EGFR (1 to 645 residues) expressed in HEK293 cells by ELISA,B,CHEMBL939,=,nM,3.22,CHEMBL203,Homo sapiens,IC50,nM,3.22
8216,18523811,CHEMBL4194205,Inhibition of EGFR (unknown origin),B,CHEMBL4210100,=,nM,267.6,CHEMBL203,Homo sapiens,IC50,nM,267.6
8217,18535068,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4214496,=,nM,800.0,CHEMBL203,Homo sapiens,IC50,uM,0.8
8218,18535069,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4209588,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
8219,18535070,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4207316,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
8220,18535071,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4208745,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
8221,18535072,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4208224,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
8222,18535073,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL4213146,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
8223,18535074,CHEMBL4196285,Inhibition of His6-tagged EGFR (unknown origin) cytoplasmic domain expressed in baculovirus infected Sf9 insect cells after 10 mins followed by addition of ATP-MgCl2 and measured after 1 hr by time-resolved fluorometric analysis,B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
8224,18536347,CHEMBL4196434,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL4207750,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
8225,18536348,CHEMBL4196434,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL4206585,=,nM,409.0,CHEMBL203,Homo sapiens,IC50,nM,409.0
8226,18536349,CHEMBL4196434,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL939,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
8227,18539746,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209801,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
8228,18539747,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4212884,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
8229,18539748,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206716,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
8230,18539749,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4203016,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
8231,18539750,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206288,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
8232,18539751,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4217992,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
8233,18539752,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215076,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
8234,18539753,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215080,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
8235,18539757,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206166,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
8236,18539758,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209019,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
8237,18539760,CHEMBL4197223,"Inhibition of wild type EGFR L858R mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
8238,18539761,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209801,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
8239,18539762,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4212884,=,nM,65.6,CHEMBL203,Homo sapiens,IC50,nM,65.6
8240,18539763,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206716,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
8241,18539764,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4203016,=,nM,23.2,CHEMBL203,Homo sapiens,IC50,nM,23.2
8242,18539765,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206288,=,nM,53.2,CHEMBL203,Homo sapiens,IC50,nM,53.2
8243,18539766,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4217992,=,nM,57.7,CHEMBL203,Homo sapiens,IC50,nM,57.7
8244,18539767,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215076,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
8245,18539768,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215080,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
8246,18539772,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206166,=,nM,44.1,CHEMBL203,Homo sapiens,IC50,nM,44.1
8247,18539773,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209019,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
8248,18539775,CHEMBL4197224,"Inhibition of wild type EGFR L858R/T790M double mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
8249,18539777,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4212884,=,nM,62.2,CHEMBL203,Homo sapiens,IC50,nM,62.2
8250,18539778,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206716,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
8251,18539779,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4203016,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8252,18539780,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206288,=,nM,56.2,CHEMBL203,Homo sapiens,IC50,nM,56.2
8253,18539781,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4217992,=,nM,54.1,CHEMBL203,Homo sapiens,IC50,nM,54.1
8254,18539782,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215076,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
8255,18539783,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4215080,=,nM,53.6,CHEMBL203,Homo sapiens,IC50,nM,53.6
8256,18539784,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4208673,=,nM,34.8,CHEMBL203,Homo sapiens,IC50,nM,34.8
8257,18539785,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4204983,=,nM,24.7,CHEMBL203,Homo sapiens,IC50,nM,24.7
8258,18539786,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4203001,=,nM,51.3,CHEMBL203,Homo sapiens,IC50,nM,51.3
8259,18539787,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4206166,=,nM,82.9,CHEMBL203,Homo sapiens,IC50,nM,82.9
8260,18539788,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4209019,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
8261,18539789,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL4204139,=,nM,51.9,CHEMBL203,Homo sapiens,IC50,nM,51.9
8262,18539790,CHEMBL4197225,"Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) using Poly (Glu, Tyr) as substrate after 40 mins by kinase-Glo luminescence assay",B,CHEMBL3353410,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
8263,18572903,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227210,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
8264,18572904,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4225863,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
8265,18572905,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4228672,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
8266,18572906,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227091,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
8267,18572907,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4225166,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
8268,18572908,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227201,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
8269,18572910,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227701,=,nM,5.1,CHEMBL203,Homo sapiens,IC50,nM,5.1
8270,18572911,CHEMBL4221420,Inhibition of recombinant human GST-tagged EGFR L858R/T790M double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL3353410,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8271,18572914,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4225863,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8272,18572915,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4228672,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
8273,18572916,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227091,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
8274,18572918,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL4227201,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
8275,18572920,CHEMBL4221421,Inhibition of recombinant human GST-tagged EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using FAM-labelled peptide as substrate pretreated for 10 mins followed by substrate addition measured after 1 hr by mobility shift assay,B,CHEMBL3353410,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
8276,18573663,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4228120,=,nM,42.3,CHEMBL203,Homo sapiens,IC50,nM,42.3
8277,18573664,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4229213,=,nM,62.5,CHEMBL203,Homo sapiens,IC50,nM,62.5
8278,18573665,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4226907,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
8279,18573666,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4227281,=,nM,24.2,CHEMBL203,Homo sapiens,IC50,nM,24.2
8280,18573667,CHEMBL4221532,Inhibition of EGFR (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL939,=,nM,29.6,CHEMBL203,Homo sapiens,IC50,nM,29.6
8281,18573675,CHEMBL4221534,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4226907,=,nM,939.7,CHEMBL203,Homo sapiens,IC50,nM,939.7
8282,18573676,CHEMBL4221534,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL4227281,=,nM,3217.2,CHEMBL203,Homo sapiens,IC50,nM,3217.2
8283,18573677,CHEMBL4221534,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using peptide substrate after 60 mins by HTRF assay,B,CHEMBL939,=,nM,2874.7,CHEMBL203,Homo sapiens,IC50,nM,2874.7
8284,18577489,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226965,=,nM,143.0,CHEMBL203,Homo sapiens,IC50,uM,0.143
8285,18577490,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227812,=,nM,348.0,CHEMBL203,Homo sapiens,IC50,uM,0.348
8286,18577494,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228473,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
8287,18577497,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL1229592,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
8288,18577498,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL3353410,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
8289,18577499,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL3699588,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
8290,18577500,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226562,=,nM,641.0,CHEMBL203,Homo sapiens,IC50,uM,0.641
8291,18577502,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225781,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
8292,18577503,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4224932,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
8293,18577504,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228176,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
8294,18577505,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225191,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
8295,18577506,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225255,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
8296,18577507,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4229010,=,nM,183.0,CHEMBL203,Homo sapiens,IC50,uM,0.183
8297,18577508,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225517,=,nM,462.0,CHEMBL203,Homo sapiens,IC50,uM,0.462
8298,18577512,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226177,=,nM,972.0,CHEMBL203,Homo sapiens,IC50,uM,0.972
8299,18577514,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226436,=,nM,273.0,CHEMBL203,Homo sapiens,IC50,uM,0.273
8300,18577515,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227278,=,nM,644.0,CHEMBL203,Homo sapiens,IC50,uM,0.644
8301,18577516,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226702,=,nM,225.0,CHEMBL203,Homo sapiens,IC50,uM,0.225
8302,18577517,CHEMBL4222198,Inhibition of recombinant human GST-tagged wild-type EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227552,=,nM,158.0,CHEMBL203,Homo sapiens,IC50,uM,0.158
8303,18577518,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL1229592,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
8304,18577521,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228473,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
8305,18577524,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227490,=,nM,192.0,CHEMBL203,Homo sapiens,IC50,uM,0.192
8306,18577525,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227812,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,uM,0.058
8307,18577526,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226965,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,uM,0.048
8308,18577527,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227552,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
8309,18577528,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226702,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
8310,18577529,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4227278,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,uM,0.087
8311,18577530,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226436,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
8312,18577531,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225571,=,nM,510.0,CHEMBL203,Homo sapiens,IC50,uM,0.51
8313,18577532,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226177,=,nM,215.0,CHEMBL203,Homo sapiens,IC50,uM,0.215
8314,18577533,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228848,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,uM,0.128
8315,18577534,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228018,=,nM,266.0,CHEMBL203,Homo sapiens,IC50,uM,0.266
8316,18577535,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4229266,=,nM,101.0,CHEMBL203,Homo sapiens,IC50,uM,0.101
8317,18577536,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225517,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,uM,0.17
8318,18577537,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4229010,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
8319,18577538,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225255,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
8320,18577539,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225191,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
8321,18577540,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4228176,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
8322,18577541,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4224932,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
8323,18577542,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4225781,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
8324,18577543,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226254,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,uM,0.27
8325,18577544,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL4226562,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,uM,0.037
8326,18577545,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL3699588,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
8327,18577546,CHEMBL4222199,Inhibition of recombinant human GST-tagged EGFR L858R/T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using tyrosine04 peptide as substrate after 60 mins in presence of ATP by Z-LYTE assay,B,CHEMBL3353410,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
8328,18577548,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL1229592,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
8329,18577549,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4228473,=,nM,906.0,CHEMBL203,Homo sapiens,IC50,uM,0.906
8330,18577550,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4227812,=,nM,391.0,CHEMBL203,Homo sapiens,IC50,uM,0.391
8331,18577551,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4226965,=,nM,3146.0,CHEMBL203,Homo sapiens,IC50,uM,3.146
8332,18577552,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4227552,=,nM,511.0,CHEMBL203,Homo sapiens,IC50,uM,0.511
8333,18577553,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4226702,=,nM,218.0,CHEMBL203,Homo sapiens,IC50,uM,0.218
8334,18577555,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4226436,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
8335,18577556,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4229010,=,nM,112.0,CHEMBL203,Homo sapiens,IC50,uM,0.112
8336,18577557,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4225255,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,uM,0.43
8337,18577558,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4225191,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,uM,0.082
8338,18577559,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4228176,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,uM,0.055
8339,18577560,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4224932,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,uM,0.105
8340,18577561,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4225781,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
8341,18577562,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL4226562,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,uM,0.131
8342,18577563,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL3699588,=,nM,132.0,CHEMBL203,Homo sapiens,IC50,uM,0.132
8343,18577564,CHEMBL4222196,Inhibition of EGFR L858R/T790M mutant phosphorylation in human NCI-H1975 cells after 1 hr by ELISA,B,CHEMBL3353410,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
8344,18577565,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL1229592,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
8345,18577572,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4226436,=,nM,4999.0,CHEMBL203,Homo sapiens,IC50,uM,4.999
8346,18577574,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4225255,=,nM,1703.0,CHEMBL203,Homo sapiens,IC50,uM,1.703
8347,18577575,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4225191,=,nM,1535.0,CHEMBL203,Homo sapiens,IC50,uM,1.535
8348,18577576,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4228176,=,nM,1013.0,CHEMBL203,Homo sapiens,IC50,uM,1.013
8349,18577577,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4224932,=,nM,2338.0,CHEMBL203,Homo sapiens,IC50,uM,2.338
8350,18577578,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4225781,=,nM,6463.0,CHEMBL203,Homo sapiens,IC50,uM,6.463
8351,18577579,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL4226562,=,nM,2210.0,CHEMBL203,Homo sapiens,IC50,uM,2.21
8352,18577580,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL3699588,=,nM,1034.0,CHEMBL203,Homo sapiens,IC50,uM,1.034
8353,18577581,CHEMBL4222201,Inhibition of wild-type EGFR phosphorylation in human A431 cells preincubated for 1 hr followed by EGF stimulation measured after 45 mins by ELISA,B,CHEMBL3353410,=,nM,141.0,CHEMBL203,Homo sapiens,IC50,uM,0.141
8354,18581460,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL3353410,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
8355,18581461,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4228518,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
8356,18581462,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4226937,=,nM,805.0,CHEMBL203,Homo sapiens,IC50,nM,805.0
8357,18581463,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4226676,=,nM,331.0,CHEMBL203,Homo sapiens,IC50,nM,331.0
8358,18581464,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4225777,=,nM,556.0,CHEMBL203,Homo sapiens,IC50,nM,556.0
8359,18581465,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4225565,=,nM,529.0,CHEMBL203,Homo sapiens,IC50,nM,529.0
8360,18581466,CHEMBL4222847,"Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4226151,=,nM,892.0,CHEMBL203,Homo sapiens,IC50,nM,892.0
8361,18581470,CHEMBL4222846,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL3353410,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
8362,18581471,CHEMBL4222846,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4228518,=,nM,189.0,CHEMBL203,Homo sapiens,IC50,nM,189.0
8363,18581473,CHEMBL4222846,"Inhibition of EGFR L858R/T790M double mutant (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4226676,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
8364,18581491,CHEMBL4222844,"Inhibition of wild type EGFR (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL3353410,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
8365,18581492,CHEMBL4222844,"Inhibition of wild type EGFR (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4228518,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
8366,18581494,CHEMBL4222844,"Inhibition of wild type EGFR (unknown origin) using poly (Glu, Tyr) as substrate after 40 mins by kinase-glo plus luminescence assay",B,CHEMBL4226676,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
8367,18585798,CHEMBL4223404,Inhibition of EGFR (unknown origin),B,CHEMBL4225828,=,nM,596.0,CHEMBL203,Homo sapiens,IC50,nM,596.0
8368,18652255,CHEMBL4229651,Inhibition of EGFR (unknown origin),B,CHEMBL4246256,=,nM,52110.0,CHEMBL203,Homo sapiens,IC50,uM,52.11
8369,18652256,CHEMBL4229651,Inhibition of EGFR (unknown origin),B,CHEMBL4251297,=,nM,38730.0,CHEMBL203,Homo sapiens,IC50,uM,38.73
8370,18656117,CHEMBL4231153,Inhibition of recombinant human EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate measured after 15 mins by LANCE assay,B,CHEMBL29197,=,nM,0.095,CHEMBL203,Homo sapiens,IC50,10'-10M,0.95
8371,18656479,CHEMBL4231196,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,B,CHEMBL4238771,=,nM,45500.0,CHEMBL203,Homo sapiens,IC50,uM,45.5
8372,18656480,CHEMBL4231196,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,B,CHEMBL47173,=,nM,10100.0,CHEMBL203,Homo sapiens,IC50,uM,10.1
8373,18656481,CHEMBL4231196,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,B,CHEMBL172517,=,nM,31800.0,CHEMBL203,Homo sapiens,IC50,uM,31.8
8374,18656482,CHEMBL4231196,Inhibition of recombinant human EGFR using peptide as substrate by fluorimetric analysis,B,CHEMBL50,=,nM,14900.0,CHEMBL203,Homo sapiens,IC50,uM,14.9
8375,18656760,CHEMBL4231282,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,B,CHEMBL4244030,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
8376,18656761,CHEMBL4231282,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,B,CHEMBL4241867,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
8377,18656762,CHEMBL4231282,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,B,CHEMBL4241486,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
8378,18656763,CHEMBL4231282,Inhibition of His-6 tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in Baculovirus infected Sf9 cells by dissociation-enhanced lanthanide fluorescence immunoassay/time-resolved fluorometric analysis,B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
8379,18665596,CHEMBL4233281,Inhibition of EGFR isolated from human A431 cells,B,CHEMBL939,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8380,18665597,CHEMBL4233281,Inhibition of EGFR isolated from human A431 cells,B,CHEMBL301018,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
8381,18676729,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4245415,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
8382,18676730,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4250210,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
8383,18676731,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4239716,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
8384,18676732,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4242522,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8385,18676733,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4237916,=,nM,7.1,CHEMBL203,Homo sapiens,IC50,nM,7.1
8386,18676734,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4250273,=,nM,10.1,CHEMBL203,Homo sapiens,IC50,nM,10.1
8387,18676735,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4241638,=,nM,92.5,CHEMBL203,Homo sapiens,IC50,nM,92.5
8388,18676736,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4245874,=,nM,283.1,CHEMBL203,Homo sapiens,IC50,nM,283.1
8389,18676737,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL553,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
8390,18676738,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL535,=,nM,172.1,CHEMBL203,Homo sapiens,IC50,nM,172.1
8391,18676740,CHEMBL4235834,Inhibition of EGF-induced EGFR activation in human A431 cells pretreated for 60 mins followed by EGF addition and measured after 10 mins by ELISA,B,CHEMBL4250191,=,nM,15.5,CHEMBL203,Homo sapiens,IC50,nM,15.5
8392,18689612,CHEMBL4252893,"Inhibition of EGFR (unknown origin) using poly(Glu, Tyr) 4:1 as substrate after 30 mins by HTRF assay",B,CHEMBL4289577,=,nM,632.8,CHEMBL203,Homo sapiens,IC50,nM,632.8
8393,18690150,CHEMBL4252972,Inhibition of C-terminal His-tagged and N-terminal GST tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using KHKKLAEGSAYEEV substrate peptide and gamma-[32P]ATP,B,CHEMBL4286031,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0
8394,18695613,CHEMBL4253971,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,B,CHEMBL4293326,=,nM,951.0,CHEMBL203,Homo sapiens,IC50,uM,0.951
8395,18696345,CHEMBL4253971,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,B,CHEMBL4290375,=,nM,901.0,CHEMBL203,Homo sapiens,IC50,uM,0.901
8396,18696349,CHEMBL4253971,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,B,CHEMBL4285894,=,nM,752.0,CHEMBL203,Homo sapiens,IC50,uM,0.752
8397,18696487,CHEMBL4253971,Inhibition of recombinant human C-terminal His/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using biotin-labeled poly[Glu:Tyr] (4:1) as substrate after 30 mins by Kinase-Glo plus luminescence assay,B,CHEMBL4292715,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
8398,18696678,CHEMBL4253972,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
8399,18696691,CHEMBL4253972,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
8400,18701235,CHEMBL4254926,Inhibition of EGFR (unknown origin),B,CHEMBL4279863,=,nM,45000.0,CHEMBL203,Homo sapiens,IC50,uM,45.0
8401,18722854,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4277911,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
8402,18722855,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4288246,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
8403,18722856,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293145,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8404,18722857,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282543,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
8405,18722858,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4287401,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8406,18722859,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293734,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8407,18722860,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4290812,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
8408,18722861,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282954,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
8409,18722862,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4294211,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8410,18722863,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279016,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8411,18722864,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4286318,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
8412,18722865,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
8413,18722866,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4278815,=,nM,22.4,CHEMBL203,Homo sapiens,IC50,nM,22.4
8414,18722867,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4289490,=,nM,30.6,CHEMBL203,Homo sapiens,IC50,nM,30.6
8415,18722868,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4287141,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5
8416,18722869,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279227,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
8417,18722870,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4290568,=,nM,5.2,CHEMBL203,Homo sapiens,IC50,nM,5.2
8418,18722871,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282688,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
8419,18722872,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293126,=,nM,14.7,CHEMBL203,Homo sapiens,IC50,nM,14.7
8420,18722873,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282523,=,nM,22.8,CHEMBL203,Homo sapiens,IC50,nM,22.8
8421,18722874,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4280993,=,nM,29.9,CHEMBL203,Homo sapiens,IC50,nM,29.9
8422,18722875,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279057,=,nM,18.9,CHEMBL203,Homo sapiens,IC50,nM,18.9
8423,18722876,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279016,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8424,18722877,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4294211,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
8425,18722878,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282954,=,nM,13.5,CHEMBL203,Homo sapiens,IC50,nM,13.5
8426,18722879,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4290812,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
8427,18722880,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293734,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
8428,18722881,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4287401,=,nM,30.4,CHEMBL203,Homo sapiens,IC50,nM,30.4
8429,18722882,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282543,=,nM,13.9,CHEMBL203,Homo sapiens,IC50,nM,13.9
8430,18722883,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293145,=,nM,29.1,CHEMBL203,Homo sapiens,IC50,nM,29.1
8431,18722884,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4288246,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
8432,18722885,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4277911,=,nM,25.4,CHEMBL203,Homo sapiens,IC50,nM,25.4
8433,18722886,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4286318,=,nM,27.9,CHEMBL203,Homo sapiens,IC50,nM,27.9
8434,18722887,CHEMBL4258549,"Inhibition of Wild type human EGFR using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,142.1,CHEMBL203,Homo sapiens,IC50,nM,142.1
8435,18722888,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279057,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8436,18722889,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4280993,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
8437,18722890,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282523,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
8438,18722891,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4293126,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
8439,18722892,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4282688,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
8440,18722893,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4290568,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8441,18722894,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4279227,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8442,18722895,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4287141,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8443,18722896,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4289490,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
8444,18722897,CHEMBL4258550,"Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using poly(Glu, Tyr) 4 : 1 as substrate after 1 hr by ELISA",B,CHEMBL4278815,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
8445,18724528,CHEMBL4258941,"Inhibition of EGFR (unknown origin) using poly (4:1 Glu, Tyr) as substrate measured after 1 hr by ELISA",B,CHEMBL4293051,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8446,18765229,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4276965,=,nM,779.0,CHEMBL203,Homo sapiens,IC50,nM,779.0
8447,18765230,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4288300,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8448,18765231,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4280395,=,nM,336.0,CHEMBL203,Homo sapiens,IC50,nM,336.0
8449,18765232,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4293690,=,nM,288.0,CHEMBL203,Homo sapiens,IC50,nM,288.0
8450,18765233,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283097,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
8451,18765234,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283517,=,nM,901.0,CHEMBL203,Homo sapiens,IC50,nM,901.0
8452,18765235,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4286871,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
8453,18765236,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4288262,=,nM,324.0,CHEMBL203,Homo sapiens,IC50,nM,324.0
8454,18765237,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283823,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
8455,18765240,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL1379917,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,nM,131.0
8456,18765243,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4282460,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8457,18765244,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4290750,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
8458,18765245,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4282879,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
8459,18765246,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4294156,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
8460,18765247,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4286263,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
8461,18765248,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283970,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
8462,18765250,CHEMBL4267255,Inhibition of N-terminal GST-tagged wild type human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283061,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8463,18765346,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4292110,=,nM,1188.0,CHEMBL203,Homo sapiens,IC50,nM,1188.0
8464,18765347,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4284911,=,nM,1229.0,CHEMBL203,Homo sapiens,IC50,nM,1229.0
8465,18765348,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4276965,=,nM,467.0,CHEMBL203,Homo sapiens,IC50,nM,467.0
8466,18765349,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4288300,=,nM,7.7,CHEMBL203,Homo sapiens,IC50,nM,7.7
8467,18765350,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4280395,=,nM,208.0,CHEMBL203,Homo sapiens,IC50,nM,208.0
8468,18765352,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283097,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,nM,102.0
8469,18765355,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4288262,=,nM,229.0,CHEMBL203,Homo sapiens,IC50,nM,229.0
8470,18765356,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283823,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8471,18765357,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4293134,=,nM,754.0,CHEMBL203,Homo sapiens,IC50,nM,754.0
8472,18765358,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4281413,=,nM,1409.0,CHEMBL203,Homo sapiens,IC50,nM,1409.0
8473,18765359,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL1379917,=,nM,63.0,CHEMBL203,Homo sapiens,IC50,nM,63.0
8474,18765360,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4278997,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,nM,105.0
8475,18765361,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4289682,=,nM,944.0,CHEMBL203,Homo sapiens,IC50,nM,944.0
8476,18765362,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4282460,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8477,18765363,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4290750,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
8478,18765365,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4294156,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8479,18765367,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4283970,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
8480,18765368,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4288761,=,nM,933.0,CHEMBL203,Homo sapiens,IC50,nM,933.0
8481,18766029,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4278031,=,nM,974.0,CHEMBL203,Homo sapiens,IC50,nM,974.0
8482,18766032,CHEMBL4267257,Inhibition of N-terminal GST-tagged human EGFR del 747-750 mutant cytoplasmic domain expressed in baculovirus expression system using FAM-labeled peptide as substrate after 10 mins by mobility shift assay,B,CHEMBL4287629,=,nM,792.0,CHEMBL203,Homo sapiens,IC50,nM,792.0
8483,18782529,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4218431,=,nM,85.2,CHEMBL203,Homo sapiens,IC50,nM,85.2
8484,18782530,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL388978,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
8485,18782531,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3545311,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
8486,18782532,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,225.0,CHEMBL203,Homo sapiens,IC50,nM,225.0
8487,18782533,CHEMBL4270447,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4294743,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8488,18782534,CHEMBL4270446,"Inhibition of recombinant human EGFR T790M/L858R double mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4218431,=,nM,367.1,CHEMBL203,Homo sapiens,IC50,nM,367.1
8489,18782535,CHEMBL4270446,"Inhibition of recombinant human EGFR T790M/L858R double mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL388978,=,nM,16.5,CHEMBL203,Homo sapiens,IC50,nM,16.5
8490,18782536,CHEMBL4270446,"Inhibition of recombinant human EGFR T790M/L858R double mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3545311,=,nM,50.9,CHEMBL203,Homo sapiens,IC50,nM,50.9
8491,18782537,CHEMBL4270446,"Inhibition of recombinant human EGFR T790M/L858R double mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL3353410,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
8492,18782538,CHEMBL4270446,"Inhibition of recombinant human EGFR T790M/L858R double mutant using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4294743,=,nM,30.5,CHEMBL203,Homo sapiens,IC50,nM,30.5
8493,18782551,CHEMBL4270448,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate after 1 hr by ELISA",B,CHEMBL4294743,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
8494,18783592,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4292351,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
8495,18783593,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4291935,=,nM,80.8,CHEMBL203,Homo sapiens,IC50,nM,80.8
8496,18783594,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4284071,=,nM,0.71,CHEMBL203,Homo sapiens,IC50,nM,0.71
8497,18783595,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4291900,=,nM,94.7,CHEMBL203,Homo sapiens,IC50,nM,94.7
8498,18783597,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4288482,=,nM,96.6,CHEMBL203,Homo sapiens,IC50,nM,96.6
8499,18783598,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4277822,=,nM,100.5,CHEMBL203,Homo sapiens,IC50,nM,100.5
8500,18783599,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4280174,=,nM,15.3,CHEMBL203,Homo sapiens,IC50,nM,15.3
8501,18783600,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4288080,=,nM,13.4,CHEMBL203,Homo sapiens,IC50,nM,13.4
8502,18783601,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4276744,=,nM,21.5,CHEMBL203,Homo sapiens,IC50,nM,21.5
8503,18783602,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4284684,=,nM,24.8,CHEMBL203,Homo sapiens,IC50,nM,24.8
8504,18783603,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL4278226,=,nM,21.7,CHEMBL203,Homo sapiens,IC50,nM,21.7
8505,18783604,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL3545308,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
8506,18783605,CHEMBL4271007,"Inhibition of N-terminal GST tagged human recombinant EGFR L858R/T790M mutant (695 to end amino acids) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) Peptide substrate by ADP-Glo assay",B,CHEMBL939,=,nM,823.3,CHEMBL203,Homo sapiens,IC50,nM,823.3
8507,18783978,CHEMBL4271076,Inhibition of human EGFR L858R mutant expressed in Sf9 cells in presence of 1 mM ATP by HTRF assay,B,CHEMBL4284413,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,uM,0.024
8508,18784564,CHEMBL4271176,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
8509,18784565,CHEMBL4271176,Inhibition of EGFR (unknown origin),B,CHEMBL4290869,=,nM,9.8,CHEMBL203,Homo sapiens,IC50,nM,9.8
8510,18784566,CHEMBL4271176,Inhibition of EGFR (unknown origin),B,CHEMBL4286374,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
8511,18784567,CHEMBL4271176,Inhibition of EGFR (unknown origin),B,CHEMBL4294264,=,nM,1935.0,CHEMBL203,Homo sapiens,IC50,uM,1.935
8512,18784575,CHEMBL4271179,Inhibition of EGFR T790M/L858R mutant (unknown origin),B,CHEMBL4290869,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
8513,18784587,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
8514,18784588,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL2138625,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
8515,18784589,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL2347958,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8516,18784590,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL31965,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
8517,18784591,CHEMBL4271184,Inhibition of GST-tagged human EGFR catalytic domain expressed in insect cells,B,CHEMBL3545154,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
8518,18784597,CHEMBL4271186,Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL2138625,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
8519,18784598,CHEMBL4271186,Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL2347958,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
8520,18784599,CHEMBL4271186,Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL31965,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8521,18784600,CHEMBL4271186,Inhibition of human EGFR T790M/L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL3545154,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
8522,18784601,CHEMBL4271187,Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL2138625,=,nM,0.51,CHEMBL203,Homo sapiens,IC50,nM,0.51
8523,18784602,CHEMBL4271187,Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL2347958,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
8524,18784603,CHEMBL4271187,Inhibition of human EGFR L858R mutant expressed in mouse Ba/F3 cells,B,CHEMBL31965,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
8525,18784604,CHEMBL4271188,Inhibition of human EGFR T790M mutant expressed in mouse Ba/F3 cells,B,CHEMBL2138625,=,nM,0.79,CHEMBL203,Homo sapiens,IC50,nM,0.79
8526,18784605,CHEMBL4271188,Inhibition of human EGFR T790M mutant expressed in mouse Ba/F3 cells,B,CHEMBL3545154,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
8527,18784648,CHEMBL4271213,Inhibition of 6x-His-tagged human EGFR cytoplasmic domain (645 to 1186 amino acids) assessed as reduction in autophosphorylation pre-incubated for 10 mins and measured after 1 hr by DELFIA/time-resolved fluorometry,B,CHEMBL4280817,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
8528,18787523,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4278886,=,nM,21.4,CHEMBL203,Homo sapiens,IC50,nM,21.4
8529,18787524,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL388978,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
8530,18787525,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4291471,=,nM,47.7,CHEMBL203,Homo sapiens,IC50,nM,47.7
8531,18787526,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4280835,=,nM,47.1,CHEMBL203,Homo sapiens,IC50,nM,47.1
8532,18787527,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4286733,=,nM,112.0,CHEMBL203,Homo sapiens,IC50,nM,112.0
8533,18787528,CHEMBL4272061,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells using Poly-(Glu, Tyr) as substrate measured after 45 minutes by Kinase-Glo luminescent assay",B,CHEMBL4288374,=,nM,91.7,CHEMBL203,Homo sapiens,IC50,nM,91.7
8534,18795773,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4286998,=,nM,9800.0,CHEMBL203,Homo sapiens,IC50,uM,9.8
8535,18795774,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4282482,=,nM,7200.0,CHEMBL203,Homo sapiens,IC50,uM,7.2
8536,18795775,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4290355,=,nM,5600.0,CHEMBL203,Homo sapiens,IC50,uM,5.6
8537,18795776,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4279008,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
8538,18795777,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4286943,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
8539,18795778,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4289274,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,uM,1.7
8540,18795779,CHEMBL4273762,Inhibition of His6-tagged recombinant EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL1079742,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
8541,18798651,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4288648,=,nM,751.0,CHEMBL203,Homo sapiens,IC50,uM,0.751
8542,18798652,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4280749,=,nM,1182.0,CHEMBL203,Homo sapiens,IC50,uM,1.182
8543,18798653,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4289083,=,nM,1931.0,CHEMBL203,Homo sapiens,IC50,uM,1.931
8544,18798654,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4284841,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,uM,0.108
8545,18798655,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4281426,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
8546,18798656,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4282506,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
8547,18798657,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL4289728,=,nM,205.0,CHEMBL203,Homo sapiens,IC50,uM,0.205
8548,18798658,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL554,=,nM,27.1,CHEMBL203,Homo sapiens,IC50,uM,0.0271
8549,18798659,CHEMBL4274200,Inhibition of EGFR in human HepG2 cells,B,CHEMBL939,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,uM,0.0125
8550,18798660,CHEMBL4274201,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL4282506,=,nM,33.8,CHEMBL203,Homo sapiens,IC50,nM,33.8
8551,18798661,CHEMBL4274201,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL554,=,nM,37.55,CHEMBL203,Homo sapiens,IC50,nM,37.55
8552,18798662,CHEMBL4274201,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus infected insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL939,=,nM,11.5,CHEMBL203,Homo sapiens,IC50,nM,11.5
8553,18798663,CHEMBL4274202,Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL4282506,=,nM,137.3,CHEMBL203,Homo sapiens,IC50,nM,137.3
8554,18798664,CHEMBL4274202,Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL554,=,nM,224.89,CHEMBL203,Homo sapiens,IC50,nM,224.89
8555,18798665,CHEMBL4274202,Inhibition of N-terminal GST-tagged recombinant human EGFR T790M mutant expressed in baculovirus infected Sf21 insect cells preincubated for 5 mins followed by ATP addition and measured after 30 mins by HTRF assay,B,CHEMBL939,=,nM,129.7,CHEMBL203,Homo sapiens,IC50,nM,129.7
8556,18851325,CHEMBL4305817,Inhibition of EGFR (unknown origin),B,CHEMBL4448494,=,nM,1970.0,CHEMBL203,Homo sapiens,IC50,nM,1970.0
8557,18854219,CHEMBL4307064,Inhibition of human EGFR by ELISA,B,CHEMBL4578764,=,nM,2160.0,CHEMBL203,Homo sapiens,IC50,uM,2.16
8558,18856436,CHEMBL4307556,Inhibition of EGFR (unknown origin) using TK substrate incubated for 60 mins by FRET assay,B,CHEMBL4520064,=,nM,384.8,CHEMBL203,Homo sapiens,IC50,nM,384.8
8559,18856437,CHEMBL4307556,Inhibition of EGFR (unknown origin) using TK substrate incubated for 60 mins by FRET assay,B,CHEMBL939,=,nM,0.769,CHEMBL203,Homo sapiens,IC50,nM,0.769
8560,18856469,CHEMBL4307584,Inhibition of EGFR (unknown origin),B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
8561,18887648,CHEMBL4313654,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4561572,=,nM,412.3,CHEMBL203,Homo sapiens,IC50,uM,0.4123
8562,18887649,CHEMBL4313654,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4535881,=,nM,275.7,CHEMBL203,Homo sapiens,IC50,uM,0.2757
8563,18887650,CHEMBL4313654,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4569755,=,nM,1128.9,CHEMBL203,Homo sapiens,IC50,uM,1.1289
8564,18887651,CHEMBL4313654,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL553,=,nM,417.8,CHEMBL203,Homo sapiens,IC50,uM,0.4178
8565,18894888,CHEMBL4315485,Inhibition of EGFR (unknown origin),B,CHEMBL75177,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,uM,0.029
8566,18894889,CHEMBL4315485,Inhibition of EGFR (unknown origin),B,CHEMBL306081,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
8567,18896895,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4552429,=,nM,511.0,CHEMBL203,Homo sapiens,IC50,nM,511.0
8568,18896896,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4471845,=,nM,570.0,CHEMBL203,Homo sapiens,IC50,nM,570.0
8569,18896899,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4583545,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
8570,18896902,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4475770,=,nM,201.0,CHEMBL203,Homo sapiens,IC50,nM,201.0
8571,18896903,CHEMBL4315818,Inhibition of wildtype EGFR (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL3353410,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
8572,18896904,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4476689,=,nM,1128.0,CHEMBL203,Homo sapiens,IC50,nM,1128.0
8573,18896905,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4454709,=,nM,1689.0,CHEMBL203,Homo sapiens,IC50,nM,1689.0
8574,18896906,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4552429,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
8575,18896907,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4471845,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
8576,18896908,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4446546,=,nM,1248.0,CHEMBL203,Homo sapiens,IC50,nM,1248.0
8577,18896909,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4522613,=,nM,1621.0,CHEMBL203,Homo sapiens,IC50,nM,1621.0
8578,18896910,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4583545,=,nM,990.0,CHEMBL203,Homo sapiens,IC50,nM,990.0
8579,18896911,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4472571,=,nM,1753.0,CHEMBL203,Homo sapiens,IC50,nM,1753.0
8580,18896912,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL4444312,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
8581,18896914,CHEMBL4315819,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using biotin as substrate in presence of ATP by mobility shift assay based ELISA,B,CHEMBL3353410,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
8582,18902577,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4439982,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8583,18902578,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4527121,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8584,18902579,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4540138,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8585,18902580,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4560430,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8586,18902581,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4473277,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8587,18902582,CHEMBL4316716,Inhibition of erbB1 (unknown origin) using FRET-capable peptide substrate by FRET assay,B,CHEMBL4516232,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
8588,18923666,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4532034,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8589,18923678,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4434788,=,nM,267.0,CHEMBL203,Homo sapiens,IC50,nM,267.0
8590,18923679,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4449589,=,nM,353.0,CHEMBL203,Homo sapiens,IC50,nM,353.0
8591,18923680,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4525935,=,nM,519.0,CHEMBL203,Homo sapiens,IC50,nM,519.0
8592,18923685,CHEMBL4324119,Inhibition of human recombinant GST-tagged wild type EGFR expressed in baculovirus expression system assessed as decrease in phosphorylation of ULight-poly-GT using ULight-poly-GT as substrate incubated for 90 mins in presence of ATP by TR-FRET LANCE assay,B,CHEMBL4532034,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
8593,18923697,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4591327,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,nM,2100.0
8594,18923698,CHEMBL4324121,Inhibition of GST-fusion tagged EGFR L858R/T790M/C797S triple mutant (unknown origin) (696 to 1022 residues) expressed in insect cells assessed as decrease in phosphorylation of ULight-poly-GT using poly-GT as substrate in presence of ATP,B,CHEMBL4444231,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,nM,2700.0
8595,18938889,CHEMBL4328395,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,B,CHEMBL388978,=,nM,155.0,CHEMBL203,Homo sapiens,IC50,10'-7M,1.55
8596,18945170,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4534611,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
8597,18945171,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4522240,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
8598,18945172,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL939,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8599,18945173,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4586581,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3
8600,18945174,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4435885,=,nM,28.2,CHEMBL203,Homo sapiens,IC50,nM,28.2
8601,18945175,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4563873,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
8602,18945176,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4439338,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
8603,18945177,CHEMBL4329616,Inhibition of wild type human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL554,=,nM,10.85,CHEMBL203,Homo sapiens,IC50,nM,10.85
8604,18945187,CHEMBL4329618,Inhibition of human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) T790M mutant expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4522240,=,nM,16.5,CHEMBL203,Homo sapiens,IC50,nM,16.5
8605,18945188,CHEMBL4329618,Inhibition of human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) T790M mutant expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL939,=,nM,148.7,CHEMBL203,Homo sapiens,IC50,nM,148.7
8606,18945192,CHEMBL4329618,Inhibition of human N-terminal GST-tagged EGFR cytoplasmic domain (669 to 1210 residues) T790M mutant expressed in baculovirus expression system after 1 hr in presence of ULight-labeled peptide substrate and ATP by LANCE ultra kinase assay,B,CHEMBL4439338,=,nM,40.6,CHEMBL203,Homo sapiens,IC50,nM,40.6
8607,18948041,CHEMBL4330453,Inhibition of EGFR (unknown origin) using FAM-labelled peptide and ATP incubated for 10 mins by mobility shift assay,B,CHEMBL4587222,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52
8608,18955274,CHEMBL4332281,Inhibition of human A431 cell-derived EGFR using Lys-His-Lys-LysLeu-Ala-Glu-Gly-Ser-Ala-Tyr472-Glu-Glu-Val as substrate measured after 10 mins in presence of [32P]ATP by scintillation counting method,B,CHEMBL29197,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
8609,18955275,CHEMBL4332282,Inhibition of human A431 cell-derived EGFR,B,CHEMBL939,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,uM,0.0037
8610,18955276,CHEMBL4332283,Inhibition of human A431 cell-derived EGFR assessed as reduction in PGT phosphorylation after 8 mins by colorimetry based immunoassay,B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
8611,18955277,CHEMBL4332284,Inhibition of EGF-induced EGFR phosphorylation at Tyr-residue in human HN5 cells preincubated for 24 hrs followed by EGF-stimulation and measured after 15 mins by Western blot analysis,B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
8612,18955278,CHEMBL4332285,Inhibition of human A431 cell-derived EGFR using polyglutamic acid/tyrosine as substrate incubated for 10 mins followed by [32P]ATP addition and measured after 10 mins by beta counting method,B,CHEMBL31965,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8613,18955279,CHEMBL4332286,Inhibition of recombinant human His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in autophosphorylation preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL607707,=,nM,38.5,CHEMBL203,Homo sapiens,IC50,nM,38.5
8614,18955280,CHEMBL4332286,Inhibition of recombinant human His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in autophosphorylation preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL94061,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
8615,18955281,CHEMBL4332286,Inhibition of recombinant human His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in autophosphorylation preincubated for 10 mins followed by ATP-MgCl2 addition and measured after 1 hr by DELFIA/time-resolved fluorometric analysis,B,CHEMBL4578561,=,nM,38.5,CHEMBL203,Homo sapiens,IC50,nM,38.5
8616,18955305,CHEMBL4332297,Inhibition of human GST-fused EGFR kinase domain expressed in baculovirus expression system measured after 30 mins by ELISA,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
8617,18955306,CHEMBL4332297,Inhibition of human GST-fused EGFR kinase domain expressed in baculovirus expression system measured after 30 mins by ELISA,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8618,18955311,CHEMBL4332301,Inhibition of EGFR (unknown origin),B,CHEMBL4578466,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
8619,18955869,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4474073,=,nM,0.76,CHEMBL203,Homo sapiens,IC50,nM,0.76
8620,18955870,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4577883,=,nM,0.94,CHEMBL203,Homo sapiens,IC50,nM,0.94
8621,18955871,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4443188,=,nM,2.73,CHEMBL203,Homo sapiens,IC50,nM,2.73
8622,18955872,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4473875,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nM,0.69
8623,18955873,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4592101,=,nM,2.84,CHEMBL203,Homo sapiens,IC50,nM,2.84
8624,18955874,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4450824,=,nM,1.54,CHEMBL203,Homo sapiens,IC50,nM,1.54
8625,18955875,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4447976,=,nM,153.5,CHEMBL203,Homo sapiens,IC50,nM,153.5
8626,18955876,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL4591886,=,nM,1.48,CHEMBL203,Homo sapiens,IC50,nM,1.48
8627,18955877,CHEMBL4332363,Inhibition of recombinant human GST-tagged EGFR catalytic domain (668 to 1210 residues) expressed in baculovirus expression system using TK-biotin peptide as substrate measured after 10 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.96,CHEMBL203,Homo sapiens,IC50,nM,0.96
8628,18973270,CHEMBL4337477,Inhibition of EGFR (unknown origin),B,CHEMBL2316916,=,ug.mL-1,6.7,CHEMBL203,Homo sapiens,IC50,ug ml-1,6.7
8629,18973271,CHEMBL4337477,Inhibition of EGFR (unknown origin),B,CHEMBL4531006,=,ug.mL-1,8.5,CHEMBL203,Homo sapiens,IC50,ug ml-1,8.5
8630,18973272,CHEMBL4337477,Inhibition of EGFR (unknown origin),B,CHEMBL4539558,=,ug.mL-1,6.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,6.0
8631,18973273,CHEMBL4337477,Inhibition of EGFR (unknown origin),B,CHEMBL1095259,=,ug.mL-1,20.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,20.0
8632,18973274,CHEMBL4337477,Inhibition of EGFR (unknown origin),B,CHEMBL4575427,=,ug.mL-1,20.0,CHEMBL203,Homo sapiens,IC50,ug ml-1,20.0
8633,18980621,CHEMBL4339258,Inhibition of EGFR (unknown origin) by HTscan assay,B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
8634,18989199,CHEMBL4340725,Inhibition of recombinant human wild-type N-terminal GST-His6-fused EGFR C-terminal domain (H672 to A1210) expressed in Sf9 insect cells using Poly(Glu:Tyr)4:1 as substrate measured after 60 mins in presence of [gamma-33P]-ATP by scintillation counting method,B,CHEMBL4446681,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,uM,10.0
8635,18992536,CHEMBL4341613,Inhibition of EGFR L858R mutant (unknown origin) using polyE4Y1 as substrate measured after 60 mins,B,CHEMBL442938,=,nM,56.48,CHEMBL203,Homo sapiens,IC50,nmol,56.48
8636,18994323,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4441392,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,uM,0.056
8637,18994324,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4567599,=,nM,188.0,CHEMBL203,Homo sapiens,IC50,uM,0.188
8638,18994325,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4456976,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
8639,18994326,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4435632,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
8640,18994327,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4539566,=,nM,168.0,CHEMBL203,Homo sapiens,IC50,uM,0.168
8641,18994328,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL3818535,=,nM,182.0,CHEMBL203,Homo sapiens,IC50,uM,0.182
8642,18994329,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4550473,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,uM,0.059
8643,18994330,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4445265,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
8644,18994331,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4565086,=,nM,77.0,CHEMBL203,Homo sapiens,IC50,uM,0.077
8645,18994332,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4570484,=,nM,141.0,CHEMBL203,Homo sapiens,IC50,uM,0.141
8646,18994333,CHEMBL4341977,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL553,=,nM,907.0,CHEMBL203,Homo sapiens,IC50,uM,0.907
8647,18994334,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4441392,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,uM,0.052
8648,18994335,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4567599,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,uM,0.086
8649,18994336,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4456976,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
8650,18994337,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4435632,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
8651,18994338,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4539566,=,nM,311.0,CHEMBL203,Homo sapiens,IC50,uM,0.311
8652,18994339,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL3818535,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,uM,0.054
8653,18994340,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4550473,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,uM,0.131
8654,18994341,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4445265,=,nM,107.0,CHEMBL203,Homo sapiens,IC50,uM,0.107
8655,18994342,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4565086,=,nM,157.0,CHEMBL203,Homo sapiens,IC50,uM,0.157
8656,18994343,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL4570484,=,nM,141.0,CHEMBL203,Homo sapiens,IC50,uM,0.141
8657,18994344,CHEMBL4341976,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system reduction in phosphorylation using tyrosine 4 peptide as substrate after 60 mins FRET based Z'-LYTE assay,B,CHEMBL553,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
8658,18994669,CHEMBL4342015,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr) 4:1 substrate incubated for 30 mins by HTRF assay",B,CHEMBL1230609,=,nM,3010.0,CHEMBL203,Homo sapiens,IC50,nM,3010.0
8659,18997205,CHEMBL4342766,Inhibition of EGFR T790M mutant (unknown origin) incubated for 60 mins by ADP-Glo kinase assay,B,CHEMBL4436337,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
8660,18997543,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL29197,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,pM,29.0
8661,18997544,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8662,18997545,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8663,18997546,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL31965,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8664,18997547,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL4547332,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8665,18997548,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL3109738,<,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
8666,18997549,CHEMBL4342860,Inhibition of EGFR in human A431 cells assessed as reduction in cell proliferation incubated for 72 hrs by Coulter counter method,B,CHEMBL29197,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
8667,18997550,CHEMBL4342861,Inhibition of EGFR in human DIFI cells assessed as reduction in cell proliferation incubated for 72 hrs by Coulter counter method,B,CHEMBL29197,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,uM,0.3
8668,18997551,CHEMBL4342862,Inhibition of EGFR in human DU145 cells assessed as reduction in cell proliferation incubated for 72 hrs by Coulter counter method,B,CHEMBL29197,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
8669,18997552,CHEMBL4342863,Inhibition of EGFR in human MDA-MB-468 cells assessed as reduction in cell proliferation incubated for 72 hrs by Coulter counter method,B,CHEMBL29197,=,nM,680.0,CHEMBL203,Homo sapiens,IC50,uM,0.68
8670,18997553,CHEMBL4342864,Inhibition of EGFR in human ME180 cells assessed as reduction in cell proliferation incubated for 72 hrs by Coulter counter method,B,CHEMBL29197,=,nM,950.0,CHEMBL203,Homo sapiens,IC50,uM,0.95
8671,18997554,CHEMBL4342865,Inhibition of EGFR (unknown origin) expressed in baculovirus system assessed as reduction in phosphorylation of Peptide A incubated for 10 mins by scintillation counting,B,CHEMBL554,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
8672,18997555,CHEMBL4342866,Inhibition of human recombinant GST-tagged EGFR using pEY as substrate incubated for 30 mins by ELISA,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8673,18997556,CHEMBL4342867,Inhibition of human recombinant GST-tagged EGFR L858R mutant using pEY as substrate incubated for 30 mins by ELISA,B,CHEMBL1173655,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
8674,18997557,CHEMBL4342868,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant using pEY as substrate incubated for 30 mins by ELISA,B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
8675,18997559,CHEMBL4342856,Inhibition of EGFR (unknown origin) expressed in insect cells by ELISA,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
8676,18997561,CHEMBL4342870,Inhibition of EGFR (unknown origin) assessed as reduction of phosphorylation of Crk incubated for 10 mins in ice with gamma-ATP followed by incubated for 20 mins in 30 degC by radioactive phosphorylation assay,B,CHEMBL2087361,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8677,18997562,CHEMBL4342871,Inhibition of EGFR (unknown origin) assessed as reduction of phosphorylation of polyglutamic acid/tyrosine incubated for 10 mins by beta scintillation counter,B,CHEMBL31965,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
8678,18997565,CHEMBL4342874,Inhibition of human recombinant GST-tagged EGFR L858R/T790M mutant (catalytic domain 695 to end) expressed in baculovirus-infected Sf9 cells assessed as reduction in phosphorylation of polyglutamic acid/tyrosine incubated for 60 mins by ADP-Glo assay,B,CHEMBL4516586,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
8679,18997566,CHEMBL4342875,Inhibition of human recombinant GST-tagged EGFR (catalytic domain 695 to end) expressed in baculovirus-infected Sf9 cells assessed as reduction in phosphorylation of polyglutamic acid/tyrosine incubated for 60 mins by ADP-Glo assay,B,CHEMBL4516586,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,nM,105.0
8680,18997567,CHEMBL4342876,Inhibition of human recombinant full length EGFR using polyglutamic acid/tyrosine as substrate by spectrophotometry,B,CHEMBL2103842,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8681,18997571,CHEMBL4342879,Inhibition of human EFGR expressed in baculovirus/Sf21 system by ELISA,B,CHEMBL2408045,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8682,18997580,CHEMBL4342887,Inhibition of human EGFR,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
8683,18997611,CHEMBL4342912,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4516586,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
8684,18997612,CHEMBL4342859,Inhibition of EGFR (unknown origin),B,CHEMBL4516586,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,nM,105.0
8685,19016021,CHEMBL4346783,Inhibition of human EGFR C-terminal domain,B,CHEMBL4553708,=,nM,66100.0,CHEMBL203,Homo sapiens,IC50,nM,66100.0
8686,19018990,CHEMBL4347068,Inhibition of human recombinant EGFR using Ulight-CAGAGAIETDKEYYTVKD measured after 15 mins in the presence of ATP by LANCE method,B,CHEMBL1873475,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8687,19026278,CHEMBL4348480,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL4465558,=,nM,765.0,CHEMBL203,Homo sapiens,IC50,nM,765.0
8688,19026281,CHEMBL4348480,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL601719,=,nM,681.0,CHEMBL203,Homo sapiens,IC50,nM,681.0
8689,19026284,CHEMBL4348480,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in Baculovirus expression system using srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL4519408,=,nM,598.0,CHEMBL203,Homo sapiens,IC50,nM,598.0
8690,19029996,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4464404,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
8691,19029997,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4465231,=,nM,1048.0,CHEMBL203,Homo sapiens,IC50,nM,1048.0
8692,19029998,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4520286,=,nM,654.0,CHEMBL203,Homo sapiens,IC50,nM,654.0
8693,19029999,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4562744,=,nM,937.0,CHEMBL203,Homo sapiens,IC50,nM,937.0
8694,19030000,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4543893,=,nM,1975.0,CHEMBL203,Homo sapiens,IC50,nM,1975.0
8695,19030001,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4593230,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
8696,19030003,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4469900,=,nM,499.0,CHEMBL203,Homo sapiens,IC50,nM,499.0
8697,19030004,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4457018,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
8698,19030005,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4458344,=,nM,138.0,CHEMBL203,Homo sapiens,IC50,nM,138.0
8699,19030006,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4463563,=,nM,903.0,CHEMBL203,Homo sapiens,IC50,nM,903.0
8700,19030009,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4549626,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
8701,19030087,CHEMBL4349142,Inhibition of recombinant human N-terminal GST-tagged EGFR kinase domain (696 to end residues) expressed in baculovirus infected Sf21 insect cells using STK as substrate by HTRF assay,B,CHEMBL4443805,=,nM,1257.0,CHEMBL203,Homo sapiens,IC50,nM,1257.0
8702,19036710,CHEMBL4351035,Inhibition of EGFR (unknown origin),B,CHEMBL496174,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8703,19054038,CHEMBL4356092,Irreversible inhibition of wild type EGFR (unknown origin),B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,uM,0.0005
8704,19054040,CHEMBL4356092,Irreversible inhibition of wild type EGFR (unknown origin),B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,uM,0.092
8705,19054042,CHEMBL4356092,Irreversible inhibition of wild type EGFR (unknown origin),B,CHEMBL607707,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
8706,19063061,CHEMBL4359338,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4098072,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8707,19063062,CHEMBL4359338,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4441037,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0
8708,19063063,CHEMBL4359338,Inhibition of human EGFR L858R/T790M mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4575583,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8709,19063064,CHEMBL4359339,Inhibition of human EGFR L858R/T790M/C797S mutant using poly[Glu:Tyr] (4:1) as substrate measured in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4098072,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
8710,19070426,CHEMBL4361551,"Inhibition of human EGFR L858R mutant (696 to end residues) using poly (Glu, Tyr) 4:1 as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis",B,CHEMBL4531109,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
8711,19070427,CHEMBL4361552,Inhibition of recombinant human EGFR T790M/L858R double mutant (696 to end residues) using GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma33P]ATP by scintillation counting analysis,B,CHEMBL4531109,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
8712,19072836,CHEMBL4362047,Inhibition of EGFR (unknown origin),B,CHEMBL4439680,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8713,19072850,CHEMBL4362038,Inhibition of recombinant His-tagged human EGFR (645 to 1186 residues) cytoplasmic domain expressed in baculovirus infected Sf9 cells incubated for 10 mins by time resolved fluorimetry,B,CHEMBL2336355,=,nM,5160.0,CHEMBL203,Homo sapiens,IC50,uM,5.16
8714,19072851,CHEMBL4362038,Inhibition of recombinant His-tagged human EGFR (645 to 1186 residues) cytoplasmic domain expressed in baculovirus infected Sf9 cells incubated for 10 mins by time resolved fluorimetry,B,CHEMBL1998736,=,nM,7370.0,CHEMBL203,Homo sapiens,IC50,uM,7.37
8715,19072857,CHEMBL4362047,Inhibition of EGFR (unknown origin),B,CHEMBL4466350,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8716,19073792,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL24828,=,nM,19.76,CHEMBL203,Homo sapiens,IC50,nmol/L,19.76
8717,19073793,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4463898,=,nM,3.23,CHEMBL203,Homo sapiens,IC50,nmol/L,3.23
8718,19073794,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4468893,=,nM,19.97,CHEMBL203,Homo sapiens,IC50,nmol/L,19.97
8719,19073795,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4532084,=,nM,6.24,CHEMBL203,Homo sapiens,IC50,nmol/L,6.24
8720,19073796,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4531912,=,nM,12.93,CHEMBL203,Homo sapiens,IC50,nmol/L,12.93
8721,19073797,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4435233,=,nM,4.95,CHEMBL203,Homo sapiens,IC50,nmol/L,4.95
8722,19073798,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4471491,=,nM,0.69,CHEMBL203,Homo sapiens,IC50,nmol/L,0.69
8723,19073799,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4460151,=,nM,16.43,CHEMBL203,Homo sapiens,IC50,nmol/L,16.43
8724,19073800,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4560187,=,nM,3.11,CHEMBL203,Homo sapiens,IC50,nmol/L,3.11
8725,19073801,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4576032,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nmol/L,3.7
8726,19073802,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4540303,=,nM,0.37,CHEMBL203,Homo sapiens,IC50,nmol/L,0.37
8727,19073803,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4515673,=,nM,20.83,CHEMBL203,Homo sapiens,IC50,nmol/L,20.83
8728,19073804,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4521028,=,nM,5.9,CHEMBL203,Homo sapiens,IC50,nmol/L,5.9
8729,19073805,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4463765,=,nM,18.54,CHEMBL203,Homo sapiens,IC50,nmol/L,18.54
8730,19073806,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4535949,=,nM,48.07,CHEMBL203,Homo sapiens,IC50,nmol/L,48.07
8731,19073807,CHEMBL4362208,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using FAM-22 peptide as substrate incubated for 10 mins followed by substrate addition by caliper method,B,CHEMBL4453429,=,nM,43.56,CHEMBL203,Homo sapiens,IC50,nmol/L,43.56
8732,19110227,CHEMBL4370315,Inhibition of EGFR (unknown origin),B,CHEMBL80302,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
8733,19110228,CHEMBL4370315,Inhibition of EGFR (unknown origin),B,CHEMBL76432,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8734,19110259,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL553,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
8735,19110260,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL535,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,nM,140.0
8736,19110261,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4546122,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
8737,19110262,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4569885,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
8738,19110263,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4473768,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
8739,19110264,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4572443,=,nM,326.0,CHEMBL203,Homo sapiens,IC50,nM,326.0
8740,19110265,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4552482,=,nM,273.0,CHEMBL203,Homo sapiens,IC50,nM,273.0
8741,19110266,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4460381,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
8742,19110267,CHEMBL4370290,Inhibition of wild type EGFR (unknown origin) by bioluminescent ADP-glo kinase assay,B,CHEMBL4541014,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
8743,19112049,CHEMBL4370681,Inhibition of EGFR (unknown origin),B,CHEMBL428690,=,nM,21000.0,CHEMBL203,Homo sapiens,IC50,uM,21.0
8744,19112698,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4585048,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
8745,19112699,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4568408,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
8746,19112700,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4588486,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
8747,19112701,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4464785,=,nM,1600.0,CHEMBL203,Homo sapiens,IC50,uM,1.6
8748,19112702,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4447196,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
8749,19112703,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4462971,=,nM,700.0,CHEMBL203,Homo sapiens,IC50,uM,0.7
8750,19112704,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4540070,=,nM,2900.0,CHEMBL203,Homo sapiens,IC50,uM,2.9
8751,19112705,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL4474429,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
8752,19112706,CHEMBL4370781,Inhibition of His6-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells after 10 mins by DELFIA/time-resolved fluorometry,B,CHEMBL553,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
8753,19114542,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4470236,=,nM,3081.0,CHEMBL203,Homo sapiens,IC50,uM,3.081
8754,19114555,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4587811,=,nM,281.0,CHEMBL203,Homo sapiens,IC50,uM,0.281
8755,19114631,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4443828,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,uM,0.149
8756,19114742,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4462318,=,nM,178.0,CHEMBL203,Homo sapiens,IC50,uM,0.178
8757,19114772,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4536115,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,uM,0.65
8758,19114797,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4447225,=,nM,592.0,CHEMBL203,Homo sapiens,IC50,uM,0.592
8759,19114831,CHEMBL4371479,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4457733,=,nM,1128.0,CHEMBL203,Homo sapiens,IC50,uM,1.128
8760,19122073,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4468464,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8761,19122074,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4454948,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8762,19122075,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4515526,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
8763,19122076,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4460706,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8764,19122077,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4436695,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8765,19122078,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4563683,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8766,19122079,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4584413,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8767,19122080,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4578487,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
8768,19122081,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4575267,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8769,19122082,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4521506,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8770,19122083,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL4476544,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8771,19122084,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL3787386,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8772,19122085,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL1173655,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
8773,19122086,CHEMBL4373060,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (696 to end residues) expressed in baculovirus infected sf21 cells using poly(Glu, Tyr) 4:1 as substrate",B,CHEMBL939,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
8774,19132060,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4443413,=,nM,81.7,CHEMBL203,Homo sapiens,IC50,nM,81.7
8775,19132064,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4529308,=,nM,498.1,CHEMBL203,Homo sapiens,IC50,nM,498.1
8776,19132065,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4529308,=,nM,56.1,CHEMBL203,Homo sapiens,IC50,nM,56.1
8777,19132066,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4453276,=,nM,587.6,CHEMBL203,Homo sapiens,IC50,nM,587.6
8778,19132067,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4453276,=,nM,227.9,CHEMBL203,Homo sapiens,IC50,nM,227.9
8779,19132068,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4462965,=,nM,207.0,CHEMBL203,Homo sapiens,IC50,nM,207.0
8780,19132069,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4462965,=,nM,37.1,CHEMBL203,Homo sapiens,IC50,nM,37.1
8781,19132091,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4450934,=,nM,224.1,CHEMBL203,Homo sapiens,IC50,nM,224.1
8782,19132101,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4459978,=,nM,518.8,CHEMBL203,Homo sapiens,IC50,nM,518.8
8783,19132102,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4459978,=,nM,27.7,CHEMBL203,Homo sapiens,IC50,nM,27.7
8784,19132106,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4446258,=,nM,65.1,CHEMBL203,Homo sapiens,IC50,nM,65.1
8785,19132109,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4450934,=,nM,88.6,CHEMBL203,Homo sapiens,IC50,nM,88.6
8786,19132111,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4474196,=,nM,27.5,CHEMBL203,Homo sapiens,IC50,nM,27.5
8787,19132112,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4214567,=,nM,73.1,CHEMBL203,Homo sapiens,IC50,nM,73.1
8788,19132113,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4443062,=,nM,73.1,CHEMBL203,Homo sapiens,IC50,nM,73.1
8789,19132114,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL3545311,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8790,19132115,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4218431,=,nM,38.7,CHEMBL203,Homo sapiens,IC50,nM,38.7
8791,19132116,CHEMBL4375049,"Inhibition of human C-terminal His-tagged and N-terminal GST-tagged EGFR L858R/T790M/C797S triple mutant ( 668 to 1210 amino acids) expressed in baculovirus infected Sf9 insect cells using Poly(Glu,Tyr) 4:1 as substrate after 60 mins by ELISA",B,CHEMBL4294743,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8792,19146016,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4464879,=,nM,101.0,CHEMBL203,Homo sapiens,IC50,uM,0.101
8793,19146017,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4454745,=,nM,122.0,CHEMBL203,Homo sapiens,IC50,uM,0.122
8794,19146018,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4566583,=,nM,215.0,CHEMBL203,Homo sapiens,IC50,uM,0.215
8795,19146019,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4447982,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,uM,0.105
8796,19146020,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4463766,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
8797,19146021,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4460261,=,nM,75.0,CHEMBL203,Homo sapiens,IC50,uM,0.075
8798,19146022,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4454929,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,uM,0.038
8799,19146023,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4570333,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,uM,0.011
8800,19146024,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
8801,19146025,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
8802,19146026,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
8803,19146027,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4592472,=,nM,195.0,CHEMBL203,Homo sapiens,IC50,uM,0.195
8804,19146028,CHEMBL4378482,Inhibition of recombinant human GST-tagged EGFR T790M/L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL3353410,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
8805,19146029,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4464879,=,nM,477.0,CHEMBL203,Homo sapiens,IC50,uM,0.477
8806,19146030,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4454745,=,nM,421.0,CHEMBL203,Homo sapiens,IC50,uM,0.421
8807,19146031,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4566583,=,nM,308.0,CHEMBL203,Homo sapiens,IC50,uM,0.308
8808,19146032,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4447982,=,nM,475.0,CHEMBL203,Homo sapiens,IC50,uM,0.475
8809,19146033,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4463766,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,uM,0.079
8810,19146034,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4460261,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,uM,0.065
8811,19146035,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4454929,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
8812,19146036,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4570333,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
8813,19146037,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
8814,19146038,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
8815,19146039,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4441606,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
8816,19146040,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4592472,=,nM,108.0,CHEMBL203,Homo sapiens,IC50,uM,0.108
8817,19146041,CHEMBL4378483,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system using Tyr 04 as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL3353410,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
8818,19158934,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4520341,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8819,19158935,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4558227,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8820,19158936,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4465103,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
8821,19158937,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4531697,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
8822,19158938,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4473365,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8823,19158939,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4448107,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8824,19158940,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4516287,=,nM,86.0,CHEMBL203,Homo sapiens,IC50,nM,86.0
8825,19158941,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL1229592,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8826,19158942,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL3353410,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8827,19158943,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL2403108,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
8828,19158944,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4467561,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8829,19158945,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4449391,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8830,19158946,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4565984,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8831,19158947,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4540442,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8832,19158948,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4581316,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8833,19158949,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4520341,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8834,19158950,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4558227,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8835,19158951,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4465103,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8836,19158952,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4531697,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8837,19158953,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4473365,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8838,19158954,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4448107,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8839,19158955,CHEMBL4382299,Inhibition of GST-tagged human EGFR T790M mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4516287,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
8840,19158956,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL1229592,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
8841,19158957,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL3353410,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
8842,19158958,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL2403108,=,nM,2156.0,CHEMBL203,Homo sapiens,IC50,nM,2156.0
8843,19158959,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4467561,=,nM,244.0,CHEMBL203,Homo sapiens,IC50,nM,244.0
8844,19158960,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4449391,=,nM,204.0,CHEMBL203,Homo sapiens,IC50,nM,204.0
8845,19158961,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4565984,=,nM,172.0,CHEMBL203,Homo sapiens,IC50,nM,172.0
8846,19158962,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4540442,=,nM,307.0,CHEMBL203,Homo sapiens,IC50,nM,307.0
8847,19158963,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4581316,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,nM,54.0
8848,19158964,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4520341,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
8849,19158965,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4558227,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
8850,19158966,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4465103,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,nM,149.0
8851,19158967,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4531697,=,nM,865.0,CHEMBL203,Homo sapiens,IC50,nM,865.0
8852,19158968,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4473365,=,nM,151.0,CHEMBL203,Homo sapiens,IC50,nM,151.0
8853,19158969,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4448107,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
8854,19158970,CHEMBL4382298,Inhibition of wild type GST-tagged human EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4516287,=,nM,2480.0,CHEMBL203,Homo sapiens,IC50,nM,2480.0
8855,19158986,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4581316,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
8856,19158987,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4540442,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8857,19158988,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4565984,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
8858,19158989,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4449391,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8859,19158990,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL4467561,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8860,19158991,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL2403108,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
8861,19158992,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL3353410,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8862,19158993,CHEMBL4382300,Inhibition of GST-tagged human EGFR T790M/L858R double mutant cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system using Poly G:T (4:1) as substrate after 30 mins by Z-LYTE assay,B,CHEMBL1229592,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8863,19163120,CHEMBL4383758,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,B,CHEMBL4545086,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
8864,19163121,CHEMBL4383758,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,B,CHEMBL3353410,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
8865,19163122,CHEMBL4383758,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,B,CHEMBL4536146,=,nM,6600.0,CHEMBL203,Homo sapiens,IC50,uM,6.6
8866,19163123,CHEMBL4383758,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant (696-end residues) by fluorescence assay,B,CHEMBL4575647,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
8867,19163124,CHEMBL4383759,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system by fluorescence assay,B,CHEMBL4545086,=,nM,5500.0,CHEMBL203,Homo sapiens,IC50,uM,5.5
8868,19163125,CHEMBL4383759,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system by fluorescence assay,B,CHEMBL3353410,=,nM,3400.0,CHEMBL203,Homo sapiens,IC50,uM,3.4
8869,19163126,CHEMBL4383759,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system by fluorescence assay,B,CHEMBL4536146,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
8870,19163127,CHEMBL4383759,Inhibition of recombinant human GST-tagged EGFR L858R mutant expressed in baculovirus expression system by fluorescence assay,B,CHEMBL4575647,=,nM,12000.0,CHEMBL203,Homo sapiens,IC50,uM,12.0
8871,19168125,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4456234,=,nM,120.7,CHEMBL203,Homo sapiens,IC50,nM,120.7
8872,19168135,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4575697,=,nM,142.7,CHEMBL203,Homo sapiens,IC50,nM,142.7
8873,19168145,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4454516,=,nM,0.5872,CHEMBL203,Homo sapiens,IC50,nM,0.5872
8874,19168151,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4476791,=,nM,2.213,CHEMBL203,Homo sapiens,IC50,nM,2.213
8875,19168156,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4451619,=,nM,54.99,CHEMBL203,Homo sapiens,IC50,nM,54.99
8876,19168166,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4563980,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
8877,19168176,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4555707,=,nM,32.61,CHEMBL203,Homo sapiens,IC50,nM,32.61
8878,19168182,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4587847,=,nM,12.57,CHEMBL203,Homo sapiens,IC50,nM,12.57
8879,19168206,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4450061,=,nM,123.2,CHEMBL203,Homo sapiens,IC50,nM,123.2
8880,19168216,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4441745,=,nM,54.69,CHEMBL203,Homo sapiens,IC50,nM,54.69
8881,19168226,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4569552,=,nM,40.19,CHEMBL203,Homo sapiens,IC50,nM,40.19
8882,19168232,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4540295,=,nM,27.92,CHEMBL203,Homo sapiens,IC50,nM,27.92
8883,19168242,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4438856,=,nM,46.52,CHEMBL203,Homo sapiens,IC50,nM,46.52
8884,19168252,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4449898,=,nM,65.34,CHEMBL203,Homo sapiens,IC50,nM,65.34
8885,19168258,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL4570293,=,nM,33.31,CHEMBL203,Homo sapiens,IC50,nM,33.31
8886,19168268,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL3353410,=,nM,20.8,CHEMBL203,Homo sapiens,IC50,nM,20.8
8887,19168286,CHEMBL4384381,"Inhibition of human N-terminal GST-tagged EGFR T790M/L858R double mutant (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) as substrate after 60 mins in presence of ATP by ADP-Glo assay",B,CHEMBL939,=,nM,823.3,CHEMBL203,Homo sapiens,IC50,nM,823.3
8888,19168484,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL939,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0
8889,19168485,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4440618,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
8890,19168486,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4435699,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8891,19168487,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4521214,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
8892,19168488,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4562352,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
8893,19168489,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4558356,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8894,19168490,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4530987,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
8895,19168491,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4530170,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
8896,19168492,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4572315,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
8897,19168493,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4526992,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8898,19168494,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4556799,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8899,19168495,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4473375,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
8900,19168496,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4559217,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,nM,197.0
8901,19168497,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4439974,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
8902,19168498,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4437599,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
8903,19168499,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4538707,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
8904,19168500,CHEMBL4384426,Inhibition of wild type EGFR autophosphorylation in human A549 cells by Western blot analysis,B,CHEMBL4449681,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
8905,19168555,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL939,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
8906,19168556,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL4440618,=,nM,0.87,CHEMBL203,Homo sapiens,IC50,nM,0.87
8907,19168557,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL4530170,=,nM,0.53,CHEMBL203,Homo sapiens,IC50,nM,0.53
8908,19168559,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL4526992,=,nM,0.62,CHEMBL203,Homo sapiens,IC50,nM,0.62
8909,19168560,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL4439974,=,nM,0.52,CHEMBL203,Homo sapiens,IC50,nM,0.52
8910,19168561,CHEMBL4384432,Inhibition of recombinant human wild type GST-tagged EGFR (668 to 1210 residues) expressed in baculovirus expression system after 1 hr by kinase tracer 199 based TR-FRET assay,B,CHEMBL4449681,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
8911,19172980,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4469866,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
8912,19172981,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL3623290,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8913,19172982,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4439066,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
8914,19172983,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4579429,=,nM,302.0,CHEMBL203,Homo sapiens,IC50,nM,302.0
8915,19172985,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4527715,=,nM,133.0,CHEMBL203,Homo sapiens,IC50,nM,133.0
8916,19172986,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4475780,=,nM,234.0,CHEMBL203,Homo sapiens,IC50,nM,234.0
8917,19172987,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4441029,=,nM,52.6,CHEMBL203,Homo sapiens,IC50,nM,52.6
8918,19172988,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL385479,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8919,19172989,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4471155,=,nM,31.7,CHEMBL203,Homo sapiens,IC50,nM,31.7
8920,19172990,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4448162,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
8921,19172991,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4555488,=,nM,368.0,CHEMBL203,Homo sapiens,IC50,nM,368.0
8922,19172992,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4441921,=,nM,844.0,CHEMBL203,Homo sapiens,IC50,nM,844.0
8923,19172994,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4448712,=,nM,499.0,CHEMBL203,Homo sapiens,IC50,nM,499.0
8924,19172995,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL4453748,=,nM,65.2,CHEMBL203,Homo sapiens,IC50,nM,65.2
8925,19172996,CHEMBL4385373,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate measured after 20 mins in presence of [gamma33P]ATP by filter-binding assay,B,CHEMBL939,<,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
8926,19181906,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL24828,=,nM,580.0,CHEMBL203,Homo sapiens,IC50,uM,0.58
8927,19181907,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4576626,=,nM,16180.0,CHEMBL203,Homo sapiens,IC50,uM,16.18
8928,19181908,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4549295,=,nM,12450.0,CHEMBL203,Homo sapiens,IC50,uM,12.45
8929,19181909,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4459564,=,nM,18690.0,CHEMBL203,Homo sapiens,IC50,uM,18.69
8930,19181910,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4442932,=,nM,24130.0,CHEMBL203,Homo sapiens,IC50,uM,24.13
8931,19181911,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4448424,=,nM,26150.0,CHEMBL203,Homo sapiens,IC50,uM,26.15
8932,19181912,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4470214,=,nM,18260.0,CHEMBL203,Homo sapiens,IC50,uM,18.26
8933,19181913,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4445843,=,nM,25410.0,CHEMBL203,Homo sapiens,IC50,uM,25.41
8934,19181914,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4522594,=,nM,36840.0,CHEMBL203,Homo sapiens,IC50,uM,36.84
8935,19181915,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4554486,=,nM,15630.0,CHEMBL203,Homo sapiens,IC50,uM,15.63
8936,19181916,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4471464,=,nM,15330.0,CHEMBL203,Homo sapiens,IC50,uM,15.33
8937,19181917,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4460897,=,nM,8770.0,CHEMBL203,Homo sapiens,IC50,uM,8.77
8938,19181918,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4439053,=,nM,10580.0,CHEMBL203,Homo sapiens,IC50,uM,10.58
8939,19181919,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4455321,=,nM,30450.0,CHEMBL203,Homo sapiens,IC50,uM,30.45
8940,19181920,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4520103,=,nM,22850.0,CHEMBL203,Homo sapiens,IC50,uM,22.85
8941,19181921,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4530048,=,nM,26970.0,CHEMBL203,Homo sapiens,IC50,uM,26.97
8942,19181922,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4549604,=,nM,9570.0,CHEMBL203,Homo sapiens,IC50,uM,9.57
8943,19181923,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4459052,=,nM,15360.0,CHEMBL203,Homo sapiens,IC50,uM,15.36
8944,19181924,CHEMBL4387504,Inhibition of EGFR (unknown origin) incubated for 30 mins by enzyme immunoassay,B,CHEMBL4552065,=,nM,34280.0,CHEMBL203,Homo sapiens,IC50,uM,34.28
8945,19187522,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL3353410,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
8946,19187523,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
8947,19187570,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4519305,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
8948,19187571,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL939,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,nM,83.0
8949,19187572,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4457447,=,nM,10.9,CHEMBL203,Homo sapiens,IC50,nM,10.9
8950,19187573,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4451538,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,nM,300.0
8951,19187574,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4547475,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
8952,19187575,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4582933,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
8953,19187577,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4441244,=,nM,199.0,CHEMBL203,Homo sapiens,IC50,nM,199.0
8954,19187578,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4446124,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
8955,19187588,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL180022,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
8956,19187589,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL554,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
8957,19187590,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL1173655,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
8958,19187591,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL31965,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
8959,19187635,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4517633,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
8960,19187636,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4531250,=,nM,26.8,CHEMBL203,Homo sapiens,IC50,nM,26.8
8961,19187637,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4456266,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
8962,19187638,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4546553,=,nM,494.0,CHEMBL203,Homo sapiens,IC50,nM,494.0
8963,19187639,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4576802,=,nM,219.0,CHEMBL203,Homo sapiens,IC50,nM,219.0
8964,19187640,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4457885,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
8965,19187641,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4463005,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,nM,420.0
8966,19187642,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4519470,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
8967,19187643,CHEMBL4388527,Inhibition of probe binding to EGFR L858R mutant (unknown origin) using rabbit reticulate lysate system after 1 hr by luminescence assay,B,CHEMBL4593016,=,nM,413.0,CHEMBL203,Homo sapiens,IC50,nM,413.0
8968,19193825,CHEMBL4390271,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
8969,19211859,CHEMBL4393296,Inhibition of EGFR (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4446992,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
8970,19211860,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4442035,=,nM,4520.0,CHEMBL203,Homo sapiens,IC50,uM,4.52
8971,19211861,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4160329,=,nM,3350.0,CHEMBL203,Homo sapiens,IC50,uM,3.35
8972,19211862,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4456494,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
8973,19211863,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4445015,=,nM,4750.0,CHEMBL203,Homo sapiens,IC50,uM,4.75
8974,19211864,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4170935,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
8975,19211865,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL4456688,=,nM,4240.0,CHEMBL203,Homo sapiens,IC50,uM,4.24
8976,19211866,CHEMBL4393297,Inhibition of c-MET (unknown origin) using FAM-labelled peptide as substrate measured after 10 mins by mobility shift assay,B,CHEMBL2105717,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
8977,19218782,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL2408045,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
8978,19218783,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
8979,19218784,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL217092,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,nM,66.0
8980,19218785,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL607707,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
8981,19218786,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL3544983,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
8982,19218787,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL939,<,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8983,19218791,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL311959,=,nM,27000.0,CHEMBL203,Homo sapiens,IC50,nM,27000.0
8984,19218792,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL309682,=,nM,5400.0,CHEMBL203,Homo sapiens,IC50,nM,5400.0
8985,19218793,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL81073,=,nM,7100.0,CHEMBL203,Homo sapiens,IC50,nM,7100.0
8986,19218794,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL1092250,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
8987,19218795,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL304929,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
8988,19218796,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL4440586,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,nM,61.0
8989,19218797,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL4468521,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,nM,2400.0
8990,19218798,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL553,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
8991,19218799,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL1089203,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,nM,340.0
8992,19218800,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL98248,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
8993,19218801,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL29197,<,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8994,19218802,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL111038,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
8995,19218803,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL4447797,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0
8996,19218804,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL4467033,<,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
8997,19218805,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL554,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
8998,19218807,CHEMBL4394508,Inhibition of EGFR in human A431 cells assessed as reduction in EGF-stimulated EGFR autophosphorylation preincuabted for 90 mins followed by EGF-stimulation by sandwich-ELISA,B,CHEMBL4462395,=,nM,2200.0,CHEMBL203,Homo sapiens,IC50,nM,2200.0
8999,19226237,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4440012,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32
9000,19226238,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4525168,=,nM,400.0,CHEMBL203,Homo sapiens,IC50,uM,0.4
9001,19226239,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4439837,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
9002,19226240,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4441404,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,uM,0.71
9003,19226241,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4529183,=,nM,820.0,CHEMBL203,Homo sapiens,IC50,uM,0.82
9004,19226242,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL4586164,=,nM,2880.0,CHEMBL203,Homo sapiens,IC50,uM,2.88
9005,19226243,CHEMBL4396109,Inhibition of human EGFR measured after 3 hrs by ELISA,B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
9006,19235719,CHEMBL4398513,Inhibition of EGFR (unknown origin) using biotin-labelled peptide as substrate preincubated for 2 hrs followed by substrate addition and measured after 30 mins by HTRF FRET assay,B,CHEMBL1229592,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
9007,19236717,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4516635,=,nM,9.3,CHEMBL203,Homo sapiens,IC50,nM,9.3
9008,19236718,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4538066,=,nM,179.6,CHEMBL203,Homo sapiens,IC50,nM,179.6
9009,19236719,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4471235,=,nM,37.1,CHEMBL203,Homo sapiens,IC50,nM,37.1
9010,19236720,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4465497,=,nM,7.9,CHEMBL203,Homo sapiens,IC50,nM,7.9
9011,19236721,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4593609,=,nM,19.2,CHEMBL203,Homo sapiens,IC50,nM,19.2
9012,19236777,CHEMBL4398840,"Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4443483,=,nM,331.3,CHEMBL203,Homo sapiens,IC50,nM,331.3
9013,19236782,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL4443483,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9014,19236796,CHEMBL4398796,"Inhibition of recombinant human C-terminal His-tagged/N-terminal GST-tagged EGFR (668 to 1210 residues) T790M/L858R/C797S mutant expressed in baculovirus expression system using poly (Glu,Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA",B,CHEMBL24828,=,nM,369.2,CHEMBL203,Homo sapiens,IC50,nM,369.2
9015,19237015,CHEMBL4398934,"Inhibition of EGFR (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate preincubated with substrate followed by enzyme challenge for 1 hr by ELISA",B,CHEMBL1336,=,nM,57.8,CHEMBL203,Homo sapiens,IC50,nM,57.8
9016,19237016,CHEMBL4398934,"Inhibition of EGFR (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate preincubated with substrate followed by enzyme challenge for 1 hr by ELISA",B,CHEMBL535,=,nM,31.8,CHEMBL203,Homo sapiens,IC50,nM,31.8
9017,19240553,CHEMBL4399533,Inhibition of EGFR-TK in human HeLa cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL4456370,=,nM,6300.0,CHEMBL203,Homo sapiens,IC50,uM,6.3
9018,19240554,CHEMBL4399533,Inhibition of EGFR-TK in human HeLa cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL553,=,nM,2720.0,CHEMBL203,Homo sapiens,IC50,uM,2.72
9019,19240555,CHEMBL4399534,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL4469453,=,nM,2750.0,CHEMBL203,Homo sapiens,IC50,uM,2.75
9020,19240556,CHEMBL4399534,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL4470431,=,nM,3660.0,CHEMBL203,Homo sapiens,IC50,uM,3.66
9021,19240557,CHEMBL4399534,Inhibition of EGFR-TK in human MCF7 cells overexpressing EGFR incubated for 18 to 24 hrs by kinase assay,B,CHEMBL553,=,nM,1880.0,CHEMBL203,Homo sapiens,IC50,uM,1.88
9022,19244253,CHEMBL4400322,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) cytoplasmic domain expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by mobility shift assay,B,CHEMBL4462528,=,nM,617.0,CHEMBL203,Homo sapiens,IC50,nM,617.0
9023,19256334,CHEMBL4402900,Inhibition of human EGFR L858R/T790M mutant (696 to 1022 residues) expressed in Sf9 insect cells by HTRF assay,B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
9024,19279692,CHEMBL4408847,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",B,CHEMBL4516916,=,nM,23340.0,CHEMBL203,Homo sapiens,IC50,uM,23.34
9025,19279693,CHEMBL4408847,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",B,CHEMBL4516736,=,nM,4340.0,CHEMBL203,Homo sapiens,IC50,uM,4.34
9026,19279694,CHEMBL4408847,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",B,CHEMBL4557318,=,nM,4710.0,CHEMBL203,Homo sapiens,IC50,uM,4.71
9027,19279695,CHEMBL4408847,"Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end residues) expressed in baculovirus infected Sf9 insect cells using Poly (4:1 Glu, Tyr) peptide as substrate incubated for 1 hr by ADP-Glo assay",B,CHEMBL553,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
9028,19287500,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4557993,=,nM,45.2,CHEMBL203,Homo sapiens,IC50,nM,45.2
9029,19287501,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4575374,=,nM,118.6,CHEMBL203,Homo sapiens,IC50,nM,118.6
9030,19287502,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4514393,=,nM,105.3,CHEMBL203,Homo sapiens,IC50,nM,105.3
9031,19287503,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4529521,=,nM,50.8,CHEMBL203,Homo sapiens,IC50,nM,50.8
9032,19287504,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4448428,=,nM,32.5,CHEMBL203,Homo sapiens,IC50,nM,32.5
9033,19287505,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4463094,=,nM,22.7,CHEMBL203,Homo sapiens,IC50,nM,22.7
9034,19287506,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4571687,=,nM,107.2,CHEMBL203,Homo sapiens,IC50,nM,107.2
9035,19287509,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4584651,=,nM,146.2,CHEMBL203,Homo sapiens,IC50,nM,146.2
9036,19287511,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4553504,=,nM,120.2,CHEMBL203,Homo sapiens,IC50,nM,120.2
9037,19287512,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4452957,=,nM,23.4,CHEMBL203,Homo sapiens,IC50,nM,23.4
9038,19287513,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL4519860,=,nM,119.7,CHEMBL203,Homo sapiens,IC50,nM,119.7
9039,19287514,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL9470,=,nM,139.2,CHEMBL203,Homo sapiens,IC50,nM,139.2
9040,19287515,CHEMBL4410222,Inhibition of C-terminal His-tagged N-terminal GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus infected Sf9 cells after 30 mins in presence of gamma-[32p-ATP] binding assay,B,CHEMBL1173655,=,nM,15.4,CHEMBL203,Homo sapiens,IC50,nM,15.4
9041,19288134,CHEMBL4410429,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate measured after 1 hr in presence of ATP by spectrophotometric analysis",B,CHEMBL1336,=,nM,43.5,CHEMBL203,Homo sapiens,IC50,nM,43.5
9042,19290295,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4558528,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
9043,19290296,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4530686,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
9044,19290297,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4533337,=,nM,930.0,CHEMBL203,Homo sapiens,IC50,uM,0.93
9045,19290298,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4520903,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
9046,19290299,CHEMBL4410892,Inhibition of EGFR triple T790M/L858R/C797S mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4452106,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
9047,19290300,CHEMBL4410891,Inhibition of EGFR double T790M/L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4558528,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,uM,0.36
9048,19290301,CHEMBL4410891,Inhibition of EGFR double T790M/L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4530686,=,nM,350.0,CHEMBL203,Homo sapiens,IC50,uM,0.35
9049,19290302,CHEMBL4410891,Inhibition of EGFR double T790M/L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4533337,=,nM,770.0,CHEMBL203,Homo sapiens,IC50,uM,0.77
9050,19290303,CHEMBL4410891,Inhibition of EGFR double T790M/L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4520903,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
9051,19290304,CHEMBL4410891,Inhibition of EGFR double T790M/L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4452106,=,nM,470.0,CHEMBL203,Homo sapiens,IC50,uM,0.47
9052,19290305,CHEMBL4410890,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4558528,=,nM,2700.0,CHEMBL203,Homo sapiens,IC50,uM,2.7
9053,19290306,CHEMBL4410890,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4530686,=,nM,3800.0,CHEMBL203,Homo sapiens,IC50,uM,3.8
9054,19290307,CHEMBL4410890,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4533337,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
9055,19290309,CHEMBL4410890,Inhibition of EGFR L858R mutant (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4452106,=,nM,840.0,CHEMBL203,Homo sapiens,IC50,uM,0.84
9056,19290310,CHEMBL4410889,Inhibition of EGFR (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4558528,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
9057,19290311,CHEMBL4410889,Inhibition of EGFR (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4530686,=,nM,4000.0,CHEMBL203,Homo sapiens,IC50,uM,4.0
9058,19290312,CHEMBL4410889,Inhibition of EGFR (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4533337,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
9059,19290313,CHEMBL4410889,Inhibition of EGFR (unknown origin) expressed in mouse Ba/F3 cells assessed as reduction in cell growth incubated for 72 hrs in presence of 1 ug/ml Cetuximab by celltiter-glo luminescent cell viability assay,B,CHEMBL4520903,=,nM,9700.0,CHEMBL203,Homo sapiens,IC50,uM,9.7
9060,19290315,CHEMBL4410888,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4558528,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
9061,19290316,CHEMBL4410888,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4530686,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
9062,19290317,CHEMBL4410888,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4533337,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
9063,19290318,CHEMBL4410888,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4520903,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
9064,19290319,CHEMBL4410888,Inhibition of human N-terminal GST-tagged EGFR triple T790M/L858R/C797S mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4452106,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
9065,19290320,CHEMBL4410887,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4558528,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
9066,19290321,CHEMBL4410887,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4530686,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
9067,19290322,CHEMBL4410887,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4533337,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
9068,19290323,CHEMBL4410887,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4520903,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
9069,19290324,CHEMBL4410887,Inhibition of human N-terminal GST-tagged EGFR double T790M/L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4452106,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9070,19290325,CHEMBL4410886,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4558528,=,nM,154.0,CHEMBL203,Homo sapiens,IC50,nM,154.0
9071,19290326,CHEMBL4410886,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4530686,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
9072,19290327,CHEMBL4410886,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4533337,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
9073,19290328,CHEMBL4410886,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4520903,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,nM,690.0
9074,19290329,CHEMBL4410886,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (696 to 1022 residues) expressed in Sf21 insect cells by HTRF assay,B,CHEMBL4452106,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
9075,19293617,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4472983,=,nM,388.0,CHEMBL203,Homo sapiens,IC50,nM,388.0
9076,19293618,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4103912,=,nM,0.07,CHEMBL203,Homo sapiens,IC50,nM,0.07
9077,19293619,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4548960,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
9078,19293620,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4434924,=,nM,38.0,CHEMBL203,Homo sapiens,IC50,nM,38.0
9079,19293621,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4460320,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
9080,19293622,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4439632,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9081,19293623,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4557005,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
9082,19293624,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4553685,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
9083,19293625,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4452628,=,nM,219.0,CHEMBL203,Homo sapiens,IC50,nM,219.0
9084,19293626,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4445797,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
9085,19293627,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4463634,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
9086,19293628,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL3353406,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
9087,19293629,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL3353410,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
9088,19293630,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4583858,=,nM,203.0,CHEMBL203,Homo sapiens,IC50,nM,203.0
9089,19293631,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4468034,=,nM,177.0,CHEMBL203,Homo sapiens,IC50,nM,177.0
9090,19293632,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4438905,=,nM,397.0,CHEMBL203,Homo sapiens,IC50,nM,397.0
9091,19293633,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4527702,=,nM,209.0,CHEMBL203,Homo sapiens,IC50,nM,209.0
9092,19293634,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4451986,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
9093,19293636,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4441933,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
9094,19293637,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4557772,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9095,19293670,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4464589,=,nM,7.5,CHEMBL203,Homo sapiens,IC50,nM,7.5
9096,19293673,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4535047,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
9097,19293674,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4470120,=,nM,201.0,CHEMBL203,Homo sapiens,IC50,nM,201.0
9098,19293675,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4551557,=,nM,591.0,CHEMBL203,Homo sapiens,IC50,nM,591.0
9099,19293676,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4445761,=,nM,998.0,CHEMBL203,Homo sapiens,IC50,nM,998.0
9100,19293677,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4553484,=,nM,892.0,CHEMBL203,Homo sapiens,IC50,nM,892.0
9101,19293678,CHEMBL4411959,Inhibition of EGFR T790M/L858R double mutant (unknown origin) using substrate-biotin by ELISA-based mobility shift assay,B,CHEMBL4579805,=,nM,923.0,CHEMBL203,Homo sapiens,IC50,nM,923.0
9102,19310275,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4447036,=,nM,2459.0,CHEMBL203,Homo sapiens,IC50,nM,2459.0
9103,19310276,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4456359,=,nM,6370.0,CHEMBL203,Homo sapiens,IC50,nM,6370.0
9104,19310278,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL1173655,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
9105,19310279,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL939,=,nM,6746.0,CHEMBL203,Homo sapiens,IC50,nM,6746.0
9106,19310280,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4447289,=,nM,4626.0,CHEMBL203,Homo sapiens,IC50,nM,4626.0
9107,19310281,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4534719,=,nM,650.0,CHEMBL203,Homo sapiens,IC50,nM,650.0
9108,19310282,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4447962,=,nM,1259.0,CHEMBL203,Homo sapiens,IC50,nM,1259.0
9109,19310283,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4475546,=,nM,1080.0,CHEMBL203,Homo sapiens,IC50,nM,1080.0
9110,19310284,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4556670,=,nM,2316.0,CHEMBL203,Homo sapiens,IC50,nM,2316.0
9111,19310285,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4559807,=,nM,157.0,CHEMBL203,Homo sapiens,IC50,nM,157.0
9112,19310286,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4448691,=,nM,1322.0,CHEMBL203,Homo sapiens,IC50,nM,1322.0
9113,19310288,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4514452,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
9114,19310289,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL1172843,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
9115,19310290,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4450843,=,nM,562.0,CHEMBL203,Homo sapiens,IC50,nM,562.0
9116,19310291,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL2310642,=,nM,238.0,CHEMBL203,Homo sapiens,IC50,nM,238.0
9117,19310292,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4583178,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
9118,19310293,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4458437,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
9119,19310294,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4463012,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9120,19310295,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4521381,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
9121,19310296,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4446953,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
9122,19310297,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4565374,=,nM,3059.0,CHEMBL203,Homo sapiens,IC50,nM,3059.0
9123,19310298,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4527132,=,nM,5004.0,CHEMBL203,Homo sapiens,IC50,nM,5004.0
9124,19310300,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4448148,=,nM,239.0,CHEMBL203,Homo sapiens,IC50,nM,239.0
9125,19310301,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4447036,=,nM,3675.0,CHEMBL203,Homo sapiens,IC50,nM,3675.0
9126,19310302,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4456359,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,nM,64.0
9127,19310303,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL1172781,=,nM,223.0,CHEMBL203,Homo sapiens,IC50,nM,223.0
9128,19310304,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL1173655,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9129,19310305,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL939,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
9130,19310306,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4447289,=,nM,416.0,CHEMBL203,Homo sapiens,IC50,nM,416.0
9131,19310307,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4534719,=,nM,136.0,CHEMBL203,Homo sapiens,IC50,nM,136.0
9132,19310308,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4447962,=,nM,107.0,CHEMBL203,Homo sapiens,IC50,nM,107.0
9133,19310309,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4475546,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
9134,19310310,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4556670,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,nM,82.0
9135,19310311,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4559807,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
9136,19310312,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4448691,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,nM,62.0
9137,19310313,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4441440,=,nM,159.0,CHEMBL203,Homo sapiens,IC50,nM,159.0
9138,19310314,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4514452,=,nM,117.0,CHEMBL203,Homo sapiens,IC50,nM,117.0
9139,19310315,CHEMBL4416105,"Inhibition of GST-tagged human EGFR kinase domain (696 to 1022 residues) using poly(Glu, Tyr) 4:1 substrate incubated for 60 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL1172843,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
9140,19310359,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL3353410,=,nM,0.95,CHEMBL203,Homo sapiens,IC50,nM,0.95
9141,19310360,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL3545154,=,nM,0.218,CHEMBL203,Homo sapiens,IC50,nM,0.218
9142,19310361,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4534719,=,nM,17.8,CHEMBL203,Homo sapiens,IC50,nM,17.8
9143,19310362,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4559807,=,nM,0.636,CHEMBL203,Homo sapiens,IC50,nM,0.636
9144,19310363,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4521381,=,nM,0.133,CHEMBL203,Homo sapiens,IC50,nM,0.133
9145,19310364,CHEMBL4416111,"Inhibition of GST-tagged human EGFR D770_N771insNPG mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4514452,=,nM,1.48,CHEMBL203,Homo sapiens,IC50,nM,1.48
9146,19310371,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL3353410,=,nM,0.421,CHEMBL203,Homo sapiens,IC50,nM,0.421
9147,19310372,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL3545154,=,nM,0.078,CHEMBL203,Homo sapiens,IC50,nM,0.078
9148,19310373,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4534719,=,nM,1.15,CHEMBL203,Homo sapiens,IC50,nM,1.15
9149,19310374,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4559807,=,nM,0.145,CHEMBL203,Homo sapiens,IC50,nM,0.145
9150,19310375,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4521381,=,nM,0.043,CHEMBL203,Homo sapiens,IC50,nM,0.043
9151,19310376,CHEMBL4416109,"Inhibition of GST-tagged human EGFR A763_Y764insFHEA mutant using poly(Glu, Tyr) 4:1 substrate incubated for 120 mins by kinase-Glo plus luminescent kinase assay",B,CHEMBL4514452,=,nM,0.214,CHEMBL203,Homo sapiens,IC50,nM,0.214
9152,19310429,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4450843,=,nM,1061.0,CHEMBL203,Homo sapiens,IC50,nM,1061.0
9153,19310430,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL2310642,=,nM,147.0,CHEMBL203,Homo sapiens,IC50,nM,147.0
9154,19310431,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4583178,=,nM,283.0,CHEMBL203,Homo sapiens,IC50,nM,283.0
9155,19310432,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4458437,=,nM,117.0,CHEMBL203,Homo sapiens,IC50,nM,117.0
9156,19310433,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4463012,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,nM,131.0
9157,19310434,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4521381,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
9158,19310435,CHEMBL4416106,Inhibition of GST-tagged human EGFR kinase domain I858R/T790M mutant (696 to 1022 residues) using EGFR L858R/T790M substrate peptide incubated for 120 mins by kinase-Glo plus luminescent kinase assay,B,CHEMBL4446953,=,nM,779.0,CHEMBL203,Homo sapiens,IC50,nM,779.0
9159,19315794,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4437863,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
9160,19315795,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4452906,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
9161,19315796,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4537422,=,nM,190.0,CHEMBL203,Homo sapiens,IC50,uM,0.19
9162,19315797,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4588786,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
9163,19315803,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3353410,=,nM,1230.0,CHEMBL203,Homo sapiens,IC50,uM,1.23
9164,19315804,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL939,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,uM,0.39
9165,19315805,CHEMBL4417016,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3545311,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
9166,19315817,CHEMBL4417017,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3353410,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
9167,19315818,CHEMBL4417017,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL939,=,nM,4990.0,CHEMBL203,Homo sapiens,IC50,uM,4.99
9168,19315819,CHEMBL4417017,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M double mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3545311,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9169,19315822,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4437863,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,uM,0.03
9170,19315823,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4452906,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
9171,19315824,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4537422,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
9172,19315825,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL4588786,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
9173,19315831,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3353410,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
9174,19315832,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL939,=,nM,3170.0,CHEMBL203,Homo sapiens,IC50,uM,3.17
9175,19315833,CHEMBL4417018,Inhibition of C-terminal His-tagged/ N-terminal GST-tagged recombinant human EGFR L858R/T790M/C797S mutant (668 to 1210 residues) expressed in a Baculovirus infected Sf9 cell expression system using poly-EY as substrate incubated for 30 mins by ADP-Glo kinase assay,B,CHEMBL3545311,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9176,19319718,CHEMBL4417509,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4439933,=,nM,315.0,CHEMBL203,Homo sapiens,IC50,nM,315.0
9177,19319719,CHEMBL4417509,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4548481,=,nM,202.0,CHEMBL203,Homo sapiens,IC50,nM,202.0
9178,19319720,CHEMBL4417509,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4537004,=,nM,528.0,CHEMBL203,Homo sapiens,IC50,nM,528.0
9179,19319721,CHEMBL4417509,Inhibition of N-terminal GST-tagged human EGFR cytoplasmic domain (669-1210 AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL1173655,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
9180,19319722,CHEMBL4417510,Inhibition of N-terminal GST-tagged human EGFR (d746-750AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4439933,=,nM,332.0,CHEMBL203,Homo sapiens,IC50,nM,332.0
9181,19319723,CHEMBL4417510,Inhibition of N-terminal GST-tagged human EGFR (d746-750AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4548481,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,nM,73.0
9182,19319724,CHEMBL4417510,Inhibition of N-terminal GST-tagged human EGFR (d746-750AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4537004,=,nM,253.0,CHEMBL203,Homo sapiens,IC50,nM,253.0
9183,19319725,CHEMBL4417510,Inhibition of N-terminal GST-tagged human EGFR (d746-750AA) expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL1173655,=,nM,0.75,CHEMBL203,Homo sapiens,IC50,nM,0.75
9184,19319726,CHEMBL4417511,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4439933,=,nM,490.0,CHEMBL203,Homo sapiens,IC50,nM,490.0
9185,19319727,CHEMBL4417511,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4548481,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
9186,19319728,CHEMBL4417511,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL4537004,=,nM,174.0,CHEMBL203,Homo sapiens,IC50,nM,174.0
9187,19319729,CHEMBL4417511,Inhibition of recombinant human EGFR L858R mutant expressed in baculovirus using FAM-labelled peptide as substrate pre-incubated for 10 mins followed by substrate addition by mobility shift assay,B,CHEMBL1173655,=,nM,11.1,CHEMBL203,Homo sapiens,IC50,nM,11.1
9188,19400494,CHEMBL4425269,Inhibition of gefitinib-resistant human GST-tagged EGFR L858R/T790M double mutant using pEY (4:1)/biotinylated pEY as substrate after 30 mins by ELISA,B,CHEMBL1173655,=,nM,0.97,CHEMBL203,Homo sapiens,IC50,nM,0.97
9189,19408281,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4290785,=,nM,7.8,CHEMBL203,Homo sapiens,IC50,nM,7.8
9190,19408282,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4288562,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9191,19408283,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4277912,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
9192,19408284,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4527443,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
9193,19408317,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4286241,=,nM,143.0,CHEMBL203,Homo sapiens,IC50,nM,143.0
9194,19408318,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4278325,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
9195,19408319,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4285217,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9196,19408320,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4293051,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9197,19408321,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4284780,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9198,19408322,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4276842,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
9199,19408323,CHEMBL4427028,"Inhibition of EGFR kinase domain L858R/T790M mutant (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4281367,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
9200,19408324,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4527443,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0
9201,19408325,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4277912,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
9202,19408326,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4288562,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
9203,19408327,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4290785,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
9204,19408328,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4286241,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
9205,19408329,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4278325,=,nM,223.0,CHEMBL203,Homo sapiens,IC50,nM,223.0
9206,19408330,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4285217,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9207,19408331,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4293051,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9208,19408332,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4284780,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
9209,19408333,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4276842,=,nM,474.0,CHEMBL203,Homo sapiens,IC50,nM,474.0
9210,19408334,CHEMBL4427027,"Inhibition of wild type EGFR kinase domain (unknown origin) expressed using baculovirus expression system incubated for 1 hr using Poly(Glu,Tyr) 4:1 by ELISA method",B,CHEMBL4281367,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
9211,19445309,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4549542,=,nM,83.0,CHEMBL203,Homo sapiens,IC50,uM,0.083
9212,19445310,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL2441561,=,nM,146.0,CHEMBL203,Homo sapiens,IC50,uM,0.146
9213,19445311,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4458843,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
9214,19445312,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4468924,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
9215,19445313,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4445017,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
9216,19445314,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL2441565,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
9217,19445315,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4476772,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
9218,19445316,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4561606,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,uM,0.018
9219,19445317,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4465727,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
9220,19445323,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4435619,=,nM,890.0,CHEMBL203,Homo sapiens,IC50,uM,0.89
9221,19445324,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4527630,=,nM,1010.0,CHEMBL203,Homo sapiens,IC50,uM,1.01
9222,19445325,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL4541573,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,uM,0.36
9223,19445327,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL939,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
9224,19445328,CHEMBL4432452,Inhibition of EGFR phosphorylation in EGF-stimulated human KB cells preincubated for 1 hr followed by EGF stimulation measured after 6 mins by ELISA,B,CHEMBL553,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
9225,19445339,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL4549542,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
9226,19445340,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL2441561,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
9227,19445341,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL4458843,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
9228,19445342,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL4468924,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
9229,19445343,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL4445017,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
9230,19445344,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL2441565,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
9231,19445345,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL4561606,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
9232,19445346,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9233,19445347,CHEMBL4432463,Inhibition of EGFR (unknown origin) using FAM-labeled peptide substrate preincubated for 10 mins followed by substrate addition measured after 40 mins by caliper motility shift assay,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9234,19449777,CHEMBL4433480,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,B,CHEMBL1336,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
9235,19449778,CHEMBL4433480,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,B,CHEMBL4437803,=,nM,147.0,CHEMBL203,Homo sapiens,IC50,uM,0.147
9236,19449779,CHEMBL4433480,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,B,CHEMBL4582195,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,uM,0.084
9237,19449780,CHEMBL4433480,Inhibition of recombinant human N-terminal GST-tagged EGFR (695 to end) expressed in baculovirus infected Sf9 cells using ATP as substrate after 40 mins by Kinase-Glo MAX luminescence assay,B,CHEMBL4437943,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
9238,19476567,CHEMBL4479715,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,B,CHEMBL4569508,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0
9239,19476667,CHEMBL4479715,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,B,CHEMBL4550702,=,nM,28000.0,CHEMBL203,Homo sapiens,IC50,nM,28000.0
9240,19476767,CHEMBL4479715,Inhibition of recombinant human His-tagged EGFR expressed in mammalian expression system by Z'-LYTE assay,B,CHEMBL4568087,=,nM,340.0,CHEMBL203,Homo sapiens,IC50,nM,340.0
9241,19485856,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4094959,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
9242,19485857,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL4094959,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
9243,19485859,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4534592,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9244,19485860,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL4534592,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
9245,19485862,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4584630,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
9246,19485863,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL4584630,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
9247,19485865,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4071151,=,nM,1489.0,CHEMBL203,Homo sapiens,IC50,nM,1489.0
9248,19485866,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL4071151,=,nM,693.0,CHEMBL203,Homo sapiens,IC50,nM,693.0
9249,19485869,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4581088,=,nM,8006.0,CHEMBL203,Homo sapiens,IC50,nM,8006.0
9250,19485896,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL4588202,=,nM,649.0,CHEMBL203,Homo sapiens,IC50,nM,649.0
9251,19485897,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL4588202,=,nM,677.0,CHEMBL203,Homo sapiens,IC50,nM,677.0
9252,19485901,CHEMBL4481537,Inhibition of wild type EGFR (unknown origin) by HTRF assay,B,CHEMBL1873475,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
9253,19485902,CHEMBL4481538,Inhibition of EGFR L858R/T790M double mutant (unknown origin) by HTRF assay,B,CHEMBL1873475,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
9254,20601685,CHEMBL4603816,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay,B,CHEMBL4646281,=,nM,2360.0,CHEMBL203,Homo sapiens,IC50,nM,2360.0
9255,20601686,CHEMBL4603816,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 mins by HTRF assay,B,CHEMBL4639739,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,nM,4500.0
9256,20613810,CHEMBL4606713,Inhibition of recombinant human N-terminal GST-tagged EGFR (668 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 2 hrs followed by EGF stimulation and measured after 30 mins by TMB peroxidase substrate based assay,B,CHEMBL4647257,=,nM,326.2,CHEMBL203,Homo sapiens,IC50,uM,0.3262
9257,20613811,CHEMBL4606713,Inhibition of recombinant human N-terminal GST-tagged EGFR (668 to end residues) expressed in baculovirus infected Sf9 insect cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 2 hrs followed by EGF stimulation and measured after 30 mins by TMB peroxidase substrate based assay,B,CHEMBL4646415,=,nM,145.0,CHEMBL203,Homo sapiens,IC50,uM,0.145
9258,20638460,CHEMBL4612446,Inhibition of EGFR (unknown origin),B,CHEMBL4637274,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
9259,20646839,CHEMBL4614415,Inhibition of EGFR (unknown origin),B,CHEMBL4635399,<,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9260,20654614,CHEMBL4616782,Inhibition of HER1 (unknown origin),B,CHEMBL1873475,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
9261,20654615,CHEMBL4616782,Inhibition of HER1 (unknown origin),B,CHEMBL4297674,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,nM,2000.0
9262,20656075,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL4640482,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
9263,20656076,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL4642842,=,nM,26000.0,CHEMBL203,Homo sapiens,IC50,uM,26.0
9264,20656077,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL4634317,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,uM,15.0
9265,20656078,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL4644209,=,nM,14000.0,CHEMBL203,Homo sapiens,IC50,uM,14.0
9266,20656079,CHEMBL4617240,Inhibition of EGFR L858R/T790M (unknown origin),B,CHEMBL3353410,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
9267,20656080,CHEMBL4617241,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4640482,=,nM,64000.0,CHEMBL203,Homo sapiens,IC50,uM,64.0
9268,20656081,CHEMBL4617241,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4642842,=,nM,47000.0,CHEMBL203,Homo sapiens,IC50,uM,47.0
9269,20656082,CHEMBL4617241,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4634317,=,nM,24000.0,CHEMBL203,Homo sapiens,IC50,uM,24.0
9270,20656083,CHEMBL4617241,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4644209,=,nM,29000.0,CHEMBL203,Homo sapiens,IC50,uM,29.0
9271,20656084,CHEMBL4617241,Inhibition of wild type EGFR (unknown origin),B,CHEMBL3353410,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,uM,0.002
9272,20657366,CHEMBL4617511,Inhibition of EGFR1 (unknown origin),B,CHEMBL939,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
9273,20657368,CHEMBL4617511,Inhibition of EGFR1 (unknown origin),B,CHEMBL553,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9274,20667648,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4638857,=,nM,7560.0,CHEMBL203,Homo sapiens,IC50,uM,7.56
9275,20667649,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4649213,=,nM,740.0,CHEMBL203,Homo sapiens,IC50,uM,0.74
9276,20667650,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4646644,=,nM,4280.0,CHEMBL203,Homo sapiens,IC50,uM,4.28
9277,20667651,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4645726,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
9278,20667652,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4644480,=,nM,4100.0,CHEMBL203,Homo sapiens,IC50,uM,4.1
9279,20667653,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4647325,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
9280,20667654,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4637355,=,nM,3910.0,CHEMBL203,Homo sapiens,IC50,uM,3.91
9281,20667655,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL4649833,=,nM,9510.0,CHEMBL203,Homo sapiens,IC50,uM,9.51
9282,20667656,CHEMBL4619916,Inhibition of human EGFR-TK using PTK substrate after 40 mins in presence of ATP by Kinase-Glo luminescent assay,B,CHEMBL939,=,nM,1740.0,CHEMBL203,Homo sapiens,IC50,uM,1.74
9283,20669683,CHEMBL4620454,Inhibition of human recombinant EGFR in presence of substrate Ulight-CAGAGAIETDKEYYTVKD and Km ATP,B,CHEMBL4635625,=,nM,4110.0,CHEMBL203,Homo sapiens,IC50,nM,4110.0
9284,20689333,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4517633,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9285,20689334,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4646030,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
9286,20689335,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4642574,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9287,20689336,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL554,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
9288,20689337,CHEMBL4625049,Inhibition of wild type EGFR (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL388978,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
9289,20689353,CHEMBL4625053,Inhibition of EGFR L858R mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4517633,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
9290,20689354,CHEMBL4625053,Inhibition of EGFR L858R mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4646030,=,nM,419.0,CHEMBL203,Homo sapiens,IC50,nM,419.0
9291,20689355,CHEMBL4625053,Inhibition of EGFR L858R mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4642574,=,nM,387.0,CHEMBL203,Homo sapiens,IC50,nM,387.0
9292,20689356,CHEMBL4625053,Inhibition of EGFR L858R mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL554,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
9293,20689357,CHEMBL4625053,Inhibition of EGFR L858R mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL388978,=,nM,58.7,CHEMBL203,Homo sapiens,IC50,nM,58.7
9294,20689362,CHEMBL4625054,Inhibition of EGFR L858R/T790M mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL388978,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
9295,20689363,CHEMBL4625055,Inhibition of EGFR ex19del mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4517633,=,nM,204.0,CHEMBL203,Homo sapiens,IC50,nM,204.0
9296,20689364,CHEMBL4625055,Inhibition of EGFR ex19del mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4646030,=,nM,1990.0,CHEMBL203,Homo sapiens,IC50,nM,1990.0
9297,20689365,CHEMBL4625055,Inhibition of EGFR ex19del mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL4642574,=,nM,1280.0,CHEMBL203,Homo sapiens,IC50,nM,1280.0
9298,20689366,CHEMBL4625055,Inhibition of EGFR ex19del mutant (unknown origin) in presence of radiolabelled gammaATP by radioisotope filter binding assay,B,CHEMBL388978,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
9299,20689367,CHEMBL4625056,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system by competitive binding assay,B,CHEMBL4646030,=,nM,12.3,CHEMBL203,Homo sapiens,IC50,nM,12.3
9300,20689368,CHEMBL4625056,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system by competitive binding assay,B,CHEMBL388978,=,nM,50.5,CHEMBL203,Homo sapiens,IC50,nM,50.5
9301,20689369,CHEMBL4625057,Inhibition of recombinant human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus expression system by competitive binding assay,B,CHEMBL4646030,=,nM,18.1,CHEMBL203,Homo sapiens,IC50,nM,18.1
9302,20689370,CHEMBL4625057,Inhibition of recombinant human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus expression system by competitive binding assay,B,CHEMBL388978,=,nM,12.6,CHEMBL203,Homo sapiens,IC50,nM,12.6
9303,20690040,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4642177,=,nM,208.0,CHEMBL203,Homo sapiens,IC50,nM,208.0
9304,20690041,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4640686,=,nM,170.1,CHEMBL203,Homo sapiens,IC50,nM,170.1
9305,20690042,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4639459,=,nM,126.8,CHEMBL203,Homo sapiens,IC50,nM,126.8
9306,20690043,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4641096,=,nM,169.3,CHEMBL203,Homo sapiens,IC50,nM,169.3
9307,20690044,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4649261,=,nM,156.6,CHEMBL203,Homo sapiens,IC50,nM,156.6
9308,20690045,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4647073,=,nM,142.0,CHEMBL203,Homo sapiens,IC50,nM,142.0
9309,20690046,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL4645434,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9310,20690047,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9311,20690048,CHEMBL4625256,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
9312,20690051,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4639459,=,nM,422.3,CHEMBL203,Homo sapiens,IC50,nM,422.3
9313,20690052,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4641096,=,nM,638.4,CHEMBL203,Homo sapiens,IC50,nM,638.4
9314,20690053,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4649261,=,nM,218.3,CHEMBL203,Homo sapiens,IC50,nM,218.3
9315,20690054,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4647073,=,nM,332.2,CHEMBL203,Homo sapiens,IC50,nM,332.2
9316,20690056,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
9317,20690057,CHEMBL4625257,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,167.1,CHEMBL203,Homo sapiens,IC50,nM,167.1
9318,20690058,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4642177,=,nM,663.4,CHEMBL203,Homo sapiens,IC50,nM,663.4
9319,20690059,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4640686,=,nM,80.5,CHEMBL203,Homo sapiens,IC50,nM,80.5
9320,20690060,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4639459,=,nM,72.5,CHEMBL203,Homo sapiens,IC50,nM,72.5
9321,20690061,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4641096,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,nM,73.0
9322,20690062,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4649261,=,nM,15.3,CHEMBL203,Homo sapiens,IC50,nM,15.3
9323,20690063,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4647073,=,nM,40.4,CHEMBL203,Homo sapiens,IC50,nM,40.4
9324,20690064,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL4645434,=,nM,17.9,CHEMBL203,Homo sapiens,IC50,nM,17.9
9325,20690065,CHEMBL4625258,Inhibition of EGFR 19D/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9326,20708019,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4643111,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
9327,20708020,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL2441563,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
9328,20708021,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4648924,=,nM,179.0,CHEMBL203,Homo sapiens,IC50,uM,0.179
9329,20708022,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4642158,=,nM,116.0,CHEMBL203,Homo sapiens,IC50,uM,0.116
9330,20708023,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4635100,=,nM,121.0,CHEMBL203,Homo sapiens,IC50,uM,0.121
9331,20708024,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4634127,=,nM,569.0,CHEMBL203,Homo sapiens,IC50,uM,0.569
9332,20708025,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4634499,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
9333,20708026,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4648271,=,nM,163.0,CHEMBL203,Homo sapiens,IC50,uM,0.163
9334,20708027,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL2441567,=,nM,126.0,CHEMBL203,Homo sapiens,IC50,uM,0.126
9335,20708029,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4639556,=,nM,4870.0,CHEMBL203,Homo sapiens,IC50,uM,4.87
9336,20708030,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4641942,=,nM,4870.0,CHEMBL203,Homo sapiens,IC50,uM,4.87
9337,20708031,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4646638,=,nM,5830.0,CHEMBL203,Homo sapiens,IC50,uM,5.83
9338,20708032,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4636996,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
9339,20708033,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4638194,=,nM,844.0,CHEMBL203,Homo sapiens,IC50,uM,0.844
9340,20708034,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4643903,=,nM,578.0,CHEMBL203,Homo sapiens,IC50,uM,0.578
9341,20708035,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL4634817,=,nM,446.0,CHEMBL203,Homo sapiens,IC50,uM,0.446
9342,20708036,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL554,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
9343,20708037,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL939,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,uM,0.025
9344,20708038,CHEMBL4628612,Inhibition of EGFR in human KB cells assessed as reduction in EGF-stimulated EGFR phosphorylation preincubated for 1 hr followed by EGF stimulation and measured after 6 mins by ELISA,B,CHEMBL553,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
9345,20708039,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL4643111,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
9346,20708040,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL2441563,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
9347,20708041,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL4635100,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
9348,20708042,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL4648271,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
9349,20708043,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL554,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
9350,20708044,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL939,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9351,20708045,CHEMBL4628613,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 40 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
9352,22392387,CHEMBL4667354,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins followed by substrate addition and measured after 1 hr by mobility shift assay,B,CHEMBL4745877,=,nM,2520.0,CHEMBL203,Homo sapiens,IC50,nM,2520.0
9353,22395647,CHEMBL4668243,Inhibition of EGF-induced EGFR phosphorylation in human A431 cells preincubated for 24 hrs followed by EGF stimulation and measured after 10 mins by HTRF based immunoassay,B,CHEMBL1873475,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
9354,22395661,CHEMBL4668250,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,uM,0.016
9355,22395821,CHEMBL4668350,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL3353410,=,nM,27.5,CHEMBL203,Homo sapiens,IC50,nM,27.5
9356,22408207,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL180022,<,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9357,22408208,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL554,=,nM,14781.0,CHEMBL203,Homo sapiens,IC50,nM,14781.0
9358,22408209,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL1173655,=,nM,714.0,CHEMBL203,Homo sapiens,IC50,nM,714.0
9359,22408210,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL3353410,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
9360,22408211,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4787483,=,nM,739.0,CHEMBL203,Homo sapiens,IC50,nM,739.0
9361,22408212,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4795165,=,nM,2664.0,CHEMBL203,Homo sapiens,IC50,nM,2664.0
9362,22408213,CHEMBL4670927,Inhibiton of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4757145,=,nM,807.0,CHEMBL203,Homo sapiens,IC50,nM,807.0
9363,22408215,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL180022,=,nM,10117.0,CHEMBL203,Homo sapiens,IC50,nM,10117.0
9364,22408216,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL554,=,nM,2685.0,CHEMBL203,Homo sapiens,IC50,nM,2685.0
9365,22408217,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL1173655,=,nM,1401.0,CHEMBL203,Homo sapiens,IC50,nM,1401.0
9366,22408218,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL3353410,=,nM,911.0,CHEMBL203,Homo sapiens,IC50,nM,911.0
9367,22408219,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4787483,=,nM,1675.0,CHEMBL203,Homo sapiens,IC50,nM,1675.0
9368,22408220,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4795165,=,nM,1570.0,CHEMBL203,Homo sapiens,IC50,nM,1570.0
9369,22408221,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4757145,=,nM,862.0,CHEMBL203,Homo sapiens,IC50,nM,862.0
9370,22408222,CHEMBL4670928,Inhibiton of EGFR (unknown origin) expressed in human A431 cells assessed as reduction in EGFR induced cell viability after 96 hrs by CellTiter-Glo assay,B,CHEMBL4756368,=,nM,2236.0,CHEMBL203,Homo sapiens,IC50,nM,2236.0
9371,22408223,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL180022,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9372,22408224,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL554,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
9373,22408225,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9374,22408226,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.02,CHEMBL203,Homo sapiens,IC50,nM,0.02
9375,22408227,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL4787483,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
9376,22408228,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL4795165,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
9377,22408229,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL4757145,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9378,22408230,CHEMBL4670929,Inhibition of human N-terminal GST-tagged EGFR L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 20 mins by HTRF assay,B,CHEMBL4756368,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9379,22408231,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL180022,=,nM,0.02,CHEMBL203,Homo sapiens,IC50,nM,0.02
9380,22408232,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL554,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9381,22408233,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.01,CHEMBL203,Homo sapiens,IC50,nM,0.01
9382,22408234,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.06,CHEMBL203,Homo sapiens,IC50,nM,0.06
9383,22408235,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL4787483,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9384,22408236,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL4795165,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9385,22408237,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL4757145,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9386,22408238,CHEMBL4670930,Inhibition of human N-terminal GST-tagged EGFR L858R mutant (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 15 mins by HTRF assay,B,CHEMBL4756368,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9387,22408239,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL180022,=,nM,0.02,CHEMBL203,Homo sapiens,IC50,nM,0.02
9388,22408240,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL554,=,nM,0.06,CHEMBL203,Homo sapiens,IC50,nM,0.06
9389,22408241,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL1173655,=,nM,0.01,CHEMBL203,Homo sapiens,IC50,nM,0.01
9390,22408242,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9391,22408243,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL4787483,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
9392,22408244,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL4795165,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9393,22408245,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL4757145,=,nM,0.09,CHEMBL203,Homo sapiens,IC50,nM,0.09
9394,22408246,CHEMBL4670931,Inhibition of human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus infected Sf9 insect cells using TK as substrate preincubated for 30 mins followed by substrate addition and measured after 25 mins by HTRF assay,B,CHEMBL4756368,=,nM,0.07,CHEMBL203,Homo sapiens,IC50,nM,0.07
9395,22409946,CHEMBL4671284,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,B,CHEMBL4746030,=,nM,205.0,CHEMBL203,Homo sapiens,IC50,uM,0.205
9396,22409947,CHEMBL4671284,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,B,CHEMBL4752492,=,nM,124.0,CHEMBL203,Homo sapiens,IC50,uM,0.124
9397,22409948,CHEMBL4671284,Inhibition of EGFR in human A549 cells measured after 30 hrs by ELISA,B,CHEMBL553,=,nM,5182.0,CHEMBL203,Homo sapiens,IC50,uM,5.182
9398,22415177,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL1545480,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,uM,0.106
9399,22415178,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4776730,=,nM,124.0,CHEMBL203,Homo sapiens,IC50,uM,0.124
9400,22415179,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4787698,=,nM,144.0,CHEMBL203,Homo sapiens,IC50,uM,0.14400000000000002
9401,22415180,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL1619395,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
9402,22415181,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4740108,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
9403,22415182,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4755651,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
9404,22415183,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4755988,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,uM,0.081
9405,22415184,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4751085,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
9406,22415185,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL4751362,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,uM,0.054000000000000006
9407,22415186,CHEMBL4672269,Inhibition of EGFR-TK (unknown origin) relative to control,B,CHEMBL553,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,uM,0.067
9408,22421711,CHEMBL4673685,Inhibition of EGFR (unknown origin) by Kinase-Glo luminescence assay,B,CHEMBL4786003,=,nM,4180.0,CHEMBL203,Homo sapiens,IC50,uM,4.18
9409,22421723,CHEMBL4673696,Inhibition of EGFR (unknown origin),B,CHEMBL4792279,=,nM,186.0,CHEMBL203,Homo sapiens,IC50,nM,186.0
9410,22468733,CHEMBL4684707,Inhibition of EGFR in human RPMI-8226 cells incubated for 2 hrs by ELISA,B,CHEMBL4778826,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
9411,22468734,CHEMBL4684707,Inhibition of EGFR in human RPMI-8226 cells incubated for 2 hrs by ELISA,B,CHEMBL939,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
9412,22473597,CHEMBL4685759,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",B,CHEMBL4757104,=,nM,1257.0,CHEMBL203,Homo sapiens,IC50,uM,1.2570000000000001
9413,22473598,CHEMBL4685759,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",B,CHEMBL4765122,=,nM,504.0,CHEMBL203,Homo sapiens,IC50,uM,0.504
9414,22473599,CHEMBL4685759,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",B,CHEMBL181617,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
9415,22473600,CHEMBL4685759,"Inhibition of EGFR (unknown origin) using poly (Glu,Tyr) 4:1 as substrate incubated for 8 mins in presence of ATP by colorimetric analysis",B,CHEMBL939,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
9416,22475271,CHEMBL4686127,"Inhibition of EGFR L858R/T790M (unknown origin) using Poly (Glu, Tyr) 4:1 as substrate measured after 1 hr by ELISA",B,CHEMBL4753700,=,nM,19.3,CHEMBL203,Homo sapiens,IC50,nM,19.3
9417,22476310,CHEMBL4686394,Inhibition of EGFR (unknown origin),B,CHEMBL1230609,=,nM,3020.0,CHEMBL203,Homo sapiens,IC50,nM,3020.0
9418,22753820,CHEMBL4700377,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,B,CHEMBL553,=,nM,239.91,CHEMBL203,Homo sapiens,IC50,nM,239.91
9419,22753821,CHEMBL4700377,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,B,CHEMBL4793639,=,nM,617.33,CHEMBL203,Homo sapiens,IC50,nM,617.33
9420,22753822,CHEMBL4700377,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,B,CHEMBL4795888,=,nM,710.0,CHEMBL203,Homo sapiens,IC50,nM,710.0
9421,22753823,CHEMBL4700377,Inhibition of EGFR (unknown origin) using Tyrosine 4 peptide and ATP as substrate incubated for 1 hr by Z'-lyte kinase assay based UV-VIS spectrophotometric method,B,CHEMBL4750343,=,nM,236.38,CHEMBL203,Homo sapiens,IC50,nM,236.38
9422,22760323,CHEMBL4701885,Inhibition of EGFR in human KYSE-520 cells assessed as reduction in p-ERK levels,B,CHEMBL553,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
9423,22771682,CHEMBL4704542,Inhibition of GST-tagged recombinant HER1 (unknown origin) expressed in baculovirus expression system incubated for 15-45 mins in presence of [gamma32P]-ATP by radiometric assay,B,CHEMBL458997,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
9424,22782705,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL939,=,nM,14.2,CHEMBL203,Homo sapiens,IC50,nM,14.2
9425,22782706,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL553,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
9426,22782707,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL3353410,=,nM,33.7,CHEMBL203,Homo sapiens,IC50,nM,33.7
9427,22782708,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4778502,=,nM,178.8,CHEMBL203,Homo sapiens,IC50,nM,178.8
9428,22782709,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4798177,=,nM,89.3,CHEMBL203,Homo sapiens,IC50,nM,89.3
9429,22782710,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4786701,=,nM,333.0,CHEMBL203,Homo sapiens,IC50,nM,333.0
9430,22782711,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4798480,=,nM,156.4,CHEMBL203,Homo sapiens,IC50,nM,156.4
9431,22782712,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4558324,=,nM,34.6,CHEMBL203,Homo sapiens,IC50,nM,34.6
9432,22782713,CHEMBL4707739,Inhibition of wild type N-terminal GST-tagged human EGFR cytoplasmic domain (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 20 mins by HTRF assay,B,CHEMBL4788364,=,nM,195.8,CHEMBL203,Homo sapiens,IC50,nM,195.8
9433,22782714,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL939,=,nM,777.1,CHEMBL203,Homo sapiens,IC50,nM,777.1
9434,22782715,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9435,22782716,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4787536,=,nM,234.4,CHEMBL203,Homo sapiens,IC50,nM,234.4
9436,22782717,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4778502,=,nM,146.9,CHEMBL203,Homo sapiens,IC50,nM,146.9
9437,22782718,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4798177,=,nM,43.1,CHEMBL203,Homo sapiens,IC50,nM,43.1
9438,22782719,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4786701,=,nM,155.7,CHEMBL203,Homo sapiens,IC50,nM,155.7
9439,22782720,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4753387,=,nM,111.6,CHEMBL203,Homo sapiens,IC50,nM,111.6
9440,22782721,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4798480,=,nM,212.7,CHEMBL203,Homo sapiens,IC50,nM,212.7
9441,22782722,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4558324,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
9442,22782723,CHEMBL4707740,Inhibition of human EGFR cytoplasmic domain L858R/T790M mutant (669 to 1210 residues) expressed in baculovirus infected Sf21 cells using biotin-labeled TK substrate preincubated for 30 mins followed by substrate and ATP addition at Km concentration and further incubated for 40 mins by HTRF assay,B,CHEMBL4788364,=,nM,143.4,CHEMBL203,Homo sapiens,IC50,nM,143.4
9443,22809890,CHEMBL4713360,Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus expression system using Tyr 4 as substrate incubated for 60 mins by Z'-Lyte assay,B,CHEMBL3353410,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
9444,22809891,CHEMBL4713360,Inhibition of recombinant human GST-tagged EGFR T790M/L858R double mutant (668 to 1210 residues) expressed in baculovirus expression system using Tyr 4 as substrate incubated for 60 mins by Z'-Lyte assay,B,CHEMBL4796010,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
9445,22809892,CHEMBL4713361,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system using tyrosine 4 peptide as substrate after 60 mins in presence of ATP FRET based Z'-LYTE assay,B,CHEMBL3353410,=,nM,5.1,CHEMBL203,Homo sapiens,IC50,nM,5.1
9446,22809893,CHEMBL4713361,Inhibition of human recombinant GST-tagged EGFR L858R mutant expressed in baculovirus expression system using tyrosine 4 peptide as substrate after 60 mins in presence of ATP FRET based Z'-LYTE assay,B,CHEMBL4796010,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9447,22809985,CHEMBL4713426,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
9448,22809986,CHEMBL4713426,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9449,22814201,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL492399,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
9450,22814202,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL535,=,nM,172.1,CHEMBL203,Homo sapiens,IC50,nM,172.1
9451,22814203,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL553,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9452,22814204,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL2420866,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
9453,22814205,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL516047,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
9454,22814206,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL4746488,=,nM,10.6,CHEMBL203,Homo sapiens,IC50,nM,10.6
9455,22814207,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL3604205,=,nM,48.9,CHEMBL203,Homo sapiens,IC50,nM,48.9
9456,22814208,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL444724,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
9457,22814209,CHEMBL4714413,Inhibition of EGFR in human A431 cells preincubated for 60 mins followed by EGF stimulation and measured after 10 mins by ELISA,B,CHEMBL2420867,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
9458,22814384,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4747078,=,nM,12.08,CHEMBL203,Homo sapiens,IC50,nM,12.08
9459,22814385,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4792967,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
9460,22814386,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4761468,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
9461,22814387,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4800367,=,nM,1.51,CHEMBL203,Homo sapiens,IC50,nM,1.51
9462,22814388,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4790568,=,nM,1.01,CHEMBL203,Homo sapiens,IC50,nM,1.01
9463,22814389,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4745195,=,nM,0.86,CHEMBL203,Homo sapiens,IC50,nM,0.86
9464,22814390,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4747958,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9465,22814391,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4744138,=,nM,2.09,CHEMBL203,Homo sapiens,IC50,nM,2.09
9466,22814392,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL4756020,=,nM,0.95,CHEMBL203,Homo sapiens,IC50,nM,0.95
9467,22814393,CHEMBL4714437,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M/L858R double mutant using biotinylated TK peptide as substrate measured after 30 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.55,CHEMBL203,Homo sapiens,IC50,nM,0.55
9468,22822942,CHEMBL4716851,Inhibition of HER1 (unknown origin),B,CHEMBL3651854,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
9469,22835791,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4780286,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9470,22835792,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4783569,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9471,22835793,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL553,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9472,22835794,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4795296,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9473,22835795,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4751641,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
9474,22835796,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4791195,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9475,22835797,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4743998,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9476,22835798,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4744798,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
9477,22835799,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4741922,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9478,22835800,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4779711,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9479,22835801,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4776056,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
9480,22835802,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4785569,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9481,22835803,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4746770,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9482,22835804,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4746697,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9483,22835805,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4800697,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
9484,22835806,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4170121,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9485,22835807,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4757806,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9486,22835808,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4778894,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
9487,22835809,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4759003,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9488,22835810,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4793053,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9489,22835811,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4776396,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9490,22835812,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4763315,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9491,22835813,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4740295,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9492,22835814,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4759127,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
9493,22835815,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4776751,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9494,22835816,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4740573,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9495,22835817,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4764993,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9496,22835818,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4780965,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9497,22835819,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4789312,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9498,22835820,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4749862,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9499,22835821,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4748320,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9500,22835822,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4784777,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9501,22835823,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4787816,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
9502,22835824,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4787951,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9503,22835825,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4778248,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9504,22835826,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4742081,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9505,22835827,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4749064,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9506,22835828,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4748149,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
9507,22835829,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4748367,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9508,22835830,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4789027,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
9509,22835831,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4784258,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9510,22835832,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4792577,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9511,22835833,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4794073,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
9512,22835834,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4786776,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9513,22835835,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4760328,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9514,22835836,CHEMBL4718820,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4753008,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,nM,900.0
9515,22836063,CHEMBL4718840,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4780286,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9516,22836064,CHEMBL4718840,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4783569,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9517,22836065,CHEMBL4718840,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4164805,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9518,22836066,CHEMBL4718840,Inhibition of EGFR (unknown origin) using Tyr 04 peptide as substrate incubated for 1 hr by Z'-LYTE assay,B,CHEMBL4175024,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9519,22843190,CHEMBL4720222,Inhibition of recombinant human EGFR using Ulight-CAGAGAIETDKEYYTVKD as substrate incubate for 15 mins by LANCE assay,B,CHEMBL1873475,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
9520,22843769,CHEMBL4720755,Inhibition of human EGFR using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay,B,CHEMBL388978,=,nM,26.7,CHEMBL203,Homo sapiens,IC50,10^-8M,2.67
9521,22844190,CHEMBL4721173,Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL3353410,=,nM,0.002,CHEMBL203,Homo sapiens,IC50,nM,0.002
9522,22844191,CHEMBL4721173,Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL1229592,=,nM,0.04,CHEMBL203,Homo sapiens,IC50,nM,0.04
9523,22844192,CHEMBL4721173,Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL1173655,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9524,22844193,CHEMBL4721173,Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL31965,=,nM,1.26,CHEMBL203,Homo sapiens,IC50,nM,1.26
9525,22844194,CHEMBL4721173,Inhibition of recombinant human N-terminal GST tagged EGFR L858R/T790M double mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4750196,=,nM,4223.0,CHEMBL203,Homo sapiens,IC50,nM,4223.0
9526,22844219,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL3353410,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9527,22844220,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL1229592,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9528,22844221,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL1173655,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
9529,22844222,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL31965,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
9530,22844224,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4747893,=,nM,194.0,CHEMBL203,Homo sapiens,IC50,nM,194.0
9531,22844225,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4757531,=,nM,475.0,CHEMBL203,Homo sapiens,IC50,nM,475.0
9532,22844226,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4756049,=,nM,666.0,CHEMBL203,Homo sapiens,IC50,nM,666.0
9533,22844227,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4755444,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0
9534,22844228,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4790485,=,nM,463.0,CHEMBL203,Homo sapiens,IC50,nM,463.0
9535,22844229,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4777554,=,nM,735.0,CHEMBL203,Homo sapiens,IC50,nM,735.0
9536,22844230,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4784185,=,nM,2245.0,CHEMBL203,Homo sapiens,IC50,nM,2245.0
9537,22844231,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4763697,=,nM,427.0,CHEMBL203,Homo sapiens,IC50,nM,427.0
9538,22844232,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4763967,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
9539,22844233,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4777353,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
9540,22844234,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4745521,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
9541,22844235,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4796407,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
9542,22844236,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4753193,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
9543,22844237,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4793852,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9544,22844238,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4757724,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
9545,22844239,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4792426,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
9546,22844240,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4743173,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,nM,74.0
9547,22844241,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4790583,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
9548,22844242,CHEMBL4721175,Inhibition of recombinant human N-terminal GST tagged EGFR L858R mutant (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4750196,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
9549,22844282,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4749765,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
9550,22844283,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4747893,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
9551,22844284,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4757531,=,nM,169.0,CHEMBL203,Homo sapiens,IC50,nM,169.0
9552,22844285,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4756049,=,nM,390.0,CHEMBL203,Homo sapiens,IC50,nM,390.0
9553,22844286,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4755444,=,nM,374.0,CHEMBL203,Homo sapiens,IC50,nM,374.0
9554,22844287,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4790485,=,nM,503.0,CHEMBL203,Homo sapiens,IC50,nM,503.0
9555,22844288,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4777554,=,nM,172.0,CHEMBL203,Homo sapiens,IC50,nM,172.0
9556,22844289,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4784185,=,nM,2426.0,CHEMBL203,Homo sapiens,IC50,nM,2426.0
9557,22844290,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4763697,=,nM,722.0,CHEMBL203,Homo sapiens,IC50,nM,722.0
9558,22844291,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4763967,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
9559,22844292,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4777353,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
9560,22844293,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4745521,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
9561,22844294,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4796407,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
9562,22844295,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4753193,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
9563,22844296,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4793852,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
9564,22844297,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4757724,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
9565,22844298,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4792426,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
9566,22844299,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4743173,=,nM,68.0,CHEMBL203,Homo sapiens,IC50,nM,68.0
9567,22844300,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4790583,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
9568,22844301,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4751768,=,nM,242.4,CHEMBL203,Homo sapiens,IC50,nM,242.4
9569,22844302,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4752951,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
9570,22844303,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4759414,=,nM,50.9,CHEMBL203,Homo sapiens,IC50,nM,50.9
9571,22844304,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4790655,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
9572,22844305,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4762998,=,nM,365.0,CHEMBL203,Homo sapiens,IC50,nM,365.0
9573,22844306,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4750608,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,nM,43.0
9574,22844307,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4782025,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3
9575,22844308,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4760606,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
9576,22844309,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4789811,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
9577,22844310,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4750196,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
9578,22844311,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4743566,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9579,22844312,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4760864,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
9580,22844313,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4754811,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
9581,22844314,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4741678,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
9582,22844315,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4755832,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
9583,22844316,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4776057,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
9584,22844317,CHEMBL4721180,Inhibition of recombinant human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in insect expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL939,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
9585,22848910,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL3353410,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
9586,22848911,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4797395,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
9587,22848912,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4752022,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
9588,22848913,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4786787,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
9589,22848914,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4758107,=,nM,561.0,CHEMBL203,Homo sapiens,IC50,nM,561.0
9590,22848915,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4795878,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
9591,22848916,CHEMBL4722830,"Inhibition of EGFR L858R/T790M/C797S (unknown origin) using Poly (Glu, Tyr) as substrate measured after 40 mins by kinase-glo assay",B,CHEMBL4780903,=,nM,122.0,CHEMBL203,Homo sapiens,IC50,nM,122.0
9592,22853104,CHEMBL4724188,Inhibition of EGFR (unknown origin),B,CHEMBL180022,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
9593,22853105,CHEMBL4724189,Inhibition of human recombinant EGFR (668 to 1211) expressed in baculovirus infected Sf9 insect cells using poly-Glu-Tyr as substrate incubated for 5 mins in presence of ATP measured after 25 mins by dye based colorimetric analysis,B,CHEMBL483321,=,nM,6400.0,CHEMBL203,Homo sapiens,IC50,nM,6400.0
9594,22853933,CHEMBL4724376,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,nM,96.0
9595,22853934,CHEMBL4724377,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL1873475,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
9596,22856449,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4741925,=,nM,307.7,CHEMBL203,Homo sapiens,IC50,nM,307.7
9597,22856450,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4792673,=,nM,259.0,CHEMBL203,Homo sapiens,IC50,nM,259.0
9598,22856451,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4746895,=,nM,15.5,CHEMBL203,Homo sapiens,IC50,nM,15.5
9599,22856452,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4782900,=,nM,24.7,CHEMBL203,Homo sapiens,IC50,nM,24.7
9600,22856453,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4750158,=,nM,23.6,CHEMBL203,Homo sapiens,IC50,nM,23.6
9601,22856454,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4791596,=,nM,4.6,CHEMBL203,Homo sapiens,IC50,nM,4.6
9602,22856455,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL939,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
9603,22856456,CHEMBL4724942,Inhibition of recombinant wild type EGFR (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL1173655,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
9604,22856457,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4741925,=,nM,134.8,CHEMBL203,Homo sapiens,IC50,nM,134.8
9605,22856458,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4792673,=,nM,65.3,CHEMBL203,Homo sapiens,IC50,nM,65.3
9606,22856459,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4746895,=,nM,5.7,CHEMBL203,Homo sapiens,IC50,nM,5.7
9607,22856460,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4782900,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
9608,22856461,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4750158,=,nM,16.6,CHEMBL203,Homo sapiens,IC50,nM,16.6
9609,22856462,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL4791596,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
9610,22856464,CHEMBL4724943,Inhibition of recombinant wild type EGFR T790M/L858R mutant (696 to C terminal end) (unknown origin) using poly (Glu-Tyr) as substrate preincubated for 30 mins followed by substrate addition and measured after 30 mins by ELISA,B,CHEMBL1173655,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
9611,22875760,CHEMBL4725783,Inhibition of EGFR (unknown origin),B,CHEMBL98,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
9612,22875761,CHEMBL4725783,Inhibition of EGFR (unknown origin),B,CHEMBL4746995,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
9613,22892148,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4780058,=,nM,109.71,CHEMBL203,Homo sapiens,IC50,nM,109.71
9614,22892149,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4747759,=,nM,278.88,CHEMBL203,Homo sapiens,IC50,nM,278.88
9615,22892150,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4749342,=,nM,1235.34,CHEMBL203,Homo sapiens,IC50,nM,1235.34
9616,22892151,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4783948,=,nM,150.36,CHEMBL203,Homo sapiens,IC50,nM,150.36
9617,22892152,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4794131,=,nM,311.75,CHEMBL203,Homo sapiens,IC50,nM,311.75
9618,22892153,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4740646,=,nM,208.09,CHEMBL203,Homo sapiens,IC50,nM,208.09
9619,22892154,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4758204,=,nM,622.64,CHEMBL203,Homo sapiens,IC50,nM,622.64
9620,22892155,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4753631,=,nM,85.03,CHEMBL203,Homo sapiens,IC50,nM,85.03
9621,22892156,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4786168,=,nM,103.71,CHEMBL203,Homo sapiens,IC50,nM,103.71
9622,22892157,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4752843,=,nM,253.74,CHEMBL203,Homo sapiens,IC50,nM,253.74
9623,22892158,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4746321,=,nM,406.09,CHEMBL203,Homo sapiens,IC50,nM,406.09
9624,22892159,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4762604,=,nM,513.63,CHEMBL203,Homo sapiens,IC50,nM,513.63
9625,22892160,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4746023,=,nM,212.82,CHEMBL203,Homo sapiens,IC50,nM,212.82
9626,22892161,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4750734,=,nM,71.67,CHEMBL203,Homo sapiens,IC50,nM,71.67
9627,22892162,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4763960,=,nM,773.24,CHEMBL203,Homo sapiens,IC50,nM,773.24
9628,22892163,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4749518,=,nM,342.06,CHEMBL203,Homo sapiens,IC50,nM,342.06
9629,22892164,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL4796408,=,nM,569.41,CHEMBL203,Homo sapiens,IC50,nM,569.41
9630,22892165,CHEMBL4729710,Inhibition of EGFR (unknown origin) using ATF-2 as substrate after 1 hr by radiometric based ELISA,B,CHEMBL553,=,nM,152.59,CHEMBL203,Homo sapiens,IC50,nM,152.59
9631,22892172,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL3353410,=,nM,12.92,CHEMBL203,Homo sapiens,IC50,nM,12.92
9632,22892173,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9633,22892174,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9634,22892175,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
9635,22892176,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9636,22892177,CHEMBL4729717,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
9637,22894015,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4793105,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,nM,70.0
9638,22894018,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4745868,=,nM,51.0,CHEMBL203,Homo sapiens,IC50,nM,51.0
9639,22894019,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4746377,=,nM,257.0,CHEMBL203,Homo sapiens,IC50,nM,257.0
9640,22894020,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4776012,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
9641,22894021,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4776073,=,nM,301.0,CHEMBL203,Homo sapiens,IC50,nM,301.0
9642,22894022,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4740234,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
9643,22894023,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4785849,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
9644,22894024,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL1173655,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9645,22894025,CHEMBL4730144,Inhibition of wild type EGFR (unknown origin) in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL3545308,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,nM,76.0
9646,22894026,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4793105,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
9647,22894027,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4794857,=,nM,213.0,CHEMBL203,Homo sapiens,IC50,nM,213.0
9648,22894028,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4789716,=,nM,174.0,CHEMBL203,Homo sapiens,IC50,nM,174.0
9649,22894029,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4745868,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
9650,22894030,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4746377,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
9651,22894031,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4776012,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
9652,22894032,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4776073,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
9653,22894033,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4740234,=,nM,7.5,CHEMBL203,Homo sapiens,IC50,nM,7.5
9654,22894034,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL4785849,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
9655,22894035,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL1173655,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
9656,22894036,CHEMBL4730145,Inhibition of recombinant human EGFR T790M/L858R mutant expressed in baculovirus insect cell expression system in presence of ATP preincubated 5 mins measured for 30 mins by detection reagent based HTRF analysis,B,CHEMBL3545308,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
9657,22894486,CHEMBL4730213,Inhibition of EGFR T790M mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins fin presence of ATP by Kinase Glo luminescence assay,B,CHEMBL3786343,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
9658,22894487,CHEMBL4730213,Inhibition of EGFR T790M mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins fin presence of ATP by Kinase Glo luminescence assay,B,CHEMBL4780534,=,nM,541.7,CHEMBL203,Homo sapiens,IC50,nM,541.7
9659,22894491,CHEMBL4730214,Inhibition of EGFR T790M/L858R mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins in presence of ATP by Kinase Glo luminescence assay,B,CHEMBL4776833,=,nM,638.4,CHEMBL203,Homo sapiens,IC50,nM,638.4
9660,22894494,CHEMBL4730214,Inhibition of EGFR T790M/L858R mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins in presence of ATP by Kinase Glo luminescence assay,B,CHEMBL3786343,=,nM,12.7,CHEMBL203,Homo sapiens,IC50,nM,12.7
9661,22894495,CHEMBL4730214,Inhibition of EGFR T790M/L858R mutant (unknown origin) using FAM-labelled peptide as substrate incubated for 10 mins in presence of ATP by Kinase Glo luminescence assay,B,CHEMBL4780534,=,nM,132.1,CHEMBL203,Homo sapiens,IC50,nM,132.1
9662,22896494,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL553,=,nM,2.17,CHEMBL203,Homo sapiens,IC50,nM,2.17
9663,22896495,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4453068,=,nM,48.7,CHEMBL203,Homo sapiens,IC50,nM,48.7
9664,22896496,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4750375,=,nM,19.7,CHEMBL203,Homo sapiens,IC50,nM,19.7
9665,22896497,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4743464,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
9666,22896498,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4744655,=,nM,3.91,CHEMBL203,Homo sapiens,IC50,nM,3.91
9667,22896499,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4743220,=,nM,2.49,CHEMBL203,Homo sapiens,IC50,nM,2.49
9668,22896500,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4759031,=,nM,10.4,CHEMBL203,Homo sapiens,IC50,nM,10.4
9669,22896501,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4759650,=,nM,41.4,CHEMBL203,Homo sapiens,IC50,nM,41.4
9670,22896502,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4778159,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
9671,22896503,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4740063,=,nM,6.41,CHEMBL203,Homo sapiens,IC50,nM,6.41
9672,22896504,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL1198370,=,nM,13.6,CHEMBL203,Homo sapiens,IC50,nM,13.6
9673,22896505,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4786797,=,nM,505.1,CHEMBL203,Homo sapiens,IC50,nM,505.1
9674,22896506,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4793453,=,nM,15.6,CHEMBL203,Homo sapiens,IC50,nM,15.6
9675,22896507,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4762453,=,nM,16.2,CHEMBL203,Homo sapiens,IC50,nM,16.2
9676,22896508,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4794223,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
9677,22896509,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4783428,=,nM,6.16,CHEMBL203,Homo sapiens,IC50,nM,6.16
9678,22896510,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4793944,=,nM,782.8,CHEMBL203,Homo sapiens,IC50,nM,782.8
9679,22896511,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4744207,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
9680,22896512,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4791756,=,nM,7.63,CHEMBL203,Homo sapiens,IC50,nM,7.63
9681,22896513,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4786961,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9682,22896514,CHEMBL4730561,"Inhibition of human recombinant EGFR expressed in baculovirus infected Sf9 insect cells using poly (Glu, Tyr) 4:1 peptide as substrate incubated for 40 mins in presence of 10 uM ATP by ADP-Glo luminescence assay",B,CHEMBL4749501,=,nM,18.9,CHEMBL203,Homo sapiens,IC50,nM,18.9
9683,22896515,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL553,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
9684,22896516,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4453068,=,nM,59.8,CHEMBL203,Homo sapiens,IC50,nM,59.8
9685,22896517,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4750375,=,nM,20.5,CHEMBL203,Homo sapiens,IC50,nM,20.5
9686,22896518,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4743464,=,nM,28.2,CHEMBL203,Homo sapiens,IC50,nM,28.2
9687,22896519,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4744655,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
9688,22896520,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4743220,=,nM,3.95,CHEMBL203,Homo sapiens,IC50,nM,3.95
9689,22896521,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4759031,=,nM,13.1,CHEMBL203,Homo sapiens,IC50,nM,13.1
9690,22896522,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4759650,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
9691,22896523,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4778159,=,nM,45.3,CHEMBL203,Homo sapiens,IC50,nM,45.3
9692,22896524,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4740063,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
9693,22896525,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL1198370,=,nM,15.5,CHEMBL203,Homo sapiens,IC50,nM,15.5
9694,22896526,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4786797,=,nM,729.1,CHEMBL203,Homo sapiens,IC50,nM,729.1
9695,22896527,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4793453,=,nM,21.9,CHEMBL203,Homo sapiens,IC50,nM,21.9
9696,22896528,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4762453,=,nM,25.3,CHEMBL203,Homo sapiens,IC50,nM,25.3
9697,22896529,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4794223,=,nM,32.6,CHEMBL203,Homo sapiens,IC50,nM,32.6
9698,22896530,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4783428,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
9699,22896531,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4793944,=,nM,2186.0,CHEMBL203,Homo sapiens,IC50,nM,2186.0
9700,22896532,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4744207,=,nM,36.7,CHEMBL203,Homo sapiens,IC50,nM,36.7
9701,22896533,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4791756,=,nM,11.1,CHEMBL203,Homo sapiens,IC50,nM,11.1
9702,22896534,CHEMBL4730562,Inhibition of wild type EGFR in human U87 cells assessed as heparin/human EGF stimulated phosphorylation after 1 hr by immunoblotting analysis,B,CHEMBL4786961,=,nM,15.8,CHEMBL203,Homo sapiens,IC50,nM,15.8
9703,22903844,CHEMBL4732636,Inhibition of recombinant human DYKDDDD-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 5 mins followed by ATP addition and measured after 10 mins by [gamma-32P]-ATP based scintillation counting method,B,CHEMBL553,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
9704,22903845,CHEMBL4732637,Inhibition of EGFR (unknown origin),B,CHEMBL4798627,=,nM,55000000.0,CHEMBL203,Homo sapiens,IC50,mM,55.0
9705,22903868,CHEMBL4732644,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,B,CHEMBL4798434,=,nM,255.6,CHEMBL203,Homo sapiens,IC50,nM,255.6
9706,22903869,CHEMBL4732644,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,B,CHEMBL4797515,=,nM,143.63,CHEMBL203,Homo sapiens,IC50,nM,143.63
9707,22903870,CHEMBL4732644,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,B,CHEMBL4750368,=,nM,33.66,CHEMBL203,Homo sapiens,IC50,nM,33.66
9708,22903871,CHEMBL4732644,Inhibition of human EGFR TK domain expressed in Escherichia coli BL21 (DE3) pLysS using poly-Glu-Tyr (51 to 68 residues) as substrate incubated for 1 hr by ADP-Glo assay,B,CHEMBL553,=,nM,28.46,CHEMBL203,Homo sapiens,IC50,nM,28.46
9709,22920018,CHEMBL4736379,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu-Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA,B,CHEMBL3353410,=,nM,152.3,CHEMBL203,Homo sapiens,IC50,nM,152.3
9710,22920026,CHEMBL4736379,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system using poly (Glu-Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA,B,CHEMBL4741340,=,nM,113.8,CHEMBL203,Homo sapiens,IC50,nM,113.8
9711,22920027,CHEMBL4736380,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system using poly (Glu-Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA,B,CHEMBL3353410,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
9712,22920035,CHEMBL4736380,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system using poly (Glu-Tyr) 4:1 as substrate incubated for 1 hr in presence of ATP by ELISA,B,CHEMBL4741340,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
9713,22921872,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4759697,=,nM,8.3,CHEMBL203,Homo sapiens,IC50,nM,8.3
9714,22921873,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4794998,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
9715,22921874,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4783641,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
9716,22921875,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4793338,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
9717,22921876,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4759072,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9718,22921877,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4744985,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
9719,22921878,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4758842,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
9720,22921879,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4794670,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
9721,22921880,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4758761,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9722,22921881,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL4759112,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
9723,22921882,CHEMBL4736786,Inhibition of EGFR L858R/T790M (unknown origin) by mobility shift assay,B,CHEMBL3353410,=,nM,0.43,CHEMBL203,Homo sapiens,IC50,nM,0.43
9724,22921883,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4759112,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
9725,22921884,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4758761,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9726,22921885,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4794670,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
9727,22921886,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4758842,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9728,22921887,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4744985,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
9729,22921888,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4759072,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
9730,22921889,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4793338,=,nM,0.33,CHEMBL203,Homo sapiens,IC50,nM,0.33
9731,22921890,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4783641,=,nM,0.44,CHEMBL203,Homo sapiens,IC50,nM,0.44
9732,22921891,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4794998,=,nM,0.36,CHEMBL203,Homo sapiens,IC50,nM,0.36
9733,22921892,CHEMBL4736787,Inhibition of EGFR (unknown origin) by mobility shift assay,B,CHEMBL4759697,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
9734,22921893,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4794670,=,nM,2.9,CHEMBL203,Homo sapiens,IC50,nM,2.9
9735,22921894,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4758842,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9736,22921895,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4744985,=,nM,0.88,CHEMBL203,Homo sapiens,IC50,nM,0.88
9737,22921896,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4759072,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9738,22921897,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4793338,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9739,22921898,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4783641,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9740,22921899,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4794998,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9741,22921900,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4759697,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9742,22921901,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4758761,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
9743,22921902,CHEMBL4736788,Inhibition of EGFR L858R (unknown origin) by mobility shift assay,B,CHEMBL4759112,=,nM,0.88,CHEMBL203,Homo sapiens,IC50,nM,0.88
9744,22924302,CHEMBL4737325,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4780210,=,nM,1887.2,CHEMBL203,Homo sapiens,IC50,uM,1.8872
9745,22924303,CHEMBL4737325,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4790553,=,nM,655.6,CHEMBL203,Homo sapiens,IC50,uM,0.6556
9746,22924304,CHEMBL4737325,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4759405,=,nM,422.25,CHEMBL203,Homo sapiens,IC50,uM,0.42225
9747,22924305,CHEMBL4737325,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL4753913,=,nM,226.7,CHEMBL203,Homo sapiens,IC50,uM,0.2267
9748,22950600,CHEMBL4766167,"Inhibition of human recombinant EGFR (696 to end residues) using poly(Glu,Tyr)4:1 as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis",B,CHEMBL4798527,=,nM,651.0,CHEMBL203,Homo sapiens,IC50,uM,0.6509999999999999
9749,22950602,CHEMBL4766169,Inhibition of human recombinant EGFR T790M mutant (696 to end residues) using GGMEDIYFEFMGGKKK as substrate incubated for 40 mins in presence of [gamma33P-ATP] by radiometric scintillation counting analysis,B,CHEMBL4798527,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
9750,22965624,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4799700,=,nM,1623.0,CHEMBL203,Homo sapiens,IC50,uM,1.6230000000000002
9751,22965625,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4778717,=,nM,1885.0,CHEMBL203,Homo sapiens,IC50,uM,1.885
9752,22965626,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4779958,=,nM,358.0,CHEMBL203,Homo sapiens,IC50,uM,0.358
9753,22965627,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4782320,=,nM,493.0,CHEMBL203,Homo sapiens,IC50,uM,0.493
9754,22965628,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4776925,=,nM,8264.0,CHEMBL203,Homo sapiens,IC50,uM,8.264
9755,22965629,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL4789796,=,nM,993.0,CHEMBL203,Homo sapiens,IC50,uM,0.993
9756,22965630,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL554,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
9757,22965631,CHEMBL4769431,Inhibition of EGFR (unknown origin) by FRET assay,B,CHEMBL553,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,uM,0.095
9758,22965632,CHEMBL4769432,Inhibition of EGFR L858R mutant (unknown origin) by FRET assay,B,CHEMBL554,=,nM,61060.0,CHEMBL203,Homo sapiens,IC50,uM,61.06
9759,22965633,CHEMBL4769432,Inhibition of EGFR L858R mutant (unknown origin) by FRET assay,B,CHEMBL553,=,nM,92000.0,CHEMBL203,Homo sapiens,IC50,uM,92.0
9760,22965634,CHEMBL4769432,Inhibition of EGFR L858R mutant (unknown origin) by FRET assay,B,CHEMBL4779958,=,nM,86020.0,CHEMBL203,Homo sapiens,IC50,uM,86.02
9761,22965635,CHEMBL4769432,Inhibition of EGFR L858R mutant (unknown origin) by FRET assay,B,CHEMBL4782320,=,nM,102600.0,CHEMBL203,Homo sapiens,IC50,uM,102.6
9762,22965636,CHEMBL4769433,Inhibition of EGFR T790M mutant (unknown origin) by FRET assay,B,CHEMBL554,=,nM,377400.0,CHEMBL203,Homo sapiens,IC50,uM,377.4
9763,22965637,CHEMBL4769433,Inhibition of EGFR T790M mutant (unknown origin) by FRET assay,B,CHEMBL553,=,nM,421000.0,CHEMBL203,Homo sapiens,IC50,uM,421.0
9764,22965638,CHEMBL4769433,Inhibition of EGFR T790M mutant (unknown origin) by FRET assay,B,CHEMBL4779958,=,nM,432670.0,CHEMBL203,Homo sapiens,IC50,uM,432.67
9765,22965639,CHEMBL4769433,Inhibition of EGFR T790M mutant (unknown origin) by FRET assay,B,CHEMBL4782320,=,nM,461630.0,CHEMBL203,Homo sapiens,IC50,uM,461.63
9766,22968038,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4781497,=,nM,250.0,CHEMBL203,Homo sapiens,IC50,uM,0.25
9767,22968047,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4800533,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
9768,22968048,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4791108,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,uM,0.33
9769,22968049,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4779681,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
9770,22968050,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4791953,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
9771,22968051,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4785528,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,uM,0.24
9772,22968052,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL4780855,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
9773,22968056,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL3786343,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,uM,0.0009
9774,22968057,CHEMBL4770070,Inhibition of N-terminal GST-fused human EGFR L858R/T790M double mutant cytoplasmic domain (669 to 1210 residues) expressed in baculovirus expression system using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 20 mins by Mobility shift assay,B,CHEMBL3353410,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,uM,0.0006
9775,22972844,CHEMBL4771079,"Inhibition of EGFR (unknown origin) using poly (Glu, Tyr)4:1 as substrate in presence of ATP measured after 30 mins by HTRF assay",B,CHEMBL1230609,=,nM,3180.0,CHEMBL203,Homo sapiens,IC50,nM,3180.0
9776,22974784,CHEMBL4771364,Inhibition of human EGFR L858R/T790M mutant GGMEDIYFEFMGGKKK as substrate measured after 40 mins in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4531109,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
9777,22974786,CHEMBL4771365,Inhibition of human EGFR L858R using poly[Glu:Tyr] (4:1) as substrate measured after 40 mins in presence of [gamma-33P]ATP by radiometric assay,B,CHEMBL4531109,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
9778,22975112,CHEMBL4771544,Inhibition of wild type EGFR in human HepG2 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL3353410,=,nM,2239.0,CHEMBL203,Homo sapiens,IC50,uM,2.239
9779,22975113,CHEMBL4771545,Inhibition of wild type EGFR in human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL4779194,=,nM,7309.0,CHEMBL203,Homo sapiens,IC50,uM,7.309
9780,22975114,CHEMBL4771545,Inhibition of wild type EGFR in human MCF7 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL3353410,=,nM,2540.0,CHEMBL203,Homo sapiens,IC50,uM,2.54
9781,22975116,CHEMBL4771546,Inhibition of wild type EGFR in human HT-29 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL3353410,=,nM,2834.0,CHEMBL203,Homo sapiens,IC50,uM,2.8339999999999996
9782,22975117,CHEMBL4771547,Inhibition of wild type EGFR in human A-431 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL4779194,=,nM,6703.0,CHEMBL203,Homo sapiens,IC50,uM,6.702999999999999
9783,22975118,CHEMBL4771547,Inhibition of wild type EGFR in human A-431 cells assessed as cell growth inhibition measured after 72 hrs by Celltiter-Glo luminescent cell viability assay,B,CHEMBL3353410,=,nM,2823.0,CHEMBL203,Homo sapiens,IC50,uM,2.823
9784,22986116,CHEMBL4774183,Inhibition of EGFR (unknown origin),B,CHEMBL4791960,=,nM,56780.0,CHEMBL203,Homo sapiens,IC50,uM,56.78
9785,22990700,CHEMBL4775141,Inhibition of EGFR (unknown origin),B,CHEMBL49120,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
9786,23148926,CHEMBL4810017,Inhibition of EGFR (unknown origin),B,CHEMBL4868909,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
9787,23148927,CHEMBL4810017,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
9788,23152276,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL4845732,=,nM,146.9,CHEMBL203,Homo sapiens,IC50,nM,146.9
9789,23152277,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL4850856,=,nM,207.1,CHEMBL203,Homo sapiens,IC50,nM,207.1
9790,23152278,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL4851555,=,nM,1032.7,CHEMBL203,Homo sapiens,IC50,nM,1032.7
9791,23152279,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL4855312,=,nM,754.3,CHEMBL203,Homo sapiens,IC50,nM,754.3
9792,23152280,CHEMBL4810720,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,96.6,CHEMBL203,Homo sapiens,IC50,nM,96.6
9793,23172271,CHEMBL4814657,Inhibition of EGFR in human A-431 cells assessed as antiproliferative activity incubated for 48 hrs by MTS method,B,CHEMBL4463898,=,nM,1640.0,CHEMBL203,Homo sapiens,IC50,umol/L,1.64
9794,23172272,CHEMBL4814657,Inhibition of EGFR in human A-431 cells assessed as antiproliferative activity incubated for 48 hrs by MTS method,B,CHEMBL24828,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,umol/L,0.85
9795,23177914,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4877054,=,nM,18.3,CHEMBL203,Homo sapiens,IC50,nM,18.3
9796,23177915,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4861346,=,nM,13.7,CHEMBL203,Homo sapiens,IC50,nM,13.7
9797,23177916,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4859542,=,nM,49.2,CHEMBL203,Homo sapiens,IC50,nM,49.2
9798,23177917,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4855080,=,nM,34.8,CHEMBL203,Homo sapiens,IC50,nM,34.8
9799,23177918,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4853833,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,nM,27.0
9800,23177919,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4873098,=,nM,16.5,CHEMBL203,Homo sapiens,IC50,nM,16.5
9801,23177920,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL939,=,nM,17.1,CHEMBL203,Homo sapiens,IC50,nM,17.1
9802,23177921,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL3353410,=,nM,58.2,CHEMBL203,Homo sapiens,IC50,nM,58.2
9803,23177922,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4846607,=,nM,51.2,CHEMBL203,Homo sapiens,IC50,nM,51.2
9804,23177923,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4857605,=,nM,42.6,CHEMBL203,Homo sapiens,IC50,nM,42.6
9805,23177924,CHEMBL4815790,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4848093,=,nM,28.4,CHEMBL203,Homo sapiens,IC50,nM,28.4
9806,23177925,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4877054,=,nM,61.9,CHEMBL203,Homo sapiens,IC50,nM,61.9
9807,23177926,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4861346,=,nM,37.5,CHEMBL203,Homo sapiens,IC50,nM,37.5
9808,23177927,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4859542,=,nM,48.5,CHEMBL203,Homo sapiens,IC50,nM,48.5
9809,23177928,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4855080,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
9810,23177929,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4853833,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
9811,23177930,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4873098,=,nM,22.8,CHEMBL203,Homo sapiens,IC50,nM,22.8
9812,23177931,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL939,=,nM,378.4,CHEMBL203,Homo sapiens,IC50,nM,378.4
9813,23177932,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL3353410,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
9814,23177933,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4846607,=,nM,135.0,CHEMBL203,Homo sapiens,IC50,nM,135.0
9815,23177934,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4857605,=,nM,93.4,CHEMBL203,Homo sapiens,IC50,nM,93.4
9816,23177935,CHEMBL4815791,Inhibition of recombinant human N-terminal GST-tagged EGFR T790M mutant (669 to 1210 residues) expressed in baculovirus expression system using peptide as substrate incubated for 2 hrs followed by substrate addition and measured after 30 mins by TR-FRET assay,B,CHEMBL4848093,=,nM,66.7,CHEMBL203,Homo sapiens,IC50,nM,66.7
9817,23178059,CHEMBL4815841,Inhibition of EGFR (unknown origin),B,CHEMBL4868797,=,nM,176090.0,CHEMBL203,Homo sapiens,IC50,uM,176.09
9818,23183198,CHEMBL4817026,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate preincubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL388978,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
9819,23193711,CHEMBL4819289,Inhibition of EGFR (unknown origin),B,CHEMBL4863294,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3
9820,23193716,CHEMBL4819292,Inhibition of EGFR (unknown origin) incubated for 40 mins by kinase-glo plus luminescence assay,B,CHEMBL4870955,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,nM,5700.0
9821,23195371,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL1229592,=,nM,4.59,CHEMBL203,Homo sapiens,IC50,nM,4.59
9822,23195372,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4860398,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
9823,23195373,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4873506,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
9824,23195374,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4851176,=,nM,0.23,CHEMBL203,Homo sapiens,IC50,nM,0.23
9825,23195375,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4852664,=,nM,0.52,CHEMBL203,Homo sapiens,IC50,nM,0.52
9826,23195376,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4868614,=,nM,0.473,CHEMBL203,Homo sapiens,IC50,nM,0.473
9827,23195377,CHEMBL4819610,Inhibition of N-terminal GST-tagged human recombinant EGFR cytoplasmic domain (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4859375,=,nM,0.538,CHEMBL203,Homo sapiens,IC50,nM,0.5379999999999999
9828,23195379,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL1229592,=,nM,1.98,CHEMBL203,Homo sapiens,IC50,nM,1.98
9829,23195380,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4860398,=,nM,323.0,CHEMBL203,Homo sapiens,IC50,nM,323.0
9830,23195381,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4873506,=,nM,326.0,CHEMBL203,Homo sapiens,IC50,nM,326.0
9831,23195382,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4851176,=,nM,153.0,CHEMBL203,Homo sapiens,IC50,nM,153.0
9832,23195383,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4852664,=,nM,228.0,CHEMBL203,Homo sapiens,IC50,nM,228.0
9833,23195384,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4868614,=,nM,581.0,CHEMBL203,Homo sapiens,IC50,nM,581.0
9834,23195385,CHEMBL4819611,Inhibition of N-terminal GST-tagged human recombinant EGFR T790M mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4859375,=,nM,448.0,CHEMBL203,Homo sapiens,IC50,nM,448.0
9835,23195387,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL1229592,=,nM,2.86,CHEMBL203,Homo sapiens,IC50,nM,2.86
9836,23195388,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4860398,=,nM,0.36,CHEMBL203,Homo sapiens,IC50,nM,0.36
9837,23195389,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4873506,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
9838,23195390,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4851176,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
9839,23195391,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4852664,=,nM,0.46,CHEMBL203,Homo sapiens,IC50,nM,0.46
9840,23195392,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4868614,=,nM,0.55,CHEMBL203,Homo sapiens,IC50,nM,0.55
9841,23195393,CHEMBL4819612,Inhibition of N-terminal GST-tagged human recombinant EGFR L861Q mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4859375,=,nM,0.49,CHEMBL203,Homo sapiens,IC50,nM,0.49
9842,23195395,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL1229592,=,nM,4.64,CHEMBL203,Homo sapiens,IC50,nM,4.64
9843,23195396,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4860398,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
9844,23195397,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4873506,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
9845,23195398,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4851176,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
9846,23195399,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4852664,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
9847,23195400,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4868614,=,nM,0.46,CHEMBL203,Homo sapiens,IC50,nM,0.46
9848,23195401,CHEMBL4819613,Inhibition of N-terminal GST-tagged human recombinant EGFR L858R mutant (668 to 1210 residues) expressed in baculovirus expression system by Z'-LYTE kinase assay,B,CHEMBL4859375,=,nM,0.48,CHEMBL203,Homo sapiens,IC50,nM,0.48
9849,23203416,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4858583,=,nM,0.39,CHEMBL203,Homo sapiens,IC50,nM,0.39
9850,23203417,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL603266,=,nM,0.36,CHEMBL203,Homo sapiens,IC50,nM,0.36
9851,23203418,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,54.34,CHEMBL203,Homo sapiens,IC50,nM,54.34
9852,23203419,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,166.0,CHEMBL203,Homo sapiens,IC50,nM,166.0
9853,23203420,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9854,23203421,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9855,23203422,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL3353410,=,nM,12.92,CHEMBL203,Homo sapiens,IC50,nM,12.92
9856,23203423,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL250318,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,nM,14.0
9857,23203424,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL210378,=,nM,204.0,CHEMBL203,Homo sapiens,IC50,nM,204.0
9858,23203425,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4857477,=,nM,81.0,CHEMBL203,Homo sapiens,IC50,nM,81.0
9859,23203426,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4856453,=,nM,33.1,CHEMBL203,Homo sapiens,IC50,nM,33.1
9860,23203427,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4859473,=,nM,143.4,CHEMBL203,Homo sapiens,IC50,nM,143.4
9861,23203428,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL1988225,=,nM,81.07,CHEMBL203,Homo sapiens,IC50,nM,81.07
9862,23203429,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4849859,=,nM,136.0,CHEMBL203,Homo sapiens,IC50,nM,136.0
9863,23203430,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4877452,=,nM,178.1,CHEMBL203,Homo sapiens,IC50,nM,178.1
9864,23203431,CHEMBL4821238,Inhibition of EGFR (unknown origin),B,CHEMBL4866476,=,nM,65.63,CHEMBL203,Homo sapiens,IC50,nM,65.63
9865,23220187,CHEMBL4824512,Inhibition of autophosphorylation of EGFR (unknown origin) by Cell free assay,B,CHEMBL4871569,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,uM,0.07200000000000001
9866,23220188,CHEMBL4824512,Inhibition of autophosphorylation of EGFR (unknown origin) by Cell free assay,B,CHEMBL553,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,uM,0.087
9867,23232603,CHEMBL4827337,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL4858176,=,nM,25300.0,CHEMBL203,Homo sapiens,IC50,uM,25.3
9868,23232604,CHEMBL4827337,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL939,=,nM,15500.0,CHEMBL203,Homo sapiens,IC50,uM,15.5
9869,23236816,CHEMBL4828267,"Inhibition of recombinant human EGFR (696 to end residues) using poly(Glu, Tyr) 4:1 as substrate after 40 mins in presence of [gamma-33ATP] by radiometric scintillation counting analysis",B,CHEMBL4869634,=,nM,1970.0,CHEMBL203,Homo sapiens,IC50,nM,1970.0
9870,23240293,CHEMBL4829094,Inhibition of EGFR (unknown origin),B,CHEMBL4873767,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
9871,23240294,CHEMBL4829094,Inhibition of EGFR (unknown origin),B,CHEMBL4876135,=,nM,2500.0,CHEMBL203,Homo sapiens,IC50,nM,2500.0
9872,23243130,CHEMBL4829483,Inhibition of wild type EGFR (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0
9873,23243131,CHEMBL4829483,Inhibition of wild type EGFR (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
9874,23243132,CHEMBL4829483,Inhibition of wild type EGFR (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
9875,23243133,CHEMBL4829484,Inhibition of wild type EGFR L858R/T790M mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,7.3,CHEMBL203,Homo sapiens,IC50,nM,7.3
9876,23243134,CHEMBL4829484,Inhibition of wild type EGFR L858R/T790M mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
9877,23243135,CHEMBL4829484,Inhibition of wild type EGFR L858R/T790M mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
9878,23243136,CHEMBL4829485,Inhibition of wild type EGFR Del E746/A750 mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
9879,23243137,CHEMBL4829485,Inhibition of wild type EGFR Del E746/A750 mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
9880,23243138,CHEMBL4829485,Inhibition of wild type EGFR Del E746/A750 mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
9881,23243139,CHEMBL4829486,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,0.39,CHEMBL203,Homo sapiens,IC50,nM,0.39
9882,23243140,CHEMBL4829486,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,0.21,CHEMBL203,Homo sapiens,IC50,nM,0.21
9883,23243141,CHEMBL4829486,Inhibition of wild type EGFR L858R mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
9884,23243145,CHEMBL4829488,Inhibition of wild type EGFR C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9885,23243146,CHEMBL4829488,Inhibition of wild type EGFR C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,0.76,CHEMBL203,Homo sapiens,IC50,nM,0.76
9886,23243147,CHEMBL4829488,Inhibition of wild type EGFR C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,0.58,CHEMBL203,Homo sapiens,IC50,nM,0.58
9887,23243148,CHEMBL4829489,Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4850239,=,nM,829.0,CHEMBL203,Homo sapiens,IC50,nM,829.0
9888,23243149,CHEMBL4829489,Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4847264,=,nM,119.0,CHEMBL203,Homo sapiens,IC50,nM,119.0
9889,23243150,CHEMBL4829489,Inhibition of wild type EGFR L858R/T790M/C797S mutant (unknown origin) pretreated with substrate for 10 mins followed by ATP addition measured after 60 mins by mobility shift assay,B,CHEMBL4297865,=,nM,279.0,CHEMBL203,Homo sapiens,IC50,nM,279.0
9890,23250025,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL3353410,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,nM,430.0
9891,23250026,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4855850,=,nM,244.0,CHEMBL203,Homo sapiens,IC50,nM,244.0
9892,23250027,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4865792,=,nM,946.0,CHEMBL203,Homo sapiens,IC50,nM,946.0
9893,23250028,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4854693,=,nM,675.0,CHEMBL203,Homo sapiens,IC50,nM,675.0
9894,23250030,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4873392,=,nM,458.0,CHEMBL203,Homo sapiens,IC50,nM,458.0
9895,23250031,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4873600,=,nM,476.0,CHEMBL203,Homo sapiens,IC50,nM,476.0
9896,23250032,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4866162,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
9897,23250033,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL4856343,=,nM,1105.0,CHEMBL203,Homo sapiens,IC50,nM,1105.0
9898,23250034,CHEMBL4830966,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate incubated for 1 hr by TR-FRET assay,B,CHEMBL3545311,=,nM,18.5,CHEMBL203,Homo sapiens,IC50,nM,18.5
9899,23250035,CHEMBL4830967,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,B,CHEMBL4855850,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9900,23250038,CHEMBL4830967,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,B,CHEMBL4866162,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
9901,23250039,CHEMBL4830967,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,B,CHEMBL3545311,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
9902,23250040,CHEMBL4830968,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme and ATP at Km for 3 hrs followed by substrate addition and measured after 1 hr by TR-FRET assay,B,CHEMBL4866162,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
9903,23250041,CHEMBL4830969,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme and ATP at 10XKm for 3 hrs followed by substrate addition and measured after 1 hr by TR-FRET assay,B,CHEMBL4866162,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
9904,23250094,CHEMBL4830995,Inhibition of EGFR del19/T790M/C797S triple mutant (unknown origin) using fluoresceine-labelled poly-GT peptide as substrate preincubated with enzyme for 3 hrs followed by substrate and ATP addition by TR-FRET assay,B,CHEMBL3353410,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,nM,330.0
9905,23256347,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4848234,=,nM,116.5,CHEMBL203,Homo sapiens,IC50,nM,116.5
9906,23256348,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4861707,=,nM,68.81,CHEMBL203,Homo sapiens,IC50,nM,68.81
9907,23256349,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4858714,=,nM,98.78,CHEMBL203,Homo sapiens,IC50,nM,98.78
9908,23256350,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4875985,=,nM,1.097,CHEMBL203,Homo sapiens,IC50,nM,1.097
9909,23256351,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4869024,=,nM,6.82,CHEMBL203,Homo sapiens,IC50,nM,6.82
9910,23256352,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4870560,=,nM,64.79,CHEMBL203,Homo sapiens,IC50,nM,64.79
9911,23256353,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4858409,=,nM,16.04,CHEMBL203,Homo sapiens,IC50,nM,16.04
9912,23256354,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4849337,=,nM,113.5,CHEMBL203,Homo sapiens,IC50,nM,113.5
9913,23256355,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4871985,=,nM,49.94,CHEMBL203,Homo sapiens,IC50,nM,49.94
9914,23256356,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4870265,=,nM,117.5,CHEMBL203,Homo sapiens,IC50,nM,117.5
9915,23256357,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4858535,=,nM,44.96,CHEMBL203,Homo sapiens,IC50,nM,44.96
9916,23256358,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4851795,=,nM,65.41,CHEMBL203,Homo sapiens,IC50,nM,65.41
9917,23256359,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4873830,=,nM,198.5,CHEMBL203,Homo sapiens,IC50,nM,198.5
9918,23256360,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4862351,=,nM,0.2446,CHEMBL203,Homo sapiens,IC50,nM,0.2446
9919,23256361,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL3353410,=,nM,20.8,CHEMBL203,Homo sapiens,IC50,nM,20.8
9920,23256362,CHEMBL4832125,Inhibition of EGFR L858R/T790M double mutant (unknown origin) measured after 60 mins by ADP-Glo kinase based luminescence assay,B,CHEMBL4862976,=,nM,3.89,CHEMBL203,Homo sapiens,IC50,nM,3.89
9921,23256926,CHEMBL4832290,Inhibition of EGFR (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4860202,=,nM,9920.0,CHEMBL203,Homo sapiens,IC50,nM,9920.0
9922,23256927,CHEMBL4832290,Inhibition of EGFR (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL388978,=,nM,39.8,CHEMBL203,Homo sapiens,IC50,nM,39.8
9923,23256942,CHEMBL4832301,Inhibition of EGFR- L861Q mutant (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4866102,=,nM,4354.0,CHEMBL203,Homo sapiens,IC50,nM,4354.0
9924,23256943,CHEMBL4832302,Inhibition of EGFR- T790M mutant (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4866102,=,nM,380.0,CHEMBL203,Homo sapiens,IC50,nM,380.0
9925,23256944,CHEMBL4832303,Inhibition of EGFR T790M/L858R mutant (unknown origin) incubated for 40 mins in presence of Mg/ATP mix by [gamma p33]-ATP based scintillation counting method,B,CHEMBL4866102,=,nM,8560.0,CHEMBL203,Homo sapiens,IC50,nM,8560.0
9926,23258730,CHEMBL4832760,Inhibition of EGFR (unknown origin),B,CHEMBL4868123,=,nM,5210.0,CHEMBL203,Homo sapiens,IC50,uM,5.21
9927,23276947,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4872030,=,nM,14260.0,CHEMBL203,Homo sapiens,IC50,uM,14.26
9928,23276948,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4868965,=,nM,1350.0,CHEMBL203,Homo sapiens,IC50,uM,1.35
9929,23276949,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4861493,=,nM,1130.0,CHEMBL203,Homo sapiens,IC50,uM,1.13
9930,23276950,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4861796,=,nM,960.0,CHEMBL203,Homo sapiens,IC50,uM,0.96
9931,23276951,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4863109,=,nM,5290.0,CHEMBL203,Homo sapiens,IC50,uM,5.29
9932,23276952,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL553,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
9933,23276953,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL1336,=,nM,1150.0,CHEMBL203,Homo sapiens,IC50,uM,1.15
9934,23276954,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL4849721,=,nM,3110.0,CHEMBL203,Homo sapiens,IC50,uM,3.11
9935,23276955,CHEMBL4836401,Inhibition of recombinant wild type EGFR-TK (unknown origin) by ELISA,B,CHEMBL180022,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
9936,23277608,CHEMBL4836513,Inhibition of EGFR (unknown origin),B,CHEMBL4647325,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
9937,23277609,CHEMBL4836513,Inhibition of EGFR (unknown origin),B,CHEMBL4873202,=,nM,690.0,CHEMBL203,Homo sapiens,IC50,uM,0.69
9938,23289742,CHEMBL4839231,Inhibition of EGFR (unknown origin),B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
9939,23299080,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4874550,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,nM,450.0
9940,23299081,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4860527,=,nM,176.0,CHEMBL203,Homo sapiens,IC50,nM,176.0
9941,23299082,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4878421,=,nM,578.0,CHEMBL203,Homo sapiens,IC50,nM,578.0
9942,23299083,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4864983,=,nM,433.0,CHEMBL203,Homo sapiens,IC50,nM,433.0
9943,23299084,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4863836,=,nM,79.4,CHEMBL203,Homo sapiens,IC50,nM,79.4
9944,23299085,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4863913,=,nM,113.0,CHEMBL203,Homo sapiens,IC50,nM,113.0
9945,23299086,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4878626,=,nM,12.6,CHEMBL203,Homo sapiens,IC50,nM,12.6
9946,23299088,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4847730,=,nM,11802.0,CHEMBL203,Homo sapiens,IC50,nM,11802.0
9947,23299089,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4849268,=,nM,16807.0,CHEMBL203,Homo sapiens,IC50,nM,16807.0
9948,23299090,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL1873475,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
9949,23299091,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL3707348,=,nM,3513.0,CHEMBL203,Homo sapiens,IC50,nM,3513.0
9950,23299092,CHEMBL4841672,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL3936761,=,nM,21.2,CHEMBL203,Homo sapiens,IC50,nM,21.2
9951,23310017,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL3647964,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9952,23310018,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL3936761,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
9953,23310019,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4863078,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,nM,109.0
9954,23310020,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4878090,=,nM,14010.0,CHEMBL203,Homo sapiens,IC50,nM,14010.0
9955,23310021,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4871192,=,nM,30.8,CHEMBL203,Homo sapiens,IC50,nM,30.8
9956,23310022,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4869409,=,nM,16.3,CHEMBL203,Homo sapiens,IC50,nM,16.3
9957,23310023,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4857353,=,nM,32.8,CHEMBL203,Homo sapiens,IC50,nM,32.8
9958,23310024,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4856592,=,nM,50.8,CHEMBL203,Homo sapiens,IC50,nM,50.8
9959,23310025,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4875332,=,nM,29.7,CHEMBL203,Homo sapiens,IC50,nM,29.7
9960,23310026,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4852264,=,nM,38.6,CHEMBL203,Homo sapiens,IC50,nM,38.6
9961,23310027,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4873984,=,nM,104.0,CHEMBL203,Homo sapiens,IC50,nM,104.0
9962,23310028,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4863088,=,nM,33.8,CHEMBL203,Homo sapiens,IC50,nM,33.8
9963,23310029,CHEMBL4843876,Inhibition of N-terminal DYKDDDD-tagged EGFR (669 to 1210 residues) (unknown origin) expressed in Sf21 insect cells using NH2-ETVYSEVRK-biotin as substrate preincubated for 1 hr followed by ATP addition and measured after 2 hrs by ELISA,B,CHEMBL4867893,=,nM,88.3,CHEMBL203,Homo sapiens,IC50,nM,88.3
9964,23312277,CHEMBL4844330,Inhibition of EGFR d747-749/A750P mutant (unknown origin),B,CHEMBL4871593,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,nM,60.0
9965,23312328,CHEMBL4844359,Inhibition of EGFR (unknown origin),B,CHEMBL7917,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
9966,23312330,CHEMBL4844361,Inhibition of human EGFR using poly(Glu:Tyr)(4:1) as substrate in presence of [gamma33P]ATP by radiometric HotSpot assay,B,CHEMBL4878790,=,nM,2980.0,CHEMBL203,Homo sapiens,IC50,uM,2.98
9967,23314404,CHEMBL4844824,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4877510,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
9968,24343039,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL1173655,=,nM,2.5,CHEMBL203,Homo sapiens,IC50,nM,2.5
9969,24343040,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL3353410,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9970,24343041,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5085136,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
9971,24343042,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5082422,=,nM,499.0,CHEMBL203,Homo sapiens,IC50,nM,499.0
9972,24343043,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5083976,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
9973,24343044,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5077776,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
9974,24343045,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5088102,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
9975,24343046,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5089073,=,nM,37.0,CHEMBL203,Homo sapiens,IC50,nM,37.0
9976,24343047,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5076067,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
9977,24343048,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5085118,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9978,24343049,CHEMBL5029924,Inhibition of EGFR T790M/L858R double mutant (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5079430,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
9979,24343050,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL1173655,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9980,24343051,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL3353410,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
9981,24343052,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5085136,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,nM,43.0
9982,24343053,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5083976,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
9983,24343054,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5077776,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
9984,24343055,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5088102,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
9985,24343056,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5089073,=,nM,192.0,CHEMBL203,Homo sapiens,IC50,nM,192.0
9986,24343057,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5076067,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
9987,24343058,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5085118,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
9988,24343059,CHEMBL5029925,Inhibition of wild type EGFR (unknown origin) preincubated for 60 mins followed by substrate addition and further incubated for 60 mins in presence of ATP by IMAP-FP assay,B,CHEMBL5079430,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
9989,24347779,CHEMBL5031335,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 4 hr followed by EGF stimulation by Western blot analysis,B,CHEMBL5082149,=,nM,17700.0,CHEMBL203,Homo sapiens,IC50,uM,17.7
9990,24348821,CHEMBL5031645,Inhibition of exogenous EGFR (unknown origin),B,CHEMBL5094282,=,nM,10.52,CHEMBL203,Homo sapiens,IC50,nM,10.52
9991,24348822,CHEMBL5031645,Inhibition of exogenous EGFR (unknown origin),B,CHEMBL5079998,=,nM,7.36,CHEMBL203,Homo sapiens,IC50,nM,7.36
9992,24348823,CHEMBL5031645,Inhibition of exogenous EGFR (unknown origin),B,CHEMBL554,=,nM,13.42,CHEMBL203,Homo sapiens,IC50,nM,13.42
9993,24349079,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL3545311,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
9994,24349080,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5077378,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,uM,0.0013
9995,24349081,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5094480,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,uM,0.0009
9996,24349082,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5087815,=,nM,0.92,CHEMBL203,Homo sapiens,IC50,uM,0.0009199999999999999
9997,24349083,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5086066,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,uM,0.0017
9998,24349084,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5087610,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,uM,0.0033
9999,24349085,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5087264,=,nM,4.4,CHEMBL203,Homo sapiens,IC50,uM,0.0044
10000,24349086,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5081299,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,uM,0.0056
10001,24349087,CHEMBL5031761,Inhibition of Wild type EGFR (unknown origin),B,CHEMBL5078413,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,uM,0.0024
10002,24349098,CHEMBL5031763,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as protein phosphorylation measured after 2 hrs by ELISA,B,CHEMBL3545311,=,nM,203.0,CHEMBL203,Homo sapiens,IC50,uM,0.203
10003,24349101,CHEMBL5031763,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in human NCI-H1975 cells assessed as protein phosphorylation measured after 2 hrs by ELISA,B,CHEMBL5087264,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
10004,24367047,CHEMBL5036279,"Inhibition of EGFR T790M mutant (unknown origin) using Poly (Glu, Tyr)4:1 as substrate by spectrophotometry",B,CHEMBL3633143,=,nM,5.27,CHEMBL203,Homo sapiens,IC50,nM,5.27
10005,24367048,CHEMBL5036279,"Inhibition of EGFR T790M mutant (unknown origin) using Poly (Glu, Tyr)4:1 as substrate by spectrophotometry",B,CHEMBL5094288,=,nM,8.04,CHEMBL203,Homo sapiens,IC50,nM,8.04
10006,24373111,CHEMBL5036476,Inhibition of EGFR (unknown origin),B,CHEMBL1714813,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
10007,24373112,CHEMBL5036476,Inhibition of EGFR (unknown origin),B,CHEMBL5087955,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,nM,2800.0
10008,24377969,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5085143,=,nM,6.4,CHEMBL203,Homo sapiens,IC50,nM,6.4
10009,24377970,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5082394,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
10010,24377971,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL3353410,=,nM,29.6,CHEMBL203,Homo sapiens,IC50,nM,29.6
10011,24377973,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5075204,=,nM,352.8,CHEMBL203,Homo sapiens,IC50,nM,352.8
10012,24377974,CHEMBL5037732,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5079081,=,nM,96.3,CHEMBL203,Homo sapiens,IC50,nM,96.3
10013,24380977,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5086894,=,nM,51.2,CHEMBL203,Homo sapiens,IC50,nM,51.2
10014,24380978,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5084760,=,nM,62.3,CHEMBL203,Homo sapiens,IC50,nM,62.3
10015,24380979,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5077866,=,nM,157.0,CHEMBL203,Homo sapiens,IC50,nM,157.0
10016,24380980,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5088423,=,nM,538.1,CHEMBL203,Homo sapiens,IC50,nM,538.1
10017,24380981,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5078816,=,nM,198.7,CHEMBL203,Homo sapiens,IC50,nM,198.7
10018,24380982,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5076986,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
10019,24380983,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5091683,=,nM,113.1,CHEMBL203,Homo sapiens,IC50,nM,113.1
10020,24380985,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5087931,=,nM,337.6,CHEMBL203,Homo sapiens,IC50,nM,337.6
10021,24380986,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5081817,=,nM,299.8,CHEMBL203,Homo sapiens,IC50,nM,299.8
10022,24380987,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL5081174,=,nM,65.9,CHEMBL203,Homo sapiens,IC50,nM,65.9
10023,24380988,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL3545311,=,nM,261.3,CHEMBL203,Homo sapiens,IC50,nM,261.3
10024,24380989,CHEMBL5038287,Inhibition of wild type EGFR (unknown origin) measured by ELISA,B,CHEMBL3353410,=,nM,207.5,CHEMBL203,Homo sapiens,IC50,nM,207.5
10025,24381003,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5086894,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
10026,24381004,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5084760,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10027,24381005,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5077866,=,nM,12.9,CHEMBL203,Homo sapiens,IC50,nM,12.9
10028,24381006,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5088423,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
10029,24381007,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5078816,=,nM,23.1,CHEMBL203,Homo sapiens,IC50,nM,23.1
10030,24381008,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5076986,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
10031,24381009,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5091683,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
10032,24381011,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5087931,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
10033,24381012,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5081817,=,nM,33.5,CHEMBL203,Homo sapiens,IC50,nM,33.5
10034,24381013,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL5081174,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10035,24381014,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL3545311,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
10036,24381015,CHEMBL5038289,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) measured by ELISA,B,CHEMBL3353410,=,nM,236.6,CHEMBL203,Homo sapiens,IC50,nM,236.6
10037,24408177,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5069689,=,nM,18.1,CHEMBL203,Homo sapiens,IC50,nM,18.1
10038,24408178,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5087214,=,nM,130.3,CHEMBL203,Homo sapiens,IC50,nM,130.3
10039,24408179,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5083645,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1
10040,24408180,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5087785,=,nM,335.5,CHEMBL203,Homo sapiens,IC50,nM,335.5
10041,24408181,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5076283,=,nM,5.1,CHEMBL203,Homo sapiens,IC50,nM,5.1
10042,24408182,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5069609,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10043,24408183,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5075594,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10044,24408185,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5087793,=,nM,136.9,CHEMBL203,Homo sapiens,IC50,nM,136.9
10045,24408186,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5086054,=,nM,462.9,CHEMBL203,Homo sapiens,IC50,nM,462.9
10046,24408188,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5077901,=,nM,379.0,CHEMBL203,Homo sapiens,IC50,nM,379.0
10047,24408189,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5077665,=,nM,279.2,CHEMBL203,Homo sapiens,IC50,nM,279.2
10048,24408190,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL2437471,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
10049,24408191,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL1873475,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10050,24408192,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL1173655,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10051,24408195,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL3936761,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
10052,24408197,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5088574,=,nM,341.6,CHEMBL203,Homo sapiens,IC50,nM,341.6
10053,24408198,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5081433,=,nM,83.2,CHEMBL203,Homo sapiens,IC50,nM,83.2
10054,24408199,CHEMBL5045467,Inhibition of GST-tagged human EGFR (668 to 1210 residues) expressed in baculovirus expression system using poly-Glu-Tyr (4:1) as substrate incubated for 1 hrs by ELISA,B,CHEMBL5080260,=,nM,33.8,CHEMBL203,Homo sapiens,IC50,nM,33.8
10055,24408253,CHEMBL5045472,Inhibition of EGFR phosphorylation in human A549 cells incubated for 4 hrs by Western blot assay,B,CHEMBL1873475,=,nM,16.6,CHEMBL203,Homo sapiens,IC50,nM,16.6
10056,24408254,CHEMBL5045472,Inhibition of EGFR phosphorylation in human A549 cells incubated for 4 hrs by Western blot assay,B,CHEMBL5085807,=,nM,117.6,CHEMBL203,Homo sapiens,IC50,nM,117.6
10057,24409324,CHEMBL5045723,Inhibition of human recombinant EGFR incubated for 1 hrs by HTRF KinEASE TK assay,B,CHEMBL5092606,=,nM,7137.0,CHEMBL203,Homo sapiens,IC50,nM,7137.0
10058,24413777,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094406,=,nM,18.7,CHEMBL203,Homo sapiens,IC50,nM,18.7
10059,24413778,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5071181,=,nM,54.35,CHEMBL203,Homo sapiens,IC50,nM,54.35
10060,24413779,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5080676,=,nM,11.61,CHEMBL203,Homo sapiens,IC50,nM,11.61
10061,24413780,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5088907,=,nM,12.59,CHEMBL203,Homo sapiens,IC50,nM,12.59
10062,24413781,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5083034,=,nM,46.36,CHEMBL203,Homo sapiens,IC50,nM,46.36
10063,24413782,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5082074,=,nM,142.8,CHEMBL203,Homo sapiens,IC50,nM,142.8
10064,24413783,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5087139,=,nM,300.5,CHEMBL203,Homo sapiens,IC50,nM,300.5
10065,24413784,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094237,=,nM,902.4,CHEMBL203,Homo sapiens,IC50,nM,902.4
10066,24413786,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089336,=,nM,723.5,CHEMBL203,Homo sapiens,IC50,nM,723.5
10067,24413787,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5076881,=,nM,948.8,CHEMBL203,Homo sapiens,IC50,nM,948.8
10068,24413788,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5084983,=,nM,212.7,CHEMBL203,Homo sapiens,IC50,nM,212.7
10069,24413789,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5072451,=,nM,9.574,CHEMBL203,Homo sapiens,IC50,nM,9.574
10070,24413790,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089161,=,nM,11.23,CHEMBL203,Homo sapiens,IC50,nM,11.23
10071,24413791,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5085816,=,nM,63.98,CHEMBL203,Homo sapiens,IC50,nM,63.98
10072,24413792,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093402,=,nM,13.11,CHEMBL203,Homo sapiens,IC50,nM,13.11
10073,24413793,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089912,=,nM,106.2,CHEMBL203,Homo sapiens,IC50,nM,106.2
10074,24413794,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093794,=,nM,287.7,CHEMBL203,Homo sapiens,IC50,nM,287.7
10075,24413795,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5087994,=,nM,625.4,CHEMBL203,Homo sapiens,IC50,nM,625.4
10076,24413797,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5070579,=,nM,22.34,CHEMBL203,Homo sapiens,IC50,nM,22.34
10077,24413798,CHEMBL5046853,Inhibition of EGFR del19 (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL3353410,=,nM,1.065,CHEMBL203,Homo sapiens,IC50,nM,1.065
10078,24413799,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094406,=,nM,8.023,CHEMBL203,Homo sapiens,IC50,nM,8.023
10079,24413800,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5071181,=,nM,21.43,CHEMBL203,Homo sapiens,IC50,nM,21.43
10080,24413801,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5080676,=,nM,5.654,CHEMBL203,Homo sapiens,IC50,nM,5.654
10081,24413802,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5088907,=,nM,6.198,CHEMBL203,Homo sapiens,IC50,nM,6.1979999999999995
10082,24413803,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5083034,=,nM,5.751,CHEMBL203,Homo sapiens,IC50,nM,5.751
10083,24413804,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5082074,=,nM,8.131,CHEMBL203,Homo sapiens,IC50,nM,8.131
10084,24413805,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5087139,=,nM,12.54,CHEMBL203,Homo sapiens,IC50,nM,12.54
10085,24413806,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094237,=,nM,27.34,CHEMBL203,Homo sapiens,IC50,nM,27.34
10086,24413807,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093625,=,nM,39.62,CHEMBL203,Homo sapiens,IC50,nM,39.62
10087,24413808,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089336,=,nM,36.61,CHEMBL203,Homo sapiens,IC50,nM,36.61
10088,24413809,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5076881,=,nM,57.97,CHEMBL203,Homo sapiens,IC50,nM,57.97
10089,24413810,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5084983,=,nM,12.34,CHEMBL203,Homo sapiens,IC50,nM,12.34
10090,24413811,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5072451,=,nM,4.014,CHEMBL203,Homo sapiens,IC50,nM,4.013999999999999
10091,24413812,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089161,=,nM,4.363,CHEMBL203,Homo sapiens,IC50,nM,4.363
10092,24413813,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5085816,=,nM,5.751,CHEMBL203,Homo sapiens,IC50,nM,5.751
10093,24413814,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093402,=,nM,2.003,CHEMBL203,Homo sapiens,IC50,nM,2.003
10094,24413815,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089912,=,nM,42.38,CHEMBL203,Homo sapiens,IC50,nM,42.38
10095,24413816,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093794,=,nM,501.5,CHEMBL203,Homo sapiens,IC50,nM,501.5
10096,24413817,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5087994,=,nM,397.0,CHEMBL203,Homo sapiens,IC50,nM,397.0
10097,24413819,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5070579,=,nM,8.58,CHEMBL203,Homo sapiens,IC50,nM,8.58
10098,24413820,CHEMBL5046854,Inhibition of EGFR T790M/C797S double mutant (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL3353410,=,nM,0.414,CHEMBL203,Homo sapiens,IC50,nM,0.414
10099,24413821,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5094406,=,nM,100.6,CHEMBL203,Homo sapiens,IC50,nM,100.6
10100,24413822,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5071181,=,nM,495.4,CHEMBL203,Homo sapiens,IC50,nM,495.4
10101,24413823,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5080676,=,nM,71.28,CHEMBL203,Homo sapiens,IC50,nM,71.28
10102,24413824,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5088907,=,nM,96.49,CHEMBL203,Homo sapiens,IC50,nM,96.49
10103,24413825,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5083034,=,nM,453.1,CHEMBL203,Homo sapiens,IC50,nM,453.1
10104,24413826,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5082074,=,nM,2468.0,CHEMBL203,Homo sapiens,IC50,nM,2468.0
10105,24413832,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5084983,=,nM,2909.0,CHEMBL203,Homo sapiens,IC50,nM,2909.0
10106,24413834,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089161,=,nM,406.4,CHEMBL203,Homo sapiens,IC50,nM,406.4
10107,24413835,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5085816,=,nM,180.8,CHEMBL203,Homo sapiens,IC50,nM,180.8
10108,24413836,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093402,=,nM,42.72,CHEMBL203,Homo sapiens,IC50,nM,42.72
10109,24413837,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5089912,=,nM,952.4,CHEMBL203,Homo sapiens,IC50,nM,952.4
10110,24413838,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5093794,=,nM,4934.0,CHEMBL203,Homo sapiens,IC50,nM,4934.0
10111,24413839,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5087994,=,nM,3184.0,CHEMBL203,Homo sapiens,IC50,nM,3184.0
10112,24413840,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5090133,=,nM,7513.0,CHEMBL203,Homo sapiens,IC50,nM,7513.0
10113,24413841,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL5070579,=,nM,50.76,CHEMBL203,Homo sapiens,IC50,nM,50.76
10114,24413842,CHEMBL5046855,Inhibition of wild type EGFR (unknown origin) using flurogenic substrate in presence of ATP by HTRF assay,B,CHEMBL3353410,=,nM,8.807,CHEMBL203,Homo sapiens,IC50,nM,8.807
10115,24661286,CHEMBL5096403,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,B,CHEMBL5173408,=,nM,88.3,CHEMBL203,Homo sapiens,IC50,nM,88.3
10116,24661287,CHEMBL5096403,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,B,CHEMBL4798627,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,nM,55.0
10117,24661288,CHEMBL5096403,Inhibition of EGFR (unknown origin) incubated for 40 mins by intrinsic ATPase activity luminescence assay,B,CHEMBL939,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
10118,24663662,CHEMBL5097717,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL5201387,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
10119,24663663,CHEMBL5097717,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL5175924,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
10120,24663666,CHEMBL5097720,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5208349,=,nM,8000.0,CHEMBL203,Homo sapiens,IC50,uM,8.0
10121,24663667,CHEMBL5097721,Inhibition of EGFR (unknown origin),B,CHEMBL5208349,=,nM,191300.0,CHEMBL203,Homo sapiens,IC50,uM,191.3
10122,24663672,CHEMBL5097724,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in presence of ATP by ADP-Glo assay,B,CHEMBL5196024,=,nM,27.5,CHEMBL203,Homo sapiens,IC50,nM,27.5
10123,24663673,CHEMBL5097724,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in presence of ATP by ADP-Glo assay,B,CHEMBL5187169,=,nM,9.1,CHEMBL203,Homo sapiens,IC50,nM,9.1
10124,24663675,CHEMBL5097726,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL5181237,=,nM,3.76,CHEMBL203,Homo sapiens,IC50,nM,3.76
10125,24663676,CHEMBL5097726,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL5207949,=,nM,3.63,CHEMBL203,Homo sapiens,IC50,nM,3.63
10126,24663680,CHEMBL5097728,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5203640,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
10127,24663681,CHEMBL5097728,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4209019,=,nM,7.2,CHEMBL203,Homo sapiens,IC50,nM,7.2
10128,24663686,CHEMBL5097732,Inhibition of EGFR (unknown origin) incubated for 30 min in presence of ATP by fluorescence based assay,B,CHEMBL5187375,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
10129,24663688,CHEMBL5097734,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",B,CHEMBL5198368,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
10130,24663689,CHEMBL5097734,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",B,CHEMBL5196209,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
10131,24663690,CHEMBL5097734,"Inhibition of recombinant EGFR (unknown origin) using Poly-(Glu,Tyr 4:1) peptide as a substrate in presence of ATP by luminescence based assay",B,CHEMBL553,<,nM,150.0,CHEMBL203,Homo sapiens,IC50,uM,0.15
10132,24663691,CHEMBL5097735,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4209019,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10133,24663702,CHEMBL5097745,"Inhibition of recombinant C-terminal His-tagged/N-terminal GST-tagged human EGFR expressed in sf9 insect cells using poly(Glu, Tyr) sodium salt (4:1, Glu:Tyr) as a substrate measured after 40 mins by Kinase-Glo reagent based luminescence analysis",B,CHEMBL5206805,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
10134,24663715,CHEMBL5097758,Inhibition of recombinant EGFR (unknown origin) using TMB as substrate incubated for 3 hrs in presence of ATP by ELISA,B,CHEMBL4780534,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.027999999999999997
10135,24663790,CHEMBL5097788,Inhibition of EGFR (unknown origin),B,CHEMBL388978,=,nM,283.0,CHEMBL203,Homo sapiens,IC50,nM,283.0
10136,24663824,CHEMBL5097800,"Inhibition of EGFR (unknown origin) using Poly(Gly,Tyr) as substrate incubated for 45 mins in the presence of ATP by ADP-Glo reagent based luminescence assay",B,CHEMBL5181237,=,nM,3760.0,CHEMBL203,Homo sapiens,IC50,uM,3.76
10137,24663825,CHEMBL5097800,"Inhibition of EGFR (unknown origin) using Poly(Gly,Tyr) as substrate incubated for 45 mins in the presence of ATP by ADP-Glo reagent based luminescence assay",B,CHEMBL388978,=,nM,430.57,CHEMBL203,Homo sapiens,IC50,nM,430.57
10138,24663912,CHEMBL5097849,Inhibition of recombinant EGFR (unknown origin) expressed in baculovirus incubated for 10 mins by europium-labeled antiphosphotyrosine/enhancement solution based assay,B,CHEMBL5195593,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
10139,24670251,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5198920,=,nM,7.696,CHEMBL203,Homo sapiens,IC50,nM,7.696000000000001
10140,24670252,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5205097,=,nM,12.32,CHEMBL203,Homo sapiens,IC50,nM,12.32
10141,24670253,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5192155,=,nM,13.42,CHEMBL203,Homo sapiens,IC50,nM,13.42
10142,24670254,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5208416,=,nM,5.681,CHEMBL203,Homo sapiens,IC50,nM,5.681
10143,24670255,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5189711,=,nM,31.35,CHEMBL203,Homo sapiens,IC50,nM,31.35
10144,24670256,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5208549,=,nM,203.8,CHEMBL203,Homo sapiens,IC50,nM,203.8
10145,24670257,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5199399,=,nM,14.2,CHEMBL203,Homo sapiens,IC50,nM,14.2
10146,24670258,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5191556,=,nM,10.32,CHEMBL203,Homo sapiens,IC50,nM,10.32
10147,24670259,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5179952,=,nM,4.902,CHEMBL203,Homo sapiens,IC50,nM,4.902
10148,24670260,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5174995,=,nM,20.23,CHEMBL203,Homo sapiens,IC50,nM,20.23
10149,24670261,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5171318,=,nM,135.0,CHEMBL203,Homo sapiens,IC50,nM,135.0
10150,24670262,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5184048,=,nM,126.0,CHEMBL203,Homo sapiens,IC50,nM,126.0
10151,24670263,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5181848,=,nM,9.664,CHEMBL203,Homo sapiens,IC50,nM,9.664
10152,24670264,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5172236,=,nM,6.532,CHEMBL203,Homo sapiens,IC50,nM,6.532
10153,24670265,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5203195,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
10154,24670266,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5183664,=,nM,20.1,CHEMBL203,Homo sapiens,IC50,nM,20.1
10155,24670267,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5199354,=,nM,42.06,CHEMBL203,Homo sapiens,IC50,nM,42.06
10156,24670268,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5184813,=,nM,12.3,CHEMBL203,Homo sapiens,IC50,nM,12.3
10157,24670269,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL5203176,=,nM,356.26,CHEMBL203,Homo sapiens,IC50,nM,356.26
10158,24670270,CHEMBL5099547,"Inhibition of N-terminal GST-tagged human recombinant EGFR T790M/L858R mutant (695 to end residues) expressed in baculovirus-infected Sf9 cells using poly (4:1 Glu,Tyr) peptide as substrate incubated for 60 mins in presence of ATP by ADP-Glo kinase assay",B,CHEMBL3353410,=,nM,19.04,CHEMBL203,Homo sapiens,IC50,nM,19.04
10159,24687381,CHEMBL5104377,Inhibition of EGFR (unknown origin),B,CHEMBL5189340,=,nM,0.45,CHEMBL203,Homo sapiens,IC50,nM,0.45
10160,24688644,CHEMBL5104912,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,B,CHEMBL4114766,=,nM,368.0,CHEMBL203,Homo sapiens,IC50,nM,368.0
10161,24688645,CHEMBL5104912,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,B,CHEMBL5189379,=,nM,980.0,CHEMBL203,Homo sapiens,IC50,nM,980.0
10162,24688646,CHEMBL5104912,Inhibition of EGFR (unknown origin) using peptide substrate in presence of ATP by caliper electrophoresis method,B,CHEMBL5184084,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,nM,3000.0
10163,24703133,CHEMBL5107925,Inhibition of EGFR L858R/T790M mutant (unknown origin) in human NCI-H1975 cells,B,CHEMBL3353410,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
10164,24703134,CHEMBL5107925,Inhibition of EGFR L858R/T790M mutant (unknown origin) in human NCI-H1975 cells,B,CHEMBL3787344,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
10165,24703135,CHEMBL5107925,Inhibition of EGFR L858R/T790M mutant (unknown origin) in human NCI-H1975 cells,B,CHEMBL2110732,=,nM,440.0,CHEMBL203,Homo sapiens,IC50,uM,0.44
10166,24713078,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5194543,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
10167,24713079,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5176561,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,uM,0.45
10168,24713080,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5204417,=,nM,153.0,CHEMBL203,Homo sapiens,IC50,uM,0.153
10169,24713081,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5170804,=,nM,246.0,CHEMBL203,Homo sapiens,IC50,uM,0.24600000000000002
10170,24713082,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5173449,=,nM,122.0,CHEMBL203,Homo sapiens,IC50,uM,0.122
10171,24713083,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL5204650,=,nM,419.0,CHEMBL203,Homo sapiens,IC50,uM,0.419
10172,24713084,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL1336,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
10173,24713085,CHEMBL5110647,Inhibition of recombinant human EGFR incubated for 40 to 45 mins and measured after 15 mins by Kinase-Glo Max assay,B,CHEMBL939,=,nM,62.0,CHEMBL203,Homo sapiens,IC50,uM,0.062
10174,24723688,CHEMBL5113705,Inhibition of EGFR (unknown origin),B,CHEMBL5178922,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3
10175,24724836,CHEMBL5114135,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL5192318,=,nM,1547.0,CHEMBL203,Homo sapiens,IC50,uM,1.547
10176,24724837,CHEMBL5114135,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL5208825,=,nM,957.0,CHEMBL203,Homo sapiens,IC50,uM,0.9570000000000001
10177,24724838,CHEMBL5114135,Inhibition of wild-type EGFR (unknown origin),B,CHEMBL5206400,=,nM,1340.0,CHEMBL203,Homo sapiens,IC50,uM,1.34
10178,24724839,CHEMBL5114136,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5192318,=,nM,87.34,CHEMBL203,Homo sapiens,IC50,nM,87.34
10179,24724840,CHEMBL5114136,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5208825,=,nM,75.42,CHEMBL203,Homo sapiens,IC50,nM,75.42
10180,24724841,CHEMBL5114136,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5206400,=,nM,82.76,CHEMBL203,Homo sapiens,IC50,nM,82.76
10181,24724842,CHEMBL5114136,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4531109,=,nM,4500.0,CHEMBL203,Homo sapiens,IC50,uM,4.5
10182,24725241,CHEMBL5114231,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL4531109,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,uM,0.37
10183,24726356,CHEMBL5114499,Inhibition of wild type EGFR (unknown origin),B,CHEMBL3545311,=,nM,74.8,CHEMBL203,Homo sapiens,IC50,nM,74.8
10184,24726357,CHEMBL5114499,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5206715,=,nM,10.4,CHEMBL203,Homo sapiens,IC50,nM,10.4
10185,24726358,CHEMBL5114500,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3545311,=,nM,28.3,CHEMBL203,Homo sapiens,IC50,nM,28.3
10186,24726359,CHEMBL5114500,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5206715,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
10187,24726360,CHEMBL5114501,Inhibition of EGFR del19 mutant (unknown origin),B,CHEMBL3545311,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5
10188,24726361,CHEMBL5114501,Inhibition of EGFR del19 mutant (unknown origin),B,CHEMBL5206715,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10189,24726362,CHEMBL5114502,Inhibition of EGFR del19/T790M mutant (unknown origin),B,CHEMBL3545311,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10190,24726363,CHEMBL5114502,Inhibition of EGFR del19/T790M mutant (unknown origin),B,CHEMBL5206715,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10191,24726365,CHEMBL5114503,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5206715,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10192,24726366,CHEMBL5114504,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL3545311,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
10193,24726367,CHEMBL5114504,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5206715,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10194,24726368,CHEMBL5114505,Inhibition of EGFR del19/T790M/C797S mutant (unknown origin),B,CHEMBL3545311,=,nM,3.9,CHEMBL203,Homo sapiens,IC50,nM,3.9
10195,24726369,CHEMBL5114505,Inhibition of EGFR del19/T790M/C797S mutant (unknown origin),B,CHEMBL5206715,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10196,24731156,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5196498,=,nM,3230.0,CHEMBL203,Homo sapiens,IC50,nM,3230.0
10197,24731157,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5201794,=,nM,647.9,CHEMBL203,Homo sapiens,IC50,nM,647.9
10198,24731158,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5206775,=,nM,364.2,CHEMBL203,Homo sapiens,IC50,nM,364.2
10199,24731159,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5175891,=,nM,838.6,CHEMBL203,Homo sapiens,IC50,nM,838.6
10200,24731160,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5200495,=,nM,614.4,CHEMBL203,Homo sapiens,IC50,nM,614.4
10201,24731161,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL3545308,=,nM,76.61,CHEMBL203,Homo sapiens,IC50,nM,76.61
10202,24731162,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5204954,=,nM,1404.0,CHEMBL203,Homo sapiens,IC50,nM,1404.0
10203,24731163,CHEMBL5115839,Inhibition of wild type EGFR (unknown origin) incubated for 10 mins by HTRF KinEASE-TK assay,B,CHEMBL5179538,=,nM,2397.0,CHEMBL203,Homo sapiens,IC50,nM,2397.0
10204,24731164,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5196498,=,nM,33.03,CHEMBL203,Homo sapiens,IC50,nM,33.03
10205,24731165,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5201794,=,nM,20.33,CHEMBL203,Homo sapiens,IC50,nM,20.33
10206,24731166,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5206775,=,nM,24.12,CHEMBL203,Homo sapiens,IC50,nM,24.12
10207,24731167,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5175891,=,nM,43.12,CHEMBL203,Homo sapiens,IC50,nM,43.12
10208,24731168,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5200495,=,nM,121.3,CHEMBL203,Homo sapiens,IC50,nM,121.3
10209,24731169,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL3545308,=,nM,4.19,CHEMBL203,Homo sapiens,IC50,nM,4.19
10210,24731170,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5204954,=,nM,133.7,CHEMBL203,Homo sapiens,IC50,nM,133.7
10211,24731171,CHEMBL5115840,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 35 mins by HTRF KinEASE-TK assay,B,CHEMBL5179538,=,nM,965.3,CHEMBL203,Homo sapiens,IC50,nM,965.3
10212,24741548,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL3545311,=,nM,0.82,CHEMBL203,Homo sapiens,IC50,nM,0.82
10213,24741549,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5209094,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10214,24741550,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5195137,=,nM,0.18,CHEMBL203,Homo sapiens,IC50,nM,0.18
10215,24741551,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5199678,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10216,24741552,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203041,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10217,24741553,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203220,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10218,24741554,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5180388,=,nM,0.11,CHEMBL203,Homo sapiens,IC50,nM,0.11
10219,24741555,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5180894,=,nM,0.83,CHEMBL203,Homo sapiens,IC50,nM,0.83
10220,24741556,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5186680,=,nM,0.06,CHEMBL203,Homo sapiens,IC50,nM,0.06
10221,24741557,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5179357,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
10222,24741558,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5188373,=,nM,0.31,CHEMBL203,Homo sapiens,IC50,nM,0.31
10223,24741559,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5206164,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10224,24741560,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5195904,=,nM,0.43,CHEMBL203,Homo sapiens,IC50,nM,0.43
10225,24741561,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5193123,=,nM,0.05,CHEMBL203,Homo sapiens,IC50,nM,0.05
10226,24741562,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5192223,=,nM,0.13,CHEMBL203,Homo sapiens,IC50,nM,0.13
10227,24741563,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5204749,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
10228,24741564,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5193149,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
10229,24741565,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5188940,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
10230,24741566,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203385,=,nM,0.49,CHEMBL203,Homo sapiens,IC50,nM,0.49
10231,24741567,CHEMBL5117929,Inhibition of EGFR del18/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5197545,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
10232,24741568,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL3545311,=,nM,3.38,CHEMBL203,Homo sapiens,IC50,nM,3.38
10233,24741569,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5209094,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
10234,24741570,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5195137,=,nM,0.93,CHEMBL203,Homo sapiens,IC50,nM,0.93
10235,24741571,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5199678,=,nM,0.84,CHEMBL203,Homo sapiens,IC50,nM,0.84
10236,24741572,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203041,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
10237,24741573,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203220,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
10238,24741574,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5180388,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
10239,24741575,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5180894,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
10240,24741576,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5186680,=,nM,0.09,CHEMBL203,Homo sapiens,IC50,nM,0.09
10241,24741577,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5179357,=,nM,0.43,CHEMBL203,Homo sapiens,IC50,nM,0.43
10242,24741578,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5188373,=,nM,0.09,CHEMBL203,Homo sapiens,IC50,nM,0.09
10243,24741579,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5206164,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
10244,24741580,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5178971,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
10245,24741581,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5195904,=,nM,0.07,CHEMBL203,Homo sapiens,IC50,nM,0.07
10246,24741582,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5193123,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10247,24741583,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5192223,=,nM,0.19,CHEMBL203,Homo sapiens,IC50,nM,0.19
10248,24741584,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5204749,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
10249,24741585,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5193149,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
10250,24741586,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5188940,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
10251,24741587,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203385,=,nM,0.41,CHEMBL203,Homo sapiens,IC50,nM,0.41
10252,24741588,CHEMBL5117930,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5197545,=,nM,0.12,CHEMBL203,Homo sapiens,IC50,nM,0.12
10253,24741589,CHEMBL5117931,Inhibition of wild type EGFR (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL3545311,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
10254,24741594,CHEMBL5117931,Inhibition of wild type EGFR (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5180894,=,nM,3003.0,CHEMBL203,Homo sapiens,IC50,nM,3003.0
10255,24741595,CHEMBL5117931,Inhibition of wild type EGFR (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5179357,=,nM,652.0,CHEMBL203,Homo sapiens,IC50,nM,652.0
10256,24741597,CHEMBL5117931,Inhibition of wild type EGFR (unknown origin) using TK as substrate incubated for 120 mins in the presence of ATP by HTRF assay,B,CHEMBL5203385,=,nM,416.0,CHEMBL203,Homo sapiens,IC50,nM,416.0
10257,24749156,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL4214567,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10258,24749157,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5208369,=,nM,938.0,CHEMBL203,Homo sapiens,IC50,nM,938.0
10259,24749159,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5195669,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
10260,24749160,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5203388,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
10261,24749161,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5173979,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10262,24749162,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5173986,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10263,24749163,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5171139,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
10264,24749164,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5189114,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10265,24749165,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5170278,=,nM,116.0,CHEMBL203,Homo sapiens,IC50,nM,116.0
10266,24749166,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5198433,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
10267,24749167,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5172668,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10268,24749168,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5187250,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10269,24749169,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5207479,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10270,24749170,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5180839,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10271,24749171,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5189574,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10272,24749172,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5184539,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10273,24749173,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5183324,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10274,24749174,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5180289,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10275,24749175,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5203543,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10276,24749176,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5202945,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10277,24749177,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5207152,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10278,24749178,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5201725,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
10279,24749179,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5208056,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10280,24749180,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5193594,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10281,24749181,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5170519,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10282,24749182,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5193772,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10283,24749183,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5184760,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10284,24749184,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5177023,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10285,24749185,CHEMBL5120428,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL4443062,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10286,24749186,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL4214567,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
10287,24749189,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5195669,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,nM,3200.0
10288,24749190,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5203388,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0
10289,24749191,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5173979,=,nM,183.0,CHEMBL203,Homo sapiens,IC50,nM,183.0
10290,24749192,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5173986,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,nM,850.0
10291,24749194,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5189114,=,nM,129.0,CHEMBL203,Homo sapiens,IC50,nM,129.0
10292,24749195,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5170278,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,nM,1100.0
10293,24749196,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5198433,=,nM,342.0,CHEMBL203,Homo sapiens,IC50,nM,342.0
10294,24749197,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5172668,=,nM,54.0,CHEMBL203,Homo sapiens,IC50,nM,54.0
10295,24749198,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5187250,=,nM,297.0,CHEMBL203,Homo sapiens,IC50,nM,297.0
10296,24749199,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5207479,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10297,24749200,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5180839,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
10298,24749201,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5189574,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
10299,24749202,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5184539,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
10300,24749203,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5183324,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
10301,24749204,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5180289,=,nM,91.0,CHEMBL203,Homo sapiens,IC50,nM,91.0
10302,24749205,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5203543,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
10303,24749206,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5202945,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
10304,24749207,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5207152,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
10305,24749208,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5201725,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10306,24749209,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5208056,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10307,24749210,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5193594,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
10308,24749211,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5170519,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10309,24749212,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5193772,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
10310,24749213,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5184760,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
10311,24749214,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL5177023,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10312,24749215,CHEMBL5120429,Inhibition of EGFR L858R/C797S mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells measured after 4 hrs by HTRF assay,B,CHEMBL4443062,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
10313,24749345,CHEMBL5120449,Inhibition of wild type EGFR expressed in human NCI-H2073 cells,B,CHEMBL5177023,=,nM,545.0,CHEMBL203,Homo sapiens,IC50,nM,545.0
10314,24749346,CHEMBL5120449,Inhibition of wild type EGFR expressed in human NCI-H2073 cells,B,CHEMBL4443062,=,nM,3910.0,CHEMBL203,Homo sapiens,IC50,nM,3910.0
10315,24749347,CHEMBL5120449,Inhibition of wild type EGFR expressed in human NCI-H2073 cells,B,CHEMBL553,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10316,24749348,CHEMBL5120449,Inhibition of wild type EGFR expressed in human NCI-H2073 cells,B,CHEMBL3353410,=,nM,240.0,CHEMBL203,Homo sapiens,IC50,nM,240.0
10317,24749349,CHEMBL5120450,Inhibition of wild type EGFR expressed in human A-431 cells,B,CHEMBL5177023,=,nM,577.0,CHEMBL203,Homo sapiens,IC50,nM,577.0
10318,24749350,CHEMBL5120450,Inhibition of wild type EGFR expressed in human A-431 cells,B,CHEMBL4443062,=,nM,4213.0,CHEMBL203,Homo sapiens,IC50,nM,4213.0
10319,24749351,CHEMBL5120450,Inhibition of wild type EGFR expressed in human A-431 cells,B,CHEMBL553,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
10320,24749352,CHEMBL5120450,Inhibition of wild type EGFR expressed in human A-431 cells,B,CHEMBL3353410,=,nM,322.0,CHEMBL203,Homo sapiens,IC50,nM,322.0
10321,24749353,CHEMBL5120451,Inhibition of EGFR L858R mutant expressed in human NCI-H3255 cells,B,CHEMBL5177023,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
10322,24749354,CHEMBL5120451,Inhibition of EGFR L858R mutant expressed in human NCI-H3255 cells,B,CHEMBL4443062,=,nM,428.0,CHEMBL203,Homo sapiens,IC50,nM,428.0
10323,24749355,CHEMBL5120451,Inhibition of EGFR L858R mutant expressed in human NCI-H3255 cells,B,CHEMBL553,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
10324,24749356,CHEMBL5120451,Inhibition of EGFR L858R mutant expressed in human NCI-H3255 cells,B,CHEMBL3353410,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
10325,24749357,CHEMBL5120452,Inhibition of EGFR L858R/T790M mutant expressed in human NCI-H1975 cells,B,CHEMBL5177023,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
10326,24749358,CHEMBL5120452,Inhibition of EGFR L858R/T790M mutant expressed in human NCI-H1975 cells,B,CHEMBL4443062,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10327,24749360,CHEMBL5120452,Inhibition of EGFR L858R/T790M mutant expressed in human NCI-H1975 cells,B,CHEMBL3353410,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
10328,24752269,CHEMBL5121366,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL2029438,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10329,24752270,CHEMBL5121366,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5188568,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
10330,24756990,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5174109,=,nM,304.0,CHEMBL203,Homo sapiens,IC50,uM,0.304
10331,24756991,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5188948,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
10332,24756992,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5179023,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
10333,24756993,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5181487,=,nM,55.0,CHEMBL203,Homo sapiens,IC50,uM,0.055
10334,24756994,CHEMBL5122790,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL3353410,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
10335,24769892,CHEMBL5125953,Inhibition of EGFR L858R mutant (unknown origin) using peptide substrate by FRET assay,B,CHEMBL5192185,=,nM,5670.0,CHEMBL203,Homo sapiens,IC50,uM,5.67
10336,24772920,CHEMBL5127052,Inhibition of wild type EGFR (unknown origin) incubated for 40 mins by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5191956,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
10337,24772921,CHEMBL5127053,Inhibition of N-terminal GST-tagged recombinant human EGFR (669 to 1210 residues) L858R/T790M double mutant expressed in baculovirus infected Sf21 cells incubated for 1 hr in presence of ATP by caliper mobility shift assay,B,CHEMBL5173070,=,nM,43.1,CHEMBL203,Homo sapiens,IC50,nM,43.1
10338,24772922,CHEMBL5127054,Inhibition of N-terminal GST-tagged recombinant wild type human EGFR (669 to 1210 residues) expressed in baculovirus infected Sf21 cells incubated for 1 hr in presence of ATP by caliper mobility shift assay,B,CHEMBL5173070,=,nM,1138.7,CHEMBL203,Homo sapiens,IC50,nM,1138.7
10339,24772926,CHEMBL5127058,"Inhibition of EGFR (unknown origin) using poly(Glu, Tyr) 4:1 as substrate incubated for 45 mins in presence of ATP by ADP-Glo Kinase assay",B,CHEMBL5181237,=,nM,3.76,CHEMBL203,Homo sapiens,IC50,nM,3.76
10340,24772928,CHEMBL5127060,Inhibition of human EGFR expressed in baculovirus expression system using CAGAGAIETDKEYYTVKD as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 1 hr by TR-FRET assay,B,CHEMBL5182231,=,nM,35.5,CHEMBL203,Homo sapiens,IC50,nM,35.5
10341,24772929,CHEMBL5127061,Inhibition of human EGFR T790M mutant expressed in baculovirus expression system using CAGAGAIETDKEYYTVKD as substrate preincubated for 10 mins followed by substrate and ATP addition measured after 1 hr by TR-FRET assay,B,CHEMBL5182231,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,nM,66.0
10342,24772931,CHEMBL5127063,Inhibition of GST-tagged EGFR (unknown origin) assessed as phosphorylation level using biotinylated peptide as substrate in presence of ATP by HTScan EGFR kinase assay,B,CHEMBL5186583,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
10343,24772935,CHEMBL5127067,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5191956,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
10344,24772944,CHEMBL5127076,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,B,CHEMBL5202119,=,nM,97.0,CHEMBL203,Homo sapiens,IC50,uM,0.09699999999999999
10345,24772945,CHEMBL5127076,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,B,CHEMBL5193175,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,uM,0.094
10346,24772946,CHEMBL5127076,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr by Z-lyte kinase assay,B,CHEMBL5203758,=,nM,195.0,CHEMBL203,Homo sapiens,IC50,uM,0.195
10347,24772950,CHEMBL5127078,Inhibition of EGFR (unknown origin),B,CHEMBL5193247,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10348,24772951,CHEMBL5127078,Inhibition of EGFR (unknown origin),B,CHEMBL5188857,=,nM,597.0,CHEMBL203,Homo sapiens,IC50,uM,0.597
10349,24772957,CHEMBL5127082,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5207327,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
10350,24772958,CHEMBL5127082,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5192572,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
10351,24772967,CHEMBL5127087,Inhibition of EGFR (unknown origin) incubated for 30 mins in presence of ATP by fluorescence based analysis,B,CHEMBL4792279,=,nM,186.0,CHEMBL203,Homo sapiens,IC50,uM,0.18600000000000003
10352,24772972,CHEMBL5127091,Inhibition of EGFR (unknown origin) by ADP-Glo kinase assay,B,CHEMBL5169900,=,nM,11120.0,CHEMBL203,Homo sapiens,IC50,uM,11.12
10353,24772974,CHEMBL5127093,Inhibition of EGFR T790M mutant (unknown origin),B,CHEMBL5193247,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10354,24772975,CHEMBL5127094,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5193247,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10355,24773292,CHEMBL5127259,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
10356,24773294,CHEMBL5127259,Inhibition of EGFR (unknown origin),B,CHEMBL5193128,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
10357,24776464,CHEMBL5128251,Inhibition of EGFR (unknown origin) using poly (glu-tyr) as substrate incubated for 1 hr in presence of ATP measured by ADP-Glo kinase assay,B,CHEMBL5201532,=,nM,7.85,CHEMBL203,Homo sapiens,IC50,nM,7.85
10358,24776465,CHEMBL5128251,Inhibition of EGFR (unknown origin) using poly (glu-tyr) as substrate incubated for 1 hr in presence of ATP measured by ADP-Glo kinase assay,B,CHEMBL553,=,nM,26.09,CHEMBL203,Homo sapiens,IC50,nM,26.09
10359,24779298,CHEMBL5129114,Inhibition of EGFR (unknown origin) assessed as kinase activity by measuring ATP remaining for 40 mins in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5185952,=,nM,55000.0,CHEMBL203,Homo sapiens,IC50,uM,55.0
10360,24779299,CHEMBL5129114,Inhibition of EGFR (unknown origin) assessed as kinase activity by measuring ATP remaining for 40 mins in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5173408,=,nM,55000.0,CHEMBL203,Homo sapiens,IC50,uM,55.0
10361,24788484,CHEMBL5131630,Inhibition of ErbB-1 (unknown origin),B,CHEMBL31965,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10362,24788905,CHEMBL5131857,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10363,24788906,CHEMBL5131857,Inhibition of EGFR (unknown origin),B,CHEMBL258940,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10364,24788907,CHEMBL5131857,Inhibition of EGFR (unknown origin),B,CHEMBL31965,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
10365,24788908,CHEMBL5131857,Inhibition of EGFR (unknown origin),B,CHEMBL1358485,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10366,24788909,CHEMBL5131857,Inhibition of EGFR (unknown origin),B,CHEMBL2093753,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
10367,24789069,CHEMBL5131965,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10368,24789070,CHEMBL5131965,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10369,24789071,CHEMBL5131965,Inhibition of EGFR (unknown origin),B,CHEMBL44,=,nM,600.0,CHEMBL203,Homo sapiens,IC50,uM,0.6
10370,24789072,CHEMBL5131965,Inhibition of EGFR (unknown origin),B,CHEMBL7917,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10371,24795676,CHEMBL5133513,Inhibition of EGFR tyrosine kinase (unknown origin) preincubated for 5 mins followed by substrate addition and further incubated for 10 mins in presence of ATP by fluorescence based microplate reader analysis,B,CHEMBL185686,=,nM,900.0,CHEMBL203,Homo sapiens,IC50,uM,0.9
10372,24795712,CHEMBL5133518,Inhibition of EGFR tyrosine kinase (unknown origin),B,CHEMBL5192793,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
10373,24795713,CHEMBL5133518,Inhibition of EGFR tyrosine kinase (unknown origin),B,CHEMBL5185036,=,nM,30.18,CHEMBL203,Homo sapiens,IC50,nM,30.18
10374,24795714,CHEMBL5133518,Inhibition of EGFR tyrosine kinase (unknown origin),B,CHEMBL5181037,=,nM,6.54,CHEMBL203,Homo sapiens,IC50,nM,6.54
10375,24795715,CHEMBL5133518,Inhibition of EGFR tyrosine kinase (unknown origin),B,CHEMBL553,=,nM,3.52,CHEMBL203,Homo sapiens,IC50,nM,3.52
10376,24796314,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5192184,=,nM,342.0,CHEMBL203,Homo sapiens,IC50,uM,0.342
10377,24796315,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5203784,=,nM,305.0,CHEMBL203,Homo sapiens,IC50,uM,0.305
10378,24796316,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5171983,=,nM,209.0,CHEMBL203,Homo sapiens,IC50,uM,0.209
10379,24796317,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5201110,=,nM,109.0,CHEMBL203,Homo sapiens,IC50,uM,0.109
10380,24796318,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5181045,=,nM,157.0,CHEMBL203,Homo sapiens,IC50,uM,0.157
10381,24796319,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL5208397,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,uM,0.114
10382,24796320,CHEMBL5133605,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,180.0,CHEMBL203,Homo sapiens,IC50,uM,0.18
10383,24805881,CHEMBL5135820,Inhibition of EGFR phosphorylation (645 to 1186 residues) (unknown origin) expressed in baculovirus infected Sf9 insect cells incubated for 15 mins in presence of ATP measured after 1 hr by DELPHIA,B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
10384,24805885,CHEMBL5135824,Inhibition of wild-type EGFR phosphorylation (unknown origin),B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10385,24805886,CHEMBL5135825,Inhibition of EGFR L858R/T790M mutant phosphorylation (unknown origin),B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10386,24805887,CHEMBL5135825,Inhibition of EGFR L858R/T790M mutant phosphorylation (unknown origin),B,CHEMBL3353410,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
10387,24805888,CHEMBL5135826,Inhibition of EGFR phosphorylation (unknown origin),B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10388,24805889,CHEMBL5135826,Inhibition of EGFR phosphorylation (unknown origin),B,CHEMBL3353410,=,nM,184.0,CHEMBL203,Homo sapiens,IC50,nM,184.0
10389,24805905,CHEMBL5135834,Inhibition of EGFR (unknown origin),B,CHEMBL1873475,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
10390,24805906,CHEMBL5135834,Inhibition of EGFR (unknown origin),B,CHEMBL3936761,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
10391,24814234,CHEMBL5138009,Inhibition of EGFR derived from human A-431 cells using copolymer of Glu/Ala/Tyr as substrate by scintillation counting method,B,CHEMBL60472,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
10392,24814242,CHEMBL5138014,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,B,CHEMBL153206,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
10393,24814243,CHEMBL5138014,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,B,CHEMBL5198809,=,nM,72.0,CHEMBL203,Homo sapiens,IC50,nM,72.0
10394,24814244,CHEMBL5138014,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,B,CHEMBL423224,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
10395,24814247,CHEMBL5138014,Inhibition of EGFR in human A-431 cell membrane vesicles using phospholipase C-gamma-1 as substrate incubated for 10 mins by scintillation counter method,B,CHEMBL5173075,=,nM,460.0,CHEMBL203,Homo sapiens,IC50,nM,460.0
10396,24814248,CHEMBL5138015,Displacement of 32P-labeled ATP from EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate incubated for 10 mins by scintillation counting method,B,CHEMBL309276,=,nM,1620.0,CHEMBL203,Homo sapiens,IC50,uM,1.62
10397,24814249,CHEMBL5138015,Displacement of 32P-labeled ATP from EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate incubated for 10 mins by scintillation counting method,B,CHEMBL81664,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
10398,24814250,CHEMBL5138016,Inhibition of EGFR derived from human A-431 cell membrane vesicles using copolymer of Glu/Ala/Tyr as substrate by scintillation counting method,B,CHEMBL156797,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
10399,24815683,CHEMBL5138501,Inhibition of human wildtype N-terminal DYKDDDD-tagged EGFR expressed in baculovirus expression system preincubated for 5 mins followed by ATP addition measured after 10 mins by microplate reader method,B,CHEMBL4290869,=,nM,9.8,CHEMBL203,Homo sapiens,IC50,nM,9.8
10400,24815684,CHEMBL5138502,Inhibition of human N-terminal DYKDDDD-tagged EGFR T790M/L858R double mutant expressed in baculovirus expression system preincubated for 5 mins followed by ATP addition measured after 10 mins by microplate reader method,B,CHEMBL4290869,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10401,24815694,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4294264,=,nM,1935.0,CHEMBL203,Homo sapiens,IC50,uM,1.935
10402,24815695,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4065300,=,nM,60.1,CHEMBL203,Homo sapiens,IC50,nM,60.1
10403,24815696,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4073912,=,nM,137.0,CHEMBL203,Homo sapiens,IC50,nM,137.0
10404,24815697,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL5194719,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
10405,24815698,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL5203711,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
10406,24815699,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4286374,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
10407,24815700,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL5201054,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3
10408,24815701,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
10409,24815702,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL587723,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10410,24815703,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL1645462,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10411,24815704,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL31965,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
10412,24815705,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4117373,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
10413,24815706,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4116552,=,nM,2.3,CHEMBL203,Homo sapiens,IC50,nM,2.3
10414,24815707,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4099329,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10415,24815708,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4569885,=,nM,30000.0,CHEMBL203,Homo sapiens,IC50,uM,30.0
10416,24815709,CHEMBL5138507,Inhibition of EGFR (unknown origin),B,CHEMBL4088718,=,nM,17.2,CHEMBL203,Homo sapiens,IC50,nM,17.2
10417,24815714,CHEMBL5138512,Inhibition of EGFR (unknown origin) using biotin as substrate incubated for 2 hrs by HTRF assay,B,CHEMBL4077930,=,nM,83900.0,CHEMBL203,Homo sapiens,IC50,uM,83.9
10418,24815724,CHEMBL5138520,Inhibition of wildtype EGFR (unknown origin) incubated for 40 mins by luminescence based assay,B,CHEMBL4746995,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
10419,24815725,CHEMBL5138520,Inhibition of wildtype EGFR (unknown origin) incubated for 40 mins by luminescence based assay,B,CHEMBL5191956,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
10420,24815726,CHEMBL5138521,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins by luminescence based assay,B,CHEMBL4746995,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
10421,24815727,CHEMBL5138521,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins by luminescence based assay,B,CHEMBL5191956,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
10422,24815734,CHEMBL5138527,Inhibition of EGFR (unknown origin) by microplate reader,B,CHEMBL5190121,=,nM,86.7,CHEMBL203,Homo sapiens,IC50,nM,86.7
10423,24815735,CHEMBL5138527,Inhibition of EGFR (unknown origin) by microplate reader,B,CHEMBL5206193,=,nM,85.4,CHEMBL203,Homo sapiens,IC50,nM,85.4
10424,24815736,CHEMBL5138527,Inhibition of EGFR (unknown origin) by microplate reader,B,CHEMBL1782692,=,nM,31.2,CHEMBL203,Homo sapiens,IC50,nM,31.2
10425,24815752,CHEMBL5138535,Inhibition of EGFR T790M/L858R double mutant (unknown origin),B,CHEMBL3353410,=,nM,11.44,CHEMBL203,Homo sapiens,IC50,nM,11.44
10426,24815753,CHEMBL5138536,Inhibition of wildtype EGFR (unknown origin),B,CHEMBL3353410,=,nM,493.8,CHEMBL203,Homo sapiens,IC50,nM,493.8
10427,24823375,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5188618,=,nM,224.0,CHEMBL203,Homo sapiens,IC50,nM,224.0
10428,24823376,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5201846,=,nM,29.0,CHEMBL203,Homo sapiens,IC50,nM,29.0
10429,24823377,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5199169,=,nM,146.0,CHEMBL203,Homo sapiens,IC50,nM,146.0
10430,24823379,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5189183,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
10431,24823381,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5173534,=,nM,743.0,CHEMBL203,Homo sapiens,IC50,nM,743.0
10432,24823382,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL5206298,=,nM,590.0,CHEMBL203,Homo sapiens,IC50,nM,590.0
10433,24823383,CHEMBL5140664,Inhibition of wild type EGFR (unknown origin) by mobility shift assay,B,CHEMBL3353410,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10434,24823384,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5174232,=,nM,391.0,CHEMBL203,Homo sapiens,IC50,nM,391.0
10435,24823387,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5191292,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
10436,24823388,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5203821,=,nM,360.0,CHEMBL203,Homo sapiens,IC50,nM,360.0
10437,24823389,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5175316,=,nM,87.0,CHEMBL203,Homo sapiens,IC50,nM,87.0
10438,24823390,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5188618,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10439,24823391,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5201846,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10440,24823392,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5199169,=,nM,30.0,CHEMBL203,Homo sapiens,IC50,nM,30.0
10441,24823393,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5196254,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,nM,110.0
10442,24823395,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5185772,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,nM,420.0
10443,24823396,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5173534,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
10444,24823397,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL5206298,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
10445,24823398,CHEMBL5140665,Inhibition of EGFR L858R/T790M mutant (unknown origin) by mobility shift assay,B,CHEMBL3353410,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10446,24823400,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL5209075,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,nM,420.0
10447,24823406,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL5201846,=,nM,242.0,CHEMBL203,Homo sapiens,IC50,nM,242.0
10448,24823411,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL5173534,=,nM,137.0,CHEMBL203,Homo sapiens,IC50,nM,137.0
10449,24823412,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL5206298,=,nM,161.0,CHEMBL203,Homo sapiens,IC50,nM,161.0
10450,24823413,CHEMBL5140666,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by mobility shift assay,B,CHEMBL3353410,=,nM,410.0,CHEMBL203,Homo sapiens,IC50,nM,410.0
10451,24824725,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5209276,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,nM,290.0
10452,24824726,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5177090,=,nM,99.0,CHEMBL203,Homo sapiens,IC50,nM,99.0
10453,24824727,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5188960,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,nM,50.0
10454,24824728,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5185287,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
10455,24824729,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5208679,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
10456,24824730,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5195164,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10457,24824731,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5174629,=,nM,106.0,CHEMBL203,Homo sapiens,IC50,nM,106.0
10458,24824732,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5184941,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
10459,24824733,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5182741,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
10460,24824734,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5203267,=,nM,3.6,CHEMBL203,Homo sapiens,IC50,nM,3.6
10461,24824735,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5207390,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10462,24824736,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5172587,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
10463,24824737,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5185207,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10464,24824738,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5205583,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
10465,24824739,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5198992,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10466,24824740,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5187021,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
10467,24824741,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5170376,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10468,24824742,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5173517,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10469,24824743,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5200991,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10470,24824744,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5206444,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10471,24824745,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5196495,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10472,24824748,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5194722,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10473,24824749,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5208737,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10474,24824750,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10475,24824751,CHEMBL5141214,Inhibition of N-terminal GST tagged recombinant human EGFR L858R/T790M (669 to end residues) double mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5193016,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10476,24824779,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5185287,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10477,24824780,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5208679,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10478,24824781,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5189778,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10479,24824782,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5195164,=,nM,7289.0,CHEMBL203,Homo sapiens,IC50,nM,7289.0
10480,24824783,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5174629,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10481,24824784,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5184941,=,nM,8171.0,CHEMBL203,Homo sapiens,IC50,nM,8171.0
10482,24824785,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5182741,=,nM,3420.0,CHEMBL203,Homo sapiens,IC50,nM,3420.0
10483,24824786,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5203267,=,nM,5521.0,CHEMBL203,Homo sapiens,IC50,nM,5521.0
10484,24824787,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5207390,=,nM,4503.0,CHEMBL203,Homo sapiens,IC50,nM,4503.0
10485,24824788,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5172587,=,nM,4194.0,CHEMBL203,Homo sapiens,IC50,nM,4194.0
10486,24824789,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5185207,=,nM,2222.0,CHEMBL203,Homo sapiens,IC50,nM,2222.0
10487,24824790,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5205583,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10488,24824791,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5198992,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10489,24824792,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5169349,=,nM,3401.0,CHEMBL203,Homo sapiens,IC50,nM,3401.0
10490,24824793,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5187021,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10491,24824794,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5170376,=,nM,10000.0,CHEMBL203,Homo sapiens,IC50,nM,10000.0
10492,24824795,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5173517,=,nM,1050.0,CHEMBL203,Homo sapiens,IC50,nM,1050.0
10493,24824796,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5200991,=,nM,270.0,CHEMBL203,Homo sapiens,IC50,nM,270.0
10494,24824797,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5206444,=,nM,385.0,CHEMBL203,Homo sapiens,IC50,nM,385.0
10495,24824798,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5196495,=,nM,505.0,CHEMBL203,Homo sapiens,IC50,nM,505.0
10496,24824802,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5194722,=,nM,761.0,CHEMBL203,Homo sapiens,IC50,nM,761.0
10497,24824803,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5208737,=,nM,1089.0,CHEMBL203,Homo sapiens,IC50,nM,1089.0
10498,24824804,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,683.0,CHEMBL203,Homo sapiens,IC50,nM,683.0
10499,24824805,CHEMBL5141216,Inhibition of N-terminal GST tagged recombinant wild type human EGFR expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5193016,=,nM,810.0,CHEMBL203,Homo sapiens,IC50,nM,810.0
10500,24824806,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5209276,=,nM,914.0,CHEMBL203,Homo sapiens,IC50,nM,914.0
10501,24824807,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5177090,=,nM,420.0,CHEMBL203,Homo sapiens,IC50,nM,420.0
10502,24824808,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5188960,=,nM,67.0,CHEMBL203,Homo sapiens,IC50,nM,67.0
10503,24824809,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5185287,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10504,24824810,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5208679,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10505,24824811,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5189778,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
10506,24824812,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5195164,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10507,24824813,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5174629,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,nM,210.0
10508,24824814,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5184941,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
10509,24824815,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5182741,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
10510,24824816,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5203267,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
10511,24824817,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5207390,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10512,24824818,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5172587,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
10513,24824819,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5185207,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
10514,24824820,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5205583,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
10515,24824821,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5198992,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
10516,24824822,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5169349,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10517,24824823,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5187021,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
10518,24824824,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5170376,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10519,24824825,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5173517,=,nM,4.8,CHEMBL203,Homo sapiens,IC50,nM,4.8
10520,24824826,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5200991,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
10521,24824827,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5206444,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
10522,24824828,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5196495,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
10523,24824829,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5194722,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
10524,24824830,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5208737,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
10525,24824831,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5095169,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10526,24824832,CHEMBL5141217,Inhibition of EGF stimulated EGFR L858R/T790M double mutant phosphorylation in human NCI-H1975 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5193016,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
10527,24824833,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5185287,=,nM,23605.0,CHEMBL203,Homo sapiens,IC50,nM,23605.0
10528,24824834,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5208679,=,nM,8668.0,CHEMBL203,Homo sapiens,IC50,nM,8668.0
10529,24824836,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5195164,=,nM,9965.0,CHEMBL203,Homo sapiens,IC50,nM,9965.0
10530,24824837,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5174629,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10531,24824838,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5184941,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10532,24824839,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5182741,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10533,24824840,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5203267,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10534,24824841,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5207390,=,nM,5290.0,CHEMBL203,Homo sapiens,IC50,nM,5290.0
10535,24824842,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5172587,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10536,24824843,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5185207,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10537,24824844,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5205583,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10538,24824845,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5198992,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10539,24824847,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5187021,=,nM,25000.0,CHEMBL203,Homo sapiens,IC50,nM,25000.0
10540,24824848,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5170376,=,nM,4126.0,CHEMBL203,Homo sapiens,IC50,nM,4126.0
10541,24824849,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5173517,=,nM,1608.0,CHEMBL203,Homo sapiens,IC50,nM,1608.0
10542,24824850,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5200991,=,nM,781.0,CHEMBL203,Homo sapiens,IC50,nM,781.0
10543,24824851,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5206444,=,nM,1362.0,CHEMBL203,Homo sapiens,IC50,nM,1362.0
10544,24824852,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5196495,=,nM,1780.0,CHEMBL203,Homo sapiens,IC50,nM,1780.0
10545,24824856,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5194722,=,nM,709.0,CHEMBL203,Homo sapiens,IC50,nM,709.0
10546,24824857,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5208737,=,nM,1206.0,CHEMBL203,Homo sapiens,IC50,nM,1206.0
10547,24824858,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5095169,=,nM,544.0,CHEMBL203,Homo sapiens,IC50,nM,544.0
10548,24824859,CHEMBL5141218,Inhibition of wild type EGFR in human A-431 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5193016,=,nM,191.0,CHEMBL203,Homo sapiens,IC50,nM,191.0
10549,24824969,CHEMBL5141246,Inhibition of N-terminal GST tagged recombinant human EGFR L858R mutant (668 to end residues) expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,7.4,CHEMBL203,Homo sapiens,IC50,nM,7.4
10550,24824970,CHEMBL5141247,Inhibition of N-terminal GST tagged recombinant human EGFR ex19del (746 to 750) mutant expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
10551,24824971,CHEMBL5141248,Inhibition of N-terminal GST tagged recombinant human EGFR ex19del(746 to 750)/T790M mutant (668 to end residues) expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10552,24824972,CHEMBL5141249,Inhibition of N-terminal GST tagged recombinant human EGFR ex19del(746 to 750)/ T790M/C790S mutant (668 to end residues) expressed in baculovirus infected Sf9 insect cells expression system using 5-FAM-EEPLYINSFPAKKK-CONH peptide as substrate preincubated for 10 mins followed by peptide substrate addition in presence of ATP,B,CHEMBL5095169,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10553,24824973,CHEMBL5141250,Inhibition of EGF-stimulated EGFR ex19del (746 to 750) mutant phosphorylation in human PC-9 cells preincubated for 4 to 5 hrs followed by EGF stimulation for 10 mins by AlphaLISA method,B,CHEMBL5095169,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
10554,24824974,CHEMBL5141251,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in mouse BaF3 cells assessed as inhibition of protein phosphorylation,B,CHEMBL5095169,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
10555,24824975,CHEMBL5141252,Inhibition of EGFR ex19del/T790M/C797S triple mutant (unknown origin) expressed in mouse BaF3 cells assessed as inhibition of protein phosphorylation,B,CHEMBL5095169,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
10556,24833300,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4090601,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
10557,24833301,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4101719,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,nM,21.0
10558,24833302,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4098072,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,nM,90.0
10559,24833303,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4061829,=,nM,7.64,CHEMBL203,Homo sapiens,IC50,nM,7.64
10560,24833304,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4089892,=,nM,8.83,CHEMBL203,Homo sapiens,IC50,nM,8.83
10561,24833305,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4100860,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
10562,24833306,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4090686,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
10563,24833307,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4071368,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
10564,24833308,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4228518,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
10565,24833309,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4209019,=,nM,662.0,CHEMBL203,Homo sapiens,IC50,nM,662.0
10566,24833310,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5206600,=,nM,27.5,CHEMBL203,Homo sapiens,IC50,nM,27.5
10567,24833311,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5190294,=,nM,290.0,CHEMBL203,Homo sapiens,IC50,nM,290.0
10568,24833312,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5195321,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,nM,53.0
10569,24833313,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4649261,=,nM,218.3,CHEMBL203,Homo sapiens,IC50,nM,218.3
10570,24833314,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4786787,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
10571,24833315,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4795878,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
10572,24833316,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4744973,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
10573,24833317,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5183865,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,nM,41.0
10574,24833318,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5205022,=,nM,9.4,CHEMBL203,Homo sapiens,IC50,nM,9.4
10575,24833319,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5206817,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
10576,24833320,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4799276,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
10577,24833321,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4753389,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
10578,24833322,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4649261,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
10579,24833323,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5169450,=,nM,0.16,CHEMBL203,Homo sapiens,IC50,nM,0.16
10580,24833324,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5174418,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
10581,24833325,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4443483,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
10582,24833326,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL24828,=,nM,369.2,CHEMBL203,Homo sapiens,IC50,nM,369.2
10583,24833327,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5190204,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10584,24833328,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5180839,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10585,24833329,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4558528,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
10586,24833330,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4530686,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
10587,24833331,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4533337,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
10588,24833332,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL4520903,=,nM,59.0,CHEMBL203,Homo sapiens,IC50,nM,59.0
10589,24833333,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5180830,=,nM,52.0,CHEMBL203,Homo sapiens,IC50,nM,52.0
10590,24833334,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5200385,=,nM,47.8,CHEMBL203,Homo sapiens,IC50,nM,47.8
10591,24833335,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5194245,=,nM,38.1,CHEMBL203,Homo sapiens,IC50,nM,38.1
10592,24833336,CHEMBL5143769,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin),B,CHEMBL5195167,=,nM,48.2,CHEMBL203,Homo sapiens,IC50,nM,48.2
10593,24833337,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL2179119,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,nM,1000.0
10594,24833338,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5202381,=,nM,287.0,CHEMBL203,Homo sapiens,IC50,nM,287.0
10595,24833339,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4101719,<=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10596,24833340,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4098072,<=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10597,24833341,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4061829,<=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10598,24833342,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4089892,<=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10599,24833343,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL1328065,=,nM,24300.0,CHEMBL203,Homo sapiens,IC50,nM,24300.0
10600,24833344,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4207984,=,nM,50000.0,CHEMBL203,Homo sapiens,IC50,nM,50000.0
10601,24833348,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5195321,=,nM,1623.0,CHEMBL203,Homo sapiens,IC50,nM,1623.0
10602,24833350,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5172794,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,nM,430.0
10603,24833351,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5187838,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,nM,260.0
10604,24833352,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5176129,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
10605,24833353,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5195167,=,nM,540.0,CHEMBL203,Homo sapiens,IC50,nM,540.0
10606,24833354,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5169450,=,nM,7.92,CHEMBL203,Homo sapiens,IC50,nM,7.92
10607,24833355,CHEMBL5143770,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5174418,=,nM,5.12,CHEMBL203,Homo sapiens,IC50,nM,5.12
10608,24833359,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL1328065,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,nM,149.0
10609,24833360,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL4207984,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
10610,24833361,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL4214588,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
10611,24833362,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL4218431,=,nM,17.9,CHEMBL203,Homo sapiens,IC50,nM,17.9
10612,24833363,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5190294,=,nM,310.0,CHEMBL203,Homo sapiens,IC50,nM,310.0
10613,24833364,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL4649261,=,nM,15.3,CHEMBL203,Homo sapiens,IC50,nM,15.3
10614,24833365,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5172794,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10615,24833366,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5187838,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10616,24833367,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5176129,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10617,24833368,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5169450,=,nM,0.218,CHEMBL203,Homo sapiens,IC50,nM,0.218
10618,24833369,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5174418,=,nM,0.212,CHEMBL203,Homo sapiens,IC50,nM,0.212
10619,24833370,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL4443483,=,nM,331.3,CHEMBL203,Homo sapiens,IC50,nM,331.3
10620,24833371,CHEMBL5143771,Inhibition of EGFR Del19/T790M/C797S triple mutant (unknown origin),B,CHEMBL5195167,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
10621,24833374,CHEMBL5143773,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in mouse BaF3 cells,B,CHEMBL5206600,=,nM,662.0,CHEMBL203,Homo sapiens,IC50,nM,662.0
10622,24833375,CHEMBL5143773,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in mouse BaF3 cells,B,CHEMBL5195321,=,nM,5420.0,CHEMBL203,Homo sapiens,IC50,nM,5420.0
10623,24833378,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4228518,=,nM,189.0,CHEMBL203,Homo sapiens,IC50,nM,189.0
10624,24833379,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4649261,=,nM,156.6,CHEMBL203,Homo sapiens,IC50,nM,156.6
10625,24833380,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5206476,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,nM,5300.0
10626,24833381,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5193027,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
10627,24833382,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4443062,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
10628,24833383,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10629,24833384,CHEMBL5143776,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL4284413,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
10630,24833385,CHEMBL5143777,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL4228518,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
10631,24833389,CHEMBL5143781,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) in human NCI-H1975 cell,B,CHEMBL5179288,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
10632,24833390,CHEMBL5143782,Inhibition of EGFR L858R/T790M double mutant (unknown origin) in human NCI-H1975 cell,B,CHEMBL5179288,=,nM,3300.0,CHEMBL203,Homo sapiens,IC50,uM,3.3
10633,24833391,CHEMBL5143783,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) by HTRF method,B,CHEMBL5179288,=,nM,630.0,CHEMBL203,Homo sapiens,IC50,uM,0.63
10634,24833555,CHEMBL5143814,Inhibition of N-terminal GST fused EGFR (668 to 1091 residues) (unknown origin) using poly (Glu-Tyr) E4Y1 peptide as substrate incubated for 2 hrs by ADP-Glo reagent method,B,CHEMBL3989868,=,nM,449.0,CHEMBL203,Homo sapiens,IC50,nM,449.0
10635,24841327,CHEMBL5145633,Inhibition of EGFR (unknown origin) by lanthascreen Tb kinase activity assay,B,CHEMBL1873475,=,nM,11.2,CHEMBL203,Homo sapiens,IC50,nM,11.2
10636,24846751,CHEMBL5146949,Inhibition of wild type EGFR (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay,B,CHEMBL5194482,=,nM,261.2,CHEMBL203,Homo sapiens,IC50,nM,261.2
10637,24846752,CHEMBL5146950,Inhibition of EGFR T790M mutant (unknown origin) incubated for 1 hr in the presence of ATP by FRET based Z'-LYTE assay,B,CHEMBL5194482,=,nM,216.3,CHEMBL203,Homo sapiens,IC50,nM,216.3
10638,24848031,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5186362,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10639,24848032,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5181469,=,nM,0.54,CHEMBL203,Homo sapiens,IC50,nM,0.54
10640,24848033,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5178898,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
10641,24848034,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5187762,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
10642,24848035,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL5178180,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
10643,24848036,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL1173655,=,nM,0.33,CHEMBL203,Homo sapiens,IC50,nM,0.33
10644,24848037,CHEMBL5147184,Inhibition of recombinant human N-terminal GST-tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells using kinase substrate 22 incubated for 30 mins in presence of ATP,B,CHEMBL3545154,=,nM,0.27,CHEMBL203,Homo sapiens,IC50,nM,0.27
10645,24848230,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL4214567,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
10646,24848231,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL4443062,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10647,24848232,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5191510,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10648,24848233,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5201543,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10649,24848234,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5182553,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10650,24848235,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5177306,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10651,24848236,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5198812,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10652,24848237,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5176460,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
10653,24848238,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5202129,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10654,24848239,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5200637,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
10655,24848240,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5187605,=,nM,6.8,CHEMBL203,Homo sapiens,IC50,nM,6.8
10656,24848241,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5195912,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
10657,24848242,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5178865,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
10658,24848243,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5197154,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
10659,24848244,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5208065,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10660,24848245,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5173701,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
10661,24848246,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5204970,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
10662,24848247,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5204270,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
10663,24848248,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5172573,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10664,24848249,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5206902,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10665,24848250,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5207462,=,nM,17.8,CHEMBL203,Homo sapiens,IC50,nM,17.8
10666,24848251,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5200988,=,nM,9.7,CHEMBL203,Homo sapiens,IC50,nM,9.7
10667,24848252,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5206436,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,nM,10.3
10668,24848253,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5178754,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
10669,24848254,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5191674,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
10670,24848255,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5207108,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
10671,24848256,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5177272,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
10672,24848257,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5196360,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10673,24848258,CHEMBL5147203,Inhibition of his-GST tagged human EGFR L858R/T790M double mutant expressed in insect cells incubated for 30 mins in presence of ATP by HTRF kinase assay,B,CHEMBL5178571,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
10674,24849483,CHEMBL5147517,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5095068,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
10675,24862033,CHEMBL5150408,Inhibition of EGFR in human A-431 cells membrane,B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10676,24862035,CHEMBL5150410,Inhibition of EGFR in human A-431 cells membrane incubated for 8 mins in presence of ATP by colorimetry assay,B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10677,24862036,CHEMBL5150411,Inhibition of EGF stimulated EGFR autophosphorylation in human HN5 cells incubated for 24 hrs by Western blotting analysis,B,CHEMBL553,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
10678,24862038,CHEMBL5150413,Inhibition of human wild type EGFR using pEY (4:1) as substrate,B,CHEMBL1173655,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10679,24862039,CHEMBL5150414,Inhibition of EGFR L858R mutant (unknown origin) using pEY (4:1) as substrate,B,CHEMBL1173655,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10680,24862040,CHEMBL5150415,Inhibition of human GST-tagged EGFR L858R/T790M double mutant using pEY (4:1) as substrate,B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10681,24862042,CHEMBL5150417,Inhibition of EGFR DEL19 mutant in human HCC827 cells,B,CHEMBL3786343,=,nM,9.2,CHEMBL203,Homo sapiens,IC50,nM,9.2
10682,24862043,CHEMBL5150418,Inhibition of EGFR L858R/T790M double mutant in human NCI-H1975 cells,B,CHEMBL3786343,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10683,24862044,CHEMBL5150419,Inhibition of GST-tagged EGFR (unknown origin) expressed in insect cells by ELISA,B,CHEMBL2110732,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10684,24862049,CHEMBL5150423,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
10685,24862052,CHEMBL5150426,Inhibition of HER1 (unknown origin) by ELISA,B,CHEMBL24828,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,nM,500.0
10686,24863001,CHEMBL5150886,Inhibition of EGFR (unknown origin) by colorimetric assay,B,CHEMBL5173862,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
10687,24863002,CHEMBL5150886,Inhibition of EGFR (unknown origin) by colorimetric assay,B,CHEMBL5209100,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
10688,24863089,CHEMBL5150940,Inhibition EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5203118,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
10689,24863090,CHEMBL5150940,Inhibition EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5200275,=,nM,47.4,CHEMBL203,Homo sapiens,IC50,nM,47.4
10690,24867145,CHEMBL5151930,Inhibition of EGFR (unknown origin),B,CHEMBL24828,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10691,24867150,CHEMBL5151935,Inhibition of EGFR (unknown origin) by ELISA method,B,CHEMBL5201128,=,nM,6500.0,CHEMBL203,Homo sapiens,IC50,nM,6500.0
10692,24871120,CHEMBL5153034,Inhibition of wild type EGFR (unknown origin) preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206697,=,nM,1795.3,CHEMBL203,Homo sapiens,IC50,nM,1795.3
10693,24871146,CHEMBL5153034,Inhibition of wild type EGFR (unknown origin) preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL3353410,=,nM,34.5,CHEMBL203,Homo sapiens,IC50,nM,34.5
10694,24871147,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206697,=,nM,11.5,CHEMBL203,Homo sapiens,IC50,nM,11.5
10695,24871148,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5190513,=,nM,1026.7,CHEMBL203,Homo sapiens,IC50,nM,1026.7
10696,24871149,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5185330,=,nM,154.6,CHEMBL203,Homo sapiens,IC50,nM,154.6
10697,24871150,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5205073,=,nM,509.3,CHEMBL203,Homo sapiens,IC50,nM,509.3
10698,24871152,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5186794,=,nM,24.9,CHEMBL203,Homo sapiens,IC50,nM,24.9
10699,24871154,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5182465,=,nM,119.1,CHEMBL203,Homo sapiens,IC50,nM,119.1
10700,24871155,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5176295,=,nM,490.6,CHEMBL203,Homo sapiens,IC50,nM,490.6
10701,24871156,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5180070,=,nM,3034.0,CHEMBL203,Homo sapiens,IC50,nM,3034.0
10702,24871157,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5196064,=,nM,63506.7,CHEMBL203,Homo sapiens,IC50,nM,63506.7
10703,24871158,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5195531,=,nM,19.6,CHEMBL203,Homo sapiens,IC50,nM,19.6
10704,24871159,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5184313,=,nM,56.8,CHEMBL203,Homo sapiens,IC50,nM,56.8
10705,24871160,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5208312,=,nM,235.5,CHEMBL203,Homo sapiens,IC50,nM,235.5
10706,24871161,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5204446,=,nM,1874.3,CHEMBL203,Homo sapiens,IC50,nM,1874.3
10707,24871162,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5192038,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
10708,24871163,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5169346,=,nM,16.2,CHEMBL203,Homo sapiens,IC50,nM,16.2
10709,24871164,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206110,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10710,24871165,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5194285,=,nM,42.9,CHEMBL203,Homo sapiens,IC50,nM,42.9
10711,24871166,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5180914,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
10712,24871167,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5183329,=,nM,33860.0,CHEMBL203,Homo sapiens,IC50,nM,33860.0
10713,24871168,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5199106,=,nM,492.9,CHEMBL203,Homo sapiens,IC50,nM,492.9
10714,24871169,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5190227,=,nM,6302.0,CHEMBL203,Homo sapiens,IC50,nM,6302.0
10715,24871170,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5173596,=,nM,70396.7,CHEMBL203,Homo sapiens,IC50,nM,70396.7
10716,24871171,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL939,=,nM,0.9,CHEMBL203,Homo sapiens,IC50,nM,0.9
10717,24871172,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL4537790,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10718,24871173,CHEMBL5153035,Inhibition of EGFR (unknown origin) Del19 mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL3353410,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10719,24871174,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206697,=,nM,18.8,CHEMBL203,Homo sapiens,IC50,nM,18.8
10720,24871176,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5185330,=,nM,685.2,CHEMBL203,Homo sapiens,IC50,nM,685.2
10721,24871177,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5205073,=,nM,3991.3,CHEMBL203,Homo sapiens,IC50,nM,3991.3
10722,24871179,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5186794,=,nM,127.5,CHEMBL203,Homo sapiens,IC50,nM,127.5
10723,24871181,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5182465,=,nM,820.8,CHEMBL203,Homo sapiens,IC50,nM,820.8
10724,24871185,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5195531,=,nM,738.6,CHEMBL203,Homo sapiens,IC50,nM,738.6
10725,24871186,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5184313,=,nM,275.1,CHEMBL203,Homo sapiens,IC50,nM,275.1
10726,24871187,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5208312,=,nM,655.1,CHEMBL203,Homo sapiens,IC50,nM,655.1
10727,24871188,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5204446,=,nM,87.6,CHEMBL203,Homo sapiens,IC50,nM,87.6
10728,24871189,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5192038,=,nM,448.5,CHEMBL203,Homo sapiens,IC50,nM,448.5
10729,24871190,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5169346,=,nM,38.3,CHEMBL203,Homo sapiens,IC50,nM,38.3
10730,24871191,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206110,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
10731,24871192,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5194285,=,nM,32.6,CHEMBL203,Homo sapiens,IC50,nM,32.6
10732,24871193,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5180914,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
10733,24871195,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5199106,=,nM,1119.0,CHEMBL203,Homo sapiens,IC50,nM,1119.0
10734,24871196,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5190227,=,nM,9680.0,CHEMBL203,Homo sapiens,IC50,nM,9680.0
10735,24871197,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5173596,=,nM,19880.0,CHEMBL203,Homo sapiens,IC50,nM,19880.0
10736,24871198,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL939,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
10737,24871199,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL4537790,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
10738,24871200,CHEMBL5153036,Inhibition of EGFR (unknown origin) L858R mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL3353410,=,nM,1.8,CHEMBL203,Homo sapiens,IC50,nM,1.8
10739,24871201,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206697,=,nM,609.0,CHEMBL203,Homo sapiens,IC50,nM,609.0
10740,24871202,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5190513,=,nM,676.7,CHEMBL203,Homo sapiens,IC50,nM,676.7
10741,24871203,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5185330,=,nM,1681.0,CHEMBL203,Homo sapiens,IC50,nM,1681.0
10742,24871206,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5186794,=,nM,3358.0,CHEMBL203,Homo sapiens,IC50,nM,3358.0
10743,24871213,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5184313,=,nM,698.3,CHEMBL203,Homo sapiens,IC50,nM,698.3
10744,24871214,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5208312,=,nM,18066.7,CHEMBL203,Homo sapiens,IC50,nM,18066.7
10745,24871215,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5204446,=,nM,1121.0,CHEMBL203,Homo sapiens,IC50,nM,1121.0
10746,24871216,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5192038,=,nM,5450.0,CHEMBL203,Homo sapiens,IC50,nM,5450.0
10747,24871217,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5169346,=,nM,326.0,CHEMBL203,Homo sapiens,IC50,nM,326.0
10748,24871218,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5206110,=,nM,102.8,CHEMBL203,Homo sapiens,IC50,nM,102.8
10749,24871219,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5194285,=,nM,126.4,CHEMBL203,Homo sapiens,IC50,nM,126.4
10750,24871220,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL5180914,=,nM,361.1,CHEMBL203,Homo sapiens,IC50,nM,361.1
10751,24871226,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL4537790,=,nM,0.02,CHEMBL203,Homo sapiens,IC50,nM,0.02
10752,24871227,CHEMBL5153037,Inhibition of EGFR (unknown origin) L858R/T790M mutant preincubated with compound 30 mins followed ATP addition incubated for 30 mins by HTRF KinEASE TK assay,B,CHEMBL3353410,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10753,24877538,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL3353410,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
10754,24877539,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL4098072,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
10755,24877540,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5183286,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
10756,24877541,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5199122,=,nM,280.0,CHEMBL203,Homo sapiens,IC50,nM,280.0
10757,24877542,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188250,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
10758,24877543,CHEMBL5155237,Inhibition of human EGFR L858R mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188399,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10759,24877545,CHEMBL5155238,Inhibition of human EGFR L858R/T790M/C797S mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL4098072,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
10760,24877546,CHEMBL5155238,Inhibition of human EGFR L858R/T790M/C797S mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5183286,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
10761,24877548,CHEMBL5155238,Inhibition of human EGFR L858R/T790M/C797S mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188250,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,nM,8.0
10762,24877549,CHEMBL5155238,Inhibition of human EGFR L858R/T790M/C797S mutant expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188399,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
10763,24877558,CHEMBL5155241,Inhibition of wild type human EGFR expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL3353410,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10764,24877559,CHEMBL5155241,Inhibition of wild type human EGFR expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL4098072,=,nM,6.5,CHEMBL203,Homo sapiens,IC50,nM,6.5
10765,24877562,CHEMBL5155241,Inhibition of wild type human EGFR expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188250,=,nM,6.2,CHEMBL203,Homo sapiens,IC50,nM,6.2
10766,24877563,CHEMBL5155241,Inhibition of wild type human EGFR expressed in Sf9 insect cells in presence of ATP measured by HTRF assay,B,CHEMBL5188399,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,nM,47.0
10767,24877607,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL5188399,=,nM,6700.0,CHEMBL203,Homo sapiens,IC50,nM,6700.0
10768,24877608,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL5188250,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,nM,330.0
10769,24877611,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL4098072,=,nM,330.0,CHEMBL203,Homo sapiens,IC50,nM,330.0
10770,24877612,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL4214567,=,nM,15000.0,CHEMBL203,Homo sapiens,IC50,nM,15000.0
10771,24877613,CHEMBL5155250,Displacement of sapitinib-BODIPY tracer from C-terminal NanoLuc-fused full length wild type EGFR (unknown origin) transfected in HEK293T cells incubated for 2 hrs by NanoBRET assay,B,CHEMBL3353410,=,nM,1700.0,CHEMBL203,Homo sapiens,IC50,nM,1700.0
10772,24900643,CHEMBL5160698,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,8.43,CHEMBL203,Homo sapiens,IC50,nM,8.43
10773,24900644,CHEMBL5160698,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10774,24900645,CHEMBL5160698,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
10775,24902217,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5186969,=,nM,251.3,CHEMBL203,Homo sapiens,IC50,nM,251.3
10776,24902218,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5183327,=,nM,164.8,CHEMBL203,Homo sapiens,IC50,nM,164.8
10777,24902219,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5199341,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
10778,24902221,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5188730,=,nM,215.1,CHEMBL203,Homo sapiens,IC50,nM,215.1
10779,24902222,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5178707,=,nM,2.98,CHEMBL203,Homo sapiens,IC50,nM,2.98
10780,24902225,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5180251,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
10781,24902226,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5199612,=,nM,183.7,CHEMBL203,Homo sapiens,IC50,nM,183.7
10782,24902228,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5180325,=,nM,25.17,CHEMBL203,Homo sapiens,IC50,nM,25.17
10783,24902229,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5174372,=,nM,4020.0,CHEMBL203,Homo sapiens,IC50,nM,4020.0
10784,24902230,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5200760,=,nM,358.3,CHEMBL203,Homo sapiens,IC50,nM,358.3
10785,24902231,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5169328,=,nM,351.9,CHEMBL203,Homo sapiens,IC50,nM,351.9
10786,24902232,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5198424,=,nM,3.01,CHEMBL203,Homo sapiens,IC50,nM,3.01
10787,24902233,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5194966,=,nM,8.38,CHEMBL203,Homo sapiens,IC50,nM,8.38
10788,24902234,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5176588,=,nM,255.0,CHEMBL203,Homo sapiens,IC50,nM,255.0
10789,24902237,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5208907,=,nM,0.74,CHEMBL203,Homo sapiens,IC50,nM,0.74
10790,24902238,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5169547,=,nM,13.7,CHEMBL203,Homo sapiens,IC50,nM,13.7
10791,24902239,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5177378,=,nM,5.8,CHEMBL203,Homo sapiens,IC50,nM,5.8
10792,24902240,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5204535,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
10793,24902241,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5172245,=,nM,6.9,CHEMBL203,Homo sapiens,IC50,nM,6.9
10794,24902242,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5182567,=,nM,0.38,CHEMBL203,Homo sapiens,IC50,nM,0.38
10795,24902243,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL5208454,=,nM,0.72,CHEMBL203,Homo sapiens,IC50,nM,0.72
10796,24902244,CHEMBL5161051,Inhibition of wild-type EGFR (14 to 721 residues) (unknown origin) by western blot analysis,B,CHEMBL1173655,=,nM,0.67,CHEMBL203,Homo sapiens,IC50,nM,0.67
10797,24902265,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5169547,=,nM,13.7,CHEMBL203,Homo sapiens,IC50,nM,13.7
10798,24902266,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5177378,=,nM,12.6,CHEMBL203,Homo sapiens,IC50,nM,12.6
10799,24902267,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5204535,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,nM,1.4
10800,24902268,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5172245,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,nM,6.0
10801,24902269,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5182567,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
10802,24902270,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL5208454,=,nM,82.0,CHEMBL203,Homo sapiens,IC50,nM,82.0
10803,24902271,CHEMBL5161054,Inhibition of recombinant human EGFR L858R/T790M double mutant using GGMEDIYFEFMGG as substrate in presence of ATP by radiometric assay,B,CHEMBL1173655,=,nM,3.7,CHEMBL203,Homo sapiens,IC50,nM,3.7
10804,24907641,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL180022,=,nM,0.58,CHEMBL203,Homo sapiens,IC50,nM,0.58
10805,24907642,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL3647420,=,nM,0.98,CHEMBL203,Homo sapiens,IC50,nM,0.98
10806,24907643,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5192750,=,nM,2.31,CHEMBL203,Homo sapiens,IC50,nM,2.31
10807,24907644,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5193451,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
10808,24907645,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5201973,=,nM,2.32,CHEMBL203,Homo sapiens,IC50,nM,2.32
10809,24907646,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5190132,=,nM,1.03,CHEMBL203,Homo sapiens,IC50,nM,1.03
10810,24907647,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5176920,=,nM,1.11,CHEMBL203,Homo sapiens,IC50,nM,1.11
10811,24907648,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5180965,=,nM,22.75,CHEMBL203,Homo sapiens,IC50,nM,22.75
10812,24907649,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5170965,=,nM,86.33,CHEMBL203,Homo sapiens,IC50,nM,86.33
10813,24907650,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5202846,=,nM,11.82,CHEMBL203,Homo sapiens,IC50,nM,11.82
10814,24907651,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5176854,=,nM,32.14,CHEMBL203,Homo sapiens,IC50,nM,32.14
10815,24907652,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5181694,=,nM,25.92,CHEMBL203,Homo sapiens,IC50,nM,25.92
10816,24907653,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5183924,=,nM,9.6,CHEMBL203,Homo sapiens,IC50,nM,9.6
10817,24907654,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5178703,=,nM,8.13,CHEMBL203,Homo sapiens,IC50,nM,8.13
10818,24907655,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5184610,=,nM,1.36,CHEMBL203,Homo sapiens,IC50,nM,1.36
10819,24907656,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5175489,=,nM,1.47,CHEMBL203,Homo sapiens,IC50,nM,1.47
10820,24907657,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5209046,=,nM,3.13,CHEMBL203,Homo sapiens,IC50,nM,3.13
10821,24907658,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5179954,=,nM,1.19,CHEMBL203,Homo sapiens,IC50,nM,1.19
10822,24907659,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5180725,=,nM,20.72,CHEMBL203,Homo sapiens,IC50,nM,20.72
10823,24907660,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5175873,=,nM,2.13,CHEMBL203,Homo sapiens,IC50,nM,2.13
10824,24907661,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5200783,=,nM,1833.8,CHEMBL203,Homo sapiens,IC50,nM,1833.8
10825,24907662,CHEMBL5162303,Inhibition of wild type human N-terminal GST tagged EGFR (669 to 1210 residues) expressed in Sf21 insect cells incubated for 30 mins in presence of ATP by HTRF analysis,B,CHEMBL5203179,=,nM,110.32,CHEMBL203,Homo sapiens,IC50,nM,110.32
10826,24907894,CHEMBL5162370,Inhibition of EGFR (unknown origin),B,CHEMBL180022,=,nM,0.39,CHEMBL203,Homo sapiens,IC50,nmol,0.39
10827,24907895,CHEMBL5162370,Inhibition of EGFR (unknown origin),B,CHEMBL3647420,=,nM,0.48,CHEMBL203,Homo sapiens,IC50,nmol,0.48
10828,24907896,CHEMBL5162370,Inhibition of EGFR (unknown origin),B,CHEMBL3989868,=,nM,449.0,CHEMBL203,Homo sapiens,IC50,nmol,449.0
10829,24919428,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5194174,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
10830,24919429,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5172338,=,nM,22.6,CHEMBL203,Homo sapiens,IC50,nM,22.6
10831,24919430,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5207083,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
10832,24919431,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5198314,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
10833,24919432,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5200598,=,nM,33.3,CHEMBL203,Homo sapiens,IC50,nM,33.3
10834,24919433,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5188281,=,nM,24.2,CHEMBL203,Homo sapiens,IC50,nM,24.2
10835,24919434,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5176897,=,nM,25.6,CHEMBL203,Homo sapiens,IC50,nM,25.6
10836,24919435,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5185864,=,nM,69.2,CHEMBL203,Homo sapiens,IC50,nM,69.2
10837,24919436,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5172251,=,nM,54.8,CHEMBL203,Homo sapiens,IC50,nM,54.8
10838,24919437,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5179495,=,nM,115.9,CHEMBL203,Homo sapiens,IC50,nM,115.9
10839,24919439,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5180778,=,nM,4.7,CHEMBL203,Homo sapiens,IC50,nM,4.7
10840,24919440,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5206683,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
10841,24919441,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5209545,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,nM,8.1
10842,24919442,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5185922,=,nM,4.9,CHEMBL203,Homo sapiens,IC50,nM,4.9
10843,24919443,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,410.7,CHEMBL203,Homo sapiens,IC50,nM,410.7
10844,24919444,CHEMBL5165816,Inhibition of EGFR 19 del/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
10845,24919445,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5194174,=,nM,41.9,CHEMBL203,Homo sapiens,IC50,nM,41.9
10846,24919446,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5172338,=,nM,124.5,CHEMBL203,Homo sapiens,IC50,nM,124.5
10847,24919447,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5207083,=,nM,77.8,CHEMBL203,Homo sapiens,IC50,nM,77.8
10848,24919448,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5198314,=,nM,34.8,CHEMBL203,Homo sapiens,IC50,nM,34.8
10849,24919449,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5200598,=,nM,222.3,CHEMBL203,Homo sapiens,IC50,nM,222.3
10850,24919450,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5188281,=,nM,145.3,CHEMBL203,Homo sapiens,IC50,nM,145.3
10851,24919451,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5176897,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
10852,24919452,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5185864,=,nM,1.5,CHEMBL203,Homo sapiens,IC50,nM,1.5
10853,24919453,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5172251,=,nM,21.8,CHEMBL203,Homo sapiens,IC50,nM,21.8
10854,24919454,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5179495,=,nM,477.7,CHEMBL203,Homo sapiens,IC50,nM,477.7
10855,24919456,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5180778,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
10856,24919457,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5206683,=,nM,4.2,CHEMBL203,Homo sapiens,IC50,nM,4.2
10857,24919458,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5209545,=,nM,30.8,CHEMBL203,Homo sapiens,IC50,nM,30.8
10858,24919459,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5185922,=,nM,14.4,CHEMBL203,Homo sapiens,IC50,nM,14.4
10859,24919460,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,465.4,CHEMBL203,Homo sapiens,IC50,nM,465.4
10860,24919461,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,37.6,CHEMBL203,Homo sapiens,IC50,nM,37.6
10861,24919463,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5188272,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
10862,24919464,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5205581,=,nM,6.2,CHEMBL203,Homo sapiens,IC50,nM,6.2
10863,24919465,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5201250,=,nM,89.9,CHEMBL203,Homo sapiens,IC50,nM,89.9
10864,24919466,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5181437,=,nM,141.9,CHEMBL203,Homo sapiens,IC50,nM,141.9
10865,24919469,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5197952,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,nM,28.0
10866,24919470,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5170653,=,nM,57.8,CHEMBL203,Homo sapiens,IC50,nM,57.8
10867,24919471,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5193609,=,nM,23.6,CHEMBL203,Homo sapiens,IC50,nM,23.6
10868,24919472,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5181684,=,nM,32.1,CHEMBL203,Homo sapiens,IC50,nM,32.1
10869,24919473,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5179214,=,nM,56.4,CHEMBL203,Homo sapiens,IC50,nM,56.4
10870,24919474,CHEMBL5165817,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5169943,=,nM,164.9,CHEMBL203,Homo sapiens,IC50,nM,164.9
10871,24919475,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5194174,=,nM,5.5,CHEMBL203,Homo sapiens,IC50,nM,5.5
10872,24919476,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5172338,=,nM,15.6,CHEMBL203,Homo sapiens,IC50,nM,15.6
10873,24919477,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5207083,=,nM,12.9,CHEMBL203,Homo sapiens,IC50,nM,12.9
10874,24919478,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5198314,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
10875,24919479,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5200598,=,nM,32.6,CHEMBL203,Homo sapiens,IC50,nM,32.6
10876,24919480,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5188281,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
10877,24919481,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5176897,=,nM,6.6,CHEMBL203,Homo sapiens,IC50,nM,6.6
10878,24919482,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5185864,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
10879,24919483,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5172251,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
10880,24919484,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5179495,=,nM,74.3,CHEMBL203,Homo sapiens,IC50,nM,74.3
10881,24919486,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5180778,=,nM,16.3,CHEMBL203,Homo sapiens,IC50,nM,16.3
10882,24919487,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5206683,=,nM,7.5,CHEMBL203,Homo sapiens,IC50,nM,7.5
10883,24919488,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5209545,=,nM,2.1,CHEMBL203,Homo sapiens,IC50,nM,2.1
10884,24919489,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL5185922,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,nM,2.2
10885,24919490,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
10886,24919491,CHEMBL5165818,Inhibition of EGFR L858R/T790M mutant (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,17.2,CHEMBL203,Homo sapiens,IC50,nM,17.2
10887,24919498,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5176897,=,nM,816.0,CHEMBL203,Homo sapiens,IC50,nM,816.0
10888,24919499,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5185864,=,nM,55.9,CHEMBL203,Homo sapiens,IC50,nM,55.9
10889,24919500,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5172251,=,nM,261.8,CHEMBL203,Homo sapiens,IC50,nM,261.8
10890,24919503,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5180778,=,nM,546.6,CHEMBL203,Homo sapiens,IC50,nM,546.6
10891,24919504,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5206683,=,nM,343.7,CHEMBL203,Homo sapiens,IC50,nM,343.7
10892,24919505,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5209545,=,nM,413.5,CHEMBL203,Homo sapiens,IC50,nM,413.5
10893,24919506,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5185922,=,nM,466.1,CHEMBL203,Homo sapiens,IC50,nM,466.1
10894,24919507,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL3353410,=,nM,120.6,CHEMBL203,Homo sapiens,IC50,nM,120.6
10895,24919508,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL3545311,=,nM,139.7,CHEMBL203,Homo sapiens,IC50,nM,139.7
10896,24919511,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5205581,=,nM,236.4,CHEMBL203,Homo sapiens,IC50,nM,236.4
10897,24919516,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5197952,=,nM,885.2,CHEMBL203,Homo sapiens,IC50,nM,885.2
10898,24919518,CHEMBL5165819,Inhibition of wild type EGFR (unknown origin) by ELISA,B,CHEMBL5193609,=,nM,307.5,CHEMBL203,Homo sapiens,IC50,nM,307.5
10899,24957272,CHEMBL5214281,Selectivity interaction (MSD Pharma/Taiwan screen (enzymes and receptors) ) EUB0000296b EGFR,B,CHEMBL204232,=,nM,3260.0,CHEMBL203,Homo sapiens,IC50,uM,3.26
10900,24957791,CHEMBL5214829,Selectivity interaction (Enzymatic activity assay) EUB0000596aBDA EGFR,B,CHEMBL2105712,=,nM,0.5,CHEMBL203,Homo sapiens,IC50,nM,0.5
10901,24957792,CHEMBL5214830,Selectivity interaction (Enzymatic activity assay) EUB0000596aBDA EGFR,B,CHEMBL2105712,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10902,24957793,CHEMBL5214831,Selectivity interaction (Enzymatic activity assay) EUB0000596aBDA EGFR,B,CHEMBL2105712,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10903,24958595,CHEMBL5213079,Selectivity interaction (33P-ATP and filter-binding assay (Reaction Biology)) EUB0000646a EGFR,B,CHEMBL3936761,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
10904,24958596,CHEMBL5213080,Selectivity interaction (p-EGFR HTRF assay) EUB0000646a EGFR,B,CHEMBL3936761,=,nM,606.0,CHEMBL203,Homo sapiens,IC50,nM,606.0
10905,24958818,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL98,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
10906,24958819,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL598377,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
10907,24958820,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL598797,=,nM,2.4,CHEMBL203,Homo sapiens,IC50,nM,2.4
10908,24958821,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL598798,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
10909,24958822,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL604094,=,nM,84.2,CHEMBL203,Homo sapiens,IC50,nM,84.2
10910,24958823,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL3218001,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,uM,0.078
10911,24958824,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL3218002,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
10912,24958825,CHEMBL5215094,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
10913,24958838,CHEMBL5215097,Inhibition of EGFR wildtype (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL5218998,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
10914,24958839,CHEMBL5215097,Inhibition of EGFR wildtype (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL3353410,=,nM,2.2,CHEMBL203,Homo sapiens,IC50,uM,0.0022
10915,24958840,CHEMBL5215097,Inhibition of EGFR wildtype (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL5191956,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,uM,5.9
10916,24958841,CHEMBL5215098,Inhibition of EGFR T790M (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL5218998,=,nM,1200.0,CHEMBL203,Homo sapiens,IC50,uM,1.2
10917,24958842,CHEMBL5215098,Inhibition of EGFR T790M (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL3353410,=,nM,1.4,CHEMBL203,Homo sapiens,IC50,uM,0.0014
10918,24958843,CHEMBL5215098,Inhibition of EGFR T790M (unknown origin) incubated for 40 mins in presence of ATP,B,CHEMBL5191956,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
10919,24959055,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5218821,=,nM,1203.0,CHEMBL203,Homo sapiens,IC50,nM,1203.0
10920,24959056,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5218797,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10921,24959057,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5218754,<,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10922,24959058,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5220645,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10923,24959059,CHEMBL5215199,Inhibition of human wild type GST-tagged EGFR expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 25 mins by HTRF assay,B,CHEMBL5220529,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10924,24959060,CHEMBL5215200,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 insect cells using ATP as substrate by HTRF assay,B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
10925,24959061,CHEMBL5215200,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 insect cells using ATP as substrate by HTRF assay,B,CHEMBL4284413,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
10926,24959062,CHEMBL5215201,Inhibition of human wild type EGFR expressed in Sf9 insect cells using ATP as substrate by HTRF assay,B,CHEMBL4214567,=,nM,4300.0,CHEMBL203,Homo sapiens,IC50,uM,4.3
10927,24959070,CHEMBL5215207,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL4228518,=,nM,114.0,CHEMBL203,Homo sapiens,IC50,nM,114.0
10928,24959071,CHEMBL5215207,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5206476,=,nM,5300.0,CHEMBL203,Homo sapiens,IC50,uM,5.3
10929,24959072,CHEMBL5215207,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5220061,=,nM,7.64,CHEMBL203,Homo sapiens,IC50,nM,7.64
10930,24959073,CHEMBL5215207,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5218879,=,nM,8.83,CHEMBL203,Homo sapiens,IC50,nM,8.83
10931,24959087,CHEMBL5215210,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5218780,=,nM,916.0,CHEMBL203,Homo sapiens,IC50,nM,916.0
10932,24959088,CHEMBL5215210,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5220061,=,nM,12.5,CHEMBL203,Homo sapiens,IC50,nM,12.5
10933,24959089,CHEMBL5215210,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5218879,=,nM,8.39,CHEMBL203,Homo sapiens,IC50,nM,8.39
10934,24959090,CHEMBL5215210,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL321494,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,nM,130.0
10935,24959091,CHEMBL5215211,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5218780,=,nM,49.2,CHEMBL203,Homo sapiens,IC50,nM,49.2
10936,24959092,CHEMBL5215211,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5220061,<,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10937,24959093,CHEMBL5215211,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5218879,<,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
10938,24959094,CHEMBL5215211,Inhibition of wild type EGFR (unknown origin),B,CHEMBL321494,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
10939,24959095,CHEMBL5215212,Inhibition of human EGFR del19/T790M/C797S mutant assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,B,CHEMBL1328065,=,nM,149.0,CHEMBL203,Homo sapiens,IC50,nM,149.0
10940,24959096,CHEMBL5215212,Inhibition of human EGFR del19/T790M/C797S mutant assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,B,CHEMBL4207984,=,nM,17.9,CHEMBL203,Homo sapiens,IC50,nM,17.9
10941,24959097,CHEMBL5215212,Inhibition of human EGFR del19/T790M/C797S mutant assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,B,CHEMBL4214588,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,nM,46.0
10942,24959098,CHEMBL5215212,Inhibition of human EGFR del19/T790M/C797S mutant assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,B,CHEMBL4218431,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
10943,24959099,CHEMBL5215213,Inhibition of human wild type EGFR assessed as enzyme remaining activity using poly-Glu-Tyr peptide substrate incubated for 2 hrs in presence of [gamma-33P]ATP by radiometric kinase assay,B,CHEMBL1328065,=,nM,24300.0,CHEMBL203,Homo sapiens,IC50,uM,24.3
10944,24959103,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5218754,<,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10945,24959104,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5220645,=,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10946,24959105,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5220529,<,nM,0.1,CHEMBL203,Homo sapiens,IC50,nM,0.1
10947,24959106,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5218821,=,nM,176.0,CHEMBL203,Homo sapiens,IC50,nM,176.0
10948,24959107,CHEMBL5215214,Inhibition of human GST-tagged EGFR L858R/T790M mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 20 mins by HTRF assay,B,CHEMBL5218797,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
10949,24959108,CHEMBL5215215,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,B,CHEMBL5218797,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,nM,22.0
10950,24959109,CHEMBL5215215,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,B,CHEMBL5218754,=,nM,9.4,CHEMBL203,Homo sapiens,IC50,nM,9.4
10951,24959110,CHEMBL5215215,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,B,CHEMBL5220645,=,nM,8.6,CHEMBL203,Homo sapiens,IC50,nM,8.6
10952,24959111,CHEMBL5215215,Inhibition of human GST-tagged EGFR L858R/T790M/C797S mutant expressed in Sf9 cells assessed as substrate phosphorylation using TK-peptide as substrate incubated for 10 mins by HTRF assay,B,CHEMBL5220529,=,nM,8.5,CHEMBL203,Homo sapiens,IC50,nM,8.5
10953,24959112,CHEMBL5215216,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) by ELISA,B,CHEMBL5219777,=,nM,3.1,CHEMBL203,Homo sapiens,IC50,nM,3.1
10954,24959115,CHEMBL5215219,Inhibition of human wild type EGFR using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5172794,=,nM,430.0,CHEMBL203,Homo sapiens,IC50,nM,430.0
10955,24959116,CHEMBL5215219,Inhibition of human wild type EGFR using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5187838,=,nM,260.0,CHEMBL203,Homo sapiens,IC50,nM,260.0
10956,24959117,CHEMBL5215219,Inhibition of human wild type EGFR using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5176129,=,nM,2.8,CHEMBL203,Homo sapiens,IC50,nM,2.8
10957,24959118,CHEMBL5215220,Inhibition of human EGFR del19/T790M/C797S mutant using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5172794,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10958,24959119,CHEMBL5215220,Inhibition of human EGFR del19/T790M/C797S mutant using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5187838,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10959,24959120,CHEMBL5215220,Inhibition of human EGFR del19/T790M/C797S mutant using ATP-labelled peptide substrate by HTRF assay,B,CHEMBL5176129,=,nM,0.2,CHEMBL203,Homo sapiens,IC50,nM,0.2
10960,24959121,CHEMBL5215221,Inhibition of EGFR del19/T790M/C797S triple mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells by fluorescence based microplate reader analysis,B,CHEMBL5204787,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
10961,24959122,CHEMBL5215221,Inhibition of EGFR del19/T790M/C797S triple mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells by fluorescence based microplate reader analysis,B,CHEMBL5219395,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
10962,24959123,CHEMBL5215221,Inhibition of EGFR del19/T790M/C797S triple mutant (unknown origin) phosphorylation expressed in mouse BaF3 cells by fluorescence based microplate reader analysis,B,CHEMBL5221031,<,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
10963,24959131,CHEMBL5215227,Inhibition of EGFR (unknown origin),B,CHEMBL268501,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
10964,24959132,CHEMBL5215227,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
10965,24959133,CHEMBL5215227,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
10966,24959134,CHEMBL5215227,Inhibition of EGFR (unknown origin),B,CHEMBL31965,=,nM,0.8,CHEMBL203,Homo sapiens,IC50,nM,0.8
10967,24959150,CHEMBL5215241,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5218459,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
10968,24959151,CHEMBL5215241,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins in presence of ATP by caliper mobility shift assay,B,CHEMBL5218990,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
10969,24962904,CHEMBL5216306,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL5221067,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
10970,24962905,CHEMBL5216306,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL939,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
10971,24962906,CHEMBL5216306,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Kinase-Glo Plus luminescence kinase assay,B,CHEMBL941,=,nM,0.11,CHEMBL203,Homo sapiens,IC50,nM,0.11
10972,24976266,CHEMBL5224779,Inhibition of EGFR d746-750/T790M/C797S triple mutant (unknown origin),B,CHEMBL5287438,=,nM,39.6,CHEMBL203,Homo sapiens,IC50,nM,39.6
10973,24976267,CHEMBL5224779,Inhibition of EGFR d746-750/T790M/C797S triple mutant (unknown origin),B,CHEMBL5274514,=,nM,55.3,CHEMBL203,Homo sapiens,IC50,nM,55.3
10974,24976268,CHEMBL5224779,Inhibition of EGFR d746-750/T790M/C797S triple mutant (unknown origin),B,CHEMBL5286055,=,nM,86.5,CHEMBL203,Homo sapiens,IC50,nM,86.5
10975,24976276,CHEMBL5224779,Inhibition of EGFR d746-750/T790M/C797S triple mutant (unknown origin),B,CHEMBL3353410,=,nM,48.6,CHEMBL203,Homo sapiens,IC50,nM,48.6
10976,24976277,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5287438,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
10977,24976278,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5274514,=,nM,0.55,CHEMBL203,Homo sapiens,IC50,nM,0.55
10978,24976279,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5286055,=,nM,7.03,CHEMBL203,Homo sapiens,IC50,nM,7.03
10979,24976280,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5272747,=,nM,13.2,CHEMBL203,Homo sapiens,IC50,nM,13.2
10980,24976281,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5269317,=,nM,0.47,CHEMBL203,Homo sapiens,IC50,nM,0.47
10981,24976282,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5289304,=,nM,0.65,CHEMBL203,Homo sapiens,IC50,nM,0.65
10982,24976283,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5290583,=,nM,0.22,CHEMBL203,Homo sapiens,IC50,nM,0.22
10983,24976284,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5286636,=,nM,0.54,CHEMBL203,Homo sapiens,IC50,nM,0.54
10984,24976285,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5273197,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
10985,24976286,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL5266919,=,nM,2.96,CHEMBL203,Homo sapiens,IC50,nM,2.96
10986,24976287,CHEMBL5224780,Inhibition of EGFR d746-750/T790M double mutant (unknown origin),B,CHEMBL3353410,=,nM,0.058,CHEMBL203,Homo sapiens,IC50,nM,0.058
10987,24976288,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5287438,=,nM,2.92,CHEMBL203,Homo sapiens,IC50,nM,2.92
10988,24976289,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5274514,=,nM,3.45,CHEMBL203,Homo sapiens,IC50,nM,3.45
10989,24976290,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5286055,=,nM,20.1,CHEMBL203,Homo sapiens,IC50,nM,20.1
10990,24976291,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5272747,=,nM,25.2,CHEMBL203,Homo sapiens,IC50,nM,25.2
10991,24976292,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5269317,=,nM,8.31,CHEMBL203,Homo sapiens,IC50,nM,8.31
10992,24976293,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5289304,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,nM,10.0
10993,24976294,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5290583,=,nM,6.49,CHEMBL203,Homo sapiens,IC50,nM,6.49
10994,24976295,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5286636,=,nM,10.5,CHEMBL203,Homo sapiens,IC50,nM,10.5
10995,24976296,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5273197,=,nM,13.2,CHEMBL203,Homo sapiens,IC50,nM,13.2
10996,24976297,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL5266919,=,nM,25.7,CHEMBL203,Homo sapiens,IC50,nM,25.7
10997,24976298,CHEMBL5224781,Inhibition of EGFR L858R/T790M double mutant (unknown origin),B,CHEMBL3353410,=,nM,0.25,CHEMBL203,Homo sapiens,IC50,nM,0.25
10998,24981337,CHEMBL5226148,Inhibition of human EGFR,B,CHEMBL301018,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,nM,9.0
10999,24981338,CHEMBL5226148,Inhibition of human EGFR,B,CHEMBL5272200,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
11000,24984416,CHEMBL5227275,Inhibition of human EGFR,B,CHEMBL554,=,nM,10.2,CHEMBL203,Homo sapiens,IC50,nM,10.2
11001,24985438,CHEMBL5227743,Inhibition of EGFR (unknown origin),B,CHEMBL5282499,=,nM,4900.0,CHEMBL203,Homo sapiens,IC50,uM,4.9
11002,24987115,CHEMBL5228411,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,48.0,CHEMBL203,Homo sapiens,IC50,nM,48.0
11003,24987116,CHEMBL5228411,Inhibition of EGFR (unknown origin),B,CHEMBL4163321,=,nM,320.0,CHEMBL203,Homo sapiens,IC50,uM,0.32
11004,24987506,CHEMBL5228534,Inhibition of human EGFR in presence of ATP by Kinase-Glo Plus luminescence kinase assay kit method,B,CHEMBL5281486,=,nM,4180.0,CHEMBL203,Homo sapiens,IC50,uM,4.18
11005,24987532,CHEMBL5228551,Inhibition of EGFR (unknown origin) by EGFR Kinase Assay Kit method,B,CHEMBL5288191,=,nM,5827.0,CHEMBL203,Homo sapiens,IC50,uM,5.827
11006,24987549,CHEMBL5228560,Inhibition of GST-fused EGFR (unknown origin) in presence of ATP by microplate reader analysis,B,CHEMBL5186583,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,uM,0.093
11007,24987550,CHEMBL5228560,Inhibition of GST-fused EGFR (unknown origin) in presence of ATP by microplate reader analysis,B,CHEMBL5283543,=,nM,75.2,CHEMBL203,Homo sapiens,IC50,nM,75.2
11008,24987551,CHEMBL5228560,Inhibition of GST-fused EGFR (unknown origin) in presence of ATP by microplate reader analysis,B,CHEMBL5284528,=,nM,867.0,CHEMBL203,Homo sapiens,IC50,uM,0.867
11009,24987552,CHEMBL5228560,Inhibition of GST-fused EGFR (unknown origin) in presence of ATP by microplate reader analysis,B,CHEMBL5206193,=,nM,31.2,CHEMBL203,Homo sapiens,IC50,nM,31.2
11010,24987554,CHEMBL5228562,Inhibition of EGFR (unknown origin) phosphorylation by ELISA,B,CHEMBL5276251,=,nM,90.0,CHEMBL203,Homo sapiens,IC50,uM,0.09
11011,24987563,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL5272853,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
11012,24987564,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL5280359,=,nM,10.3,CHEMBL203,Homo sapiens,IC50,uM,0.0103
11013,24987565,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL5287477,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
11014,24987566,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL4072410,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
11015,24987567,CHEMBL5228569,Inhibition of EGFR (unknown origin),B,CHEMBL5275784,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
11016,24987579,CHEMBL5228581,Inhibition of EGFR (unknown origin) by ELISA,B,CHEMBL5266387,=,nM,38.8,CHEMBL203,Homo sapiens,IC50,uM,0.0388
11017,24987584,CHEMBL5228585,Inhibition of EGFR (unknown origin) phosphorylation using kit-tyr4 peptide as substrate incubated for 1 hr in presence of ATP by UV-Vis spectrophotometer,B,CHEMBL5286373,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
11018,24987606,CHEMBL5228600,Inhibition of wild type EGFR (unknown origin) incubated for 40 mins in presence of ATP by kinase-glo plus luminescence assay,B,CHEMBL5191956,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
11019,24987607,CHEMBL5228601,Inhibition of EGFR T790M mutant (unknown origin) incubated for 40 mins in presence of ATP by kinase-glo plus luminescence assay,B,CHEMBL5191956,=,nM,5000.0,CHEMBL203,Homo sapiens,IC50,uM,5.0
11020,24993019,CHEMBL5230642,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
11021,24993529,CHEMBL5230828,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 min in presence of ATP by TR-FRET assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11022,24993530,CHEMBL5230828,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 min in presence of ATP by TR-FRET assay,B,CHEMBL1173655,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11023,24993531,CHEMBL5230828,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 min in presence of ATP by TR-FRET assay,B,CHEMBL5272590,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
11024,24993532,CHEMBL5230828,Inhibition of EGFR (unknown origin) using TK as substrate incubated for 30 min in presence of ATP by TR-FRET assay,B,CHEMBL3353410,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11025,24993533,CHEMBL5230829,Inhibition of EGFR L858R mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11026,24993534,CHEMBL5230829,Inhibition of EGFR L858R mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL1173655,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11027,24993535,CHEMBL5230829,Inhibition of EGFR L858R mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL5272590,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
11028,24993536,CHEMBL5230829,Inhibition of EGFR L858R mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11029,24993537,CHEMBL5230830,Inhibition of EGFR L858R/T790M mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL1173655,=,nM,185.0,CHEMBL203,Homo sapiens,IC50,nM,185.0
11030,24993538,CHEMBL5230830,Inhibition of EGFR L858R/T790M mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL939,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11031,24993539,CHEMBL5230830,Inhibition of EGFR L858R/T790M mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL5272590,=,nM,1682.0,CHEMBL203,Homo sapiens,IC50,nM,1682.0
11032,24993540,CHEMBL5230830,Inhibition of EGFR L858R/T790M mutant (unknown origin) using TK as substrate incubated for 1 hrs in presence of ATP by TR-FRET assay,B,CHEMBL3353410,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11033,24993541,CHEMBL5230831,Inhibition of human EGFR incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL553,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
11034,24993542,CHEMBL5230831,Inhibition of human EGFR incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL5277831,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
11035,24993543,CHEMBL5230831,Inhibition of human EGFR incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL5280584,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,uM,0.012
11036,24993544,CHEMBL5230831,Inhibition of human EGFR incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL5281270,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
11037,24993557,CHEMBL5230835,Inhibition of EGFR (unknown origin) incubated for 1 hrs by ELISA assay,B,CHEMBL553,=,nM,520.0,CHEMBL203,Homo sapiens,IC50,uM,0.52
11038,24993558,CHEMBL5230835,Inhibition of EGFR (unknown origin) incubated for 1 hrs by ELISA assay,B,CHEMBL5270336,=,nM,640.0,CHEMBL203,Homo sapiens,IC50,uM,0.64
11039,24993570,CHEMBL5230842,Inhibition of EGFR (unknown origin),B,CHEMBL554,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
11040,24993571,CHEMBL5230842,Inhibition of EGFR (unknown origin),B,CHEMBL5270419,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,uM,0.12
11041,24993572,CHEMBL5230842,Inhibition of EGFR (unknown origin),B,CHEMBL5199520,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
11042,24993573,CHEMBL5230842,Inhibition of EGFR (unknown origin),B,CHEMBL1336,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
11043,24993598,CHEMBL5230853,Inhibition of EGFR (unknown origin) by microplate reader analysis,B,CHEMBL553,=,nM,201.34,CHEMBL203,Homo sapiens,IC50,nM,201.34
11044,24993599,CHEMBL5230853,Inhibition of EGFR (unknown origin) by microplate reader analysis,B,CHEMBL5282557,=,nM,157.63,CHEMBL203,Homo sapiens,IC50,nM,157.63
11045,24993632,CHEMBL5230862,Inhibition of human EGFR incubated for 10 mins in presence of ATP by mobility shift assay,B,CHEMBL1336,=,nM,56.0,CHEMBL203,Homo sapiens,IC50,nM,56.0
11046,24993646,CHEMBL5230868,Inhibition of EGFR L858R/T790M (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL939,=,nM,832.3,CHEMBL203,Homo sapiens,IC50,nM,832.3
11047,24993647,CHEMBL5230868,Inhibition of EGFR L858R/T790M (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL5283875,=,nM,4.3,CHEMBL203,Homo sapiens,IC50,nM,4.3
11048,24993648,CHEMBL5230868,Inhibition of EGFR L858R/T790M (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL3545308,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
11049,24993649,CHEMBL5230869,Inhibition of EGFR (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL939,=,nM,15.5,CHEMBL203,Homo sapiens,IC50,nM,15.5
11050,24993650,CHEMBL5230869,Inhibition of EGFR (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL5283875,=,nM,24.4,CHEMBL203,Homo sapiens,IC50,nM,24.4
11051,24993651,CHEMBL5230869,Inhibition of EGFR (unknown origin) incubated for 60 mins in presence of ATP by ADP-Glo kinase assay,B,CHEMBL3545308,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
11052,24993667,CHEMBL5230875,Inhibition of human EGFR incubated for 2 hrs by ELISA assay,B,CHEMBL939,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,uM,0.045
11053,24993668,CHEMBL5230875,Inhibition of human EGFR incubated for 2 hrs by ELISA assay,B,CHEMBL5286575,=,nM,21.4,CHEMBL203,Homo sapiens,IC50,uM,0.0214
11054,24993675,CHEMBL5230879,Inhibition of EGFR (unknown origin) incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL553,=,nM,6210.0,CHEMBL203,Homo sapiens,IC50,uM,6.21
11055,24993676,CHEMBL5230879,Inhibition of EGFR (unknown origin) incubated for 1 hrs in presence of ATP by ELISA assay,B,CHEMBL5286730,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
11056,24993687,CHEMBL5230885,Inhibition of EGFR (unknown origin) incubated for 10 mins in presence of ATP by mobility shift assay,B,CHEMBL1173655,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
11057,24993688,CHEMBL5230885,Inhibition of EGFR (unknown origin) incubated for 10 mins in presence of ATP by mobility shift assay,B,CHEMBL5271803,=,nM,0.05,CHEMBL203,Homo sapiens,IC50,nM,0.05
11058,24993689,CHEMBL5230886,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 10 mins in presence of ATP by mobility shift assay,B,CHEMBL1173655,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
11059,24993690,CHEMBL5230886,Inhibition of EGFR L858R/T790M mutant (unknown origin) incubated for 10 mins in presence of ATP by mobility shift assay,B,CHEMBL5271803,=,nM,5.6,CHEMBL203,Homo sapiens,IC50,nM,5.6
11060,24993699,CHEMBL5230889,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL939,=,nM,3.25,CHEMBL203,Homo sapiens,IC50,nM,3.25
11061,24993700,CHEMBL5230889,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL1173655,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,nM,4.0
11062,24993701,CHEMBL5230889,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL5289358,=,nM,6.3,CHEMBL203,Homo sapiens,IC50,nM,6.3
11063,24993702,CHEMBL5230889,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL1173655,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
11064,24993703,CHEMBL5230889,Inhibition of EGFR (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL4168254,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,nM,5.0
11065,24993704,CHEMBL5230890,Inhibition of EGFR L858R/T790M mutant (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL939,=,nM,823.7,CHEMBL203,Homo sapiens,IC50,nM,823.7
11066,24993705,CHEMBL5230890,Inhibition of EGFR L858R/T790M mutant (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL1173655,=,nM,3.8,CHEMBL203,Homo sapiens,IC50,nM,3.8
11067,24993706,CHEMBL5230890,Inhibition of EGFR L858R/T790M mutant (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL5289358,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
11068,24993707,CHEMBL5230891,Inhibition of recombinant EGFR (unknown origin) using by ELISA assay,B,CHEMBL554,=,nM,27.06,CHEMBL203,Homo sapiens,IC50,nM,27.06
11069,24993708,CHEMBL5230891,Inhibition of recombinant EGFR (unknown origin) using by ELISA assay,B,CHEMBL5280092,=,nM,15.6,CHEMBL203,Homo sapiens,IC50,nM,15.6
11070,24993717,CHEMBL5230896,Inhibition of EGFR T790M (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL1173655,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
11071,24993718,CHEMBL5230896,Inhibition of EGFR T790M (unknown origin) using FAM-labeled peptide as substrate incubated for 10 mins by mobility shift assay,B,CHEMBL4168254,=,nM,26.0,CHEMBL203,Homo sapiens,IC50,nM,26.0
11072,24993721,CHEMBL5230898,Inhibition of human EGFR using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL939,=,nM,0.96,CHEMBL203,Homo sapiens,IC50,nmol/L,0.96
11073,24993722,CHEMBL5230898,Inhibition of human EGFR using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL5281903,=,nM,0.81,CHEMBL203,Homo sapiens,IC50,nmol/L,0.81
11074,24993723,CHEMBL5230899,Inhibition of human EGFR d746-750 mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL939,=,nM,1.43,CHEMBL203,Homo sapiens,IC50,nmol/L,1.43
11075,24993724,CHEMBL5230899,Inhibition of human EGFR d746-750 mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL5281903,=,nM,1.23,CHEMBL203,Homo sapiens,IC50,nmol/L,1.23
11076,24993725,CHEMBL5230900,Inhibition of human EGFR L858R mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL939,=,nM,1.268,CHEMBL203,Homo sapiens,IC50,nmol/L,1.268
11077,24993726,CHEMBL5230900,Inhibition of human EGFR L858R mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL5281903,=,nM,1.05,CHEMBL203,Homo sapiens,IC50,nmol/L,1.05
11078,24993727,CHEMBL5230901,Inhibition of human EGFR L858R/T790M mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL939,=,nM,296.4,CHEMBL203,Homo sapiens,IC50,nmol/L,296.4
11079,24993728,CHEMBL5230901,Inhibition of human EGFR L858R/T790M mutant using 5-FAM-EEPLYWSFPAKKKCONH2 as substrate incubated for 30 mins in presence of ATP,B,CHEMBL5281903,=,nM,208.9,CHEMBL203,Homo sapiens,IC50,nmol/L,208.9
11080,24995091,CHEMBL5231460,"Inhibition of EGFR (unknown origin) using Poly(Glu, Tyr) as substrate incubated for 45 mins in presence of ATP by ADP-Glo luminescent assay",B,CHEMBL5181237,=,nM,3.76,CHEMBL203,Homo sapiens,IC50,nM,3.76
11081,24997676,CHEMBL5232098,Inhibition of wild type human EGFR measured by ELISA analysis,B,CHEMBL5291481,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102
11082,24997677,CHEMBL5232098,Inhibition of wild type human EGFR measured by ELISA analysis,B,CHEMBL5279539,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
11083,24999311,CHEMBL5232555,Inhibition of EGFR (unknown origin),B,CHEMBL5286675,=,nM,2230.0,CHEMBL203,Homo sapiens,IC50,uM,2.23
11084,24999312,CHEMBL5232555,Inhibition of EGFR (unknown origin),B,CHEMBL5284920,=,nM,1110.0,CHEMBL203,Homo sapiens,IC50,uM,1.11
11085,24999313,CHEMBL5232555,Inhibition of EGFR (unknown origin),B,CHEMBL1336,=,nM,1140.0,CHEMBL203,Homo sapiens,IC50,uM,1.14
11086,24999314,CHEMBL5232555,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
11087,24999351,CHEMBL5232559,Inhibition of human EGFR,B,CHEMBL5274305,=,nM,37.07,CHEMBL203,Homo sapiens,IC50,nM,37.07
11088,24999352,CHEMBL5232559,Inhibition of human EGFR,B,CHEMBL5273741,=,nM,31.8,CHEMBL203,Homo sapiens,IC50,nM,31.8
11089,24999353,CHEMBL5232559,Inhibition of human EGFR,B,CHEMBL5269307,=,nM,42.52,CHEMBL203,Homo sapiens,IC50,nM,42.52
11090,24999354,CHEMBL5232559,Inhibition of human EGFR,B,CHEMBL939,=,nM,29.16,CHEMBL203,Homo sapiens,IC50,nM,29.16
11091,25001912,CHEMBL5233313,Inhibition of recombinant HER1 (645 to 1186 residues) (unknown origin) expressed in baculovirus infected sf9 cells autophosphorylation incubated for 1 hrs in presence of ATP by time-resolved fluorometry,B,CHEMBL180022,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,nM,92.0
11092,25003721,CHEMBL5234031,Inhibition of human EGFR T790M mutant (696 to 1022 residues) expressed in insect sf9 cells in presence of ATP by HTRF assay,B,CHEMBL4214567,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
11093,25003722,CHEMBL5234032,Inhibition of human EGFR L858R/T790M mutant (696 to 1022 residues) expressed in insect sf9 cells in presence of ATP by HTRF assay,B,CHEMBL4443062,=,nM,0.26,CHEMBL203,Homo sapiens,IC50,nM,0.26
11094,25011333,CHEMBL5236808,Inhibition of EGF-R (unknown origin),B,CHEMBL5267342,<,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
11095,25015449,CHEMBL5238131,Inhibition of EGFR (unknown origin),B,CHEMBL4286374,=,nM,120.0,CHEMBL203,Homo sapiens,IC50,nM,120.0
11096,25015450,CHEMBL5238131,Inhibition of EGFR (unknown origin),B,CHEMBL939,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,nM,33.0
11097,25015451,CHEMBL5238131,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11098,25018367,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL3353410,=,nM,300.0,CHEMBL203,Homo sapiens,IC50,nM,300.0
11099,25018368,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL1173655,=,nM,3.5,CHEMBL203,Homo sapiens,IC50,nM,3.5
11100,25018369,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL3545308,=,nM,1983.0,CHEMBL203,Homo sapiens,IC50,nM,1983.0
11101,25018370,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL4104658,=,nM,405.0,CHEMBL203,Homo sapiens,IC50,nM,405.0
11102,25018371,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5291010,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,nM,210.0
11103,25018372,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5266482,=,nM,71.0,CHEMBL203,Homo sapiens,IC50,nM,71.0
11104,25018373,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5284255,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,nM,36.0
11105,25018374,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5266896,=,nM,288.0,CHEMBL203,Homo sapiens,IC50,nM,288.0
11106,25018375,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5286532,=,nM,2969.0,CHEMBL203,Homo sapiens,IC50,nM,2969.0
11107,25018376,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL3353404,=,nM,95.0,CHEMBL203,Homo sapiens,IC50,nM,95.0
11108,25018377,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5283216,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
11109,25018378,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5279491,=,nM,42.0,CHEMBL203,Homo sapiens,IC50,nM,42.0
11110,25018379,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5281266,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
11111,25018380,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5286091,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,nM,40.0
11112,25018381,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5275712,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,nM,32.0
11113,25018382,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5279794,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,nM,39.0
11114,25018383,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5276760,=,nM,147.0,CHEMBL203,Homo sapiens,IC50,nM,147.0
11115,25018384,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5271640,=,nM,45.0,CHEMBL203,Homo sapiens,IC50,nM,45.0
11116,25018385,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5270000,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
11117,25018386,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5271718,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,nM,49.0
11118,25018387,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5266834,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
11119,25018388,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5291353,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
11120,25018389,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5284387,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
11121,25018390,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5284486,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,nM,20.0
11122,25018391,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5268143,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
11123,25018392,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL4650319,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,nM,31.0
11124,25018393,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5273438,=,nM,84.0,CHEMBL203,Homo sapiens,IC50,nM,84.0
11125,25018394,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5272345,=,nM,142.0,CHEMBL203,Homo sapiens,IC50,nM,142.0
11126,25018395,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5266798,=,nM,24.0,CHEMBL203,Homo sapiens,IC50,nM,24.0
11127,25018396,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5281203,=,nM,224.0,CHEMBL203,Homo sapiens,IC50,nM,224.0
11128,25018397,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5266100,=,nM,79.0,CHEMBL203,Homo sapiens,IC50,nM,79.0
11129,25018398,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5290929,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,nM,43.0
11130,25018399,CHEMBL5238849,Inhibition of EGR-induced EGFR phosphorylation in human A549 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL5270335,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,nM,57.0
11131,25018495,CHEMBL5238867,Inhibition of EGR-induced wild type EGFR phosphorylation in human A-431 cells pretreated for 2 hrs followed by EGF stimulation by immune assay,B,CHEMBL4650319,=,nM,34.5,CHEMBL203,Homo sapiens,IC50,nM,34.5
11132,25023159,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5269391,=,nM,87.27,CHEMBL203,Homo sapiens,IC50,nM,87.27
11133,25023160,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5287505,=,nM,120.5,CHEMBL203,Homo sapiens,IC50,nM,120.5
11134,25023161,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5280531,=,nM,937.7,CHEMBL203,Homo sapiens,IC50,nM,937.7
11135,25023162,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5269684,=,nM,47.22,CHEMBL203,Homo sapiens,IC50,nM,47.22
11136,25023163,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5275916,=,nM,45.6,CHEMBL203,Homo sapiens,IC50,nM,45.6
11137,25023164,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5267140,=,nM,534.0,CHEMBL203,Homo sapiens,IC50,nM,534.0
11138,25023165,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5278452,=,nM,70.61,CHEMBL203,Homo sapiens,IC50,nM,70.61
11139,25023166,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5271937,=,nM,70.28,CHEMBL203,Homo sapiens,IC50,nM,70.28
11140,25023167,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5271978,=,nM,837.8,CHEMBL203,Homo sapiens,IC50,nM,837.8
11141,25023168,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5286368,=,nM,25.69,CHEMBL203,Homo sapiens,IC50,nM,25.69
11142,25023169,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5276304,=,nM,40.7,CHEMBL203,Homo sapiens,IC50,nM,40.7
11143,25023170,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5290595,=,nM,148.4,CHEMBL203,Homo sapiens,IC50,nM,148.4
11144,25023171,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL939,=,nM,11.75,CHEMBL203,Homo sapiens,IC50,nM,11.75
11145,25023172,CHEMBL5240016,Inhibition of wild type EGFR (unknown origin) autophosphorylation by Kinase-Glo luminescent assay,B,CHEMBL5284397,=,nM,10.29,CHEMBL203,Homo sapiens,IC50,nM,10.29
11146,25023542,CHEMBL5240117,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
11147,25023543,CHEMBL5240117,Inhibition of EGFR (unknown origin),B,CHEMBL5275672,=,nM,64.65,CHEMBL203,Homo sapiens,IC50,nM,64.65
11148,25028977,CHEMBL5241194,Inhibition of human EGFR,B,CHEMBL5277101,=,nM,610.0,CHEMBL203,Homo sapiens,IC50,uM,0.61
11149,25028981,CHEMBL5241198,Inhibition of human EGFR phosphorylation by invitro enzyme assay,B,CHEMBL5290094,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102
11150,25030068,CHEMBL5241413,Inhibition of EGFR (unknown origin) by Z'-LYTE Kinase assay,B,CHEMBL4092990,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,nM,43.0
11151,25030069,CHEMBL5241414,Inhibition of EGFR (unknown origin) using biotin as substrate incubated for 1 hrs in the presence of ATP by HTRF assay,B,CHEMBL4077930,=,nM,86.2,CHEMBL203,Homo sapiens,IC50,nM,86.2
11152,25033656,CHEMBL5242666,Inhibition of wildtype EGFR (unknown origin) by ELISA,B,CHEMBL5203118,=,nM,28.8,CHEMBL203,Homo sapiens,IC50,nM,28.8
11153,25033657,CHEMBL5242666,Inhibition of wildtype EGFR (unknown origin) by ELISA,B,CHEMBL5200275,=,nM,47.4,CHEMBL203,Homo sapiens,IC50,nM,47.4
11154,25033659,CHEMBL5242668,Inhibition of EGFR (unknown origin),B,CHEMBL5289623,=,nM,4310.0,CHEMBL203,Homo sapiens,IC50,nM,4310.0
11155,25035245,CHEMBL5243099,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by ADP-Glo kinase assay,B,CHEMBL5273124,=,nM,2800.0,CHEMBL203,Homo sapiens,IC50,uM,2.8
11156,25035246,CHEMBL5243099,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by ADP-Glo kinase assay,B,CHEMBL553,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
11157,25036499,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4650281,=,nM,1.1,CHEMBL203,Homo sapiens,IC50,nM,1.1
11158,25036500,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4090601,=,nM,16.0,CHEMBL203,Homo sapiens,IC50,nM,16.0
11159,25036501,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4095447,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
11160,25036502,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL4094959,=,nM,58.0,CHEMBL203,Homo sapiens,IC50,nM,58.0
11161,25036503,CHEMBL5243469,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5268867,=,nM,13.0,CHEMBL203,Homo sapiens,IC50,nM,13.0
11162,25036505,CHEMBL5243471,Inhibition of EGFR (unknown origin),B,CHEMBL5286014,=,nM,65.0,CHEMBL203,Homo sapiens,IC50,nM,65.0
11163,25036510,CHEMBL5243475,Inhibition of EGFR T790M/C797S mutant (unknown origin),B,CHEMBL4090601,<,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11164,25036511,CHEMBL5243475,Inhibition of EGFR T790M/C797S mutant (unknown origin),B,CHEMBL4095447,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
11165,25036512,CHEMBL5243475,Inhibition of EGFR T790M/C797S mutant (unknown origin),B,CHEMBL4094959,=,nM,1.9,CHEMBL203,Homo sapiens,IC50,nM,1.9
11166,25036513,CHEMBL5243476,Inhibition of EGFR L858R T790M/C797S mutant (unknown origin),B,CHEMBL4090601,=,nM,88.0,CHEMBL203,Homo sapiens,IC50,nM,88.0
11167,25036514,CHEMBL5243477,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5268867,=,nM,2.0,CHEMBL203,Homo sapiens,IC50,nM,2.0
11168,25036515,CHEMBL5243478,Inhibition of EGFR L858R/T790M mutant (unknown origin),B,CHEMBL5268867,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
11169,25036561,CHEMBL5243511,Inhibition of human recombinant His-tagged EGFR expressed in baculovirus using poly-Gluo-Tyr as a substrate measured after 24 hrs by western blot analysis,B,CHEMBL475584,=,nM,150.0,CHEMBL203,Homo sapiens,IC50,nM,150.0
11170,25037442,CHEMBL5243749,Inhibition of EGFR (unknown origin),B,CHEMBL1095259,=,nM,44640.0,CHEMBL203,Homo sapiens,IC50,uM,44.64
11171,25037443,CHEMBL5243749,Inhibition of EGFR (unknown origin),B,CHEMBL4575427,=,nM,44640.0,CHEMBL203,Homo sapiens,IC50,uM,44.64
11172,25043255,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL5279914,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
11173,25043256,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL1830231,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
11174,25043257,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL4279709,=,nM,5480.0,CHEMBL203,Homo sapiens,IC50,uM,5.48
11175,25043258,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL1821869,=,nM,60.0,CHEMBL203,Homo sapiens,IC50,uM,0.06
11176,25043259,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL3114107,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
11177,25043260,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL5269346,=,nM,8280.0,CHEMBL203,Homo sapiens,IC50,uM,8.28
11178,25043261,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL5275471,=,nM,10100.0,CHEMBL203,Homo sapiens,IC50,uM,10.1
11179,25043262,CHEMBL5245316,Inhibition of EGFR (unknown origin),B,CHEMBL5274657,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
11180,25046103,CHEMBL5246174,Inhibition of EGFR (unknown origin) infected in insect sf9 cells incubated for 1 hrs in presence of ATP,B,CHEMBL4216765,=,nM,3600.0,CHEMBL203,Homo sapiens,IC50,uM,3.6
11181,25046104,CHEMBL5246174,Inhibition of EGFR (unknown origin) infected in insect sf9 cells incubated for 1 hrs in presence of ATP,B,CHEMBL5287053,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
11182,25059890,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5288957,=,nM,609.0,CHEMBL203,Homo sapiens,IC50,uM,0.609
11183,25059891,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5274670,=,nM,672.0,CHEMBL203,Homo sapiens,IC50,uM,0.672
11184,25059893,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5284848,=,nM,128.0,CHEMBL203,Homo sapiens,IC50,uM,0.128
11185,25059894,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5271568,=,nM,142.0,CHEMBL203,Homo sapiens,IC50,uM,0.142
11186,25059895,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5281945,=,nM,679.0,CHEMBL203,Homo sapiens,IC50,uM,0.679
11187,25059896,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5289352,=,nM,550.0,CHEMBL203,Homo sapiens,IC50,uM,0.55
11188,25059897,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5280288,=,nM,712.0,CHEMBL203,Homo sapiens,IC50,uM,0.712
11189,25059902,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL24828,=,nM,369.0,CHEMBL203,Homo sapiens,IC50,uM,0.369
11190,25059903,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL3545311,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
11191,25059904,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5268092,=,nM,47.0,CHEMBL203,Homo sapiens,IC50,uM,0.047
11192,25059905,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5290503,=,nM,952.0,CHEMBL203,Homo sapiens,IC50,uM,0.952
11193,25059906,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5271155,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,uM,0.034
11194,25059908,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5275486,=,nM,107.0,CHEMBL203,Homo sapiens,IC50,uM,0.107
11195,25059909,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5280471,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,uM,0.007
11196,25059910,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5284179,=,nM,22.0,CHEMBL203,Homo sapiens,IC50,uM,0.022
11197,25059911,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5290340,=,nM,20.0,CHEMBL203,Homo sapiens,IC50,uM,0.02
11198,25059912,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5279933,=,nM,41.0,CHEMBL203,Homo sapiens,IC50,uM,0.041
11199,25059913,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5268062,=,nM,160.0,CHEMBL203,Homo sapiens,IC50,uM,0.16
11200,25059914,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5284866,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
11201,25059915,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5273000,=,nM,36.0,CHEMBL203,Homo sapiens,IC50,uM,0.036
11202,25059916,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5290879,=,nM,729.0,CHEMBL203,Homo sapiens,IC50,uM,0.729
11203,25059917,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5273342,=,nM,352.0,CHEMBL203,Homo sapiens,IC50,uM,0.352
11204,25059918,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5280575,=,nM,891.0,CHEMBL203,Homo sapiens,IC50,uM,0.891
11205,25059919,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5280292,=,nM,337.0,CHEMBL203,Homo sapiens,IC50,uM,0.337
11206,25059920,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5273994,=,nM,3754.0,CHEMBL203,Homo sapiens,IC50,uM,3.754
11207,25059921,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL5265927,=,nM,230.0,CHEMBL203,Homo sapiens,IC50,uM,0.23
11208,25059927,CHEMBL5250194,Inhibition of EGFR L858R/T790M/C797S triple mutant (unknown origin) expressed in Bac-to-Bac baculovirus expression system measured after 2 hrs by ELISA method,B,CHEMBL97771,=,nM,373.0,CHEMBL203,Homo sapiens,IC50,uM,0.373
11209,25066902,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3973435,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
11210,25066903,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3935034,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
11211,25066904,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3902845,=,nM,1.7,CHEMBL203,Homo sapiens,IC50,nM,1.7
11212,25066905,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5274187,=,nM,61.0,CHEMBL203,Homo sapiens,IC50,nM,61.0
11213,25066906,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3927293,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
11214,25066907,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5266785,=,nM,4713.0,CHEMBL203,Homo sapiens,IC50,nM,4713.0
11215,25066908,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5265797,=,nM,2458.0,CHEMBL203,Homo sapiens,IC50,nM,2458.0
11216,25066909,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5266477,=,nM,713.0,CHEMBL203,Homo sapiens,IC50,nM,713.0
11217,25066910,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5283553,=,nM,603.0,CHEMBL203,Homo sapiens,IC50,nM,603.0
11218,25066911,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5272121,=,nM,656.0,CHEMBL203,Homo sapiens,IC50,nM,656.0
11219,25066912,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5286702,=,nM,1999.0,CHEMBL203,Homo sapiens,IC50,nM,1999.0
11220,25066913,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5289250,=,nM,1760.0,CHEMBL203,Homo sapiens,IC50,nM,1760.0
11221,25066914,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5266481,=,nM,3326.0,CHEMBL203,Homo sapiens,IC50,nM,3326.0
11222,25066919,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5272694,=,nM,4496.0,CHEMBL203,Homo sapiens,IC50,nM,4496.0
11223,25066920,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5288582,=,nM,271.0,CHEMBL203,Homo sapiens,IC50,nM,271.0
11224,25066921,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5273525,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,nM,100.0
11225,25066922,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5266823,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
11226,25066923,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5268388,=,nM,129.0,CHEMBL203,Homo sapiens,IC50,nM,129.0
11227,25066924,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3936761,=,nM,2.6,CHEMBL203,Homo sapiens,IC50,nM,2.6
11228,25066925,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5275348,=,nM,1092.0,CHEMBL203,Homo sapiens,IC50,nM,1092.0
11229,25066926,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5276374,=,nM,621.0,CHEMBL203,Homo sapiens,IC50,nM,621.0
11230,25066927,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5288751,=,nM,450.0,CHEMBL203,Homo sapiens,IC50,nM,450.0
11231,25066928,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5282956,=,nM,18.0,CHEMBL203,Homo sapiens,IC50,nM,18.0
11232,25066929,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5272404,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,nM,64.0
11233,25066930,CHEMBL5251900,Inhibition of EGFR (unknown origin) preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL3932338,=,nM,2613.0,CHEMBL203,Homo sapiens,IC50,nM,2613.0
11234,25067027,CHEMBL5251914,Inhibition of human EGFR preincubated for 1 hrs followed by substrate addition and measured after 1 hrs in the presence of ATP at Km concentration by TR-FRET assay,B,CHEMBL5276374,=,nM,621.0,CHEMBL203,Homo sapiens,IC50,nM,621.0
11235,25067046,CHEMBL5251928,Inhibition of EGFR autophosphorylation at Tyr1068 residue in EGFR-amplified human A-431 cells preincubated with compound for 1 hrs followed by stimulation with human recombinant EGF and measured after 10 mins by HTRF-based analysis,B,CHEMBL3973435,=,nM,370.0,CHEMBL203,Homo sapiens,IC50,nM,370.0
11236,25067047,CHEMBL5251928,Inhibition of EGFR autophosphorylation at Tyr1068 residue in EGFR-amplified human A-431 cells preincubated with compound for 1 hrs followed by stimulation with human recombinant EGF and measured after 10 mins by HTRF-based analysis,B,CHEMBL1873475,=,nM,170.0,CHEMBL203,Homo sapiens,IC50,nM,170.0
11237,25067049,CHEMBL5251928,Inhibition of EGFR autophosphorylation at Tyr1068 residue in EGFR-amplified human A-431 cells preincubated with compound for 1 hrs followed by stimulation with human recombinant EGF and measured after 10 mins by HTRF-based analysis,B,CHEMBL4650321,=,nM,5900.0,CHEMBL203,Homo sapiens,IC50,nM,5900.0
11238,25067053,CHEMBL5251928,Inhibition of EGFR autophosphorylation at Tyr1068 residue in EGFR-amplified human A-431 cells preincubated with compound for 1 hrs followed by stimulation with human recombinant EGF and measured after 10 mins by HTRF-based analysis,B,CHEMBL4650323,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,nM,74.0
11239,25072993,CHEMBL5253395,Inhibition of human EGFR L858R mutant phosphorylation in human NSCLC cells,B,CHEMBL939,=,nM,7.0,CHEMBL203,Homo sapiens,IC50,nM,7.0
11240,25073465,CHEMBL5253687,Inhibition of EGFR (unknown origin) using flurogenic substrate in presence of ATP,B,CHEMBL5270270,=,nM,44.0,CHEMBL203,Homo sapiens,IC50,nM,44.0
11241,25073488,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280555,=,nM,3900.0,CHEMBL203,Homo sapiens,IC50,uM,3.9
11242,25073489,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5273791,=,nM,850.0,CHEMBL203,Homo sapiens,IC50,uM,0.85
11243,25073490,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5276357,=,nM,1500.0,CHEMBL203,Homo sapiens,IC50,uM,1.5
11244,25073491,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5285503,=,nM,96.0,CHEMBL203,Homo sapiens,IC50,uM,0.096
11245,25073492,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282716,=,nM,210.0,CHEMBL203,Homo sapiens,IC50,uM,0.21
11246,25073494,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280589,=,nM,580.0,CHEMBL203,Homo sapiens,IC50,uM,0.58
11247,25073495,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282118,=,nM,218.0,CHEMBL203,Homo sapiens,IC50,uM,0.218
11248,25073496,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL553,=,nM,6.0,CHEMBL203,Homo sapiens,IC50,uM,0.006
11249,25073497,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL939,=,nM,8.0,CHEMBL203,Homo sapiens,IC50,uM,0.008
11250,25073498,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL1173655,=,nM,4.0,CHEMBL203,Homo sapiens,IC50,uM,0.004
11251,25073499,CHEMBL5253702,Inhibition of EGFR autophosphorylation in human NCI-H292 cells harboring harboring wild type EGFR preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL3353410,=,nM,483.0,CHEMBL203,Homo sapiens,IC50,uM,0.483
11252,25073500,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280555,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,uM,0.08
11253,25073501,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5273791,=,nM,76.0,CHEMBL203,Homo sapiens,IC50,uM,0.076
11254,25073502,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5276357,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
11255,25073503,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5285503,=,nM,28.0,CHEMBL203,Homo sapiens,IC50,uM,0.028
11256,25073504,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282716,=,nM,130.0,CHEMBL203,Homo sapiens,IC50,uM,0.13
11257,25073505,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5281446,=,nM,3000.0,CHEMBL203,Homo sapiens,IC50,uM,3.0
11258,25073506,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280589,=,nM,57.0,CHEMBL203,Homo sapiens,IC50,uM,0.057
11259,25073507,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282118,=,nM,33.0,CHEMBL203,Homo sapiens,IC50,uM,0.033
11260,25073508,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL553,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,uM,0.003
11261,25073509,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL939,=,nM,5.0,CHEMBL203,Homo sapiens,IC50,uM,0.005
11262,25073510,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL1173655,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,uM,0.001
11263,25073511,CHEMBL5253703,Inhibition of EGFR del (746 to 750) mutant autophosphorylation in human PC-9 cells harboring harboring EGFR del (746 to 750) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL3353410,=,nM,31.0,CHEMBL203,Homo sapiens,IC50,uM,0.031
11264,25073512,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280555,=,nM,14.0,CHEMBL203,Homo sapiens,IC50,uM,0.014
11265,25073513,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5273791,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
11266,25073514,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5276357,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
11267,25073515,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5285503,=,nM,8.1,CHEMBL203,Homo sapiens,IC50,uM,0.0081
11268,25073516,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282716,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
11269,25073517,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5281446,=,nM,910.0,CHEMBL203,Homo sapiens,IC50,uM,0.91
11270,25073518,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280589,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,uM,0.015
11271,25073519,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282118,=,nM,9.0,CHEMBL203,Homo sapiens,IC50,uM,0.009
11272,25073520,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL553,=,nM,1800.0,CHEMBL203,Homo sapiens,IC50,uM,1.8
11273,25073521,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL939,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
11274,25073522,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL1173655,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
11275,25073523,CHEMBL5253704,Inhibition of EGFR T790M/del (746 to 750 residues) mutant autophosphorylation in human PC-9/ER1 cells harboring harboring EGFR T790M/del (746 to 750 residues) mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL3353410,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,uM,0.017
11276,25073524,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280555,=,nM,64.0,CHEMBL203,Homo sapiens,IC50,uM,0.064
11277,25073525,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5273791,=,nM,74.0,CHEMBL203,Homo sapiens,IC50,uM,0.074
11278,25073526,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5276357,=,nM,92.0,CHEMBL203,Homo sapiens,IC50,uM,0.092
11279,25073527,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5285503,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
11280,25073528,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282716,=,nM,32.0,CHEMBL203,Homo sapiens,IC50,uM,0.032
11281,25073529,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5281446,=,nM,2400.0,CHEMBL203,Homo sapiens,IC50,uM,2.4
11282,25073530,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5280589,=,nM,40.0,CHEMBL203,Homo sapiens,IC50,uM,0.04
11283,25073531,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL5282118,=,nM,27.0,CHEMBL203,Homo sapiens,IC50,uM,0.027
11284,25073532,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL553,=,nM,2600.0,CHEMBL203,Homo sapiens,IC50,uM,2.6
11285,25073533,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL939,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
11286,25073534,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL1173655,=,nM,10.0,CHEMBL203,Homo sapiens,IC50,uM,0.01
11287,25073535,CHEMBL5253705,Inhibition of EGFR L858R/T790M double mutant autophosphorylation in human NCI-H1975 cells harboring harboring EGFR L858R/T790M double mutant preincubated for 60 mins followed by EGF stimulation and measured after 8 mins by SULFO-TAG based electrochemiluminescent assay,B,CHEMBL3353410,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
11288,25078681,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5282641,=,nM,0.053,CHEMBL203,Homo sapiens,IC50,nM,0.053
11289,25078682,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5280967,=,nM,0.24,CHEMBL203,Homo sapiens,IC50,nM,0.24
11290,25078683,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5281167,=,nM,0.551,CHEMBL203,Homo sapiens,IC50,nM,0.551
11291,25078684,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5286007,=,nM,1.79,CHEMBL203,Homo sapiens,IC50,nM,1.79
11292,25078685,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5284701,=,nM,18.9,CHEMBL203,Homo sapiens,IC50,nM,18.9
11293,25078686,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5273261,=,nM,83.5,CHEMBL203,Homo sapiens,IC50,nM,83.5
11294,25078687,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5281140,=,nM,1.21,CHEMBL203,Homo sapiens,IC50,nM,1.21
11295,25078688,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5266601,=,nM,10.8,CHEMBL203,Homo sapiens,IC50,nM,10.8
11296,25078689,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5281205,=,nM,1.67,CHEMBL203,Homo sapiens,IC50,nM,1.67
11297,25078690,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5280664,=,nM,1.04,CHEMBL203,Homo sapiens,IC50,nM,1.04
11298,25078691,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5290095,=,nM,227.0,CHEMBL203,Homo sapiens,IC50,nM,227.0
11299,25078692,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5270309,=,nM,272.0,CHEMBL203,Homo sapiens,IC50,nM,272.0
11300,25078693,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5272004,=,nM,38.9,CHEMBL203,Homo sapiens,IC50,nM,38.9
11301,25078694,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5288888,=,nM,0.027,CHEMBL203,Homo sapiens,IC50,nM,0.027
11302,25078695,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5268781,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
11303,25078696,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5274692,=,nM,0.153,CHEMBL203,Homo sapiens,IC50,nM,0.153
11304,25078697,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5271930,=,nM,0.403,CHEMBL203,Homo sapiens,IC50,nM,0.403
11305,25078698,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5266649,=,nM,1.67,CHEMBL203,Homo sapiens,IC50,nM,1.67
11306,25078699,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5288249,=,nM,10.7,CHEMBL203,Homo sapiens,IC50,nM,10.7
11307,25078700,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5270938,=,nM,1.21,CHEMBL203,Homo sapiens,IC50,nM,1.21
11308,25078701,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5290971,=,nM,227.0,CHEMBL203,Homo sapiens,IC50,nM,227.0
11309,25078702,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5281741,=,nM,0.817,CHEMBL203,Homo sapiens,IC50,nM,0.817
11310,25078703,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5283507,=,nM,1.53,CHEMBL203,Homo sapiens,IC50,nM,1.53
11311,25078704,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5277739,=,nM,0.81,CHEMBL203,Homo sapiens,IC50,nM,0.81
11312,25078705,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL5281748,=,nM,12.8,CHEMBL203,Homo sapiens,IC50,nM,12.8
11313,25078706,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL3545154,=,nM,0.061,CHEMBL203,Homo sapiens,IC50,nM,0.061
11314,25078707,CHEMBL5255138,Inhibition of EGFR D770-N771 ins NPG mutant (unknown origin),B,CHEMBL1173655,=,nM,0.166,CHEMBL203,Homo sapiens,IC50,nM,0.166
11315,25078762,CHEMBL5255141,Inhibition of wild type EGFR (unknown origin),B,CHEMBL3545154,=,nM,0.137,CHEMBL203,Homo sapiens,IC50,nM,0.137
11316,25078763,CHEMBL5255141,Inhibition of wild type EGFR (unknown origin),B,CHEMBL1173655,=,nM,0.641,CHEMBL203,Homo sapiens,IC50,nM,0.641
11317,25078764,CHEMBL5255141,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5282641,=,nM,0.34,CHEMBL203,Homo sapiens,IC50,nM,0.34
11318,25078765,CHEMBL5255141,Inhibition of wild type EGFR (unknown origin),B,CHEMBL5288888,=,nM,0.406,CHEMBL203,Homo sapiens,IC50,nM,0.406
11319,25078766,CHEMBL5255142,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL3545154,=,nM,0.151,CHEMBL203,Homo sapiens,IC50,nM,0.151
11320,25078767,CHEMBL5255142,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL1173655,=,nM,0.259,CHEMBL203,Homo sapiens,IC50,nM,0.259
11321,25078768,CHEMBL5255142,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5282641,=,nM,0.053,CHEMBL203,Homo sapiens,IC50,nM,0.053
11322,25078769,CHEMBL5255142,Inhibition of EGFR L858R mutant (unknown origin),B,CHEMBL5288888,=,nM,0.112,CHEMBL203,Homo sapiens,IC50,nM,0.112
11323,25078774,CHEMBL5255144,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL3545154,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,nM,197.0
11324,25078775,CHEMBL5255144,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL1173655,=,nM,212.0,CHEMBL203,Homo sapiens,IC50,nM,212.0
11325,25078776,CHEMBL5255144,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5282641,=,nM,492.0,CHEMBL203,Homo sapiens,IC50,nM,492.0
11326,25078777,CHEMBL5255144,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin),B,CHEMBL5288888,=,nM,818.0,CHEMBL203,Homo sapiens,IC50,nM,818.0
11327,25078782,CHEMBL5255146,Inhibition of EGFR A763-Y764 ins FQEA mutant (unknown origin),B,CHEMBL3545154,=,nM,0.262,CHEMBL203,Homo sapiens,IC50,nM,0.262
11328,25078783,CHEMBL5255146,Inhibition of EGFR A763-Y764 ins FQEA mutant (unknown origin),B,CHEMBL1173655,=,nM,0.161,CHEMBL203,Homo sapiens,IC50,nM,0.161
11329,25078784,CHEMBL5255146,Inhibition of EGFR A763-Y764 ins FQEA mutant (unknown origin),B,CHEMBL5282641,=,nM,0.097,CHEMBL203,Homo sapiens,IC50,nM,0.097
11330,25078785,CHEMBL5255146,Inhibition of EGFR A763-Y764 ins FQEA mutant (unknown origin),B,CHEMBL5288888,=,nM,0.116,CHEMBL203,Homo sapiens,IC50,nM,0.116
11331,25084778,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5265881,=,nM,1.2,CHEMBL203,Homo sapiens,IC50,nM,1.2
11332,25084779,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5291403,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
11333,25084780,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5289003,=,nM,111.0,CHEMBL203,Homo sapiens,IC50,nM,111.0
11334,25084781,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5291034,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
11335,25084782,CHEMBL5256648,Inhibition of recombinant human EGFR del19/T790M using biotinEEPLYWSFPAKKK-NH2 as substrate incubated for 120 mins by TR-FRET assay,B,CHEMBL5272088,=,nM,741.0,CHEMBL203,Homo sapiens,IC50,nM,741.0
11336,25086625,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5287042,=,nM,134.0,CHEMBL203,Homo sapiens,IC50,nM,134.0
11337,25086626,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5287016,=,nM,117.0,CHEMBL203,Homo sapiens,IC50,nM,117.0
11338,25086627,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5289560,=,nM,94.0,CHEMBL203,Homo sapiens,IC50,nM,94.0
11339,25086628,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5280635,=,nM,85.0,CHEMBL203,Homo sapiens,IC50,nM,85.0
11340,25086629,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL553,=,nM,80.0,CHEMBL203,Homo sapiens,IC50,nM,80.0
11341,25086630,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5281464,=,nM,89.0,CHEMBL203,Homo sapiens,IC50,nM,89.0
11342,25086631,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5267773,=,nM,93.0,CHEMBL203,Homo sapiens,IC50,nM,93.0
11343,25086632,CHEMBL5256977,Inhibition of EGFR (unknown origin),B,CHEMBL5280144,=,nM,98.0,CHEMBL203,Homo sapiens,IC50,nM,98.0
11344,25089030,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5275872,=,nM,500.0,CHEMBL203,Homo sapiens,IC50,uM,0.5
11345,25089031,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5279636,=,nM,70.0,CHEMBL203,Homo sapiens,IC50,uM,0.07
11346,25089032,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5285192,=,nM,3200.0,CHEMBL203,Homo sapiens,IC50,uM,3.2
11347,25089033,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5286853,=,nM,4600.0,CHEMBL203,Homo sapiens,IC50,uM,4.6
11348,25089034,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5278115,=,nM,2100.0,CHEMBL203,Homo sapiens,IC50,uM,2.1
11349,25089035,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5279992,=,nM,8400.0,CHEMBL203,Homo sapiens,IC50,uM,8.4
11350,25089036,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5287962,=,nM,4200.0,CHEMBL203,Homo sapiens,IC50,uM,4.2
11351,25089037,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5281589,=,nM,2000.0,CHEMBL203,Homo sapiens,IC50,uM,2.0
11352,25089038,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5281118,=,nM,1900.0,CHEMBL203,Homo sapiens,IC50,uM,1.9
11353,25089039,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL5271106,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
11354,25089040,CHEMBL5257509,Inhibition of recombinant 6His-tagged EGFR cytoplasmic domain (645 to 1186 residues) (unknown origin) autophosphorylation expressed in baculovirus infected Sf9 insect cells preincubated for 10 mins followed by ATP and MgCl2 addition measured after 60 mins by DELFIA/time-resolved fluorometric analysis,B,CHEMBL553,=,nM,50.0,CHEMBL203,Homo sapiens,IC50,uM,0.05
11355,25091634,CHEMBL5258450,Inhibition of EGFR (unknown origin) incubated for 1 hr in presence of ATP by Z'LYTE assay,B,CHEMBL1873475,=,nM,5.3,CHEMBL203,Homo sapiens,IC50,nM,5.3
11356,25091695,CHEMBL5258481,Inhibition of EGFR (unknown origin) by Z'LYTE assay,B,CHEMBL5271284,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,nM,197.0
11357,25093832,CHEMBL5259434,Inhibition of EGFR (unknown origin) by fluorimetric assay,B,CHEMBL1336,=,nM,110.0,CHEMBL203,Homo sapiens,IC50,uM,0.11
11358,25093833,CHEMBL5259434,Inhibition of EGFR (unknown origin) by fluorimetric assay,B,CHEMBL5276173,=,nM,131.0,CHEMBL203,Homo sapiens,IC50,uM,0.131
11359,25093834,CHEMBL5259434,Inhibition of EGFR (unknown origin) by fluorimetric assay,B,CHEMBL5269071,=,nM,143.0,CHEMBL203,Homo sapiens,IC50,uM,0.143
11360,25093835,CHEMBL5259434,Inhibition of EGFR (unknown origin) by fluorimetric assay,B,CHEMBL5282535,=,nM,9202.0,CHEMBL203,Homo sapiens,IC50,uM,9.202
11361,25094726,CHEMBL5259685,Inhibition of EGFR L858R/T790M double mutant (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL5284780,=,nM,1.08,CHEMBL203,Homo sapiens,IC50,nM,1.08
11362,25094727,CHEMBL5259685,Inhibition of EGFR L858R/T790M double mutant (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL3353410,=,nM,0.3,CHEMBL203,Homo sapiens,IC50,nM,0.3
11363,25094728,CHEMBL5259686,Inhibition of wild type EGFR (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL1173655,=,nM,0.08,CHEMBL203,Homo sapiens,IC50,nM,0.08
11364,25094729,CHEMBL5259686,Inhibition of wild type EGFR (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL5284780,=,nM,23.25,CHEMBL203,Homo sapiens,IC50,nM,23.25
11365,25094730,CHEMBL5259686,Inhibition of wild type EGFR (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL3353410,=,nM,14.67,CHEMBL203,Homo sapiens,IC50,nM,14.67
11366,25094731,CHEMBL5259687,Inhibition of EGFR Del19 mutant (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL5284780,=,nM,0.72,CHEMBL203,Homo sapiens,IC50,nM,0.72
11367,25094732,CHEMBL5259687,Inhibition of EGFR Del19 mutant (unknown origin) pre-incubated for 10 mins followed by substrate addition measured after 60 mins in presence of ATP by mobility shifting assay,B,CHEMBL3353410,=,nM,0.7,CHEMBL203,Homo sapiens,IC50,nM,0.7
11368,25098067,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5270693,=,nM,0.008,CHEMBL203,Homo sapiens,IC50,nM,0.008
11369,25098068,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5280082,=,nM,0.4,CHEMBL203,Homo sapiens,IC50,nM,0.4
11370,25098069,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5285308,=,nM,34.0,CHEMBL203,Homo sapiens,IC50,nM,34.0
11371,25098070,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5289859,=,nM,0.16,CHEMBL203,Homo sapiens,IC50,nM,0.16
11372,25098071,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5284924,=,nM,0.053,CHEMBL203,Homo sapiens,IC50,nM,0.053
11373,25098072,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL3545311,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
11374,25098073,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5285052,=,nM,0.28,CHEMBL203,Homo sapiens,IC50,nM,0.28
11375,25098074,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL553,=,nM,0.029,CHEMBL203,Homo sapiens,IC50,nM,0.029
11376,25098075,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5288276,=,nM,0.86,CHEMBL203,Homo sapiens,IC50,nM,0.86
11377,25098076,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5287229,=,nM,0.35,CHEMBL203,Homo sapiens,IC50,nM,0.35
11378,25098077,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5275642,=,nM,1.0,CHEMBL203,Homo sapiens,IC50,nM,1.0
11379,25098078,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5278657,=,nM,5.2,CHEMBL203,Homo sapiens,IC50,nM,5.2
11380,25098079,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL5269375,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,nM,23.0
11381,25098080,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL4650319,=,nM,0.025,CHEMBL203,Homo sapiens,IC50,nM,0.025
11382,25098081,CHEMBL5260455,Inhibition of wild type EGFR (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 25 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.24,CHEMBL203,Homo sapiens,IC50,nM,0.24
11383,25098082,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL5275642,=,nM,0.17,CHEMBL203,Homo sapiens,IC50,nM,0.17
11384,25098083,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL5278657,=,nM,0.68,CHEMBL203,Homo sapiens,IC50,nM,0.68
11385,25098084,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL5269375,=,nM,3.4,CHEMBL203,Homo sapiens,IC50,nM,3.4
11386,25098085,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL5285308,=,nM,5.4,CHEMBL203,Homo sapiens,IC50,nM,5.4
11387,25098086,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL4650319,=,nM,0.01,CHEMBL203,Homo sapiens,IC50,nM,0.01
11388,25098087,CHEMBL5260456,Inhibition of EGFR L858R mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 15 mins by HTRF assay,B,CHEMBL3353410,=,nM,0.05,CHEMBL203,Homo sapiens,IC50,nM,0.05
11389,25098088,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL3545311,=,nM,11.0,CHEMBL203,Homo sapiens,IC50,nM,11.0
11390,25098089,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5285052,=,nM,0.15,CHEMBL203,Homo sapiens,IC50,nM,0.15
11391,25098090,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL553,=,nM,0.059,CHEMBL203,Homo sapiens,IC50,nM,0.059
11392,25098091,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5288276,=,nM,3.0,CHEMBL203,Homo sapiens,IC50,nM,3.0
11393,25098092,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5287229,=,nM,0.56,CHEMBL203,Homo sapiens,IC50,nM,0.56
11394,25098093,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5270693,=,nM,0.02,CHEMBL203,Homo sapiens,IC50,nM,0.02
11395,25098094,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5280082,=,nM,0.42,CHEMBL203,Homo sapiens,IC50,nM,0.42
11396,25098095,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5289859,=,nM,0.32,CHEMBL203,Homo sapiens,IC50,nM,0.32
11397,25098096,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5284924,=,nM,0.064,CHEMBL203,Homo sapiens,IC50,nM,0.064
11398,25098097,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5275642,=,nM,1.6,CHEMBL203,Homo sapiens,IC50,nM,1.6
11399,25098098,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5278657,=,nM,17.0,CHEMBL203,Homo sapiens,IC50,nM,17.0
11400,25098099,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5269375,=,nM,73.0,CHEMBL203,Homo sapiens,IC50,nM,73.0
11401,25098100,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL5285308,=,nM,125.0,CHEMBL203,Homo sapiens,IC50,nM,125.0
11402,25098101,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL4650319,=,nM,25.0,CHEMBL203,Homo sapiens,IC50,nM,25.0
11403,25098102,CHEMBL5260457,Inhibition of EGFR L858R/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 20 mins by HTRF assay,B,CHEMBL3353410,=,nM,354.0,CHEMBL203,Homo sapiens,IC50,nM,354.0
11404,25098103,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5270693,=,nM,0.64,CHEMBL203,Homo sapiens,IC50,nM,0.64
11405,25098104,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5280082,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,nM,19.0
11406,25098105,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL3353410,=,nM,151.0,CHEMBL203,Homo sapiens,IC50,nM,151.0
11407,25098106,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5289859,=,nM,15.0,CHEMBL203,Homo sapiens,IC50,nM,15.0
11408,25098107,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5284924,=,nM,8.8,CHEMBL203,Homo sapiens,IC50,nM,8.8
11409,25098108,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5275642,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,nM,35.0
11410,25098109,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL4650319,=,nM,364.0,CHEMBL203,Homo sapiens,IC50,nM,364.0
11411,25098110,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL3545311,=,nM,1.3,CHEMBL203,Homo sapiens,IC50,nM,1.3
11412,25098111,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5285052,=,nM,6.2,CHEMBL203,Homo sapiens,IC50,nM,6.2
11413,25098112,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL553,=,nM,313.0,CHEMBL203,Homo sapiens,IC50,nM,313.0
11414,25098113,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5288276,=,nM,78.0,CHEMBL203,Homo sapiens,IC50,nM,78.0
11415,25098114,CHEMBL5260458,Inhibition of EGFR L858R/T790M/C797S mutant (unknown origin) using TK-substrate preincubated with enzyme for 30 mins followed by substrate and ATP addition for 10 mins by HTRF assay,B,CHEMBL5287229,=,nM,12.0,CHEMBL203,Homo sapiens,IC50,nM,12.0
11416,25104807,CHEMBL5262914,Inhibition of EGFR (unknown origin),B,CHEMBL185853,=,nM,1440.0,CHEMBL203,Homo sapiens,IC50,uM,1.44
11417,25104808,CHEMBL5262914,Inhibition of EGFR (unknown origin),B,CHEMBL188522,=,nM,66.0,CHEMBL203,Homo sapiens,IC50,uM,0.066
11418,25104809,CHEMBL5262914,Inhibition of EGFR (unknown origin),B,CHEMBL184750,=,nM,405.0,CHEMBL203,Homo sapiens,IC50,uM,0.405
11419,25104811,CHEMBL5262914,Inhibition of EGFR (unknown origin),B,CHEMBL186001,=,nM,23.0,CHEMBL203,Homo sapiens,IC50,uM,0.023
11420,25105694,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5284972,=,nM,46.0,CHEMBL203,Homo sapiens,IC50,uM,0.046
11421,25105695,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267338,=,nM,220.0,CHEMBL203,Homo sapiens,IC50,uM,0.22
11422,25105696,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5282227,=,nM,121.0,CHEMBL203,Homo sapiens,IC50,uM,0.121
11423,25105697,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272096,=,nM,906.0,CHEMBL203,Homo sapiens,IC50,uM,0.906
11424,25105698,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5270506,=,nM,155.0,CHEMBL203,Homo sapiens,IC50,uM,0.155
11425,25105699,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5198664,=,nM,171.0,CHEMBL203,Homo sapiens,IC50,uM,0.171
11426,25105700,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5271043,=,nM,181.0,CHEMBL203,Homo sapiens,IC50,uM,0.181
11427,25105701,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5287550,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
11428,25105702,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267161,=,nM,140.0,CHEMBL203,Homo sapiens,IC50,uM,0.14
11429,25105703,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5287295,=,nM,19.0,CHEMBL203,Homo sapiens,IC50,uM,0.019
11430,25105704,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5277940,=,nM,39.0,CHEMBL203,Homo sapiens,IC50,uM,0.039
11431,25105705,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5173070,=,nM,43.0,CHEMBL203,Homo sapiens,IC50,uM,0.043
11432,25105706,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5288264,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
11433,25105707,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272533,=,nM,21.0,CHEMBL203,Homo sapiens,IC50,uM,0.021
11434,25105708,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5274133,=,nM,35.0,CHEMBL203,Homo sapiens,IC50,uM,0.035
11435,25105709,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5280953,=,nM,6000.0,CHEMBL203,Homo sapiens,IC50,uM,6.0
11436,25105710,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5275932,=,nM,8600.0,CHEMBL203,Homo sapiens,IC50,uM,8.6
11437,25105711,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5275574,=,nM,7800.0,CHEMBL203,Homo sapiens,IC50,uM,7.8
11438,25105712,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272206,=,nM,236.0,CHEMBL203,Homo sapiens,IC50,uM,0.236
11439,25105713,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL2347958,=,nM,1000.0,CHEMBL203,Homo sapiens,IC50,uM,1.0
11440,25105714,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL1229592,=,nM,7000.0,CHEMBL203,Homo sapiens,IC50,uM,7.0
11441,25105715,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5289059,=,nM,200.0,CHEMBL203,Homo sapiens,IC50,uM,0.2
11442,25105716,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5286092,=,nM,16.4,CHEMBL203,Homo sapiens,IC50,nM,16.4
11443,25105717,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5291434,=,nM,2.7,CHEMBL203,Homo sapiens,IC50,nM,2.7
11444,25105718,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272858,=,nM,27.8,CHEMBL203,Homo sapiens,IC50,nM,27.8
11445,25105719,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5270334,=,nM,4.1,CHEMBL203,Homo sapiens,IC50,nM,4.1
11446,25105720,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5271151,=,nM,0.6,CHEMBL203,Homo sapiens,IC50,nM,0.6
11447,25105721,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5265870,=,nM,27.7,CHEMBL203,Homo sapiens,IC50,nM,27.7
11448,25105722,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5269747,=,nM,3.2,CHEMBL203,Homo sapiens,IC50,nM,3.2
11449,25105723,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5286080,=,nM,8.4,CHEMBL203,Homo sapiens,IC50,nM,8.4
11450,25105724,CHEMBL5263205,Inhibition of EGFR L858R/T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL3353410,=,nM,3.3,CHEMBL203,Homo sapiens,IC50,nM,3.3
11451,25105725,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5284972,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,uM,0.105
11452,25105726,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267338,=,nM,100.0,CHEMBL203,Homo sapiens,IC50,uM,0.1
11453,25105727,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5282227,=,nM,102.0,CHEMBL203,Homo sapiens,IC50,uM,0.102
11454,25105729,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5270506,=,nM,224.0,CHEMBL203,Homo sapiens,IC50,uM,0.224
11455,25105730,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5198664,=,nM,197.0,CHEMBL203,Homo sapiens,IC50,uM,0.197
11456,25105731,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5271043,=,nM,232.0,CHEMBL203,Homo sapiens,IC50,uM,0.232
11457,25105732,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5287550,=,nM,53.0,CHEMBL203,Homo sapiens,IC50,uM,0.053
11458,25105733,CHEMBL5263206,Inhibition of EGFR T790M mutant (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267161,=,nM,105.0,CHEMBL203,Homo sapiens,IC50,uM,0.105
11459,25105734,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5284972,=,nM,557.0,CHEMBL203,Homo sapiens,IC50,uM,0.557
11460,25105735,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267338,=,nM,49.0,CHEMBL203,Homo sapiens,IC50,uM,0.049
11461,25105742,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5267161,=,nM,127.0,CHEMBL203,Homo sapiens,IC50,uM,0.127
11462,25105743,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5287295,=,nM,1400.0,CHEMBL203,Homo sapiens,IC50,uM,1.4
11463,25105744,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5277940,=,nM,393.0,CHEMBL203,Homo sapiens,IC50,uM,0.393
11464,25105745,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5173070,=,nM,1100.0,CHEMBL203,Homo sapiens,IC50,uM,1.1
11465,25105746,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5288264,=,nM,325.0,CHEMBL203,Homo sapiens,IC50,uM,0.325
11466,25105747,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272533,=,nM,1300.0,CHEMBL203,Homo sapiens,IC50,uM,1.3
11467,25105748,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5274133,=,nM,6800.0,CHEMBL203,Homo sapiens,IC50,uM,6.8
11468,25105749,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5280953,=,nM,14300.0,CHEMBL203,Homo sapiens,IC50,uM,14.3
11469,25105750,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5275932,=,nM,5700.0,CHEMBL203,Homo sapiens,IC50,uM,5.7
11470,25105752,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272206,=,nM,408.0,CHEMBL203,Homo sapiens,IC50,uM,0.408
11471,25105753,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL2347958,=,nM,3700.0,CHEMBL203,Homo sapiens,IC50,uM,3.7
11472,25105754,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL1229592,=,nM,223900.0,CHEMBL203,Homo sapiens,IC50,uM,223.9
11473,25105755,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5289059,=,nM,8.7,CHEMBL203,Homo sapiens,IC50,nM,8.7
11474,25105756,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5286092,=,nM,233.8,CHEMBL203,Homo sapiens,IC50,nM,233.8
11475,25105757,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5291434,=,nM,92.1,CHEMBL203,Homo sapiens,IC50,nM,92.1
11476,25105758,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5272858,=,nM,414.1,CHEMBL203,Homo sapiens,IC50,nM,414.1
11477,25105759,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5270334,=,nM,280.4,CHEMBL203,Homo sapiens,IC50,nM,280.4
11478,25105760,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5271151,=,nM,26.2,CHEMBL203,Homo sapiens,IC50,nM,26.2
11479,25105761,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5265870,=,nM,465.7,CHEMBL203,Homo sapiens,IC50,nM,465.7
11480,25105762,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5269747,=,nM,202.5,CHEMBL203,Homo sapiens,IC50,nM,202.5
11481,25105763,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL5286080,=,nM,26.9,CHEMBL203,Homo sapiens,IC50,nM,26.9
11482,25105764,CHEMBL5263207,Inhibition of wild type EGFR (unknown origin) expressed in baculovirus expression system by ELISA,B,CHEMBL3353410,=,nM,228.9,CHEMBL203,Homo sapiens,IC50,nM,228.9
11483,25106404,CHEMBL5263429,"Inhibition of EGFR (unknown origin) using (Glu, Tyr) 4:1 as substrate incubated for [gamma-32P]-ATP incubated for 60 mins by scintillation counter analysis",B,CHEMBL244948,=,nM,7670.0,CHEMBL203,Homo sapiens,IC50,uM,7.67
11484,25109727,CHEMBL5264736,Inhibition of human EGFR L858R mutant (669 to 1210 residues) expressed in Sf21 insect cells using 5-FAM-EEPLYWSFPAKKK-CONH2 as substrate incubated for 60 mins,B,CHEMBL1173655,=,nM,0.85,CHEMBL203,Homo sapiens,IC50,nM,0.85
